Clustering O 0 2.183264541599783e-06
of O 0 3.051818850963173e-07
missense O 0 1.3290620870520797e-07
mutations O 0 3.039611673472109e-09
in O 0 2.2205595140434298e-09
the O 0 1.4748491139471298e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 8.571566922910279e-08
in O 0 6.411443043141674e-10
a O 0 4.318138902004165e-10
sporadic B-Disease 0 0.00010627369192661718
T I-Disease 1 1.0
- I-Disease 1 0.8463163375854492
cell I-Disease 0 0.24677275121212006
leukaemia I-Disease 1 0.9999876022338867
. O 0 1.6213991926861127e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.022045575082302094
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.817230196494052e-10
is O 0 2.0860594068111693e-12
a O 0 7.439808318021601e-12
recessive B-Disease 0 4.616760662656816e-08
multi I-Disease 1 0.9545239210128784
- I-Disease 1 0.9999457597732544
system I-Disease 1 0.9999973773956299
disorder I-Disease 1 1.0
caused O 0 1.895516188454849e-09
by O 0 3.4790889787139623e-12
mutations O 0 1.1814341172033949e-11
in O 0 1.2661793488688566e-11
the O 0 2.6397359298435674e-10
ATM O 0 2.6879435608861968e-05
gene O 0 8.062396972263741e-09
at O 0 3.246512747523411e-08
11q22 O 0 1.0956537153106183e-06
- O 0 5.311316044753767e-07
q23 O 0 1.6829399100970477e-06
( O 0 6.63996746474993e-10
ref O 0 2.6931388674711343e-07
. O 0 1.528103060755015e-10
3 O 0 6.334503144245218e-09
) O 0 4.7979911710349654e-11
. O 0 2.191651304883635e-10

The O 0 1.3747340688041731e-07
risk O 0 4.2679818790247737e-08
of O 0 4.236537733959267e-07
cancer B-Disease 0 5.2846397011308e-05
, O 0 2.077262944988334e-10
especially O 0 1.9299548625895113e-09
lymphoid B-Disease 0 1.306815192947397e-05
neoplasias I-Disease 0 0.01358447503298521
, O 0 1.044043851372578e-09
is O 0 1.238659088492744e-11
substantially O 0 2.8885577263437767e-10
elevated O 0 6.846307201158197e-07
in O 0 1.9585767674357157e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 8.555119279662904e-08
and O 0 1.1600675281497885e-10
has O 0 1.3598709831807998e-12
long O 0 1.5982235066630546e-12
been O 0 7.370258374959915e-13
associated O 0 8.267258405636468e-11
with O 0 1.0104793668475054e-09
chromosomal O 1 1.0
instability O 1 1.0
. O 0 1.0022016283528501e-07

By O 0 4.5667332138066286e-09
analysing O 0 2.8074189231119817e-06
tumour B-Disease 1 1.0
DNA O 0 2.8162248781882226e-06
from O 0 6.332361301986111e-10
patients O 0 4.903133107858615e-11
with O 0 7.135604607189094e-12
sporadic B-Disease 0 1.4191255104378797e-05
T I-Disease 1 0.9999995231628418
- I-Disease 0 0.00018815371731761843
cell I-Disease 0 3.860513970721513e-05
prolymphocytic I-Disease 1 0.999860405921936
leukaemia I-Disease 1 0.9999996423721313
( O 0 3.8678948044434946e-08
T B-Disease 1 0.9999991655349731
- I-Disease 0 0.00033211251138709486
PLL I-Disease 1 0.9999983310699463
) O 0 1.325056037115857e-10
, O 0 7.205258525239122e-12
a O 0 6.545027107091039e-12
rare O 0 5.761668364634431e-10
clonal B-Disease 0 1.880780587271147e-06
malignancy I-Disease 0 1.4128086149867158e-05
with O 0 4.9085881193011716e-11
similarities O 0 5.744922315642498e-10
to O 0 2.5163471306655083e-10
a O 0 2.0489554497515883e-09
mature B-Disease 0 4.880662913819833e-07
T I-Disease 1 0.9999920129776001
- I-Disease 0 0.0003043357573915273
cell I-Disease 0 1.9190383682143874e-05
leukaemia I-Disease 0 0.01684999279677868
seen O 0 1.5516824491967895e-09
in O 0 6.1103311299604e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 5.323378959865011e-10
we O 0 1.4412029512508862e-12
demonstrate O 0 7.859278332300601e-12
a O 0 7.8236028766554e-13
high O 0 1.9531159675678644e-11
frequency O 0 1.694189927237133e-11
of O 0 9.139228956955847e-11
ATM O 0 8.124562214106845e-07
mutations O 0 5.744793973860851e-09
in O 0 2.7648082934206286e-08
T B-Disease 1 0.9999997615814209
- I-Disease 0 0.0017384224338456988
PLL I-Disease 1 0.9981160163879395
. O 0 1.3281645117046992e-08

In O 0 4.729073133091788e-09
marked O 0 1.4418292115792042e-09
contrast O 0 9.231381631336077e-11
to O 0 1.2506333642303691e-11
the O 0 1.2808316907086947e-10
ATM O 0 4.498805083130719e-06
mutation O 0 2.2099753138604683e-09
pattern O 0 8.325339528880704e-09
in O 0 1.1834786484143933e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 4.584709001331788e-10
the O 0 1.2842729484041637e-11
most O 0 1.1637045493895215e-13
frequent O 0 6.234878607326577e-13
nucleotide O 0 1.8586037223156104e-11
changes O 0 2.0557245142271974e-12
in O 0 5.3035605421247745e-12
this O 0 1.6149237979865005e-12
leukaemia B-Disease 0 1.7372050251651672e-06
were O 0 9.753690077829447e-10
missense O 0 2.8737923685184796e-07
mutations O 0 7.900202803057255e-08
. O 0 1.71569372042768e-08

These O 0 2.5674231629579936e-09
clustered O 0 4.214253479517538e-08
in O 0 1.339254401822032e-10
the O 0 1.5160665778335414e-10
region O 0 2.0459708927056397e-10
corresponding O 0 7.491487291622079e-11
to O 0 1.1519177105234757e-11
the O 0 7.784166367041934e-11
kinase O 0 7.481990721425191e-11
domain O 0 2.9016044775231897e-11
, O 0 1.2442205469045953e-12
which O 0 2.293045581972658e-13
is O 0 6.319884258932859e-14
highly O 0 8.705917063644986e-12
conserved O 0 5.3145706585544517e-11
in O 0 1.646553032808029e-11
ATM O 0 4.333614072038472e-07
- O 0 5.9569607024911875e-09
related O 0 1.9986989840958813e-09
proteins O 0 2.38154686943437e-11
in O 0 1.6701977301192272e-10
mouse O 0 1.5130429131815504e-09
, O 0 2.915356844823691e-11
yeast O 0 9.36932198492002e-10
and O 0 9.130817768543409e-10
Drosophila O 0 6.791552209506335e-08
. O 0 1.5707160017086608e-09

The O 0 2.4370370610427017e-08
resulting O 0 8.978415344529367e-09
amino O 0 5.9784279748953395e-09
- O 0 1.0547164031038392e-08
acid O 0 6.595021195821005e-10
substitutions O 0 4.223247529466789e-09
are O 0 3.5583066441274847e-12
predicted O 0 1.0319427951044347e-10
to O 0 1.5619221194196342e-11
interfere O 0 2.563405709921085e-09
with O 0 4.872268699607218e-10
ATP O 1 0.9999994039535522
binding O 0 1.0603400824038545e-08
or O 0 5.908818989652787e-10
substrate O 0 1.1346058315098162e-08
recognition O 0 8.262285078330933e-09
. O 0 7.059521855978801e-09

Two O 0 2.3615845279323366e-08
of O 0 2.309654973942088e-07
seventeen O 0 8.932963169172581e-07
mutated O 0 1.550723823129374e-06
T B-Disease 1 0.7371272444725037
- I-Disease 0 3.5414318517723586e-06
PLL I-Disease 0 0.0002832588506862521
samples O 0 3.807999693350439e-09
had O 0 2.420140129966164e-11
a O 0 1.2574381640095833e-11
previously O 0 3.109515145371944e-10
reported O 0 4.5774939394505054e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 1.1363864871327678e-07
. O 0 8.397169182217112e-09

In O 0 9.01862939883813e-09
contrast O 0 1.6166149530150165e-09
, O 0 8.352465941108278e-11
no O 0 3.173045159954313e-11
mutations O 0 4.158212316140997e-11
were O 0 7.969248871919632e-11
detected O 0 9.50888368045355e-10
in O 0 1.8161101095204302e-11
the O 0 2.9809082285892075e-11
p53 O 0 6.208707159505167e-11
gene O 0 1.7475833280489184e-10
, O 0 5.24407253732484e-12
suggesting O 0 2.3377300095717146e-11
that O 0 3.5236307686752066e-13
this O 0 3.851492909323628e-12
tumour B-Disease 1 1.0
suppressor O 0 1.0355031321296337e-07
is O 0 4.4579947372502815e-12
not O 0 3.151593569450384e-13
frequently O 0 8.880166567359904e-12
altered O 0 5.535935043710083e-10
in O 0 8.658428835017773e-11
this O 0 3.995451886007473e-11
leukaemia B-Disease 0 0.00010221364937024191
. O 0 4.161595956730935e-09

Occasional O 0 9.8909242751688e-07
missense O 0 5.002154921385227e-07
mutations O 0 1.7281404085522922e-09
in O 0 3.960642924738522e-10
ATM O 0 3.705482185978326e-06
were O 0 5.7911542228339385e-09
also O 0 2.6306574973933294e-11
found O 0 2.120451383924582e-11
in O 0 9.161324476814059e-11
tumour B-Disease 1 0.9999996423721313
DNA O 0 6.683619631075999e-07
from O 0 4.479367154974767e-10
patients O 0 7.521869932469727e-11
with O 0 7.208850877349349e-11
B B-Disease 0 0.02000771090388298
- I-Disease 0 7.615082608936063e-07
cell I-Disease 0 1.2797971749023418e-06
non I-Disease 1 0.8949878811836243
- I-Disease 1 0.999969482421875
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999911785125732
( O 0 4.408232889829833e-09
B B-Disease 0 1.3198407032177784e-05
- I-Disease 0 2.2809940602996903e-08
NHL I-Disease 0 2.6419447749503888e-05
) O 0 4.5759420558288966e-12
and O 0 1.1181817624605905e-11
a O 0 1.7704578081367828e-10
B B-Disease 0 6.852115348010557e-06
- I-Disease 0 1.0776795278388818e-07
NHL I-Disease 0 0.018459219485521317
cell O 0 6.87858459968993e-07
line O 0 2.731855488491419e-07
. O 0 1.7607734159597044e-09

The O 0 1.7943110108831206e-08
evidence O 0 5.368235633795848e-09
of O 0 3.309469809309462e-09
a O 0 1.865230365993842e-11
significant O 0 4.875963782041692e-12
proportion O 0 3.887963562210217e-11
of O 0 1.091193246871569e-09
loss O 0 6.487160675305859e-08
- O 0 5.8912025480140073e-08
of O 0 8.316074939784812e-08
- O 0 1.1123167276139156e-08
function O 0 4.636261860535562e-12
mutations O 0 1.3188173643430279e-11
and O 0 5.613238172885726e-12
a O 0 4.75752813880459e-12
complete O 0 6.545895492315879e-10
absence O 0 2.823309142030439e-09
of O 0 3.264817527437458e-09
the O 0 7.916466787660781e-11
normal O 0 5.401136135563256e-11
copy O 0 6.776717520473596e-10
of O 0 3.867537123891651e-10
ATM O 0 2.1763328561519302e-07
in O 0 7.431274345881533e-11
the O 0 6.182755696304554e-11
majority O 0 5.706584076808907e-12
of O 0 8.121086580992198e-10
mutated O 0 1.7900882198773616e-07
tumours B-Disease 1 1.0
establishes O 0 2.8726820033853073e-08
somatic O 0 1.6177887118828949e-07
inactivation O 0 1.7622076029510936e-06
of O 0 3.195241760067802e-08
this O 0 6.136276382850969e-12
gene O 0 3.97650627703694e-11
in O 0 1.30446504292836e-11
the O 0 2.4152807531763187e-10
pathogenesis O 0 3.18185072956112e-07
of O 0 4.169440259715884e-08
sporadic B-Disease 0 3.569095133570954e-05
T I-Disease 1 0.9999914169311523
- I-Disease 0 4.79157915833639e-06
PLL I-Disease 0 0.2678900957107544
and O 0 1.9916880644732515e-10
suggests O 0 1.4638351295004348e-11
that O 0 1.9251347206910435e-13
ATM O 0 5.668918561241298e-07
acts O 0 3.895808120546462e-08
as O 0 1.0863049348941445e-09
a O 0 9.126417843674517e-09
tumour B-Disease 1 1.0
suppressor O 0 4.137538780923933e-05
. O 0 4.237636375137299e-08

As O 0 6.103811678315196e-09
constitutional O 0 2.7640597366485053e-08
DNA O 0 3.8421350723183423e-07
was O 0 5.219709109383075e-10
not O 0 1.0434623949400965e-13
available O 0 4.7666744683316775e-12
, O 0 2.5960240901401477e-12
a O 0 9.462882734345701e-12
putative O 0 7.605046903336188e-08
hereditary O 1 1.0
predisposition O 1 0.8448519110679626
to O 0 3.309615294710966e-06
T B-Disease 1 1.0
- I-Disease 1 0.9983394145965576
PLL I-Disease 1 0.9999629259109497
will O 0 2.946781013646316e-11
require O 0 2.681079490363114e-11
further O 0 1.500287914735221e-11
investigation O 0 2.9783239763325753e-10
. O 0 3.2246736531016396e-11
. O 0 1.1306124092502756e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 2.3111884672744054e-07
kinase O 0 1.6822975013042196e-08
is O 0 2.8118703546131663e-11
involved O 0 3.0261576664664114e-12
in O 0 2.5039252355557595e-12
the O 0 2.9856865677718725e-12
modulation O 0 2.0810212927879768e-11
of O 0 5.822958781820375e-11
the O 0 1.3398565243405436e-11
Ca2 O 0 1.5459028154807264e-11
+ O 0 1.7181447931058358e-10
homeostasis O 0 2.7899815790988214e-08
in O 0 3.2047859921391364e-09
skeletal O 0 0.00021661219943780452
muscle O 0 4.8199299271800555e-06
cells O 0 1.4516956525767455e-07
. O 0 1.5547049869724106e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8974513411521912
DM B-Disease 1 1.0
) O 0 1.3482800653719096e-08
, O 0 5.600055835719431e-11
the O 0 2.1122853466337688e-11
most O 0 2.8878895802497695e-11
prevalent O 0 0.00019509829871822149
muscular B-Disease 1 1.0
disorder I-Disease 1 0.9999988079071045
in O 0 3.15110715298772e-09
adults O 0 2.4157048583717255e-10
, O 0 4.2030569996631684e-11
is O 0 6.879464446024608e-12
caused O 0 2.950214517127847e-09
by O 0 5.980705930497265e-10
( O 0 1.4340949539004555e-09
CTG O 0 0.00017467451107222587
) O 0 8.484176555745293e-11
n O 0 1.0785889542619387e-10
- O 0 5.823361237666802e-10
repeat O 0 1.2484842326632162e-10
expansion O 0 4.1845152343178427e-11
in O 0 1.675760875549659e-12
a O 0 7.143798898788523e-13
gene O 0 1.0180068593657055e-12
encoding O 0 1.3653859943715818e-12
a O 0 1.707216833179981e-11
protein O 0 5.3092516494324116e-11
kinase O 0 5.48711831527271e-09
( O 0 1.6373942202108083e-09
DM B-Disease 1 1.0
protein O 0 2.0585015914065252e-09
kinase O 0 3.602901088584076e-09
; O 0 1.6600251728782212e-10
DMPK O 1 0.9535660147666931
) O 0 1.3938364351595567e-11
and O 0 1.9553627380458627e-12
involves O 0 5.79883840598483e-12
changes O 0 3.312995277421349e-12
in O 0 2.9238767657036036e-11
cytoarchitecture O 0 2.304409747466707e-07
and O 0 9.290329616717941e-10
ion O 0 2.043274918150928e-07
homeostasis O 0 5.251276888884604e-05
. O 0 7.859143380528621e-08

To O 0 6.666922569564804e-10
obtain O 0 1.3258909525859508e-09
clues O 0 1.2192061582538827e-08
to O 0 2.3909730098581328e-11
the O 0 6.381195571947273e-11
normal O 0 8.386628197465384e-11
biological O 0 1.1579237568781764e-09
role O 0 7.018913922296477e-11
of O 0 8.995552636115178e-10
DMPK O 0 0.4473763704299927
in O 0 2.515277153225526e-10
cellular O 0 2.457757330986965e-09
ion O 0 3.52517082191639e-09
homeostasis O 0 3.595654050059238e-07
, O 0 6.78737621662151e-10
we O 0 7.196509447388033e-12
have O 0 3.506333678265916e-13
compared O 0 6.419389759343419e-12
the O 0 1.5396563191050205e-10
resting O 0 1.1140412681243106e-07
[ O 0 7.489890929690546e-10
Ca2 O 0 3.7083783960278893e-11
+ O 0 5.232009270272897e-10
] O 0 1.456159082202646e-09
i O 0 1.3176011670612553e-10
, O 0 3.9190981189485274e-12
the O 0 4.720729883389563e-12
amplitude O 0 3.5937967879373645e-11
and O 0 1.8785979716273715e-11
shape O 0 1.2039583774381413e-09
of O 0 1.551238471009242e-09
depolarization O 0 2.204893378987549e-09
- O 0 2.4049219504718167e-08
induced O 0 3.6740196662776725e-08
Ca2 O 0 7.207406893527946e-11
+ O 0 9.199496719958233e-11
transients O 0 1.2059900855732053e-09
, O 0 1.377697608773154e-11
and O 0 5.590682430889338e-12
the O 0 9.139764466092881e-12
content O 0 7.275356532499e-12
of O 0 5.325278551460144e-10
ATP O 0 0.004681054037064314
- O 0 8.424536623863332e-09
driven O 0 8.699419518087836e-10
ion O 0 3.6583316931348975e-10
pumps O 0 1.5196515157356316e-09
in O 0 1.1277544870180733e-10
cultured O 0 1.41137190823315e-08
skeletal O 0 8.593499387643533e-07
muscle O 0 2.1579879216915288e-08
cells O 0 6.549079611950503e-10
of O 0 1.9078058244303975e-08
wild O 0 1.222308014803275e-07
- O 0 1.2955331030184425e-08
type O 0 1.2558318829292148e-08
and O 0 1.1905221253272202e-09
DMPK O 1 0.9999978542327881
[ O 0 4.3608931576955e-08
- O 0 3.3219686201846343e-07
/ O 0 2.267653513854384e-07
- O 0 3.73913820794769e-07
] O 0 4.938383213470843e-08
knockout O 1 0.99978107213974
mice O 0 1.1415089318234095e-07
. O 0 1.6778424205554643e-09

In O 0 1.497442703168872e-08
vitro O 0 6.902478588699523e-08
- O 0 3.590010635434737e-07
differentiated O 0 1.84716014928199e-07
DMPK O 1 0.9999402761459351
[ O 0 1.1716589654042764e-07
- O 0 7.252426712511806e-07
/ O 0 1.4274796455993055e-07
- O 0 1.6669268632085732e-07
] O 0 2.5276720716504997e-09
myotubes O 0 1.183723625786115e-07
exhibit O 0 3.80230957830463e-09
a O 0 2.4337459825218843e-10
higher O 0 2.464634496490703e-09
resting O 0 1.3008721566620807e-07
[ O 0 1.1435672409021436e-09
Ca2 O 0 6.288283088684565e-11
+ O 0 4.307740830711282e-10
] O 0 6.214562753292796e-10
i O 0 7.90623608248886e-11
than O 0 1.6005418561684803e-12
do O 0 7.168016180614245e-12
wild O 0 7.475437158177556e-09
- O 0 1.4797137959376983e-09
type O 0 8.692320196956871e-10
myotubes O 0 1.399183560124584e-07
because O 0 8.019349073684623e-12
of O 0 1.0557358459672983e-10
an O 0 3.6144505899567136e-13
altered O 0 9.494942332377576e-11
open O 0 2.7199897889573776e-10
probability O 0 1.8845841553982723e-11
of O 0 1.1863098003939143e-10
voltage O 0 9.330129557838518e-09
- O 0 1.2639107538348071e-08
dependent O 0 1.0017096041536888e-09
l O 0 2.295490603154704e-10
- O 0 1.078361178130649e-09
type O 0 1.8228643594575544e-10
Ca2 O 0 1.6480643239003e-11
+ O 0 4.9184566142113084e-11
and O 0 7.419094505412005e-11
Na O 0 2.1131427274667658e-08
+ O 0 2.3172393170955985e-10
channels O 0 1.6713386230549077e-10
. O 0 2.423495015779764e-10

The O 0 3.301106232811435e-07
mutant O 0 1.309605437427308e-07
myotubes O 0 2.039849277934991e-06
exhibit O 0 1.260182092011064e-08
smaller O 0 3.043374996458681e-10
and O 0 1.9481798119169724e-10
slower O 0 5.886546250444269e-10
Ca2 O 0 1.2016079103949195e-11
+ O 0 1.2910810441579823e-11
responses O 0 3.684405645160149e-12
upon O 0 3.507889465015346e-11
triggering O 0 3.336010079291185e-10
by O 0 4.114667374183201e-12
acetylcholine O 0 1.1154797086021517e-09
or O 0 7.39727792908873e-11
high O 0 6.903041693817613e-09
external O 0 1.645880409739675e-08
K O 0 4.0616808405502525e-07
+ O 0 1.721410392008238e-08
. O 0 2.1801700444967764e-09

In O 0 1.1536564592518062e-08
addition O 0 1.130871840615555e-09
, O 0 5.5685917682568586e-11
we O 0 6.89414616974332e-13
observed O 0 7.2468133924252776e-12
that O 0 3.7924494138618856e-14
these O 0 1.525427326771675e-13
Ca2 O 0 1.064805275202696e-11
+ O 0 1.1051846937615295e-10
transients O 0 8.595182343640317e-10
partially O 0 1.1384920783896746e-09
result O 0 7.397076007276127e-12
from O 0 2.7354494537557006e-12
an O 0 3.695098561981233e-14
influx O 0 1.8568087063568217e-13
of O 0 1.749176324616908e-11
extracellular O 0 1.360785008980292e-11
Ca2 O 0 5.726952332502089e-12
+ O 0 1.3801936156465633e-11
through O 0 3.775103927378121e-12
the O 0 5.965319384293455e-12
l O 0 1.4511918576542993e-11
- O 0 3.2575009356605733e-10
type O 0 4.186050117649387e-10
Ca2 O 0 1.0478297396421254e-10
+ O 0 5.236451827705935e-10
channel O 0 1.1928632526192473e-09
. O 0 5.081484122371194e-10

Neither O 0 8.440591869884884e-08
the O 0 8.918860650020122e-10
content O 0 4.651445895120787e-11
nor O 0 9.471066986233012e-11
the O 0 2.755433207990432e-11
activity O 0 4.458269170504181e-11
of O 0 2.0746218631906288e-10
Na O 0 1.0779421799611555e-08
+ O 0 2.252912995048817e-10
/ O 0 1.964888030059342e-09
K O 0 4.661051544729844e-09
+ O 0 1.655475201367551e-10
ATPase O 0 1.9702883768957236e-09
and O 0 1.7069126112545518e-09
sarcoplasmic O 0 2.3375557134386327e-07
reticulum O 0 1.3018546241028162e-08
Ca2 O 0 1.3575561785827972e-09
+ O 0 1.5171116585221966e-09
- O 0 3.178409091475487e-09
ATPase O 0 1.820190220769291e-09
are O 0 2.5307360373982846e-12
affected O 0 2.440127822023186e-10
by O 0 4.4111070351959825e-10
DMPK O 1 0.9999964237213135
absence O 0 4.394754341774387e-06
. O 0 1.3449077407301502e-08

In O 0 1.0568469654970158e-08
conclusion O 0 5.871657826617138e-09
, O 0 8.184854877191228e-11
our O 0 3.0284920404799465e-11
data O 0 4.49105926059179e-11
suggest O 0 6.8507751554980345e-12
that O 0 1.5088559741915919e-12
DMPK O 1 0.5090357661247253
is O 0 1.0868468451608049e-11
involved O 0 9.115948447491196e-12
in O 0 1.3085342705221326e-11
modulating O 0 3.738351406212814e-09
the O 0 7.648224414902316e-11
initial O 0 1.6316000633898042e-11
events O 0 1.0131047910311164e-11
of O 0 2.164705220630836e-10
excitation O 0 1.9543598739346635e-08
- O 0 7.266162782570973e-08
contraction O 0 5.456778140455754e-09
coupling O 0 2.1506727510001156e-09
in O 0 2.345002636516824e-09
skeletal O 0 0.00025115851894952357
muscle O 0 6.363217153193546e-07
. O 0 1.5114738349808476e-09
. O 0 2.2602570926011367e-09

Constitutional O 0 1.7192442101077177e-05
RB1 O 1 0.9995172023773193
- O 0 2.1113770344527438e-05
gene O 0 7.15513204241347e-09
mutations O 0 9.634265607516568e-10
in O 0 2.4743315729658377e-10
patients O 0 8.858217492857534e-10
with O 0 1.3002203480549923e-10
isolated O 0 2.081077809634735e-06
unilateral B-Disease 0 6.654592289123684e-05
retinoblastoma I-Disease 1 0.9999960660934448
. O 0 4.224071403768903e-07

In O 0 2.0814610479646944e-08
most O 0 2.0178733683984262e-10
patients O 0 1.5558336563525899e-10
with O 0 1.6633616359285064e-11
isolated O 0 1.9807908202551516e-08
unilateral B-Disease 0 8.822611903269717e-07
retinoblastoma I-Disease 1 0.9979522228240967
, O 0 3.8884269137895444e-09
tumor B-Disease 0 4.008740859262616e-07
development O 0 2.9019948666331175e-09
is O 0 1.903694649835197e-12
initiated O 0 4.131900724346771e-11
by O 0 2.04998431424519e-12
somatic O 0 5.351398435493593e-09
inactivation O 0 1.0317770460233078e-07
of O 0 7.127100687398524e-09
both O 0 2.125391355967121e-11
alleles O 0 8.424363637238308e-12
of O 0 1.1567140578705448e-09
the O 0 2.5614019794062415e-09
RB1 O 0 0.020643694326281548
gene O 0 4.002902898037064e-08
. O 0 4.451323309950794e-09

However O 0 4.667421116266723e-09
, O 0 3.5402333842249334e-11
some O 0 3.2934560027092497e-13
of O 0 3.6488107674204073e-11
these O 0 3.2061629826746207e-12
patients O 0 8.860139705246795e-11
can O 0 1.575932960518056e-11
transmit O 0 2.3759257601341233e-06
retinoblastoma B-Disease 0 0.025746051222085953
predisposition O 0 1.8151607719119056e-06
to O 0 5.937877411987813e-10
their O 0 5.033045091806798e-09
offspring O 0 9.518564070276625e-08
. O 0 5.73437208828409e-09

To O 0 6.627264848013681e-10
determine O 0 6.367958382824668e-10
the O 0 7.128480444817953e-11
frequency O 0 2.272311505624458e-10
and O 0 6.508924909470748e-12
nature O 0 6.178503264564483e-10
of O 0 8.25522372682741e-10
constitutional O 0 1.7103616301028524e-08
RB1 O 0 0.19409549236297607
- O 0 1.7549479025547043e-07
gene O 0 2.1023785490292823e-10
mutations O 0 7.3046992066228e-11
in O 0 4.736181585807131e-11
patients O 0 9.449648008530431e-11
with O 0 3.796291059288137e-11
isolated O 0 5.984077233733842e-08
unilateral B-Disease 0 3.4215809137094766e-06
retinoblastoma I-Disease 1 0.7726472020149231
, O 0 1.236163282847258e-09
we O 0 1.4393658140376964e-11
analyzed O 0 6.166341881552739e-10
DNA O 0 4.928916652602311e-08
from O 0 1.0020422269718665e-09
peripheral O 0 3.841046805064252e-07
blood O 0 2.4172742030259542e-08
and O 0 2.4806978693447945e-09
from O 0 1.1948995570776333e-08
tumor B-Disease 0 2.9494951377273537e-05
tissue O 0 1.1884367268066853e-05
. O 0 3.3298849899665584e-08

The O 0 9.620095831053277e-09
analysis O 0 5.859907559191413e-10
of O 0 3.6822772386813085e-08
tumors B-Disease 1 0.9999998807907104
from O 0 4.486030213968206e-09
54 O 0 4.239857798182811e-09
( O 0 2.0225385602423707e-11
71 O 0 2.0399943956306288e-09
% O 0 1.3338841749893637e-12
) O 0 1.008842748922989e-12
of O 0 4.6227477401572514e-10
76 O 0 7.859934036957839e-09
informative O 0 2.826110678810778e-09
patients O 0 1.8123679224046896e-09
showed O 0 2.6566431277075253e-09
loss O 0 4.953193766255026e-08
of O 0 1.579588726485781e-08
constitutional O 0 1.219099772242771e-07
heterozygosity O 0 0.00015034331590868533
( O 0 1.391451007748401e-07
LOH O 1 1.0
) O 0 1.6808597846917905e-09
at O 0 2.7077042830114806e-08
intragenic O 0 1.1201921552128624e-05
loci O 0 1.6192147711535654e-07
. O 0 6.935984231404291e-09

Three O 0 7.077820640688515e-08
of O 0 1.889630141249654e-07
13 O 0 1.3495309758582152e-07
uninformative O 0 0.0001604763383511454
patients O 0 1.9121337402339122e-08
had O 0 7.581056338246128e-10
constitutional O 0 5.0911999949221354e-08
deletions O 0 1.4071150644667796e-06
. O 0 1.3221217898262694e-07

For O 0 2.177295499450338e-08
39 O 0 2.0734725936222276e-08
randomly O 0 1.3353600447629788e-09
selected O 0 1.0689340257385993e-07
tumors B-Disease 1 1.0
, O 0 4.770149786281763e-08
SSCP O 1 1.0
, O 0 2.926910980249886e-08
hetero O 0 2.6623822577676037e-06
- O 0 1.9772462778178124e-08
duplex O 0 1.7134437868548957e-08
analysis O 0 4.88568525913724e-11
, O 0 2.0382137817798185e-12
sequencing O 0 4.987503812725613e-11
, O 0 2.42992149838972e-12
and O 0 4.444715862722548e-12
Southern O 0 8.719969191162136e-10
blot O 0 7.453028416648522e-09
analysis O 0 1.0746970154074109e-11
were O 0 2.4505402047847458e-12
used O 0 2.5203842918958275e-12
to O 0 5.134038159881893e-12
identify O 0 4.831300914887038e-10
mutations O 0 1.6660282042835206e-08
. O 0 4.436540912422515e-09

Mutations O 0 7.295840021015465e-08
were O 0 2.2706532210037267e-09
detected O 0 7.946701963135183e-09
in O 0 1.2292783457823475e-10
21 O 0 1.512157066230202e-09
( O 0 5.295828012230608e-12
91 O 0 4.535082587242556e-10
% O 0 7.021062333953387e-13
) O 0 7.758603872212722e-13
of O 0 3.263547432297287e-09
23 O 0 1.7491862308816053e-05
tumors B-Disease 1 1.0
with O 0 2.243382368760649e-06
LOH O 1 1.0
. O 0 5.95959988913819e-07

In O 0 1.130324065456989e-07
6 O 0 1.2374334801279474e-07
( O 0 1.5797799179928518e-10
38 O 0 1.048721998131441e-09
% O 0 1.4606660065502597e-12
) O 0 9.876859529897586e-13
of O 0 6.514694339543325e-10
16 O 0 2.222248667749227e-06
tumors B-Disease 1 1.0
without O 0 4.461432183688885e-07
LOH O 1 1.0
, O 0 8.342884716405763e-10
one O 0 5.523409854490957e-12
mutation O 0 1.2592119187637696e-11
was O 0 8.073713919642955e-11
detected O 0 1.136693295045177e-09
, O 0 7.047604687338005e-12
and O 0 5.011512906050175e-12
in O 0 2.0058309180281952e-11
9 O 0 1.894330692309154e-09
( O 0 8.166294897249404e-12
56 O 0 1.6445671213727309e-10
% O 0 5.24836250848093e-13
) O 0 1.0975204035520991e-12
of O 0 7.749534902679045e-10
the O 0 1.1783925657482541e-07
tumors B-Disease 1 1.0
without O 0 1.926737695612246e-06
LOH O 1 1.0
, O 0 1.1899885521415854e-09
both O 0 5.47889268676105e-11
mutations O 0 4.2250661302922765e-10
were O 0 5.058035101868086e-10
found O 0 1.147964168168869e-09
. O 0 1.3104812790487586e-09

Thus O 0 2.0861072869138297e-08
, O 0 1.350304035252492e-10
a O 0 1.3549110618182869e-11
total O 0 3.256261362979962e-12
of O 0 8.907041076922084e-11
45 O 0 7.268633611667852e-11
mutations O 0 2.3940259497035044e-11
were O 0 9.636687281489031e-11
identified O 0 1.7980229805036885e-10
in O 0 2.659436670882087e-09
tumors B-Disease 1 1.0
of O 0 3.9679548535787035e-06
36 O 0 5.413876351667568e-07
patients O 0 3.9174615551473835e-08
. O 0 1.3918779018240457e-08

Thirty O 0 6.0293477872619405e-06
- O 0 1.4232914224976412e-07
nine O 0 3.7023466514796155e-09
of O 0 9.866066852382005e-10
the O 0 1.080683251220016e-10
mutations O 0 1.3206455373726556e-10
- O 0 6.984359757211678e-09
including O 0 5.670632297061218e-10
34 O 0 1.3415534239058502e-09
small O 0 1.761063864180734e-11
mutations O 0 8.573696613778381e-11
, O 0 8.554225383594627e-11
2 O 0 9.660284794321683e-10
large O 0 3.201263906738028e-11
structural O 0 3.046107721615954e-08
alterations O 0 7.154656600505405e-07
, O 0 9.579972370943324e-10
and O 0 8.426541131534293e-10
hypermethylation O 0 3.219430072931573e-05
in O 0 5.2906994341128666e-08
3 O 0 4.022303528472548e-06
tumors O 1 1.0
- O 0 1.1662277188406733e-07
were O 0 4.2371067765500925e-10
not O 0 1.5226404121923554e-12
detected O 0 4.453478141819289e-10
in O 0 4.965348011226611e-12
the O 0 4.6591246485871984e-12
corresponding O 0 1.3795020681328651e-10
peripheral O 0 8.082698741418426e-07
blood O 0 2.5362075461998757e-07
DNA O 0 1.3655102520715445e-05
. O 0 7.902595910991295e-09

In O 0 3.8014849934597805e-08
6 O 0 5.122916491018259e-08
( O 0 5.7472429593197205e-11
17 O 0 3.894214395394613e-10
% O 0 1.7884467778256363e-13
) O 0 4.4001491361113365e-14
of O 0 6.103048622030371e-11
the O 0 2.3177521013550972e-10
36 O 0 2.8358193571165202e-09
patients O 0 2.4566498835199013e-10
, O 0 1.5609751338740985e-11
a O 0 3.3944291821796924e-11
mutation O 0 1.5749720971847125e-10
was O 0 3.271573012497697e-10
detected O 0 1.127344217977111e-09
in O 0 1.2680330743752855e-11
constitutional O 0 5.065159403017105e-10
DNA O 0 6.123310214434241e-08
, O 0 1.1819052680994702e-11
and O 0 9.383584187450111e-12
1 O 0 1.384558023787008e-10
of O 0 2.3921363154211228e-11
these O 0 7.088990310565035e-13
mutations O 0 1.479672807891408e-11
is O 0 2.644428729811632e-13
known O 0 5.092753475877121e-12
to O 0 3.8155093776311155e-13
be O 0 1.8076561298166482e-12
associated O 0 1.780760122693792e-10
with O 0 5.353852777778556e-11
reduced O 0 3.1936696842649326e-08
expressivity O 0 1.1905625797226094e-05
. O 0 3.0830840103135415e-08

The O 0 2.7094866794641348e-08
presence O 0 8.832168885142266e-10
of O 0 2.06082728659851e-09
a O 0 1.1226738289016325e-11
constitutional O 0 3.828520278581493e-10
mutation O 0 3.151741020945842e-11
was O 0 6.230701371512382e-11
not O 0 3.9950519021419995e-13
associated O 0 9.26192282590943e-12
with O 0 5.875835842189536e-13
an O 0 2.328666773299126e-13
early O 0 1.9108338522588753e-10
age O 0 1.9355969951839747e-11
at O 0 5.918067702559426e-10
treatment O 0 8.41666736306479e-09
. O 0 2.7031101801355817e-09

In O 0 8.963942832451721e-08
1 O 0 3.249244784342409e-08
patient O 0 1.1576417158210006e-08
, O 0 1.8297197090788586e-10
somatic O 0 7.777712198731024e-07
mosaicism O 0 7.681766874156892e-05
was O 0 8.144871443960255e-09
demonstrated O 0 9.663818356653309e-11
by O 0 4.160556176923541e-13
molecular O 0 5.2694015817422724e-11
analysis O 0 4.023531507968414e-12
of O 0 7.528486167807102e-11
DNA O 0 5.761660037961747e-09
and O 0 3.803770839971854e-11
RNA O 0 7.33370209005102e-09
from O 0 1.2020631157128037e-09
peripheral O 0 4.6808772822259925e-06
blood O 0 4.58684809245824e-07
. O 0 1.0151818941039892e-08

In O 0 2.207508202900499e-07
2 O 0 1.6230258381710883e-07
patients O 0 3.74497960420328e-10
without O 0 3.1479562012659557e-11
a O 0 1.921798137294317e-11
detectable O 0 2.4323933089931415e-08
mutation O 0 9.549755430882101e-11
in O 0 1.5470331959921424e-10
peripheral O 0 2.0470054096222157e-06
blood O 0 2.477914620158117e-07
, O 0 2.177751312615328e-09
mosaicism O 0 9.668118764238898e-06
was O 0 1.6701132921070894e-08
suggested O 0 2.5563834382680284e-10
because O 0 2.8903913984468232e-11
1 O 0 6.425717735680792e-10
of O 0 4.74182415555191e-10
the O 0 2.459988324154949e-10
patients O 0 2.514218389038092e-09
showed O 0 3.434892548170865e-08
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 3.3047704572908287e-09
the O 0 1.046571940221952e-09
other O 0 2.8624715445180193e-11
later O 0 7.648067734677966e-10
developed O 0 4.094201866422509e-09
bilateral B-Disease 0 7.265309704962419e-07
retinoblastoma I-Disease 0 0.005607010331004858
. O 0 3.8546826175434035e-08

In O 0 1.1707872893396143e-08
conclusion O 0 3.759789368729116e-09
, O 0 3.4845230867386334e-11
our O 0 5.7872172332107397e-11
results O 0 6.784784539748401e-11
emphasize O 0 2.1174575981497412e-10
that O 0 7.052872825694112e-13
the O 0 2.5030193195885175e-11
manifestation O 0 4.930192698537894e-09
and O 0 4.627288482939029e-11
transmissibility O 0 4.85027094043744e-08
of O 0 6.87855594705411e-09
retinoblastoma B-Disease 0 2.5477799425743797e-08
depend O 0 7.422109454813253e-11
on O 0 6.077136571747133e-10
the O 0 8.46035672075196e-11
nature O 0 6.573044886160062e-10
of O 0 7.233149634799929e-10
the O 0 1.6439578864879678e-11
first O 0 3.121326808130931e-11
mutation O 0 2.841315724366744e-12
, O 0 6.292259465204286e-13
its O 0 1.4663828961855585e-12
time O 0 1.300824357085284e-12
in O 0 3.0315244672202146e-12
development O 0 5.5278077254472535e-11
, O 0 2.400508394492795e-12
and O 0 1.7852133616866328e-12
the O 0 3.794392751388376e-12
number O 0 2.9244036120652794e-13
and O 0 4.864758227328403e-13
types O 0 8.783111737908911e-11
of O 0 5.450045970079032e-10
cells O 0 3.104097534567529e-11
that O 0 6.565178630769941e-13
are O 0 2.2772077192673157e-12
affected O 0 2.1475397848913502e-10
. O 0 1.3032146195524064e-10
. O 0 7.652256051038364e-10

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.99998939037323
the I-Disease 0 3.1854649478191277e-06
fifth I-Disease 0 1.3177705113776028e-05
component I-Disease 0 2.3630985168665575e-08
of I-Disease 0 2.8768107895871253e-08
complement I-Disease 0 1.2740083654705359e-08
in O 0 7.3581940540634605e-09
man O 0 1.7302758692494535e-07
. O 0 3.714675678168078e-09

I O 0 0.013392704539000988
. O 0 5.534066076506861e-07

Clinical O 0 0.0006695121410302818
, O 0 7.473355267961779e-09
immunochemical O 0 3.2397940231021494e-05
, O 0 7.544417313098961e-10
and O 0 6.568667137996087e-11
family O 0 1.9243290988457673e-11
studies O 0 7.87625797915581e-10
. O 0 4.3718823006244634e-10

The O 0 2.257543663120032e-08
first O 0 9.72332103721385e-10
recognized O 0 7.583138561528813e-10
human O 0 2.4205579762792695e-09
kindred O 0 8.404576874454506e-06
with O 0 2.6312232392911028e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999997615814209
the I-Disease 0 3.168908369843848e-05
fifth I-Disease 0 9.725840936880559e-05
component I-Disease 0 4.608016013207816e-08
of I-Disease 0 1.600779313548628e-07
complement I-Disease 0 1.5155643495745608e-07
( O 0 2.870638837748629e-08
C5 O 1 1.0
) O 0 2.926260622704291e-10
is O 0 7.580297500808797e-12
described O 0 1.268721350200508e-09
. O 0 1.8949812830015844e-09

The O 0 5.47619436019886e-07
proband O 0 4.3375919631216675e-05
, O 0 4.327160851858025e-09
a O 0 3.439412643579942e-10
20 O 0 2.6580675438481194e-09
- O 0 4.9832111770342635e-09
year O 0 1.8775170307350209e-10
- O 0 1.005849536994674e-08
old O 0 1.012984629511493e-08
black O 0 1.8600657125666942e-10
female O 0 1.488141207484084e-11
with O 0 7.222258346928356e-10
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 4.659303613152588e-06
age O 0 4.024015609616072e-08
11 O 0 9.86737003216831e-09
, O 0 1.602146193491194e-11
lacked O 0 3.1013914991717684e-08
serum O 0 1.9840204856791388e-07
hemolytic O 1 0.9999767541885376
complement O 0 6.792770079755428e-08
activity O 0 4.379021945055683e-08
, O 0 8.62144869384629e-11
even O 0 1.046375312785397e-11
during O 0 7.703936932834665e-10
remission O 0 6.160868792903784e-08
. O 0 5.41472366943907e-10

C5 O 1 0.9999085664749146
was O 0 1.5346918189607095e-06
undetectable O 0 1.826414745664806e-06
in O 0 3.0558694463778124e-10
her O 0 1.9608538751048066e-11
serum O 0 1.614611222500173e-10
by O 0 9.817194800143536e-12
both O 0 8.081108698876349e-11
immunodiffusion O 0 1.952212187461555e-05
and O 0 1.523488890597946e-08
hemolytic O 1 0.9999995231628418
assays O 0 3.97136955143651e-06
. O 0 1.4216772115105414e-07

Other O 0 7.981148519853321e-10
complement O 0 2.2736001970002917e-09
components O 0 2.5030040262663533e-08
were O 0 2.355059758318845e-10
normal O 0 1.0753906098948107e-10
during O 0 2.766634490947162e-11
remission O 0 1.0310875486752025e-09
of O 0 2.886405559010541e-09
lupus O 0 0.00014738831669092178
, O 0 1.5066612402137025e-09
but O 0 4.449080270862993e-10
C1 O 0 0.004822983872145414
, O 0 9.46210221286492e-09
C4 O 1 0.999987006187439
, O 0 2.8401077045714374e-08
C2 O 0 3.593699511839077e-05
, O 0 8.582011767899189e-10
and O 0 6.108143768557284e-09
C3 O 1 0.9999998807907104
levels O 0 1.2655423233809415e-06
fell O 0 5.248728484730236e-06
during O 0 2.0287194146817455e-08
exacerbations O 0 6.565989315276965e-05
. O 0 4.331587089012601e-09

A O 0 3.490625022095628e-05
younger O 0 5.853054219073783e-08
half O 0 5.423812066140954e-09
- O 0 3.299500406228617e-08
sister O 0 9.251978738689104e-09
, O 0 6.157065829404118e-11
who O 0 2.593164745434695e-11
had O 0 5.6406844473055884e-11
no O 0 5.800768754227192e-10
underlying O 1 0.9998747110366821
disease O 1 0.9999977350234985
, O 0 9.565068875838634e-11
was O 0 7.392796375071953e-10
also O 0 8.291668567028676e-12
found O 0 1.2295966328457197e-11
to O 0 3.716953828059033e-11
lack O 0 1.416510144736094e-07
immunochemically O 1 0.9055114984512329
detectable O 1 0.9823914170265198
C5 O 1 0.9999626874923706
. O 0 1.3602543447177595e-07

By O 0 1.6173427752619318e-07
hemolytic O 1 0.9999728202819824
assay O 0 1.1810426485681091e-06
, O 0 5.233249389391403e-09
she O 0 5.5746705862613766e-11
exhibited O 0 4.967648070675068e-09
1 O 0 2.7196904728299387e-09
- O 0 1.4017079719153003e-09
2 O 0 1.3936563014738113e-10
% O 0 8.846009591067377e-14
of O 0 2.9836428466767373e-12
the O 0 8.497937596663174e-12
normal O 0 1.1960503698560387e-09
serum O 0 1.09135198655963e-08
C5 O 0 8.372095180675387e-05
level O 0 3.6857745744356407e-09
and O 0 7.945841033751844e-12
normal O 0 2.2942333796627246e-11
concentrations O 0 1.183855097286468e-10
of O 0 5.3858698750852696e-11
other O 0 3.706043284756877e-12
complement O 0 1.6946763992109481e-09
components O 0 5.429481575447426e-07
. O 0 1.481075528886322e-08

C5 O 0 0.07697100192308426
levels O 0 4.5439275453418304e-08
of O 0 5.586512141775302e-09
other O 0 1.2343996484698305e-11
family O 0 4.7671927169701256e-12
members O 0 2.2494198344269467e-12
were O 0 2.0877919185147142e-11
either O 0 6.210767317105237e-11
normal O 0 7.455342454498748e-10
or O 0 8.41338387846946e-11
approximately O 0 5.595720761752965e-11
half O 0 1.165676860592768e-10
- O 0 1.6902440558297371e-09
normal O 0 1.4947195703385319e-09
, O 0 1.0452263186910837e-11
consistent O 0 5.954776671757145e-10
with O 0 2.736536344749574e-11
autosomal O 0 2.2300943669506523e-07
codominant O 0 9.03262503015867e-07
inheritance O 0 1.8021129033485295e-09
of O 0 1.184667297593478e-08
the O 0 3.2020610607474964e-09
gene O 0 1.2207773636419006e-07
determining O 0 0.001611440791748464
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.3917046999267768e-06

Normal O 0 0.0006844899035058916
hemolytic O 1 1.0
titers O 0 0.00012171865091659129
were O 0 8.873865198211206e-09
restored O 0 2.767784046397992e-08
to O 0 7.400326185180717e-11
both O 0 1.0102436942549531e-10
homozygous O 0 1.8585728867037687e-06
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 4.1470116229902487e-07
C5D B-Disease 1 1.0
) O 0 4.801271602516977e-10
sera O 0 2.3249315361795198e-08
by O 0 6.068651657586965e-12
addition O 0 1.166054891532653e-10
of O 0 1.4557119953906295e-09
highly O 0 3.74330468844164e-08
purified O 0 2.5362608084833482e-06
human O 0 6.108146521910385e-07
C5 O 1 0.9999810457229614
. O 0 2.2169636793023528e-08

In O 0 5.1883681351228006e-08
specific O 0 1.6892039766958078e-08
C5 O 0 0.03140630945563316
titrations O 0 1.6271217191388132e-06
, O 0 2.9431201920004924e-10
however O 0 4.6059527719632953e-11
, O 0 7.2273775506004334e-12
it O 0 6.162240856477652e-13
was O 0 8.355350439304132e-11
noted O 0 3.1651012106365117e-12
that O 0 8.813236192272214e-14
when O 0 2.9774674479426944e-13
limited O 0 1.0733587412978252e-12
amounts O 0 1.4798703928953216e-11
of O 0 2.734368509393903e-09
C5 O 0 4.5349017455009744e-05
were O 0 4.298154887560912e-10
assayed O 0 1.3393675057926657e-09
in O 0 5.4754321736349976e-12
the O 0 5.934361509141173e-12
presence O 0 5.589808130257445e-12
of O 0 1.6998615015584306e-10
low O 0 8.916768434730216e-10
dilutions O 0 3.8057653028999994e-08
of O 0 8.243584481704147e-09
either O 0 2.9103496501647896e-08
C5D B-Disease 1 1.0
serum O 0 5.064175070401689e-07
, O 0 2.9269081602834035e-10
curving O 0 9.564585568000439e-09
rather O 0 9.277959477083098e-12
than O 0 3.7809965119754707e-13
linear O 0 3.1799524818909575e-11
dose O 0 1.9075101498344793e-09
- O 0 3.0325988387147618e-09
response O 0 1.3360745669543928e-11
plots O 0 2.515627428589795e-10
were O 0 8.651857702490773e-11
consistently O 0 7.497433923697727e-11
obtained O 0 2.535849655260769e-11
, O 0 3.967156030765251e-12
suggesting O 0 3.496926706536563e-11
some O 0 2.7508214889976346e-12
inhibitory O 0 4.760331240305504e-09
effect O 0 9.32648180906881e-09
. O 0 2.5865185548923364e-09

Further O 0 2.8083355640973195e-09
studies O 0 3.241263091258162e-10
suggested O 0 2.5806516645854316e-11
that O 0 1.1485648586731512e-12
low O 0 1.3833603151880425e-09
dilutions O 0 6.002791224091197e-07
of O 0 3.4596482123561145e-07
C5D B-Disease 1 1.0
serum O 0 1.6472505137699045e-07
contain O 0 1.804923432935368e-09
a O 0 4.4278965910526935e-11
factor O 0 2.1558945600963497e-11
( O 0 3.1024974256332882e-12
or O 0 4.508686392984407e-12
factors O 0 2.9002102802655472e-11
) O 0 1.7869200043263422e-12
interfering O 0 5.531206603848204e-10
at O 0 7.303295745941796e-10
some O 0 2.1975342552604804e-12
step O 0 7.774447058350731e-11
in O 0 1.6614655831692637e-11
the O 0 2.8428473464181536e-10
hemolytic O 1 0.8470976948738098
assay O 0 9.020404689863426e-08
of O 0 1.6215331925195642e-05
C5 O 1 1.0
, O 0 1.6986015927145104e-09
rather O 0 5.7025394822884934e-11
than O 0 1.6336887355070107e-12
a O 0 4.0952911201097564e-11
true O 0 2.3914725755247446e-09
C5 O 0 0.04283634573221207
inhibitor O 0 2.0411862422520244e-08
or O 0 2.6535591501897215e-09
inactivator O 0 8.907390110834967e-06
. O 0 1.762635726265671e-08

Of O 0 1.326513483945746e-06
clinical O 0 1.4323127288662363e-06
interest O 0 1.3207193116926419e-09
are O 0 1.2824517489629095e-11
( O 0 1.4493937300352755e-11
a O 0 1.758368624316109e-11
) O 0 6.474055232880138e-13
the O 0 1.5346851393871486e-12
documentation O 0 2.8330404688858835e-09
of O 0 4.8001496111282904e-08
membranous O 1 0.9999642372131348
glomerulonephritis B-Disease 1 1.0
, O 0 9.966922789317323e-07
vasculitis B-Disease 1 1.0
, O 0 6.672800736851059e-06
and O 1 0.7135106325149536
arthritis B-Disease 1 1.0
in O 0 5.897948085475946e-08
an O 0 4.001568520983767e-11
individual O 0 2.6995539137431024e-10
lacking O 0 5.148521267983597e-06
C5 O 1 0.9999990463256836
( O 0 3.806763237967914e-10
and O 0 3.383118091226933e-11
its O 0 1.106234374936843e-11
biologic O 0 4.134900866148428e-09
functions O 0 7.91111967601843e-12
) O 0 9.215538488566155e-13
, O 0 1.2668984784858228e-12
and O 0 1.5952031362509445e-11
( O 0 5.4182852649020674e-11
b O 0 9.347688179062175e-10
) O 0 4.2521831867224635e-13
a O 0 6.823269163222512e-13
remarkable O 0 6.339839070390596e-11
propensity O 0 2.3864433984499556e-08
to O 0 3.742960608121848e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 1.1446032316397847e-10
the O 0 1.4418284621786626e-10
proband O 0 3.221387316898472e-07
, O 0 1.6579643907776997e-11
even O 0 9.576468307584407e-13
during O 0 1.1560799192955606e-11
periods O 0 2.5673679848736697e-10
of O 0 2.1550733420028223e-10
low O 0 3.0181039889498606e-09
- O 0 5.006912662253171e-10
dose O 0 4.92847929134399e-10
or O 0 2.816131876304251e-11
alternate O 0 3.1607143569090113e-09
- O 0 4.796717689714569e-08
day O 0 5.402213343330686e-09
corticosteroid O 0 4.270933277439326e-05
therapy O 0 5.4432898650702555e-06
. O 0 8.708387788658456e-09

Other O 0 2.5111270840483257e-09
observations O 0 1.6262958979496034e-08
indicate O 0 4.346970838842168e-10
that O 0 4.408075033462966e-12
the O 0 3.741095766507385e-10
C5D B-Disease 1 1.0
state O 0 1.8997645123697282e-10
is O 0 4.66451042287902e-13
compatible O 0 9.894612906791167e-11
with O 0 2.5204033738540632e-12
normal O 0 1.3797600562082124e-10
coagulation O 0 2.2627371087935444e-09
function O 0 1.3298355472368684e-11
and O 0 2.0866771852090515e-11
the O 0 1.698651809489693e-11
capacity O 0 3.376298199353478e-11
to O 0 5.0493470515888816e-11
mount O 0 4.962838374922285e-06
a O 0 1.076898303864482e-08
neutrophilic O 0 0.2609885334968567
leukocytosis O 0 0.0004939158097840846
during O 0 1.5138770095290965e-06
pyogenic B-Disease 1 0.9945353269577026
infection I-Disease 0 5.208841685089283e-06
. O 0 3.4609443089195224e-10
. O 0 1.0055841714873281e-09

Susceptibility O 0 0.0005990174831822515
to O 0 9.008675078803208e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 8.372844604309648e-07
twins O 0 3.910191139766539e-07
: O 0 7.682505673289874e-12
the O 0 6.231494487085598e-12
role O 0 6.016706230460578e-12
of O 0 3.9347933245004185e-10
genes O 0 2.119464846683794e-11
, O 0 5.4282571493313725e-11
HLA O 0 2.2719784453784087e-07
, O 0 8.210748747572438e-11
and O 0 5.4856792719437664e-11
the O 0 7.453507810950555e-10
environment O 0 1.5072656012193875e-08
. O 0 3.740191711898433e-09

OBJECTIVE O 0 1.926291361087351e-06
To O 0 4.856048549384262e-11
determine O 0 4.7527235619293506e-11
the O 0 1.2318359873808582e-11
relative O 0 3.6489498922431807e-11
effects O 0 7.467157558949111e-09
of O 0 4.282917076547932e-10
genetic O 0 4.834038724865763e-10
and O 0 1.7514599146006837e-11
environmental O 0 4.083702265234024e-10
factors O 0 2.444859766026486e-11
in O 0 3.4732161591222166e-11
susceptibility O 0 5.530209890025617e-08
to O 0 6.320336609633159e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 8.869560019775236e-07
AS B-Disease 1 1.0
) O 0 5.695596216881427e-10
. O 0 2.2664289889284817e-10

METHODS O 0 1.325640914728865e-05
Twins O 0 2.6106233690370573e-06
with O 0 7.015072550631274e-11
AS B-Disease 1 0.9999996423721313
were O 0 4.054139315923244e-11
identified O 0 2.0883843699498472e-12
from O 0 3.276303056978791e-12
the O 0 4.504526092408145e-12
Royal O 0 1.0715326226318211e-07
National O 0 2.8728275083267363e-06
Hospital O 1 0.9998395442962646
for O 0 1.059988576912474e-07
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 8.148666097440582e-08
. O 0 6.399595076089781e-09

Clinical O 0 4.308905772631988e-05
and O 0 2.2663437793113417e-09
radiographic O 0 1.0105204637511633e-06
examinations O 0 3.702164619312498e-08
were O 0 2.369748841601904e-10
performed O 0 7.256835132807282e-10
to O 0 2.19889688055086e-12
establish O 0 2.3180968256042433e-10
diagnoses O 0 8.325585440616123e-06
, O 0 1.252448811328577e-09
and O 0 1.6181343198695686e-07
disease O 1 0.9999986886978149
severity O 0 4.415187140693888e-05
was O 0 2.2016408696146073e-09
assessed O 0 5.27845767095414e-10
using O 0 1.5455577789813546e-11
a O 0 1.459396839487148e-11
combination O 0 3.570881645931223e-10
of O 0 5.094429322838323e-10
validated O 0 1.245932956805973e-08
scoring O 0 1.9502637726986904e-08
systems O 0 1.5643357755834586e-06
. O 0 5.257881685594157e-09

HLA O 0 5.522661376744509e-05
typing O 0 1.8337399865231419e-07
for O 0 2.067201076982883e-09
HLA O 0 1.8554117104940815e-06
- O 0 9.615164486831418e-08
B27 O 0 6.271940833357803e-07
, O 0 2.701109336200602e-10
HLA O 0 7.936934309782373e-08
- O 0 9.650970689278893e-09
B60 O 0 8.85386839399871e-08
, O 0 3.90869350774814e-11
and O 0 9.725727168063969e-11
HLA O 0 1.4086739383856184e-06
- O 0 2.6869460612033436e-07
DR1 O 0 0.3393373191356659
was O 0 5.011539627730599e-09
performed O 0 2.633049556166611e-09
by O 0 3.30771065919222e-12
polymerase O 0 2.2717145942152683e-09
chain O 0 9.240616605232788e-10
reaction O 0 1.4123069033700197e-11
with O 0 4.398198385352492e-12
sequence O 0 2.0172181633415498e-11
- O 0 4.9943202351521165e-11
specific O 0 1.1505952440815648e-12
primers O 0 9.069356932123185e-10
, O 0 1.5839760059144226e-11
and O 0 2.214880882867032e-11
zygosity O 0 6.906356020408566e-07
was O 0 4.2231323993391356e-10
assessed O 0 4.126517794134088e-09
using O 0 4.3804213034626116e-10
microsatellite O 0 2.072493003879572e-07
markers O 0 1.017574959405465e-06
. O 0 7.21173210038728e-09

Genetic O 0 5.143983230482263e-07
and O 0 2.9319535688188125e-10
environmental O 0 1.772972879621193e-09
variance O 0 5.1166005460290265e-11
components O 0 3.6668283964758075e-09
were O 0 9.451504856539117e-11
assessed O 0 2.7208730823957694e-09
with O 0 8.263311909728621e-12
the O 0 9.797072875183943e-11
program O 0 4.1807658029968664e-11
Mx O 0 3.505700618688934e-08
, O 0 4.104514850829938e-13
using O 0 1.8050091857377965e-13
data O 0 2.1955818239882685e-12
from O 0 3.55977779805533e-13
this O 0 1.1434400992780917e-14
and O 0 1.4618470008716938e-13
previous O 0 6.3625858054416895e-12
studies O 0 1.2795588373581968e-11
of O 0 1.3590892300463508e-10
twins O 0 4.0268563594736406e-08
with O 0 2.5674903869621346e-10
AS B-Disease 1 1.0
. O 0 2.7588768602981872e-08

RESULTS O 0 9.515170859231148e-06
Six O 0 4.8879762459819176e-08
of O 0 2.5939701941979365e-08
8 O 0 8.706764731414296e-08
monozygotic O 0 1.72423040112335e-06
( O 0 1.6180472073301644e-08
MZ O 1 0.9999997615814209
) O 0 1.7121493112171038e-09
twin O 0 3.0899755643076787e-07
pairs O 0 8.520684713353432e-10
were O 0 5.019941440309594e-08
disease O 0 4.868181349593215e-06
concordant O 0 3.892517952408525e-08
, O 0 7.497877319018187e-11
compared O 0 7.529057238775394e-12
with O 0 1.140105371222333e-11
4 O 0 4.4239167884541075e-09
of O 0 1.2175980224071736e-08
15 O 0 5.152763549176598e-09
B27 O 0 1.078633715678734e-07
- O 0 1.5407243481035948e-08
positive O 0 2.474081495229541e-10
dizygotic O 0 2.131709379682434e-06
( O 0 4.258823516067878e-09
DZ O 1 0.992324948310852
) O 0 3.899670308893377e-10
twin O 0 5.408030645526196e-08
pairs O 0 1.776594149571764e-10
( O 0 4.353805857504334e-11
27 O 0 2.683599342745424e-09
% O 0 9.844510189677136e-13
) O 0 1.7961351264812742e-13
and O 0 1.1237493574567381e-11
4 O 0 1.3719432256920072e-09
of O 0 1.1541406941262267e-08
32 O 0 7.669198254234288e-08
DZ O 1 0.999980092048645
twin O 0 3.928752903448185e-06
pairs O 0 2.2726378556825466e-09
overall O 0 4.365137584727563e-08
( O 0 5.516161416529997e-10
12 O 0 2.4216384453268347e-09
. O 0 1.3565867179599067e-11
5 O 0 2.535144871806949e-10
% O 0 1.4566763593959475e-12
) O 0 8.211370819410924e-12
. O 0 1.3133907850182425e-10

Nonsignificant O 0 2.9410881325020455e-05
increases O 0 1.0138462291919836e-09
in O 0 2.620911300488249e-11
similarity O 0 1.182536620708552e-11
with O 0 3.8273320602209837e-13
regard O 0 2.176744201554115e-11
to O 0 9.887589011436937e-12
age O 0 2.443564794951669e-10
at O 0 4.0478326468473824e-08
disease O 0 1.3449917787511367e-05
onset O 0 2.1394738780600164e-07
and O 0 2.343739265164846e-11
all O 0 6.3761921090255136e-12
of O 0 1.685209416457667e-09
the O 0 1.2835843499203747e-08
disease O 0 0.004305585753172636
severity O 0 1.977721630908036e-08
scores O 0 8.604367773834554e-10
assessed O 0 8.720417721264084e-10
were O 0 1.4856291197240523e-10
noted O 0 9.090584535131896e-11
in O 0 1.1148691969609104e-09
disease O 0 0.0004806693468708545
- O 0 5.948493253526976e-07
concordant O 0 2.07285975193372e-05
MZ O 1 0.9999986886978149
twins O 0 7.450088332916494e-07
compared O 0 4.6318918145438204e-10
with O 0 4.982486090376881e-10
concordant O 0 0.0002649078378453851
DZ O 1 1.0
twins O 0 0.03086630441248417
. O 0 1.7282903286286455e-07

HLA O 0 0.00035176376695744693
- O 0 2.0913994376314804e-06
B27 O 0 8.97280131084699e-07
and O 0 3.9947761765191103e-10
B60 O 0 3.034428885939633e-08
were O 0 7.534002588460709e-11
associated O 0 1.882257266716536e-10
with O 0 1.484019851449858e-11
the O 0 4.869632252990641e-09
disease O 0 6.609936917811865e-07
in O 0 2.136650405215601e-11
probands O 0 1.205729404318845e-06
, O 0 2.6322635043873888e-11
and O 0 1.640337171648909e-11
the O 0 5.68727807903624e-11
rate O 0 3.21586757223713e-10
of O 0 3.3908480467914615e-09
disease O 0 6.476813041444984e-08
concordance O 0 1.7361354576195254e-09
was O 0 1.4016109106673724e-10
significantly O 0 8.595370075414888e-12
increased O 0 1.895615608926704e-11
among O 0 5.643807643451737e-10
DZ O 1 0.9997013211250305
twin O 0 8.935365940487827e-07
pairs O 0 1.3557287237286886e-10
in O 0 1.022873730160967e-10
which O 0 1.4561381614375257e-11
the O 0 4.742393699963543e-10
co O 0 4.107955220433723e-08
- O 0 4.507887041427239e-08
twin O 0 2.3405515037211444e-07
was O 0 1.0762407631759174e-09
positive O 0 2.423178194557729e-12
for O 0 1.5185278165116833e-12
both O 0 6.480955355714357e-11
B27 O 0 8.543188414478209e-07
and O 0 4.166522415971485e-08
DR1 O 1 0.9988777041435242
. O 0 5.4107339053643955e-08

Additive O 0 5.2406832651286095e-08
genetic O 0 2.5652168389456165e-08
effects O 0 1.3142441801505811e-08
were O 0 2.296899649645301e-11
estimated O 0 2.611318279666097e-13
to O 0 1.2557568374906014e-13
contribute O 0 2.1522944017304813e-12
97 O 0 2.793184294969109e-10
% O 0 6.913842057459235e-14
of O 0 1.1338377068834116e-12
the O 0 7.523942948707563e-13
population O 0 6.250876569423346e-15
variance O 0 2.5414956597580307e-11
. O 0 6.591059920069142e-10

CONCLUSION O 0 6.804752956668381e-06
Susceptibility O 0 2.9929057632216427e-07
to O 0 8.146451846435809e-10
AS B-Disease 1 1.0
is O 0 7.305852103844934e-12
largely O 0 2.731675996514582e-11
genetically O 0 1.1695451551663183e-10
determined O 0 6.68831656724933e-11
, O 0 9.82500625995586e-12
and O 0 1.7992912715314446e-11
the O 0 8.1626233550125e-11
environmental O 0 1.081983658224317e-08
trigger O 0 4.390577679203034e-09
for O 0 2.2942243591006495e-11
the O 0 7.79198749967236e-09
disease O 0 0.00035529601154848933
is O 0 7.134407214309801e-12
probably O 0 4.802351849519937e-10
ubiquitous O 0 9.883384421982555e-08
. O 0 3.3079929906421057e-09

HLA O 0 0.0007950420258566737
- O 0 1.2996473515158868e-06
B27 O 0 1.1155636769899502e-07
accounts O 0 1.683013797770805e-11
for O 0 2.5571367939791756e-12
a O 0 6.745798798030167e-12
minority O 0 2.7685319314851853e-13
of O 0 1.5706934017312157e-11
the O 0 3.058876762995766e-11
overall O 0 7.902079546262541e-10
genetic O 0 2.7074702479978896e-09
susceptibility O 0 1.1768321428462514e-08
to O 0 6.294777477044988e-10
AS B-Disease 1 1.0
. O 0 2.117306330262636e-08

Cell O 0 5.612036147795152e-06
cycle O 0 7.432475257473925e-08
- O 0 3.000953796572503e-08
dependent O 0 2.5147124382840502e-09
colocalization O 0 1.1807138662334182e-06
of O 0 4.688480359504865e-08
BARD1 O 1 0.9999994039535522
and O 0 2.2653843245734606e-09
BRCA1 O 0 2.6348581094737256e-09
proteins O 0 7.949236754956068e-12
in O 0 2.0472228079437826e-11
discrete O 0 5.631409782935748e-10
nuclear O 0 1.0412383062430308e-06
domains O 0 1.9841447596036232e-08
. O 0 6.567984822680728e-09

Germ O 1 0.990879237651825
- O 0 1.0055799975816626e-05
line O 0 7.842476890118633e-08
mutations O 0 9.077109619504142e-10
of O 0 7.625988729387245e-09
the O 0 4.221073268695363e-09
BRCA1 O 0 4.497375414302951e-07
gene O 0 7.767237519828996e-09
predispose O 0 4.526080843447744e-09
women O 0 1.778539295005377e-11
to O 0 2.907770725590897e-11
early O 0 1.7100895775001845e-06
- O 0 0.001131963450461626
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.181549580397956e-10
compromising O 0 1.0647261206031544e-07
the O 0 2.5260766811641133e-09
genes O 0 3.046337071488381e-10
presumptive O 0 4.136417075528698e-08
function O 0 8.671418444405887e-11
as O 0 1.317023295976938e-10
a O 0 4.807428899411548e-10
tumor B-Disease 0 3.270503725616436e-07
suppressor O 0 2.583990863058716e-06
. O 0 1.978257380130799e-08

Although O 0 6.508736216659372e-09
the O 0 2.606883042766128e-10
biochemical O 0 1.9589689870258553e-08
properties O 0 1.2302341367842473e-08
of O 0 1.6332222685377928e-07
BRCA1 O 0 5.1084466434758724e-08
polypeptides O 0 2.879927629706458e-09
are O 0 2.180915387520188e-12
not O 0 1.5157295991247155e-12
understood O 0 1.2215606304266657e-10
, O 0 2.2541744946341646e-12
their O 0 2.096989899433299e-12
expression O 0 1.4193065125955862e-11
pattern O 0 1.5459594715494518e-10
and O 0 9.025240624294106e-12
subcellular O 0 1.4249180502190484e-08
localization O 0 1.8190874584433914e-08
suggest O 0 3.9082612146579265e-11
a O 0 5.283670202749224e-12
role O 0 4.249585058846428e-11
in O 0 6.496066878858286e-11
cell O 0 6.289911169687912e-08
- O 0 1.8554847258656082e-07
cycle O 0 1.9562769182357442e-08
regulation O 0 4.562555844245253e-08
. O 0 4.598669500754937e-10

When O 0 4.034475153957828e-08
resting O 0 3.912286956619937e-06
cells O 0 4.058529956552093e-09
are O 0 1.8693975187278333e-11
induced O 0 5.742540309938704e-08
to O 0 1.735531163227222e-11
proliferate O 0 7.185712913582165e-09
, O 0 1.7649813902065326e-11
the O 0 1.385761991268275e-11
steady O 0 3.8871347807223344e-10
- O 0 3.828898309521378e-11
state O 0 5.297919221380898e-12
levels O 0 3.051022282041238e-11
of O 0 8.842598875347107e-11
BRCA1 O 0 5.205091566096165e-11
increase O 0 1.958048794718087e-13
in O 0 4.109647951805462e-12
late O 0 6.5225429501936105e-09
G1 O 0 2.737997988333518e-07
and O 0 2.742252432075265e-11
reach O 0 1.230075156316568e-11
a O 0 1.623196694243434e-12
maximum O 0 2.7774681859993322e-11
during O 0 1.507983737880636e-09
S O 0 2.7822793526866008e-06
phase O 0 2.751150418589532e-07
. O 0 2.570416768321593e-09

Moreover O 0 1.204051329750655e-07
, O 0 4.03404781801342e-10
in O 0 1.7660260753782353e-10
S O 0 4.983508574696316e-07
phase O 0 3.4740697429924694e-08
cells O 0 7.035980686964649e-10
, O 0 8.651725863506599e-11
BRCA1 O 0 4.17005052710806e-09
polypeptides O 0 1.8382032562769268e-09
are O 0 2.7257323134688427e-11
hyperphosphorylated O 0 3.92246050751055e-07
and O 0 5.243847578384475e-10
accumulate O 0 5.783824530425363e-09
into O 0 9.601612838139317e-10
discrete O 0 7.303884608234057e-09
subnuclear O 0 4.9119203140435275e-06
foci O 0 4.907996299152728e-06
termed O 0 2.9759048629784957e-06
" O 0 2.874886320114456e-07
BRCA1 O 0 6.080236744310241e-06
nuclear O 0 0.0028035708237439394
dots O 0 3.139888940495439e-05
. O 0 5.2684953288917313e-08

" O 0 7.347184237005422e-06
BRCA1 O 0 2.254434093629243e-06
associates O 0 1.152692448158632e-07
in O 0 9.76044578493429e-10
vivo O 0 1.047910735962887e-08
with O 0 1.2898651764736702e-11
a O 0 1.7435679289246053e-10
structurally O 0 3.3845694247247593e-07
related O 0 3.1930642307997914e-07
protein O 0 1.3229352191501675e-07
termed O 0 2.962222060887143e-05
BARD1 O 1 1.0
. O 0 5.978578343501795e-08

Here O 0 9.107310461331508e-08
we O 0 2.813835275894405e-10
show O 0 1.470815830240113e-10
that O 0 1.0843470218957485e-12
the O 0 1.489811052302059e-11
steady O 0 3.858371400156102e-10
- O 0 6.700318772034919e-11
state O 0 5.519818543214816e-12
levels O 0 7.590399142554105e-11
of O 0 3.439950269079617e-10
BARD1 O 1 0.9997040629386902
, O 0 2.6002474479147608e-11
unlike O 0 1.3262285367132698e-11
those O 0 1.1531883087334549e-11
of O 0 3.0147784269018985e-09
BRCA1 O 0 4.604079961723073e-08
, O 0 1.5984140400160385e-10
remain O 0 1.4397290304390964e-10
relatively O 0 1.3165403663084607e-11
constant O 0 2.756742230325404e-11
during O 0 5.808430403320131e-10
cell O 0 2.6626253202266525e-08
cycle O 0 1.4718191110318912e-08
progression O 0 3.78155426972171e-08
. O 0 3.547549198845701e-10

However O 0 5.9378152172939735e-08
, O 0 4.482224369439791e-09
immunostaining O 0 4.836487278225832e-06
revealed O 0 1.8324037398542714e-08
that O 0 5.017024296005701e-11
BARD1 O 1 0.9999781847000122
resides O 0 1.435858649756483e-07
within O 0 1.389395176687458e-08
BRCA1 O 0 5.938483482736956e-08
nuclear O 0 4.263793925929349e-06
dots O 0 7.600841200883224e-08
during O 0 1.2231308410548536e-08
S O 0 3.545337960986217e-07
phase O 0 4.571473866121778e-09
of O 0 6.608645852779205e-10
the O 0 3.381911764521739e-11
cell O 0 6.938957741731144e-10
cycle O 0 1.401402466294499e-10
, O 0 7.195133703251366e-13
but O 0 3.757915880602328e-14
not O 0 4.7761436732657314e-14
during O 0 1.771240619452552e-11
the O 0 6.204918523433633e-11
G1 O 0 9.835409855440957e-07
phase O 0 2.7309924988117018e-08
. O 0 3.774834056446963e-10

Nevertheless O 0 1.6338032082785503e-06
, O 0 2.2232942598066074e-08
BARD1 O 1 0.6498737931251526
polypeptides O 0 3.073379062357162e-08
are O 0 1.1691565250659952e-11
found O 0 1.0169147642014043e-11
exclusively O 0 2.548009372937976e-11
in O 0 3.369875342315587e-12
the O 0 3.2763342820013586e-12
nuclear O 0 1.2192520326692602e-09
fractions O 0 1.8117414513074692e-10
of O 0 6.954234410549986e-10
both O 0 2.941850235638199e-11
G1 O 0 8.065804308898805e-07
- O 0 1.3122503084161963e-08
and O 0 3.083716337837217e-10
S O 0 1.4747521390745533e-06
- O 0 3.486655586470988e-08
phase O 0 6.809348462866183e-08
cells O 0 2.693157252764422e-09
. O 0 5.554401383278673e-10

Therefore O 0 7.060400264435884e-08
, O 0 2.2238655361661586e-09
progression O 0 8.080994540193842e-09
to O 0 4.0072205970131947e-11
S O 0 1.2449191899577272e-07
phase O 0 7.059320239477529e-09
is O 0 8.924342926978912e-13
accompanied O 0 1.6963692603400027e-11
by O 0 3.381411632901593e-13
the O 0 3.7452684183147955e-12
aggregation O 0 1.2258505321938173e-10
of O 0 7.945030189304703e-10
nuclear O 0 2.9930190521554323e-06
BARD1 O 1 0.999998927116394
polypeptides O 0 8.678320000399253e-07
into O 0 3.951983984507024e-08
BRCA1 O 0 1.6701982303857221e-06
nuclear O 0 0.000173859647475183
dots O 0 3.956505224778084e-06
. O 0 2.0068290140784484e-08

This O 0 1.0289048502087894e-09
cell O 0 3.4431771211984596e-08
cycle O 0 3.6352960641750087e-09
- O 0 4.6512820262023524e-09
dependent O 0 6.264200269612274e-10
colocalization O 0 4.28883168979155e-07
of O 0 4.9592436823786556e-08
BARD1 O 1 1.0
and O 0 6.971117016973949e-09
BRCA1 O 0 2.3490148493010565e-08
indicates O 0 1.8873837215327427e-10
a O 0 1.9163224826423964e-11
role O 0 9.803464984248222e-11
for O 0 9.135603384891056e-11
BARD1 O 1 0.9999979734420776
in O 0 7.109858035647676e-09
BRCA1 O 0 7.029051403151243e-07
- O 0 1.8138750874641119e-06
mediated O 0 2.547184340073727e-05
tumor B-Disease 0 9.7035059297923e-05
suppression O 0 0.00041784578934311867
. O 0 2.122137665594437e-08

Ethnic O 0 7.515323474649449e-09
differences O 0 9.8019423688811e-09
in O 0 3.652864954961643e-10
the O 0 1.1920353593097843e-09
HFE O 0 0.0009704738040454686
codon O 0 1.7340587987746403e-07
282 O 0 2.035934016930696e-07
( O 0 5.160651905811164e-09
Cys O 1 0.9994286894798279
/ O 0 1.1443977200542577e-05
Tyr O 0 0.0005211224197410047
) O 0 7.252213274355768e-10
polymorphism O 0 5.2518906556997536e-08
. O 0 2.759333206370229e-09

Recent O 0 2.7966666760192993e-09
studies O 0 3.7360614602022224e-10
have O 0 1.0813172189247378e-12
shown O 0 7.602671964201946e-11
that O 0 4.1353875879224233e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 4.7641307787671394e-07
HH B-Disease 1 1.0
) O 0 4.00558752833291e-10
is O 0 2.5895455484786778e-12
likely O 0 5.923414536646021e-12
to O 0 3.988293202639159e-12
be O 0 2.641588163487807e-11
caused O 0 1.7014137654314254e-08
by O 0 1.55408977353666e-10
homozygosity O 0 1.506339344814478e-06
for O 0 5.4060936283129024e-11
a O 0 1.6817279513414718e-10
Cys282Tyr O 0 1.1600873222050723e-06
mutation O 0 1.5304219003198227e-10
in O 0 3.239252963083139e-11
the O 0 2.8991384293242106e-10
HFE O 0 0.0002411715977359563
gene O 0 5.790403267980082e-09
located O 0 2.3801019821689806e-08
4 O 0 4.4042177904657365e-08
. O 0 2.116929742612683e-09

5 O 0 3.302077402622672e-06
Mb O 0 5.533487637876533e-06
telomeric O 0 2.4123375624185428e-05
to O 0 1.8712125182673844e-08
HLA O 0 0.00013960094656795263
- O 0 2.931293920482858e-06
A O 0 7.831383754819399e-07
. O 0 3.3670022325793525e-09

Population O 0 6.0384930562762396e-12
studies O 0 1.7305662111666287e-11
of O 0 2.6273379305497002e-11
this O 0 1.2062246546647865e-13
polymorphism O 0 3.3040549463070334e-11
are O 0 1.2531775205222584e-13
facilitated O 0 5.613098961326779e-12
by O 0 9.199838156906393e-13
the O 0 5.938732144938896e-12
fact O 0 1.7685795319563602e-12
that O 0 4.854791021231472e-14
the O 0 1.8065196907834924e-11
Cys282Tyr O 0 8.713692295714281e-06
mutation O 0 5.070824316000255e-10
creates O 0 5.061451258114857e-10
a O 0 2.1136646599639874e-10
Rsal O 0 1.940747779372032e-06
restriction O 0 2.0113035681390556e-09
site O 0 1.7540870089760574e-08
. O 0 9.435316972172814e-10

We O 0 2.7506681377076347e-09
have O 0 3.3536144781326493e-12
studied O 0 7.297196735756017e-10
the O 0 7.152232278651027e-11
codon O 0 3.871037268510236e-09
282 O 0 1.1345517414440565e-08
( O 0 7.691075554205895e-10
Cys O 1 0.9991719722747803
/ O 0 1.644919052523619e-06
Tyr O 0 2.0255978597560897e-05
) O 0 1.5298491640169942e-11
polymorphism O 0 5.852130585681792e-11
in O 0 1.5918529515379642e-12
different O 0 1.471532531244213e-12
ethnic O 0 1.7595721971477851e-12
groups O 0 4.996318463124094e-12
. O 0 2.466086224117703e-10

In O 0 1.0243430104139861e-08
agreement O 0 5.573418393467477e-10
with O 0 1.8825543554590318e-11
previous O 0 2.4154650501984065e-10
observations O 0 4.01550304118814e-09
the O 0 7.810464497381986e-10
Tyr O 0 5.4941061534918845e-05
allele O 0 6.397614660258455e-10
appeared O 0 3.9858330524999985e-10
to O 0 9.181471555264054e-12
be O 0 3.259001575550702e-12
rare O 0 5.531438640460351e-10
or O 0 1.5173655387723528e-10
absent O 0 3.991198482822256e-09
in O 0 1.186282738707689e-10
Asiatic O 0 5.4168260987808026e-08
( O 0 3.604217271857557e-11
Indian O 0 1.1741943528598142e-10
, O 0 2.875433398330518e-12
Chinese O 0 2.5275056353413206e-11
) O 0 1.7402041179587213e-12
populations O 0 1.4498638400972652e-11
. O 0 1.4904315281949465e-10

The O 0 2.2563986235013545e-08
highest O 0 1.237272595489003e-08
allele O 0 6.201463648158878e-11
frequency O 0 3.314958030298243e-10
( O 0 8.307466693724397e-12
7 O 0 2.445821600804976e-10
. O 0 3.101868805213681e-13
5 O 0 9.873549026984119e-12
% O 0 1.0454604440187157e-13
) O 0 5.822749780167585e-14
was O 0 1.3703699633382804e-11
found O 0 1.3614807198303325e-11
in O 0 4.2535339833671415e-11
Swedes O 0 1.6381734724291164e-07
. O 0 7.535188473184462e-09

Saamis O 0 0.00015288010763470083
( O 0 8.176764154654848e-09
2 O 0 7.4437940256188995e-09
% O 0 4.671207864959115e-12
) O 0 7.634531028199998e-13
and O 0 2.3962644368769048e-11
Mordvinians O 0 2.3070558654580964e-06
( O 0 1.4566112205294246e-10
1 O 0 5.1307441628623e-10
. O 0 1.2707853432741834e-12
8 O 0 6.393537088644763e-11
% O 0 1.0557080519025056e-13
) O 0 8.70295385779242e-14
had O 0 4.714285060415657e-13
significantly O 0 5.324318676919182e-12
lower O 0 8.005984764025698e-10
frequencies O 0 4.2072217931732325e-10
of O 0 8.314941513098972e-10
the O 0 1.671728311336551e-09
Tyr O 0 0.0001229114568559453
allele O 0 1.4167715889357169e-08
. O 0 2.6508073514008856e-09

Comparisons O 0 1.0778357761864754e-07
with O 0 1.544642053152856e-10
allele O 0 5.797536409279935e-11
frequencies O 0 1.7177417821478969e-10
based O 0 2.014519939752546e-10
on O 0 1.058639953477325e-09
prevalence O 0 7.946879265752216e-10
estimates O 0 2.358618855780037e-11
of O 0 4.1800024552784976e-10
HH B-Disease 1 0.9999972581863403
showed O 0 1.2924480152776141e-08
some O 0 1.1736361882341839e-11
disagreements O 0 4.823505150852725e-09
with O 0 2.705500753985568e-11
the O 0 1.512574648865339e-10
RFLP O 0 6.278763748923666e-07
data O 0 1.2616773181761687e-09
, O 0 1.9386747415750527e-11
particularly O 0 9.424735991636624e-11
in O 0 1.3129450304738555e-10
Finns O 0 1.0353826951359224e-07
. O 0 3.1440110515035258e-09

The O 0 2.090800279574978e-07
newly O 0 2.7732276066672057e-06
described O 0 9.533935241279323e-08
HFE O 1 0.9993547797203064
marker O 0 5.6749232868469335e-08
provides O 0 3.893811315047735e-11
a O 0 3.514115647779148e-12
new O 0 6.108297895268677e-12
approach O 0 1.985152493777509e-11
to O 0 7.600097851404031e-13
the O 0 8.213328454853563e-12
screening O 0 1.0939060074433016e-10
of O 0 4.004471754193162e-10
HH B-Disease 1 0.7503300309181213
as O 0 7.88277637608914e-11
well O 0 3.665172765981994e-12
as O 0 6.956678072142508e-13
studies O 0 6.577929607259891e-12
of O 0 2.1178645642772054e-11
the O 0 2.312425598227641e-11
relationship O 0 6.154867414343013e-12
between O 0 4.0932528200254836e-11
the O 0 4.87762441547801e-10
HFE O 1 0.8076805472373962
Tyr O 0 2.834717270161491e-05
allele O 0 2.2506281560641384e-10
and O 0 1.6380556633333043e-10
different O 0 1.5488645921379884e-09
disorders O 1 1.0
including O 1 0.5378164649009705
cancer B-Disease 1 1.0

Autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.999984622001648
associated O 0 1.206389157459853e-07
with O 0 7.7858036684475e-10
a O 0 1.070528665714221e-09
missense O 0 6.397961982429479e-08
mutation O 0 4.647626172804564e-10
encoding O 0 1.616167866203e-09
Gly23 O 0 2.687617961782962e-05
- O 0 2.4096755169011885e-06
- O 0 5.000361511520168e-07
> O 0 1.7353881887061107e-08
Val O 0 5.158406111149816e-07
in O 0 5.902466293505881e-10
neurophysin O 0 0.00021084585750941187
II O 1 1.0
. O 0 6.704457433670541e-08

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.1811564490926685e-06
ADNDI B-Disease 1 1.0
) O 0 2.184190828202759e-09
is O 0 1.1471204194868356e-11
an O 0 1.4855895680288e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 3.319709867355414e-05
by O 0 4.2372119701816757e-10
progressive O 1 0.9859018325805664
degeneration O 1 1.0
of O 0 1.3852872143615969e-05
the O 0 3.920496283171815e-08
magnocellular O 0 8.464298298349604e-05
neurons O 0 1.552734971710379e-07
of O 0 1.0929893505817745e-06
the O 0 1.7634437199376407e-07
hypothalamus O 0 6.598168511118274e-06
leading O 0 4.129028354782349e-07
to O 0 8.174776133795802e-11
decreased O 0 6.499701332707275e-10
ability O 0 1.6680734918339546e-11
to O 0 1.1967041940730283e-11
produce O 0 1.1006245914657597e-09
the O 0 3.3006253286060883e-09
hormone O 0 1.9891466251920065e-08
arginine O 0 5.553209803110803e-07
vasopressin O 0 2.1949462336579018e-07
( O 0 6.0156257752908004e-09
AVP O 0 0.03904702141880989
) O 0 9.746791151954426e-10
. O 0 9.238784182130644e-10

Affected O 0 9.286421942533707e-08
individuals O 0 1.74882955339406e-11
are O 0 2.1700937487961758e-12
not O 0 8.672770834827759e-12
symptomatic O 0 1.901688051475503e-08
at O 0 6.129314389369256e-09
birth O 0 1.3984053914839478e-08
, O 0 6.627169299444624e-12
but O 0 1.825500037591632e-12
usually O 0 7.384396982779151e-10
develop O 0 6.68231732561253e-05
diabetes B-Disease 1 1.0
insipidus I-Disease 0 0.0006815242813900113
at O 0 1.227280904458894e-06
1 O 0 1.5677051123930141e-07
- O 0 1.0401217878097668e-06
6 O 0 3.987377681369253e-07
yr O 0 3.482872216409305e-06
of O 0 1.83146049437255e-08
age O 0 4.298509548306129e-09
. O 0 1.2766396828567395e-09

The O 0 1.0949925410841388e-08
genetic O 0 2.9544660051783467e-09
locus O 0 6.755346282361074e-10
of O 0 2.4465975911880378e-09
the O 0 1.1141428224448191e-08
disease O 0 0.000682758167386055
is O 0 6.693123486001262e-12
the O 0 2.4352702077123922e-09
AVP O 1 0.999995231628418
- O 0 1.4845877558400389e-06
neurophysin O 0 0.00017640688747633249
II O 1 1.0
( O 0 1.3643787433181842e-08
NPII O 1 0.9999996423721313
) O 0 1.3032444567961932e-10
gene O 0 2.2038242064592595e-10
, O 0 1.1387754454694754e-11
and O 0 4.1979853621088026e-11
mutations O 0 8.785528415877764e-10
that O 0 2.4941123819011146e-11
cause O 0 3.235559233871754e-07
ADNDI B-Disease 1 1.0
have O 0 2.2982494379819585e-11
been O 0 5.540693771843852e-12
found O 0 1.563125388674702e-12
in O 0 9.480220428126351e-13
both O 0 6.445667025296864e-13
the O 0 1.9906467099706227e-11
signal O 0 5.999328811512328e-10
peptide O 0 4.3887340983594925e-10
of O 0 2.621143968539741e-09
the O 0 2.9611342267088503e-09
prepro O 0 0.00014428902068175375
- O 0 3.693922553793527e-05
AVP O 1 0.9999977350234985
- O 0 3.4527440675446996e-06
NPII O 1 0.9997935891151428
precursor O 0 1.9807083617706667e-07
and O 0 9.445165760624263e-10
within O 0 9.493520636283392e-09
NPII O 1 0.9999972581863403
itself O 0 1.3392511277743324e-07
. O 0 5.186228335674059e-09

An O 0 3.195069542272222e-09
affected O 0 3.5872140813353326e-08
girl O 0 5.4557300899205075e-08
who O 0 2.231345490322223e-11
presented O 0 9.096625674942516e-10
at O 0 3.4751350685979787e-09
9 O 0 2.1558268503696354e-09
months O 0 1.1179003903127871e-11
of O 0 1.9571406995044782e-10
age O 0 7.656646150433488e-11
and O 0 3.442061913272454e-11
her O 0 2.499508065800793e-11
similarly O 0 5.093001576028655e-10
affected O 0 3.34986083316835e-09
younger O 0 3.894780942204079e-09
brother O 0 7.506745447471985e-08
and O 0 9.259388811244662e-10
father O 0 1.025066076465464e-08
were O 0 3.5642744311559227e-10
all O 0 2.3722801500980495e-11
found O 0 7.562563422713886e-12
to O 0 2.108484394025556e-12
have O 0 1.5505676170118887e-12
a O 0 2.1141312658845557e-11
novel O 0 3.554972982655613e-10
missense O 0 1.3733680859218111e-08
mutation O 0 6.0787130884421e-10
( O 0 1.030078591868211e-10
G1758 O 0 1.8800815837494156e-07
- O 0 3.964275094858749e-07
- O 0 1.2758897582898499e-07
> O 0 8.755354663492199e-09
T O 0 3.621557311817014e-07
) O 0 6.088891869003576e-13
encoding O 0 1.0622325501835617e-12
the O 0 8.384097235913934e-12
amino O 0 3.550620561454387e-11
acid O 0 4.570954725835463e-11
substitution O 0 7.816261526905066e-10
Gly23 O 0 4.298501153243706e-06
- O 0 2.77256674507953e-07
- O 0 1.2967871043656487e-07
> O 0 2.434361157099829e-08
Val O 0 2.623781938382308e-06
within O 0 1.0198731104082981e-07
NPII O 1 0.9999974966049194
. O 0 3.5837878442634974e-08

The O 0 4.395842267967964e-08
mutation O 0 1.3389485076231722e-09
was O 0 1.2986199893205708e-09
confirmed O 0 8.691951325356939e-11
by O 0 7.494152325614178e-13
restriction O 0 1.6254251417047172e-11
endonuclease O 0 1.0281599571726474e-08
analysis O 0 8.338780776995236e-10
. O 0 9.073526374692165e-10

A O 0 4.5456956286216155e-05
T1 O 0 0.002993261441588402
- O 0 2.096354378977594e-08
weighted O 0 6.18523565698581e-10
magnetic O 0 1.4707604023556087e-09
resonance O 0 2.7584950990089396e-10
imaging O 0 1.9582915911087184e-07
of O 0 4.554765453690379e-08
the O 0 4.8743462599531995e-08
fathers O 0 0.00010755264520412311
pituitary O 1 0.999051034450531
gland O 0 4.355336568551138e-05
demonstrates O 0 1.2971402618688899e-08
an O 0 1.516723135974729e-10
attenuated O 0 8.195665031962562e-06
posterior O 0 5.453817266243277e-06
pituitary O 1 0.9993919134140015
bright O 0 0.00032036026823334396
spot O 0 7.23483826732263e-05
. O 0 3.4313302421651315e-08

This O 0 7.842798632751169e-10
mutation O 0 6.38311015155324e-10
may O 0 7.958919634454276e-11
be O 0 2.007257424510578e-12
valuable O 0 1.9300937237343163e-10
for O 0 6.584569695045062e-12
developing O 0 3.440880566585314e-11
models O 0 1.884189609890896e-10
of O 0 9.621049734676035e-09
dominantly B-Disease 1 0.9998612403869629
inherited I-Disease 1 0.9999996423721313
neurodegeneration I-Disease 1 1.0
, O 0 1.1572348634913965e-09
as O 0 6.266954403338909e-12
the O 0 4.889150716225199e-12
early O 0 1.7228793044998802e-11
age O 0 2.4604036256287154e-12
of O 0 4.77422927580573e-11
onset O 0 0.000157991933519952
of O 0 1.7394550013705157e-05
symptoms O 1 0.9999997615814209
suggests O 0 4.239499862279672e-10
that O 0 4.2611137600172266e-13
this O 0 3.575183226724177e-13
mutation O 0 1.9230303113793035e-11
may O 0 1.8075570554221265e-11
be O 0 7.276786812004943e-12
particularly O 0 1.2843985597310592e-10
deleterious O 0 7.46230277570703e-09
to O 0 2.440974922190975e-10
the O 0 1.8869310558500274e-09
magnocellular O 0 6.251653303479543e-06
neuron O 0 6.250945148167375e-07
. O 0 1.4023577854516134e-09
. O 0 5.009561210300717e-09

Frequent O 0 3.7584797496492683e-07
inactivation O 0 4.765077756019309e-05
of O 0 1.7918895537150092e-05
PTEN O 1 1.0
/ O 0 0.0013159096706658602
MMAC1 O 1 1.0
in O 0 2.969285795018095e-08
primary O 1 0.9939821362495422
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.5833251982021466e-08

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 5.585170104183135e-09
the O 0 2.3334467691427108e-09
most O 0 2.9786690475264166e-11
common O 0 7.034960392005019e-10
male B-Disease 0 6.907635019537395e-10
cancer I-Disease 0 2.3190975806386405e-09
in O 0 1.3627017916850725e-11
the O 0 4.6292064626030083e-10
Western O 0 3.0687516527905245e-08
world O 0 2.488000028222359e-09
, O 0 1.1405557054366966e-11
yet O 0 2.429064328152153e-12
many O 0 2.011967117432692e-13
of O 0 2.0619693452683663e-11
the O 0 9.832430009071302e-12
major O 0 2.3795457271269527e-10
genetic O 0 2.5525245805901875e-10
events O 0 2.470326547487911e-11
involved O 0 5.874886514767308e-12
in O 0 1.309183404046843e-11
the O 0 6.618620235210315e-11
progression O 0 3.897634659466576e-09
of O 0 3.1556884882988356e-10
this O 0 4.544187075239403e-12
often O 0 2.576360902395436e-09
fatal O 1 1.0
cancer B-Disease 0 0.07734480500221252
remain O 0 1.9447430332775184e-09
to O 0 8.771960935405332e-11
be O 0 5.775707689892329e-10
elucidated O 0 9.877682714432012e-06
. O 0 4.921626484133412e-08

Numerous O 0 8.394023325308808e-07
cytogenetic O 0 0.0001244604936800897
and O 0 1.4791699420868554e-08
allelotype O 0 4.562352842185646e-06
studies O 0 2.644352237179959e-10
have O 0 8.838239385147717e-13
reported O 0 2.278816371714676e-11
frequent O 0 1.588087994441878e-10
loss O 0 5.321811258340858e-08
of O 0 8.358374259387347e-08
heterozygosity O 0 1.3752649465459399e-05
on O 0 1.3952821973362006e-06
chromosomal O 0 0.28058046102523804
arm O 0 0.0541577972471714
10q O 0 1.7913735064212233e-05
in O 0 1.89545943385383e-08
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.045095801709977e-08

Deletion O 0 2.3693655748502351e-07
mapping O 0 1.1889932594044694e-08
studies O 0 4.966773659020873e-10
have O 0 3.6295127060076426e-12
unambiguously O 0 8.394222206220547e-09
identified O 0 1.3756291938893384e-10
a O 0 6.967467575114128e-11
region O 0 9.469462991518185e-10
of O 0 1.390561799041734e-08
chromosome O 0 1.3287270839157372e-08
10q23 O 0 4.005897125125557e-08
to O 0 2.032930768169905e-11
be O 0 3.3004126775287856e-12
the O 0 3.8282262776467846e-11
minimal O 0 7.465402185324876e-10
area O 0 1.6430127258715288e-09
of O 0 2.0006556411544807e-09
loss O 0 8.531358730579086e-07
. O 0 8.13819411860095e-09

A O 0 1.2786090337613132e-06
new O 0 2.413495181485814e-09
tumor B-Disease 0 4.689339050401031e-08
suppressor O 0 3.235065548778948e-07
gene O 0 3.092507228075192e-08
, O 0 3.8556362547126355e-09
PTEN O 1 0.9997180104255676
/ O 0 2.5505483790766448e-05
MMAC1 O 1 1.0
, O 0 3.985667795802783e-09
was O 0 4.134853348602974e-09
isolated O 0 2.1975878894409107e-09
recently O 0 2.2888800577103297e-10
at O 0 1.959478967972217e-10
this O 0 9.638915100113055e-14
region O 0 7.260735068737034e-11
of O 0 3.43304384919918e-09
chromosome O 0 5.178083739565409e-09
10q23 O 0 6.753496961664496e-08
and O 0 3.841145179706018e-10
found O 0 3.007664603482674e-11
to O 0 1.5294689343151036e-12
be O 0 2.2639726465073506e-12
inactivated O 0 1.2440545482661491e-08
by O 0 2.3829907231515124e-12
mutation O 0 3.86892219650381e-11
in O 0 6.160037757663162e-11
three O 0 1.8614800367799944e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.00030447973404079676
lines O 0 5.460268539536628e-07
. O 0 8.52927506400647e-09

We O 0 3.0881871282417706e-08
screened O 0 1.895696300380223e-06
80 O 0 4.4788130253436975e-06
prostate B-Disease 1 0.9999970197677612
tumors I-Disease 1 1.0
by O 0 1.7498447135722017e-10
microsatellite O 0 7.754906050649879e-09
analysis O 0 2.1053921106517492e-10
and O 0 1.3516027186355473e-10
found O 0 1.7043937095007067e-10
chromosome O 0 2.353121253406698e-09
10q23 O 0 2.5153756411100403e-08
to O 0 4.659748628621507e-11
be O 0 2.5487287627634636e-11
deleted O 0 1.938595284300959e-09
in O 0 2.6499868965856876e-10
23 O 0 4.361515149042816e-09
cases O 0 1.93570492967865e-10
. O 0 7.380046018745645e-10

We O 0 5.103330646960558e-09
then O 0 8.534164347429041e-11
proceeded O 0 3.1716734794073886e-10
with O 0 2.4385468687729284e-13
sequence O 0 8.08415346383734e-13
analysis O 0 6.999401600850386e-13
of O 0 2.750822659935981e-11
the O 0 7.82047829273047e-11
entire O 0 6.19890627717723e-08
PTEN O 1 0.9998401403427124
/ O 0 1.3759799003310036e-05
MMAC1 O 1 0.9999997615814209
coding O 0 8.060570166890102e-08
region O 0 2.2536792432248376e-09
and O 0 2.776927993108913e-11
tested O 0 1.7154008769004747e-10
for O 0 4.697735690034621e-12
homozygous O 0 1.4375886592254972e-10
deletion O 0 1.2919390557364352e-10
with O 0 7.960585315935909e-12
new O 0 1.272604022162227e-09
intragenic O 0 4.8659953790775035e-06
markers O 0 2.903989759772685e-08
in O 0 6.264340435269133e-11
these O 0 1.1927846731152325e-11
23 O 0 9.561224034726479e-10
cases O 0 7.997292064687578e-12
with O 0 3.280129856966796e-12
10q23 O 0 3.4556782679828757e-07
loss O 0 9.508181619821698e-07
of O 0 9.437167136638891e-07
heterozygosity O 0 0.0022176015190780163
. O 0 4.050629343055334e-07

The O 0 3.243181723178168e-09
identification O 0 5.044548778698754e-09
of O 0 7.026811132959665e-09
the O 0 1.1545495670617356e-09
second O 0 4.092281180589907e-09
mutational O 0 9.680545787205119e-08
event O 0 2.6306501421657913e-09
in O 0 2.9879623775208586e-10
10 O 0 3.8777525634969834e-10
( O 0 1.5888627219462492e-11
43 O 0 1.2202314714215845e-09
% O 0 2.331624823770362e-11
) O 0 1.5525083441048082e-09
tumors B-Disease 1 1.0
establishes O 0 6.910706724738702e-05
PTEN O 1 1.0
/ O 0 0.0007560025551356375
MMAC1 O 1 0.9999998807907104
as O 0 4.869741832003172e-10
a O 0 9.000421935523306e-11
main O 0 1.0275164052941932e-09
inactivation O 0 9.527336430892319e-08
target O 0 1.4010157478594465e-09
of O 0 5.569192218501939e-09
10q O 0 6.627332709285838e-07
loss O 0 4.017857690996607e-07
in O 0 5.228340427265721e-09
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1269357669263513e-09
. O 0 1.5070004133477255e-09

Risk O 0 2.1677197992175934e-07
reversals O 0 4.374138740104172e-08
in O 0 6.45950723465738e-11
predictive O 0 6.195590707136489e-10
testing O 0 1.2121896375560937e-08
for O 0 8.725380418184159e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 7.287380920928399e-09

The O 0 5.5597464410084285e-09
first O 0 9.504527026527043e-11
predictive O 0 2.040382446333311e-10
testing O 0 1.5056385027634178e-09
for O 0 1.1299748914339602e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.0314114839982125e-10
HD B-Disease 0 8.81032883626176e-06
) O 0 1.5821242970240346e-12
was O 0 1.3279852044412177e-11
based O 0 1.2261959676795886e-11
on O 0 2.933792445092287e-11
analysis O 0 7.49141287198496e-12
of O 0 1.5435963618415371e-10
linked O 0 2.152872324856503e-09
polymorphic O 0 1.050279951897437e-08
DNA O 0 1.1551629341965963e-07
markers O 0 2.673820276299921e-09
to O 0 4.729940831366131e-12
estimate O 0 1.6341353617499443e-11
the O 0 6.765190404406374e-12
likelihood O 0 1.1349293033147134e-10
of O 0 8.506605975178161e-10
inheriting O 0 3.865429754057459e-09
the O 0 3.280571092556528e-10
mutation O 0 2.65330479809478e-10
for O 0 1.011635844538894e-10
HD B-Disease 0 0.0004656143137253821
. O 0 1.3032806833734867e-08

Limits O 0 3.6182099538706325e-09
to O 0 1.2672254738610444e-11
accuracy O 0 5.095975308400114e-10
included O 0 5.014785461887605e-11
recombination O 0 1.2029975973715246e-11
between O 0 4.228786591731204e-12
the O 0 1.5338870798520254e-11
DNA O 0 8.725247191421204e-09
markers O 0 1.456114673281661e-09
and O 0 1.2409291476334072e-11
the O 0 2.624733243250521e-11
mutation O 0 9.826693278536247e-12
, O 0 2.6298635578264618e-12
pedigree O 0 6.759419135526912e-10
structure O 0 9.293750213856811e-10
, O 0 1.5340508377481576e-11
and O 0 2.603739923320858e-12
whether O 0 3.5023119387272983e-12
DNA O 0 1.0828419272357337e-09
samples O 0 3.135611909010905e-11
were O 0 1.9637347303813613e-12
available O 0 1.1529062210122176e-12
from O 0 3.742999313272044e-11
family O 0 2.2124233001186155e-11
members O 0 2.7169771987800573e-10
. O 0 1.8367769527571909e-09

With O 0 3.6773464828776525e-10
direct O 0 1.6283209502976348e-10
tests O 0 5.020970306190975e-10
for O 0 2.079877286023657e-12
the O 0 8.563171005615544e-11
HD B-Disease 0 2.6364628865849227e-05
mutation O 0 9.588650706771062e-11
, O 0 3.7708434465211216e-12
we O 0 2.9171166892640044e-13
have O 0 2.897297541313605e-14
assessed O 0 1.1220664675182235e-10
the O 0 2.0856625454479527e-11
accuracy O 0 1.412076677809182e-09
of O 0 2.3135561522114045e-10
results O 0 1.5541779668781786e-11
obtained O 0 1.992082367119341e-11
by O 0 3.2964113209910106e-12
linkage O 0 1.7055653556141692e-09
approaches O 0 7.301025339856437e-10
when O 0 5.26110405241198e-12
requested O 0 1.6844654143755022e-11
to O 0 9.849304531683867e-12
do O 0 7.111419959848764e-12
so O 0 6.576006557866554e-13
by O 0 7.683088106696934e-13
the O 0 2.5925466634602046e-11
test O 0 5.870220975978668e-10
individuals O 0 5.62252848446132e-12
. O 0 1.198857457751501e-09

For O 0 2.6880253578553948e-09
six O 0 1.451131576013509e-10
such O 0 9.628359741442605e-12
individuals O 0 2.8282042506544425e-12
, O 0 3.839268139516072e-11
there O 0 9.759393813923989e-12
was O 0 2.632887241560411e-10
significant O 0 3.773896126157972e-11
disparity O 0 3.4393010661659673e-10
between O 0 4.634451850060728e-11
the O 0 1.2197259868784727e-10
tests O 0 1.9704462506098253e-09
. O 0 7.039229199534702e-10

Three O 0 5.878642284073976e-08
went O 0 3.890098199121894e-08
from O 0 6.350322490078497e-10
a O 0 7.096707943521352e-11
decreased O 0 7.405356328149537e-10
risk O 0 8.573793758293036e-11
to O 0 1.6990494297944303e-12
an O 0 5.107527356780495e-13
increased O 0 5.2707161551923676e-12
risk O 0 9.570999548458303e-11
, O 0 6.212304542313474e-12
while O 0 2.638776783886465e-12
in O 0 2.3620569476051623e-12
another O 0 3.2749723072322823e-12
three O 0 4.7654111559602974e-12
the O 0 5.1295183378652354e-11
risk O 0 8.265244044736164e-10
was O 0 5.008920833660113e-09
decreased O 0 1.3242842378247133e-08
. O 0 1.4944971926666994e-09

Knowledge O 0 1.6392941404319572e-07
of O 0 1.034162906421443e-07
the O 0 4.4990697278812775e-10
potential O 0 1.9262239372985768e-11
reasons O 0 3.822445832080135e-12
for O 0 2.4416138056683467e-13
these O 0 1.1247903650146718e-13
changes O 0 7.379232858442664e-13
in O 0 3.623439439118248e-12
results O 0 2.197032486495054e-11
and O 0 1.4253397941088597e-11
impact O 0 4.658577967830979e-10
of O 0 4.652220275680463e-10
these O 0 1.0400656898224003e-11
risk O 0 1.4989899599360257e-10
reversals O 0 2.32542252120993e-09
on O 0 7.494224796289473e-09
both O 0 4.4867699833250896e-11
patients O 0 7.479736274795812e-11
and O 0 2.8042701841202167e-11
the O 0 2.2082760620101283e-10
counseling O 0 9.876930384677962e-10
team O 0 2.0667267897067632e-10
can O 0 4.905494413454115e-13
assist O 0 1.3249498720391273e-10
in O 0 1.429292708493568e-11
the O 0 2.9506785903521404e-11
development O 0 3.221151470556016e-11
of O 0 1.4830697780965352e-10
strategies O 0 7.898684484253238e-11
for O 0 2.462234626257609e-12
the O 0 4.8421565368439445e-11
prevention O 0 5.8114729029057344e-08
and O 0 8.702696549511835e-12
, O 0 3.941969092726566e-13
where O 0 3.7390281300807293e-13
necessary O 0 6.719089260670552e-12
, O 0 6.457187649161478e-12
management O 0 4.038482326329529e-10
of O 0 2.414268784889373e-09
a O 0 1.19088031103054e-10
risk O 0 3.0101685033478986e-10
reversal O 0 3.548645266526762e-10
in O 0 8.728196984608694e-12
any O 0 4.695935047066557e-12
predictive O 0 4.5214193500342503e-10
testing O 0 4.273877252103375e-09
program O 0 6.559531251504325e-10
. O 0 2.680506858143694e-11
. O 0 2.555378963986499e-10

A O 0 2.393131353528588e-06
novel O 0 1.9851441379614698e-08
common O 0 2.6829851673682015e-09
missense O 0 7.340142360590107e-08
mutation O 0 1.4729444330896513e-09
G301C O 0 8.507993243256351e-08
in O 0 5.898257438019527e-10
the O 0 3.187217822997468e-09
N O 0 1.7411711894510518e-07
- O 0 7.529416734541883e-08
acetylgalactosamine O 0 4.657441877498059e-06
- O 0 1.9580936339025357e-07
6 O 0 4.6859593538783884e-08
- O 0 1.4998038366798028e-08
sulfate O 0 3.1698244029598754e-09
sulfatase O 0 2.551486659285729e-06
gene O 0 2.9009821211900544e-09
in O 0 1.8073279539621012e-09
mucopolysaccharidosis B-Disease 0 0.21680936217308044
IVA I-Disease 1 1.0
. O 0 1.309233255142317e-07

Mucopolysaccharidosis B-Disease 1 0.9999977350234985
IVA I-Disease 1 1.0
( O 0 4.953777533955872e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 4.283140064842428e-09
is O 0 2.367162672475831e-12
an O 0 4.1264327024781444e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 8.760025957599282e-05
by O 0 3.187884956012965e-10
a O 0 1.2826029127666061e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.6253718371217474e-08
N O 0 1.8811160771292634e-06
- O 0 2.87289367406629e-07
acetylgalactosamine O 0 3.521153485053219e-05
- O 0 1.5667948218833772e-06
6 O 0 8.467373504572606e-07
- O 0 4.3712364572456863e-07
sulfate O 0 3.708857931883358e-08
sulfatase O 0 4.165036807535216e-05
( O 0 1.8100266174769786e-08
GALNS O 1 1.0
) O 0 1.7586991862827972e-09
. O 0 6.08029016024858e-10

In O 0 4.017625343522013e-09
previous O 0 1.0713252507343896e-09
studies O 0 1.6051200646405306e-10
, O 0 3.1624943549329876e-12
we O 0 2.567863456592878e-13
have O 0 4.752417263973602e-14
found O 0 1.1979139468570876e-12
two O 0 3.2101632550102233e-13
common O 0 5.2164991076741885e-12
mutations O 0 1.0381016359028994e-11
in O 0 4.073338541465965e-11
Caucasians O 0 2.6008946107936026e-09
and O 0 1.8480987573621377e-10
Japanese O 0 2.9595219075417845e-07
, O 0 5.053589768877487e-10
respectively O 0 7.009730129681202e-09
. O 0 2.6913753448098987e-09

To O 0 3.6928395896751454e-09
characterize O 0 1.446215378564375e-07
the O 0 3.988603225479892e-09
mutational O 0 3.056551918234618e-07
spectrum O 0 5.376638245735421e-09
in O 0 2.1889471138458738e-11
various O 0 1.1935311246269453e-11
ethnic O 0 3.5395278830292753e-13
groups O 0 1.0723146410531945e-13
, O 0 4.4866370276126777e-13
mutations O 0 5.859096194327229e-12
in O 0 7.396032571105327e-12
the O 0 4.3678816119552266e-10
GALNS O 1 0.9996567964553833
gene O 0 8.900252757015892e-10
in O 0 4.879271431335042e-10
Colombian O 0 4.6354812184290495e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 5.3809703359775085e-08
were O 0 2.2718997516602002e-10
investigated O 0 1.0934732230793998e-08
, O 0 2.937656368162678e-11
and O 0 1.547534149437535e-11
genetic O 0 1.0130377092743004e-10
backgrounds O 0 1.389477942426165e-11
were O 0 1.0315054366216714e-11
extensively O 0 6.727658707905704e-11
analyzed O 0 1.347936762208235e-10
to O 0 1.8270536993048037e-12
identify O 0 3.84879211834388e-11
racial O 0 5.40144561023137e-11
origin O 0 7.20224964737004e-12
, O 0 5.872911206829257e-13
based O 0 8.282563870865012e-12
on O 0 1.3488522798699165e-10
mitochondrial O 0 1.691923684488117e-10
DNA O 0 1.5301198530437432e-08
( O 0 2.3684916874988637e-11
mtDNA O 0 6.15109463364405e-10
) O 0 2.1137402592130705e-11
lineages O 0 8.568517562146383e-10
. O 0 5.535618075036552e-10

Three O 0 5.033661665265754e-08
novel O 0 1.747151756603671e-08
missense O 0 2.352108907643924e-07
mutations O 0 8.505782744805401e-09
never O 0 2.0337007633486337e-09
identified O 0 1.3621463679225343e-10
previously O 0 1.8470484863808423e-10
in O 0 3.1333082829709813e-12
other O 0 1.3917742826274893e-12
populations O 0 5.22884849567945e-13
and O 0 1.5239595609756185e-12
found O 0 7.763937062699178e-12
in O 0 1.5965942110063303e-11
16 O 0 6.36961039468531e-10
out O 0 2.580110430860927e-11
of O 0 7.156739090241615e-10
19 O 0 1.908876079426136e-08
Colombian O 0 1.3974781722936314e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 6.232611440282199e-07
alleles O 0 2.626977108066697e-11
account O 0 2.726241801753737e-11
for O 0 2.2270395250156838e-10
84 O 0 3.0590015853704244e-07
. O 0 6.290460596858338e-09

2 O 0 9.454673488562548e-08
% O 0 2.3782968650021274e-11
of O 0 6.435452865050095e-11
the O 0 1.046445135405305e-11
alleles O 0 1.2858851353506062e-12
in O 0 3.8493114945525875e-12
this O 0 7.278989693978999e-13
study O 0 1.0681682621749289e-10
. O 0 2.4291593736514017e-10

The O 0 3.0947148843551986e-07
G301C O 0 3.77594346900878e-06
and O 0 3.6753429188962627e-09
S162F O 0 1.3392178743742988e-07
mutations O 0 1.0241270331778907e-10
account O 0 2.081513607310459e-11
for O 0 2.6503813033151857e-10
68 O 0 2.124179303564233e-07
. O 0 1.4671909243091363e-09

4 O 0 5.314066697792441e-07
% O 0 1.7865776913428277e-10
and O 0 2.1569362962381433e-10
10 O 0 6.061616097952083e-09
. O 0 1.918587955174189e-09

5 O 0 2.5405590520222177e-08
% O 0 7.642227128901169e-12
of O 0 1.1442146535811659e-10
mutations O 0 5.092192986722033e-11
, O 0 5.6187575425692415e-11
respectively O 0 6.885220726893237e-10
, O 0 1.8360431230934893e-11
whereas O 0 2.155109250778775e-11
the O 0 1.0763797492208127e-10
remaining O 0 4.8098347527059104e-09
F69V O 1 0.9999995231628418
is O 0 1.10781384066172e-11
limited O 0 7.493583878415144e-12
to O 0 3.0805976259512535e-12
a O 0 7.473348329067875e-11
single O 0 1.495338408652458e-09
allele O 0 1.0987557530484082e-09
. O 0 7.899457199478377e-10

The O 0 4.912782713972774e-08
skewed O 0 3.6663543312442926e-08
prevalence O 0 5.6831009231927965e-08
of O 0 2.816446187381416e-09
G301C O 0 4.065955039322944e-08
in O 0 6.997059182056731e-11
only O 0 1.4945383472464435e-11
Colombian O 0 7.691387970965025e-09
patients O 0 1.8018783687345774e-10
and O 0 2.8379536567979535e-11
haplotype O 0 2.53583154474768e-10
analysis O 0 1.7054789872017473e-11
by O 0 6.716983740051585e-13
restriction O 0 6.37875906608909e-12
fragment O 0 6.281081765813212e-10
length O 0 2.864749236441977e-11
polymorphisms O 0 3.173845908310824e-10
in O 0 2.3533073059689436e-11
the O 0 3.2039837449815423e-10
GALNS O 1 0.9999995231628418
gene O 0 9.202835715704794e-10
suggest O 0 2.336152105097966e-11
that O 0 5.297007407353838e-13
G301C O 0 6.459464518826508e-09
originated O 0 1.7392169648910993e-10
from O 0 8.234269169293817e-12
a O 0 1.6819099932230408e-11
common O 0 1.6251591739013804e-10
ancestor O 0 1.6976340333485496e-08
. O 0 4.311351720076573e-09

Investigation O 0 1.0001870265341495e-07
of O 0 1.5145998233379032e-08
the O 0 2.6268481834179624e-10
genetic O 0 1.7707009469791757e-10
background O 0 1.2146919754763008e-11
by O 0 1.0554750433031113e-12
means O 0 1.1493543963791986e-11
of O 0 1.2120611458943387e-10
mtDNA O 0 1.8294196713064537e-10
lineages O 0 1.6762478557974525e-11
indicate O 0 8.22406639316986e-12
that O 0 3.8005181141921585e-13
all O 0 1.4145876310600602e-11
our O 0 2.523480036042969e-10
patients O 0 5.838283329007155e-11
are O 0 3.296013635634143e-13
probably O 0 5.002156328037799e-11
of O 0 5.576598072210004e-10
native O 0 6.894840809401614e-10
American O 0 2.6181572465588943e-08
descent O 0 2.072566047672808e-07

Low O 0 8.642798832170229e-08
frequency O 0 6.931606399973589e-09
of O 0 7.473783369960074e-09
BRCA1 O 0 2.168397550406098e-08
germline O 0 1.59433550805943e-08
mutations O 0 1.9165061204695633e-10
in O 0 1.000941343698436e-10
45 O 0 4.39195169121831e-09
German O 1 1.0
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.5880735615425579e-09
. O 0 1.4532762770969043e-09

In O 0 5.251407309003753e-09
this O 0 4.844131606257518e-12
study O 0 6.464877678330483e-12
we O 0 7.889612899623921e-13
investigated O 0 1.3552071687072953e-09
45 O 0 2.65742872151975e-09
German O 1 0.9999983310699463
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.0844619353386236e-12
for O 0 1.1694018149654983e-11
germline O 0 7.860983863849924e-09
mutations O 0 4.1753650537046383e-10
in O 0 1.4950894688947614e-10
the O 0 3.4186684594317285e-09
BRCA1 O 0 6.087914243835257e-07
gene O 0 5.2491365920559474e-08
. O 0 1.0561880259274403e-08

We O 0 7.661855150331576e-09
identified O 0 4.9600732410226556e-09
four O 0 8.512822669004549e-10
germline O 0 4.77155133182805e-08
mutations O 0 5.192246188556737e-09
in O 0 3.1972033909255515e-09
three O 0 1.2201464016925456e-07
breast B-Disease 1 0.9999607801437378
cancer I-Disease 0 7.86980235716328e-05
families O 0 2.011209601637809e-11
and O 0 6.055245194147574e-10
in O 0 1.2973927709936106e-08
one O 0 2.1223913790890947e-05
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 9.379907961459821e-10
. O 0 2.942163006280918e-12
among O 0 2.025939095304241e-12
these O 0 1.7904443119082236e-12
were O 0 1.2678305627567e-10
one O 0 3.8062383106440834e-11
frameshift O 0 3.8438752625324923e-08
mutation O 0 1.1628016327591695e-09
, O 0 1.421873174756172e-10
one O 0 9.38255098614782e-11
nonsense O 0 4.5722262598246743e-07
mutation O 0 1.9825627806113744e-09
, O 0 1.264063853589903e-10
one O 0 8.765801452759181e-12
novel O 0 1.093326124079752e-10
splice O 0 2.1597006849560785e-08
site O 0 7.196242490792315e-10
mutation O 0 1.9836129960815185e-10
, O 0 2.6355992041593446e-11
and O 0 1.6192741592035986e-10
one O 0 4.253325469605329e-10
missense O 0 1.7512206795800012e-06
mutation O 0 5.58978747733363e-08
. O 0 2.765536244453415e-08

The O 0 5.8280345882621987e-08
missense O 0 2.395576359504048e-07
mutation O 0 2.5765820588219412e-09
was O 0 5.141777670303327e-09
also O 0 2.4363643047475847e-11
found O 0 3.054760611131968e-11
in O 0 1.454207171347477e-10
2 O 0 2.7870191487977536e-08
. O 0 1.1969610858031388e-09

8 O 0 2.1384846604632912e-07
% O 0 2.7689944087638807e-11
of O 0 1.5483203608113172e-10
the O 0 1.1137756515677832e-11
general O 0 2.6966191432609143e-11
population O 0 1.9926502939013324e-13
, O 0 5.486248933449234e-13
suggesting O 0 6.2436653069930514e-12
that O 0 1.0753151028029123e-13
it O 0 1.0717733124609996e-12
is O 0 1.4909644699412361e-12
not O 0 2.6482474199673867e-11
disease O 0 4.217544756102143e-06
associated O 0 9.884586482655777e-09
. O 0 6.285926446025769e-09

The O 0 1.4757910449247902e-08
average O 0 2.493861506192019e-10
age O 0 1.7053627954233264e-10
of O 0 4.574125078704583e-09
disease O 0 0.005856264848262072
onset O 0 4.856954660681367e-07
in O 0 5.186101981885516e-12
those O 0 7.971856139619982e-13
families O 0 4.750054516389213e-13
harbouring O 0 4.8896083626459586e-08
causative O 0 1.1368153529645042e-08
mutations O 0 2.4437338819183196e-09
was O 0 1.490461443154345e-08
between O 0 6.289140319637454e-09
32 O 0 4.0792457411953364e-08
. O 0 1.5527926722214147e-09

3 O 0 1.88013325441716e-06
and O 0 1.1987575376792847e-08
37 O 0 7.939705426451837e-08
. O 0 2.3882271715791603e-09

4 O 0 4.876624757343961e-07
years O 0 7.386848355217523e-10
, O 0 1.6647296388616617e-11
whereas O 0 2.747592604823712e-11
the O 0 8.82155806736229e-11
family O 0 1.0338696565526106e-10
harbouring O 0 5.075125955045223e-07
the O 0 1.7607163504962386e-09
missense O 0 2.6164000743733595e-08
mutation O 0 1.2855823350310658e-10
had O 0 1.7901242987949928e-11
an O 0 6.822670141522214e-13
average O 0 6.4157667893638415e-12
age O 0 5.893396187728328e-11
of O 0 1.2787841896511054e-09
onset O 0 1.2251934094820172e-05
of O 0 4.290337471957173e-07
51 O 0 1.8783720179271768e-07
. O 0 1.3135675658304535e-08

2 O 0 5.3812755140825175e-06
years O 0 1.0072509049052769e-08
. O 0 3.3195977078293026e-09

These O 0 2.2994399717646274e-09
findings O 0 8.717861099682978e-09
show O 0 6.768114402255776e-10
that O 0 5.543536983620978e-12
BRCA1 O 0 7.452872097246654e-09
is O 0 2.6518766349514777e-11
implicated O 0 3.7739703029338045e-10
in O 0 3.5549573701443293e-11
a O 0 7.43912743905728e-12
small O 0 2.1349176766716216e-12
fraction O 0 2.662712585144167e-11
of O 0 1.028646238410147e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.961024216958542e-12
suggesting O 0 2.765057106890456e-11
the O 0 1.682256590973541e-11
involvement O 0 3.445459750839319e-10
of O 0 1.8368681020675126e-09
another O 0 1.76613404456738e-10
susceptibility O 0 3.177446927793426e-08
gene O 0 5.970952621225933e-09
( O 0 2.1414463535762707e-09
s O 0 5.952284141130804e-07
) O 0 2.0287039603772428e-08

Paternal O 0 4.7057634219527245e-05
transmission O 0 0.449815571308136
of O 1 0.9999961853027344
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0007221581181511283

We O 0 1.7980109845439074e-08
report O 0 1.0059409971674427e-09
a O 0 6.704933830370408e-11
rare O 0 1.89751936385818e-10
case O 0 1.010760294906099e-10
of O 0 1.4168229256483755e-08
paternally O 1 0.9999988079071045
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9087168574333191
DM B-Disease 1 1.0
) O 0 4.860995517219635e-08
. O 0 3.562644845800378e-09

The O 0 5.285444899527647e-07
proband O 0 6.490537634817883e-05
is O 0 3.0930941141704693e-10
a O 0 1.388424236692387e-10
23 O 0 5.780626199936023e-09
year O 0 1.7542491070887678e-10
old O 0 2.9012667823735683e-07
, O 0 1.302853203100085e-08
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 3.609864620557346e-07
who O 0 2.4782730534411712e-08
suffers O 1 0.9999996423721313
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 9.034652612172067e-05

He O 0 6.415741893306404e-08
presented O 0 8.208442636714608e-08
with O 0 1.7196054358237234e-08
respiratory O 1 1.0
and O 0 7.460612039267289e-08
feeding O 0 3.848071514767071e-07
difficulties O 0 5.7901296202089725e-08
at O 0 1.6470619357278338e-07
birth O 0 4.585938313539373e-07
. O 0 2.9597566619798954e-09

His O 0 1.2807421398974839e-06
two O 0 2.7661798185363295e-08
sibs O 1 0.9763653874397278
suffer O 0 2.5105427994276397e-06
from O 0 4.1685902374410944e-07
childhood O 1 0.9999972581863403
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 6.97122573001252e-07

Their O 0 8.557955233357006e-09
late O 0 6.915696104670133e-08
father O 0 5.6677702531260366e-09
had O 0 3.0384320059972936e-11
the O 0 2.6824400339853227e-11
adult O 0 1.709126069837641e-11
type O 0 3.3841909830023553e-10
of O 0 3.818700378133144e-08
DM B-Disease 1 1.0
, O 0 4.448589940864167e-09
with O 0 1.4937953651816827e-10
onset O 0 6.130833935458213e-05
around O 0 1.0169605157983597e-09
30 O 0 5.343389064549342e-10
years O 0 4.956682633783238e-11
. O 0 1.895569534671182e-10

Only O 0 1.7453356537799891e-09
six O 0 2.010259458895547e-10
other O 0 2.5624424457304507e-13
cases O 0 6.241399541292991e-13
of O 0 4.250184926224421e-11
paternal O 0 6.835148891326526e-09
transmission O 0 0.0002511822385713458
of O 1 0.9997791647911072
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 8.80398420832762e-09
been O 0 4.925114760467864e-10
reported O 0 1.5470575931431085e-09
recently O 0 7.243507571530472e-09
. O 0 4.081337490191572e-09

We O 0 1.7710395372461107e-09
review O 0 5.802118785425137e-10
the O 0 2.6819898732433067e-11
sex O 0 5.299152176091448e-12
related O 0 5.82020508177461e-11
effects O 0 5.139934700082449e-09
on O 0 2.0016899249242215e-09
transmission O 0 4.76893092127284e-07
of O 0 1.7014646118695964e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.8748942238744348e-06

Decreased O 0 1.6522945145425183e-07
fertility O 0 1.0429182850657526e-07
of O 0 2.6831388222348096e-09
males O 0 1.956429809824023e-12
with O 0 2.5038536782123755e-12
adult O 0 1.5297930033852936e-08
onset O 0 0.22350634634494781
DM B-Disease 1 1.0
and O 0 1.936563620574816e-08
contraction O 0 5.5366797369060805e-08
of O 0 3.944519377796496e-09
the O 0 1.0752634893584911e-10
repeat O 0 2.5236290834840247e-10
upon O 0 7.848241501129394e-11
male O 0 9.76785388684398e-11
transmission O 0 4.519108420808493e-10
contribute O 0 4.5444646309955594e-12
to O 0 2.5293753636718153e-12
the O 0 5.483451193111222e-11
almost O 0 4.625371700234249e-12
absent O 0 3.1221841084727586e-11
occurrence O 0 1.3636767930147453e-11
of O 0 4.5077080956801296e-11
paternal O 0 4.199647740676937e-09
transmission O 0 4.185969373793341e-06
of O 0 0.003424231428653002
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.2721292478090618e-05

Also O 0 5.6232125622557305e-09
the O 0 9.84786807656235e-10
fathers O 0 5.893098897757909e-09
of O 0 2.5492172817109804e-09
the O 0 1.1159713153574558e-09
reported O 0 5.51164180961905e-09
congenitally O 0 1.7928485249285586e-05
affected O 0 1.6951426928812907e-08
children O 0 4.694399868832022e-10
showed O 0 5.538258740500623e-10
, O 0 2.1842383804426824e-11
on O 0 2.5441351803046075e-10
average O 0 1.7895449011540165e-10
, O 0 1.2904564916649264e-10
shorter O 0 1.761643488862319e-07
CTG O 0 0.14351841807365417
repeat O 0 2.7428956173025654e-07
lengths O 0 1.871975285894223e-07
and O 0 4.6242645823646455e-10
hence O 0 2.630999862418548e-10
less O 0 2.8126226347957584e-10
severe O 0 0.012210196815431118
clinical O 1 0.9999796152114868
symptoms O 1 0.857703685760498
than O 0 7.555223807687028e-12
the O 0 1.0538708100638061e-10
mothers O 0 2.3821920130950858e-11
of O 0 3.6694361438271983e-10
children O 0 2.970500512233798e-10
with O 0 7.691171077794934e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 3.8883285014890134e-05

We O 0 2.7573916483447647e-09
conclude O 0 5.4434621254983995e-09
that O 0 4.101339493717271e-12
paternal O 0 3.085025568339006e-08
transmission O 0 1.622430318093393e-05
of O 1 0.9057857990264893
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 1.2530492199402943e-08
rare O 0 2.5485658028401303e-09
and O 0 3.882960966650195e-11
preferentially O 0 1.489794815290324e-10
occurs O 0 1.9824244676391878e-11
with O 0 1.6383475522421809e-12
onset O 0 2.2698870907333912e-06
of O 0 4.276240588296787e-07
DM B-Disease 1 1.0
past O 0 2.3017190642349306e-07
30 O 0 3.1923144683254634e-10
years O 0 1.6121661297607837e-12
in O 0 9.63178972343548e-13
the O 0 3.1277869183554685e-11
father O 0 1.7868513335628222e-09
. O 0 7.562364623403539e-11
. O 0 5.497360899830994e-10

The O 0 7.989240771166806e-07
RB1 O 0 0.0013335985131561756
gene O 0 5.968197047678814e-09
mutation O 0 4.2720476461921564e-11
in O 0 1.0061549683693105e-11
a O 0 2.211985594691157e-10
child O 0 7.852415961906445e-08
with O 0 1.740473010158894e-08
ectopic B-Disease 1 0.9999921321868896
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.9999998807907104
. O 0 2.5384315449628048e-06

The O 0 1.0804689054566552e-06
RB1 O 0 0.13540798425674438
gene O 0 4.220262184162493e-08
mutation O 0 1.630827139997848e-09
was O 0 8.249793070902456e-10
investigated O 0 4.060280112128112e-09
in O 0 9.02490096543751e-11
a O 0 2.827532652460718e-10
child O 0 1.1970895386070879e-08
with O 0 7.26439575160498e-10
ectopic B-Disease 0 2.465260331518948e-05
intracranial I-Disease 0 1.6156058336491697e-05
retinoblastoma I-Disease 0 4.287067440600367e-06
using O 0 9.193817929187276e-10
DNA O 0 4.9282959935226245e-08
obtained O 0 3.7176009493045115e-10
from O 0 2.374160312790252e-10
both O 0 3.730555100944777e-11
the O 0 1.0544946027479796e-09
pineal B-Disease 0 0.004097350873053074
and I-Disease 0 4.3483929346166406e-08
retinal I-Disease 1 0.9999651908874512
tumours I-Disease 1 1.0
of O 0 0.0007375961286015809
the O 0 4.4789274511458643e-07
patient O 0 1.5641624486306682e-05
. O 0 1.3109994867477326e-08

A O 0 1.1068375897593796e-05
nonsense O 0 2.0731899894599337e-06
mutation O 0 1.8017590752705814e-09
in O 0 1.0930680804932535e-09
exon O 0 1.6891031862087402e-07
17 O 0 6.525656459643869e-08
( O 0 1.241900610127189e-10
codon O 0 3.5913405582732594e-09
556 O 0 1.1995718196544658e-08
) O 0 7.698670694000764e-12
of O 0 3.279832794245152e-10
the O 0 2.4473070237007732e-09
RB1 O 1 0.8441532254219055
gene O 0 1.7772932014992193e-09
was O 0 5.522193813334297e-10
found O 0 1.003839286001229e-11
to O 0 6.980044255262829e-13
be O 0 8.985729911883955e-13
present O 0 6.065380142583621e-11
homozygously O 0 2.6878481662606646e-07
in O 0 1.0304872927191511e-10
both O 0 1.6181866610565088e-11
the O 0 6.081797843116021e-10
retinal B-Disease 0 7.729051958449418e-07
and I-Disease 0 7.431097959198496e-09
the I-Disease 0 2.612735272577993e-07
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 4.2768647290358786e-07

The O 0 8.715550059434918e-09
same O 0 3.8831906440384145e-11
mutation O 0 4.8659784535054484e-11
was O 0 2.8696670040240235e-10
present O 0 4.9899782222917466e-11
heterozygously O 0 1.1434832458689925e-07
in O 0 7.43805295133626e-11
the O 0 3.486916658190786e-11
DNA O 0 4.325328983867394e-09
from O 0 2.2463727059052196e-11
the O 0 4.222218061289418e-12
constitutional O 0 1.1633180529990739e-10
cells O 0 3.1572525843737154e-11
of O 0 1.538417587765295e-10
the O 0 1.0490235763382927e-10
patient O 0 5.481961107278721e-09
, O 0 2.3390010414625628e-11
proving O 0 2.7741142716308786e-09
it O 0 3.8940896405874337e-13
to O 0 9.855576641251695e-13
be O 0 3.3334368251813906e-12
of O 0 4.6397433117739695e-10
germline O 0 2.515687391735355e-08
origin O 0 7.118511335946209e-10
. O 0 1.466866295096736e-09

The O 0 1.9008103535611554e-08
initial O 0 6.873674407437136e-10
mutation O 0 1.2124727610807184e-10
was O 0 1.4565666728305615e-10
shown O 0 4.764238916571406e-12
to O 0 1.0825925659402325e-12
have O 0 1.2783379227127717e-13
occurred O 0 7.404759444495923e-11
in O 0 3.446540578974644e-12
the O 0 7.026213638683387e-11
paternally O 0 1.1727522775117905e-07
derived O 0 1.346558242687479e-08
RB1 O 0 0.00027992474497295916
allele O 0 3.037115448023542e-08
. O 0 7.321011796790344e-09

The O 0 3.013721894262744e-08
mutation O 0 7.108457156235204e-10
is O 0 3.553518156812485e-12
in O 0 1.1758246286353025e-12
an O 0 3.6104127500158345e-13
area O 0 6.689260256820262e-11
of O 0 1.0499624086834913e-10
the O 0 4.165983877313373e-11
gene O 0 3.892680448813746e-12
that O 0 2.205793192414443e-13
encodes O 0 2.233418094563233e-12
the O 0 5.383220605392758e-11
protein O 0 8.642720566998108e-11
- O 0 3.5159311018162498e-09
binding O 0 1.728028276026805e-09
region O 0 2.5090254318627103e-09
known O 0 1.5738731151682117e-10
as O 0 1.4427576321141e-11
the O 0 1.315707542914879e-10
pocket O 0 2.8452106448639825e-07
region O 0 1.712861297242796e-09
and O 0 8.175025933976343e-11
has O 0 2.0955823881729785e-12
been O 0 1.3671294998851558e-12
detected O 0 9.823868107883271e-11
in O 0 1.1684536801656598e-12
other O 0 8.203163625805643e-13
cases O 0 3.053455752133338e-11
of O 0 3.3757863171501867e-09
retinoblastoma B-Disease 0 2.3640780000278028e-06
. O 0 1.6898411558941007e-09
. O 0 3.3240583618976416e-09

Low O 0 8.810655458546535e-07
levels O 0 9.061856154346515e-09
of O 0 3.961022621012944e-09
beta O 0 4.201618164501042e-09
hexosaminidase O 0 2.0694749025551573e-07
A O 0 5.218825371855473e-09
in O 0 2.561555828561879e-11
healthy O 0 1.0489735469132455e-10
individuals O 0 2.883527563859317e-13
with O 0 3.259618616691107e-11
apparent O 0 0.0010283731389790773
deficiency O 1 0.999985933303833
of O 0 0.00011319453187752515
this O 0 3.147441474116164e-10
enzyme O 0 2.6842458922260448e-08
. O 0 4.271351272677748e-09

Appreciable O 0 7.355414254561765e-06
beta O 0 1.1319351642669062e-06
hexosaminidase O 0 7.804438791936263e-05
A O 0 1.0041262612503488e-05
( O 0 2.7618025644216004e-09
hex O 0 1.6559795312787173e-07
A O 0 1.2394519899316947e-07
) O 0 4.79575667372556e-12
activity O 0 4.620136564992272e-11
has O 0 3.5226230027558814e-13
been O 0 6.006487082883816e-13
detected O 0 3.0613414581104337e-10
in O 0 5.87469933810425e-11
cultured O 0 8.217966751544736e-08
skin O 0 0.0003477422578725964
fibroblasts O 0 1.190870619893758e-07
and O 0 6.078764869243969e-08
melanoma B-Disease 1 0.9998409748077393
tissue O 0 5.65254094908596e-06
from O 0 9.871891393231635e-08
healthy O 0 1.0657252857981803e-08
individuals O 0 2.3373273802529404e-12
previously O 0 1.1250759213154993e-09
reported O 0 5.447468032215852e-10
as O 0 6.436389199393489e-10
having O 0 6.473589309052841e-08
deficiency B-Disease 1 0.864395022392273
of I-Disease 0 0.0009698111680336297
hex I-Disease 0 2.9184211598476395e-06
A I-Disease 0 1.4091949651628966e-07
activity O 0 2.5942298309544753e-10
indistinguishable O 0 3.237320966853474e-10
from O 0 4.201612148480027e-12
that O 0 6.148665696601233e-14
of O 0 4.232379724466995e-11
patients O 0 1.0269103623006259e-10
with O 0 6.0782179289731175e-09
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 7.582283956253377e-07
TSD B-Disease 1 1.0
) O 0 7.322519923746995e-09
. O 0 1.5265423369825726e-09

Identification O 0 1.6997813645502902e-07
and O 0 2.2175714597949536e-09
quantitation O 0 2.5822768293437548e-05
of O 0 1.6104073665701435e-06
hex O 0 1.930342477862723e-06
A O 0 1.4989077499194536e-06
, O 0 9.040889564770893e-11
amounting O 0 2.8579721922383783e-10
to O 0 2.1353273316204735e-10
3 O 0 3.3123889409125695e-08
. O 0 1.866972798580946e-09

5 O 0 4.87205966237525e-07
% O 0 2.3604034282698194e-09
- O 0 1.0567566732788691e-07
6 O 0 1.722026752304373e-07
. O 0 1.896825363445487e-09

9 O 0 4.263816038019286e-07
% O 0 6.592690976470195e-11
of O 0 6.723057111024389e-10
total O 0 4.303862127796876e-11
beta O 0 8.973035647841243e-10
hexosaminidase O 0 1.6001291669454076e-07
activity O 0 4.781476881099422e-10
, O 0 5.1776812004522554e-12
has O 0 1.6981738010148767e-13
been O 0 2.3606596820553716e-13
obtained O 0 9.072981081714726e-12
by O 0 7.000583446270525e-11
cellulose O 0 7.254568572534481e-06
acetate O 0 2.872745596960158e-07
gel O 0 1.7301795551816213e-08
electrophoresis O 0 8.342539103978197e-09
, O 0 6.599651936056716e-10
DEAE O 0 0.04671313613653183
- O 0 6.623631065849622e-08
cellulose O 0 2.407655870229064e-07
ion O 0 2.5776536460853094e-09
- O 0 6.192191648324297e-09
exchange O 0 2.7076291209127135e-10
chromatography O 0 4.4862634496212195e-08
, O 0 3.055496133885782e-10
radial O 0 3.438491091856122e-08
immunodiffusion O 0 1.9668145796458703e-06
, O 0 6.524144557928935e-10
and O 0 2.8960120967980174e-09
radioimmunoassay O 0 9.848416084423661e-05
. O 0 3.0343592527515284e-08

Previous O 0 2.4945069299064926e-07
family O 0 2.2335992777566815e-10
studies O 0 1.0988453202909199e-10
suggested O 0 1.2863371826044023e-11
that O 0 7.30673591835089e-14
these O 0 3.032500194965343e-13
individuals O 0 9.286235653051603e-14
may O 0 1.9748831476401607e-12
be O 0 1.5647421509543125e-12
compound O 0 4.491070570988853e-10
heterozygotes O 0 8.95723550886629e-10
for O 0 5.8927190384194805e-12
the O 0 3.879126533878896e-11
common O 0 1.2814792282878074e-10
mutant O 0 8.206466617366459e-09
TSD B-Disease 0 0.2896991968154907
gene O 0 5.268560032689606e-10
and O 0 3.538221798882191e-11
a O 0 4.682110602005629e-11
rare O 0 6.830962462345269e-10
( O 0 4.7572397410267087e-11
allelic O 0 4.338120618285757e-08
) O 0 4.265045955298419e-11
mutant O 0 7.69788854881881e-09
gene O 0 5.115922352416646e-09
. O 0 1.1403763489070684e-09

Thus O 0 4.697341893233897e-08
, O 0 1.5769861805292607e-10
the O 0 1.5135059872051215e-11
postulated O 0 6.059970858451891e-10
rate O 0 7.524151440785332e-11
mutant O 0 4.723355595537271e-10
gene O 0 4.2425715718330537e-11
appears O 0 4.727965848688731e-12
to O 0 2.043557516132402e-13
code O 0 1.1432100925634625e-12
for O 0 2.373898603733049e-13
the O 0 1.4987082755379966e-12
expression O 0 1.6977082717070657e-12
of O 0 2.8217235839567145e-11
low O 0 1.4302206641225723e-10
amounts O 0 1.128031435621013e-11
of O 0 1.1297766056017622e-09
hex O 0 3.218823110273661e-07
A O 0 8.592499511905771e-07
. O 0 5.594274821163481e-09

Heterozygotes O 0 3.3929959499801043e-06
for O 0 2.3388562198078944e-09
the O 0 1.2146167405191477e-09
rare O 0 3.379857949070697e-09
mutant O 0 3.1349451923290417e-09
may O 0 1.6209235342845574e-11
be O 0 1.3083540327529786e-12
indistinguishable O 0 1.0739030775752667e-09
from O 0 3.0599505568273955e-11
heterozygotes O 0 9.485334739878226e-10
for O 0 1.9543420701206848e-11
the O 0 3.9943875984604915e-10
common O 0 7.802397838929664e-09
TSD B-Disease 1 0.9967003464698792
mutant O 0 4.844362706535321e-07
. O 0 9.072545381627606e-09

However O 0 2.8753828207328525e-09
, O 0 2.3329905715629984e-11
direct O 0 8.038491747242027e-12
visualization O 0 7.61960627926328e-09
and O 0 2.098224233249013e-10
quantitation O 0 7.33997057977831e-06
of O 0 4.182550981113309e-07
hex O 0 3.740015301900712e-07
A O 0 3.8199463148202994e-08
by O 0 9.075871998387441e-12
the O 0 1.2609904440075148e-11
methods O 0 1.8796131318055131e-10
described O 0 3.2692151763491495e-10
may O 0 4.8543447039861576e-11
prevent O 0 3.0231145364822964e-10
false O 0 2.8451161426801264e-09
- O 0 3.794977221360796e-09
positive O 0 1.3324785719248666e-11
prenatal O 0 9.04762575970608e-09
diagnosis O 0 2.3195942944198578e-08
of O 0 7.916052702228171e-09
TSD B-Disease 1 0.9999951124191284
in O 0 4.014201415714069e-09
fetuses O 0 3.2571001895576046e-08
having O 0 1.5335367697932867e-10
the O 0 3.410291216088268e-10
incomplete O 0 4.3412788386376633e-07
hex B-Disease 0 2.0224111722200178e-05
A I-Disease 1 0.9990202188491821
deficiency I-Disease 1 0.9843730926513672
of O 0 5.326204700395465e-06
the O 0 3.931352132724442e-09
type O 0 7.103896138005439e-08
described O 0 1.6322180274030984e-09
in O 0 1.8001848622883898e-10
the O 0 1.0766718627763794e-09
four O 0 1.8089970632573227e-09
healthy O 0 1.5434508782163903e-08
individuals O 0 1.437561958361755e-09

The O 0 2.9836405701644253e-07
tumor B-Disease 0 1.1728992603821098e-06
suppressor O 0 1.8418633089822833e-06
gene O 0 8.819148433758528e-08
Smad4 O 0 0.00036273300065658987
/ O 0 1.666424395807553e-06
Dpc4 O 0 1.0210364962404128e-05
is O 0 5.51510399848798e-12
required O 0 4.2948726172720164e-12
for O 0 1.4097576188018546e-12
gastrulation O 0 1.4698488826070388e-07
and O 0 1.3167261551927378e-11
later O 0 9.953555341057907e-11
for O 0 3.446448638630417e-12
anterior O 0 2.537835941396338e-09
development O 0 5.312212336683331e-10
of O 0 7.741443042164065e-09
the O 0 2.881938909737869e-09
mouse O 0 6.8212790971244885e-09
embryo O 0 1.3286763689279724e-08
. O 0 3.2928972881762775e-09

Mutations O 0 3.532347392365409e-08
in O 0 4.231221595318857e-09
the O 0 2.0315074067411842e-08
SMAD4 O 1 1.0
/ O 0 7.136032945709303e-05
DPC4 O 1 0.9999885559082031
tumor B-Disease 0 1.3821220079535124e-07
suppressor O 0 3.705852336111093e-08
gene O 0 1.0886279655508702e-09
, O 0 3.734135917143888e-11
a O 0 6.02716140885029e-11
key O 0 9.631882846861117e-09
signal O 0 3.840189322090737e-08
transducer O 0 9.46351335073814e-08
in O 0 4.54832782548209e-10
most O 0 8.217453800751784e-11
TGFbeta O 0 2.252251397294458e-05
- O 0 8.660290262696435e-08
related O 0 3.278053739563802e-08
pathways O 0 3.149400518154266e-09
, O 0 7.095973548337797e-12
are O 0 1.0515199821981014e-13
involved O 0 1.437548756248741e-12
in O 0 7.26786686389147e-12
50 O 0 9.185942978495731e-11
% O 0 3.421402701084264e-12
of O 0 7.170104954212775e-09
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 3.00791072049833e-07

Homozygous O 0 3.642257070168853e-05
Smad4 O 0 0.006460761651396751
mutant O 0 1.1683549928420689e-05
mice O 0 1.2254832881808397e-06
die O 0 4.3375669633860525e-07
before O 0 1.9781365878657198e-08
day O 0 1.9110290239154892e-08
7 O 0 4.812084952732221e-08
. O 0 1.6962284909993741e-09

5 O 0 8.880232940100541e-07
of O 0 1.9093464231900725e-07
embryogenesis O 0 4.6818950067972764e-06
. O 0 2.456877368217647e-08

Mutant O 0 1.5299075073471613e-07
embryos O 0 5.8920757162184145e-09
have O 0 2.8514952985642106e-12
reduced O 0 5.575925138279203e-11
size O 0 6.469519364671328e-11
, O 0 5.150537635278951e-11
fail O 0 1.8084245212435235e-09
to O 0 1.4044368445986777e-10
gastrulate O 0 3.8136386137921363e-06
or O 0 9.329875760855089e-10
express O 0 3.9615796754155497e-10
a O 0 1.4663507907908269e-10
mesodermal O 0 4.2311714310017123e-07
marker O 0 1.483796268075821e-07
, O 0 7.93548490807261e-11
and O 0 1.804499050184205e-10
show O 0 5.347613019068831e-09
abnormal O 0 5.137408152222633e-07
visceral O 0 9.501133718003985e-06
endoderm O 1 0.8934674859046936
development O 0 4.4969038981435006e-07
. O 0 1.2867464427301911e-08

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 0.00025272852508351207
the O 0 2.8961966336282785e-07
Smad4 O 1 0.9980018734931946
- O 0 3.243853598178248e-06
deficient O 0 2.6303050404408168e-08
embryos O 0 1.4467263498296745e-10
results O 0 2.987231642603838e-11
from O 0 6.212556857843055e-11
reduced O 0 2.8276136987415157e-10
cell O 0 1.734163923572396e-08
proliferation O 0 3.6402521885747774e-08
rather O 0 3.3055786840402446e-12
than O 0 2.7715067111959424e-13
increased O 0 1.1550065591448e-11
apoptosis O 0 2.5426396632610704e-07
. O 0 1.7880786851165453e-09

Aggregation O 0 2.0834953318171756e-07
of O 0 2.62864091382653e-07
mutant O 0 1.9285359087461984e-07
Smad4 O 0 8.516544767189771e-05
ES O 0 0.0003821762220468372
cells O 0 3.111664259591862e-09
with O 0 8.266375084442501e-11
wild O 0 2.0608132444976945e-07
- O 0 7.216261366238541e-08
type O 0 4.5177685592534544e-08
tetraploid O 0 1.3817374338032096e-06
morulae O 0 2.456000765960198e-05
rescues O 0 4.287267984182108e-06
the O 0 1.866756527135749e-08
gastrulation B-Disease 0 0.03508525341749191
defect I-Disease 0 2.447074803058058e-05
. O 0 3.5227326833364714e-08

These O 0 4.092164385127717e-09
results O 0 2.9011482105545383e-09
indicate O 0 3.6158764871174753e-10
that O 0 3.278440886822498e-12
Smad4 O 0 4.0958644831334823e-07
is O 0 4.4179061450821955e-12
initially O 0 3.0349900110443473e-12
required O 0 1.0374854187561455e-12
for O 0 1.1759502876670935e-12
the O 0 5.192159202582758e-12
differentiation O 0 7.973628007862388e-11
of O 0 3.9059080969572335e-10
the O 0 1.5366052874554725e-10
visceral O 0 2.995417958118196e-08
endoderm O 0 0.0001743571920087561
and O 0 2.4773252893517395e-10
that O 0 1.597053327258291e-12
the O 0 9.381476845371495e-11
gastrulation B-Disease 0 1.7938683640750241e-06
defect I-Disease 0 5.220010201867353e-09
in O 0 3.103398787951406e-11
the O 0 1.0030780372982662e-10
epiblast O 0 1.390839656778553e-06
is O 0 7.935178555906752e-12
secondary O 0 6.594030654838434e-09
and O 0 1.3334885973215194e-10
non O 0 3.2890909551497316e-06
- O 0 1.8772989278659225e-06
cell O 0 8.050649853430514e-07
autonomous O 0 8.161979394571972e-07
. O 0 5.077233744543719e-09

Rescued O 0 8.103615073196124e-06
embryos O 0 6.432792929444986e-07
show O 0 1.8721448213909753e-07
severe O 1 0.8623979687690735
anterior O 0 0.0071946801617741585
truncations O 1 0.9999927282333374
, O 0 1.1787758324999231e-07
indicating O 0 9.558424807210031e-08
a O 0 1.1172619496235825e-09
second O 0 5.528245416996924e-09
important O 0 2.1859901389031933e-10
role O 0 3.8108310951301405e-10
for O 0 1.1565635255061935e-10
Smad4 O 0 6.901414599269629e-05
in O 0 1.2037706831335981e-08
anterior O 0 8.711962209417834e-07
patterning O 0 5.404923740570666e-06
during O 0 8.470611874145106e-07
embryogenesis O 0 1.316776979365386e-05
. O 0 3.5681345877947024e-08

Prevalence O 0 3.1719357593829045e-06
of O 0 7.058797990566745e-08
p16 O 0 6.016270504005661e-08
and O 0 1.4594380814969554e-08
CDK4 O 1 0.9999998807907104
germline O 0 1.1938775514863664e-06
mutations O 0 7.179438377136194e-09
in O 0 4.169207645787765e-09
48 O 0 1.6165747638297034e-06
melanoma B-Disease 1 0.9999998807907104
- O 0 0.03354423865675926
prone O 0 0.0745350569486618
families O 0 1.4195995767796177e-10
in O 0 2.0391384136786428e-09
France O 0 5.4397974054154474e-06
. O 0 8.920484617647162e-08

The O 0 1.2205980226553947e-07
French O 0 1.2034688552375883e-05
Familial B-Disease 1 0.9999752044677734
Melanoma I-Disease 1 1.0
Study O 0 2.9018008262937656e-07
Group O 0 4.588020630080791e-08
. O 0 3.743888754570435e-09

Germline O 0 8.490948857797775e-06
mutations O 0 2.4462908143618733e-08
in O 0 1.979305608301729e-09
the O 0 3.0681708285129616e-09
p16 O 0 9.636293540893348e-09
and O 0 2.717263747342713e-09
CDK4 O 1 0.9999959468841553
genes O 0 7.984071737077159e-10
have O 0 6.347131587675081e-12
been O 0 1.6893302728915316e-11
reported O 0 3.829548136935479e-11
in O 0 1.108680508510318e-11
a O 0 1.2706817369145806e-11
subset O 0 6.138132224720039e-10
of O 0 3.54543558955811e-08
melanoma B-Disease 0 0.18614819645881653
pedigrees O 0 2.039871418446637e-07
, O 0 3.051739694281963e-10
but O 0 4.544880530948925e-12
their O 0 6.49834699939511e-11
prevalence O 0 2.8183755329536098e-09
is O 0 5.228928184539128e-13
not O 0 4.718341602844012e-13
well O 0 7.715064004321093e-11
known O 0 3.884920829477778e-09
. O 0 3.0668834138936063e-09

We O 0 1.0502974046033842e-09
searched O 0 1.7309839117629622e-09
for O 0 5.064903357832051e-12
such O 0 2.2921775588713444e-11
germline O 0 1.8253366818044015e-08
mutations O 0 8.877736878964981e-10
in O 0 1.0499969782529206e-09
48 O 0 3.701303441516757e-08
French O 0 0.0003113086859229952
melanoma B-Disease 1 1.0
- O 1 0.9785208702087402
prone O 0 0.010364595800638199
families O 0 1.6178411041400942e-11
selected O 0 3.9582867539245115e-10
according O 0 2.9745417934323726e-11
to O 0 9.437755264796177e-12
two O 0 1.262357232634237e-11
major O 0 2.651356911798075e-10
criteria O 0 2.8888552661143763e-10
families O 0 7.44030054580791e-13
with O 0 1.353556914988896e-12
at O 0 3.0696281072550846e-09
least O 0 1.0226234789523225e-11
three O 0 3.3351495176692225e-11
affected O 0 4.4630701911962944e-10
members O 0 8.899500580916708e-11
( O 0 6.23027324175851e-11
n O 0 1.842593855272412e-10
= O 0 2.393396869582176e-10
20 O 0 2.9918689747887584e-10
) O 0 8.286130570751837e-13
or O 0 1.0691843460933215e-12
families O 0 8.301264406776476e-14
with O 0 3.765537415299086e-13
two O 0 1.0549642756596533e-11
affected O 0 2.0618523555171464e-10
members O 0 1.946763583671185e-11
, O 0 7.156826780513326e-12
one O 0 3.2251519163639664e-12
of O 0 1.8797385870072958e-10
them O 0 1.3576377001778273e-11
affected O 0 1.0796490090836386e-10
before O 0 2.844675328628199e-10
the O 0 1.8952468067157113e-11
age O 0 9.674251850999571e-12
of O 0 8.476816470981419e-11
50 O 0 6.446780609348224e-11
( O 0 6.555722111001305e-12
n O 0 5.5976421414749566e-11
= O 0 1.6576712225102597e-10
28 O 0 2.479236149710573e-09
) O 0 4.342027605519494e-12
, O 0 2.196469785567534e-12
and O 0 4.371661019297868e-12
one O 0 9.66172671382215e-13
additional O 0 1.8495717110655896e-11
minor O 0 4.083496776274842e-07
criterion O 0 3.941234353987966e-06
. O 0 1.3348692817771735e-08

Sixteen O 0 1.677771706454223e-06
different O 0 8.436978893300306e-10
p16 O 0 3.742348297919307e-08
germline O 0 1.0496155056216594e-07
mutations O 0 5.73095737532725e-10
were O 0 1.316084047298105e-10
found O 0 1.1133169039445612e-11
in O 0 8.279672954192296e-12
21 O 0 2.2608938332613349e-10
families O 0 2.665362234307439e-13
, O 0 5.832715387066312e-12
while O 0 2.891510815505871e-11
one O 0 1.2089366834000526e-11
germline O 0 8.494757786081664e-09
mutation O 0 4.3299244745220733e-10
, O 0 1.0290809177027072e-10
Arg24His O 0 8.9996428869199e-06
, O 0 3.1518629373117335e-10
was O 0 4.87762441547801e-10
detected O 0 1.041841724003234e-09
in O 0 4.767359076951472e-11
the O 0 1.5520909002475491e-09
CDK4 O 1 0.9999995231628418
gene O 0 1.2961936590727419e-07
. O 0 1.0956151541563486e-08

The O 0 4.305894751865935e-09
frequency O 0 1.6608303621268306e-09
of O 0 1.6037774441812758e-09
p16 O 0 1.2080919598034257e-09
gene O 0 9.002688178272322e-11
mutation O 0 1.547180092376088e-11
in O 0 5.752591979157895e-12
our O 0 1.7405335853148962e-11
sample O 0 1.3496957024239364e-11
( O 0 1.886906646555997e-12
44 O 0 3.6644125234186475e-11
% O 0 1.754413807156588e-13
) O 0 2.673631173226443e-13
is O 0 2.2680949729025207e-13
among O 0 2.4042978979260665e-12
the O 0 3.172851564814394e-11
highest O 0 3.4417177996459714e-09
rates O 0 1.486031714348357e-10
yet O 0 1.4637792714045084e-11
reported O 0 6.63402666134516e-11
and O 0 5.368660030424799e-11
the O 0 1.0480182277561312e-09
CDK4 O 1 0.9999933242797852
mutation O 0 3.8258343715291687e-10
is O 0 3.935127397547422e-12
the O 0 1.1913272451868906e-11
second O 0 1.4609935483633762e-10
mutation O 0 4.018055853316493e-12
detected O 0 7.450207117898344e-11
in O 0 2.1402916331597632e-12
this O 0 1.8627692704303866e-12
gene O 0 4.873076941969146e-10
worldwide O 0 3.0349249779959564e-09
. O 0 5.514586565169566e-09

In O 0 3.469646259190995e-08
summary O 0 1.8931312695258384e-07
, O 0 5.97202010066411e-10
our O 0 2.6928273499926547e-10
results O 0 1.1829928703299686e-10
show O 0 9.92182586090351e-11
frequent O 0 2.133860622921535e-11
involvement O 0 1.3235454399129765e-10
of O 0 7.5197936766358e-10
the O 0 3.136695903016573e-10
p16 O 0 1.9201293888215787e-09
gene O 0 3.360924594186798e-10
in O 0 2.4664814635144694e-10
familial B-Disease 0 4.8369765863753855e-06
melanoma I-Disease 0 0.4679979383945465
and O 0 7.065997786881439e-10
confirm O 0 2.1578960840429318e-09
the O 0 1.024182183506639e-09
role O 0 6.336819957653006e-10
of O 0 1.921573833385537e-08
the O 0 7.085867892442366e-09
CDK4 O 1 1.0
gene O 0 1.3263013798336942e-08
as O 0 4.4756012784752386e-10
a O 0 2.8227276072101404e-09
melanoma B-Disease 0 0.2569980025291443
- O 0 2.418133362880326e-06
predisposing O 0 1.0700157417886658e-06
gene O 0 6.464444091136556e-09
. O 0 3.5627109595814943e-10
. O 0 1.272516647610189e-09

Progression O 0 1.869594598247204e-05
of O 0 1.6421197415183997e-06
somatic O 0 6.191991997184232e-05
CTG O 0 0.005808994174003601
repeat O 0 8.017147479222331e-08
length O 0 4.2264688970838904e-10
heterogeneity O 0 2.796282760897384e-09
in O 0 8.686382862999054e-11
the O 0 9.383051974287682e-11
blood O 0 1.6344861020201051e-09
cells O 0 4.628043726029318e-09
of O 0 3.455912974459352e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.00357419578358531
. O 0 3.0930028316333846e-08

The O 0 1.4312973029007026e-08
genetic O 0 2.5743518428100742e-09
basis O 0 1.251068804108968e-09
of O 0 8.125562089844607e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.00047767351497896016
DM B-Disease 1 1.0
) O 0 4.0429676273490145e-10
is O 0 1.879801219198396e-12
the O 0 3.753907774906029e-12
expansion O 0 2.1262844263070235e-10
of O 0 5.156202131928467e-10
an O 0 1.6319704268519253e-11
unstable O 0 3.977153824052948e-07
CTG O 0 0.0007858317694626749
repeat O 0 1.7902566540328735e-08
in O 0 2.501531481957642e-10
the O 0 2.0210010054366734e-10
34 O 0 1.5198834413254758e-09
UTR O 0 2.132800182153005e-05
of O 0 1.2110526803610355e-08
the O 0 3.268175730042344e-09
DM B-Disease 1 1.0
protein O 0 3.5375911089374767e-09
kinase O 0 1.6135537350692175e-08
gene O 0 2.797280185262707e-09
on O 0 9.68285007729719e-09
chromosome O 0 3.480237609210235e-08
19 O 0 7.70826531493185e-08
. O 0 3.033223672233021e-09

One O 0 8.207029722484549e-09
of O 0 1.3651439978445978e-08
the O 0 4.715776102948155e-10
principal O 0 2.8513094108006953e-09
features O 0 9.409832912865568e-10
of O 0 1.1611733796712542e-08
the O 0 2.7119630985339427e-08
DM B-Disease 1 1.0
mutation O 0 7.573659921433773e-09
is O 0 2.030596827837239e-12
an O 0 8.124684193651366e-13
extraordinarily O 0 1.717814779311766e-09
high O 0 6.581744571576564e-08
level O 0 8.589876365761029e-09
of O 0 2.4668400655514233e-09
somatic O 0 5.576416697294917e-07
mosaicism O 0 2.68057356151985e-05
, O 0 1.2626180656560848e-10
due O 0 4.391095265177114e-10
to O 0 7.803309214071685e-12
an O 0 1.368613989499723e-12
extremely O 0 3.771751660996969e-11
high O 0 3.9448252997509314e-10
degree O 0 6.990740208934199e-10
of O 0 4.267863285001283e-10
somatic O 0 2.316285616643654e-07
instability O 0 5.428479887825688e-09
both O 0 2.3510462673903554e-11
within O 0 1.0747959466872459e-10
and O 0 1.8041885693764748e-11
between O 0 9.273540962917437e-11
different O 0 2.0250873200566843e-10
tissues O 0 8.39753852233116e-07
. O 0 2.4471496828937234e-08

This O 0 2.74811973177691e-09
instability O 0 1.7517967521030187e-08
appears O 0 6.071572411503467e-11
to O 0 4.871824514987577e-13
be O 0 1.9076409831127183e-13
biased O 0 4.735874192807188e-11
towards O 0 5.6020639516152215e-11
further O 0 1.4140367479362204e-12
expansion O 0 4.633302769230241e-11
and O 0 7.318879009787782e-12
continuous O 0 5.489436682992732e-11
throughout O 0 2.1745364189862393e-11
the O 0 1.2178353811509446e-11
life O 0 1.1878669922693597e-11
of O 0 1.9133129108839242e-11
an O 0 1.0903463461969798e-13
individual O 0 1.3308270501236064e-12
, O 0 4.800680252631251e-12
features O 0 1.1035984626150963e-10
that O 0 6.177842932315533e-14
could O 0 1.2783824563170065e-12
be O 0 5.217013886865685e-13
associated O 0 3.006620993839526e-11
with O 0 2.3933580811652533e-12
the O 0 3.789723812541723e-10
progressive O 0 3.264663206437035e-08
nature O 0 8.362547987417202e-09
of O 0 4.3755740364304074e-08
the O 0 2.673039602996141e-07
disease O 0 0.27586477994918823
. O 0 1.6111757483727729e-09

Although O 0 1.865680721024887e-09
increasing O 0 5.777544762053388e-11
measured O 0 5.380902945439914e-10
allele O 0 5.368086530843641e-11
size O 0 6.800434521059273e-11
between O 0 1.8540194379745856e-10
patients O 0 2.497736462103717e-10
clearly O 0 3.4235454748898775e-11
correlates O 0 1.181567621522106e-10
with O 0 3.202152356208271e-13
an O 0 1.1332835982581085e-13
increased O 0 4.277197953456158e-12
severity O 0 2.0543554057894653e-07
of O 0 5.980683113193663e-07
symptoms O 0 0.0007617307710461318
and O 0 4.551484536485795e-11
an O 0 4.29218428377523e-13
earlier O 0 1.4091641048485926e-11
age O 0 1.2298076619565723e-11
of O 0 3.531845094162378e-10
onset O 0 1.1073569794461946e-06
, O 0 5.813544957933292e-12
this O 0 7.536980479831701e-14
correlation O 0 1.329695359895966e-12
is O 0 1.6199391275010383e-13
not O 0 6.017400661952055e-14
precise O 0 4.011397880532286e-10
and O 0 4.8282863818194244e-11
measured O 0 1.9129864359257454e-09
allele O 0 1.017757475518799e-10
length O 0 1.9337554127418777e-11
cannot O 0 4.644059008879209e-12
be O 0 7.427156762870868e-13
used O 0 1.7690021322791516e-11
as O 0 3.2528038422519057e-12
an O 0 1.4518825052801942e-13
accurate O 0 3.489992184135815e-10
predictor O 0 5.170901573592346e-08
of O 0 1.7827457288177584e-09
age O 0 4.6253584295996575e-10
of O 0 5.7673443798478274e-09
onset O 0 0.00030628248350694776
. O 0 1.2080120015411921e-08

In O 0 3.779893731348238e-09
order O 0 3.556498706647204e-10
to O 0 1.1352728652991306e-11
further O 0 1.733572660422844e-11
characterize O 0 1.9228965086881544e-09
the O 0 1.8828388848035615e-10
dynamics O 0 5.924488633013425e-08
of O 0 1.1940472859350848e-06
DM B-Disease 1 1.0
CTG O 1 0.9998741149902344
repeat O 0 2.3711150731742237e-07
somatic O 0 1.864523710537469e-06
instability O 0 2.546662436486713e-08
, O 0 8.909113724531181e-11
we O 0 1.9782081788627393e-12
have O 0 1.7620129801835388e-13
studied O 0 5.361274757476053e-10
repeat O 0 1.9082843638607017e-10
length O 0 1.6053824936079764e-11
changes O 0 6.6677544562077085e-12
over O 0 2.5549489607312736e-11
time O 0 6.603687215112064e-12
in O 0 3.9419502384507865e-11
111 O 0 9.835296077653766e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 3.352233690634421e-08
with O 0 1.705862881506981e-11
varying O 0 2.2990496173491692e-09
clinical O 0 9.284150110033806e-06
severity O 0 0.00012141457409597933
and O 0 3.103042445218307e-08
CTG O 0 9.942606266122311e-05
repeat O 0 1.7894978832089237e-09
size O 0 3.631065240150555e-11
over O 0 3.1950848217165984e-11
time O 0 2.483402155792347e-12
intervals O 0 2.728792192208118e-10
of O 0 5.218195875400511e-10
1 O 0 1.3500472961780474e-09
- O 0 5.895628429897215e-09
7 O 0 5.105170952646176e-09
years O 0 9.340447859607082e-11
. O 0 1.7774549887494828e-10

We O 0 1.5455416946252853e-09
have O 0 3.546111321250933e-12
found O 0 2.38393181063723e-12
a O 0 3.843498869865458e-13
direct O 0 3.501744250469785e-12
progression O 0 6.45354991668512e-10
of O 0 2.506293228510259e-10
the O 0 6.9169756727882614e-12
size O 0 3.9633743335876215e-12
heterogeneity O 0 2.768679174813826e-10
over O 0 4.681690798924443e-11
time O 0 1.4501237884101403e-11
related O 0 3.246038993154343e-10
to O 0 3.2047461906437036e-11
initial O 0 1.8411684399310957e-09
CTG O 0 1.0140003723790869e-05
repeat O 0 3.5586651403463065e-09
size O 0 1.2754464151498723e-10
and O 0 3.630912931429364e-11
the O 0 3.35494687586646e-11
time O 0 1.4857297250120416e-12
interval O 0 3.6318757029585313e-11
and O 0 2.9613163050196123e-12
always O 0 8.637575030223665e-12
biased O 0 3.131226389285757e-10
towards O 0 1.9114755611671086e-10
further O 0 6.82866610479671e-11
expansion O 0 8.412077256991779e-09
. O 0 3.918042335016025e-09

Attempts O 0 5.072822162333068e-08
to O 0 1.199497307036168e-10
mathematically O 0 2.572673185596841e-09
model O 0 1.6776592615119768e-10
the O 0 1.2635166524166408e-10
dynamics O 0 1.1019380075083518e-08
have O 0 1.174516213453547e-11
proved O 0 2.05046046808377e-09
only O 0 3.497665698737329e-12
partially O 0 2.318995884209585e-09
successful O 0 1.2664964910147347e-10
suggesting O 0 1.5612252809993343e-11
that O 0 2.2214265745900547e-14
individual O 0 4.927491859094309e-14
specific O 0 2.530678141002274e-12
genetic O 0 8.209891100285915e-10
and O 0 6.767520432937602e-10
/ O 0 5.201993502623736e-08
or O 0 4.009162446472203e-11
environmental O 0 1.4165331130300274e-09
factors O 0 1.1821899015274084e-10
also O 0 9.442814585813863e-12
play O 0 2.047844810393329e-10
a O 0 9.995862644551767e-12
role O 0 6.711049077567921e-11
in O 0 1.3413813115814577e-10
somatic O 0 1.230050884259981e-06
mosaicism O 0 3.576188100851141e-05
. O 0 2.6097799477042827e-09
. O 0 7.544507241163956e-09

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 1.130644164959449e-07
Palestinian O 0 5.075324338577047e-07
Arabs O 0 4.634626904476136e-08
. O 0 1.67155693731047e-08

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9746745824813843
AGU B-Disease 1 1.0
) O 0 7.2939725370702035e-09
is O 0 1.6858958673537927e-11
a O 0 3.396106659780962e-11
rare O 0 2.7053690132561314e-07
disorder B-Disease 1 1.0
of I-Disease 1 0.9999978542327881
glycoprotein I-Disease 1 0.9995694756507874
metabolism I-Disease 1 1.0
caused O 0 8.121626819956873e-07
by O 0 2.9870564355327645e-10
the O 0 1.3617248839636886e-07
deficiency B-Disease 1 0.7480554580688477
of I-Disease 0 7.138338787626708e-06
the I-Disease 0 4.3630151935758477e-08
lysosomal I-Disease 0 0.0002198894217144698
enzyme I-Disease 0 3.145644456026275e-08
aspartylglucosaminidase I-Disease 0 5.083856012788601e-05
( O 0 5.658901347516121e-09
AGA O 1 0.7429789304733276
) O 0 5.837932803842705e-09
. O 0 6.8967644928363825e-09

AGU B-Disease 1 1.0
is O 0 2.7070490205005626e-07
inherited O 0 4.076721234014258e-05
as O 0 6.11350192691873e-10
an O 0 1.1811711331244368e-10
autosomal O 0 0.0003495168930385262
recessive O 0 1.0688483598642051e-05
trait O 0 5.386964652132065e-09
and O 0 7.735431739597232e-10
occurs O 0 4.7429431909717934e-11
with O 0 3.798027430751416e-12
a O 0 1.131505045909309e-11
high O 0 2.4265578435489488e-09
frequency O 0 1.3730969139480464e-10
in O 0 1.9706998186097557e-11
Finland O 0 3.597840247948625e-09
because O 0 1.9648224020007987e-11
of O 0 1.1974908842304899e-09
a O 0 2.405112220493777e-10
founder O 0 4.556116550702427e-07
effect O 0 3.530528758233231e-08
. O 0 2.527932307927472e-09

While O 0 9.215050766897548e-08
very O 0 6.032017663137879e-10
few O 0 4.835698508287578e-10
patients O 0 1.2812061411793252e-09
with O 0 1.4333947362388244e-09
AGU B-Disease 1 1.0
have O 0 2.3108129298954339e-10
been O 0 2.7750218789535097e-11
reported O 0 2.7014427153582155e-11
from O 0 5.6579782525822964e-11
non O 0 1.0696030017243174e-07
- O 0 2.3278023064676745e-08
Finnish O 0 3.1734623462398304e-07
origin O 0 1.795891074740652e-10
, O 0 1.1979471581380352e-10
we O 0 7.886159780756685e-11
diagnosed O 0 2.4048497380135814e-06
the O 0 5.199500829888848e-09
disorder O 0 0.008358394727110863
in O 0 2.5340196607714915e-09
8 O 0 4.138050968549578e-08
patients O 0 2.0333507100289694e-10
originating O 0 5.671021985342861e-10
from O 0 5.965962723841756e-10
3 O 0 3.1225981800275804e-09
unrelated O 0 1.0365672764578449e-09
families O 0 1.3601147118291745e-12
, O 0 2.9426344173855146e-12
all O 0 1.6659580616071312e-12
Palestinian O 0 1.4731292574676758e-10
Arabs O 0 1.1985956498150596e-11
from O 0 5.23721760403717e-11
the O 0 1.0056796367896581e-10
region O 0 4.871506531500813e-10
of O 0 1.6421418669310128e-09
Jerusalem O 0 7.009431328697246e-07
. O 0 3.1834041180900385e-08

The O 0 3.633488887544445e-08
clinical O 0 5.83610426474479e-06
diagnosis O 1 0.9998924732208252
of O 1 0.9999746084213257
AGU B-Disease 1 1.0
is O 0 6.5772240986916586e-09
often O 0 9.358922664626235e-11
difficult O 0 1.7469367619149523e-10
, O 0 2.7099308040623438e-12
in O 0 1.3093874942637918e-12
particular O 0 5.892872995127973e-13
early O 0 5.487992352226634e-11
in O 0 1.3208155272628752e-12
the O 0 6.728232988112426e-12
course O 0 4.4021139511407625e-10
of O 0 4.680184018113209e-10
the O 0 5.20781773261092e-09
disease O 0 7.570762682007626e-05
, O 0 3.048554247583879e-12
and O 0 7.61028479817627e-12
most O 0 3.513472282209995e-12
of O 0 6.371408955985203e-10
the O 0 3.154052019560538e-10
patients O 0 6.509129901743904e-10
are O 0 1.3584250911635731e-11
diagnosed O 0 1.1740073802002371e-08
after O 0 2.0549739687680812e-10
the O 0 1.3838240275898528e-10
age O 0 1.56908930293298e-10
of O 0 1.1513301423349276e-09
5 O 0 5.970656413722963e-09
years O 0 8.737899848121344e-10
. O 0 1.4632504097278343e-09

However O 0 7.2127090966489504e-09
, O 0 5.7176562096028505e-11
since O 0 4.41436861023381e-12
these O 0 1.924276710196793e-12
patients O 0 7.96845402162294e-12
excrete O 0 4.2451234194551546e-10
early O 0 1.2674340743590307e-10
large O 0 2.1157275150590626e-12
amounts O 0 1.058798448222431e-11
of O 0 3.804986548061606e-09
aspartylglucosamine O 0 1.4578210993931862e-06
in O 0 5.961549587318871e-10
urine O 0 3.431237072248905e-09
, O 0 1.3018823866173257e-11
biochemical O 0 4.849444845689277e-09
screening O 0 5.244560785655494e-09
is O 0 9.648563198405569e-12
easy O 0 6.237407118581118e-11
by O 0 1.4084600673258674e-11
urine O 0 5.312600137585832e-09
chromatography O 0 1.807088096938969e-07
. O 0 2.1700639063482186e-09
. O 0 4.10948164386582e-09

Detection O 0 3.512736839184072e-06
of O 0 5.55453425477026e-08
heterozygous O 0 2.0793718136236095e-10
carriers O 0 5.677577852303273e-11
of O 0 1.0083888390965967e-08
the O 0 1.3591053971140354e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 9.128945066549932e-08
ATM O 0 0.08768321573734283
) O 0 7.153804770787531e-10
gene O 0 2.3484300615272957e-10
by O 0 3.2316312820190873e-11
G2 O 0 1.760195300448686e-05
phase O 0 1.034518035680776e-07
chromosomal O 0 2.2861561888021242e-07
radiosensitivity O 0 3.937150722777005e-06
of O 0 3.1126518251767266e-07
peripheral O 0 0.005114699713885784
blood O 0 1.0513728739169892e-05
lymphocytes O 0 1.522090997241321e-06
. O 0 9.34730071122658e-09

In O 0 3.97596613765927e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 9.394877270096913e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.1828418506639764e-10
patients O 0 5.814989809116433e-11
, O 0 1.935477819681175e-12
mutations O 0 8.172371633585751e-12
in O 0 1.3506640250682267e-11
a O 0 2.6132937827605396e-11
single O 0 5.015935999885812e-10
gene O 0 1.4345866161669107e-10
, O 0 2.100016861794618e-11
ATM O 0 2.3546597731183283e-05
, O 0 5.477294312550285e-11
result O 0 2.1638619715491636e-11
in O 0 2.6884021050999074e-11
an O 0 1.1028458146711273e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 5.468903663263802e-10
embraces O 0 9.432191028224679e-09
a O 0 7.274943841784065e-11
variety O 0 1.6703897154357605e-09
of O 0 3.291655659154458e-08
clinical O 0 2.9630282369907945e-06
features O 0 9.653754773353285e-08
and O 0 2.5344886189770932e-09
manifests O 0 6.921450079744318e-08
extreme O 0 1.7760761465979158e-06
radiosensitivity O 0 6.141765334177762e-05
and O 0 2.0382830978604716e-09
a O 0 6.108816785754811e-10
strong O 0 3.2395339744084595e-09
pre O 0 0.005853372160345316
- O 0 1.5315031305362936e-06
disposition O 0 1.5476742191822268e-05
to O 0 1.276623340373817e-08
malignancy B-Disease 1 0.6309261918067932
. O 0 5.334776176368905e-09

Heterozygotes O 0 8.903977004592889e-07
for O 0 1.1107940123267213e-09
the O 0 4.666554920262911e-10
ATM O 0 2.166375816159416e-05
gene O 0 6.630602733537216e-10
have O 0 1.5491398311709426e-12
no O 0 5.619011766294646e-12
clinical O 0 6.481259084978319e-09
expression O 0 3.536563819572791e-10
of O 0 4.5391979597297905e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 2.060389914237959e-10
may O 0 1.6852631790076344e-10
be O 0 1.807233945827491e-10
cancer B-Disease 0 4.133896254643332e-06
prone O 0 1.9914760684969224e-07
with O 0 1.833012908125653e-11
a O 0 2.606321269915668e-10
moderate O 0 9.922702659537208e-10
increase O 0 9.461004896182956e-12
in O 0 4.3026308210736275e-11
in O 0 9.944674250750296e-11
vitro O 0 6.052317758076242e-08
radiosensitivity O 0 2.1775484128738753e-05
. O 0 8.280016672301826e-09

We O 0 5.509479805709816e-08
performed O 0 6.774480425519869e-07
a O 0 2.9590339067908644e-09
blind O 0 3.317402885727461e-08
chromosomal O 0 2.7329623009109127e-08
analysis O 0 8.903479065125453e-10
on O 0 3.450551622208309e-09
G2 O 0 4.280604571249569e-06
- O 0 4.265253483737297e-09
phase O 0 3.785174840231775e-09
lymphocytes O 0 9.125959987699162e-10
from O 0 2.6746094228258244e-10
7 O 0 5.424329874159639e-09
unrelated O 0 2.3677573324221157e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.1642940478395758e-07
, O 0 7.719686001550485e-11
13 O 0 1.244127578736709e-09
obligate O 0 1.535247484696356e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 3.2976640795823187e-07
( O 0 5.37751440599088e-11
parents O 0 5.96486445306188e-12
of O 0 1.2971736185196647e-10
the O 0 5.580968673313258e-11
patients O 0 1.8836928544763154e-11
) O 0 1.0534999522054944e-12
, O 0 4.902597425249233e-12
and O 0 2.9249422328625485e-11
14 O 0 1.2575905872225235e-09
normal O 0 3.8737091312412986e-10
controls O 0 3.056971065173997e-10
following O 0 4.9794626755250704e-11
X O 0 2.520894248903005e-08
- O 0 1.7575154664939419e-09
irradiation O 0 2.779198648994452e-09
with O 0 1.0484649606845586e-11
1 O 0 1.5283158072421088e-10
Gy O 0 7.514954347698222e-08
in O 0 2.0213921682332714e-12
order O 0 2.96850933591275e-12
to O 0 4.059342651515502e-13
evaluate O 0 1.6660296753290282e-10
this O 0 6.731335324208776e-13
cytogenetic O 0 1.7232236970698978e-08
method O 0 3.451449889779745e-11
as O 0 9.0931770576827e-13
a O 0 7.265299473147024e-13
tool O 0 7.640478527637384e-12
for O 0 5.752915640611436e-14
detection O 0 3.1732361183145485e-09
of O 0 7.946879265752216e-10
ATM O 0 1.8543432815931737e-05
carriers O 0 2.7103704169917364e-08
. O 0 1.4080646870695546e-08

Both O 0 7.410732223434024e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 2.5427855234738672e-06
and O 0 2.0303124459442046e-10
heterozygotes O 0 6.228354720860807e-09
showed O 0 1.0617819817815288e-10
significantly O 0 1.7069426384505593e-12
increased O 0 2.4510124832510805e-12
levels O 0 3.5035967183016936e-11
of O 0 7.223357328944857e-11
radiation O 0 0.02469809167087078
- O 0 1.7203474271809682e-06
induced O 0 0.00010786116763483733
chromatid O 0 2.1672456114174565e-06
damage O 0 1.5232687644584075e-07
relative O 0 1.853464326462273e-10
to O 0 3.1260556209583568e-12
that O 0 1.3398859116404288e-13
of O 0 4.291576816140008e-10
normal O 0 7.3953954071726e-09
controls O 0 4.7963609972612176e-08
. O 0 5.173187656026812e-09

These O 0 5.210023523716245e-09
results O 0 3.4586300490246913e-09
show O 0 7.212594965722019e-10
that O 0 3.1755260313653944e-12
the O 0 3.927033420669801e-10
G2 O 0 4.5725075324298814e-05
- O 0 6.88487276079286e-08
phase O 0 6.174161626404384e-08
chromosomal O 0 1.4681930338156235e-07
radiosensitivity O 0 1.503332782704092e-07
assay O 0 5.42289935179241e-10
can O 0 1.0168076233427192e-12
be O 0 1.3651613747864971e-13
used O 0 3.057148935045606e-12
for O 0 7.631182469790276e-13
the O 0 1.984966227844276e-12
detection O 0 1.5261909069863577e-08
of O 0 4.2877825734422e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.3095723261358216e-05
. O 0 6.206475333669914e-09

In O 0 7.7469675119346e-09
combination O 0 1.8501487009103812e-09
with O 0 1.5660566593522773e-11
molecular O 0 2.153834621765327e-08
genetic O 0 2.8143358754562087e-09
analyses O 0 4.250124252536125e-09
, O 0 1.1670354786719184e-11
this O 0 1.3169810565445e-13
test O 0 1.2964464224385353e-10
may O 0 2.323038679821754e-12
be O 0 1.4207080336389039e-13
of O 0 8.540135612578048e-12
value O 0 6.65339528263531e-13
in O 0 4.36781660102456e-13
studies O 0 2.912759443363111e-12
of O 0 3.411903051753207e-11
familial B-Disease 0 1.959674422735702e-09
and I-Disease 0 6.892604820230019e-10
sporadic I-Disease 0 5.5959967539820354e-06
cancers I-Disease 0 8.888762386050075e-05
aimed O 0 9.123423794221708e-09
at O 0 1.990314579813912e-09
determination O 0 7.434198812106274e-10
of O 0 2.4044988222726715e-09
the O 0 7.075205005202534e-11
potential O 0 3.393471267876258e-11
involvement O 0 3.9043290822604604e-10
of O 0 5.968584293469803e-09
ATM O 0 0.001651604543440044
mutations O 0 3.4408380589212584e-09
in O 0 6.145911002342075e-10
tumor B-Disease 0 6.5897920649149455e-06
risk O 0 5.580825135353962e-09
or O 0 1.2453217346219958e-09
development O 0 6.003269437115932e-09
. O 0 2.548185551454196e-10
. O 0 1.1905084695840173e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 9.255155752896371e-09
identification O 0 8.202131418499903e-09
and O 0 6.096754351370137e-11
detection O 0 1.9184945188044367e-07
of O 0 1.8894747100262066e-08
founder O 0 2.5617366645747097e-06
- O 0 1.7935857243855935e-08
effect O 0 2.7231772392610765e-10
mutations O 0 1.4507766515903242e-11
in O 0 3.967004242461103e-12
the O 0 2.5345538168242143e-11
ATM O 0 4.052766087170312e-07
gene O 0 1.394017956624083e-10
in O 0 4.803354762550338e-12
ethnic O 0 1.2672006456312945e-12
populations O 0 1.6051897658297953e-11
. O 0 9.610476303656412e-11

To O 0 7.062171403227069e-10
facilitate O 0 3.505563617167695e-10
the O 0 4.1690682156536596e-11
evaluation O 0 8.133100304341667e-10
of O 0 2.083310857159404e-09
ATM O 0 4.293073288863525e-06
heterozygotes O 0 2.4066425297064598e-08
for O 0 9.556552771350368e-11
susceptibility O 0 1.1911767572314602e-08
to O 0 4.216433799331121e-11
other O 0 8.519713823318398e-09
diseases O 1 1.0
, O 0 6.089757864646828e-11
such O 0 3.7287428700238934e-10
as O 0 3.203932052997516e-08
breast B-Disease 1 0.9999994039535522
cancer I-Disease 0 0.021678132936358452
, O 0 5.57798911227092e-11
we O 0 4.8950292604044154e-12
have O 0 4.480513995843566e-13
attempted O 0 2.4858071157041195e-10
to O 0 3.310904501951928e-12
define O 0 1.1123135745805257e-10
the O 0 2.4336472073671622e-11
most O 0 7.389232455079497e-13
common O 0 5.1026613490101624e-12
mutations O 0 1.5052456893774324e-12
and O 0 1.8191531180739018e-12
their O 0 3.405620620580696e-12
frequencies O 0 2.885055805368353e-10
in O 0 1.4552428151404229e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.4189246232708683e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.732615245193415e-10
homozygotes O 0 1.6508668210235555e-08
from O 0 9.271012429978853e-11
10 O 0 2.2430501900316813e-11
ethnic O 0 1.2752311142824602e-12
populations O 0 2.3221050082788963e-11
. O 0 2.393132081390803e-10

Both O 0 4.685206000942799e-09
genomic O 0 1.411522632110973e-08
mutations O 0 5.665270474963791e-10
and O 0 7.624352538204704e-11
their O 0 8.471256335296218e-11
effects O 0 2.7148510994834396e-08
on O 0 1.9574701859426114e-09
cDNA O 0 4.152366894771831e-09
were O 0 7.30524585268455e-10
characterized O 0 1.4008961990441549e-08
. O 0 4.537040076968424e-09

Protein O 0 3.8224754916882375e-08
- O 0 2.9396895584454796e-08
truncation O 0 3.757776667612234e-08
testing O 0 1.0976733300083197e-08
of O 0 1.1961257539994108e-09
the O 0 7.340734270444571e-11
entire O 0 8.853758282079127e-10
ATM O 0 1.3246066998817696e-07
cDNA O 0 1.589943510182934e-09
detected O 0 1.7515018324587572e-09
92 O 0 2.8638671434322305e-09
( O 0 2.464157176917947e-11
66 O 0 1.89872584321904e-09
% O 0 1.3055621037386111e-12
) O 0 8.865134104238392e-13
truncating O 0 2.325413639425733e-09
mutations O 0 1.3347992156020894e-10
in O 0 1.5946380327314102e-10
140 O 0 2.504717322437955e-09
mutant O 0 3.0841003084702834e-09
alleles O 0 7.735752316495592e-11
screened O 0 5.573488337518029e-08
. O 0 9.543593471050826e-09

The O 0 2.43391639287438e-07
haplotyping O 0 7.663658470846713e-05
of O 0 3.210668069186795e-07
patients O 0 1.8208430319077706e-09
with O 0 5.5293263023781236e-11
identical O 0 4.052352835515194e-07
mutations O 0 5.112976264598501e-09
indicates O 0 4.870335801321346e-10
that O 0 6.920772548796306e-13
almost O 0 2.842009613757135e-12
all O 0 6.719559804413411e-13
of O 0 2.2829144824543235e-11
these O 0 5.277845760258415e-13
represent O 0 3.1081599967397455e-12
common O 0 2.6770733199676933e-11
ancestry O 0 9.014918152250306e-12
and O 0 6.5162905453497455e-12
that O 0 4.564494398770491e-13
very O 0 9.969701279810561e-12
few O 0 8.722509520220356e-11
spontaneously O 0 2.7224633214473215e-08
recurring O 0 3.1379653364638216e-07
ATM O 0 0.00023105944273993373
mutations O 0 2.867457737920631e-07
exist O 0 4.988291735230632e-08
. O 0 1.9336367174105362e-08

Assays O 0 6.31493861646959e-08
requiring O 0 3.897969058641593e-09
minimal O 0 1.3934948750460308e-09
amounts O 0 5.97818253234017e-11
of O 0 3.553372873721372e-10
genomic O 0 3.1315550153010463e-10
DNA O 0 5.991452667331032e-09
were O 0 6.372848429525568e-12
designed O 0 1.110378247681787e-10
to O 0 1.598665535888777e-12
allow O 0 2.3017007137055012e-12
rapid O 0 4.1629041880320017e-10
screening O 0 7.933245727009819e-11
for O 0 1.7496494704449805e-12
common O 0 1.9591866323720453e-11
ethnic O 0 2.871575156479511e-12
mutations O 0 1.0585491372339106e-09
. O 0 7.530529533283925e-10

These O 0 4.323002844586199e-09
rapid O 0 3.7758390192266233e-08
assays O 0 1.1880365136107685e-08
detected O 0 8.510683713325307e-09
mutations O 0 3.2741559463644876e-11
in O 0 4.496527802877459e-11
76 O 0 2.0808565981411675e-09
% O 0 7.496696948113002e-13
of O 0 1.9178662824526072e-10
Costa O 0 4.739098358186311e-08
Rican O 0 9.605172408555518e-07
patients O 0 1.3459848791086415e-09
( O 0 2.4278148935685806e-11
3 O 0 6.447890554817093e-10
) O 0 1.0934000016157852e-12
, O 0 8.963955337552842e-13
50 O 0 4.738564141765211e-12
% O 0 6.846731975861456e-14
of O 0 4.1840284709104836e-11
Norwegian O 0 5.8239006506255464e-08
patients O 0 2.1077555256709957e-09
( O 0 1.775549846039226e-11
1 O 0 4.4827008771619603e-10
) O 0 1.057869286960611e-12
, O 0 5.853207458647591e-13
25 O 0 6.383371262130844e-12
% O 0 5.850804189007006e-14
of O 0 1.0929919296021051e-11
Polish O 0 1.3899779105486232e-06
patients O 0 3.578717988617086e-09
( O 0 4.768159131418592e-11
4 O 0 2.0203814177222057e-09
) O 0 1.389567389105395e-12
, O 0 1.0469296870402323e-12
and O 0 4.977086017626808e-12
14 O 0 8.512428262275051e-11
% O 0 2.537409843871019e-13
of O 0 1.9484910213085627e-11
Italian O 0 7.88332954471116e-08
patients O 0 4.0629140052317325e-09
( O 0 4.584864432555236e-11
1 O 0 3.1009994572173127e-09
) O 0 3.649839111496966e-12
, O 0 1.0403250526661023e-12
as O 0 1.400110604711513e-12
well O 0 8.349084444636556e-12
as O 0 3.170587490469723e-12
in O 0 4.962725543011803e-12
patients O 0 1.5622916155200173e-11
of O 0 2.866586967797957e-10
Amish O 0 6.965563557059795e-07
/ O 0 9.001156087151685e-08
Mennonite O 0 1.6753989484641352e-06
and O 0 1.2669464366510397e-09
Irish O 0 1.3902334217164025e-07
English O 0 2.464038750815689e-08
backgrounds O 0 1.5598910607650396e-08
. O 0 2.2034933877534968e-09

Additional O 0 6.2793117372450524e-09
mutations O 0 1.0690146545755397e-09
were O 0 1.6047466133706223e-10
observed O 0 1.2986541009230024e-10
in O 0 2.687274361368175e-11
Japanese O 0 2.025827150475834e-08
, O 0 1.699743991390168e-11
Utah O 0 1.3328815828828056e-09
Mormon O 0 3.440698559398214e-10
, O 0 3.6341259862515685e-12
and O 0 1.0381293047423412e-11
African O 0 5.037431582977092e-10
American O 0 2.268341736666457e-09
patients O 0 9.391185606943964e-10
. O 0 5.548345116679343e-10

These O 0 7.600891582804081e-10
assays O 0 3.1906481900989547e-09
should O 0 6.612131848993119e-12
facilitate O 0 2.6947680198396995e-11
screening O 0 5.236601707814259e-10
for O 0 7.022609577189698e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999967813491821
T I-Disease 1 1.0
heterozygotes O 0 2.7975538330338168e-08
in O 0 1.4426474771733755e-11
the O 0 4.0833400029305356e-12
populations O 0 2.460276990814969e-12
studied O 0 1.839780827683768e-10
. O 0 1.516803523060606e-11
. O 0 2.9410213153724385e-10

The O 0 4.7542769721076183e-07
von B-Disease 1 0.9998843669891357
Hippel I-Disease 1 0.9999992847442627
- I-Disease 1 0.8721352815628052
Lindau I-Disease 0 0.2343669980764389
tumor I-Disease 0 5.845980695085018e-07
suppressor O 0 1.2309281771649694e-07
gene O 0 3.952507487969825e-10
is O 0 4.226768674647774e-13
required O 0 3.816159194203195e-12
for O 0 1.8679788618691795e-11
cell O 0 1.777456759555207e-08
cycle O 0 1.5611136827686778e-09
exit O 0 3.165744333344378e-10
upon O 0 9.987235344288692e-11
serum O 0 4.756592009158567e-09
withdrawal O 0 1.4343691567830774e-08
. O 0 1.4302276696298577e-08

The O 0 7.390209333379971e-08
inactivation O 0 1.8645345107870526e-06
of O 0 3.090862321641907e-08
the O 0 8.934132322835353e-10
von B-Disease 1 0.9966182112693787
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999947547912598
Lindau I-Disease 1 0.9999998807907104
( I-Disease 0 1.5546937959243223e-07
VHL I-Disease 1 1.0
) I-Disease 0 7.948394720180829e-10
tumor I-Disease 0 4.2293478941246576e-07
suppressor O 0 1.9195671484339982e-05
gene O 0 9.85168995271124e-08
predisposes O 0 1.9597001710280892e-07
affected O 0 1.0572517306073337e-09
individuals O 0 9.670557540517044e-13
to O 0 6.521429229966458e-11
the O 0 1.174016350802276e-08
human O 1 0.9951691031455994
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 0.9999997615814209
and O 0 2.2684011613538502e-10
is O 0 4.448159288822362e-12
associated O 0 1.0971321767749842e-10
with O 0 1.4202955478381796e-10
sporadic B-Disease 1 0.5078110098838806
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 3.6151018321106676e-06
RCC B-Disease 1 1.0
) O 0 1.0197544497714262e-07
and O 0 5.009506480746495e-07
brain B-Disease 1 1.0
hemangioblastomas I-Disease 1 0.9999946355819702
. O 0 1.5322905255743535e-07

VHL O 1 0.9999784231185913
- O 0 4.459051524463575e-06
negative O 0 9.538388745511384e-09
786 O 0 1.1023730621673167e-06
- O 0 4.1008323137248226e-07
0 O 0 3.75794151352693e-08
RCC B-Disease 1 0.9999876022338867
cells O 0 2.3301300444700246e-08
are O 0 4.4780752023187986e-11
tumorigenic O 0 1.8680727862374624e-06
in O 0 2.2231276819439927e-09
nude O 0 3.191910309396917e-07
mice O 0 2.603272042378535e-09
which O 0 1.1113311659816105e-11
is O 0 1.6910153832760955e-12
suppressed O 0 4.907308448487413e-10
by O 0 4.81493967960378e-12
the O 0 3.784867558254135e-11
reintroduction O 0 2.959408185176926e-08
of O 0 1.2659084447363966e-08
VHL B-Disease 1 0.9997854828834534
. O 0 2.657896480684485e-08

Remarkably O 0 4.87963916384615e-06
, O 0 2.691959433143154e-10
this O 0 9.787369482580632e-13
occurs O 0 2.6705239582203166e-12
without O 0 2.822233549290565e-12
affecting O 0 6.774077826454672e-11
the O 0 2.20281466678518e-11
growth O 0 1.312483715459889e-11
rate O 0 5.3661593397980045e-12
and O 0 4.315911343588663e-12
cell O 0 5.75589020890277e-10
cycle O 0 3.849709787062672e-11
profile O 0 8.31095348791111e-12
of O 0 5.624247595426013e-11
these O 0 2.3719036717356756e-12
cells O 0 5.162487451415565e-11
in O 0 1.050238784827684e-10
culture O 0 2.223958794900227e-09
. O 0 5.630765853581465e-10

The O 0 4.682939049871493e-07
786 O 0 2.1787820969620952e-06
- O 0 1.613125135691007e-07
0 O 0 3.0313440646523304e-09
cell O 0 3.4530205361704702e-09
line O 0 6.737283619884238e-09
, O 0 1.9770322531864615e-11
like O 0 4.389635877011244e-11
many O 0 2.597288183137092e-11
cancer B-Disease 0 5.7449941692766515e-08
cells O 0 4.4270881405239493e-10
, O 0 4.8254324147567473e-11
fails O 0 2.4923588193281887e-10
to O 0 1.3291964751083185e-11
exit O 0 3.2552107676053765e-09
the O 0 2.3946480909309287e-10
cell O 0 1.1429327484435703e-09
cycle O 0 3.4029165596471955e-10
upon O 0 2.4786203645099647e-10
serum O 0 4.521309104887905e-09
withdrawal O 0 8.507941018365273e-09
. O 0 5.525515156534766e-09

Here O 0 1.0871681865864957e-07
, O 0 2.340934668332295e-10
it O 0 1.2605376811802849e-12
is O 0 9.876194778440581e-14
shown O 0 2.0924020437303181e-13
that O 0 3.9990753086414574e-14
reintroduction O 0 2.9181898564267783e-10
of O 0 3.719514279909575e-11
the O 0 7.01352101395436e-11
wild O 0 4.721387725226123e-08
- O 0 7.651255629070874e-08
type O 0 4.4068946181141655e-07
VHL B-Disease 1 0.9999997615814209
gene O 0 3.3868792215230314e-09
restores O 0 1.3874091209231665e-08
the O 0 7.959621850517351e-10
ability O 0 6.37554176119437e-10
of O 0 5.404689318311284e-08
VHL O 1 1.0
- O 0 3.1934818252921104e-05
negative O 0 1.5838129741041485e-07
RCC B-Disease 1 1.0
cancer I-Disease 0 0.00012693635653704405
cells O 0 2.3312124453056526e-10
to O 0 1.5483225812573664e-11
exit O 0 1.3660654829550367e-09
the O 0 1.3942413890077887e-10
cell O 0 2.01049044079582e-09
cycle O 0 1.382315095721509e-10
and O 0 3.5894124478241807e-11
enter O 0 4.039008238976294e-09
G0 O 0 0.08089393377304077
/ O 0 6.006135322422779e-08
quiescence O 0 4.6883641857675684e-08
in O 0 9.483851481917327e-10
low O 0 5.85660586693848e-08
serum O 0 1.2569766738579347e-07
. O 0 4.18817691638651e-09

Both O 0 1.233065972883196e-06
VHL O 1 0.9999924898147583
- O 0 2.8018473585689208e-06
positive O 0 2.7601489982487237e-09
and O 0 4.947657838982877e-09
VHL O 1 0.9999995231628418
- O 0 6.123661364654254e-07
negative O 0 1.338412936036093e-08
RCC B-Disease 1 0.9999996423721313
cells O 0 1.005337324500033e-08
exit O 0 8.013398833384144e-09
the O 0 2.402292531566985e-10
cell O 0 1.4935853664965748e-09
cycle O 0 4.827752433933519e-11
by O 0 1.7575696757352044e-12
contact O 0 8.658828654084516e-10
inhibition O 0 8.052100319844158e-09
. O 0 2.3430086759645974e-09

The O 0 3.843018134830345e-07
cyclin O 0 2.364050288861108e-07
- O 0 5.119546742093917e-08
dependent O 0 2.344416660804427e-09
kinase O 0 5.255425428174476e-09
inhibitor O 0 2.6673614428318615e-09
, O 0 9.777396947630024e-11
p27 O 0 1.1599889937485841e-08
, O 0 1.1071336555867894e-11
accumulates O 0 8.411715768374961e-11
upon O 0 6.719515222020078e-11
serum O 0 2.8695409937107286e-10
withdrawal O 0 1.2826235906704397e-10
, O 0 1.3230147880016752e-11
only O 0 3.934074474607613e-13
in O 0 1.6869306515912563e-12
the O 0 7.586458371233729e-12
presence O 0 4.3262324278536823e-11
of O 0 1.0657984716999636e-08
VHL B-Disease 1 0.9999998807907104
, O 0 9.851789523063204e-11
as O 0 3.1189326295255615e-12
a O 0 5.034189645009013e-12
result O 0 1.85010097519811e-11
of O 0 3.8874684027412343e-10
the O 0 8.502010900857115e-11
stabilization O 0 2.241060848007237e-08
of O 0 2.9073591534256593e-08
the O 0 4.230277461658716e-09
protein O 0 3.1870597272387613e-09
. O 0 1.630954593601075e-09

We O 0 3.12880410469063e-09
propose O 0 1.0676820538790821e-09
that O 0 5.479015678655497e-12
the O 0 1.6914010469992746e-10
loss O 0 1.647702241314164e-08
of O 0 3.937357462291402e-08
wild O 0 3.024940269824583e-06
- O 0 6.870428705951781e-07
type O 0 2.2623642053076765e-06
VHL B-Disease 1 1.0
gene O 0 9.220053609482193e-10
results O 0 1.181777314895882e-10
in O 0 1.8849435901024947e-11
a O 0 1.906198983381291e-11
specific O 0 2.7086519138741494e-10
cellular O 0 2.757430820565787e-06
defect O 0 9.180926099361386e-07
in O 0 1.955895445604483e-09
serum O 0 1.8090050346586395e-08
- O 0 3.735958387096616e-08
dependent O 0 1.2427495699185442e-09
growth O 0 1.3780504515281677e-10
control O 0 1.7636371252294225e-09
, O 0 8.910656067173672e-12
which O 0 1.2256856770850866e-12
may O 0 2.0459073671319494e-11
initiate O 0 1.6401831004486667e-08
tumor B-Disease 0 4.724126483779401e-06
formation O 0 5.812240851810202e-05
. O 0 2.9219243913303217e-08

This O 0 2.5974540296402893e-09
is O 0 1.1765909080363457e-10
corrected O 0 1.7077331770920523e-09
by O 0 5.8777665894182984e-12
the O 0 1.8916208877062246e-11
reintroduction O 0 1.1414056366731984e-09
of O 0 3.040764307016275e-10
wild O 0 3.168641171669151e-08
- O 0 2.96297855584271e-07
type O 0 1.8483970052329823e-05
VHL B-Disease 1 1.0
, O 0 2.0797109812065173e-08
implicating O 1 0.9999775886535645
VHL B-Disease 1 1.0
as O 0 1.5940732067676322e-09
the O 0 8.697295661441728e-10
first O 0 5.055951768362377e-10
tumor B-Disease 0 1.4570008532999168e-09
suppressor O 0 4.55737003690615e-09
involved O 0 9.555859575849368e-11
in O 0 5.2481675255622307e-11
the O 0 1.2384919478858336e-10
regulation O 0 2.7287327952763007e-08
of O 0 2.3267723747721902e-08
cell O 0 1.4069828857543598e-08
cycle O 0 4.2608117034603765e-10
exit O 0 1.4779932833164366e-09
, O 0 5.555804948043086e-12
which O 0 1.1967080972008493e-12
is O 0 7.78742576066499e-13
consistent O 0 3.971588891094058e-10
with O 0 5.029822478658241e-12
its O 0 3.7124830987167456e-11
gatekeeper O 0 1.3984926550136834e-09
function O 0 1.004398560849884e-11
in O 0 2.350355673974569e-11
the O 0 1.6912568012728002e-09
kidney O 0 4.704847071934637e-07
. O 0 4.1362474556549955e-10
. O 0 1.211800659817186e-09

Piebaldism B-Disease 1 1.0
with O 0 0.0002553650410845876
deafness B-Disease 1 1.0
: O 0 3.831882811056175e-09
molecular O 0 1.0727449151204382e-08
evidence O 0 9.380086707366786e-10
for O 0 8.553617016071602e-12
an O 0 1.3112901389722431e-11
expanded O 0 1.2286276387385442e-06
syndrome O 1 0.9999978542327881
. O 0 1.850738939879193e-08

In O 0 7.031261795020782e-09
a O 0 7.324136852560059e-10
South O 0 1.5327399793818586e-08
African O 0 1.6257926116480803e-09
girl O 0 5.893582066818226e-09
of O 0 2.867988513344244e-09
Xhosa O 0 7.763151188555639e-07
stock O 0 2.1924049242727506e-09
with O 0 1.7261364559928438e-10
severe O 1 0.9727609753608704
piebaldism B-Disease 1 0.9999995231628418
and O 0 2.393325303273741e-06
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 2.5503743472654605e-07
identified O 0 4.247733720319502e-09
a O 0 1.4344551935163707e-10
novel O 0 2.491560291417727e-10
missense O 0 4.4728554193795844e-09
substitution O 0 9.955408053485826e-09
at O 0 2.2413514599861628e-08
a O 0 1.705271618357429e-10
highly O 0 1.7325297863024502e-09
conserved O 0 7.5745854033471e-09
residue O 0 3.495378564366547e-08
in O 0 5.61614366123564e-11
the O 0 1.45645197291433e-11
intracellular O 0 6.382181588771019e-11
kinase O 0 3.430535022719283e-10
domain O 0 1.2288470241372806e-10
of O 0 2.170432278347789e-09
the O 0 2.7454476470012423e-09
KIT O 1 0.9998713731765747
proto O 0 1.7956612282432616e-05
- O 0 5.949536898697261e-07
oncogene O 0 2.5971046397899045e-06
, O 0 5.647881273773692e-09
R796G O 0 3.8005168789823074e-06
. O 0 1.3098897966301593e-08

Though O 0 5.814266756942743e-08
auditory B-Disease 0 1.522747606941266e-05
anomalies I-Disease 0 2.3976249394763727e-06
have O 0 3.690892383390043e-11
been O 0 9.190267470648994e-12
observed O 0 1.0828166835397113e-10
in O 0 4.7318742674162806e-11
mice O 0 5.866012675603827e-10
with O 0 2.5241283022059413e-11
dominant O 0 5.8796064905664025e-08
white O 0 3.147214933107989e-09
spotting O 0 1.170523660221079e-06
( O 0 4.89259077696147e-09
W O 1 0.9984661340713501
) O 0 9.313531196264435e-11
due O 0 8.316004551645051e-10
to O 0 1.9794141326023862e-10
KIT O 1 1.0
mutations O 0 3.837070892132033e-07
, O 0 4.280438758996752e-08
deafness B-Disease 1 1.0
is O 0 5.146374298936607e-11
not O 0 1.3440638576070474e-12
typical O 0 3.200862630503565e-10
in O 0 1.0679788303713522e-10
human O 0 3.050955488248519e-09
piebaldism B-Disease 0 4.441898636287078e-05
. O 0 2.0236104347759465e-08

Thus O 0 2.99784730373176e-08
, O 0 8.999392203667966e-11
the O 0 1.1972612137811645e-11
occurrence O 0 2.2651942543916448e-09
of O 0 6.203968609952426e-07
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 2.222294170906025e-07
this O 0 7.108657412713271e-11
patient O 0 5.233648181501849e-09
extends O 0 2.1837065489194174e-10
considerably O 0 1.7148634942620866e-11
the O 0 2.0529475688868537e-11
phenotypic O 0 1.9352619506918245e-10
range O 0 1.4643475321207688e-09
of O 0 3.217120791987327e-09
piebaldism B-Disease 0 5.926194717176259e-07
due O 0 4.115638940760391e-09
to O 0 1.75378753186628e-10
KIT O 1 0.9999945163726807
gene O 0 2.4084997884976644e-10
mutation O 0 8.795713289655449e-12
in O 0 7.907560023445726e-12
humans O 0 5.098947306048096e-11
and O 0 3.344130874993745e-11
tightens O 0 9.932282774016699e-10
the O 0 2.1822229787082925e-11
clinical O 0 2.974851032178094e-09
similarity O 0 8.175930071852022e-11
between O 0 5.967268346118715e-11
piebaldism B-Disease 0 2.1888006074277655e-07
and O 0 1.6988299655906758e-11
the O 0 4.486177054841001e-12
various O 0 5.534789206812496e-12
forms O 0 7.444130867284571e-10
of O 0 2.4297253276017727e-07
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.1888533208169747e-09
. O 0 8.057262412819455e-09

Cycloheximide O 0 6.867205229355022e-05
facilitates O 0 3.020011263288325e-08
the O 0 7.23259785395669e-10
identification O 0 3.1533617939061287e-09
of O 0 4.150245036527167e-09
aberrant O 0 4.4169713220298945e-08
transcripts O 0 1.549255870259003e-07
resulting O 0 3.1495448471474674e-09
from O 0 3.5898045647186905e-10
a O 0 5.99045257843045e-11
novel O 0 2.905061469160586e-10
splice O 0 1.765984904977813e-07
- O 0 1.0952390105956056e-08
site O 0 1.5844399126052622e-09
mutation O 0 1.280795053348882e-10
in O 0 1.1721804082931442e-10
COL17A1 O 1 0.9999786615371704
in O 0 2.5167312678320286e-10
a O 0 1.006416477933314e-10
patient O 0 1.1471002814289477e-08
with O 0 7.723475192733531e-10
generalized O 1 0.7314949035644531
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999969005584717
. O 0 2.687473852347466e-06

Patients O 0 1.6536660041310824e-06
with O 0 2.3763051970604465e-08
generalized O 1 0.9977103471755981
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999960660934448
often O 0 1.2544194127883657e-08
show O 0 7.062467277663131e-10
decreased O 0 1.530608695343716e-10
expression O 0 3.747385388108704e-11
of O 0 8.783149763047504e-10
type O 0 3.2585114695393713e-07
XVII O 1 1.0
collagen O 1 0.9999974966049194
, O 0 7.007831648309093e-09
a O 0 3.231941103631897e-10
transmembrane O 0 9.234313758099688e-09
hemidesmosomal O 0 1.0846439408851438e-06
protein O 0 1.7055198364701596e-09
encoded O 0 9.746939921839726e-10
by O 0 1.078404365806307e-09
COL17A1 O 1 0.9999717473983765
. O 0 6.568814114871202e-08

This O 0 1.9262405004383254e-09
report O 0 3.3757910355980414e-10
documents O 0 3.2631863877696787e-09
a O 0 2.4528856723549097e-10
novel O 0 4.2454231796718034e-10
splice O 0 2.298284158541719e-07
- O 0 1.646093927831771e-08
site O 0 7.153900249967649e-10
mutation O 0 6.16365777861283e-11
in O 0 1.1523906828792008e-10
COL17A1 O 1 0.9999957084655762
in O 0 5.680776404837218e-10
a O 0 3.147873628428499e-10
patient O 0 2.8151427855505062e-08
with O 0 8.022815189967503e-10
generalized O 1 0.5579214096069336
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999995231628418
, O 0 8.928328298907218e-09
and O 0 2.0936269384819184e-10
applies O 0 1.1510046388218953e-10
a O 0 1.2295098099357471e-11
new O 0 1.2990646752752966e-11
methodology O 0 4.291337424300323e-11
to O 0 1.411982943760881e-12
define O 0 1.0705403924449186e-10
and O 0 3.7006907954717505e-11
characterize O 0 3.741397414103176e-09
the O 0 1.7489171222351274e-10
resulting O 0 2.5047205975958775e-10
mRNA O 0 3.741832621528829e-09
splice O 0 3.894307951668452e-07
variants O 0 1.760660239824574e-08
. O 0 4.635782868689375e-09

Mutational O 0 1.3282528925628867e-05
analysis O 0 4.620196492055584e-08
of O 0 4.37754437143667e-07
COL17A1 O 1 0.9999910593032837
identified O 0 2.095370810195618e-08
a O 0 3.325922648400592e-09
maternally O 0 4.299504325899761e-07
inherited O 0 1.0851284969248809e-05
G O 0 0.0038035293109714985
- O 0 3.555204784788657e-06
to O 0 7.226465204013266e-09
- O 0 9.364053767058067e-06
T O 0 0.00011663271288853139
transversion O 0 8.425028568126436e-07
at O 0 1.3259769948703592e-09
the O 0 9.001417666798517e-11
- O 0 4.157992283815304e-10
1 O 0 1.234489732659938e-10
position O 0 2.0438997716532015e-10
of O 0 9.424758751208628e-10
exon O 0 1.2891494804989634e-07
32 O 0 1.8306153037883632e-08
. O 0 1.901803159398696e-09

This O 0 6.897721283039004e-10
acceptor O 0 6.385436068789829e-10
splice O 0 1.6050045132942614e-06
- O 0 4.245913132194801e-08
site O 0 2.63548138867975e-09
mutation O 0 7.329471751749139e-11
led O 0 2.2424781476182432e-10
to O 0 5.4985508333993405e-12
the O 0 3.423180142125837e-11
formation O 0 8.589712940931804e-09
of O 0 3.7037590772115436e-09
aberrant O 0 2.7074614550315346e-08
transcripts O 0 4.142211906810189e-08
present O 0 7.413412106416217e-10
at O 0 8.545590901576361e-09
extremely O 0 6.304658128897245e-09
low O 0 1.0801304739516127e-07
levels O 0 1.8664788825617507e-08
. O 0 1.1952089318256753e-09

Based O 0 1.4328247743833344e-07
on O 0 2.478963345708962e-08
our O 0 4.339059667124445e-10
recent O 0 1.5601834060796627e-11
finding O 0 8.481474550459112e-11
that O 0 1.7203992137143631e-12
cycloheximide O 0 3.723576753600355e-07
stabilized O 0 3.3731623716448667e-07
mutant O 0 4.648499540849116e-08
COL17A1 O 0 0.0005826178821735084
transcripts O 0 2.728435966048437e-08
in O 0 1.6381805634235747e-10
keratinocytes O 0 3.0905955572535504e-09
homozygous O 0 1.7599532942114138e-10
for O 0 2.7849054659578876e-11
a O 0 1.5200304903650874e-10
frameshift O 0 4.6958369637195574e-08
mutation O 0 3.7837291633202597e-10
, O 0 1.8568851317679602e-11
the O 0 1.4040511808754985e-10
effects O 0 9.636645614818917e-08
of O 0 1.006006744574961e-08
the O 0 7.686118963512456e-10
splice O 0 2.06060889240689e-07
- O 0 6.186843926059282e-09
site O 0 3.788032942875219e-10
mutation O 0 5.067927848212417e-12
on O 0 5.578074113721243e-11
splicing O 0 2.8704949528446377e-09
of O 0 7.765045495489176e-09
COL17A1 O 1 0.994592010974884
transcripts O 0 9.442634762990565e-08
were O 0 1.4506611190068242e-10
determined O 0 2.021983101785363e-11
using O 0 3.529760685128114e-12
reverse O 0 2.717946423480555e-10
transcriptase O 0 2.3016634431716199e-10
polymerase O 0 4.3194894883136215e-10
chain O 0 1.9304030596245525e-10
reaction O 0 8.870230071289509e-12
of O 0 1.0574835451748754e-09
total O 0 1.1279711539802229e-11
RNA O 0 2.0295156666350067e-09
from O 0 2.888398131783987e-10
keratinocytes O 0 2.1602515332119765e-09
incubated O 0 1.3594703140995534e-10
for O 0 2.3816832186995818e-11
2 O 0 1.6524356993841138e-08
. O 0 1.6048025130999122e-09

5 O 0 1.622801306666588e-07
h O 0 9.58187751365358e-09
in O 0 7.007610464127012e-11
the O 0 1.705719766820213e-11
presence O 0 2.689366437880203e-11
or O 0 4.201501993539303e-11
absence O 0 5.556788362781617e-09
of O 0 9.86473569497548e-09
10 O 0 5.338837816282194e-09
microg O 0 4.322339464124525e-06
cycloheximide O 0 2.3450409116776427e-06
per O 0 2.2973576374596405e-09
ml O 0 1.939974794140653e-07
. O 0 1.6856120055308565e-08

Using O 0 2.4408737253622803e-09
this O 0 8.615477255224935e-12
approach O 0 4.2011197298741365e-10
, O 0 1.1269174829409145e-11
an O 0 1.6965009041677859e-12
abnormally O 0 2.482521388458281e-08
spliced O 0 1.1393380816571153e-07
transcript O 0 9.438979020615079e-08
was O 0 2.6185653645427465e-09
identified O 0 3.4618537203545685e-11
that O 0 2.169960039563254e-13
contains O 0 1.0999183334969853e-11
an O 0 1.369924274930226e-13
extra O 0 2.5266571820892203e-11
264 O 0 6.419469955609713e-10
bases O 0 4.695805411181198e-10
upstream O 0 2.5605556563945697e-10
from O 0 1.9216708779801195e-10
exon O 0 1.876201594086524e-08
32 O 0 2.943727928084172e-09
, O 0 1.0440746357753827e-11
resulting O 0 5.455035034795941e-11
in O 0 6.833825172414265e-11
a O 0 2.735911497353527e-10
premature O 0 3.578439589091431e-08
termination O 0 1.606873070159054e-07
codon O 0 1.135791691808663e-07
27 O 0 5.087782994905865e-08
bp O 0 2.716073232988947e-08
downstream O 0 1.2476189859000897e-08
from O 0 8.81394346397002e-10
the O 0 9.797095357200192e-10
cryptic O 0 1.0118630200395273e-07
splice O 0 1.4479156789093395e-06
site O 0 1.2315388175920816e-07
. O 0 7.2224000113862985e-09

Three O 0 6.378330752454531e-09
other O 0 1.6934368837762115e-11
splice O 0 2.216122219067529e-08
variants O 0 2.1396338034662676e-09
, O 0 4.177083332002063e-11
including O 0 2.548796763923722e-11
one O 0 2.316194111506853e-12
derived O 0 1.6850116787980873e-11
from O 0 6.184961570676606e-11
the O 0 6.0125453227311e-11
skipping O 0 2.9036115734015766e-09
of O 0 1.430194185303435e-09
exon O 0 1.6508856504060532e-08
32 O 0 3.1301532477101546e-09
, O 0 2.2758973525216497e-11
were O 0 1.7055189205361643e-10
also O 0 3.505387993762987e-11
identified O 0 2.088307748948637e-09
. O 0 4.9198223273094754e-09

These O 0 1.0709724662660847e-08
results O 0 7.502519494551052e-09
indicate O 0 6.766397442348193e-10
the O 0 6.017409487357739e-11
usefulness O 0 1.4268483061741222e-09
of O 0 1.9739221368553217e-09
cycloheximide O 0 1.8069468410431e-07
treatment O 0 1.2087673084693051e-09
in O 0 1.670387959895603e-11
evaluating O 0 7.069206331422606e-10
the O 0 1.292483758907892e-10
abnormal O 0 8.199921852636294e-10
processing O 0 2.7499231780581113e-09
of O 0 1.8867114537357565e-09
mRNA O 0 1.8840495830119153e-10
due O 0 3.2431179963765544e-10
to O 0 2.5630022409961484e-11
splice O 0 1.147140196167129e-07
- O 0 5.865009367056473e-09
site O 0 8.911769655561841e-10
mutations O 0 1.2029109652811343e-10
, O 0 3.1116491328031515e-11
because O 0 8.262150685833802e-11
( O 0 1.826909040714142e-10
i O 0 1.1619547546359854e-09
) O 0 1.4805649761751027e-11
aberrant O 0 6.839061317265305e-09
splicing O 0 9.812715973112063e-09
often O 0 2.1582725190372187e-11
generates O 0 4.030561995271853e-11
a O 0 4.8343315461885084e-11
premature O 0 2.4688453503785013e-09
termination O 0 1.7075061364835165e-08
codon O 0 2.2432718793652384e-08
, O 0 1.523071946341048e-10
( O 0 3.328762612775371e-11
ii O 0 0.001582390978001058
) O 0 1.993223502916308e-10
transcripts O 0 1.6867110730345303e-07
with O 0 2.2037990876633273e-10
premature O 0 6.266536445309612e-08
termination O 0 7.066247320608454e-08
codons O 0 4.192860281193589e-09
can O 0 5.376373825305425e-12
occur O 0 3.031213821613754e-11
at O 0 1.3356581396450906e-09
low O 0 1.2778901492538353e-08
or O 0 2.4917029550763914e-10
undetectable O 0 1.8886412078700232e-07
levels O 0 9.939592898744465e-11
due O 0 8.496381549705223e-12
to O 0 6.920970415692784e-13
nonsense O 0 6.888872805532742e-10
- O 0 1.8128648582305118e-10
mediated O 0 8.70404581743145e-11
mRNA O 0 3.199017786781333e-11
decay O 0 1.3471920246033164e-09
, O 0 2.9966519717039564e-12
and O 0 5.771561180367701e-12
( O 0 7.255359941310546e-12
iii O 0 3.848192591249244e-06
) O 0 2.3079708283413325e-11
the O 0 2.428481721272746e-11
levels O 0 7.99519131455817e-11
of O 0 1.678237583624398e-11
these O 0 1.404847375582885e-13
transcripts O 0 4.271723808013661e-10
can O 0 7.118540782877214e-13
be O 0 6.99086242453989e-13
increased O 0 3.5922939969901257e-12
by O 0 8.669798212679325e-11
cycloheximide O 0 6.095744538470171e-06
. O 0 3.869088160968204e-09

A O 0 2.40544159169076e-06
deletion O 0 2.8062862256206245e-08
mutation O 0 6.500543991982966e-10
in O 0 7.246958588780217e-10
COL17A1 O 1 0.999993085861206
in O 0 6.179646239168335e-10
five O 0 6.087109982733097e-11
Austrian O 0 4.368627415374249e-08
families O 0 1.0601423384992703e-11
with O 0 7.411941616020101e-10
generalized O 1 0.9693804979324341
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9989244341850281
represents O 0 7.974429649948434e-08
propagation O 0 4.9648265303403605e-06
of O 0 6.115129025374699e-08
an O 0 3.241162546685494e-11
ancestral O 0 5.260733360046288e-08
allele O 0 1.8812389424027742e-09
. O 0 3.144484672645831e-09

Patients O 0 1.8990492662851466e-06
with O 0 1.4096609213254396e-08
generalized O 1 0.9984657764434814
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 1.1324675419643881e-08
a O 0 1.306769137343622e-10
usually O 0 6.374456518187799e-11
nonlethal O 0 2.4853984541550744e-06
form O 0 4.0334054318691415e-08
of O 0 3.2835685033205664e-06
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999973773956299
, O 0 7.472984897560764e-09
have O 0 4.7408178077690266e-11
generalized O 0 5.972287198119375e-08
blistering B-Disease 1 0.9863830804824829
, O 0 2.8303684302954935e-06
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.7581052816240117e-05
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 8.70233009209187e-07
and O 0 0.0001103649556171149
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 7.3926298682636116e-06

Skin B-Disease 1 1.0
fragility I-Disease 0 0.010041673667728901
in O 0 5.135750047458032e-09
most O 0 1.7311737113279158e-11
cases O 0 1.8857060010701865e-11
is O 0 1.7593263272001197e-13
due O 0 1.084244152793623e-11
to O 0 1.501913285580081e-12
mutations O 0 8.617597087312578e-12
in O 0 8.48528886043809e-12
the O 0 3.284075442144818e-11
gene O 0 2.1337751010541695e-11
encoding O 0 5.2199251865392426e-11
type O 0 4.0150996483134804e-07
XVII O 1 1.0
collagen O 1 0.9999982118606567
( O 0 5.12054327828082e-07
COL17A1 O 1 1.0
) O 0 3.733320763643633e-09
. O 0 1.285788919780373e-09

Recently O 0 7.943687023725943e-07
, O 0 1.0366385527760258e-09
we O 0 1.667090597512466e-11
reported O 0 7.677163071928561e-11
five O 0 1.1514739682583208e-11
Austrian O 0 3.37184964394055e-08
families O 0 3.537803383579785e-11
with O 0 5.52674572773526e-10
generalized O 0 0.28477683663368225
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.999996542930603
who O 0 3.124577574453724e-08
share O 0 6.48484155263418e-10
the O 0 2.332903870083669e-09
same O 0 5.580655049186589e-09
COL17A1 O 1 1.0
mutation O 0 8.059863176868021e-08
. O 0 1.1006838995797352e-08

Affected O 0 2.8059224277399153e-08
individuals O 0 7.318795743060935e-12
in O 0 3.309630694503518e-11
three O 0 5.957542618950651e-12
families O 0 3.276874689021707e-14
are O 0 8.403812314008302e-14
homozygous O 0 3.144211974115407e-11
for O 0 2.889867685429426e-11
4003delTC O 0 7.687841474535162e-08
, O 0 7.173203003807416e-11
whereas O 0 7.235477494926812e-11
those O 0 2.7286178958668694e-12
in O 0 7.330614414102765e-12
two O 0 8.511677473954649e-12
others O 0 2.6885252704667018e-11
are O 0 5.1226327867082144e-12
compound O 0 7.447898298096334e-09
heterozygotes O 0 3.11104344064006e-07
. O 0 1.4609977228019488e-08

To O 0 1.7306471811195934e-09
determine O 0 1.6867691687849629e-09
if O 0 5.143329338819225e-12
the O 0 1.6542305719680073e-11
occurrence O 0 4.152967136850094e-10
of O 0 3.073891974292309e-10
4003delTC O 0 1.0092662705574185e-08
in O 0 1.1306032499103225e-11
these O 0 1.0596465111617492e-12
unrelated O 0 1.554392031755114e-10
families O 0 1.678351061644781e-13
signifies O 0 1.0153738960738679e-11
propagation O 0 9.60231361091246e-09
of O 0 2.871085036382226e-10
an O 0 6.588674376049874e-13
ancestral O 0 5.48669720767947e-10
allele O 0 2.9128609246864556e-11
or O 0 5.811707712299885e-11
a O 0 2.4987087399175323e-10
mutational O 0 2.5873148388200207e-06
hot O 0 0.0002276257728226483
spot O 0 6.316968210740015e-07
, O 0 8.098854226146202e-11
haplotypes O 0 6.648813721810143e-10
were O 0 8.678268520467824e-11
determined O 0 1.4728257502483189e-10
for O 0 2.6670991803978694e-11
polymorphisms O 0 4.042815415772338e-09
both O 0 3.712270768563286e-11
within O 0 4.37805924846657e-09
and O 0 4.454058011305051e-09
flanking O 0 0.003120024688541889
COL17A1 O 1 1.0
. O 0 3.834082349385426e-07

Five O 0 2.6739803615782876e-07
intragenic O 0 1.0619322893035132e-05
polymorphisms O 0 1.6384946732728167e-08
were O 0 2.609738536385464e-10
chosen O 0 2.1623941526272006e-10
based O 0 8.946308138746417e-10
on O 0 6.329369917068561e-09
their O 0 4.8987724987625825e-09
informativeness O 0 4.147185245528817e-05
. O 0 1.2544911776046774e-08

One O 0 8.90142803910976e-09
of O 0 7.294084003461876e-09
these O 0 3.227085612622638e-11
, O 0 1.101173666140376e-11
not O 0 8.889007693975437e-13
previously O 0 1.1883254102951213e-10
reported O 0 1.202167948521904e-10
, O 0 1.843106049725929e-11
was O 0 1.0605721856293826e-09
2988 O 0 6.548848432430532e-07
A O 0 5.663266477995421e-08
or O 0 8.954160746199591e-10
C O 0 8.928560077947623e-07
that O 0 1.1412928978618564e-12
introduces O 0 7.416873365473364e-11
a O 0 3.6120399206363007e-12
new O 0 3.04754268695695e-12
restriction O 0 4.413594056201786e-12
site O 0 3.0745078705152196e-10
for O 0 2.8515892772085216e-11
Eco0109 O 0 2.526907792343991e-06
I O 0 7.23588482287596e-06
. O 0 1.0821364249125054e-08

All O 0 1.066742161270895e-08
the O 0 3.3301630342208455e-09
4003delTC O 0 1.003996317194833e-07
alleles O 0 5.47070617973322e-11
showed O 0 1.1802928079340802e-10
the O 0 2.0201751729787e-11
same O 0 1.3304970189823018e-12
haplotype O 0 1.916052733141882e-10
for O 0 4.394919324302027e-12
these O 0 1.7802771409836105e-11
five O 0 2.638870233440116e-10
polymorphic O 0 5.515767398378557e-08
markers O 0 1.284169229620602e-06
. O 0 3.547606652887225e-08

Fourteen O 0 5.331155080057215e-06
microsatellite O 0 6.072461360417947e-07
polymorphisms O 0 4.314191670573564e-08
were O 0 2.4634161377434793e-10
selected O 0 6.489456749747546e-10
based O 0 2.46583226060082e-10
on O 0 6.167282795566109e-10
their O 0 7.008092023363943e-11
high O 0 7.576578475720908e-09
heterozygosity O 0 7.799246759532252e-08
and O 0 1.3389325759227688e-10
their O 0 4.291566407799152e-11
location O 0 1.8502792631380771e-09
within O 0 1.0832799102189483e-09
10q23 O 0 5.318087801242655e-07
- O 0 1.5476537384984113e-07
q25 O 0 6.84550468577072e-06
near O 0 7.592445854243124e-06
COL17A1 O 1 0.9999911785125732
. O 0 5.7149936338873886e-08

Three O 0 3.3953522216023657e-09
families O 0 1.84402736136402e-11
shared O 0 4.877233616973342e-10
microsatellite O 0 1.061117416156776e-07
polymorphisms O 0 2.9044724669802235e-07
covering O 0 7.80358550400706e-06
at O 0 1.0321057430928704e-07
most O 0 1.9331627965080145e-10
19 O 0 8.863935363478959e-09
cM O 0 1.927923820588262e-09
, O 0 1.0254399759879185e-11
whereas O 0 2.3458681178145646e-11
the O 0 4.416964710651783e-11
others O 0 1.778878606917278e-11
shared O 0 1.7155603326823865e-11
smaller O 0 3.424995703715794e-11
regions O 0 7.623541797840971e-10
consistent O 0 1.2149302008879204e-08
with O 0 2.1774843039779057e-10
cross O 0 9.819909507768898e-08
- O 0 5.369405542410277e-08
over O 0 1.5154305588183092e-10
events O 0 2.533060393383746e-11
during O 0 1.6900102844941145e-11
passage O 0 5.770923235809411e-12
of O 0 2.4979150692328034e-12
this O 0 1.9011889976282108e-14
mutation O 0 6.912909372540355e-13
through O 0 4.327137606563447e-12
several O 0 2.0052341731524592e-11
generations O 0 1.3618612904053862e-09
. O 0 9.078495177838874e-10

These O 0 9.297850489531356e-09
results O 0 4.1193932709404635e-09
indicate O 0 4.1672496009503845e-10
that O 0 3.2567646496284297e-12
4003delTC O 0 2.9567168269295507e-08
occurs O 0 3.46563958086854e-11
on O 0 5.989584522803071e-11
a O 0 8.40536060892072e-12
single O 0 4.542802592433226e-11
ancestral O 0 9.61799861975976e-10
allele O 0 1.001117036492083e-10
. O 0 6.244811612265977e-11
. O 0 5.767968880299179e-10

The O 0 3.3946943744922464e-07
haptoglobin O 0 2.7700409191311337e-05
- O 0 9.986465556721669e-07
gene O 0 1.5090541038986771e-09
deletion O 0 2.0620460894349435e-09
responsible O 0 1.1462035764964185e-08
for O 0 4.730823288667807e-09
anhaptoglobinemia B-Disease 0 0.0031635151244699955
. O 0 1.169950678558962e-07

We O 0 3.112827773321669e-09
have O 0 4.571022380051026e-12
found O 0 4.107171634043505e-12
an O 0 7.023095077501526e-14
allelic O 0 1.0395927452222509e-09
deletion O 0 5.898234678447523e-10
of O 0 9.030729941628124e-09
the O 0 1.6190033758078926e-09
haptoglobin O 0 4.7101087830014876e-07
( O 0 3.19760412592629e-10
Hp O 0 4.530935182600615e-09
) O 0 4.7068054315202446e-11
gene O 0 8.043587323980361e-11
from O 0 3.2463719212838527e-11
an O 0 1.0621028796037324e-12
individual O 0 4.221501620493839e-12
with O 0 8.287944774920675e-10
anhaptoglobinemia B-Disease 1 0.9002910852432251
. O 0 4.1909036241349895e-08

The O 0 8.49498889010647e-08
Hp O 0 2.7770381549885315e-08
gene O 0 7.885502251170351e-10
cluster O 0 9.862477945432602e-09
consists O 0 5.601255015363904e-10
of O 0 3.8696029713847224e-10
coding O 0 1.17727616544272e-09
regions O 0 4.52776233172969e-10
of O 0 3.869117914945264e-09
the O 0 5.821718107590357e-10
alpha O 0 2.9329338957495565e-09
chain O 0 7.068532426046659e-10
and O 0 8.217731183035593e-12
beta O 0 3.383752167351872e-10
chain O 0 3.22740750791084e-10
of O 0 1.3338855020528229e-10
the O 0 3.6028700856061135e-11
haptoglobin O 0 3.84877587578103e-08
gene O 0 2.653031405674966e-10
( O 0 8.027445028147007e-12
Hp O 0 5.903479927127364e-10
) O 0 2.891625090414851e-12
and O 0 1.2171549358674927e-11
of O 0 8.496633396859465e-10
the O 0 7.569811444341212e-11
alpha O 0 9.8466845788181e-10
chain O 0 5.06071740069558e-10
and O 0 8.90377528650621e-12
beta O 0 3.804933867979088e-10
chain O 0 3.877153320619442e-10
of O 0 2.200149229469872e-10
the O 0 1.0279196244189492e-10
haptoglobin O 0 5.765026855897304e-08
- O 0 4.8698738375207995e-09
related O 0 1.235767932428189e-08
gene O 0 2.467954451912391e-10
( O 0 2.2224302259621354e-11
Hpr O 0 5.7467147485112946e-08
) O 0 2.957344091836234e-11
, O 0 5.287985327395717e-12
in O 0 1.2013374670050148e-11
tandem O 0 2.5478759102526283e-09
from O 0 6.601049151733207e-10
the O 0 3.0477798063088812e-09
5 O 0 2.0986266946465548e-08
side O 0 3.461489583855837e-08
. O 0 1.8351311581454866e-09

Southern O 0 3.6824851576966466e-06
blot O 0 4.921715571981622e-06
and O 0 1.3766009443472171e-09
PCR O 0 5.6944834625483054e-08
analyses O 0 3.3858327253000198e-09
have O 0 4.47477688583775e-12
indicated O 0 2.0446434476073527e-11
that O 0 1.7370261858658947e-13
the O 0 4.7037699256458065e-12
individual O 0 4.01129216648366e-13
with O 0 3.874207812198938e-12
anhaptoglobinemia B-Disease 0 1.136910555032955e-06
was O 0 1.4331433817460493e-09
homozygous O 0 4.3918969155898324e-11
for O 0 3.203497796894217e-12
the O 0 5.100961320003705e-11
gene O 0 3.791326974589282e-11
deletion O 0 6.178582645510744e-11
and O 0 2.9608548252069156e-11
that O 0 6.632400791767301e-13
the O 0 9.990874100251901e-11
gene O 0 2.6739910632955777e-11
deletion O 0 5.288441906614594e-11
was O 0 1.5727538715815115e-10
included O 0 7.760580372773163e-11
at O 0 3.6729724817163856e-10
least O 0 7.638259599471175e-13
from O 0 8.024062317368852e-12
the O 0 1.0148594464798322e-10
promoter O 0 1.3859909131497261e-06
region O 0 1.0140709605366283e-08
of O 0 4.380492413247339e-08
Hp O 0 2.115393016310918e-08
to O 0 2.464883630537429e-09
Hpr O 0 9.676683703219169e-07
alpha O 0 1.3890931960247599e-08
but O 0 7.091630668115689e-12
not O 0 4.86032492464511e-13
to O 0 1.6371551683769248e-11
Hpr O 0 2.2750181472019904e-07
beta O 0 6.033415189676816e-08
( O 0 6.016288578436502e-10
Hpdel O 0 3.067515717702918e-05
) O 0 5.338621211770089e-10
. O 0 7.168843851879103e-10

In O 0 8.900494563590655e-09
addition O 0 4.907224071537541e-10
, O 0 8.313731647557887e-11
we O 0 3.5127486856800783e-12
found O 0 4.424686311788051e-12
seven O 0 5.027137126717429e-12
individuals O 0 3.011966151207461e-14
with O 0 5.036119524876037e-12
hypohaptoglobinemia B-Disease 0 1.3060598575975746e-06
in O 0 3.053806651998059e-10
three O 0 3.734812806244214e-11
families O 0 3.835845757780426e-13
, O 0 3.052219718288618e-12
and O 0 2.6716255943637357e-11
the O 0 2.969967882737734e-10
genotypes O 0 5.8738307551209346e-09
of O 0 9.062980588225855e-09
six O 0 1.2266651028269848e-09
of O 0 8.915888471960898e-09
the O 0 9.68674362944455e-10
seven O 0 2.2848933856067788e-10
individuals O 0 9.555024957016989e-14
were O 0 4.524436381103669e-11
found O 0 2.2848223313332028e-11
to O 0 6.629204563762814e-12
be O 0 3.101021661677805e-10
Hp2 O 1 0.762775182723999
/ O 0 4.3725194700527936e-05
Hpdel O 0 0.002447858452796936
. O 0 2.6437295019832163e-08

The O 0 7.765136444959353e-08
phenotypes O 0 7.704135640551613e-08
and O 0 1.4329682995750659e-09
genotypes O 0 6.773360983203247e-09
in O 0 4.9045264377545195e-11
one O 0 5.287238962620178e-12
of O 0 1.4722921493071084e-10
these O 0 3.3882308850957665e-12
three O 0 1.0618360357650403e-11
families O 0 2.0279715678018367e-13
showed O 0 3.9624088732370666e-11
the O 0 8.122569283841585e-11
father O 0 4.4434236845525277e-10
to O 0 1.2093380116762198e-11
be O 0 2.3329015802486808e-11
hypohaptoglobinemic B-Disease 0 6.366713023453485e-07
( O 0 2.3427659812114143e-10
Hp2 O 0 4.377725417725742e-06
) O 0 6.504162486375975e-11
and O 0 3.576955120987435e-10
Hp2 O 0 0.0001827500673243776
/ O 0 4.93420316161064e-07
Hpdel O 0 3.611398642533459e-05
, O 0 1.9744557377965322e-10
the O 0 1.9792519012629128e-10
mother O 0 6.865494284191698e-11
to O 0 9.926250793546032e-12
be O 0 1.554948704518555e-11
Hp2 O 0 2.094263663821039e-06
- O 0 4.3055681686610114e-08
1 O 0 8.342423418739031e-10
and O 0 4.570440553797184e-11
Hp1 O 0 9.992057130148169e-06
/ O 0 2.6662183572057074e-08
Hp2 O 0 1.5234169268296682e-06
, O 0 1.9090696037893373e-11
one O 0 3.1404581626176542e-12
of O 0 7.246374333913508e-11
the O 0 5.983098738671089e-11
two O 0 1.1062386250093592e-11
children O 0 3.747505344237068e-12
to O 0 2.8333982295819515e-12
be O 0 2.8621330999678563e-11
hypohaptoglobinemic B-Disease 0 1.0452876040289993e-06
( O 0 3.8506223209999746e-10
Hp2 O 0 8.071236152318306e-06
) O 0 4.617432131093224e-11
and O 0 1.6250847889587305e-10
Hp2 O 0 8.9316199591849e-05
/ O 0 3.828097590030666e-07
Hpdel O 0 1.7871261661639437e-05
, O 0 1.0703075925544425e-10
and O 0 1.5589340582322642e-11
the O 0 1.799099237642654e-11
other O 0 3.2599339894190393e-12
child O 0 4.4164758655762526e-11
to O 0 1.6483652550552952e-12
be O 0 1.0273976981667321e-11
Hp1 O 0 7.3123874244629405e-06
and O 0 6.367645966065538e-09
Hp1 O 0 0.01698119379580021
/ O 0 2.4400060283369385e-06
Hpdel O 0 9.138125460594893e-05
, O 0 3.264579162554071e-10
showing O 0 1.1255780751895372e-09
an O 0 3.1964058136435547e-12
anomalous O 0 9.927666688724912e-09
inheritance O 0 6.643315675347594e-09
of O 0 3.0117513460936607e-07
Hp O 0 3.621125088670851e-08
phenotypes O 0 3.2914044822973665e-08
in O 0 4.96508778535798e-10
the O 0 1.1849445868961084e-09
child O 0 4.391214503129959e-09
with O 0 2.1015726658912826e-10
Hp1 O 0 0.043718062341213226
. O 0 5.063001040639392e-08

The O 0 5.5552857247676e-07
Hp2 O 0 0.2986426055431366
/ O 0 1.1010914022335783e-05
Hpdel O 0 1.5212801372399554e-05
individuals O 0 1.080616672533008e-11
had O 0 8.49876835573582e-11
an O 0 2.9137486694252868e-12
extremely O 0 2.6374311068444456e-10
low O 0 1.0179798337617285e-08
level O 0 5.0435287057837286e-09
of O 0 1.8901153975292573e-09
Hp O 0 3.707957718646071e-09
( O 0 8.686680541547531e-11
mean O 0 2.15215692489501e-10
+ O 0 7.984005817585071e-11
/ O 0 3.784951019270011e-09
- O 0 6.160350007888837e-09
SD O 0 6.057821337890346e-07
= O 0 2.138498267356681e-10
0 O 0 4.814060608482329e-11
. O 0 1.4201397219651413e-12
049 O 0 6.869902868800182e-09
+ O 0 1.2137153782010301e-10
/ O 0 9.196834405145182e-10
- O 0 1.0044417519949889e-09
0 O 0 5.662934010608467e-11
. O 0 1.3367418066553838e-12
043 O 0 6.076350977934908e-09
mg O 0 4.633661010444712e-09
/ O 0 1.6958533466393533e-09
ml O 0 1.475631977720937e-10
; O 0 4.181497596095207e-12
n O 0 1.723017388488568e-11
= O 0 1.385946999526988e-11
6 O 0 1.593385562381755e-10
) O 0 1.600559284718403e-13
, O 0 5.818775501579068e-14
compared O 0 2.1559295147743907e-13
with O 0 7.372307110490098e-14
the O 0 4.0556318720019746e-11
level O 0 6.655601625382701e-10
( O 0 1.7943074326690067e-12
1 O 0 3.924785149655996e-11
. O 0 6.456618009340054e-13
64 O 0 7.396685347549337e-11
+ O 0 1.3884897571980748e-11
/ O 0 7.296612203333552e-10
- O 0 1.3275687216207643e-09
1 O 0 1.466210902689724e-10
. O 0 2.9533066530501584e-12
07 O 0 3.327978781442198e-09
mg O 0 4.620255733556178e-09
/ O 0 1.983303965502614e-09
ml O 0 1.9054474664770282e-10
) O 0 5.623297509062264e-13
obtained O 0 1.3921493298429954e-11
from O 0 8.94162938136489e-11
52 O 0 7.428259674036042e-10
healthy O 0 2.610894000998343e-10
volunteers O 0 5.881271580854275e-10
having O 0 1.1246333725400959e-10
phenotype O 0 2.5442141726728096e-09
Hp2 O 0 3.2992506930895615e-06
, O 0 2.3775634239164845e-10
whereas O 0 1.3450654479107982e-10
the O 0 1.1468474780951254e-10
serum O 0 8.099229620306403e-10
Hp O 0 5.502091560138922e-10
level O 0 1.2561092166407661e-09
of O 0 1.1186581522215633e-10
an O 0 1.7708199544306386e-13
individual O 0 4.880315444301397e-13
with O 0 1.2908890102691917e-11
Hp1 O 0 0.10785423219203949
/ O 0 1.0189265822191373e-06
Hpdel O 0 4.075784090673551e-05
was O 0 3.668159109793123e-08
0 O 0 8.984274657564129e-09
. O 0 7.907959842512469e-10

50 O 0 2.796487592604535e-07
mg O 0 4.83218116187345e-07
/ O 0 9.882460716426067e-08
ml O 0 2.604548354767644e-09
, O 0 1.0593499168154441e-11
which O 0 1.0013642475978357e-12
was O 0 2.4183219662909927e-11
approximately O 0 8.212039446890695e-13
half O 0 1.43837708670852e-12
the O 0 2.801355284895446e-12
level O 0 9.295411662613162e-11
of O 0 2.179699198912033e-10
Hp O 0 2.6070073877448863e-10
in O 0 1.527138554502372e-10
control O 0 1.91910420888064e-09
sera O 0 5.1331475958704686e-08
from O 0 2.0837311043298001e-10
the O 0 1.7373867622350048e-10
Hp1 O 0 4.3482563683028275e-07
phenotype O 0 6.99708957441203e-10
( O 0 3.115010333010204e-11
1 O 0 3.054866914986576e-10
. O 0 2.2268929322083464e-12
26 O 0 4.0899852948861337e-10
+ O 0 1.9646499704872866e-11
/ O 0 4.89126350533553e-10
- O 0 7.176381711104796e-10
0 O 0 2.6160167782007804e-11
. O 0 1.1424645951496615e-12
33 O 0 6.06266217784146e-11
mg O 0 1.825213757911115e-09
/ O 0 1.0713825382424602e-09
ml O 0 1.3373449569975548e-10
; O 0 3.9988195046913866e-12
n O 0 2.3178924057898342e-11
= O 0 3.778246118746331e-11
9 O 0 5.610140130229979e-10
) O 0 1.0243800165760097e-12
, O 0 9.320683331051627e-13
showing O 0 4.504322262399718e-11
a O 0 2.8605885021848465e-11
gene O 0 2.6814594988877616e-10
- O 0 1.0214086465509808e-08
dosage O 0 7.780140265367663e-08
effect O 0 2.4378135066172035e-08
. O 0 3.0833475772595875e-09

The O 0 3.5086106464632394e-08
other O 0 2.8575145027964766e-10
allele O 0 8.300913428849199e-11
( O 0 1.7189864115474407e-11
Hp2 O 0 2.630636970479827e-07
) O 0 4.076725068635767e-12
of O 0 1.6507392675002563e-10
individuals O 0 1.8462039893824694e-13
with O 0 5.0392738593085795e-11
Hp2 O 1 0.9999949932098389
/ O 0 2.083637264149729e-05
Hpdel O 0 0.0003900801239069551
was O 0 2.2132360388837924e-09
found O 0 7.0940792303020306e-12
to O 0 7.266214539780602e-13
have O 0 4.3539092687075454e-13
, O 0 1.9753502219360675e-12
in O 0 2.5232654507489904e-12
all O 0 1.3077906813041551e-11
exons O 0 6.194645907342533e-10
, O 0 5.4995153396519836e-12
no O 0 4.052506160506786e-12
mutation O 0 5.7893564074651405e-12
, O 0 8.511737864015656e-13
by O 0 2.235821987620068e-12
DNA O 0 2.4123828268329817e-08
sequencing O 0 6.28053387075056e-09
. O 0 1.2783258895865401e-09

On O 0 6.087176274149897e-08
the O 0 1.028347129672369e-10
basis O 0 2.8993474288085963e-11
of O 0 4.4042113706010966e-11
the O 0 4.387431824098842e-12
present O 0 1.6205271716543401e-12
study O 0 6.038331726992974e-12
, O 0 3.9727875394794665e-13
the O 0 3.5803235376441478e-12
mechanism O 0 1.955062639558136e-10
of O 0 7.779940025542942e-10
anhaptoglobinemia B-Disease 0 4.30748656299329e-07
and O 0 6.230808230478502e-11
the O 0 3.284288466187668e-11
mechanism O 0 1.7694888609920412e-10
of O 0 2.904224916111531e-10
anomalous O 0 4.666379282980415e-09
inheritance O 0 5.032708916274942e-09
of O 0 9.389491850697596e-08
Hp O 0 2.5795436897624313e-08
phenotypes O 0 6.669890950661284e-08
were O 0 6.342723679608753e-09
well O 0 1.2815727368220564e-09
explained O 0 1.5891076898810752e-08
. O 0 4.202115100326864e-09

However O 0 1.1656401177617681e-08
, O 0 1.3331834247676255e-10
the O 0 6.533007468334517e-11
mechanism O 0 2.4687700772574317e-09
of O 0 2.0320461757705743e-08
hypohaptoglobinemia B-Disease 0 9.783913264982402e-05
remains O 0 1.3807360232931387e-07
unknown O 0 1.4743160647867626e-07

ATM O 0 0.0002926097367890179
mutations O 0 7.059094286887557e-08
and O 0 3.4226350642541092e-09
phenotypes O 0 3.1613885198567004e-07
in O 0 1.6982323813863331e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 3.762699873899322e-10
in O 0 2.0473722717184728e-10
the O 0 4.728321623126419e-10
British O 0 4.193476232927651e-09
Isles O 0 1.1928017329410068e-07
: O 0 2.621331277041783e-11
expression O 0 1.4079658446075616e-11
of O 0 4.74805084138552e-10
mutant O 0 4.552172527816367e-10
ATM O 0 4.3959181539321435e-07
and O 0 1.2896984868948635e-10
the O 0 1.3544053378833354e-10
risk O 0 2.781811725416361e-10
of O 0 5.055493801364719e-08
leukemia B-Disease 1 1.0
, O 0 7.195739271992352e-06
lymphoma B-Disease 1 1.0
, O 0 1.4373290468938649e-06
and O 0 0.1388475000858307
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.8309283689177391e-07

We O 0 5.676089376294158e-09
report O 0 2.523354580841186e-10
the O 0 3.689611463575382e-11
spectrum O 0 1.0118004212245069e-09
of O 0 2.235978735498634e-09
59 O 0 2.8068041224571516e-09
ATM O 0 5.198779717829893e-07
mutations O 0 8.528945327768156e-10
observed O 0 1.84140713788139e-09
in O 0 1.1189515092269176e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0001210864502354525
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.371899591821716e-10
patients O 0 2.9885538488372276e-11
in O 0 9.400997341701967e-12
the O 0 1.2222829692820625e-10
British O 0 3.058321595972302e-08
Isles O 0 5.6407961892546155e-06
. O 0 6.769563576369819e-09

Of O 0 3.5112734622089192e-06
51 O 0 1.0490910540283949e-07
ATM O 0 9.85264796327101e-06
mutations O 0 1.7669098406614125e-09
identified O 0 4.8124629281609543e-11
in O 0 8.212873957302858e-12
families O 0 3.106765333275169e-13
native O 0 8.37070690540287e-12
to O 0 1.6688521224661468e-12
the O 0 1.39804390286713e-10
British O 0 1.6004130243274517e-09
Isles O 0 1.6366057309369353e-07
, O 0 5.219228174646595e-11
11 O 0 4.827901967097148e-10
were O 0 1.1811530920002866e-10
founder O 0 1.9159708486427007e-08
mutations O 0 2.5121654756432577e-10
, O 0 6.891431869604503e-11
and O 0 1.2432231633052737e-10
2 O 0 4.067876702151807e-09
of O 0 1.593507881203493e-09
these O 0 2.6530604102514843e-11
11 O 0 5.586210938268721e-10
conferred O 0 2.0585211313317586e-09
a O 0 5.3106793268531405e-11
milder O 0 2.9262411160857482e-08
clinical O 0 5.4589254006032206e-08
phenotype O 0 1.8347103003524268e-10
with O 0 2.6790130443904436e-12
respect O 0 7.748614250235875e-11
to O 0 1.103503746713308e-10
both O 0 5.49262635374248e-09
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 3.4496298439989914e-07
cellular O 0 1.7123373254435137e-05
features O 0 5.403436489359592e-07
. O 0 2.902129203619097e-08

We O 0 5.445725648201005e-09
report O 0 4.288246424621889e-10
, O 0 4.436959480380587e-11
in O 0 3.479528470906601e-11
two O 0 9.606113821059026e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999738931655884
T I-Disease 1 1.0
families O 0 6.923209228126836e-11
, O 0 5.860370782401203e-12
an O 0 9.719764056115299e-13
ATM O 0 2.5649242161307484e-06
mutation O 0 2.1326174159952416e-09
( O 0 1.0898074803700197e-10
7271T O 0 1.052638793908045e-07
- O 0 2.0463482997001847e-07
- O 0 8.511726434790035e-08
> O 0 9.487167496047277e-09
G O 0 1.2118009635742055e-06
) O 0 8.095267511887272e-12
that O 0 9.538400749580997e-14
may O 0 1.4735268127202827e-12
be O 0 1.8922901711283108e-13
associated O 0 1.2907166654918534e-11
with O 0 3.2103958163762214e-13
an O 0 6.69537735258248e-14
increased O 0 3.4366025650212073e-12
risk O 0 3.7480735182171543e-10
of O 0 5.505561517793467e-08
breast B-Disease 1 0.9753181338310242
cancer I-Disease 0 2.1490217250175192e-07
in O 0 5.4244067571040944e-11
both O 0 4.093948097194655e-11
homozygotes O 0 9.635852116218757e-09
and O 0 2.254856162897667e-10
heterozygotes O 0 7.035568128088698e-09
( O 0 6.137895053326403e-11
relative O 0 1.160156526403e-09
risk O 0 1.789009940189601e-09
12 O 0 2.7278621583803897e-09
. O 0 8.249627543588378e-12
7 O 0 1.4159955430415039e-09
; O 0 3.629500519575224e-11
P O 0 7.246122635251595e-08
= O 0 6.270930441587552e-10
. O 0 5.578201789369075e-11
0025 O 0 4.1930184124794323e-07
) O 0 9.67373490340373e-12
, O 0 5.776073521389369e-13
although O 0 5.901376392766777e-13
there O 0 7.60018458757783e-13
is O 0 2.95737474223165e-13
a O 0 5.6323604634422875e-12
less O 0 1.0089747093378065e-10
severe O 1 0.9999969005584717
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 5.46862222172706e-10
in O 0 2.1472754130336114e-12
terms O 0 1.6255855168900712e-12
of O 0 2.876125899942128e-11
the O 0 2.4287631367886364e-12
degree O 0 2.0187058691334414e-09
of O 0 5.21054310809177e-08
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 1.2739297972075292e-07

This O 0 3.215734345474175e-09
mutation O 0 1.2228222878718498e-09
( O 0 1.428317880636243e-10
7271T O 0 1.5073798920184345e-07
- O 0 8.140044371884869e-08
- O 0 4.021752175731308e-08
> O 0 5.288255167101852e-09
G O 0 2.033657722222415e-07
) O 0 4.380449995788904e-12
also O 0 2.038045703338029e-13
allows O 0 2.0236750101175482e-13
expression O 0 6.9211589584505795e-12
of O 0 6.754054954205557e-11
full O 0 6.96002977473853e-11
- O 0 6.532711593898455e-10
length O 0 9.642492533601388e-12
ATM O 0 3.852595398257108e-08
protein O 0 8.720912880733067e-11
at O 0 3.8147876524341484e-10
a O 0 7.316282996105983e-12
level O 0 3.6277147952290534e-11
comparable O 0 3.4503722101675294e-10
with O 0 2.437218395850982e-12
that O 0 5.481960371755967e-13
in O 0 6.9207100987511705e-12
unaffected O 0 4.816756771219843e-09
individuals O 0 1.45862332628921e-11
. O 0 7.471413487891709e-10

In O 0 1.341884203753807e-08
addition O 0 1.4070599130278083e-09
, O 0 5.7448101831170106e-11
we O 0 4.985199753004821e-12
have O 0 1.5826546345167058e-13
studied O 0 2.557799083646728e-09
18 O 0 1.323132892139256e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.214537708766784e-08
, O 0 8.203371142101457e-12
in O 0 4.847957972564654e-12
15 O 0 2.866782679300517e-11
families O 0 5.754320360051163e-14
, O 0 1.1081048188407716e-12
who O 0 2.3345203808283754e-12
developed O 0 6.258854909901856e-07
leukemia B-Disease 1 1.0
, O 0 6.62858656141907e-05
lymphoma B-Disease 1 1.0
, O 0 1.6875346773304045e-06
preleukemic O 1 1.0
T O 1 1.0
- O 0 0.00015157865709625185
cell O 0 7.633917448401917e-06
proliferation O 1 0.9881020784378052
, O 0 4.880853499145132e-10
or O 0 5.940340770393959e-07
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 6.427534948727498e-09
mostly O 0 1.428211715559513e-10
in O 0 4.952716570194582e-10
childhood O 0 6.003253929520724e-06
. O 0 4.24581347857611e-09

A O 0 4.3404734242358245e-06
wide O 0 3.244272051006192e-08
variety O 0 3.838144468915061e-09
of O 0 1.454952158752576e-08
ATM O 0 3.8397242860810366e-06
mutation O 0 1.6141277203729487e-10
types O 0 1.14990150734684e-09
, O 0 6.892233311850404e-11
including O 0 2.799798171082557e-10
missense O 0 5.685453530190898e-08
mutations O 0 2.653913533379182e-09
and O 0 1.1181616743627387e-09
in O 0 8.137883256154055e-09
- O 0 1.4025810912698944e-07
frame O 0 2.0336473838256097e-08
deletions O 0 8.051731725799982e-09
, O 0 1.0509641767963984e-10
were O 0 1.1056654203311922e-10
seen O 0 5.0673406443157987e-11
in O 0 1.706279388613563e-11
these O 0 6.37090727395595e-11
patients O 0 1.899997492671446e-09
. O 0 4.113582807718785e-09

We O 0 5.992653040465257e-09
also O 0 8.055010131124973e-11
show O 0 3.157288666622016e-11
that O 0 1.5233834701512683e-13
25 O 0 9.085900434802063e-12
% O 0 7.911081051316035e-14
of O 0 7.48414264589714e-12
all O 0 4.394075381330964e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.515990413902273e-09
carried O 0 9.463180239421831e-10
in O 0 3.1072858175384965e-10
- O 0 1.1149016820866109e-08
frame O 0 2.1561930019231568e-09
deletions O 0 1.6280081727160223e-09
or O 0 5.284139237282659e-10
missense O 0 2.7552273351716394e-08
mutations O 0 6.830453980199991e-10
, O 0 1.1994257149983145e-11
many O 0 8.473218871332677e-13
of O 0 1.6955548076680316e-10
which O 0 5.254873684627792e-13
were O 0 9.056694630360518e-12
also O 0 7.842293437906878e-13
associated O 0 1.1913340106084469e-11
with O 0 2.0907837093575576e-12
expression O 0 8.402992190958969e-11
of O 0 5.57911183918236e-09
mutant O 0 5.61634161400093e-09
ATM O 0 1.3895821211917792e-05
protein O 0 3.630585965197497e-08
. O 0 9.237731468658694e-09

The O 0 3.4382392755105684e-07
DMPK O 1 0.9999964237213135
gene O 0 9.03517829442535e-08
of O 0 1.1020372170378323e-07
severely O 1 0.999990701675415
affected O 1 0.9999954700469971
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.00048248213715851307
is O 0 1.4984467833212278e-10
hypermethylated O 0 1.0892747923207935e-05
proximal O 0 2.3786344627296785e-07
to O 0 5.283655180043922e-10
the O 0 3.2168752106542797e-09
largely O 0 4.050116686471483e-09
expanded O 0 1.2990120978884079e-08
CTG O 0 0.0002717550378292799
repeat O 0 8.044440846788348e-07
. O 0 1.7561994525294722e-08

Using O 0 6.415277198357217e-08
methylation O 0 1.0729391988206771e-06
- O 0 9.544233137148694e-08
sensitive O 0 1.0807832850900922e-08
restriction O 0 7.568613097364008e-11
enzymes O 0 1.0683210566186929e-10
, O 0 1.9154088037875994e-11
we O 0 6.42242389912312e-13
characterized O 0 1.4298162480386178e-11
the O 0 4.941425740812022e-12
methylation O 0 5.266309610618691e-10
pattern O 0 3.9069811275105337e-10
on O 0 7.741818991435778e-11
the O 0 3.608895127182876e-11
5 O 0 1.211051398053442e-10
side O 0 3.3638550278602963e-10
of O 0 9.941039103011917e-10
the O 0 2.6403315089851276e-09
CTG O 0 7.792034739395604e-05
repeat O 0 1.1734119453876701e-08
in O 0 1.4199137698955866e-10
the O 0 3.0303942688547636e-10
DMPK O 1 0.8635392785072327
gene O 0 7.084671044266244e-11
of O 0 1.2657115633363247e-10
normal O 0 6.0222431208512e-11
individuals O 0 4.1913622908767295e-14
and O 0 1.6096781893515377e-11
of O 0 2.019622469262572e-09
patients O 0 5.941457326130717e-10
affected O 0 3.4259921566359708e-09
with O 0 1.5470176606413588e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 8.402071038915437e-09
showing O 0 7.769233589804969e-10
expansions O 0 5.6676077164752314e-09
of O 0 2.1327489108102782e-08
the O 0 5.2389417248832615e-09
repetitive O 0 2.3007276467978954e-05
sequence O 0 1.4320018948410507e-08
. O 0 2.2711255098784022e-09

The O 0 1.9678975604620064e-07
gene O 0 2.9463680384367308e-09
segment O 0 1.1297938140586439e-09
analyzed O 0 1.4847001406081972e-10
corresponds O 0 4.8672874758404205e-11
to O 0 6.857717085168025e-12
the O 0 1.0520190968366094e-10
genomic O 0 5.199044306181122e-09
SacI O 0 2.2019416974217165e-06
- O 0 2.5647961976460465e-08
HindIII O 0 2.4689626343388227e-07
fragment O 0 4.0668060030668585e-09
carrying O 0 6.466367441504417e-09
exons O 0 7.753740760563232e-08
11 O 0 2.5696534677877025e-08
- O 0 5.895721244542074e-08
15 O 0 1.8224282527512514e-08
. O 0 8.421207620123994e-10

There O 0 6.946403008356583e-09
is O 0 8.099672321737472e-11
constitutive O 0 5.0345931867923355e-08
methylation O 0 5.000494951445944e-08
in O 0 1.8074245433652436e-09
intron O 0 7.262934076379679e-08
12 O 0 3.179324581381593e-09
at O 0 7.827521963932327e-11
restriction O 0 1.9543188681941936e-12
sites O 0 4.984004528529873e-11
of O 0 3.152085537028171e-10
SacII O 0 9.238578400072583e-07
and O 0 6.695773935305738e-10
HhaI O 0 3.4470390346541535e-06
, O 0 1.3754009042798998e-10
localized O 0 9.599585126807142e-09
1 O 0 2.4394959385887205e-09
, O 0 1.1470722809103773e-11
159 O 0 1.165115004475581e-09
- O 0 2.8077196123632575e-09
1 O 0 9.813385659640517e-10
, O 0 1.6097886912369574e-11
232 O 0 5.750777076762859e-10
bp O 0 2.824079414764924e-09
upstream O 0 1.271885818887597e-09
of O 0 2.798705267537116e-09
the O 0 2.093815565373802e-09
CTG O 0 0.00017061684047803283
repeat O 0 2.1589428911283903e-08
, O 0 4.836840303279466e-11
whereas O 0 1.3743224440421198e-11
most O 0 2.2340358729611154e-12
, O 0 5.523396410384018e-13
if O 0 5.909855260331429e-14
not O 0 5.435573391669897e-14
all O 0 4.638232072723403e-13
, O 0 7.473311791454662e-13
of O 0 1.047725361330576e-11
the O 0 1.4175094474946914e-12
other O 0 5.915595433208382e-14
sites O 0 1.1369566746410875e-11
of O 0 1.4085199673274929e-10
SacII O 0 9.251662049791776e-07
, O 0 1.5495107974494715e-10
HhaI O 0 5.60088255951996e-06
, O 0 2.718776037635706e-10
and O 0 1.3158581169125938e-10
HpaII O 0 9.161386742562172e-07
in O 0 5.2808920431024475e-11
this O 0 5.298421749087845e-13
region O 0 6.243180278309168e-11
are O 0 1.4870820503817828e-12
unmethylated O 0 3.2068179223188054e-08
, O 0 6.838594360930594e-12
in O 0 4.377426806451146e-12
normal O 0 7.601323043227026e-11
individuals O 0 1.3555766210059106e-13
and O 0 1.1483113071530937e-11
most O 0 9.266729744661362e-12
of O 0 5.848228012972356e-10
the O 0 1.00946606629293e-09
patients O 0 1.845225416907681e-09
. O 0 1.1710458158731285e-09

In O 0 8.802305551114387e-09
a O 0 7.85381204515545e-11
number O 0 1.73071487696852e-11
of O 0 1.96438976196589e-09
young O 0 4.1027517494462984e-10
and O 0 8.457763378544314e-10
severely O 0 0.0006807168247178197
affected O 0 1.8488055530951897e-08
patients O 0 9.679318457855857e-10
, O 0 9.649115707832667e-12
however O 0 2.9796388880537483e-12
, O 0 1.3090628841333496e-12
complete O 0 1.123175649708763e-10
methylation O 0 1.112560155114295e-09
of O 0 4.910107320732493e-10
these O 0 7.753722251931106e-13
restriction O 0 1.203501924854078e-12
sites O 0 2.06178060735418e-11
was O 0 1.1463838905934054e-10
found O 0 6.9030705630857e-12
in O 0 2.517400784357582e-12
the O 0 2.3549237213038587e-11
mutated O 0 9.362141062396745e-10
allele O 0 6.823123177568391e-10
. O 0 8.208403401432918e-10

In O 0 4.7966781657748925e-09
most O 0 5.6397806563746045e-11
of O 0 3.6860961505347234e-10
these O 0 5.108757600985614e-12
patients O 0 2.130932062749391e-11
, O 0 8.954676193259625e-13
the O 0 1.3562788912790946e-11
onset O 0 8.330504215336987e-07
of O 0 4.660908992093482e-09
the O 0 7.143312785728995e-08
disease O 1 1.0
was O 0 8.245287608588114e-05
congenital O 1 1.0
. O 0 1.6297744309667905e-07

Preliminary O 0 1.5029328324089875e-06
in O 0 1.5364896910341486e-08
vivo O 0 3.717130141467351e-07
footprinting O 0 6.110738013376249e-06
data O 0 2.241064001040627e-09
gave O 0 3.919251312378691e-10
evidence O 0 4.064694969496685e-10
for O 0 2.1676003006398936e-11
protein O 0 1.7893672654700765e-10
- O 0 9.094565101008811e-09
DNA O 0 3.785653035492942e-08
contact O 0 1.7182923139902329e-10
in O 0 1.1363604501823943e-11
normal O 0 2.6184940327134143e-10
genes O 0 1.864234634718631e-11
at O 0 3.6685682269776976e-10
an O 0 1.339191669884332e-12
Sp1 O 0 2.410648747286359e-08
consensus O 0 3.818572957836608e-10
binding O 0 5.102082645258577e-10
site O 0 1.803041271841721e-09
upstream O 0 1.4342097509612017e-09
of O 0 1.750012579293525e-09
the O 0 9.020121871650133e-10
CTG O 0 5.053876884630881e-05
repeat O 0 2.7111601852425338e-09
and O 0 2.665538102741838e-11
for O 0 1.270181876344978e-12
a O 0 6.656569284495262e-13
significant O 0 7.037392044974278e-13
reduction O 0 9.043131521391246e-11
of O 0 4.835382441670255e-11
this O 0 3.9052149101298506e-14
interaction O 0 1.3378309961578627e-12
in O 0 3.3470069164126537e-12
cells O 0 1.2316104733289812e-11
with O 0 4.229504767250258e-12
a O 0 2.9464339301732423e-10
hypermethylated O 0 3.853642920148559e-05
DMPK O 1 0.9999998807907104
gene O 0 1.7110401984155033e-08
. O 0 3.1322838767167127e-10
. O 0 1.7885083414270753e-09

The O 0 8.604180038673803e-06
hemochromatosis B-Disease 1 1.0
gene O 0 5.508426159650526e-09
product O 0 2.679414468076402e-10
complexes O 0 7.890633146878656e-10
with O 0 4.2422801382890896e-11
the O 0 4.769089012590655e-10
transferrin O 0 2.6296669286551833e-09
receptor O 0 1.2846607111427488e-10
and O 0 8.539732809786926e-11
lowers O 0 3.3010978395253687e-09
its O 0 1.868830611095884e-11
affinity O 0 1.1113225791004044e-11
for O 0 3.7531202104479355e-12
ligand O 0 2.5192490316072735e-09
binding O 0 4.532839170678926e-08
. O 0 1.2673337934643314e-08

We O 0 1.2546634842180993e-08
recently O 0 2.0121400101658082e-09
reported O 0 1.1583516784652303e-10
the O 0 2.6651871681826478e-11
positional O 0 4.3115097270174374e-08
cloning O 0 2.144475041987448e-09
of O 0 3.5015540467142614e-10
a O 0 7.126356362657793e-12
candidate O 0 4.15608693293823e-11
gene O 0 2.68532995839621e-09
for O 0 7.350338560030423e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999619722366333
HFE O 1 1.0
. O 0 1.3479952087891434e-07

The O 0 6.730556378897745e-08
gene O 0 1.000380778215515e-09
product O 0 2.266619392177205e-10
, O 0 1.1285090917301233e-11
a O 0 9.09051132980121e-12
member O 0 7.684854141931652e-11
of O 0 1.1715551861968265e-09
the O 0 5.265566316303705e-10
major O 0 2.1504602543132023e-08
histocompatibility O 0 1.5252052435243968e-05
complex O 0 7.398141974590544e-07
class O 0 1.9638287440670865e-08
I O 0 5.346011221263325e-06
- O 0 3.7072098280077626e-08
like O 0 1.0246780507428e-10
family O 0 8.643870341717985e-12
, O 0 8.204639224962396e-12
was O 0 7.648793404202436e-11
found O 0 1.774658436697052e-12
to O 0 6.411285890205176e-13
have O 0 4.828419565214292e-13
a O 0 3.289679986751004e-11
mutation O 0 1.3870213311228952e-10
, O 0 1.6839844796390224e-10
Cys O 0 6.367848982336e-05
- O 0 4.103155788470758e-07
282 O 0 1.846249659820387e-07
- O 0 2.548825648318598e-07
- O 0 1.2022212558804313e-07
> O 0 8.926233974193565e-09
Tyr O 0 1.6333033272530884e-05
( O 0 2.383197805766457e-10
C282Y O 0 1.5904600303429106e-08
) O 0 8.624860808187362e-13
, O 0 1.6302856688330675e-13
in O 0 8.255211293196896e-13
85 O 0 5.589555207574648e-11
% O 0 4.616766496011449e-13
of O 0 9.206903989200654e-11
patient O 0 1.0512940740170507e-08
chromosomes O 0 1.1310191005975412e-08
. O 0 8.426240150072317e-09

This O 0 6.641639460625015e-10
mutation O 0 2.626362183288933e-10
eliminates O 0 4.879710857608188e-09
the O 0 1.831437640431588e-10
ability O 0 4.738838141338242e-11
of O 0 5.374976908001372e-09
HFE O 0 0.0005147811025381088
to O 0 2.463500514693351e-10
associate O 0 1.1646179132185353e-08
with O 0 5.734935096257665e-11
beta2 O 0 0.0001313554384978488
- O 0 3.5251334793429123e-06
microglobulin O 0 4.162741606705822e-05
( O 0 9.757727958970008e-10
beta2m O 0 3.535411678967648e-06
) O 0 7.966558662753087e-11
and O 0 1.2725984155359527e-10
prevents O 0 1.0998186805721843e-09
cell O 0 3.157083199312183e-07
- O 0 1.6936859026372986e-07
surface O 0 1.2809458382889716e-07
expression O 0 1.3219875860670527e-08
. O 0 2.712468694099357e-09

A O 0 3.2547488899581367e-06
second O 0 1.1612818262562996e-08
mutation O 0 5.477033410139498e-11
that O 0 4.537585042950487e-13
has O 0 3.4610446561673947e-13
no O 0 2.2165700264836774e-12
effect O 0 1.3085899031040071e-10
on O 0 3.1302367364816064e-09
beta2m O 0 5.016849172534421e-06
association O 0 3.5455705926779046e-08
, O 0 1.3009447685785602e-10
H63D O 1 0.9999991655349731
, O 0 2.101861323877685e-10
was O 0 3.5705888246084783e-10
found O 0 1.5394558891546062e-11
in O 0 8.16961255589721e-12
eight O 0 6.08615796648948e-11
out O 0 1.363442778817836e-11
of O 0 7.5453387982094e-10
nine O 0 9.45924560902256e-10
patients O 0 2.7125900484148424e-11
heterozygous O 0 1.5742355335968128e-11
for O 0 6.218875414631952e-11
the O 0 7.023622128343732e-09
C282Y O 0 3.6226149404683383e-06
mutant O 0 2.1833906771462352e-07
. O 0 6.3818355044986674e-09

In O 0 6.555181730760751e-09
this O 0 9.01147993032092e-12
report O 0 3.461536959847855e-11
, O 0 5.03913664268163e-12
we O 0 2.7353230899924974e-13
demonstrate O 0 1.1197013802255462e-11
in O 0 2.4493032602102005e-11
cultured O 0 1.8047684458011304e-09
293 O 0 1.1944393918383867e-08
cells O 0 2.947750932236204e-09
overexpressing O 0 4.2286904999855324e-07
wild O 0 1.1533511212746816e-07
- O 0 1.922516013053155e-08
type O 0 8.445934618350748e-09
or O 0 8.591166666960248e-10
mutant O 0 8.892451219821851e-09
HFE O 0 6.798233243898721e-06
proteins O 0 2.866727862038676e-11
that O 0 1.4309450976565663e-12
both O 0 8.475744411873265e-12
the O 0 6.920080480865565e-11
wild O 0 1.7269352170501406e-08
- O 0 5.304873873512861e-09
type O 0 3.4365290613180832e-09
and O 0 2.6753814719171487e-09
H63D O 1 0.9999992847442627
HFE O 0 0.00020642028539441526
proteins O 0 3.229618239508625e-10
form O 0 1.324176740480354e-10
stable O 0 4.055355773413538e-10
complexes O 0 2.5716120899410555e-10
with O 0 1.7231686563756732e-11
the O 0 4.0678979629227285e-10
transferrin O 0 6.562312471203313e-09
receptor O 0 1.3544679822174999e-09
( O 0 2.3115932779038673e-10
TfR O 0 9.186321676679654e-07
) O 0 1.9359154557196945e-10
. O 0 7.819198621916712e-10

The O 0 1.542973222967703e-06
C282Y O 0 1.785378481145017e-05
mutation O 0 2.321391256998595e-08
nearly O 0 4.840765011060455e-10
completely O 0 4.7727315433121476e-09
prevents O 0 1.7568878296625456e-10
the O 0 9.787733123989284e-11
association O 0 8.708151977288026e-10
of O 0 4.533750597168762e-10
the O 0 2.503980633949965e-10
mutant O 0 7.1611938601279235e-09
HFE O 0 1.8658807675819844e-05
protein O 0 2.5317237195565667e-10
with O 0 2.3202367110952693e-11
the O 0 2.1056982824063653e-09
TfR O 0 2.7840183975058608e-05
. O 0 1.0227166669096732e-08

Studies O 0 4.054160740452062e-08
on O 0 6.742296942974235e-09
cell O 0 2.1148119699887502e-08
- O 0 1.0829830365821635e-08
associated O 0 4.92701268672846e-10
transferrin O 0 3.493310751778722e-09
at O 0 1.7489948378468512e-09
37 O 0 2.583549207901825e-10
degrees O 0 2.6764634952769484e-09
C O 0 7.854423245134967e-08
suggest O 0 3.982168414462528e-11
that O 0 1.1355647325239637e-12
the O 0 3.437641837855665e-10
overexpressed O 0 1.1286442713753786e-06
wild O 0 2.1680880024632643e-07
- O 0 1.8246472777150302e-08
type O 0 1.4974597561945302e-08
HFE O 0 1.0652288437995594e-05
protein O 0 7.874391416695659e-11
decreases O 0 9.232397832348305e-12
the O 0 3.50423639758346e-12
affinity O 0 8.783542469747996e-12
of O 0 3.6570760308940464e-10
the O 0 3.8865272111721083e-10
TfR O 0 2.4723249225644395e-07
for O 0 1.3393207376477534e-10
transferrin O 0 1.4216419685908477e-07
. O 0 7.808650615004353e-09

The O 0 2.8295696665736614e-06
overexpressed O 0 0.0004502018273342401
H63D O 1 0.9999951124191284
protein O 0 1.6383938650221808e-09
does O 0 8.520773496500933e-12
not O 0 8.934250773006899e-14
have O 0 2.0757931506500127e-14
this O 0 1.788653894321899e-14
effect O 0 6.2139638053182455e-12
, O 0 5.967615182393693e-13
providing O 0 2.2696625395085546e-12
the O 0 1.4423028743548727e-12
first O 0 6.181063148293087e-13
direct O 0 3.0412930745842004e-13
evidence O 0 7.735674947828564e-12
for O 0 2.6085204959599984e-13
a O 0 2.3298943069988143e-12
functional O 0 8.252448724377359e-11
consequence O 0 4.290766630887788e-10
of O 0 3.514201374343884e-09
the O 0 6.622390191779459e-09
H63D O 1 0.9999997615814209
mutation O 0 3.214123012185155e-08
. O 0 4.220002569610415e-09

Addition O 0 1.489649150698824e-07
of O 0 5.573519388235582e-07
soluble O 0 1.1154587582495878e-06
wild O 0 9.47938588069519e-06
- O 0 1.7679274151305435e-06
type O 0 4.362692379800137e-06
HFE O 1 1.0
/ O 0 8.124769374262542e-05
beta2m O 0 1.6239069736911915e-05
heterodimers O 0 1.6294975466735195e-06
to O 0 1.3177620106219479e-10
cultured O 0 3.1245106502097997e-09
cells O 0 3.4940417226181353e-10
also O 0 1.2897519857668627e-11
decreased O 0 4.936322878235089e-11
the O 0 8.979566222533375e-12
apparent O 0 7.453263006773625e-11
affinity O 0 2.92946465696442e-11
of O 0 1.1491976259492276e-09
the O 0 2.091671141846163e-10
TfR O 0 6.764581783613721e-09
for O 0 2.299765629668049e-12
its O 0 3.6486278408298656e-12
ligand O 0 1.446698733031937e-10
under O 0 1.5400976050017334e-09
steady O 0 1.0206511191768186e-08
- O 0 8.401281337278022e-10
state O 0 2.5069469070104766e-11
conditions O 0 1.9044019694547387e-09
, O 0 9.826562306913811e-12
both O 0 1.1780245832634928e-12
in O 0 2.256213445239741e-12
293 O 0 1.8022598691214142e-10
cells O 0 6.227323778168481e-12
and O 0 3.238054616105934e-11
in O 0 7.100801058257389e-10
HeLa O 0 7.843799721740652e-06
cells O 0 8.376676241539371e-09
. O 0 1.6493302279485533e-09

Furthermore O 0 1.2593343967637338e-07
, O 0 8.158113629086472e-10
at O 0 1.2351545342070835e-09
4 O 0 2.0588579452418543e-10
degrees O 0 2.960038880672755e-09
C O 0 3.452107648627134e-07
, O 0 1.0088568001831444e-11
the O 0 2.359824835540536e-11
added O 0 6.8557160816384854e-12
soluble O 0 1.5631448913033807e-10
complex O 0 3.5530085540358414e-09
of O 0 3.68771004843893e-08
HFE O 1 0.9999691247940063
/ O 0 2.4717331825740985e-07
beta2m O 0 1.477498585700232e-07
inhibited O 0 6.152620080079885e-10
binding O 0 7.738235607845922e-10
of O 0 7.414405978067862e-09
transferrin O 0 3.121938618733111e-08
to O 0 1.8073726959499936e-09
HeLa O 0 1.7948188542504795e-05
cell O 0 2.9212594654381974e-07
TfR O 0 1.823094635255984e-07
in O 0 6.232674099049262e-11
a O 0 3.972700640675342e-11
concentration O 0 5.969177863107689e-08
- O 0 3.147792781987846e-08
dependent O 0 1.6817961467907594e-09
manner O 0 1.717776321186193e-08
. O 0 6.113610506730538e-09

Scatchard O 0 9.220180800184608e-06
plots O 0 9.774539222462408e-08
of O 0 1.55323789385875e-08
these O 0 2.6106285536120488e-11
data O 0 1.0357802116001125e-10
indicate O 0 1.6594765492317087e-11
that O 0 1.6399913111558861e-13
the O 0 7.552505149055477e-11
added O 0 2.7389488246876148e-11
heterodimer O 0 1.3351946215323096e-09
substantially O 0 4.2174153058738284e-11
reduced O 0 1.228336182768075e-10
the O 0 1.4714042484431644e-11
affinity O 0 3.982905324995123e-11
of O 0 4.846058554441868e-10
TfR O 0 1.0726552801543221e-07
for O 0 1.9336533763070207e-10
transferrin O 0 2.3693023365467525e-07
. O 0 1.0710500930599665e-08

These O 0 2.4759376771044117e-09
results O 0 4.820871479793709e-10
establish O 0 6.071690927811346e-10
a O 0 5.235180344786983e-11
molecular O 0 3.6607485931483552e-09
link O 0 2.105658092332874e-09
between O 0 3.460983999392653e-10
HFE O 0 0.027280569076538086
and O 0 8.792854777617265e-10
a O 0 1.7743589930674375e-10
key O 0 5.334654495925406e-09
protein O 0 4.394729025136712e-11
involved O 0 1.0826596563706659e-10
in O 0 1.0804049321855302e-10
iron O 0 1.5787009033374488e-07
transport O 0 1.953748629546226e-08
, O 0 7.862025613869505e-11
the O 0 1.1869526195251723e-10
TfR O 0 2.2421197343192034e-07
, O 0 3.821696778483208e-11
and O 0 1.8968814366471243e-11
raise O 0 3.252898644889868e-11
the O 0 4.356239674541129e-11
possibility O 0 4.557626151480143e-11
that O 0 2.1720139250537562e-13
alterations O 0 7.057673889754312e-10
in O 0 2.0273005496562746e-11
this O 0 2.9130970097095144e-13
regulatory O 0 1.6364222477083246e-10
mechanism O 0 6.768372529109001e-10
may O 0 4.448093629538796e-11
play O 0 3.8835776261514354e-10
a O 0 6.43422207874389e-12
role O 0 1.4669711626003057e-11
in O 0 9.989000945842541e-12
the O 0 6.342572300699345e-11
pathogenesis O 0 6.206979378475808e-06
of O 0 9.241372754331678e-05
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 2.319044085652422e-07
. O 0 2.6100700267761567e-08

Genomic O 0 2.504064866570843e-07
organization O 0 5.662680546691945e-09
of O 0 8.119959815644506e-09
the O 0 1.756279743858613e-08
UBE3A O 1 0.9999939203262329
/ O 0 2.124658522006939e-06
E6 O 0 0.0004592894692905247
- O 0 6.243885763979051e-07
AP O 0 1.4747684872418176e-05
gene O 0 7.986843963969648e-10
and O 0 4.625515248601886e-11
related O 0 1.5122472163398015e-08
pseudogenes O 0 8.075079449554323e-07
. O 0 9.231249542551723e-09

The O 0 1.23981897104386e-06
UBE3A O 0 0.06888922303915024
gene O 0 3.508898416271222e-08
encodes O 0 1.472385546819055e-09
the O 0 2.8996931522584646e-09
E6 O 0 8.427838474744931e-05
- O 0 3.2519410524400882e-06
AP O 0 1.279895514016971e-05
ubiquitin O 0 9.429316349951478e-08
- O 0 6.828724696816835e-09
protein O 0 3.744698995333806e-11
ligase O 0 5.980568817953724e-10
and O 0 6.321244222506905e-11
has O 0 1.5809539007788365e-12
recently O 0 9.024414895919541e-12
been O 0 7.616146754062247e-13
shown O 0 4.753806940108185e-13
to O 0 4.918592659899912e-13
be O 0 2.8439995584245148e-12
mutated O 0 8.497188730416383e-09
in O 0 1.7932354978711373e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.0669030220688e-07
who O 0 4.2988762549711623e-10
lack O 0 5.972321304170691e-08
15q11 O 0 3.3171021641464904e-05
- O 0 6.902030236233259e-06
q13 O 0 9.769652251634398e-07
deletions O 0 7.301520099645131e-08
or O 0 4.001551801025016e-08
chromosome O 0 7.263778911692498e-07
15 O 0 3.293710051366361e-07
paternal O 0 2.864910857169889e-05
uniparental B-Disease 1 0.9947553873062134
disomy I-Disease 1 0.7955483794212341
. O 0 8.022499287108076e-07

Previous O 0 3.2405359888798557e-06
UBE3A O 0 0.0003198420745320618
cDNA O 0 7.19967863105353e-09
analysis O 0 2.057845005509762e-10
has O 0 3.2653606381327638e-12
shown O 0 7.1174988645894555e-12
a O 0 1.397712588030453e-11
coding O 0 8.267813655926659e-10
region O 0 7.950730074313128e-10
of O 0 1.6583583395402002e-09
approximately O 0 6.0155536107942e-10
2 O 0 2.4645887108931674e-08
. O 0 3.416706251258006e-09

6 O 0 4.00531916966429e-06
kb O 0 1.124767322835396e-06
and O 0 5.420130566591297e-09
a O 0 1.5254741914105807e-09
3 O 0 2.1138077954674372e-08
- O 0 1.285429647168712e-07
untranslated O 0 0.0008892403566278517
region O 0 1.150505291036552e-08
( O 0 2.904363416433853e-10
UTR O 0 0.0006416490068659186
) O 0 3.172779053373098e-11
of O 0 1.039245689504753e-09
< O 0 1.7537348240281858e-09
50 O 0 9.196974848357797e-10
bp O 0 2.1058510490945537e-09
, O 0 9.29065678556551e-12
whereas O 0 1.0235835616601019e-11
Northern O 0 3.927001432368904e-11
analysis O 0 1.7243973176456207e-12
has O 0 9.971288795736569e-14
indicated O 0 1.010508625561013e-12
mRNA O 0 5.8921231609054825e-12
sizes O 0 8.88881329652591e-11
of O 0 2.3379820301983045e-09
5 O 0 2.28594077000821e-09
- O 0 4.387775831560248e-08
8 O 0 3.883803856297163e-08
kb O 0 4.979931418347405e-07
. O 0 4.128690722637884e-09

We O 0 2.7941606806081154e-09
have O 0 1.8961208471390822e-12
analyzed O 0 8.637842524583661e-11
additional O 0 6.8367165227678495e-12
cDNA O 0 1.079270672832422e-09
clones O 0 2.2780799469046542e-09
and O 0 8.194817220641415e-12
provide O 0 2.8818134944347262e-12
evidence O 0 6.822182402332899e-11
for O 0 8.285656232301375e-13
an O 0 2.906997017236568e-13
additional O 0 1.3296834119880252e-11
0 O 0 2.0946107071040387e-09
. O 0 1.714792335905102e-10

5 O 0 5.579667003985378e-07
kb O 0 9.286622457693738e-07
of O 0 2.811285355619475e-07
5 O 0 2.450802405462582e-08
- O 0 1.4061181730085082e-07
UTR O 0 0.00013030762784183025
and O 0 7.344827523958486e-10
> O 0 1.0524912053000435e-09
2 O 0 1.88225812713938e-09
kb O 0 5.9042960742772266e-08
of O 0 2.0910031039989008e-08
3 O 0 2.3465055676297197e-07
- O 0 1.9617755242506973e-06
UTR O 1 0.9871222376823425
. O 0 2.0611546247550905e-08

We O 0 1.5619475712824737e-09
have O 0 3.281118432507668e-12
established O 0 5.463480015621691e-11
the O 0 4.1517275728431e-12
genomic O 0 7.328339324264022e-11
organization O 0 8.923092820189993e-11
of O 0 1.548350558877587e-09
UBE3A O 0 0.0012223905650898814
and O 0 1.0271631462055453e-10
the O 0 3.9566013659841914e-11
sequence O 0 2.8244481406480837e-11
of O 0 4.3417419659519396e-10
intron O 0 6.008386890243855e-07
- O 0 6.458499797190598e-07
exon O 0 7.849268968129763e-07
borders O 0 1.9181683796887228e-08
. O 0 3.609965437689766e-09

We O 0 1.064404919759454e-08
have O 0 2.6456120280626827e-11
also O 0 1.4961927530254826e-11
mapped O 0 1.928383674965062e-09
two O 0 1.2738024177116891e-11
highly O 0 2.298127799171823e-10
homologous O 0 1.122925086249893e-10
processed O 0 4.272361575630157e-09
pseudogenes O 0 4.2857816850983e-08
, O 0 3.6392208691005123e-10
UBE3AP1 O 0 0.015877844765782356
and O 0 3.1741984596322936e-09
UBE3AP2 O 1 0.9994402527809143
, O 0 1.864263882156436e-10
to O 0 8.4158036442461e-12
chromosomes O 0 3.600094874989246e-11
2 O 0 1.490954582017423e-10
and O 0 4.825871473268517e-12
21 O 0 3.21832199778882e-10
, O 0 1.560349289012053e-12
respectively O 0 1.7547970021514203e-11
, O 0 1.8017768266959111e-12
and O 0 2.4982199468837063e-12
determined O 0 2.83574067005965e-11
their O 0 8.284938013414234e-11
genomic O 0 7.468282881006871e-09
organization O 0 1.0747437606539734e-08
. O 0 2.279636035495969e-09

These O 0 3.75877151626014e-09
results O 0 9.601429651340254e-10
will O 0 8.233420022152327e-12
form O 0 1.5709092013316273e-11
the O 0 4.248650476573745e-12
basis O 0 1.106368902742405e-12
for O 0 4.459878172606742e-14
studies O 0 1.1662427750955273e-12
of O 0 7.848776316377037e-12
mutation O 0 5.315024028534898e-12
and O 0 4.867380457018733e-11
imprinting O 0 1.4031218142918078e-06
of O 0 8.668187660987314e-07
UBE3A O 1 0.9999681711196899
. O 0 9.591133220965276e-08

Mutation O 0 6.979168887255582e-08
spectrum O 0 6.979062305845218e-08
and O 0 2.060611237197918e-09
genotype O 0 1.508081481915724e-07
- O 0 5.062344854422918e-08
phenotype O 0 4.2908235298178e-10
analyses O 0 2.481890470917847e-09
in O 0 9.491560870600324e-10
Cowden B-Disease 1 0.9999998807907104
disease I-Disease 1 0.99998939037323
and O 0 3.2055762488880646e-08
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.3347393735283504e-09
two O 0 6.895146231755689e-09
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 0.9999998807907104
with O 0 1.2931355968248681e-06
germline O 1 0.9999918937683105
PTEN O 1 1.0
mutation O 0 7.604721304232953e-06
. O 0 1.8884935570895323e-07

The O 0 1.7032131154337549e-06
tumour B-Disease 1 1.0
suppressor O 0 1.563295882078819e-05
gene O 0 2.831730228081142e-07
PTEN O 0 0.0016656923107802868
, O 0 5.056587926155487e-10
which O 0 1.1757714593607638e-11
maps O 0 4.0413046242804285e-09
to O 0 1.03016950525614e-09
10q23 O 0 5.080687969893916e-06
. O 0 2.1121032034443488e-08

3 O 0 4.026833835268917e-07
and O 0 9.743296169872906e-10
encodes O 0 1.2561515716491556e-10
a O 0 1.616601123799466e-11
403 O 0 7.936756807325196e-11
amino O 0 6.505353200569886e-11
acid O 0 2.8549360792107237e-11
dual O 0 3.7819955500673075e-11
specificity O 0 2.308108287829569e-10
phosphatase O 0 2.120772677471905e-07
( O 0 5.656459745040365e-10
protein O 0 3.4521627223504936e-10
tyrosine O 0 8.725846711854501e-09
phosphatase O 0 1.3662594255947624e-07
; O 0 6.721925793762296e-11
PTPase O 0 1.0827804999280488e-06
) O 0 1.010744266061181e-11
, O 0 4.038678679679775e-12
was O 0 5.0530565842699104e-11
shown O 0 9.5830877955283e-12
recently O 0 3.0488351426827265e-11
to O 0 6.252173691961849e-12
play O 0 2.4328701275777576e-09
a O 0 1.158890969299442e-10
broad O 0 1.2049140574177386e-09
role O 0 1.268979643587187e-10
in O 0 1.7726609069512733e-10
human O 0 8.334332335380168e-09
malignancy B-Disease 0 0.00032879828359000385
. O 0 4.9767900911490415e-09

Somatic O 0 0.0036377767100930214
PTEN O 1 0.7629204392433167
deletions O 0 5.063720891484991e-07
and O 0 8.398194140113446e-09
mutations O 0 2.039371782558419e-09
were O 0 2.4890142724665054e-10
observed O 0 2.661383613489221e-10
in O 0 2.4490615091465884e-10
sporadic B-Disease 0 2.5108372483373387e-06
breast I-Disease 0 0.00010255712550133467
, I-Disease 0 8.094724002205567e-09
brain I-Disease 1 1.0
, I-Disease 0 1.4828781047526718e-07
prostate I-Disease 1 1.0
and I-Disease 1 0.7743592262268066
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 0 0.0008765315287746489
lines O 0 1.8441114946199377e-07
and O 0 4.102743977885126e-10
in O 0 7.912632354889482e-11
several O 0 1.4425437233622773e-10
primary O 0 3.5819090271616005e-07
tumours B-Disease 1 1.0
such O 0 3.6504432809891796e-09
as O 0 5.794780832957258e-08
endometrial B-Disease 1 0.999998927116394
carcinomas I-Disease 1 1.0
, O 1 0.9998127818107605
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 8.493540917697828e-06

In O 0 8.090387026982171e-09
addition O 0 1.0460610155860195e-09
, O 0 1.3545249366586631e-09
PTEN O 0 0.008689134381711483
was O 0 5.59190649340735e-09
identified O 0 6.546728437140104e-11
as O 0 3.0356034526335396e-12
the O 0 1.8024515907599792e-11
susceptibility O 0 4.913124351801912e-10
gene O 0 3.964374314935348e-11
for O 0 5.321069539848677e-12
two O 0 2.1891204404766995e-09
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.0930331306724383e-08
CD B-Disease 1 1.0
; O 0 5.3296504987088156e-09
MIM O 0 0.022259270772337914
158350 O 0 1.5838590115890838e-05
) O 0 7.480792374447987e-11
and O 0 2.021625644665903e-10
Bannayan B-Disease 0 0.0010413030395284295
- I-Disease 0 2.7894824597751722e-05
Zonana I-Disease 1 0.9432772397994995
( I-Disease 0 1.1513482611746895e-08
BZS I-Disease 1 0.9996535778045654
) I-Disease 0 3.2818101014520096e-10
or I-Disease 0 2.414009825368879e-10
Ruvalcaba I-Disease 0 3.6415547128854087e-06
- I-Disease 0 4.87007173433085e-06
Riley I-Disease 0 0.0007025716477073729
- I-Disease 1 0.9708821177482605
Smith I-Disease 1 0.9389569759368896
syndrome I-Disease 1 1.0
( O 0 8.60956319570505e-08
MIM O 1 1.0
153480 O 1 0.9508033394813538
) O 0 6.133009655684418e-09
. O 0 4.693237798392147e-09

Constitutive O 0 7.528836704295827e-06
DNA O 0 3.4475585835025413e-06
from O 0 4.409276055383771e-09
37 O 0 1.017368411737607e-08
CD B-Disease 0 8.28151769383112e-06
families O 0 6.627864489877622e-12
and O 0 2.0096029007543592e-11
seven O 0 6.36448560520364e-10
BZS B-Disease 0 0.00044125562999397516
families O 0 7.369980493943107e-12
was O 0 2.0050364146761979e-10
screened O 0 2.113210051390979e-09
for O 0 3.81742248922734e-10
germline O 0 1.4798361007706262e-05
PTEN O 1 0.9043809175491333
mutations O 0 7.342627554862702e-07
. O 0 6.759760395880221e-08

PTEN O 0 0.028059503063559532
mutations O 0 3.871201670335722e-08
were O 0 1.3551657573884768e-09
identified O 0 1.002676414119108e-10
in O 0 4.399123773590752e-11
30 O 0 3.58793578181249e-10
of O 0 1.2899894485940422e-09
37 O 0 8.828834330287805e-10
( O 0 6.8479271732313496e-12
81 O 0 2.432081425141064e-09
% O 0 1.5944601325021401e-12
) O 0 1.2194130254161717e-12
CD B-Disease 0 2.7750351364375092e-05
families O 0 1.9441319214219543e-12
, O 0 2.1065950633197827e-12
including O 0 4.985563697990081e-11
missense O 0 3.847146601287932e-08
and O 0 5.822475390715454e-09
nonsense O 0 2.3468865038012154e-06
point O 0 2.038412461047301e-08
mutations O 0 5.849298823079607e-10
, O 0 5.82175974095378e-11
deletions O 0 3.72764263900649e-09
, O 0 4.426784216970958e-10
insertions O 0 2.452242497952284e-08
, O 0 5.66053925954435e-10
a O 0 3.45251827127413e-10
deletion O 0 1.0164373343002353e-08
/ O 0 5.126014812617541e-08
insertion O 0 6.653942730139306e-09
and O 0 1.956873107999968e-09
splice O 0 9.485381269769277e-06
site O 0 2.1744844502791238e-07
mutations O 0 1.9333607781391038e-07
. O 0 2.224604855882717e-08

These O 0 1.0106528947062543e-09
mutations O 0 5.015840520705694e-10
were O 0 3.0956556762440357e-10
scattered O 0 1.2285341632889413e-08
over O 0 1.0512930109785046e-10
the O 0 1.729095616687104e-10
entire O 0 1.1399458044181188e-09
length O 0 6.311558220506441e-11
of O 0 8.36835667428204e-09
PTEN O 0 0.00041169673204421997
, O 0 2.2432652957427024e-10
with O 0 2.5760966710502986e-12
the O 0 3.5977817947063784e-11
exception O 0 4.25933906200715e-11
of O 0 1.0684637202773573e-10
the O 0 1.8521417038952492e-11
first O 0 1.6211222642059653e-10
, O 0 1.8671774196232782e-11
fourth O 0 2.2422236511943083e-08
and O 0 3.3658512088585724e-10
last O 0 5.846814143950496e-09
exons O 0 2.69834742994135e-07
. O 0 1.258277482207859e-08

A O 0 8.076820813585073e-05
hot O 0 2.793398562062066e-05
spot O 0 5.621584477921715e-07
for O 0 8.299524401067515e-10
PTEN O 0 2.459730239934288e-05
mutation O 0 1.4940688963793747e-10
in O 0 1.2559360496045002e-10
CD B-Disease 0 0.008265236392617226
was O 0 1.493004275765486e-09
identified O 0 4.144861537325184e-11
in O 0 1.94913026690946e-11
exon O 0 5.3906852315321885e-09
5 O 0 8.542620499873976e-10
that O 0 1.2122426543484388e-12
contains O 0 1.1726992987792784e-10
the O 0 1.3288574407521736e-10
PTPase O 0 1.1815192237918382e-06
core O 0 1.1472758387753856e-07
motif O 0 1.1572879321519736e-09
, O 0 3.3805490958632722e-12
with O 0 1.0064500231485307e-12
13 O 0 1.5373409489871648e-10
of O 0 3.2760877344273354e-10
30 O 0 9.982149828946518e-11
( O 0 3.653878848791647e-12
43 O 0 8.113743704685206e-11
% O 0 7.241793427946452e-13
) O 0 1.943968640574778e-12
CD B-Disease 0 0.010004115290939808
mutations O 0 2.0249983634368363e-10
identified O 0 2.5378237705764306e-11
in O 0 3.678789564642848e-11
this O 0 1.0513846737669752e-11
exon O 0 2.624427679620567e-07
. O 0 1.2556498951710182e-08

Seven O 0 1.7071323554773699e-07
of O 0 2.28796146473087e-08
30 O 0 1.7535509710953079e-09
( O 0 1.774165363233049e-11
23 O 0 4.826723465356508e-10
% O 0 2.4802908208179653e-13
) O 0 1.2850606538085396e-13
were O 0 3.3365918535033234e-12
within O 0 8.025259623511971e-11
the O 0 8.635865633710438e-11
core O 0 4.6795463504167856e-08
motif O 0 1.0828791197070586e-09
, O 0 2.7885502067170886e-12
the O 0 5.5840432104659055e-12
majority O 0 1.6186788780007955e-13
( O 0 8.239669255054316e-13
five O 0 5.74715275369897e-12
of O 0 2.397056442227097e-10
seven O 0 2.988977121365366e-10
) O 0 1.9424045705207504e-12
of O 0 1.3926412800735477e-10
which O 0 9.909830768484174e-12
were O 0 3.966963146861957e-10
missense O 0 6.000284002993794e-08
mutations O 0 1.5721067780916087e-09
, O 0 1.0167388458937054e-10
possibly O 0 3.607501630753518e-09
pointing O 0 3.1091311747388772e-09
to O 0 2.0266279973646384e-11
the O 0 3.05955955015591e-11
functional O 0 4.9097493431959904e-11
significance O 0 1.9111912052949265e-10
of O 0 4.803854536383767e-10
this O 0 3.551438223364789e-12
region O 0 2.833586254524789e-09
. O 0 2.480877725474784e-09

Germline O 0 0.0012108900118619204
PTEN O 0 0.10026586055755615
mutations O 0 4.125040220515075e-08
were O 0 1.6408205905094064e-09
identified O 0 1.2999649967593285e-10
in O 0 2.58305495048905e-11
four O 0 6.403910735031104e-11
of O 0 3.1034492753434506e-09
seven O 0 1.1261600540990457e-09
( O 0 4.288359251036766e-11
57 O 0 1.7109413885663116e-09
% O 0 6.723409589487472e-12
) O 0 3.492207911737211e-11
BZS B-Disease 0 0.002320619998499751
families O 0 8.444767107818052e-11
studied O 0 1.5637137096291553e-07
. O 0 8.351406677320483e-09

Interestingly O 0 3.9851914834798663e-07
, O 0 1.0226127722390288e-09
none O 0 1.5789243523745e-10
of O 0 1.8979645632910547e-10
these O 0 4.346908250019155e-12
mutations O 0 7.181417266410861e-11
was O 0 1.9296446385208554e-10
observed O 0 1.0411439765878328e-10
in O 0 2.371185539584708e-11
the O 0 7.914025546007508e-10
PTPase O 0 7.965371332829818e-05
core O 0 9.351257176604122e-06
motif O 0 3.817870890543418e-07
. O 0 2.9160658332472167e-09

It O 0 2.1369499503265388e-09
is O 0 1.904748928027722e-11
also O 0 1.6914863606998232e-12
worthy O 0 1.1131481292281364e-09
of O 0 4.030604294769091e-09
note O 0 2.032369827986713e-10
that O 0 9.628079583601235e-13
a O 0 1.30883377053026e-11
single O 0 1.482696465604505e-10
nonsense O 0 1.1650843845245618e-08
point O 0 1.0458057753126582e-09
mutation O 0 2.895876594077862e-11
, O 0 1.6906002639482942e-11
R233X O 0 3.0679849771786394e-08
, O 0 7.541018504086949e-11
was O 0 6.454187184701254e-11
observed O 0 3.708633053434163e-11
in O 0 4.1366771119655255e-12
the O 0 2.2621609446771274e-11
germline O 0 1.1963082746646592e-09
DNA O 0 1.7999530754764237e-08
from O 0 1.0849480341912354e-10
two O 0 9.06322586424757e-12
unrelated O 0 1.8329062712041377e-09
CD B-Disease 1 0.8334569931030273
families O 0 1.684182654448918e-11
and O 0 1.6692422444286592e-10
one O 0 5.253167900676203e-10
BZS B-Disease 1 0.9977781176567078
family O 0 4.7723702323310135e-08
. O 0 1.933338111825833e-08

Genotype O 0 6.100111477280734e-06
- O 0 1.7851989753125963e-07
phenotype O 0 1.4853636098877132e-09
studies O 0 6.075580316622364e-11
were O 0 2.6926565144247405e-11
not O 0 7.849999946948905e-13
performed O 0 8.303831511291548e-10
on O 0 6.025242110796469e-11
this O 0 1.5462608136170702e-13
small O 0 9.997921761317752e-12
group O 0 2.3359661427413414e-10
of O 0 5.333728125833659e-09
BZS B-Disease 1 0.9998745918273926
families O 0 7.199592033657609e-10
. O 0 3.849875085393251e-09

However O 0 1.936504467892064e-08
, O 0 8.742735424505099e-10
genotype O 0 1.2342461275238747e-08
- O 0 1.4078418431040518e-08
phenotype O 0 7.073225893883262e-10
analysis O 0 1.446389813475335e-10
inthe O 0 2.742796141319559e-07
group O 0 6.941552332939693e-10
of O 0 1.0736108002618039e-08
CD B-Disease 1 0.9999995231628418
families O 0 8.824246021388316e-12
revealed O 0 1.3448474278643374e-10
two O 0 1.0042409612220915e-12
possible O 0 4.070020362401117e-12
associations O 0 5.366182498356409e-11
worthy O 0 3.951446725380947e-09
of O 0 9.573930981332524e-09
follow O 0 1.0731597832602802e-09
- O 0 7.0949019992383455e-09
up O 0 8.11574002446136e-11
in O 0 4.9318214442872765e-12
independent O 0 6.065345448114101e-11
analyses O 0 1.878751199058115e-08
. O 0 8.128234973980852e-09

The O 0 2.942618060330915e-08
first O 0 3.834324857621141e-09
was O 0 1.3122246622643274e-09
an O 0 1.9795443496201104e-12
association O 0 4.4799058906974665e-10
noted O 0 1.3820402287867406e-11
in O 0 5.783275334320104e-12
the O 0 3.8236872001995437e-11
group O 0 2.8237964050381592e-11
of O 0 4.68812710874289e-10
CD B-Disease 1 0.9999940395355225
families O 0 2.977629601219611e-11
with O 0 4.421790933406555e-09
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.4974855133687015e-08

A O 0 6.122925810814195e-07
correlation O 0 7.675292623687824e-10
was O 0 3.4592484432494075e-10
observed O 0 3.4643704571735157e-11
between O 0 3.101988717973958e-12
the O 0 7.091887407190134e-12
presence O 0 8.576476334676286e-11
/ O 0 1.351578315933466e-08
absence O 0 1.1356747764423858e-09
of O 0 2.5157964600452942e-09
a O 0 3.5895580952072237e-10
PTEN O 0 0.16831202805042267
mutation O 0 2.314434338623883e-10
and O 0 3.051819560950797e-11
the O 0 7.602569962461558e-11
type O 0 1.561376450354146e-08
of O 0 7.773581955916598e-07
breast O 0 0.00016102645895443857
involvement O 0 9.85768622285832e-08
( O 0 4.157327815335066e-09
unaffected O 0 1.501987185292819e-06
versus O 0 3.292018845968414e-06
benign O 0 0.001501804101280868
versus O 0 3.08194721583277e-05
malignant O 1 0.871580183506012
) O 0 3.833929618224374e-09
. O 0 2.497366091702702e-09

Specifically O 0 1.8321278716371125e-08
and O 0 4.6024689615009606e-10
more O 0 7.694761711488085e-13
directly O 0 5.3812079792159295e-11
, O 0 6.445375483332683e-12
an O 0 1.2031667979625627e-12
association O 0 6.330755364380991e-10
was O 0 7.231025223042309e-10
also O 0 2.635427032854354e-12
observed O 0 1.5544742576478754e-11
between O 0 3.129455895811706e-12
the O 0 4.9155939735312515e-12
presence O 0 4.9283047261206026e-12
of O 0 3.8124381429582854e-10
a O 0 4.777920836751548e-10
PTEN O 1 0.999998927116394
mutation O 0 2.860236349988554e-07
and O 0 2.5198135062964866e-06
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.4435200057505426e-07

Secondly O 0 2.127211018887465e-06
, O 0 4.126218478006649e-09
there O 0 9.951467427882221e-11
appeared O 0 1.5569498468259724e-10
to O 0 1.4281365803489598e-12
be O 0 1.4370443853981008e-12
an O 0 6.0722984800143376e-12
interdependent O 0 3.817073661593895e-07
association O 0 6.905151650471453e-08
between O 0 9.109647480798344e-10
mutations O 0 8.363118531029556e-10
upstream O 0 1.5825794008605953e-09
and O 0 2.2573132252290407e-10
within O 0 8.894313063834147e-10
the O 0 9.426502911580315e-10
PTPase O 0 3.5748962545767426e-05
core O 0 1.8588600596558535e-06
motif O 0 1.685181238997302e-08
, O 0 3.927173863882416e-11
the O 0 1.6556014892366022e-10
core O 0 1.60029482998425e-08
motif O 0 2.6307286904447835e-10
containing O 0 2.120245298775636e-11
the O 0 5.677553045757566e-12
majority O 0 1.9419553042455268e-13
of O 0 2.417206018678897e-11
missense O 0 2.982475377777405e-09
mutations O 0 5.910171796408292e-10
, O 0 8.285790803475024e-11
and O 0 1.3439678536730781e-10
the O 0 4.0950121071858803e-10
involvement O 0 6.570650690207458e-10
of O 0 2.7913429345716168e-09
all O 0 6.542144430354835e-12
major O 0 2.194094905760835e-09
organ O 1 0.914178192615509
systems O 1 0.9991777539253235
( O 0 1.0756624924113112e-08
central O 0 0.003112591104581952
nervous O 0 6.417641998268664e-06
system O 0 0.00013527186820283532
, O 0 1.7415149500266125e-07
thyroid O 1 1.0
, O 0 3.547035930751008e-06
breast O 1 1.0
, O 0 5.959974259894807e-06
skin O 1 1.0
and O 1 0.9999896287918091
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 3.4902294032690406e-07
. O 0 1.4979345053234283e-07

However O 0 8.530738782042135e-09
, O 0 5.014383699930569e-11
these O 0 8.341472044343101e-13
observations O 0 2.542568378061105e-10
would O 0 4.456609126873845e-12
need O 0 4.80503137278987e-12
to O 0 3.0219470589093467e-12
be O 0 2.573115765597267e-12
confirmed O 0 1.9221868888252835e-11
by O 0 7.176137939088334e-13
studying O 0 3.664880898757161e-11
a O 0 1.266422622152319e-12
larger O 0 1.5166752402595574e-12
number O 0 7.16298634989565e-12
of O 0 9.470656481269657e-10
CD B-Disease 1 0.6139097809791565
families O 0 1.8313049687801453e-10
. O 0 8.98862317910698e-10

Molecular O 1 0.999153733253479
defects O 1 0.9999998807907104
leading O 0 1.2641996818274492e-06
to O 0 2.530265996725234e-10
human O 0 1.2013640082741972e-09
complement B-Disease 0 1.3155955684851506e-06
component I-Disease 1 0.9999997615814209
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.025064088113538e-10
an O 0 1.6333553433389714e-12
African O 0 6.27717391954441e-11
- O 0 1.0744541922846906e-09
American O 0 1.0003577965989052e-09
family O 0 2.452310299272398e-10
. O 0 6.575188726820613e-10

Complement B-Disease 0 9.026885527418926e-05
component I-Disease 1 0.9999908208847046
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.948668592101967e-08
C6D B-Disease 1 1.0
) O 0 5.190758378681437e-10
was O 0 2.1004527894774583e-08
diagnosed O 0 7.36127105938067e-08
in O 0 1.1411807609995606e-10
a O 0 6.553000503339845e-11
16 O 0 6.070721259021639e-09
- O 0 5.432249761128105e-09
year O 0 9.47710243615063e-11
- O 0 5.382568613043759e-09
old O 0 1.760586343380055e-08
African O 0 7.105217525449348e-10
- O 0 1.1467758964656127e-09
American O 0 2.0182967797044427e-10
male O 0 1.38288477891102e-10
with O 0 5.516887502388101e-10
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 7.023126524785539e-09

The O 0 1.8909030075064948e-07
patients O 0 5.89436899289808e-09
father O 0 1.9137319284823207e-08
and O 0 5.004163194932687e-10
two O 0 7.071512264644753e-10
brothers O 0 1.5050742376843118e-06
also O 0 8.345972801748758e-10
had O 0 3.5766161143868658e-09
C6D B-Disease 1 1.0
, O 0 6.347005143680917e-10
but O 0 4.729607330777874e-12
gave O 0 2.648272746930136e-11
no O 0 4.1132626818485285e-12
history O 0 1.5952351661852049e-09
of O 0 1.249381682555395e-07
meningitis B-Disease 1 1.0
or O 0 9.175213921963632e-10
other O 0 2.9024929126819643e-09
neisserial B-Disease 1 0.9999932050704956
infection I-Disease 0 0.001428331364877522
. O 0 7.903832255351517e-09

By O 0 1.6376784373051123e-09
using O 0 4.737385483899459e-10
exon O 0 2.5140948878288327e-08
- O 0 1.9129646755544627e-09
specific O 0 9.507532781893868e-12
polymerase O 0 1.1497588436881756e-09
chain O 0 2.1724160248481894e-09
reaction O 0 5.797292854103908e-11
( O 0 1.839783360380043e-11
PCR O 0 4.1103536574382815e-08
) O 0 3.7603951202891395e-11
/ O 0 9.62596335973842e-10
single O 0 2.373014562628839e-10
- O 0 5.171606476395141e-10
strand O 0 9.744777901277146e-11
conformation O 0 2.5912268858396814e-11
polymorphism O 0 1.6555848705857024e-11
as O 0 8.030059364845521e-13
a O 0 2.9070856507641685e-13
screening O 0 4.82557700395847e-12
step O 0 5.4332467344653246e-12
and O 0 2.6740190465536495e-13
nucleotide O 0 5.244362669826197e-12
sequencing O 0 2.142195795751256e-11
of O 0 4.675346221283405e-11
target O 0 2.448930780385439e-10
exons O 0 7.285712921856202e-09
, O 0 4.26433818812022e-11
we O 0 5.0136444475212816e-12
determined O 0 5.845927908421089e-11
that O 0 1.2098403875948627e-12
the O 0 5.268316338735701e-11
proband O 0 2.6949348352900415e-07
was O 0 7.159360326802755e-10
a O 0 1.1528452671660805e-11
compound O 0 2.345726113350821e-10
heterozygote O 0 4.630153593865316e-09
for O 0 6.307261657401142e-11
two O 0 8.945420515438229e-10
C6 O 1 0.9999581575393677
gene O 0 9.128596900609409e-08
mutations O 0 3.309919449634435e-08
. O 0 1.8203717644382778e-08

The O 0 7.017438008460886e-08
first O 0 3.23242366206955e-09
, O 0 4.148262636172184e-11
1195delC O 0 1.094272317203604e-08
located O 0 1.9416925844950583e-09
in O 0 6.701392218921853e-11
exon O 0 1.7593977830188123e-08
7 O 0 2.4980629120818776e-08
, O 0 2.9286042341203355e-11
is O 0 4.4483180702305225e-13
a O 0 1.5449880957918438e-12
novel O 0 7.877452162796672e-12
mutation O 0 4.227133400258598e-12
, O 0 3.2779219876627463e-12
while O 0 7.2281217469716275e-12
the O 0 2.6222362822792e-11
second O 0 1.2718129882571816e-09
, O 0 1.6398491939351167e-11
1936delG O 0 6.8123076069070976e-09
in O 0 1.9820926844271725e-10
exon O 0 2.6155419163842453e-08
12 O 0 8.288391306621179e-09
, O 0 2.7367660221377932e-11
has O 0 7.076385918208805e-13
been O 0 3.4680973370893042e-12
described O 0 4.9369633381424194e-11
before O 0 1.8747545182939973e-10
to O 0 3.047253768762026e-11
cause O 0 3.4167666029816246e-08
C6D B-Disease 1 0.9999992847442627
in O 0 2.112761771089211e-10
an O 0 3.383619556415751e-12
unrelated O 0 4.541837128613224e-09
African O 0 2.7977176131344095e-09
- O 0 1.1514471154328021e-08
American O 0 7.220206654778849e-10
individual O 0 1.4474274556697253e-10
. O 0 1.3344689797634146e-09

Both O 0 2.3202490595508607e-08
mutations O 0 5.997021101933342e-09
result O 0 1.7745764857579616e-09
in O 0 9.304675918642147e-10
premature O 0 8.487700853265778e-08
termination O 0 3.737519307378534e-07
codons O 0 2.766497004813573e-07
and O 0 2.395344900207874e-08
C6 O 0 0.04820968955755234
null O 0 7.379961175502103e-07
alleles O 0 5.699804628278571e-09
. O 0 5.529162905304474e-09

Allele O 0 5.9324722911924255e-08
- O 0 3.030957884675445e-08
specific O 0 1.6375964473347437e-10
PCR O 0 5.2696911723160156e-08
indicated O 0 6.321994594493674e-10
that O 0 8.222619091689809e-13
the O 0 4.8986183165400377e-11
probands O 0 4.868084602094314e-07
two O 0 3.7145389542025953e-10
brothers O 0 2.172952520140825e-07
also O 0 4.2409234457529976e-10
inherited O 0 2.476426175235247e-07
the O 0 4.7754271648159374e-09
1195delC O 0 1.083621867792317e-07
mutation O 0 8.054779759847364e-11
from O 0 3.0301098435936424e-11
their O 0 6.016652454032823e-11
heterozygous O 0 7.724944989240257e-11
mother O 0 9.466316619466397e-11
and O 0 2.7597146790014904e-11
the O 0 8.700262038585649e-11
1936delG O 0 1.1899732754727665e-08
mutation O 0 8.078639320008296e-12
from O 0 4.362043018457662e-11
their O 0 6.23181853343091e-11
homozygous O 0 6.40368558180171e-09
father O 0 2.882192973174824e-08
. O 0 9.299317427213794e-10
. O 0 3.8994563134053806e-09

PAX6 O 1 0.9998806715011597
mutations O 0 2.2692445327265887e-06
reviewed O 0 2.655505340953823e-06
. O 0 1.984646900154985e-07

Mutations O 0 1.534952360771058e-07
in O 0 9.770173114986846e-09
PAX6 O 1 0.9479333162307739
are O 0 2.5312507645480764e-10
responsible O 0 5.916084955259748e-09
for O 0 2.590679337721724e-10
human O 0 1.129820326184472e-08
aniridia B-Disease 1 1.0
and O 0 5.108957146227056e-10
have O 0 1.6806519283901755e-12
also O 0 7.495496194206974e-13
been O 0 5.432052377352115e-13
found O 0 9.857944538796404e-13
in O 0 2.5500693136976116e-12
patients O 0 2.305432234006588e-11
with O 0 5.4796767817721914e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 7.058084605660042e-08
with O 0 0.00489623099565506
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 8.542072578165971e-07
with O 0 4.338948400572917e-08
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999685287475586
keratitis I-Disease 1 0.9999998807907104
, O 0 1.495946655438729e-08
and O 0 1.3459753311906297e-08
with O 0 4.64912055520017e-08
isolated B-Disease 1 0.9999997615814209
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 6.345283054542961e-06

No O 0 4.419676713496301e-08
locus O 0 5.988105566956392e-09
other O 0 7.040138610969748e-11
than O 0 7.827577995500601e-12
chromosome O 0 1.1234161378936847e-09
11p13 O 0 2.7742217412196624e-08
has O 0 6.661424016563e-12
been O 0 1.219492649223719e-11
implicated O 0 1.1796091881066673e-09
in O 0 1.065521448850859e-09
aniridia B-Disease 1 1.0
, O 0 2.0357149299599087e-09
and O 0 8.695852371509716e-10
PAX6 O 1 0.9999957084655762
is O 0 2.392657738603532e-10
clearly O 0 1.8999095352523199e-10
the O 0 2.385935615745183e-10
major O 0 8.444710708488401e-09
, O 0 3.140711649085581e-11
if O 0 5.356646658356834e-13
not O 0 3.5954591626023713e-13
only O 0 1.0744524844494285e-12
, O 0 1.6028400828815847e-11
gene O 0 3.3263269916261606e-10
responsible O 0 3.273823523386454e-08
. O 0 1.49872843024923e-08

Twenty O 0 2.1541031856031623e-06
- O 0 7.030755000414501e-08
eight O 0 7.818811154081118e-10
percent O 0 3.4116168223796706e-11
of O 0 1.36236980030624e-10
identified O 0 1.3808005849824667e-09
PAX6 O 1 0.9648329615592957
mutations O 0 6.440973532306771e-09
are O 0 3.9233050141973536e-10
C O 0 0.00032797647872939706
- O 0 3.006964107044041e-05
T O 0 2.6593739676172845e-05
changes O 0 2.806443966107963e-10
at O 0 3.372233825515991e-09
CpG O 0 4.991013824451329e-08
dinucleotides O 0 1.8969753057263006e-07
, O 0 2.3677101945729362e-11
20 O 0 3.2725575721537226e-11
% O 0 1.1069973198741048e-13
are O 0 1.6923333733182867e-14
splicing O 0 5.217638543442149e-10
errors O 0 9.51838217133627e-08
, O 0 7.925819722753857e-11
and O 0 1.0685528850640225e-11
more O 0 1.1713472260286434e-13
than O 0 2.1821459298809048e-13
30 O 0 1.4355602644122722e-11
% O 0 1.6028689063963403e-13
are O 0 7.159018115734245e-14
deletion O 0 5.101836661469683e-11
or O 0 7.703609278264523e-11
insertion O 0 4.494868921511852e-09
events O 0 1.5273499798240664e-08
. O 0 2.686422639897046e-08

There O 0 7.279490343847783e-09
is O 0 7.192561130020536e-11
a O 0 8.271390516956245e-11
noticeably O 0 6.692023379883949e-09
elevated O 0 1.6728445473290776e-07
level O 0 2.6603752534271052e-09
of O 0 2.167630380744967e-10
mutation O 0 2.711605896418834e-12
in O 0 3.2114753564793652e-12
the O 0 5.1960654529059624e-11
paired O 0 1.5728107705115235e-10
domain O 0 1.757825308923433e-11
compared O 0 5.396108473249006e-12
with O 0 1.1375721328463206e-12
the O 0 5.3864041699158705e-11
rest O 0 1.0118409443649057e-09
of O 0 1.0110615678016188e-09
the O 0 1.0547480666645015e-09
gene O 0 1.9541352980212423e-09
. O 0 1.2611551802876875e-09

Increased O 0 3.4158131878569975e-09
mutation O 0 5.125266877570311e-10
in O 0 6.312785710838043e-11
the O 0 1.1347929540495016e-10
homeodomain O 0 1.1759347273709864e-08
is O 0 1.686859853189393e-12
accounted O 0 2.993791325955897e-11
for O 0 4.315382144508273e-13
by O 0 7.166812716202786e-12
the O 0 5.813972636659059e-10
hypermutable O 0 4.0255154090118594e-06
CpG O 0 1.5417671193063143e-06
dinucleotide O 0 7.297872173239739e-08
in O 0 1.3184615621497642e-09
codon O 0 3.348175781070495e-08
240 O 0 2.3316770736414583e-08
. O 0 2.270124754844005e-09

Very O 0 7.176699678979048e-09
nearly O 0 2.1258018956249458e-10
all O 0 1.6785801915109033e-11
mutations O 0 4.385534990714035e-11
appear O 0 8.700277998041628e-11
to O 0 5.112054876632577e-11
cause O 0 1.488098000379523e-08
loss O 0 8.94090845804385e-08
of O 0 1.2576776065031936e-08
function O 0 4.0641576909417054e-11
of O 0 7.417739755766206e-10
the O 0 4.10973581554952e-11
mutant O 0 1.2485056044564402e-10
allele O 0 1.8101264844666565e-12
, O 0 1.7748243196294422e-12
and O 0 1.7072876315818442e-12
more O 0 6.880152507828322e-14
than O 0 2.6752024532249175e-13
80 O 0 6.773483163247107e-11
% O 0 3.568390971164098e-13
of O 0 6.57337934084623e-11
exonic O 0 8.716602195590895e-08
substitutions O 0 6.336968283449096e-09
result O 0 6.665802909644469e-10
in O 0 4.131918696081982e-10
nonsense O 0 2.791486224396067e-07
codons O 0 1.2981927000055293e-07
. O 0 3.5177423196586233e-09

In O 0 1.552313833030894e-08
a O 0 1.0113855308802044e-09
gene O 0 2.442083202325307e-10
with O 0 6.68647559196045e-12
such O 0 2.1997591248545945e-10
extraordinarily O 0 3.868330011869148e-08
high O 0 1.1698971036366856e-07
sequence O 0 6.603916719027936e-11
conservation O 0 1.235493235496321e-10
throughout O 0 2.5670470523569966e-12
evolution O 0 2.3545464189478338e-11
, O 0 4.927127499401718e-13
there O 0 2.3697637276977324e-13
are O 0 9.517724065474797e-13
presumed O 0 3.562665495948636e-09
undiscovered O 0 3.476699248494697e-06
missense O 0 9.738585760032947e-08
mutations O 0 2.7549105219293324e-09
, O 0 8.87268800098262e-11
these O 0 7.429739982967032e-12
are O 0 2.7919936328169026e-12
hypothesized O 0 2.3109795327380667e-11
to O 0 2.739574409341139e-12
exist O 0 4.768650405106989e-11
in O 0 2.619641829848529e-11
as O 0 1.3591773539989305e-10
- O 0 1.2497959112067747e-08
yet O 0 7.457457568138537e-11
unidentified O 0 3.9243923666276714e-09
phenotypes O 0 3.873498499729067e-08
. O 0 3.553122240873563e-10
. O 0 1.2152030492984522e-09

Genetic O 0 1.3039417581239832e-06
heterogeneity O 0 2.435495218833239e-07
and O 0 1.892290324434498e-09
penetrance O 0 3.216987209953004e-08
analysis O 0 3.447399032907583e-10
of O 0 4.945733156347387e-09
the O 0 2.4590327551976543e-09
BRCA1 O 0 1.331376040525356e-07
and O 0 1.2490285250521538e-08
BRCA2 O 0 6.005001296216506e-07
genes O 0 5.66216229458405e-09
in O 0 1.0816003737090796e-07
breast B-Disease 1 0.9999998807907104
cancer I-Disease 0 0.08803585171699524
families O 0 2.6192134572333714e-10
. O 0 4.8021160381495065e-09

The O 0 0.0008117916877381504
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 8.374505705432966e-05
Consortium O 0 2.51994805466893e-07
. O 0 1.6634308153129496e-08

The O 0 6.729603541089091e-09
contribution O 0 1.1282046408211954e-09
of O 0 3.7618139714368226e-08
BRCA1 O 0 3.504130461351451e-07
and O 0 2.574657642639977e-08
BRCA2 O 0 1.131182762037497e-05
to O 0 2.3617315036972286e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 5.95628762312117e-07
assessed O 0 8.764660996973817e-09
by O 0 2.7320876463954313e-11
linkage O 0 1.9345987034569134e-09
and O 0 1.6865293883672194e-11
mutation O 0 4.017948300460983e-12
analysis O 0 2.6005833771158837e-12
in O 0 1.499071374845562e-12
237 O 0 2.8586140399244897e-11
families O 0 1.5080439067644003e-13
, O 0 2.1309878774772306e-12
each O 0 2.5395256644106246e-13
with O 0 4.525262543159103e-12
at O 0 8.960708619554225e-09
least O 0 3.377075528943063e-12
four O 0 5.837311970596781e-12
cases O 0 4.418414245588309e-11
of O 0 1.3189004732794274e-07
breast B-Disease 1 1.0
cancer I-Disease 1 0.8584677577018738
, O 0 6.965846649498175e-11
collected O 0 1.0467151451143408e-10
by O 0 3.305063167591271e-11
the O 0 2.5982294005189033e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 7.01544286130229e-06
Consortium O 0 1.7821014353103237e-07
. O 0 5.4317008668647304e-09

Families O 0 4.3922257497719386e-10
were O 0 1.837294621997998e-10
included O 0 3.1865840521838606e-10
without O 0 2.5019167293471867e-11
regard O 0 5.899649518914529e-11
to O 0 2.550453771787975e-12
the O 0 1.92129246540107e-11
occurrence O 0 5.731190189095514e-09
of O 0 3.2912325309553125e-07
ovarian B-Disease 1 0.790052592754364
or I-Disease 0 3.4203004872779275e-08
other I-Disease 0 7.462211897291127e-07
cancers I-Disease 1 1.0
. O 0 7.6256142733655e-08

Overall O 0 2.3654090909985825e-05
, O 0 1.8838093751583074e-07
disease O 0 0.056709568947553635
was O 0 4.295452438185521e-09
linked O 0 6.817584718987746e-09
to O 0 6.517823086804597e-11
BRCA1 O 0 1.64221702902978e-09
in O 0 3.044337351654214e-11
an O 0 4.630082667093915e-13
estimated O 0 2.1897758671445e-13
52 O 0 6.0139640663259275e-12
% O 0 1.0647513144605714e-13
of O 0 1.2783244948688655e-11
families O 0 2.691796167474808e-13
, O 0 6.487185354869807e-12
to O 0 3.917127039398949e-11
BRCA2 O 0 4.173774659221863e-09
in O 0 1.3745198035319817e-10
32 O 0 2.733673565291639e-10
% O 0 3.054652613753567e-13
of O 0 1.2257399956139281e-11
families O 0 1.4771052490956255e-13
, O 0 2.65268449567424e-12
and O 0 8.9062203792456e-12
to O 0 7.969821851083747e-12
neither O 0 1.1308863567816019e-10
gene O 0 1.0142900408460775e-11
in O 0 1.4483822127764334e-11
16 O 0 2.234809559631401e-10
% O 0 2.015201021462673e-13
( O 0 2.544723600676063e-13
95 O 0 1.3581330504663924e-10
% O 0 1.1172772776402162e-12
confidence O 0 8.275781171462882e-10
interval O 0 3.328005604430473e-08
[ O 0 3.547092575217903e-08
CI O 0 0.0006019959691911936
] O 0 9.307432158323081e-09
6 O 0 3.7063101476775273e-09
% O 0 1.5104340304536445e-12
- O 0 1.0009642420483189e-10
28 O 0 3.758640065854024e-10
% O 0 2.901767368057584e-13
) O 0 3.179657871634628e-13
, O 0 1.9237922886661263e-12
suggesting O 0 7.37520183813345e-11
other O 0 8.762262443395841e-11
predisposition O 0 1.4726916788276867e-06
genes O 0 2.817296618218279e-08
. O 0 1.5314045143099975e-08

The O 0 4.7683393233910465e-08
majority O 0 8.626811071055229e-11
( O 0 3.758437658318847e-11
81 O 0 5.199718433601674e-09
% O 0 1.9380081307113217e-12
) O 0 9.165230423560655e-13
of O 0 8.688044172977527e-10
the O 0 4.3793733084385167e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.512973320382809e-12
were O 0 3.548508362150038e-11
due O 0 3.6253924862172937e-10
to O 0 8.432324977158956e-11
BRCA1 O 0 9.665449773876844e-09
, O 0 2.2958222128943717e-11
with O 0 2.678614491671838e-12
most O 0 3.885767142081109e-12
others O 0 3.657130154266497e-11
( O 0 3.2951605853648314e-12
14 O 0 3.692795513821068e-10
% O 0 6.122407810761621e-13
) O 0 3.77542588121324e-13
due O 0 4.824413091242263e-10
to O 0 3.004972937148409e-09
BRCA2 O 0 1.8115217244485393e-05
. O 0 3.843420870452974e-08

Conversely O 0 1.969609826346641e-07
, O 0 2.6730490043647137e-10
the O 0 4.396573730081066e-11
majority O 0 7.209049438135218e-13
of O 0 3.1054832316801395e-11
families O 0 1.8103673128742198e-13
with O 0 4.199865281939719e-12
male B-Disease 0 8.363996162330523e-10
and I-Disease 0 7.6053918718344e-09
female I-Disease 0 3.9566381815347995e-07
breast I-Disease 1 0.9999619722366333
cancer I-Disease 0 0.08006958663463593
were O 0 1.0284776585933741e-08
due O 0 9.719435212218741e-08
to O 0 3.1431477420795773e-09
BRCA2 O 0 7.467687623829988e-08
( O 0 2.8207616797892854e-10
76 O 0 4.861709257397706e-08
% O 0 2.40934425188577e-11
) O 0 3.646904653265004e-11
. O 0 1.3540650822818634e-09

The O 0 1.510116476310941e-07
largest O 0 3.09816350352321e-08
proportion O 0 2.9433783188537177e-10
( O 0 6.137239327852484e-11
67 O 0 1.493152379516971e-09
% O 0 8.523662461609738e-13
) O 0 2.3201723203282454e-13
of O 0 2.1603854122309585e-11
families O 0 5.966281207145721e-14
due O 0 2.3939997206845476e-10
to O 0 7.778715171991024e-12
other O 0 1.8752542921274262e-11
genes O 0 3.111969709701512e-11
was O 0 4.118691776522354e-10
found O 0 4.961608381093274e-12
in O 0 8.105305706121446e-13
families O 0 3.776323939425237e-14
with O 0 2.7153412439535896e-13
four O 0 3.0044997739731016e-11
or O 0 3.107900742316261e-11
five O 0 4.360928285151999e-11
cases O 0 6.417960607407736e-11
of O 0 3.291003025651662e-08
female O 0 5.951404205006838e-07
breast B-Disease 1 0.9999992847442627
cancer I-Disease 0 0.05288388207554817
only O 0 1.7662225015868671e-09
. O 0 1.1867727245373771e-08

These O 0 2.008811561537982e-09
estimates O 0 5.580045314701465e-10
were O 0 5.348770037993944e-11
not O 0 7.03014740605773e-13
substantially O 0 1.5269951969543172e-11
affected O 0 2.6281497811364574e-11
either O 0 9.216211127593965e-12
by O 0 1.869749580857283e-12
changing O 0 6.2996032001994e-11
the O 0 2.9062958636916214e-11
assumed O 0 1.5782498918870402e-10
penetrance O 0 2.0769508335405362e-09
model O 0 4.391486480015416e-11
for O 0 5.831216759455415e-11
BRCA1 O 0 2.3806865367959062e-09
or O 0 1.8565487688859683e-11
by O 0 5.455895717848547e-12
including O 0 7.908649429788639e-11
or O 0 1.9515269955583392e-10
excluding O 0 3.267485482183474e-08
BRCA1 O 0 1.5677169074024278e-07
mutation O 0 8.06777644690726e-10
data O 0 6.439953903480955e-09
. O 0 1.6240943034873112e-09

Among O 0 1.3240265772651583e-08
those O 0 3.029949346977645e-10
families O 0 1.0854235912849397e-11
with O 0 1.1778555908392718e-09
disease O 0 0.014445911161601543
due O 0 7.096255139060759e-09
to O 0 2.1997675903051572e-10
BRCA1 O 0 6.2086540353334385e-09
that O 0 1.106472227209443e-12
were O 0 9.908322773366507e-11
tested O 0 8.047378041720066e-11
by O 0 1.7747903841014434e-12
one O 0 1.1877962806036702e-12
of O 0 1.940032336167352e-11
the O 0 4.565637364700725e-12
standard O 0 9.93297371437718e-12
screening O 0 5.053863577630935e-12
methods O 0 1.7793062162541062e-11
, O 0 1.4944892112039865e-12
mutations O 0 9.630177731645428e-12
were O 0 1.9941426981917587e-11
detected O 0 4.6115811169755716e-10
in O 0 1.0468144580333405e-11
the O 0 4.070402348510527e-11
coding O 0 2.151812061867986e-10
sequence O 0 2.3797715534290553e-11
or O 0 5.540640429096966e-12
splice O 0 1.8951402669387107e-09
sites O 0 1.0024947538767037e-10
in O 0 4.789741086391741e-12
an O 0 2.1312022513517853e-13
estimated O 0 6.776474455356951e-13
63 O 0 2.2528183485359676e-10
% O 0 4.831570798828622e-13
( O 0 2.0285372773903854e-12
95 O 0 1.3999765791083973e-09
% O 0 1.1905117516808339e-11
CI O 0 9.77304716798244e-06
51 O 0 1.0408233386272059e-08
% O 0 8.484025981747578e-12
- O 0 1.2574131735831884e-09
77 O 0 3.0637439252245713e-09
% O 0 4.57470302958618e-12
) O 0 9.542122300643108e-12
. O 0 3.273545323700944e-10

The O 0 5.1906816622704355e-09
estimated O 0 2.0358952371180017e-11
sensitivity O 0 9.75243913403645e-11
was O 0 6.158486914875638e-11
identical O 0 4.77169831425428e-11
for O 0 1.0593710289422478e-13
direct O 0 3.6973709142094913e-13
sequencing O 0 1.2002060803539827e-11
and O 0 2.5988677355981427e-12
other O 0 4.468781247823905e-12
techniques O 0 1.716230535464547e-08
. O 0 1.1856681192412566e-09

The O 0 1.2156631612469937e-07
penetrance O 0 2.705141696424107e-06
of O 0 1.2461728147172835e-06
BRCA2 O 0 2.4923193109316344e-07
was O 0 3.511534840683339e-09
estimated O 0 6.221340283218968e-12
by O 0 1.8683199518726434e-12
maximizing O 0 3.9888772285223695e-09
the O 0 1.343409827825326e-09
LOD O 0 0.04473327845335007
score O 0 5.2426230467972346e-08
in O 0 5.017064541590344e-10
BRCA2 O 0 3.61394931758241e-08
- O 0 7.450640993056368e-09
mutation O 0 2.8531451506941252e-11
families O 0 2.690743949266411e-13
, O 0 2.9828006384291506e-12
over O 0 1.0606721230488336e-11
all O 0 3.977020102130524e-12
possible O 0 1.1448018921722536e-10
penetrance O 0 1.0456809462766614e-07
functions O 0 7.399740820090983e-09
. O 0 3.4264757697854975e-09

The O 0 1.4293712879975828e-08
estimated O 0 7.726742162761369e-11
cumulative O 0 7.550466918360144e-09
risk O 0 3.0753535273930765e-09
of O 0 5.75461683638423e-07
breast B-Disease 1 0.9703162312507629
cancer I-Disease 0 4.137713858654024e-06
reached O 0 9.122953947837686e-09
28 O 0 2.322638747997985e-09
% O 0 1.512918479731895e-13
( O 0 2.311567549786314e-13
95 O 0 2.363425011253639e-10
% O 0 1.530931306205352e-12
CI O 0 8.755490057410498e-07
9 O 0 9.412655543883375e-09
% O 0 9.830493623991243e-13
- O 0 1.188076165226093e-10
44 O 0 3.295181141838022e-11
% O 0 1.0699876043778617e-13
) O 0 1.3536432683038026e-14
by O 0 1.0897226588972575e-13
age O 0 8.359442478511614e-12
50 O 0 4.9721429230820124e-12
years O 0 7.946594229001069e-13
and O 0 1.1205489661159085e-12
84 O 0 1.3372608576034395e-10
% O 0 1.458076552291604e-13
( O 0 2.416272748290843e-13
95 O 0 1.8014625902118553e-10
% O 0 3.366894220022121e-12
CI O 0 1.2838165730499895e-06
43 O 0 1.5573456968454025e-09
% O 0 6.72625312652525e-13
- O 0 7.368776422378431e-11
95 O 0 1.9660378880459461e-10
% O 0 2.437226310526841e-13
) O 0 2.093219328880465e-14
by O 0 2.652106507496088e-13
age O 0 5.2025508900932493e-11
70 O 0 2.5629939837124027e-10
years O 0 7.79730169320203e-11
. O 0 1.4186521402059782e-10

The O 0 8.819171739560261e-07
corresponding O 1 0.9615079760551453
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 5.676643581864482e-07
were O 0 7.532602097626295e-09
0 O 0 1.3412598143247578e-08
. O 0 3.496788414381058e-10

4 O 0 3.1260145760825253e-07
% O 0 7.507407889795203e-11
( O 0 1.1069414482256512e-11
95 O 0 1.0806755490477826e-09
% O 0 4.993479154474789e-12
CI O 0 7.005221505096415e-07
0 O 0 3.6370417788589293e-10
% O 0 1.1798684858982389e-12
- O 0 6.171162886259296e-11
1 O 0 2.808504297180381e-11
% O 0 5.494708149849509e-14
) O 0 1.1551326267852848e-14
by O 0 1.8257637968751433e-13
age O 0 4.8478287356656935e-12
50 O 0 4.402017379084855e-12
years O 0 1.865877027537599e-12
and O 0 5.8548738773867015e-12
27 O 0 3.49434176039054e-10
% O 0 2.8400247648399657e-13
( O 0 4.231753565186319e-13
95 O 0 2.2952890976757345e-10
% O 0 1.786657735820818e-12
CI O 0 3.9952453789737774e-07
0 O 0 3.781074342512625e-10
% O 0 7.035164551610906e-13
- O 0 8.68032173917399e-11
47 O 0 7.26328441835733e-11
% O 0 1.261470311889057e-13
) O 0 2.5532691805556403e-14
by O 0 6.279395406427746e-13
age O 0 6.521491680011593e-11
70 O 0 4.013250010093117e-10
years O 0 1.310020841804871e-10
. O 0 7.14818537694839e-10

The O 0 5.307791539621576e-08
lifetime O 0 1.7391000994848582e-07
risk O 0 8.50530028628782e-08
of O 0 0.0016270470805466175
breast B-Disease 1 1.0
cancer I-Disease 1 0.999966025352478
appears O 0 3.0281122054276466e-10
similar O 0 5.076860459807264e-11
to O 0 1.4316173246875508e-11
the O 0 2.832034329269817e-10
risk O 0 1.368338636842381e-10
in O 0 1.9389492789123608e-10
BRCA1 O 0 2.6780413442395457e-09
carriers O 0 5.892609317159625e-11
, O 0 1.1618738089691494e-11
but O 0 4.491740096188024e-13
there O 0 8.917503237573787e-13
was O 0 3.172476517598888e-11
some O 0 3.8897989104898223e-13
suggestion O 0 8.422455788359429e-11
of O 0 1.1654572862340729e-09
a O 0 3.0174515663894397e-10
lower O 0 2.5033765282955756e-08
risk O 0 4.5632303491416337e-10
in O 0 8.287849850852069e-10
BRCA2 O 0 1.3582457825123129e-08
carriers O 0 2.5057289576579933e-10
< O 0 1.8074209906515648e-09
50 O 0 2.846319846483425e-10
years O 0 6.412662068022712e-11
of O 0 7.635095888858245e-10
age O 0 1.458691500921816e-09
. O 0 9.107284926201942e-10

Eye B-Disease 1 0.9999996423721313
movement I-Disease 0 8.966642781160772e-05
abnormalities I-Disease 1 0.967564046382904
correlate O 0 4.223893768084963e-08
with O 0 1.8431561832343846e-10
genotype O 0 4.9503412924423174e-08
in O 0 7.746490671145523e-10
autosomal O 0 0.02339882031083107
dominant O 1 0.6345358490943909
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 2.251486421300797e-06

We O 0 9.35689747905144e-09
compared O 0 2.154910250240505e-09
horizontal O 0 2.2606661786994664e-07
eye O 0 0.00012306334974709898
movements O 0 1.1521202623043791e-06
( O 0 4.061093239471347e-09
visually O 0 9.843722281743794e-09
guided O 0 6.021057856742118e-07
saccades O 0 4.5749006858386565e-06
, O 0 1.3288227185270785e-09
antisaccades O 0 9.943073564500082e-07
, O 0 1.1314645748106145e-10
and O 0 1.0935659322530711e-10
smooth O 0 8.117478356162167e-10
pursuit O 0 3.6193972263731666e-09
) O 0 1.5787480914589147e-12
in O 0 5.177236677561536e-12
control O 0 3.9046491040473086e-10
subjects O 0 4.743291981412767e-09
( O 0 6.54544266009971e-11
n O 0 2.9533994694297405e-10
= O 0 3.287793648443227e-10
14 O 0 2.334791249225532e-09
) O 0 3.8331490759269116e-12
and O 0 1.519907984193214e-11
patients O 0 8.102867335435526e-12
with O 0 1.0866887901681e-12
three O 0 1.0821636989288841e-11
forms O 0 2.9272557711124136e-09
of O 0 1.6574520600443066e-07
autosomal O 0 0.0625666081905365
dominant O 0 0.0014319460606202483
cerebellar B-Disease 1 0.9999978542327881
ataxias I-Disease 1 0.7657188177108765
type I-Disease 1 0.9504908919334412
I I-Disease 1 0.9999979734420776
spinocerebellar B-Disease 1 0.9999324083328247
ataxias I-Disease 0 0.00022679757967125624
1 I-Disease 0 2.214145524703781e-07
and I-Disease 0 2.3243671432027213e-09
2 I-Disease 0 1.5112467721678513e-08
( O 0 2.2856604109389167e-10
SCA1 B-Disease 1 0.9728154540061951
, O 0 4.321764057735322e-10
n O 0 1.2203495158846778e-10
= O 0 9.09472983035009e-11
11 O 0 2.8949667663091816e-10
; O 0 1.5714216386464308e-11
SCA2 B-Disease 0 8.623404573881999e-05
, O 0 1.0759835383788996e-10
n O 0 3.493587016900612e-11
= O 0 4.208046411324773e-11
10 O 0 3.060949063660168e-11
) O 0 1.231783663784014e-12
and O 0 1.1001140276523103e-10
SCA3 B-Disease 1 1.0
/ O 0 1.4094424614086165e-06
Machado B-Disease 0 3.54886310560687e-07
- I-Disease 0 1.8361514264597645e-07
Joseph I-Disease 0 0.000531700614374131
disease I-Disease 0 0.1344677060842514
( O 0 9.100998843436514e-10
MJD B-Disease 1 1.0
) O 0 3.649167357178129e-10
( O 0 2.4234196246974982e-11
n O 0 2.5625440658316734e-10
= O 0 9.350327179191709e-10
16 O 0 7.325760886800481e-09
) O 0 7.240626848092901e-11
. O 0 4.2050476989352603e-10

In O 0 4.201051808649936e-07
SCA1 B-Disease 1 0.9993667006492615
, O 0 5.670978686644901e-10
saccade O 0 1.6396139557173228e-08
amplitude O 0 3.0123398220283093e-10
was O 0 1.4042253471124866e-10
significantly O 0 1.5571412432038856e-12
increased O 0 4.965007138063582e-12
, O 0 2.49415874238601e-12
resulting O 0 2.6953746526392486e-11
in O 0 9.933793371219579e-11
hypermetria B-Disease 0 2.470392701070523e-06
. O 0 4.182492574500429e-09

The O 0 3.423747614306194e-07
smooth O 0 1.231929900313844e-07
pursuit O 0 9.768761088935207e-08
gain O 0 7.776072230569753e-09
was O 0 4.61589566569387e-09
decreased O 0 2.5067258491162647e-08
. O 0 1.0712721820738125e-09

In O 0 2.7567261895455886e-07
SCA2 B-Disease 1 0.9999003410339355
, O 0 2.1384993775797057e-09
saccade O 0 5.502517197442103e-08
velocity O 0 6.87751988692753e-09
was O 0 3.587280916761415e-09
markedly O 0 3.298359807502038e-09
decreased O 0 5.558304483344045e-09
. O 0 5.827783811085396e-10

The O 0 3.68201718004002e-08
percentage O 0 7.2499211078991266e-09
of O 0 9.543411394474788e-09
errors O 0 8.657497119202162e-07
in O 0 2.3956223671461885e-09
antisaccades O 0 9.171752935799304e-06
was O 0 1.3252688946252533e-09
greatly O 0 8.838462947635684e-12
increased O 0 3.088280716226355e-12
and O 0 5.998750541441611e-12
was O 0 1.7495234427844508e-11
significantly O 0 8.368945727393884e-13
correlated O 0 6.871494345750406e-11
with O 0 4.535389858811856e-12
age O 0 3.1049041115949194e-10
at O 0 1.0136576378272366e-07
disease O 0 0.0012150643160566688
onset O 0 4.198102396912873e-05
. O 0 1.7684979036758364e-09

In O 0 7.654610278962082e-09
addition O 0 4.16777418132952e-10
, O 0 3.659390498955695e-11
a O 0 5.044877710025375e-12
correlation O 0 5.241312592274561e-12
between O 0 2.3797261036739847e-11
smooth O 0 2.036043972308832e-10
pursuit O 0 1.6697080384986407e-09
gain O 0 7.873821039616757e-11
and O 0 8.995576852854903e-12
the O 0 9.114991747494194e-12
number O 0 3.948381985946492e-12
of O 0 3.576450524622743e-10
trinucleotide O 0 5.204749868426006e-06
repeats O 0 3.8901649901390556e-08
was O 0 2.7058094431708923e-08
found O 0 4.8102104521774436e-09
. O 0 2.9273898860537884e-09

In O 0 2.1003620531701017e-06
SCA3 B-Disease 1 1.0
, O 0 1.5136329523102177e-07
gaze B-Disease 0 1.486663859395776e-05
- I-Disease 0 1.264941374756745e-06
evoked I-Disease 0 5.63971866540669e-07
nystagmus I-Disease 0 6.756053335266188e-05
was O 0 6.088974213724896e-09
often O 0 7.923351211247542e-12
present O 0 3.623745400971323e-11
as O 0 4.3683043293718526e-11
was O 0 2.094011408715346e-09
saccade O 0 6.117146966744258e-08
hypometria O 0 9.798325208976166e-07
and O 0 1.0994831711741426e-09
smooth O 0 1.298576179920019e-08
pursuit O 0 4.916316242997709e-08
gain O 0 3.3391309717245576e-09
was O 0 8.137014617659588e-09
markedly O 0 2.073539917546441e-08
decreased O 0 5.040435269165755e-08
. O 0 2.064623805253518e-09

Three O 0 2.9870196982528796e-08
major O 0 1.401885096896649e-08
criteria O 0 7.0559007525616835e-09
, O 0 8.605331724975684e-11
saccade O 0 6.922041162482628e-09
amplitude O 0 1.9527780781292137e-10
, O 0 1.1361567069101408e-11
saccade O 0 1.0492703372833034e-09
velocity O 0 6.492180126826952e-10
, O 0 2.778384987356386e-11
and O 0 8.936850391660922e-12
presence O 0 7.471124413571673e-11
of O 0 4.8159298771111025e-09
gaze B-Disease 0 1.061496391230321e-06
- I-Disease 0 5.194408458919497e-07
evoked I-Disease 0 3.3052580761250283e-07
nystagmus I-Disease 0 3.501876335576526e-06
, O 0 4.243218623689593e-11
permitted O 0 4.838168754517369e-11
the O 0 3.3218996997597117e-11
correct O 0 2.6282614973283103e-10
assignment O 0 2.3097641854707973e-10
of O 0 3.3523903097965047e-10
90 O 0 1.0172044456746576e-10
% O 0 1.7233770291912032e-13
of O 0 1.7987321701551373e-11
the O 0 1.3868124704163876e-10
SCA1 B-Disease 1 0.9819774031639099
, O 0 5.5115311620168583e-11
90 O 0 4.756723140375563e-11
% O 0 7.735991209602278e-14
of O 0 8.582199187423534e-12
the O 0 1.9458393230031845e-11
SCA2 B-Disease 1 0.9951373934745789
, O 0 2.162079716649945e-11
and O 0 6.1734319913020475e-12
93 O 0 3.9406292118293607e-10
% O 0 1.5013454346922417e-13
of O 0 1.209836397730868e-11
the O 0 3.631120751301786e-11
patients O 0 2.135693982774356e-10
with O 0 1.1802686605832946e-09
SCA3 B-Disease 1 1.0
to O 0 2.9507885024315783e-09
their O 0 1.7914786321071574e-09
genetically O 0 4.9062180096370867e-08
confirmed O 0 9.535000566884833e-10
patient O 0 1.339991584359268e-08
group O 0 1.934723076191247e-10
and O 0 2.0285162438682391e-10
, O 0 2.0223109645223225e-11
therefore O 0 5.4564710388893545e-11
, O 0 2.4261946618420183e-11
may O 0 5.5659581110756307e-11
help O 0 5.953785381374033e-11
orient O 0 6.838815238552343e-07
diagnoses O 0 1.385195446346188e-06
of O 0 1.0133353498531505e-06
SCA1 B-Disease 1 1.0
, O 0 1.8868888673750916e-08
SCA2 B-Disease 1 1.0
, O 0 2.8207254310075314e-09
and O 0 4.371934370084318e-09
SCA3 B-Disease 1 1.0
at O 0 1.8252427125275972e-08
early O 0 1.0155764007535595e-09
clinical O 0 1.1093590046584723e-08
stages O 0 2.8980082333873725e-08
of O 0 1.5381726115037964e-08
the O 0 2.3726239817278838e-07
diseases O 1 1.0
. O 0 1.3118642838705341e-09
. O 0 4.105368489604189e-09

Genetic O 0 9.591846605871979e-08
basis O 0 1.6867754970562032e-09
and O 0 2.802441438631842e-11
molecular O 0 6.085189241389344e-09
mechanism O 0 2.5712910911579456e-08
for O 0 8.703473497462255e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 4.679368885263102e-06

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.9999998807907104
causes O 0 7.870946774346521e-07
more O 0 2.4174273693944315e-11
than O 0 7.545704512612605e-12
300 O 0 7.414712732689566e-10
, O 0 2.3966802500940965e-11
000 O 0 8.613728064155168e-10
sudden O 0 1.7770152016538532e-09
deaths O 0 3.1909752618020093e-10
each O 0 1.1015889806245682e-12
year O 0 5.215981726397478e-12
in O 0 3.1866918825951274e-11
the O 0 7.931947876294032e-10
USA O 0 0.0007998858345672488
alone O 0 2.3234540957872696e-09
. O 0 4.292338151579145e-10

In O 0 1.7504605764884218e-08
approximately O 0 8.662479622500996e-10
5 O 0 2.099926899035154e-09
- O 0 2.7898205967602507e-09
12 O 0 4.4602788129566306e-10
% O 0 1.297325013258424e-13
of O 0 2.154767250045486e-12
these O 0 2.527358476580449e-13
cases O 0 5.506715743119894e-12
, O 0 1.1577011051200348e-12
there O 0 3.7073984290522666e-13
are O 0 4.719287027138419e-13
no O 0 2.02184033404329e-11
demonstrable O 0 1.4844551515125204e-05
cardiac O 1 0.9999949932098389
or O 0 6.932402385473324e-08
non O 1 1.0
- O 1 0.9999995231628418
cardiac O 1 1.0
causes O 0 6.825850107361475e-08
to O 0 9.621622075461911e-12
account O 0 5.3306387082230344e-12
for O 0 5.115495266966308e-12
the O 0 7.463775431038044e-11
episode O 0 2.8401050955473295e-10
, O 0 4.761883704192116e-13
which O 0 9.844335497602094e-14
is O 0 4.345378630489158e-14
therefore O 0 5.347050927029251e-13
classified O 0 6.308997213544387e-10
as O 0 2.8622506587083762e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 3.3428336791985203e-06
IVF B-Disease 1 1.0
) O 0 9.779420828692764e-09
. O 0 1.0063003763605138e-08

A O 0 2.929055654021795e-06
distinct O 0 8.213732805018026e-09
group O 0 1.1774962116462007e-09
of O 0 3.717676122505509e-07
IVF B-Disease 1 1.0
patients O 0 2.309475810591266e-08
has O 0 5.094703955585422e-13
been O 0 5.972101610983438e-13
found O 0 4.711219478772954e-13
to O 0 1.5936260828759014e-13
present O 0 1.0123455893018551e-11
with O 0 1.4251278109000953e-11
a O 0 4.606376946547641e-10
characteristic O 0 1.3359590411710087e-06
electrocardiographic O 0 0.011425504460930824
pattern O 0 2.9892025850131176e-06
. O 0 1.2079336642045746e-08

Because O 0 5.246881595866171e-09
of O 0 1.302237073730339e-08
the O 0 1.5440086709173073e-10
small O 0 2.811439666142168e-12
size O 0 1.8184254449438164e-11
of O 0 8.500524173449264e-10
most O 0 4.434165708222526e-12
pedigrees O 0 1.1158350909923342e-09
and O 0 4.298644426525833e-11
the O 0 1.3783790775434568e-10
high O 0 1.10293250088489e-08
incidence O 0 7.3963541957766665e-09
of O 0 7.394742596034121e-10
sudden B-Disease 0 7.17136350303349e-09
death I-Disease 0 8.49425987325958e-08
, O 0 2.3053354364366285e-11
however O 0 4.090714746107782e-12
, O 0 9.565332467070808e-13
molecular O 0 1.8665055612210324e-10
genetic O 0 5.7574580519803575e-11
studies O 0 2.184830094620338e-11
of O 0 1.7351985404090442e-09
IVF B-Disease 1 1.0
have O 0 1.0266455220675486e-11
not O 0 1.7990056059430382e-12
yet O 0 4.584838064758401e-11
been O 0 6.77579659047467e-11
done O 0 5.77630332454504e-10
. O 0 9.043739646052984e-10

Because O 0 6.747748102498008e-07
IVF B-Disease 1 1.0
causes O 0 0.012296703644096851
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 1.0
, O 0 3.129901060550111e-10
we O 0 2.9852596089563477e-12
investigated O 0 4.845929213459499e-10
whether O 0 6.477223618572836e-11
malfunction O 0 0.00011751723650377244
of O 0 8.447256227839262e-09
ion O 0 4.695171806901044e-09
channels O 0 7.893192210950417e-10
could O 0 1.7235310401098047e-10
cause O 0 2.1125865501403496e-08
the O 0 3.246548585522646e-09
disorder O 0 1.1363648155793271e-07
by O 0 1.3168410589389778e-12
studying O 0 7.98125038281583e-11
mutations O 0 7.596043585800238e-12
in O 0 1.2052069411905286e-11
the O 0 2.3477583765973975e-10
cardiac O 0 4.1596547362132696e-07
sodium O 0 3.325402397891253e-09
channel O 0 2.860145720262608e-08
gene O 0 1.2956424200183392e-07
SCN5A O 1 0.9999897480010986
. O 0 6.191130808019807e-08

We O 0 4.395622088537721e-09
have O 0 1.4425704554510421e-11
now O 0 1.9273006801601156e-11
identified O 0 1.9164064432586336e-11
a O 0 3.854015023785351e-11
missense O 0 2.1414882311887595e-08
mutation O 0 1.2140168870189427e-09
, O 0 1.1508509423219238e-10
a O 0 1.1964629287319895e-10
splice O 0 2.0827603464113054e-07
- O 0 5.536880109957565e-08
donor O 0 2.023168577114376e-10
mutation O 0 3.002817161590343e-10
, O 0 3.8675056213133274e-11
and O 0 9.024453406780708e-11
a O 0 5.875684661038605e-11
frameshift O 0 1.1170622649103734e-08
mutation O 0 2.7112865771949934e-11
in O 0 8.278867175137705e-12
the O 0 5.247697068555546e-11
coding O 0 3.668465309303315e-09
region O 0 1.6223913323898387e-09
of O 0 1.7382502548457524e-08
SCN5A O 1 0.9999988079071045
in O 0 1.4229617484318169e-09
three O 0 1.2016367900713476e-09
IVF B-Disease 1 1.0
families O 0 2.5374136125577706e-10
. O 0 2.521344910633161e-09

We O 0 3.0713676046900673e-09
show O 0 3.08810144122873e-10
that O 0 2.659542779146623e-13
sodium O 0 2.2262983557369553e-12
channels O 0 3.426862743224901e-12
with O 0 4.155678351349529e-13
the O 0 2.221323992801505e-11
missense O 0 1.0451900678276616e-08
mutation O 0 2.9458496753065333e-10
recover O 0 6.808618557840873e-09
from O 0 1.2382351810558134e-09
inactivation O 0 1.0297735997255586e-07
more O 0 3.958455958852358e-12
rapidly O 0 5.390494994816919e-11
than O 0 5.523122649335466e-13
normal O 0 5.1723143129622784e-11
and O 0 4.68205422349266e-12
that O 0 1.9641383517451233e-13
the O 0 7.514799893471036e-11
frameshift O 0 2.061162440725184e-08
mutation O 0 2.052474717961772e-10
causes O 0 3.3809521848837676e-10
the O 0 1.7298346088878702e-10
sodium O 0 5.078836309846402e-11
channel O 0 8.045735605533011e-11
to O 0 4.146456615561345e-12
be O 0 9.959058751285443e-12
non O 0 1.5323927016197558e-07
- O 0 1.1385854037371246e-07
functional O 0 1.6306350048012064e-08
. O 0 7.055641071396224e-10

Our O 0 4.117801211123151e-07
results O 0 6.781944783540439e-09
indicate O 0 3.450688068618035e-10
that O 0 1.211308831017277e-12
mutations O 0 1.726234433174767e-11
in O 0 5.909008005122729e-11
cardiac O 0 2.600852440082235e-07
ion O 0 6.809839359078751e-09
- O 0 3.457639934367762e-07
channel O 0 4.0221700969844676e-10
genes O 0 1.113087573501037e-11
contribute O 0 1.9870001911198587e-12
to O 0 9.60823001022737e-13
the O 0 1.98309008103692e-11
risk O 0 4.486419222238247e-11
of O 0 4.2543718548060383e-10
developing O 0 1.3190884828873095e-08
IVF B-Disease 1 1.0
. O 0 8.498902692721799e-10
. O 0 7.230142595737732e-10

Molecular O 0 1.0173459941142937e-06
heterogeneity O 0 3.387281992672797e-07
in O 0 1.4320292507363774e-08
mucopolysaccharidosis B-Disease 0 0.00031621105154044926
IVA I-Disease 1 1.0
in O 0 8.983241928106622e-10
Australia O 0 5.679985370932172e-10
and O 0 5.915150314006468e-12
Northern O 0 1.8612378305249422e-09
Ireland O 0 8.976737575494553e-09
: O 0 4.067158762555145e-11
nine O 0 4.458161062537158e-10
novel O 0 1.1991267701016994e-10
mutations O 0 3.66996100176209e-10
including O 0 2.1220436519087116e-09
T312S O 0 6.62430829834193e-06
, O 0 3.974097162462442e-10
a O 0 8.994004152551582e-11
common O 0 5.787584855809769e-10
allele O 0 9.833203695741588e-11
that O 0 4.148102000778309e-12
confers O 0 2.325502457267703e-09
a O 0 1.634720625531827e-08
mild O 0 0.000132762870634906
phenotype O 0 4.0435008941130945e-07
. O 0 3.6509117506966504e-08

Mucopolysaccharidosis B-Disease 1 0.9999933242797852
IVA I-Disease 1 1.0
( O 0 0.00010495210881344974
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 5.7588587232260124e-09
is O 0 6.117135444017041e-12
an O 0 1.3507155463554632e-11
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 0.00028457760345190763
by O 0 7.970955562264237e-10
a O 0 2.9124153755333282e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.553131134812702e-08
N O 0 2.156366463168524e-06
- O 0 3.8715822370249953e-07
acetylgalactosamine O 0 8.136477845255286e-05
- O 0 2.2595352220378118e-06
6 O 0 1.4968393315939466e-06
- O 0 2.9561144287981733e-07
sulfate O 0 4.672028097729708e-08
sulfatase O 0 3.9977057895157486e-05
( O 0 2.6972765354571493e-08
GALNS O 1 1.0
) O 0 3.1787548149253553e-09
. O 0 8.662876527232299e-10

Previous O 0 1.5725184709936002e-08
studies O 0 7.302153326449456e-10
of O 0 1.0803828942584914e-09
patients O 0 7.680531904918908e-11
from O 0 1.08064612813763e-10
a O 0 1.2307892205409843e-10
British O 0 3.1597274130490405e-08
- O 0 2.170396697920296e-07
Irish O 0 1.0674300554569527e-08
population O 0 1.2390736765614807e-13
showed O 0 2.4621357470194782e-12
that O 0 3.1003533616270895e-14
the O 0 1.9237713852482408e-11
I113F O 0 4.427667121831291e-08
mutation O 0 7.635354154489349e-11
is O 0 2.049725271241129e-13
the O 0 1.024438563493324e-12
most O 0 4.1112450358156416e-13
common O 0 1.1508174621588374e-11
single O 0 6.811806674278387e-11
mutation O 0 7.303974786099232e-11
among O 0 2.4203722359672497e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 4.899477062281221e-05
and O 0 8.955292507550894e-09
produces O 0 5.380056578019321e-08
a O 0 7.934342960425056e-09
severe O 1 0.9538225531578064
clinical O 0 0.2899705767631531
phenotype O 0 5.421187552201445e-07
. O 0 1.1814291767109353e-08

We O 0 2.3959925155025985e-09
studied O 0 1.216100997680769e-08
mutations O 0 8.086628588976907e-11
in O 0 4.836009717679168e-11
the O 0 3.5647093610258196e-10
GALNS O 1 0.9997078776359558
gene O 0 4.3850190145633405e-10
from O 0 1.2621076406205134e-10
23 O 0 5.706241590353045e-10
additional O 0 2.963613243700536e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 8.839759857437457e-07
( O 0 1.8549142777324334e-10
15 O 0 7.989586214840472e-10
from O 0 1.8614428054508636e-10
Australia O 0 1.64284280623761e-10
, O 0 1.8487171429132365e-12
8 O 0 3.0939129730400694e-11
from O 0 2.52191822112946e-12
Northern O 0 3.0946639695272893e-10
Ireland O 0 2.330937887151663e-09
) O 0 5.386319428674069e-12
, O 0 9.29591690082554e-13
with O 0 2.2136788658654732e-13
various O 0 1.0968790459253697e-10
clinical O 0 2.7374571800464764e-06
phenotypes O 0 1.2684614603131195e-06
( O 0 6.428172216743633e-09
severe O 1 0.9997841715812683
, O 0 8.910648330306969e-10
16 O 0 1.7350894054857235e-09
cases O 0 1.0955090133657475e-11
; O 0 4.104501027252239e-12
intermediate O 0 7.681872915554777e-09
, O 0 1.8387239647532638e-11
4 O 0 1.9769993975238265e-10
cases O 0 1.2428478385340114e-11
; O 0 1.5998405725192733e-11
mild O 0 6.963743430787872e-07
, O 0 1.25473881285032e-10
3 O 0 2.4580666391216255e-09
cases O 0 1.3696625777992466e-10
) O 0 1.7328321069709496e-11
. O 0 2.744849347813272e-10

We O 0 1.1708319647141252e-08
found O 0 3.18267245891235e-10
two O 0 7.973562782259691e-12
common O 0 5.292347116103713e-11
mutations O 0 2.1591043189439496e-11
that O 0 3.0463281636833317e-12
together O 0 1.364387075541984e-11
accounted O 0 1.7494108939253294e-10
for O 0 5.426183807832885e-12
32 O 0 1.3577315660651124e-10
% O 0 3.6054170174555644e-13
of O 0 3.526835073985879e-11
the O 0 5.562753035981416e-11
44 O 0 6.640879512964659e-10
unrelated O 0 1.0294565200297257e-09
alleles O 0 6.6544400198487175e-12
in O 0 1.523530260283401e-11
these O 0 8.05550209870276e-11
patients O 0 4.204905312832352e-09
. O 0 5.146487236373787e-09

One O 0 2.7165397042949735e-08
is O 0 1.035436528185052e-10
the O 0 5.975665517965467e-10
T312S O 0 5.902145403524628e-07
mutation O 0 2.1799955174373054e-09
, O 0 5.831050226001722e-11
a O 0 6.984122481734634e-12
novel O 0 5.484099632746542e-11
mutation O 0 7.1278239387184694e-12
found O 0 1.7654787137430517e-12
exclusively O 0 5.388685678231475e-11
in O 0 8.290945013866846e-11
milder O 0 8.856078466124018e-07
patients O 0 2.4567038181544376e-08
. O 0 5.050749152246681e-09

The O 0 1.171259000898317e-07
other O 0 1.0834576569251908e-09
is O 0 2.0828876817757802e-11
the O 0 9.032374848061409e-11
previously O 0 8.121396888327581e-10
described O 0 2.815891686491767e-10
I113F O 0 1.0401450367680809e-07
that O 0 1.0587176968446244e-11
produces O 0 1.3794291264801473e-09
a O 0 9.885204876880493e-10
severe O 0 0.004934844095259905
phenotype O 0 4.536912854291586e-07
. O 0 1.425168072444194e-08

The O 0 5.272074190543208e-07
I113F O 0 3.960929916502209e-06
and O 0 3.2017313245091827e-09
T312S O 0 2.5303174311375187e-07
mutations O 0 3.3399191745608903e-10
accounted O 0 1.443485664331945e-09
for O 0 2.272895413546472e-11
8 O 0 1.6524790424909952e-09
( O 0 8.426388926896511e-12
18 O 0 1.642880415042569e-10
% O 0 1.935679806545909e-13
) O 0 1.1359844136324057e-13
and O 0 7.810039073796737e-12
6 O 0 3.4321532282888256e-09
( O 0 1.0314464560234882e-11
14 O 0 1.55706267324085e-10
% O 0 1.297735925881796e-13
) O 0 4.638158618026217e-14
of O 0 3.701580014725536e-11
44 O 0 1.045344505401502e-10
unrelated O 0 1.1287212275945535e-09
alleles O 0 3.832858683217033e-11
, O 0 1.4796114333748278e-10
respectively O 0 4.7983070849966225e-09
. O 0 2.689040767833717e-09

The O 0 8.929064421181465e-08
relatively O 0 1.0056154131632411e-08
high O 0 5.192744367832347e-08
residual O 0 6.497061235677393e-07
GALNS O 1 0.9974653720855713
activity O 0 6.959226972469423e-09
seen O 0 1.7429430121396194e-10
when O 0 5.5398376858084575e-12
the O 0 1.254752465124076e-11
T312S O 0 3.969039319429157e-09
mutant O 0 6.315197809136919e-10
cDNA O 0 9.617632246161634e-10
is O 0 9.086454678952638e-12
overexpressed O 0 2.83486354391016e-08
in O 0 1.4647462409644874e-10
mutant O 0 1.453564490994097e-09
cells O 0 3.0184688082357525e-11
provides O 0 1.923117264393537e-12
an O 0 8.472551409370241e-14
explanation O 0 2.9327503967002677e-12
for O 0 7.519843255032743e-12
the O 0 5.270057723549826e-10
mild O 0 1.735045998429996e-06
phenotype O 0 7.919582212245757e-10
in O 0 2.3401747553664087e-11
patients O 0 1.0365425531788652e-11
with O 0 9.444989278531435e-13
this O 0 7.2231881934059494e-12
mutation O 0 1.4164844852615488e-09
. O 0 1.7994579160074409e-09

The O 0 1.0823753004984837e-09
distribution O 0 1.9068571374680765e-11
and O 0 1.2327496879196986e-12
relative O 0 1.9049078720662083e-12
frequencies O 0 4.579061435583398e-11
of O 0 1.628727985814038e-10
the O 0 4.59165552801899e-11
I113F O 0 2.3487011446832184e-08
and O 0 1.6232942767757663e-10
T312S O 0 3.4925662362184084e-08
mutations O 0 1.2623724288118865e-10
in O 0 3.291700939600517e-11
Australia O 0 1.0879756817683273e-10
corresponded O 0 1.5210274012522618e-11
to O 0 2.448433383123172e-12
those O 0 1.820750147873973e-12
observed O 0 2.3305888469105085e-11
in O 0 5.4104342533944916e-12
Northern O 0 1.493667967089607e-09
Ireland O 0 3.0586349009098512e-09
and O 0 3.0950641355387276e-11
are O 0 6.507307713510269e-13
unique O 0 1.7738700048772205e-12
to O 0 9.718855494694756e-13
these O 0 7.492980303065722e-13
two O 0 1.3903043213220334e-12
populations O 0 1.9928793858203786e-12
, O 0 6.042775329596906e-13
suggesting O 0 4.682849594206395e-12
that O 0 6.744209140804869e-14
both O 0 5.440173918985769e-12
mutations O 0 6.314135325702352e-11
were O 0 7.784552169542991e-11
probably O 0 3.1049027932050777e-11
introduced O 0 2.087079294110783e-11
to O 0 5.442996747762052e-12
Australia O 0 4.0329069944666784e-11
by O 0 1.951889821646957e-12
Irish O 0 2.2670688937243e-10
migrants O 0 1.9618020315886886e-13
during O 0 3.6226241190845387e-12
the O 0 1.8334071240355687e-12
19th O 0 3.314662544440239e-09
century O 0 1.1383081144344942e-08
. O 0 5.723245211086692e-10

Haplotype O 0 5.145999466549256e-07
analysis O 0 4.961701272065966e-09
using O 0 1.2851024688842472e-09
6 O 0 3.182736207918424e-08
RFLPs O 0 8.988765785034047e-07
provides O 0 1.0581282378074874e-11
additional O 0 2.7248888909148228e-12
data O 0 3.920744978680446e-11
that O 0 1.1285467189665194e-13
the O 0 6.031931031047488e-12
I113F O 0 6.026593002417258e-09
mutation O 0 1.2857042687441922e-11
originated O 0 3.856735764085073e-11
from O 0 7.307803667755408e-12
a O 0 9.823263730224241e-12
common O 0 2.3049363806482148e-10
ancestor O 0 8.347632807215177e-09
. O 0 1.8621467701152028e-09

The O 0 9.178057069902934e-08
other O 0 7.60534413224434e-10
9 O 0 1.5178244439084665e-08
novel O 0 1.617397465958348e-10
mutations O 0 2.0305436151946132e-11
identified O 0 1.7220449025079354e-11
in O 0 8.433881197589255e-12
these O 0 7.272873275843139e-12
23 O 0 5.90994941873646e-09
patients O 0 4.239675624462258e-11
were O 0 3.000788506568597e-11
each O 0 4.919662225343069e-13
limited O 0 1.2767917799416661e-11
to O 0 1.7438731014784992e-11
a O 0 1.3916535979152656e-10
single O 0 1.3924135178200459e-09
family O 0 3.7096109517520404e-10
. O 0 2.2097854657232574e-09

These O 0 4.106400219860973e-10
data O 0 2.143230870554902e-10
provide O 0 6.084738615741436e-12
further O 0 2.0054780319050947e-12
evidence O 0 1.4097340482466247e-11
for O 0 8.107409058336068e-13
extensive O 0 2.0076691698012183e-10
allelic O 0 1.613972422376264e-08
heterogeneity O 0 2.3256633951973527e-08
in O 0 6.736435409493424e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 6.8466707858760856e-09
British O 0 5.257824042814718e-08
- O 0 1.3361042192627792e-06
Irish O 0 9.516330834458131e-08
patients O 0 5.747264816835518e-11
and O 0 1.282857283943506e-12
provide O 0 8.534692592411519e-13
evidence O 0 8.24939561105964e-11
for O 0 1.0687703977038665e-12
their O 0 2.5294731587077735e-11
transmission O 0 1.9363928238647077e-09
to O 0 4.245920455503427e-12
Australia O 0 2.076643891568697e-11
by O 0 2.2451636903786376e-12
British O 0 1.6490470100549715e-09
- O 0 1.1951230227680298e-08
Irish O 0 2.6551993936863028e-09
migrants O 0 3.685488112609159e-12
. O 0 3.796492200475177e-12
. O 0 1.01605251989767e-10

Identification O 0 4.849128458772611e-07
of O 0 1.7259382900647324e-07
constitutional O 0 3.4797369607986184e-07
WT1 O 1 0.999998927116394
mutations O 0 2.1977399455863633e-08
, O 0 1.1724599069395936e-10
in O 0 4.1145833268307896e-11
patients O 0 1.9502023607120833e-10
with O 0 7.387548905946062e-11
isolated O 0 5.261382830212824e-05
diffuse B-Disease 1 0.9999994039535522
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 4.837931166790099e-10
and O 0 2.184846921438055e-11
analysis O 0 3.240216775446392e-11
of O 0 1.4724220731565651e-09
genotype O 0 1.3057655223747133e-07
/ O 0 1.0922208559804858e-07
phenotype O 0 1.4348164323330082e-10
correlations O 0 1.5299900235632435e-10
by O 0 1.4766835757656915e-12
use O 0 5.534295591247407e-11
of O 0 1.2343208677378925e-09
a O 0 1.1914369490995114e-10
computerized O 0 2.5377125894010533e-06
mutation O 0 1.8589884076547492e-09
database O 0 2.829238843204962e-09
. O 0 2.7737863117494044e-09

Constitutional O 0 4.56650866453856e-07
mutations O 0 1.793927673077178e-08
of O 0 4.9525418432949664e-08
the O 0 4.4014778488588036e-09
WT1 O 0 0.003995516337454319
gene O 0 9.184177862664455e-10
, O 0 4.62061257311408e-11
encoding O 0 8.624902181342264e-11
a O 0 7.601297924431094e-10
zinc O 0 1.0711153208831092e-06
- O 0 7.768009027131484e-07
finger O 0 5.995422043270082e-07
transcription O 0 5.845019135364282e-09
factor O 0 8.445588672856275e-11
involved O 0 2.3857570433105657e-11
in O 0 5.11173547934618e-10
renal O 1 0.9625072479248047
and O 0 3.2977009567503046e-08
gonadal O 1 0.9944337010383606
development O 0 3.2371762159755235e-08
, O 0 7.019972103616823e-11
are O 0 3.923067112051454e-13
found O 0 4.3716111459979334e-12
in O 0 3.776169481273239e-12
most O 0 1.906921669181383e-12
patients O 0 3.078578711401825e-11
with O 0 1.5580726986375026e-10
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.62032482775976e-07
DDS B-Disease 1 1.0
) O 0 2.7914919265015214e-09
, O 0 1.0772340658382618e-10
or O 0 2.373083729523273e-09
diffuse B-Disease 1 0.9999673366546631
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.4539347148456727e-07
DMS B-Disease 1 1.0
) O 0 2.3007767913085786e-10
associated O 0 1.5179567602885413e-09
with O 0 4.726554703182728e-10
pseudohermaphroditism B-Disease 1 1.0
and O 0 8.036021768020873e-07
/ O 0 7.284865660039941e-06
or O 0 3.289107652904022e-08
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9412282109260559
( O 0 1.3391080244673503e-07
WT B-Disease 1 1.0
) O 0 1.4408890747219516e-09
. O 0 1.77401826562118e-09

Most O 0 1.253343295815057e-08
mutations O 0 5.488353771454513e-09
in O 0 1.670753668747693e-08
DDS B-Disease 1 1.0
patients O 0 7.443256322403613e-07
lie O 0 3.599314766233874e-07
in O 0 2.284868516611027e-09
exon O 0 5.531180846674033e-08
8 O 0 3.7038457634253064e-08
or O 0 7.264008283769385e-10
exon O 0 2.493873552111836e-08
9 O 0 3.773441292764801e-08
, O 0 8.717586374995534e-11
encoding O 0 6.637309035717465e-10
zinc O 0 6.394649858521007e-07
finger O 0 2.6471411729289684e-06
2 O 0 5.732297481131354e-08
or O 0 1.0159101115903013e-08
zinc O 0 3.290028871560935e-06
finger O 0 2.2561785044672433e-06
3 O 0 7.805345703104649e-09
, O 0 8.05881663484831e-12
respectively O 0 8.436717297000129e-11
, O 0 2.4179332581281132e-12
with O 0 1.7984841046980726e-12
a O 0 1.0982586368113445e-10
hot O 0 1.2567601288537844e-06
spot O 0 3.8739756291761296e-07
( O 0 5.562785301838069e-11
R394W O 0 2.3494719059158342e-08
) O 0 9.639182681209224e-12
in O 0 5.7939104902704486e-11
exon O 0 1.521046328889497e-07
9 O 0 4.131974833398999e-07
. O 0 7.315009931119221e-09

We O 0 4.7514774337287236e-09
analyzed O 0 2.1508037573170213e-09
a O 0 5.112990933420214e-11
series O 0 2.008760796590181e-10
of O 0 7.249917333140843e-10
24 O 0 2.2060711035720715e-09
patients O 0 7.784225347640117e-11
, O 0 1.6859118268097717e-11
10 O 0 2.710047186660347e-10
with O 0 9.814016960207894e-11
isolated B-Disease 0 8.288849130622111e-06
DMS I-Disease 1 1.0
( O 0 1.410175087812604e-07
IDMS B-Disease 1 1.0
) O 0 1.3035136303685135e-09
, O 0 1.0703524871980008e-10
10 O 0 2.503316720581239e-10
with O 0 2.5794116842448034e-11
DDS B-Disease 1 1.0
, O 0 2.8900140058851775e-09
and O 0 4.875541081972301e-10
4 O 0 7.299205240229867e-09
with O 0 2.7072882824441535e-10
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 0 3.856208877550671e-06
/ O 0 0.002059870632365346
or O 0 4.0045592868409585e-06
WT B-Disease 1 1.0
. O 0 9.092487829320817e-08

We O 0 2.5468080977475438e-08
report O 0 1.7661829332382695e-08
WT1 O 0 0.00024600618053227663
heterozygous O 0 6.381092987339798e-09
mutations O 0 8.265811368701748e-10
in O 0 5.139745296034448e-10
16 O 0 7.849432215323304e-09
patients O 0 9.838532072370398e-11
, O 0 2.0953598231510107e-11
4 O 0 1.1934139232394614e-09
of O 0 8.920034155757151e-10
whom O 0 1.0954050166933627e-10
presented O 0 5.1077353901973765e-08
with O 0 6.815728426090573e-08
IDMS B-Disease 1 1.0
. O 0 5.144075885255006e-07

One O 0 9.287870916807606e-09
male O 0 1.6463599372684712e-09
and O 0 1.6779407030487192e-10
two O 0 1.3293441347705937e-10
female O 0 3.809205395555182e-09
IDMS B-Disease 1 1.0
patients O 0 7.533869705866891e-08
with O 0 2.6209551862166336e-08
WT1 O 1 1.0
mutations O 0 4.570587861962849e-06
underwent O 0 0.0016813770635053515
normal O 0 2.1021733118686825e-05
puberty O 0 0.00034729184699244797
. O 0 2.214034067193893e-09

Two O 0 2.159799628032033e-08
mutations O 0 2.1405000438790012e-08
associated O 0 2.1742826206150312e-08
with O 0 4.336662584591977e-09
IDMS B-Disease 1 1.0
are O 0 7.337248170147248e-11
different O 0 5.928613936584393e-12
from O 0 5.607323633194383e-11
those O 0 1.1820585309185727e-11
described O 0 4.977585010834673e-10
in O 0 7.61874918708827e-09
DDS B-Disease 1 1.0
patients O 0 2.7938081075262744e-06
. O 0 9.467590267320247e-09

No O 0 1.3048809250904014e-06
WT1 O 1 0.8788465857505798
mutations O 0 9.255402666497048e-09
were O 0 2.717645830596638e-10
detected O 0 2.8487328052051453e-09
in O 0 2.332759159451303e-11
the O 0 8.097340159496369e-11
six O 0 1.6687265458337208e-10
other O 0 4.716297352658216e-10
IDMS B-Disease 1 1.0
patients O 0 6.791811557604888e-08
, O 0 9.842923698322181e-11
suggesting O 0 4.778340501054856e-10
genetic O 0 2.758459682894454e-09
heterogeneity O 0 7.942322355347642e-09
of O 0 8.416445496095548e-08
this O 0 3.6028118266528963e-09
disease O 1 0.732001006603241
. O 0 3.0387130589559774e-09

We O 0 1.1666455357328687e-08
analyzed O 0 6.40365129811471e-08
genotype O 0 3.9780226757102355e-07
/ O 0 1.604612833716601e-07
phenotype O 0 5.108529155251063e-10
correlations O 0 1.237257851727236e-09
, O 0 2.386817653243778e-11
on O 0 5.175037828819562e-11
the O 0 3.1008884696093197e-12
basis O 0 9.998456056148353e-12
of O 0 6.386699502591853e-11
the O 0 8.717616038766973e-12
constitution O 0 5.595589963602876e-12
of O 0 3.210841870160408e-10
a O 0 6.006195540919634e-11
WT1 O 0 2.381717786192894e-05
mutation O 0 6.029656635098135e-11
database O 0 6.503542149260966e-11
of O 0 1.224299550628416e-09
84 O 0 3.074780607903449e-08
germ O 0 0.05133270099759102
- O 0 2.7222638436796842e-06
line O 0 1.3323692371614015e-07
mutations O 0 3.646739021867518e-10
, O 0 7.30171478835473e-12
to O 0 8.897319187829711e-13
compare O 0 7.735398432906493e-11
the O 0 1.2766286291987505e-11
distribution O 0 1.506774566228941e-11
and O 0 2.1811734276372396e-12
type O 0 3.1335448125169307e-10
of O 0 4.4468490001392524e-10
mutations O 0 5.336785874332506e-11
, O 0 1.2568548632407861e-12
according O 0 9.675243462306526e-13
to O 0 1.4031877873174614e-12
the O 0 5.5501839235638784e-11
different O 0 5.006425829456873e-10
symptoms O 0 4.1192786738974974e-05
. O 0 4.87511542246466e-09

This O 0 3.6112240975327836e-10
demonstrated O 0 3.068773457570728e-09
( O 0 1.1626747481452426e-10
1 O 0 7.589013306663617e-10
) O 0 1.6112469431589505e-12
the O 0 1.3397543491278086e-11
association O 0 1.4744673537681052e-10
between O 0 8.629801734327813e-12
mutations O 0 3.1681105655545494e-11
in O 0 2.1103131742084003e-10
exons O 0 2.4789621466680956e-09
8 O 0 2.6484319182173977e-09
and O 0 1.9935884887356536e-10
9 O 0 1.188186082856646e-08
and O 0 2.461621739779929e-10
DMS B-Disease 0 0.1891879141330719
; O 0 3.7953803988521884e-10
( O 0 8.411747687286919e-11
2 O 0 3.215568478154296e-09
) O 0 8.33412939355016e-12
among O 0 1.0395381604133558e-11
patients O 0 6.608780883654575e-11
with O 0 9.107176124345528e-11
DMS B-Disease 1 1.0
, O 0 4.361662697682789e-10
a O 0 1.3825727888938655e-11
higher O 0 5.427345725617094e-11
frequency O 0 2.5214014209851143e-10
of O 0 7.149862368827087e-10
exon O 0 1.8465572182435608e-08
8 O 0 4.916182572145544e-09
mutations O 0 2.059391962516699e-10
among O 0 7.39392019832863e-11
46 O 0 3.77269104845368e-09
, O 0 7.303406768244258e-10
XY O 0 0.00024102797033265233
patients O 0 5.399429237051834e-10
with O 0 3.5521106889202514e-11
female O 0 3.032209761055782e-10
phenotype O 0 1.9112787741359938e-10
than O 0 7.637127041881797e-12
among O 0 1.2278864036652237e-10
46 O 0 9.666445421885328e-09
, O 0 2.2395727494739504e-09
XY O 0 0.005838465876877308
patients O 0 2.213530470029923e-10
with O 0 4.326378665042707e-12
sexual O 0 1.2369881507989788e-10
ambiguity O 0 2.6117655260726735e-10
or O 0 1.16943815742232e-10
male O 0 2.6819796383747985e-11
phenotype O 0 1.3123685298210841e-11
; O 0 6.818940377628646e-12
and O 0 1.3912872243171392e-10
( O 0 6.817409137216401e-11
3 O 0 2.1793469251463193e-09
) O 0 1.1991347585033063e-12
statistically O 0 7.159066308520812e-12
significant O 0 2.2433144751532463e-12
evidence O 0 8.263962431032112e-11
that O 0 2.826228834296174e-13
mutations O 0 8.847030746883533e-12
in O 0 1.230239937699551e-10
exons O 0 3.3087250717045436e-09
8 O 0 4.660340113815664e-09
and O 0 1.735664389990177e-10
9 O 0 3.2702334173961844e-09
preferentially O 0 3.2817726314249285e-10
affect O 0 1.4931410552421198e-09
amino O 0 1.2892319434243404e-09
acids O 0 1.2362830204004638e-10
with O 0 1.8416923801972684e-12
different O 0 2.033643435941923e-12
functions O 0 6.644068628602895e-11
. O 0 4.654241575474671e-11
. O 0 3.3018390799277597e-10

The O 0 2.656797164490854e-07
185delAG O 0 1.1419588190619834e-05
BRCA1 O 0 1.6654426815421175e-07
mutation O 0 1.3744543003735288e-10
originated O 0 4.2876494021903966e-10
before O 0 6.537619751112445e-11
the O 0 2.8254221878798447e-12
dispersion O 0 2.579329527740981e-10
of O 0 7.093568787919224e-11
Jews O 0 3.0975090548057693e-11
in O 0 6.5094834904300125e-12
the O 0 3.707980537198674e-12
diaspora O 0 4.278315982736425e-12
and O 0 7.866611008433555e-12
is O 0 4.849537113028879e-13
not O 0 1.7507467643586988e-13
limited O 0 1.1179899020441475e-11
to O 0 1.1147582162918113e-10
Ashkenazim O 0 8.040537068154663e-06
. O 0 1.377799563329063e-08

The O 0 9.426295832781761e-08
185delAG O 0 1.4093510571910883e-06
mutation O 0 1.5041000667181947e-09
in O 0 5.935363311948549e-10
BRCA1 O 0 2.509352192703318e-08
is O 0 1.45672710005762e-11
detected O 0 7.500770005108848e-10
in O 0 1.0310766129784099e-11
Ashkenazi O 0 1.4675071158265496e-09
Jews O 0 2.221982042804882e-10
both O 0 2.9284370067772514e-11
in O 0 3.782394397688904e-10
familial B-Disease 1 0.9950993657112122
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.993794906951507e-09
in O 0 6.170280258954719e-11
the O 0 2.1282685336299068e-10
general O 0 2.686906530602329e-10
population O 0 1.4968856232658312e-12
. O 0 7.854111805372099e-11

All O 0 2.4741074966527776e-08
tested O 0 6.611311675897014e-08
Ashkenazi O 0 4.6358383798406066e-08
mutation O 0 4.95879393103138e-10
carriers O 0 7.179375843824332e-11
share O 0 3.360185393819215e-11
the O 0 4.542733550438882e-11
same O 0 4.3950815209470306e-11
allelic O 0 1.2356976242244855e-07
pattern O 0 3.605852327837056e-08
at O 0 9.12892517135333e-09
the O 0 1.7301124977109339e-09
BRCA1 O 0 8.097228487713437e-08
locus O 0 2.6124606478106216e-08
. O 0 9.513895449231313e-09

Our O 0 2.601048265660211e-07
previous O 0 2.1311954867542227e-08
study O 0 2.2250015718761063e-10
showed O 0 5.255690674332847e-11
that O 0 2.942906538578281e-14
this O 0 5.231299537978261e-14
Ashkenazi O 0 6.858247303398457e-10
mutation O 0 3.3248539338393e-11
also O 0 2.7589026983104725e-12
occurs O 0 1.4063172284681236e-12
in O 0 5.43618806653906e-13
Iraqi O 0 7.739604790391041e-11
Jews O 0 6.35385771774466e-11
with O 0 4.304878068600582e-12
a O 0 2.1752830439702997e-11
similar O 0 1.790316367378253e-10
allelic O 0 1.9581061678763945e-06
pattern O 0 8.109236091513594e-07
. O 0 1.3818077349014857e-08

We O 0 5.250816226265442e-09
extended O 0 2.7936863933319955e-09
our O 0 1.7937891449992804e-10
analysis O 0 1.0146285721324144e-11
to O 0 1.4258013172896433e-12
other O 0 1.0139804794417895e-11
non O 0 2.8597419543530123e-08
- O 0 1.8006534929781992e-08
Ashkenazi O 0 6.368301885828487e-09
subsets O 0 5.961518390051879e-09
354 O 0 3.4024705275470524e-09
of O 0 2.813266286594285e-10
Moroccan O 0 4.082769677893339e-09
origin O 0 1.6119833246008852e-10
, O 0 1.2109352583167254e-11
200 O 0 3.444518281714437e-11
Yemenites O 0 4.877685100268536e-08
and O 0 1.5611187342834398e-10
150 O 0 1.40228481604332e-10
Iranian O 0 8.043684052161382e-10
Jews O 0 4.828576649629213e-09
. O 0 2.578907754013926e-09

Heteroduplex O 0 3.043127799173817e-05
analysis O 0 1.3015112321212996e-09
complemented O 0 2.827162060015098e-09
by O 0 2.9853619576414303e-12
direct O 0 1.0388107908598787e-11
DNA O 0 2.382203767581359e-09
sequencing O 0 1.163719676178232e-10
of O 0 3.0866939559892614e-10
abnormally O 0 9.2365866066757e-09
migrating O 0 2.3883717226169665e-10
bands O 0 8.247296179320074e-09
were O 0 7.909569527120297e-11
employed O 0 2.32916907982883e-09
. O 0 7.52026663164429e-10

Four O 0 4.699286293430305e-08
of O 0 2.7145816261509026e-08
Moroccan O 0 4.52964101782527e-08
origin O 0 8.999843092993842e-10
( O 0 2.5715618870436607e-11
1 O 0 1.0453823223732783e-10
. O 0 3.341494290466651e-13
1 O 0 7.1152463261558996e-12
% O 0 7.652999599056659e-14
) O 0 3.667070919382946e-14
and O 0 1.354429806157964e-12
none O 0 1.365637464223468e-10
of O 0 6.017803477753603e-10
the O 0 3.380268842612111e-10
Yemenites O 0 2.1835218433352566e-07
or O 0 1.0722610299662705e-10
Iranians O 0 5.2131195193982904e-11
was O 0 2.906668794544487e-10
a O 0 1.3095579308453065e-11
carrier O 0 1.287724649134958e-10
of O 0 2.2938635435565402e-09
the O 0 1.601570320808321e-09
185delAG O 0 1.2351986242720159e-06
mutation O 0 1.2090769274664126e-08
. O 0 3.15972559228328e-09

BRCA1 O 0 4.819668174604885e-05
allelic O 0 1.2164220606791787e-05
patterns O 0 3.046483243451803e-07
were O 0 8.543924456816399e-10
determined O 0 6.627842719097998e-11
for O 0 1.8377695198967814e-12
four O 0 2.971579796465229e-12
of O 0 1.0060206140360961e-11
these O 0 3.65853560554269e-13
individuals O 0 9.749783581392349e-14
and O 0 7.18867630353226e-12
for O 0 1.1436512327434034e-11
12 O 0 3.424958372466591e-10
additional O 0 1.1015727392760244e-11
non O 0 5.6596814346221436e-08
- O 0 7.470879381799023e-08
Ashkenazi O 0 2.3586853359347515e-08
185delAG O 0 6.067621427519043e-08
mutation O 0 1.4819953597644542e-10
carriers O 0 3.498276390789812e-10
who O 0 2.2907800656390975e-10
had O 0 3.4668818216232467e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.2812733391219808e-07

Six O 0 6.015742997078632e-07
non O 0 1.065406650013756e-05
- O 0 5.535950435842096e-07
Ashkenazi O 0 4.9087269360370556e-08
individuals O 0 7.425263529037274e-12
shared O 0 1.963650630987246e-10
the O 0 3.293995076703027e-10
common O 0 4.735479230966178e-10
Ashkenazi O 0 7.994864326121842e-09
haplotype O 0 5.982534467818823e-09
, O 0 1.0235978037398397e-10
four O 0 1.914182701234779e-10
had O 0 4.822561794348701e-11
a O 0 2.610324977003753e-11
closely O 0 8.086042946331418e-11
related O 0 1.0708436803952281e-08
pattern O 0 4.8698023391580136e-08
, O 0 7.955883868371316e-11
and O 0 6.436287613986735e-11
the O 0 4.906502981683047e-10
rest O 0 4.936864250737472e-09
( O 0 1.075460345778545e-10
n O 0 4.1417655416431387e-10
= O 0 1.334374721828624e-09
6 O 0 1.076865441262953e-08
) O 0 5.675636609997481e-12
displayed O 0 1.0629638280690301e-09
a O 0 1.1095547397532712e-10
distinct O 0 1.7539188990056687e-09
BRCA1 O 0 2.3785847247381753e-07
allelic O 0 3.1838585528021213e-06
pattern O 0 1.3696504765903228e-06
. O 0 2.6131683483754387e-08

We O 0 7.0605183921657044e-09
conclude O 0 1.8472899654398134e-08
that O 0 1.2238874844139325e-11
the O 0 3.4410332916401387e-10
185delAG O 0 1.925734750329866e-06
BRCA1 O 0 1.720373887792448e-07
mutation O 0 2.157738571151313e-10
occurs O 0 1.6315565218305572e-11
in O 0 3.1060915558350777e-12
some O 0 1.5258500843037814e-12
non O 0 4.34841815888376e-08
- O 0 1.7883932557083426e-08
Ashkenazi O 0 4.849241452831166e-09
populations O 0 1.017343501108492e-11
at O 0 9.299614550650759e-11
rates O 0 8.263029149802037e-12
comparable O 0 7.129676710126986e-11
with O 0 3.932373524029309e-12
that O 0 3.360594138038242e-12
of O 0 7.397369827799594e-09
Ashkenazim O 0 1.5343348422902636e-05
. O 0 1.852794540013747e-08

The O 0 1.1153504786420854e-08
majority O 0 3.408182763786627e-11
of O 0 1.530369303504031e-10
Jewish O 0 1.4542022030994417e-09
185delAG O 0 2.9326986350497464e-07
mutation O 0 3.325895669981094e-10
carriers O 0 4.352419466502333e-11
have O 0 7.492265813834054e-13
a O 0 1.158174424420455e-11
common O 0 1.2038613161902134e-10
allelic O 0 9.859247285248784e-08
pattern O 0 5.341040676398734e-08
, O 0 1.6224524501673443e-10
supporting O 0 3.1305039116524824e-10
the O 0 8.508179716315567e-10
founder O 0 4.442928158709947e-08
effect O 0 9.421576852020053e-10
notion O 0 1.0366029146169353e-09
, O 0 8.054283802405582e-12
but O 0 1.0011555386796323e-13
dating O 0 2.0936020278528034e-11
the O 0 9.366663260984565e-13
mutations O 0 1.5137159104297582e-12
origin O 0 5.41892052063897e-13
to O 0 5.369616968946278e-13
an O 0 2.3297685937569146e-13
earlier O 0 1.9732198514033072e-11
date O 0 2.3922150371724626e-10
than O 0 8.612449403817835e-13
currently O 0 3.311979510089991e-11
estimated O 0 9.247541621348887e-11
. O 0 2.099506346553426e-09

However O 0 1.0715956122453463e-08
, O 0 9.814391660478705e-11
the O 0 1.4316937392566675e-11
different O 0 3.258926982441235e-12
allelic O 0 2.954394240362035e-08
pattern O 0 1.4993002395158328e-08
at O 0 3.54947293779162e-09
the O 0 4.3399536742150246e-10
BRCA1 O 0 2.9762470266092578e-09
locus O 0 1.3348246119537777e-10
even O 0 7.802178174365348e-12
in O 0 2.528458779155196e-12
some O 0 1.875685072755609e-13
Jewish O 0 1.1915300690557018e-10
mutation O 0 4.258526517531003e-11
carriers O 0 2.2377086295044535e-11
, O 0 1.7603082186345986e-11
might O 0 1.7069630431354454e-11
suggest O 0 1.3643402380081326e-11
that O 0 2.2508908528295207e-13
the O 0 1.9817968446855794e-11
mutation O 0 1.0759522613146277e-11
arose O 0 4.222067487291703e-11
independently O 0 5.643538414368265e-10
. O 0 5.297042665608487e-11
. O 0 6.582140388289304e-10

Crystal O 0 0.00010381727042840794
structure O 0 3.069668252919655e-07
of O 0 1.3996910865898826e-06
the O 0 3.611420993365755e-07
hemochromatosis B-Disease 1 1.0
protein O 0 8.14490590528294e-08
HFE O 0 0.011620034463703632
and O 0 6.138928254628695e-10
characterization O 0 1.694431439602795e-08
of O 0 1.1096362051432607e-08
its O 0 2.911968166596779e-10
interaction O 0 3.903964373996871e-10
with O 0 1.140615032979575e-10
transferrin O 0 3.316726093771649e-08
receptor O 0 8.543537433070014e-09
. O 0 1.4478148679941683e-09

HFE O 1 0.999895453453064
is O 0 1.6426753290943452e-08
an O 0 3.9260822370934534e-10
MHC O 0 0.00010917608597083017
- O 0 1.916634346343926e-06
related O 0 1.913031866251913e-07
protein O 0 2.8913632599270045e-10
that O 0 9.676905544236947e-13
is O 0 2.0897617403897728e-13
mutated O 0 1.4334041766039807e-11
in O 0 5.2416748025363447e-11
the O 0 7.967721593615806e-09
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 8.60191630636109e-06

HFE O 0 0.0021630956325680017
binds O 0 1.5367914940611627e-08
to O 0 4.82295037240732e-10
transferrin O 0 6.984213207772427e-09
receptor O 0 4.53448584236682e-10
( O 0 5.600974545272308e-11
TfR O 0 2.182338931788763e-08
) O 0 4.672990293330681e-12
and O 0 4.162876206942334e-12
reduces O 0 1.9303945594795202e-11
its O 0 1.060407230774052e-11
affinity O 0 4.775021350544861e-11
for O 0 7.092946369136044e-11
iron O 0 5.910673621656315e-07
- O 0 1.8982813543289012e-08
loaded O 0 2.982886471158963e-08
transferrin O 0 3.2997395038592003e-08
, O 0 5.029424654523496e-10
implicating O 0 1.5252779121510684e-05
HFE O 1 0.9999793767929077
in O 0 5.643952931677632e-07
iron O 1 0.999772846698761
metabolism O 0 0.009586634114384651
. O 0 2.0315384929858737e-08

The O 0 3.0220596727303928e-06
2 O 0 2.472924279572908e-06
. O 0 1.6456606743986413e-08

6 O 0 2.4964088879642077e-05
A O 0 3.4678844258451136e-06
crystal O 0 8.96701112651499e-06
structure O 0 2.472588960245048e-07
of O 0 1.9345516193425283e-06
HFE O 1 0.9999951124191284
reveals O 0 1.6061783014720277e-08
the O 0 7.210225472231713e-11
locations O 0 2.4286324062927633e-09
of O 0 4.638075949969789e-07
hemochromatosis B-Disease 1 1.0
mutations O 0 1.4769547362902813e-07
and O 0 1.3720458547084036e-08
a O 0 7.06914562442762e-08
patch O 1 0.9999954700469971
of O 0 0.11984465271234512
histidines O 1 0.996921956539154
that O 0 4.6086596344752095e-11
could O 0 2.4106128551637518e-11
be O 0 7.432745391389162e-12
involved O 0 1.0409532957833534e-10
in O 0 4.034471090541558e-10
pH O 0 1.2058231391165464e-07
- O 0 6.00263092565001e-08
dependent O 0 6.456483792049994e-09
interactions O 0 1.4463968689426565e-08
. O 0 3.804587755951161e-09

We O 0 8.54348858325693e-09
also O 0 6.542384689556258e-11
demonstrate O 0 3.895685440902241e-10
that O 0 1.318203705913401e-11
soluble O 0 2.2242570452135624e-08
TfR O 0 2.202664290962275e-06
and O 0 7.309765681640101e-09
HFE O 0 0.00022402641479857266
bind O 0 1.1583963788197593e-09
tightly O 0 9.202137718489212e-09
at O 0 3.5624410088530567e-09
the O 0 5.6399742515145235e-11
basic O 0 6.155178589040133e-10
pH O 0 1.6870875807484254e-09
of O 0 1.5656640428574065e-09
the O 0 3.1251884413663333e-10
cell O 0 4.481130133626721e-09
surface O 0 1.013568251551078e-08
, O 0 2.9564416886840306e-11
but O 0 4.501843776233416e-13
not O 0 3.300410888595201e-13
at O 0 7.892089065597574e-11
the O 0 2.5180503515631614e-11
acidic O 0 2.872400983733314e-09
pH O 0 3.44285524533916e-08
of O 0 4.326073721472312e-08
intracellular O 0 1.4039741813576256e-07
vesicles O 0 3.644935532065574e-06
. O 0 6.145002373614261e-08

TfR O 0 0.001026612939313054
HFE O 0 0.0025875114370137453
stoichiometry O 0 1.4471025906459545e-06
( O 0 2.326319936685195e-08
2 O 0 3.456798225442981e-08
1 O 0 1.2353760237004963e-09
) O 0 1.7609923935735239e-12
differs O 0 9.032714680390352e-12
from O 0 2.5322827168494655e-11
TfR O 0 1.2836674834204587e-08
transferrin O 0 8.618099012203118e-10
stoichiometry O 0 5.90420334845021e-09
( O 0 1.5938747544019805e-10
2 O 0 1.3540341070594764e-09
2 O 0 1.0480121215294957e-09
) O 0 5.081604408097018e-12
, O 0 9.731098305626462e-13
implying O 0 3.6111996639526245e-12
a O 0 6.674011386945122e-13
different O 0 5.132507916935647e-13
mode O 0 1.3736863035962443e-10
of O 0 2.7949946176941687e-11
binding O 0 2.023214928925654e-10
for O 0 1.4606368892167154e-10
HFE O 0 0.0029425215907394886
and O 0 2.8246234240469903e-09
transferrin O 0 4.6044994483906976e-09
to O 0 7.468417551059758e-11
TfR O 0 3.80974938707368e-07
, O 0 3.0352175633963085e-11
consistent O 0 1.0830691898888745e-09
with O 0 9.688877304625532e-12
our O 0 2.946805022219223e-10
demonstration O 0 3.964423900271186e-09
that O 0 1.8183215350076054e-11
HFE O 0 0.00013297318946570158
, O 0 3.049057673010225e-10
transferrin O 0 8.967992570774186e-09
, O 0 2.0822929491792763e-10
and O 0 1.673539640201227e-10
TfR O 0 4.254258954006218e-07
form O 0 2.3158430728642543e-10
a O 0 1.572246915992892e-10
ternary O 0 1.426893021516662e-07
complex O 0 1.4497051097350777e-06
. O 0 2.2419971656972848e-08

Identification O 0 3.217141397726664e-07
of O 0 1.5103195494248212e-07
three O 0 2.462058612540119e-10
novel O 0 1.783812958455755e-10
mutations O 0 2.3454519576526778e-11
and O 0 1.648139784371505e-11
a O 0 1.9231623238358253e-11
high O 0 1.0740218714389016e-09
frequency O 0 2.459622505668335e-10
of O 0 2.5607560516505146e-10
the O 0 4.8833933424807796e-11
Arg778Leu O 0 1.6491587473410618e-07
mutation O 0 2.741143943774116e-11
in O 0 1.3467256823607165e-11
Korean O 0 5.8870462282811786e-08
patients O 0 1.1815225187117306e-10
with O 0 5.86724141493633e-11
Wilson B-Disease 1 0.9917857050895691
disease I-Disease 1 0.9995315074920654
. O 0 9.037105286324731e-09

Four O 0 8.042740518021674e-08
mutations O 0 7.574267435472848e-09
- O 0 5.748293006035965e-07
- O 0 1.8956480118959007e-07
R778L O 0 1.9676892293318815e-07
, O 0 1.9645610138674385e-10
A874V O 0 2.4165276002463543e-08
, O 0 4.106351023103194e-11
L1083F O 0 1.0347524614928716e-08
, O 0 2.4879310417391665e-11
and O 0 2.232737779384042e-11
2304delC O 0 3.16054702409474e-08
- O 0 7.439337146308844e-09
- O 0 2.085851491528956e-09
in O 0 4.107494899763253e-11
the O 0 1.354203832404366e-10
copper O 0 8.645598015277756e-09
- O 0 2.408611532445093e-09
transporting O 0 8.855351119052557e-09
enzyme O 0 1.5853854340441842e-10
, O 0 6.264089941199202e-11
P O 0 6.460181367629048e-08
- O 0 5.049130891165987e-09
type O 0 1.5785578399984956e-09
ATPase O 0 8.793680450480679e-09
( O 0 7.911520327752442e-10
ATP7B O 1 0.9999953508377075
) O 0 1.653050960004343e-11
, O 0 1.2322208140999602e-12
were O 0 1.5233493719929436e-12
identified O 0 6.8621393289891586e-12
in O 0 1.4079470228578472e-11
Korean O 0 1.104701539134112e-07
Patients O 0 1.0296430374978627e-09
with O 0 3.401521564416754e-10
Wilson B-Disease 1 0.9997005462646484
disease I-Disease 1 0.9999860525131226
. O 0 7.800255552581348e-09

Arg778Leu O 0 0.008577797561883926
, O 0 9.23258802743021e-09
the O 0 2.882916128044144e-10
most O 0 5.3814929942830325e-12
frequently O 0 1.175901563621462e-11
reported O 0 1.5532769515047562e-11
mutation O 0 6.386014113346494e-12
of O 0 1.2965378770601887e-10
this O 0 3.8679812391223534e-13
enzyme O 0 4.333142351875541e-12
, O 0 4.6545588563984275e-12
was O 0 6.603879249000855e-11
found O 0 4.312899429953498e-12
in O 0 3.5137804124674155e-12
six O 0 5.847377443357615e-11
of O 0 1.0848782983075012e-09
eight O 0 1.0441931763693901e-09
unrelated O 0 9.907576981049715e-09
patients O 0 3.2568672758692685e-10
studied O 0 4.53871074057588e-09
, O 0 4.460954609181167e-12
an O 0 2.3025646059965377e-13
allele O 0 2.3090043332202326e-12
frequency O 0 1.5597556579649563e-10
of O 0 3.2123259607885757e-09
37 O 0 1.4050761443229476e-08
. O 0 1.880377853424875e-09

5 O 0 1.265120914695217e-07
% O 0 1.0953507545430341e-10
, O 0 8.327725661838592e-12
which O 0 1.0123973057454827e-12
is O 0 1.7152901007119054e-13
considerably O 0 1.7859285014396042e-12
higher O 0 2.1072954145551215e-11
than O 0 7.505191672134426e-14
those O 0 1.5307582133285147e-13
in O 0 7.079477520703648e-13
other O 0 1.4478898765699078e-12
Asian O 0 2.410097989236082e-11
populations O 0 1.1036000238662247e-11
. O 0 4.2956038032171406e-11

The O 0 2.024645162634897e-08
novel O 0 1.661169424238551e-09
single O 0 7.306357602265834e-11
nucleotide O 0 2.430387557872393e-10
deletion O 0 3.0314292742694704e-10
, O 0 3.4234670653887633e-11
2304delC O 0 4.157472943688845e-08
, O 0 7.882295510741599e-11
was O 0 2.0982161841320845e-10
found O 0 1.225718918723695e-11
in O 0 2.0509632187026838e-11
one O 0 5.515506801279102e-11
patient O 0 2.4748624483095227e-08
. O 0 4.643729401010432e-09

Since O 0 8.727077727144206e-09
a O 0 2.2434022695083655e-10
mutation O 0 9.699235858917632e-11
at O 0 1.1648416675669182e-09
cDNA O 0 1.5865809777082518e-09
nucleotide O 0 1.1292191182121769e-08
2302 O 0 4.795803306478774e-06
( O 0 1.677153693702138e-10
2302insC O 0 3.708199969310044e-08
) O 0 2.0497702493682546e-11
had O 0 1.01820149533971e-11
been O 0 9.514425705625662e-12
previously O 0 9.171446935241079e-11
described O 0 4.772481021486641e-11
, O 0 1.7600085885222105e-12
this O 0 6.653493945033007e-14
region O 0 8.338840729038566e-11
of O 0 8.553707742109395e-10
the O 0 1.320029197060535e-09
ATP7B O 1 1.0
gene O 0 1.7941597096893247e-09
may O 0 2.5498714251170895e-11
be O 0 6.5488231157373455e-12
susceptible O 0 8.524264849540941e-09
to O 0 1.8515068644919808e-10
gene O 0 4.1898644553839404e-08
rearrangements O 0 0.07835030555725098
causing O 1 0.999976396560669
Wilson B-Disease 1 0.9999947547912598
disease I-Disease 1 0.9999872446060181
. O 0 8.777459648001695e-09

Disruption O 0 7.462329449481331e-06
of O 0 4.2797898913704557e-07
splicing O 0 4.827547783747832e-08
regulated O 0 4.530313013617615e-09
by O 0 6.28520152590184e-11
a O 0 8.389047789769677e-10
CUG O 1 0.6877574920654297
- O 0 4.3825902906746705e-08
binding O 0 7.728253592631518e-09
protein O 0 1.7035016952604565e-08
in O 0 3.011331628499647e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.0604228464217158e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9981344938278198
DM B-Disease 1 1.0
) O 0 5.148640269680982e-08
is O 0 9.696406177983619e-11
caused O 0 9.094578423685107e-10
by O 0 2.1594339164043852e-11
a O 0 1.489828815870453e-10
CTG O 0 5.012516339775175e-06
expansion O 0 1.2157501672049875e-09
in O 0 3.6513451984188094e-11
the O 0 9.899595726503563e-11
3 O 0 7.852677397224284e-10
untranslated O 0 3.998945430794265e-06
region O 0 1.2617230593647832e-09
of O 0 3.6587242124852537e-09
the O 0 2.8191026402168973e-08
DM B-Disease 1 1.0
gene O 0 1.17165279789333e-06
. O 0 2.0453095217476402e-08

One O 0 7.304455706957924e-09
model O 0 2.9519762190233223e-09
of O 0 1.818739434611416e-07
DM B-Disease 1 1.0
pathogenesis O 0 0.024742523208260536
suggests O 0 3.3116279163358797e-10
that O 0 4.2595454615747264e-13
RNAs O 0 1.0664079619360223e-09
from O 0 1.2907763746738965e-10
the O 0 3.9660531803153987e-11
expanded O 0 1.4354706312502685e-10
allele O 0 7.89071585849399e-12
create O 0 9.698491142129395e-12
a O 0 2.9097625350860135e-11
gain O 0 9.21421272614964e-11
- O 0 1.7711038191592365e-09
of O 0 1.1375999031670858e-09
- O 0 1.613503664010807e-09
function O 0 1.9459052424952716e-12
mutation O 0 4.591020489122521e-13
by O 0 1.715100500856992e-13
the O 0 3.728347925530118e-12
inappropriate O 0 4.533195346878571e-11
binding O 0 8.462794354180403e-11
of O 0 1.0988207010953488e-09
proteins O 0 1.1838251733065075e-11
to O 0 2.6131045244293105e-11
the O 0 2.564119805370524e-09
CUG O 1 0.9999995231628418
repeats O 0 2.1829013974183908e-07
. O 0 3.738279907850028e-09

Data O 0 1.0324777832693144e-07
presented O 0 4.253808327803199e-08
here O 0 1.3034284762625248e-10
indicate O 0 6.87173096203253e-11
that O 0 5.947252781392243e-13
the O 0 2.1410194797621962e-11
conserved O 0 1.2476754074342011e-09
heterogeneous O 0 3.5122596386827354e-08
nuclear O 0 3.902184744219994e-06
ribonucleoprotein O 0 7.026102139207069e-06
, O 0 2.8487978642743883e-09
CUG O 0 0.21424748003482819
- O 0 3.42539294706512e-08
binding O 0 5.986575235539249e-09
protein O 0 2.059153514366585e-09
( O 0 4.556915678133322e-10
CUG O 1 0.9998688697814941
- O 0 4.084131433046423e-07
BP O 0 1.21090806715074e-05
) O 0 9.147512608498332e-11
, O 0 2.518160853448581e-11
may O 0 7.782147148915897e-11
mediate O 0 5.978382233706725e-09
the O 0 4.480044335508637e-09
trans O 0 1.5704742395428184e-08
- O 0 2.5416738935746253e-08
dominant O 0 1.133078297854695e-09
effect O 0 1.0349843898582733e-10
of O 0 2.279617467015882e-10
the O 0 6.540226693552142e-11
RNA O 0 2.8931536277809755e-08
. O 0 4.2723921622744854e-10

CUG O 1 0.9999997615814209
- O 0 0.00012479204451665282
BP O 0 5.6426968512823805e-05
was O 0 1.566737317659772e-08
found O 0 3.326534880887522e-11
to O 0 2.1798673977002636e-12
bind O 0 2.077483844675765e-11
to O 0 3.789613414739712e-11
the O 0 9.99034632798157e-10
human O 0 2.5488201771395325e-08
cardiac O 1 0.9999915361404419
troponin O 1 0.9999561309814453
T O 1 0.999992847442627
( O 0 4.375663387179429e-09
cTNT O 0 1.278843114960182e-06
) O 0 1.5900268948709773e-11
pre O 0 9.450742055605588e-08
- O 0 4.254073981968531e-09
messenger O 0 5.52089818306456e-10
RNA O 0 2.762887918450474e-09
and O 0 2.6923071411166788e-11
regulate O 0 1.5536391617665402e-10
its O 0 4.455804128444818e-11
alternative O 0 1.9698263020728746e-09
splicing O 0 3.518743696417914e-08
. O 0 1.0471649103394043e-09

Splicing O 0 1.8744473209153512e-06
of O 0 1.071313477041258e-06
cTNT O 0 4.948499190504663e-05
was O 0 1.5996729985090496e-07
disrupted O 0 1.8467794689058792e-06
in O 0 1.9266309436716256e-08
DM B-Disease 1 1.0
striated O 0 0.00034022150794044137
muscle O 0 1.1651965223791194e-06
and O 0 1.0819150020324741e-09
in O 0 2.3126207893131578e-10
normal O 0 1.428991591723161e-09
cells O 0 1.5289514099237067e-10
expressing O 0 8.625264391604048e-11
transcripts O 0 2.7018899118047557e-08
that O 0 3.9619401509538577e-11
contain O 0 3.7418342202499844e-08
CUG O 1 0.9999995231628418
repeats O 0 5.617265514956671e-07
. O 0 7.38425987023561e-09

Altered O 0 5.063387789050466e-07
expression O 0 8.906540394093554e-09
of O 0 2.0675884115917142e-08
genes O 0 3.112113899916835e-10
regulated O 0 1.6741063646463772e-08
posttranscriptionally O 0 3.381970145710511e-06
by O 0 4.397928243804472e-09
CUG O 1 1.0
- O 0 6.909367584739812e-06
BP O 0 4.613715645973571e-06
therefore O 0 2.8650018468745486e-10
may O 0 8.664342160402683e-11
contribute O 0 1.9659777972247383e-10
to O 0 3.4915654811840113e-09
DM B-Disease 1 1.0
pathogenesis O 1 0.7718799114227295
. O 0 1.9312105248303624e-09
. O 0 2.3453154973651635e-09

Identification O 0 2.765887643363385e-07
of O 0 7.98607402430207e-08
a O 0 2.2698812274235536e-10
novel O 0 1.8223091924340906e-09
nonsense O 0 6.791901796532329e-08
mutation O 0 1.2976313079615664e-10
and O 0 3.243401033858895e-11
a O 0 1.8622622541264455e-11
missense O 0 7.876228003134145e-10
substitution O 0 6.059797663660049e-10
in O 0 2.0767003394706052e-10
the O 0 3.9313352573344673e-10
vasopressin O 0 2.498882523127577e-08
- O 0 4.620002513888721e-08
neurophysin O 0 8.971655915956944e-06
II O 1 1.0
gene O 0 6.882791558915358e-10
in O 0 1.093511132338465e-11
two O 0 9.725629156187576e-12
Spanish O 0 6.939305574604759e-09
kindreds O 0 3.7027160715297214e-07
with O 0 8.408543861193607e-10
familial B-Disease 1 0.9997619986534119
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999982118606567
. O 0 4.6651541651954176e-07

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.00038258812855929136
FNDI B-Disease 1 1.0
) O 0 5.2733581945574315e-09
is O 0 3.422055607632535e-12
an O 0 5.899331370629035e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.00012902003072667867
by O 0 1.6146620041013193e-08
deficiency O 1 0.9919527173042297
in O 0 7.234132848310537e-09
the O 0 3.017949623540517e-08
antidiuretic O 0 1.3882980738344486e-06
hormone O 0 1.0959561791423766e-07
arginine O 0 3.194800513028895e-07
vasopressin O 0 6.67130422016271e-08
( O 0 1.5224859151174996e-09
AVP O 0 0.0003295555943623185
) O 0 5.364859598233629e-12
encoded O 0 1.0796401966883806e-11
by O 0 6.3456067657396975e-12
the O 0 9.179099147438308e-10
AVP O 1 0.8970637321472168
- O 0 3.90318689369451e-07
neurophysin O 0 7.206730515463278e-05
II O 1 1.0
( O 0 6.601206337109033e-08
AVP O 1 0.9999902248382568
- O 0 9.77891772890871e-07
NPII O 1 0.9996744394302368
) O 0 9.509023429776775e-11
gene O 0 1.6723269991025802e-10
on O 0 1.690427908762615e-09
chromosome O 0 3.753442712195465e-08
20p13 O 0 2.2076501409173943e-06
. O 0 9.188878102861509e-09

In O 0 7.228766918387919e-09
this O 0 2.531865992902449e-12
study O 0 4.599193248466804e-11
, O 0 5.779448968012968e-12
we O 0 2.4252716263224727e-13
analyzed O 0 5.80320097531839e-11
two O 0 2.7023123322367226e-12
families O 0 3.070412305482273e-13
with O 0 1.53078313913646e-11
FNDI B-Disease 1 1.0
using O 0 5.765842664429144e-11
direct O 0 4.292205132983007e-11
automated O 0 1.634661472849075e-08
fluorescent O 0 1.3788248764967648e-08
, O 0 2.7449842746052333e-11
solid O 0 1.690141027133052e-09
phase O 0 5.937812019851663e-09
, O 0 1.166474642572135e-11
single O 0 4.5725853659028814e-11
- O 0 1.0232991537462155e-10
stranded O 0 2.8676793578652493e-11
DNA O 0 3.9675834839769664e-10
sequencing O 0 3.3696587187215243e-11
of O 0 3.696770112249226e-10
PCR O 0 6.08554046266363e-07
- O 0 1.3177881328374497e-06
amplified O 0 5.310009146342054e-05
AVP O 1 0.9999247789382935
- O 0 5.705882813344942e-06
NPII O 1 0.9992764592170715
DNA O 0 4.445133981789695e-06
. O 0 1.9139900775400065e-09

In O 0 4.540208653480704e-09
one O 0 3.4346251537309413e-11
of O 0 3.1103455921943635e-10
the O 0 4.050823218526567e-11
families O 0 7.239846200844668e-13
, O 0 4.648756206371285e-12
affected O 0 1.683110248396069e-11
individuals O 0 4.660437075316992e-13
presented O 0 7.596920315044997e-10
a O 0 3.7213893078202886e-10
novel O 0 2.1544899198033818e-10
nonsense O 0 5.151044035756058e-09
mutation O 0 2.4347057356322033e-11
in O 0 2.9134611390091436e-11
exon O 0 2.3371795609961055e-09
3 O 0 7.792756995250727e-10
of O 0 3.488075661639556e-10
the O 0 2.940963791941975e-11
gene O 0 1.2244664483740397e-11
, O 0 1.3808327311432e-12
consisting O 0 5.36820934926574e-11
in O 0 3.969792203295519e-11
a O 0 1.915274744357376e-10
G O 0 2.589936912045232e-06
to O 0 9.127270494957429e-09
T O 0 0.00032033948809839785
transition O 0 2.0951709700511856e-08
at O 0 3.6609022480149633e-09
nucleotide O 0 4.403896358695647e-09
2101 O 0 2.082717855955707e-06
, O 0 1.3279522446951741e-11
which O 0 1.8250544304987404e-12
produces O 0 2.1078340461944123e-11
a O 0 1.6030539742861727e-11
stop O 0 1.8977582005863525e-10
signal O 0 1.345235367544717e-09
in O 0 9.570853831686321e-11
codon O 0 3.127611059028368e-09
82 O 0 1.040950348141223e-08
( O 0 2.3306034879766457e-10
Glu O 0 0.004382727667689323
) O 0 1.1825151968736236e-09
of O 0 8.267175388709802e-08
NPII O 1 1.0
. O 0 7.4386164783391e-08

The O 0 4.2709791614470305e-07
premature O 0 2.1304421693457698e-07
termination O 0 4.48356018978302e-08
eliminates O 0 1.0873958622426017e-08
part O 0 9.4836338782045e-10
of O 0 1.3588928871044459e-09
the O 0 6.909111061048634e-10
C O 0 5.077962441646378e-07
- O 0 2.2228476836971822e-09
terminal O 0 9.727062905140471e-11
domain O 0 6.842717798632991e-12
of O 0 2.9935529055613586e-10
NPII O 1 0.9684505462646484
, O 0 4.453747787236395e-11
including O 0 3.947774052104336e-11
a O 0 2.0679480697283203e-11
cysteine O 0 4.2749515039020025e-10
residue O 0 6.816193387493286e-09
in O 0 2.7604989474849795e-11
position O 0 2.9819846592005206e-10
85 O 0 1.5309833401033757e-09
, O 0 3.9166317758465574e-12
which O 0 1.2269720829627406e-12
could O 0 3.2224648296996783e-12
be O 0 1.5591324889138725e-12
involved O 0 2.1230616223388843e-11
in O 0 1.4671586862080588e-11
the O 0 6.914710470873331e-11
correct O 0 2.0972650283113126e-09
folding O 0 2.6348292436750853e-08
of O 0 5.07243225200682e-09
the O 0 5.63562485567104e-09
prohormone O 0 0.00035862706135958433
. O 0 2.619970729256238e-08

In O 0 8.484395408459022e-09
the O 0 6.489840331802554e-10
second O 0 2.586513447866423e-09
family O 0 2.7304361896463014e-11
, O 0 1.4593245015182e-11
a O 0 9.364899480890365e-12
G279A O 0 2.8435049870267903e-09
substitution O 0 8.979832988309511e-10
at O 0 2.0911496978470723e-09
position O 0 1.505457536410404e-09
- O 0 1.2580367858561203e-09
1 O 0 1.8961300585207397e-10
of O 0 1.3010167942972828e-10
the O 0 2.165323476077674e-11
signal O 0 1.1158521884269135e-09
peptide O 0 2.8220639713971707e-10
was O 0 5.271693498398733e-11
observed O 0 6.1727606533168444e-12
in O 0 2.648498607926708e-12
all O 0 3.786801167776632e-12
affected O 0 8.41991823485877e-11
individuals O 0 3.890112624388431e-12
. O 0 1.4831611494514618e-09

This O 0 3.22213167258667e-09
missense O 0 3.2246884984488133e-07
mutation O 0 4.526564456597271e-09
, O 0 6.919370632019195e-10
which O 0 2.449383751379486e-10
replaces O 0 3.257438038417604e-06
Ala O 0 4.9686615966493264e-05
with O 0 5.410462744492861e-09
Thr O 1 0.8661583065986633
, O 0 1.885157585590491e-09
is O 0 1.4114882873617063e-11
frequent O 0 5.342553621723312e-10
among O 0 5.058973240323894e-09
FNDI B-Disease 1 1.0
patients O 0 1.604048236458766e-07
and O 0 8.525220529520539e-10
is O 0 3.267019293984319e-11
thought O 0 4.636494313481343e-11
to O 0 5.563631153004955e-12
reduce O 0 1.202860588911392e-10
the O 0 7.519187356086476e-11
efficiency O 0 1.1767014029828715e-09
of O 0 1.1163652224865928e-09
cleavage O 0 7.024555936929744e-10
by O 0 7.319272965489176e-11
signal O 0 9.72288418665812e-08
peptidases O 0 2.151140961359488e-06
. O 0 1.2604048915676458e-09
. O 0 2.385468267362967e-09

Genetic O 0 4.960851924806775e-07
heterogeneity O 0 6.825478067185031e-07
of O 0 2.13098155654734e-06
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.4780432140179016e-10
due O 0 3.3886109473968418e-09
to O 0 3.0933006156530496e-10
TWIST O 0 0.0008899680688045919
and O 0 2.3226933265618754e-08
FGFR O 1 1.0
mutations O 0 8.773309900789172e-07
. O 0 2.0377203924226706e-08

Thirty O 0 1.9628476366051473e-05
- O 0 2.749516454514378e-07
two O 0 6.549801673250144e-11
unrelated O 0 2.5131827730007217e-09
patients O 0 2.7020816140144177e-11
with O 0 1.2135473832428079e-12
features O 0 7.08754432920955e-09
of O 0 9.333020898338873e-06
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.673747612202959e-10
a O 0 1.1380116987647071e-10
common O 0 2.5359986111084254e-08
autosomal B-Disease 0 0.009664938785135746
dominant I-Disease 0 6.578084867214784e-05
condition I-Disease 0 1.2940982742293272e-05
of O 1 0.9998370409011841
craniosynostosis B-Disease 1 1.0
and O 1 0.5995892286300659
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999988079071045
, O 0 1.939602256584294e-08
were O 0 2.4255955022312037e-09
screened O 0 2.3524571179933673e-09
for O 0 2.295270570829011e-11
mutations O 0 1.0802916894370185e-10
in O 0 1.6433379657065927e-10
TWIST O 0 8.448808330285829e-06
, O 0 1.7035300947654264e-09
FGFR2 O 1 0.9999992847442627
, O 0 1.7275338937139395e-09
and O 0 8.001974194371542e-09
FGFR3 O 1 0.9999997615814209
. O 0 3.420059258019137e-08

Nine O 0 1.0572510973361204e-06
novel O 0 1.1762532281522908e-08
and O 0 6.594920165525764e-10
three O 0 7.38765160157584e-10
recurrent O 0 3.859074695355957e-06
TWIST O 0 5.5628956033615395e-05
mutations O 0 1.6095877963806515e-09
were O 0 1.503806662528362e-10
found O 0 1.0337947164984485e-10
in O 0 1.0320844873179524e-10
12 O 0 5.0240962501391095e-09
families O 0 2.0542831324910082e-11
. O 0 1.8830625947430235e-09

Seven O 0 7.226233833534934e-08
families O 0 4.646380502570935e-12
were O 0 8.612540541852454e-11
found O 0 1.3945969379314249e-11
to O 0 4.7676476482017005e-12
have O 0 4.026310534976929e-12
the O 0 1.1544813993680236e-09
FGFR3 O 1 0.9999971389770508
P250R O 0 2.703287691474543e-07
mutation O 0 3.335831888495733e-10
, O 0 1.563707670293457e-11
and O 0 2.53391578552975e-11
one O 0 3.5977041658308284e-12
individual O 0 2.994726428645622e-12
was O 0 9.334112371917058e-10
found O 0 3.752785929234115e-11
to O 0 1.3169221789455232e-11
have O 0 4.95335326575197e-12
an O 0 4.2871647204512087e-11
FGFR2 O 1 0.9999558925628662
VV269 O 0 2.408377440588083e-06
- O 0 7.775956589739508e-08
270 O 0 1.2455266151789601e-08
deletion O 0 3.632331413427892e-08
. O 0 7.160128934202703e-09

To O 0 9.611562656886008e-10
date O 0 1.5100683370405932e-08
, O 0 2.3780562588560095e-11
our O 0 9.802113981605132e-12
detection O 0 2.45418774191819e-09
rate O 0 1.3342205812394425e-11
for O 0 9.79704381856572e-13
TWIST O 0 1.9143220697515062e-07
or O 0 9.883149854061912e-10
FGFR O 1 0.9997515082359314
mutations O 0 7.237013210925625e-10
is O 0 1.0853718965253556e-11
68 O 0 5.501703537191815e-10
% O 0 3.1826673458149046e-13
in O 0 6.482361956244853e-12
our O 0 7.558189629719436e-09
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.0972979797306834e-08
, O 0 5.992121382414339e-11
including O 0 4.102503670111446e-09
our O 0 3.408682047734146e-08
five O 0 8.234355974856555e-10
patients O 0 1.5910349426828674e-10
elsewhere O 0 4.159681765703027e-10
reported O 0 3.424004690888438e-10
with O 0 2.839411761268451e-10
TWIST O 1 0.8791471719741821
mutations O 0 1.3501050943887094e-07
. O 0 1.6881957165537642e-08

More O 0 2.2573908020628863e-10
than O 0 5.902629079956867e-12
35 O 0 5.489269455649648e-11
different O 0 1.2038876839870483e-12
TWIST O 0 2.792894093772702e-08
mutations O 0 2.7707166422308305e-11
are O 0 9.336341378826662e-13
now O 0 2.1064103152695912e-12
known O 0 1.097144250450377e-11
in O 0 3.2666686196336503e-12
the O 0 2.55317572639413e-11
literature O 0 1.0353895518733225e-09
. O 0 2.5199206610260205e-10

The O 0 3.216877075828961e-08
most O 0 5.766854702105029e-11
common O 0 3.31073536641302e-11
phenotypic O 0 9.89956339125797e-10
features O 0 6.458869550307611e-10
, O 0 1.1860604512414774e-11
present O 0 1.4025302620679359e-11
in O 0 1.083969112386507e-11
more O 0 9.383431667309497e-14
than O 0 4.4649191028450774e-13
a O 0 7.950039931925446e-12
third O 0 1.503448199269286e-10
of O 0 9.041376536345069e-10
our O 0 7.109718369591178e-10
patients O 0 2.139403931789019e-10
with O 0 4.670925451977226e-11
TWIST O 0 0.002592110773548484
mutations O 0 4.531885533509694e-09
, O 0 3.274707172096214e-10
are O 0 4.3556415418866123e-11
coronal B-Disease 0 0.0007636411464773118
synostosis I-Disease 0 0.0007711760117672384
, O 0 2.055563896874446e-08
brachycephaly B-Disease 0 0.0006085548084229231
, O 0 4.3199062105259145e-08
low B-Disease 0 0.00022714122314937413
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 5.662034823217255e-07
facial B-Disease 1 1.0
asymmetry I-Disease 0 0.32273486256599426
, O 0 6.918037342984462e-07
ptosis B-Disease 1 0.9999991655349731
, O 0 2.1722395615597634e-07
hypertelorism B-Disease 1 0.9501659870147705
, O 0 1.6912308353767003e-07
broad B-Disease 0 3.983457645517774e-05
great I-Disease 1 0.6428750157356262
toes I-Disease 1 0.9999241828918457
, O 0 5.661884117103e-08
and O 0 1.0085181401109367e-07
clinodactyly B-Disease 0 0.3239980638027191
. O 0 1.4885556254284893e-07

Significant O 0 3.3718245617819775e-07
intra O 0 6.770888285245746e-05
- O 0 2.9135193813090154e-07
and O 0 1.9362587921900598e-10
interfamilial O 0 1.5329189295698598e-07
phenotypic O 0 4.81398299001512e-09
variability O 0 3.776463142202147e-09
is O 0 2.0718912696615632e-12
present O 0 9.66280007397291e-12
for O 0 1.1289224763344485e-11
either O 0 1.9281887198019376e-09
TWIST O 0 7.73773790569976e-05
mutations O 0 5.53584520446293e-08
or O 0 3.153423833168745e-08
FGFR O 1 1.0
mutations O 0 6.531110443575017e-07
. O 0 4.51303172610551e-08

The O 0 2.3564640017070815e-08
overlap O 0 7.630466258845559e-10
in O 0 3.735154546768982e-11
clinical O 0 3.1134395062082376e-09
features O 0 3.387587987901952e-10
and O 0 4.25601741349535e-11
the O 0 2.9903329812341894e-11
presence O 0 1.4159724608109325e-11
, O 0 4.3334292317703804e-13
in O 0 4.1466445077978364e-13
the O 0 1.1667811898943836e-12
same O 0 2.8815811499091626e-13
genes O 0 5.489891852748785e-13
, O 0 1.0293272310890611e-12
of O 0 1.0023054608510051e-10
mutations O 0 2.9520014904749203e-11
for O 0 1.1375770984922706e-11
more O 0 7.17969791692169e-13
than O 0 6.506367927067158e-12
one O 0 6.021749071605242e-11
craniosynostotic B-Disease 0 7.446409426847822e-07
condition I-Disease 0 3.624469613328074e-08
- O 0 8.038427701251294e-09
such O 0 2.0150195401136273e-10
as O 0 3.7951269904468177e-10
Saethre B-Disease 0 3.128187745460309e-05
- I-Disease 0 2.437563182411395e-07
Chotzen I-Disease 0 1.5496090782107785e-05
, I-Disease 0 4.407465781230968e-10
Crouzon I-Disease 0 6.123898856458254e-06
, I-Disease 0 6.088111681457065e-10
and I-Disease 0 3.314188479208724e-09
Pfeiffer I-Disease 0 0.00795772485435009
syndromes I-Disease 1 0.9999665021896362
- O 0 1.9198905647499487e-06
support O 0 6.20393958428167e-10
the O 0 1.2658353254479948e-09
hypothesis O 0 1.9778856330532335e-10
that O 0 1.3085037610729988e-12
TWIST O 0 2.3500125223563373e-07
and O 0 2.360105166854254e-10
FGFRs O 0 7.218532118713483e-07
are O 0 3.040053452030289e-12
components O 0 7.315902994520229e-09
of O 0 1.693060913687816e-09
the O 0 1.9835818751423595e-11
same O 0 8.895758478802418e-13
molecular O 0 1.1601515581549648e-10
pathway O 0 4.777351257645446e-12
involved O 0 5.781606205075562e-13
in O 0 7.579699671730888e-13
the O 0 2.293628178010043e-12
modulation O 0 4.139064924135738e-10
of O 0 1.590399278939003e-08
craniofacial O 1 1.0
and O 0 5.362560841604136e-06
limb O 1 0.9999996423721313
development O 0 8.153047126313595e-09
in O 0 1.0290853724725935e-09
humans O 0 8.355337532961471e-10
. O 0 2.0489457353001228e-11
. O 0 3.8009587144394175e-10

Mutation O 0 1.0318611742832218e-08
analysis O 0 1.2360690249124673e-09
of O 0 3.11122683172016e-08
UBE3A O 1 1.0
in O 0 0.0007969839498400688
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.6327303455909714e-05
. O 0 1.773183377906662e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.419236458692467e-06
AS B-Disease 1 1.0
) O 0 7.931373335878789e-10
is O 0 6.936131790452604e-12
caused O 0 8.007405294385705e-10
by O 0 1.5764868577239355e-10
chromosome O 0 4.9279670122359676e-08
15q11 O 0 4.981807819604001e-07
- O 0 7.814345792667154e-08
q13 O 0 1.3010533450596995e-07
deletions O 0 5.321981078054705e-09
of O 0 3.807070214634223e-09
maternal O 0 1.4605511244880631e-09
origin O 0 5.355139942597731e-11
, O 0 7.296689294444825e-12
by O 0 3.411590801527531e-11
paternal O 0 4.5899813017058477e-07
uniparental B-Disease 0 0.482173889875412
disomy I-Disease 1 0.9950913190841675
( O 0 4.2556186485853686e-07
UPD B-Disease 1 1.0
) O 0 2.174671331900413e-09
15 O 0 2.7427784488054385e-09
, O 0 5.028709653548402e-12
by O 0 8.735891350586389e-12
imprinting O 0 0.0002619079896248877
defects O 1 0.9984183311462402
, O 0 3.445571328253294e-10
and O 0 3.302114484626806e-11
by O 0 9.396265016059502e-12
mutations O 0 2.817159283630133e-10
in O 0 2.533718790331818e-10
the O 0 6.048461287377904e-09
UBE3A O 1 0.9999724626541138
gene O 0 1.3600998727270053e-07
. O 0 9.574222303854185e-09

UBE3A O 1 0.918478786945343
encodes O 0 1.111704222012122e-07
a O 0 3.861001296456834e-09
ubiquitin O 0 4.4438351665121445e-08
- O 0 3.912712287501563e-08
protein O 0 7.535928131519043e-11
ligase O 0 1.7305680222179376e-09
and O 0 7.637979693164709e-10
shows O 0 1.0540206041298461e-08
brain O 0 3.816312528215349e-06
- O 0 4.746661019794374e-08
specific O 0 2.172979574055489e-09
imprinting O 0 1.1644938240351621e-05
. O 0 1.4064704068061928e-08

Here O 0 6.054557388779358e-08
we O 0 3.348044896878122e-10
describe O 0 7.444333594008867e-09
UBE3A O 0 0.17203804850578308
coding O 0 4.4609811311602243e-07
- O 0 3.42876006698134e-07
region O 0 2.3182749053773932e-09
mutations O 0 3.3988883929580993e-10
detected O 0 2.376150165517288e-09
by O 0 3.514170898721858e-11
SSCP O 0 0.0007181665860116482
analysis O 0 1.4390975910938408e-10
in O 0 6.39997915774515e-11
13 O 0 1.7234496052509485e-09
AS B-Disease 1 0.9262247085571289
individuals O 0 1.2780556777822194e-12
or O 0 1.294778312344036e-10
families O 0 2.685081323949845e-11
. O 0 1.7393970708212692e-09

Two O 0 2.0314532278575825e-08
identical O 0 1.22610700259429e-07
de O 0 3.824758550763363e-06
novo O 0 1.5298885500669712e-06
5 O 0 8.070784929259389e-08
- O 0 1.852370523636182e-08
bp O 0 5.354410248514796e-09
duplications O 0 4.08470341994871e-08
in O 0 5.952278114840226e-10
exon O 0 6.433596411170583e-08
16 O 0 1.2369327784256257e-08
were O 0 7.93228094320142e-10
found O 0 2.0063992689500765e-09
. O 0 1.9365036241225653e-09

Among O 0 6.661818474640313e-08
the O 0 5.398896441022316e-09
other O 0 2.134777493667528e-10
11 O 0 7.662669387897836e-10
unique O 0 2.6700157709780292e-11
mutations O 0 7.715079269887681e-11
, O 0 4.289569741078303e-11
8 O 0 1.053212184132235e-09
were O 0 3.030173334472863e-11
small O 0 1.569094507103408e-11
deletions O 0 7.22617188309016e-10
or O 0 3.8492123377587006e-10
insertions O 0 4.2048274195849444e-08
predicted O 0 9.335701101065297e-09
to O 0 7.448051064784522e-10
cause O 0 1.5976071665591007e-07
frameshifts O 0 0.00010656016820576042
, O 0 6.617513204076886e-10
1 O 0 1.256823312090205e-09
was O 0 1.2055961784440683e-10
a O 0 4.673828164769578e-12
mutation O 0 4.113898458002474e-12
to O 0 4.1870040420888266e-12
a O 0 5.868450170254391e-11
stop O 0 6.476756908568859e-10
codon O 0 3.0340683299101556e-09
, O 0 5.63540429598941e-11
1 O 0 6.148115350157468e-10
was O 0 3.4965552675458866e-10
a O 0 1.478784109054665e-11
missense O 0 4.0641698895171885e-09
mutation O 0 1.0660779897753159e-10
, O 0 2.484677914804667e-11
and O 0 7.639287119554083e-11
1 O 0 1.2100960233851765e-09
was O 0 6.681332709312926e-10
predicted O 0 9.651255489240285e-11
to O 0 3.968034234524964e-12
cause O 0 1.9919389748768168e-10
insertion O 0 2.434749069024633e-10
of O 0 3.41586559038376e-09
an O 0 8.885622272691851e-12
isoleucine O 0 1.5966293176461477e-06
in O 0 6.870816138260238e-10
the O 0 2.371111085253119e-09
hect O 0 6.896266881994961e-07
domain O 0 7.947970614985422e-10
of O 0 2.711330715499116e-09
the O 0 1.0223085711302815e-09
UBE3A O 0 0.0002901481057051569
protein O 0 1.8608392604591018e-10
, O 0 5.665081251327031e-12
which O 0 2.661501390371218e-13
functions O 0 2.615217504359224e-12
in O 0 8.7452779393149e-12
E2 O 0 1.3605644255676452e-07
binding O 0 7.23189452767059e-10
and O 0 8.093201803172079e-11
ubiquitin O 0 9.563126290856871e-09
transfer O 0 3.672590409564691e-08
. O 0 4.909773032579778e-09

Eight O 0 2.0840418812895223e-07
of O 0 1.6712890626990884e-08
the O 0 9.285541779924245e-11
cases O 0 1.228204257047727e-11
were O 0 1.9540662490880045e-11
familial O 0 3.240634205425863e-09
, O 0 3.586654584442073e-11
and O 0 4.5665190379073906e-11
five O 0 9.263181888208294e-11
were O 0 2.0372520337375022e-10
sporadic O 0 1.893093468652296e-07
. O 0 3.653131797065612e-09

In O 0 1.2423900130897891e-08
two O 0 1.4128896663745394e-10
familial O 0 1.2491714329598835e-08
cases O 0 8.499843051623657e-10
and O 0 1.3347305205524407e-10
one O 0 3.593968178616791e-11
sporadic O 0 1.0541493011828607e-08
case O 0 5.791571111579685e-10
, O 0 9.153149765905866e-11
mosaicism O 0 8.64139565237565e-07
for O 0 2.449754177291652e-09
UBE3A O 1 0.9999810457229614
mutations O 0 6.549632836083674e-09
was O 0 1.855630205049863e-09
detected O 0 2.224383122140239e-09
in O 0 2.0135126205245157e-11
the O 0 6.740747543476644e-11
mother O 0 5.377760389779773e-11
of O 0 4.726617985895132e-10
three O 0 1.2463856335909185e-10
AS B-Disease 1 1.0
sons O 0 2.4129539610839856e-07
, O 0 1.970541958773442e-11
in O 0 9.896380590013187e-12
the O 0 1.2692095985311624e-10
maternal O 0 5.49212364475693e-09
grandfather O 0 4.513358931035327e-08
of O 0 6.454762768726141e-08
two O 0 8.880141622036319e-10
AS B-Disease 1 1.0
first O 0 4.502222150648549e-09
cousins O 0 7.330345663802973e-09
, O 0 1.800822685416037e-11
and O 0 2.5786345281275658e-11
in O 0 3.9752097447109946e-11
the O 0 3.9972986032310587e-10
mother O 0 1.6349185893993479e-10
of O 0 1.9240669058007143e-09
an O 0 5.296042770996934e-11
AS B-Disease 1 1.0
daughter O 0 2.427329263809952e-06
. O 0 7.57926787997576e-09

The O 0 1.4448857221793787e-08
frequencies O 0 3.86169363153499e-09
with O 0 5.050625716263024e-12
which O 0 3.5948850233419316e-12
we O 0 2.274967540738526e-12
detected O 0 2.501636675589225e-10
mutations O 0 2.3579846408772198e-11
were O 0 8.178331623032165e-11
5 O 0 4.6377879314718484e-10
( O 0 6.24011736380381e-12
14 O 0 1.4890959298963224e-10
% O 0 1.1205248426175707e-13
) O 0 7.403590408924451e-14
of O 0 3.6271059072889855e-11
35 O 0 8.449616700767493e-11
in O 0 6.708870004673573e-12
sporadic O 0 1.6115998535681797e-09
cases O 0 1.1761707059687598e-11
and O 0 1.645551403473e-11
8 O 0 7.562094284097043e-10
( O 0 2.2983973665263724e-12
80 O 0 4.217149893182004e-11
% O 0 1.0419727689177372e-13
) O 0 8.0640064124924e-14
of O 0 5.7442401529828047e-11
10 O 0 6.630067328483591e-11
in O 0 1.7331759291638882e-11
familial O 0 6.122187201640372e-09
cases O 0 3.1999103367041926e-10
. O 0 7.132288509792417e-11
. O 0 7.378483934949998e-10

The O 0 2.3626787879038602e-05
hemochromatosis B-Disease 1 1.0
845 O 0 2.1150692191440612e-05
G O 0 2.8571075745276175e-05
- O 0 9.450253060094838e-07
- O 0 6.13642896496458e-08
> O 0 1.7423654741222094e-09
A O 0 4.0562704306523756e-09
and O 0 3.577171892032993e-11
187 O 0 3.7636044281086356e-10
C O 0 4.161725186691001e-08
- O 0 5.005655001610876e-09
- O 0 1.9248091120971367e-08
> O 0 7.942882795930473e-09
G O 0 8.818262813292677e-07
mutations O 0 8.637154880197784e-10
: O 0 2.5427659977594885e-11
prevalence O 0 3.5941344345147286e-10
in O 0 3.761921330003304e-12
non O 0 2.5961581329170258e-08
- O 0 7.034524429627709e-08
Caucasian O 0 1.663230975168517e-08
populations O 0 1.3803128084965977e-10
. O 0 3.193020847724881e-10

Hemochromatosis B-Disease 1 0.9999961853027344
, O 0 5.206539910318497e-08
the O 0 1.3480105565122358e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 2.6462823043971184e-08
leads O 0 1.5810587683517952e-07
, O 0 4.162102329452466e-10
if O 0 9.17020487323228e-11
untreated O 1 0.6848784685134888
, O 0 9.540416373576832e-11
to O 0 8.541105600556875e-10
progressive O 1 0.9999996423721313
iron B-Disease 1 1.0
overload I-Disease 1 0.9999998807907104
and O 0 6.677757937723072e-07
premature B-Disease 0 0.00010314283281331882
death I-Disease 0 9.92303012026241e-06
. O 0 1.7006222208237887e-08

The O 0 1.4979937077441718e-05
hemochromatosis B-Disease 1 1.0
gene O 0 3.952308702537266e-07
, O 0 5.404449776591491e-09
HFE O 1 0.9998985528945923
, O 0 1.5919585649726287e-09
recently O 0 5.362685850940352e-10
has O 0 1.970420788338645e-12
been O 0 2.4112463328090916e-12
identified O 0 2.3312468275249465e-11
, O 0 4.748154560502149e-12
and O 0 7.489554983142188e-12
characterization O 0 1.3316847624622596e-09
of O 0 6.40027897347295e-09
this O 0 1.171236631986039e-11
gene O 0 1.5098564065674225e-10
has O 0 1.3710281824771964e-12
shown O 0 3.974608836498916e-12
that O 0 6.795731105667738e-14
it O 0 3.4983241347166794e-13
contains O 0 5.63865881070269e-12
two O 0 7.035688221260217e-13
mutations O 0 1.6700366133395872e-12
that O 0 1.5205965284668943e-13
result O 0 2.534273312038149e-11
in O 0 9.337419726307417e-11
amino O 0 2.9877175733439287e-10
acid O 0 2.2040889946506326e-10
substitutions O 0 9.420468849441477e-09
- O 0 1.3689978928255186e-08
cDNA O 0 1.8434455073546019e-09
nucleotides O 0 4.159983468809969e-10
845 O 0 9.859732585937309e-09
G O 0 1.4098671385909256e-07
- O 0 2.7372660582614117e-08
- O 0 1.0168271558086417e-08
> O 0 8.387207595106361e-10
A O 0 7.59854756893219e-09
( O 0 5.520345031789775e-12
C282Y O 0 3.0486286828335096e-09
) O 0 8.692059116736928e-13
and O 0 2.0946994139237063e-12
187 O 0 2.1929559557154477e-10
C O 0 3.259480507722401e-08
- O 0 5.89445914300768e-09
- O 0 1.5815361464888156e-08
> O 0 8.068611556666383e-09
G O 0 1.2904696404802962e-06
( O 0 2.6724948920531233e-09
H63D O 1 0.9999978542327881
) O 0 5.131478020281577e-10
. O 0 2.4247712171465707e-10

Although O 0 4.854064627579646e-06
hemochromatosis B-Disease 1 1.0
is O 0 9.63086721483819e-10
common O 0 5.687888493532967e-10
in O 0 2.632103979216538e-10
Caucasians O 0 1.7415755948491096e-08
, O 0 9.860737920641682e-11
affecting O 0 2.772347684754095e-09
> O 0 2.083950567666193e-09
= O 0 1.14123799299648e-09
1 O 0 2.8378861482991624e-09
/ O 0 1.2193170917385032e-09
300 O 0 1.168688323199829e-11
individuals O 0 1.193511706566036e-13
of O 0 7.419886927095831e-11
northern O 0 1.4605198994654955e-10
European O 0 7.145251057494306e-11
origin O 0 2.0130900418857678e-11
, O 0 2.34746033375699e-12
it O 0 2.8869007878684627e-13
has O 0 2.7077371581355446e-14
not O 0 1.7408861488878505e-14
been O 0 7.375640354544133e-14
recognized O 0 2.3809415810455148e-12
in O 0 1.2422879565321399e-12
other O 0 2.220624075247035e-12
populations O 0 2.8478169475376625e-11
. O 0 3.406553095164355e-10

The O 0 1.3477169602538197e-08
present O 0 1.1121290000026818e-10
study O 0 5.5546396475480986e-12
used O 0 2.7988451400257075e-12
PCR O 0 2.6777196016070093e-09
and O 0 9.888870972085684e-12
restriction O 0 1.3725516383178427e-11
- O 0 5.529898761125196e-10
enzyme O 0 7.34052055251233e-12
digestion O 0 7.165613935544712e-11
to O 0 9.75127639225859e-13
analyze O 0 7.28535842764444e-11
the O 0 3.5882332261732985e-12
frequency O 0 4.676469975151143e-11
of O 0 9.703213926792742e-11
the O 0 7.11446249135328e-11
845 O 0 4.7447215045792746e-09
G O 0 8.427657860465843e-08
- O 0 2.1614562584204577e-08
- O 0 8.308302490434016e-09
> O 0 2.4057131287058553e-10
A O 0 1.377189251527966e-09
and O 0 1.518224608532126e-11
187 O 0 1.0806996963985682e-10
C O 0 1.2080949574055921e-08
- O 0 1.282998707274885e-09
- O 0 2.8344944169589326e-09
> O 0 2.15408002546269e-09
G O 0 1.707795149741287e-07
mutations O 0 3.6316627483046204e-10
in O 0 3.0578517495882807e-10
HLA O 0 3.2131401894730516e-07
- O 0 1.1672108612970078e-08
typed O 0 1.0182065190988965e-09
samples O 0 1.1115903336689215e-10
from O 0 1.49446999914149e-11
non O 0 1.835313945264261e-08
- O 0 5.758979071401882e-09
Caucasian O 0 6.146638198423204e-10
populations O 0 2.7018587020477547e-12
, O 0 5.875499739516066e-13
comprising O 0 7.937755314157968e-11
Australian O 0 1.2002164817559446e-09
Aboriginal O 0 1.2895121637157558e-09
, O 0 1.565058629568461e-12
Chinese O 0 1.1508328144615998e-11
, O 0 9.700342092078262e-12
and O 0 1.2938623783487202e-10
Pacific O 0 2.426971832392155e-07
Islanders O 0 6.058116355234233e-07
. O 0 2.6257573892962682e-09

Results O 0 2.1002888672683184e-07
showed O 0 1.664300341985836e-08
that O 0 1.0874378654490702e-11
the O 0 2.854060876522624e-10
845 O 0 4.6569123668405155e-08
G O 0 2.7624105314316694e-06
- O 0 7.272776088029786e-07
- O 0 5.528744040361744e-08
> O 0 7.025869330767875e-10
A O 0 9.899487896092296e-10
mutation O 0 2.604668650901809e-12
was O 0 9.01013898907399e-12
present O 0 1.286748702380991e-12
in O 0 5.988527273896593e-13
these O 0 1.8475249542043715e-13
populations O 0 2.2129866027783412e-13
( O 0 1.62258607157989e-13
allele O 0 1.2483346604683088e-13
frequency O 0 3.915063585824274e-12
0 O 0 4.891874232082483e-12
. O 0 8.707834800447678e-14
32 O 0 3.961001231872485e-12
% O 0 6.431001429085467e-14
) O 0 9.932035933708089e-14
, O 0 8.083444395616535e-13
and O 0 6.9696973886701485e-12
, O 0 2.8597087805420918e-12
furthermore O 0 3.59361151947013e-11
, O 0 5.487737868292708e-12
it O 0 1.7004175845158898e-12
was O 0 3.408099913393414e-10
always O 0 3.2102032837544314e-11
seen O 0 1.5239923906174013e-11
in O 0 2.658073414152362e-12
conjunction O 0 3.893352862327504e-10
with O 0 4.678468376595468e-11
HLA O 0 1.2129224842283293e-06
haplotypes O 0 4.280118481858608e-09
common O 0 3.483474897425509e-10
in O 0 2.249872649295881e-10
Caucasians O 0 2.0707060954805456e-08
, O 0 1.5763967908810628e-10
suggesting O 0 5.494362742552994e-10
that O 0 2.693514335183611e-11
845 O 0 1.2253074999080127e-07
G O 0 0.00011530968185979873
- O 0 0.00022065368830226362
- O 0 6.418976226996165e-06
> O 0 1.9041559440324818e-08
A O 0 4.157647026659106e-08
may O 0 1.961355210189364e-11
have O 0 1.6318971998371956e-13
been O 0 3.1480129917757504e-13
introduced O 0 2.0711089093738977e-12
into O 0 9.000481566642793e-13
these O 0 6.310994478744836e-14
populations O 0 5.40622234479482e-13
by O 0 1.9330613498791394e-12
Caucasian O 0 6.623741999334243e-09
admixture O 0 1.673956262493448e-08
. O 0 6.097527815995818e-09

187 O 0 6.460581971623469e-07
C O 0 1.945126314240042e-06
- O 0 8.018661645792236e-08
- O 0 1.6875551622774765e-08
> O 0 1.2583920572240004e-09
G O 0 6.326089874164609e-08
was O 0 2.9542784885094875e-10
present O 0 5.80335259015019e-12
at O 0 1.804615311351565e-11
an O 0 2.1411957832327168e-14
allele O 0 1.8130004333753724e-13
frequency O 0 3.621464933489804e-11
of O 0 8.006671992077941e-10
2 O 0 1.6500106170269646e-08
. O 0 2.230092555066676e-09

68 O 0 1.1840244269478717e-06
% O 0 3.1591923521645526e-11
in O 0 5.283488924145985e-12
the O 0 5.434117565650265e-12
two O 0 7.146879117160554e-13
populations O 0 1.0409164849511932e-12
analyzed O 0 1.2749988564930703e-10
( O 0 1.5320187826683984e-11
Australian O 0 1.9105359516657927e-09
Aboriginal O 0 1.2416880856847001e-09
and O 0 1.3284514113753865e-11
Chinese O 0 1.255686804535472e-10
) O 0 3.5541302539909836e-11
. O 0 2.751191496841443e-10

In O 0 3.293816419613904e-08
the O 0 4.996211888652624e-09
Australian O 0 7.55432782995058e-09
Aboriginal O 0 4.989316515491282e-09
samples O 0 2.2058091464494112e-10
, O 0 2.4780034794946726e-12
187 O 0 7.773483939876868e-11
C O 0 1.8026021564310213e-08
- O 0 1.0502158254155347e-08
- O 0 7.888019126767176e-09
> O 0 2.5373763090641432e-09
G O 0 2.282224187410975e-07
was O 0 6.807550079201974e-10
found O 0 3.3839294213966475e-12
to O 0 1.1834831075210883e-13
be O 0 2.0822658376197511e-13
associated O 0 7.137296309522867e-11
with O 0 4.44510817043664e-11
HLA O 0 4.713704129244434e-06
haplotypes O 0 3.0158480157638223e-09
common O 0 1.7106925598309175e-10
in O 0 3.313294083540086e-11
Caucasians O 0 5.627955435016929e-09
, O 0 1.767069823799261e-11
suggesting O 0 3.263705972145203e-11
that O 0 5.855418146877289e-13
it O 0 2.285065366092187e-12
was O 0 6.866463647670074e-11
introduced O 0 7.546640395927895e-12
by O 0 1.4707048513057375e-12
recent O 0 3.775249557413929e-11
admixture O 0 4.647344731267822e-09
. O 0 1.0920115922630202e-09

In O 0 2.6706972633405712e-08
the O 0 1.5349362891825535e-09
Chinese O 0 1.705369317983596e-10
samples O 0 1.4767104206114823e-10
analyzed O 0 5.690373172662078e-10
, O 0 2.5703848771652105e-11
187 O 0 5.04984110083484e-10
C O 0 3.167752993249451e-08
- O 0 5.2979474141068295e-09
- O 0 5.556608506651628e-09
> O 0 1.0403424788307802e-09
G O 0 8.983763422065749e-08
was O 0 9.469246498028383e-10
present O 0 6.739706015501667e-11
in O 0 5.837726829716061e-11
association O 0 6.011929287730311e-10
with O 0 4.24788112671215e-12
a O 0 3.964449948878901e-11
wide O 0 4.355377725140386e-10
variety O 0 1.286326156701989e-09
of O 0 3.0040116172358466e-08
HLA O 0 3.467983560767607e-06
haplotypes O 0 4.970263756121085e-09
, O 0 9.978647769193216e-11
showing O 0 1.8402966650565844e-10
this O 0 4.382687518022371e-13
mutation O 0 2.1766598939931825e-12
to O 0 7.927852710247485e-13
be O 0 2.189818855760639e-12
widespread O 0 1.040175834354784e-09
and O 0 2.5413610105218254e-10
likely O 0 3.369106035822078e-11
to O 0 1.8057895456724538e-11
predate O 0 1.087070771177423e-07
the O 0 1.9550328023143493e-10
more O 0 8.195344359737677e-13
genetically O 0 1.7480109582024284e-09
restricted O 0 9.941227840926103e-10
845 O 0 9.06419401758285e-08
G O 0 6.19315551375621e-06
- O 0 1.5986007610990782e-06
- O 0 4.6469841663565603e-07
> O 0 1.2083069655943746e-08
A O 0 1.7492759241122258e-08
mutation O 0 9.992937588521045e-10
. O 0 4.826548050118618e-10

Genotype O 0 2.3185222744359635e-05
- O 0 1.7516600792077952e-06
phenotype O 0 2.2826217360716328e-08
correlations O 0 5.554947435371105e-08
in O 0 1.2204485422273592e-08
attenuated B-Disease 1 0.9999313354492188
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 3.478326959793776e-07

Germ O 1 0.9995866417884827
- O 0 1.1127729521831498e-05
line O 0 8.403934259604284e-08
mutations O 0 5.834412952765433e-10
of O 0 6.213226377838055e-09
the O 0 2.086571804227333e-09
tumor B-Disease 0 8.613634463472408e-07
suppressor O 0 1.7503791696071858e-06
APC O 0 1.9098849861620693e-06
are O 0 1.029300880639461e-10
implicated O 0 2.7028743687651513e-08
in O 0 1.502136903752671e-08
attenuated B-Disease 1 0.9999974966049194
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.296410755458055e-05
AAPC B-Disease 1 1.0
) O 0 1.007329220037434e-09
, O 0 1.478335683036125e-11
a O 0 7.736796446555783e-12
variant O 0 1.9023232766812725e-07
of O 0 0.003908948972821236
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.196107288909843e-06
FAP B-Disease 1 0.552445650100708
) O 0 1.3222346773034133e-08
. O 0 4.9804271817777135e-09

AAPC B-Disease 1 1.0
is O 0 9.264763178862268e-09
recognized O 0 3.0837767894809076e-09
by O 0 1.9059588976522157e-11
the O 0 4.5154702893457355e-11
occurrence O 0 1.5068767345027823e-09
of O 0 1.9608559220785082e-09
< O 0 9.036105197424149e-09
100 O 0 6.022904397440243e-09
colonic B-Disease 0 5.1722592615988106e-05
adenomas I-Disease 0 3.9654651118326e-06
and O 0 2.772859442057296e-10
a O 0 7.49418860301887e-11
later O 0 2.665052623029851e-09
onset O 0 0.189496248960495
of O 1 0.5724799036979675
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.837516888121172e-10
age O 0 1.91424473494628e-10
> O 0 5.108479750326467e-10
40 O 0 2.0854964977168322e-10
years O 0 4.570195957787071e-11
) O 0 2.3248748412529885e-11
. O 0 3.461181896646792e-10

The O 0 5.783827461414148e-08
aim O 0 6.948814856855279e-09
of O 0 5.132711478061935e-10
this O 0 9.263821806014538e-14
study O 0 2.245686058985341e-12
was O 0 1.6314756837165767e-11
to O 0 1.6748438573521707e-12
assess O 0 5.915565814973434e-09
genotype O 0 1.0380739468018874e-07
- O 0 1.366499304822355e-07
phenotype O 0 3.6031486683185676e-09
correlations O 0 3.3244084818306874e-08
in O 0 1.797390325464221e-08
AAPC B-Disease 1 1.0
families O 0 1.5121225382941361e-09
. O 0 5.271578729093562e-09

By O 0 4.693658350873875e-09
protein O 0 1.4767363998302585e-09
- O 0 1.4222244715256238e-08
truncation O 0 6.931952611921588e-08
test O 0 1.9932940631406382e-08
( O 0 8.665499567905854e-11
PTT O 0 6.946809776309237e-07
) O 0 3.6253476349418223e-12
assay O 0 3.1264463240532336e-10
, O 0 3.683829283285256e-12
the O 0 6.2959481378355164e-12
entire O 0 7.445234706526804e-11
coding O 0 2.1443062603321295e-10
region O 0 2.8415136910098227e-10
of O 0 2.0626547692081942e-10
the O 0 3.043978957784077e-10
APC B-Disease 0 2.2656733733583678e-07
gene O 0 7.896489573333554e-10
was O 0 5.081823295505217e-10
screened O 0 7.004647417652166e-10
in O 0 3.093883482740978e-11
affected O 0 2.634262426248757e-11
individuals O 0 2.937171447899012e-13
from O 0 1.1768742647078057e-09
11 O 0 6.813700110797072e-07
AAPC B-Disease 1 1.0
kindreds O 0 8.122981853375677e-06
, O 0 2.9366042930689673e-10
and O 0 3.1585175447323977e-11
their O 0 4.681538837147947e-11
phenotypic O 0 4.1085645996474796e-09
differences O 0 1.1014603673586976e-09
were O 0 3.1298725833295293e-09
examined O 0 6.967091508158774e-07
. O 0 3.2508630454231024e-08

Five O 0 1.1040821590313499e-07
novel O 0 1.566372809236327e-08
germ O 0 0.0002582867455203086
- O 0 2.7923886136704823e-06
line O 0 3.5758000649366295e-07
APC B-Disease 0 2.00552847218205e-07
mutations O 0 2.1530191518515096e-10
were O 0 8.522988564907408e-11
identified O 0 1.6366596966577163e-10
in O 0 4.075174642181878e-10
seven O 0 1.600600008089259e-08
kindreds O 0 1.8682205336517654e-05
. O 0 4.0736864548307494e-08

Mutations O 0 2.338099136522942e-08
were O 0 1.3721341840522427e-09
located O 0 2.2770807461824916e-09
in O 0 1.0032344746613298e-11
three O 0 1.8517591973687964e-12
different O 0 3.5209839601216264e-13
regions O 0 5.448484025061262e-11
of O 0 7.103997945456797e-10
the O 0 1.4899319555894408e-09
APC B-Disease 0 1.059620728938171e-07
gene O 0 8.799095896350195e-10
( O 0 3.049718810821389e-11
1 O 0 5.035087902172108e-10
) O 0 5.515753327169082e-13
at O 0 4.703135103589773e-11
the O 0 2.9418842362183284e-11
5 O 0 1.8786418254368442e-10
end O 0 9.808814871448135e-11
spanning O 0 1.0280769568993264e-09
exons O 0 3.2576621955549e-10
4 O 0 8.821423452820554e-11
and O 0 1.0754680132563088e-11
5 O 0 1.4752436772180744e-10
, O 0 1.331548760141743e-11
( O 0 1.5209744271341141e-12
2 O 0 8.443381410705442e-11
) O 0 2.2066600120513452e-13
within O 0 1.089923290509276e-11
exon O 0 5.955844151195322e-10
9 O 0 1.0138906381129686e-09
, O 0 6.699279585936635e-12
and O 0 1.8538205692752996e-11
( O 0 1.0510979239763962e-11
3 O 0 3.6183187002158945e-10
) O 0 8.309284250246352e-13
at O 0 2.0813717416245936e-10
the O 0 5.5725021819164056e-11
3 O 0 9.48862877159229e-10
distal O 0 5.009752612750162e-09
end O 0 4.706349754357575e-10
of O 0 2.0327002303588415e-09
the O 0 1.6615052667035002e-09
gene O 0 9.466001316127404e-09
. O 0 2.4220634387006612e-09

Variability O 0 2.0846732695645187e-06
in O 0 2.584245040182509e-09
the O 0 1.569717966720674e-10
number O 0 1.0123770571857094e-10
of O 0 2.0253885395504767e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.3328852332961105e-07
most O 0 1.141051836350826e-11
apparent O 0 8.899941894568997e-11
in O 0 8.564947362454944e-12
individuals O 0 6.785110667761884e-14
with O 0 2.1232792000308587e-12
mutations O 0 6.971030697133784e-11
in O 0 4.510669338042561e-10
region O 0 1.0418760076902345e-08
1 O 0 5.0735767587184455e-08
, O 0 2.0527096689093582e-10
and O 0 1.6365574451171483e-09
upper O 1 0.9981518387794495
- O 1 0.9847054481506348
gastrointestinal O 1 0.9999990463256836
manifestations O 1 0.99998939037323
were O 0 5.922836443517099e-09
more O 0 1.1709328819053955e-11
severe O 0 9.432029628442251e-07
in O 0 3.487703181814794e-10
them O 0 3.4199970633252974e-10
. O 0 2.235356344471029e-09

In O 0 1.8098254006559955e-09
individuals O 0 7.93299562325267e-13
with O 0 2.94964747071802e-12
mutations O 0 3.6297839733911985e-11
in O 0 7.96611873687958e-11
either O 0 3.866563458299055e-10
region O 0 8.91837181882238e-09
2 O 0 7.593389916848992e-09
or O 0 4.732427227871483e-10
region O 0 9.458542837847972e-10
3 O 0 2.421587597112307e-09
, O 0 5.241072766754007e-12
the O 0 2.92039179297654e-12
average O 0 1.522832207556668e-12
number O 0 2.1146988240378084e-12
of O 0 7.851209682385729e-10
adenomas B-Disease 0 1.8478521042197826e-06
tended O 0 2.2547281819385034e-09
to O 0 7.675830804299011e-11
be O 0 4.454266122611017e-11
lower O 0 4.9834394388881265e-09
than O 0 4.695950659577841e-13
those O 0 3.862768666127586e-13
in O 0 1.2385120056260246e-12
individuals O 0 1.2348122538038443e-14
with O 0 2.311444221789194e-13
mutations O 0 3.8577639346892845e-12
in O 0 2.251528651020518e-11
region O 0 5.681989878603133e-10
1 O 0 1.2710466013032828e-09
, O 0 4.1766911110241445e-12
although O 0 3.190710282791054e-12
age O 0 1.450804320429766e-11
at O 0 2.7331781282669e-10
diagnosis O 0 4.8936481533701226e-08
was O 0 6.780466743627755e-10
similar O 0 1.3537603260616038e-09
. O 0 3.421133820680211e-09

In O 0 3.5954758459411096e-07
all O 0 1.6143209791152913e-07
AAPC B-Disease 1 1.0
kindreds O 0 3.6477249523159117e-05
, O 0 1.2008897209980773e-09
a O 0 1.3320092251412063e-10
predominance O 0 1.0400933803111911e-07
of O 0 1.4342413123813458e-06
right O 1 0.9999163150787354
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.008071957156062126
rectal B-Disease 1 1.0
polyp I-Disease 0 0.0020450172014534473
sparing O 0 4.809387519344455e-07
was O 0 4.1315601606584096e-08
observed O 0 2.0499728137224338e-08
. O 0 5.055336593784432e-09

No O 0 1.9560327473300276e-06
desmoid B-Disease 1 0.9999978542327881
tumors I-Disease 1 1.0
were O 0 1.5224983940242964e-08
found O 0 2.369821283654261e-10
in O 0 1.1877272776406045e-10
these O 0 4.5609332977036843e-10
kindreds O 0 9.952733307727613e-06
. O 0 2.4089066741339593e-08

Our O 0 1.19544367294111e-07
data O 0 5.04639663390094e-09
suggest O 0 2.0996734906297831e-10
that O 0 2.0965659763838573e-12
, O 0 7.024950933465224e-12
in O 0 1.3994713721210417e-10
AAPC B-Disease 1 1.0
families O 0 2.010266085539225e-11
, O 0 3.671112459163739e-12
the O 0 2.4244909465481745e-12
location O 0 1.0333018468644539e-10
of O 0 9.846083948161777e-10
the O 0 3.534474934951959e-09
APC B-Disease 0 6.939585546206217e-06
mutation O 0 6.476436054114743e-10
may O 0 1.9194912326270241e-10
partially O 0 5.193196983555026e-09
predict O 0 1.0791795929110393e-10
specific O 0 3.0288847818749076e-11
phenotypic O 0 1.4410601600900463e-08
expression O 0 3.4173122109848464e-09
. O 0 2.491048478603375e-09

This O 0 3.941892090519872e-10
should O 0 1.9164173720165323e-11
help O 0 4.402008705467475e-12
in O 0 3.5539995425770687e-12
the O 0 2.0176289024925742e-12
design O 0 2.5555255134257493e-10
of O 0 2.29967114795393e-10
tailored O 0 7.3863875016400016e-09
clinical O 0 3.1187690183287486e-05
- O 0 5.997103471599985e-07
management O 0 8.06012057097405e-09
protocols O 0 7.817055447389976e-09
in O 0 2.3749955994911698e-12
this O 0 1.4969240582328458e-14
subset O 0 1.1320231210754095e-11
of O 0 3.0686841956395483e-10
FAP B-Disease 0 4.3882459976885e-06
patients O 0 2.4972899304032126e-09
. O 0 5.372080905119425e-11
. O 0 1.198066534868758e-09

Wilms B-Disease 1 0.9970813393592834
' I-Disease 0 9.387229511048645e-05
tumor I-Disease 0 1.2529305877251318e-06
1 O 0 2.1714644304893227e-08
and O 0 1.142980710078234e-09
Dax O 0 0.00351705402135849
- O 0 3.217991206838633e-07
1 O 0 2.0124970578905277e-09
modulate O 0 2.1925388171695204e-09
the O 0 1.3233233953080514e-10
orphan O 0 9.683196466880872e-10
nuclear O 0 1.4206791298931876e-08
receptor O 0 4.8764337012841e-10
SF O 0 0.03204677999019623
- O 0 5.550499082573879e-08
1 O 0 2.0929961930260532e-10
in O 0 7.977316181760619e-13
sex O 0 3.0730210043294903e-12
- O 0 2.3710951604916097e-11
specific O 0 3.1611917944429635e-12
gene O 0 5.6036779383372703e-11
expression O 0 1.3120388109300052e-10
. O 0 6.840584210188183e-10

Products O 0 1.2586503999045817e-06
of O 0 5.391314630287525e-07
steroidogenic O 0 5.899708412471227e-06
factor O 0 5.524419144364856e-09
1 O 0 5.582858619845865e-09
( O 0 6.031772997738827e-11
SF O 1 0.703296422958374
- O 0 2.2881017969211825e-07
1 O 0 2.300181378700472e-09
) O 0 4.610697240670092e-12
and O 0 3.7367935135090846e-11
Wilms B-Disease 0 0.08934471011161804
tumor I-Disease 0 2.0375123312987853e-06
1 O 0 3.640404955262966e-08
( O 0 2.262956072529576e-10
WT1 O 0 0.0005526242894120514
) O 0 1.4507102116811943e-11
genes O 0 4.935962229224433e-12
are O 0 4.12388141213596e-13
essential O 0 3.2087527079838196e-11
for O 0 7.58527182037616e-12
mammalian O 0 6.274212260848344e-09
gonadogenesis O 0 6.78073206472618e-08
prior O 0 9.733192030125792e-10
to O 0 1.4714715557140323e-11
sexual O 0 1.9564463937804533e-10
differentiation O 0 2.9696693992775636e-09
. O 0 1.7676985430981063e-09

In O 0 1.0199291189394444e-08
males O 0 1.1546238964932343e-10
, O 0 1.0140197709285204e-10
SF O 1 0.9998438358306885
- O 0 4.68816750753831e-07
1 O 0 1.5996652891203667e-09
participates O 0 2.614874289319502e-11
in O 0 8.370925480560842e-13
sexual O 0 2.1705738335181524e-12
development O 0 3.0110614522571577e-12
by O 0 1.3777645474152833e-13
regulating O 0 3.638582490861353e-10
expression O 0 3.51785926777648e-11
of O 0 2.490562478474345e-10
the O 0 2.857399872269184e-10
polypeptide O 0 3.1437306091675055e-08
hormone O 0 4.384971052928677e-09
Mullerian O 0 6.115763881098246e-06
inhibiting O 0 3.2907141900295755e-08
substance O 0 1.7965717802326253e-07
( O 0 4.251421437118097e-09
MIS O 1 1.0
) O 0 2.473813598413699e-09
. O 0 1.6490847576378087e-09

Here O 0 9.797759048524313e-08
, O 0 8.547738628017498e-10
we O 0 1.89138652656462e-11
show O 0 2.0852061743958927e-10
that O 0 1.4103580282809336e-11
WT1 O 0 0.0008639666484668851
- O 0 1.345480768577545e-06
KTS O 0 0.3320057988166809
isoforms O 0 3.879389254279886e-09
associate O 0 1.92704998625004e-08
and O 0 2.864248005440828e-10
synergize O 0 7.060210691633984e-07
with O 0 3.058004960365679e-09
SF O 1 1.0
- O 0 2.704860435187584e-06
1 O 0 1.8847872151894762e-09
to O 0 3.741015136560222e-11
promote O 0 5.675897085666293e-08
MIS O 1 0.9999995231628418
expression O 0 2.899274242906813e-08
. O 0 3.193777908805373e-09

In O 0 1.6550096404444048e-08
contrast O 0 6.037097044497841e-09
, O 0 1.4423876537605906e-09
WT1 O 0 0.19540223479270935
missense O 0 1.3829551903654647e-07
mutations O 0 2.621963979265729e-09
, O 0 1.2483936107088311e-10
associated O 0 6.556504228427684e-10
with O 0 2.0896455399377345e-10
male B-Disease 0 8.246823668400793e-09
pseudohermaphroditism I-Disease 1 1.0
in O 0 9.033089831689267e-09
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.6117562274284865e-09
fail O 0 1.52226320437876e-08
to O 0 3.011627336402256e-10
synergize O 0 5.121811227581929e-06
with O 0 1.209748301533864e-08
SF O 1 1.0
- O 0 0.004570122808218002
1 O 0 3.0823912311461754e-07
. O 0 1.2101790680674185e-09

Additionally O 0 2.3113295810617274e-07
, O 0 3.906727441549407e-10
the O 0 3.13659431760982e-10
X O 0 8.441942895842658e-07
- O 0 1.6964339977221243e-07
linked O 0 7.279299296669706e-08
, O 0 2.2533459473339512e-11
candidate O 0 3.2476707954864903e-12
dosage O 0 7.977225990885017e-09
- O 0 6.4661085374950744e-09
sensitive O 0 1.328757548435533e-08
sex O 0 2.8957067299550943e-10
- O 0 2.674981902650586e-10
reversal O 0 1.4941486936592696e-10
gene O 0 3.778441101665031e-11
, O 0 2.0876685796755723e-11
Dax O 0 2.3643537133466452e-05
- O 0 1.208358071380644e-07
1 O 0 2.8035938015591455e-09
, O 0 3.113851884672947e-11
antagonizes O 0 2.1934098981546413e-08
synergy O 0 1.7172652633234975e-08
between O 0 2.76269296328735e-09
SF O 1 0.9999269247055054
- O 0 7.685706577831297e-07
1 O 0 5.907436317897918e-09
and O 0 3.221712341350269e-10
WT1 O 0 0.01577449031174183
, O 0 2.8003628929629265e-11
most O 0 5.624455979083565e-13
likely O 0 1.435077642657212e-12
through O 0 9.927684759339361e-13
a O 0 2.2105693740347848e-13
direct O 0 1.6201067180518502e-12
interaction O 0 1.221959061714628e-10
with O 0 2.8856500522422834e-10
SF O 1 1.0
- O 0 0.00010064680100185797
1 O 0 2.0378104181872914e-07
. O 0 2.219128436564688e-09

We O 0 7.093020837345421e-09
propose O 0 6.003429309231478e-09
that O 0 3.380487834103718e-10
WT1 O 0 0.0002667694934643805
and O 0 1.9984101484737948e-08
Dax O 0 0.08046285063028336
- O 0 9.616729812478297e-07
1 O 0 3.258944225592586e-09
functionally O 0 1.2255425563267863e-09
oppose O 0 1.8237539950449744e-11
each O 0 1.7885389350102976e-13
other O 0 2.1134045034842952e-12
in O 0 2.137494174714316e-11
testis O 0 1.1080204309621422e-08
development O 0 2.1241441938713024e-10
by O 0 6.935448049194548e-11
modulating O 0 6.154398306534858e-07
SF O 1 0.9999969005584717
- O 0 3.1153235795500223e-06
1 O 0 3.806382409266007e-08
- O 0 2.141039168179759e-08
mediated O 0 5.099422395460351e-08
transactivation O 0 5.012761334910465e-07
. O 0 1.8938169088489332e-10
. O 0 6.062711443988178e-10

A O 0 8.227373655245174e-06
mouse O 0 3.4310488672417705e-08
model O 0 7.719381245330226e-10
for O 0 7.539328272798684e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999978542327881
- O 0 0.048927728086709976
centre O 0 9.23410480027087e-05
mutations O 0 6.872539870528271e-08
. O 0 1.1876241323705017e-08

Imprinting O 0 7.809583621565253e-06
in O 0 7.999257256585679e-09
the O 0 5.217084098063651e-09
15q11 O 0 1.3127856846040231e-06
- O 0 2.3882515165496443e-07
q13 O 0 3.6115105217504606e-07
region O 0 6.238017324911027e-10
involves O 0 4.003385470352505e-11
an O 0 1.4467691367842095e-12
imprinting O 0 9.672535838944896e-08
centre O 0 6.640049150519189e-07
( O 0 2.1074893219452662e-10
IC O 1 0.9998434782028198
) O 0 7.153705405826827e-11
, O 0 1.9694963975663837e-12
mapping O 0 1.3886116215222621e-11
in O 0 2.5097491359454827e-12
part O 0 1.5919144474851876e-11
to O 0 6.10779656018412e-12
the O 0 3.24605148316337e-10
promoter O 0 7.838556257411256e-07
and O 0 4.1314929255520383e-10
first O 0 2.939004151158997e-09
exon O 0 1.4366258938025567e-07
of O 0 1.3600765669252723e-07
SNRPN O 1 1.0
. O 0 1.1464019422646743e-07

Deletion O 0 4.1441174403189507e-07
of O 0 9.646630871884554e-08
this O 0 4.883356219398394e-11
IC O 0 0.03336215764284134
abolishes O 0 1.5410570597396145e-07
local O 0 9.082444241137466e-10
paternally O 0 1.270211136272792e-08
derived O 0 2.190656545053571e-10
gene O 0 3.260234096580383e-11
expression O 0 7.656788397758518e-12
and O 0 1.8660845438334128e-11
results O 0 3.3518274267230197e-10
in O 0 8.760232539373192e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.4446678161621094
PWS B-Disease 1 1.0
) O 0 9.741279427544214e-08
. O 0 9.32176913437388e-09

We O 0 7.193639017799569e-09
have O 0 1.2460949806725186e-11
created O 0 1.2926539005864157e-10
two O 0 7.508921436027993e-12
deletion O 0 3.158651395995804e-10
mutations O 0 1.3468419435280765e-10
in O 0 3.680476201584071e-10
mice O 0 2.7271600533396168e-09
to O 0 2.49529841234164e-10
understand O 0 7.780258926004535e-08
PWS B-Disease 1 1.0
and O 0 2.6060391622451107e-09
the O 0 2.4203627990715404e-10
mechanism O 0 2.2497965712631185e-09
of O 0 3.219305932944394e-09
this O 0 2.4812915611072128e-11
IC O 1 0.9990115165710449
. O 0 2.6500352134917193e-08

Mice O 0 0.00011393047316232696
harbouring O 0 3.6249526601750404e-05
an O 0 1.141616801092482e-09
intragenic O 0 8.472708032059018e-06
deletion O 0 1.583806152893885e-08
in O 0 8.166832210498853e-10
Snrpn O 0 0.0002157755079679191
are O 0 1.3105581897487895e-10
phenotypically O 0 7.329921913878934e-07
normal O 0 4.881436055370614e-08
, O 0 7.371250831944565e-11
suggesting O 0 8.284590374829648e-11
that O 0 6.192320419450004e-13
mutations O 0 4.477360149302001e-10
of O 0 1.8823094194431178e-08
SNRPN O 1 1.0
are O 0 2.5003664069767062e-11
not O 0 2.8248510301753793e-12
sufficient O 0 1.1266992894221062e-09
to O 0 2.3508017754636512e-09
induce O 0 0.002724403515458107
PWS B-Disease 1 1.0
. O 0 7.35757907932566e-07

Mice O 0 9.130135936175066e-07
with O 0 2.2459882564884737e-10
a O 0 5.446883916127021e-11
larger O 0 5.2999632460526414e-11
deletion O 0 4.1941300432668527e-10
involving O 0 1.296140417217373e-09
both O 0 2.2644414121586465e-10
Snrpn O 0 2.0761812265845947e-05
and O 0 9.175353254953222e-10
the O 0 5.906027666924274e-09
putative O 0 3.843010745185893e-06
PWS O 1 1.0
- O 0 3.537263910402544e-05
IC O 1 0.9997715353965759
lack O 0 1.7915274597157804e-08
expression O 0 8.801562811910912e-10
of O 0 6.106652516990607e-09
the O 0 4.791948504667687e-10
imprinted O 0 3.912324331167838e-08
genes O 0 5.904313149507345e-10
Zfp127 O 0 3.808477686106926e-06
( O 0 5.509621647803442e-10
mouse O 0 3.1675340128600737e-09
homologue O 0 1.5019278265526737e-08
of O 0 1.9700150843959818e-08
ZNF127 O 1 0.9999997615814209
) O 0 1.1697108837083192e-09
, O 0 6.663540830231796e-10
Ndn O 0 6.621953070862219e-05
and O 0 4.935310826681416e-09
Ipw O 0 1.6493158909725025e-05
, O 0 7.046589978187967e-10
and O 0 6.019108128585415e-11
manifest O 0 1.4635190836997936e-08
several O 0 1.8303061843916169e-10
phenotypes O 0 2.139792343314184e-07
common O 0 3.1610834838602386e-08
to O 0 1.8756189490432007e-07
PWS B-Disease 1 1.0
infants O 0 0.34505900740623474
. O 0 2.105843854849354e-08

These O 0 6.792245654807516e-10
data O 0 4.1834000152896067e-10
demonstrate O 0 7.066749269091233e-11
that O 0 6.406249771113981e-13
both O 0 1.8825531411525986e-12
the O 0 1.299510759417144e-11
position O 0 1.211832439951266e-10
of O 0 2.907311891231501e-10
the O 0 2.8696670040240235e-10
IC O 0 0.013112741522490978
and O 0 2.1032808827925464e-10
its O 0 4.723272120643607e-11
role O 0 1.908749373835672e-11
in O 0 2.5932426778868534e-12
the O 0 2.554080428054939e-12
coordinate O 0 4.215292351283928e-11
expression O 0 1.9909351944846776e-11
of O 0 4.950770904343926e-10
genes O 0 1.0969391193993427e-11
is O 0 4.944082252975046e-13
conserved O 0 1.5119630547566487e-10
between O 0 6.62008503571343e-11
mouse O 0 5.258921631501323e-10
and O 0 1.718940614847675e-11
human O 0 7.494245501948882e-11
, O 0 6.2250439178401784e-12
and O 0 6.1533881288988734e-12
indicate O 0 1.3547999527796506e-11
that O 0 6.535428394207482e-14
the O 0 8.226926084820008e-11
mouse O 0 3.711224660918333e-10
is O 0 2.301870716606147e-13
a O 0 2.446415466039742e-13
suitable O 0 7.663830507709246e-12
model O 0 1.881867491698719e-12
system O 0 4.2833233487860056e-11
in O 0 2.729216592306516e-12
which O 0 1.9127708856918335e-13
to O 0 2.410900255475634e-13
investigate O 0 2.763412242090535e-11
the O 0 1.465276511236624e-11
molecular O 0 2.719097447201335e-10
mechanisms O 0 1.7307528743515377e-09
of O 0 1.1454380777209394e-09
imprinting O 0 4.607170200898736e-09
in O 0 5.467782476786809e-12
this O 0 1.2172535657391237e-13
region O 0 3.734199754967804e-11
of O 0 1.3979692403687238e-10
the O 0 7.885859326650646e-11
genome O 0 4.698750416531894e-11
. O 0 3.565931577798054e-11
. O 0 8.462604506043192e-10

Mutations O 0 1.9189666033980757e-07
of O 0 1.6241871492184146e-07
the O 0 2.4139557019964286e-09
ATM O 0 2.192438842030242e-05
gene O 0 8.927830141836068e-10
detected O 0 3.4452445341059956e-09
in O 0 7.913779354051798e-11
Japanese O 0 0.33049124479293823
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 2.0912777472403832e-05
: O 0 8.117721772560316e-11
possible O 0 3.642755819210919e-10
preponderance O 0 4.151334906055126e-06
of O 0 2.2412110922687134e-07
the O 0 1.3684359201349139e-09
two O 0 5.436006852987951e-11
founder O 0 1.9565386821795983e-07
mutations O 0 8.153575592473317e-09
4612del165 O 0 1.4148981790640391e-06
and O 0 3.122945102518315e-08
7883del5 O 0 2.3939666789374314e-05
. O 0 4.856843460743221e-08

The O 0 4.1449874288446154e-07
ATM O 0 0.0002560393768362701
( O 0 1.2939014482071798e-07
A O 1 1.0
- O 1 0.9999998807907104
T O 1 1.0
, O 0 4.49531245561019e-10
mutated O 0 3.679507254439329e-10
) O 0 3.0896123333346015e-12
gene O 0 1.926885213887619e-11
on O 0 2.100562779272508e-10
human O 0 5.764503874239324e-10
chromosome O 0 1.33697639626007e-08
11q22 O 0 8.797322266218544e-07
. O 0 4.4136005961092906e-09

3 O 0 2.04786442736804e-06
has O 0 9.766884523365604e-11
recently O 0 1.181959807805555e-10
been O 0 1.3038151287780853e-12
identified O 0 1.4067571977097182e-12
as O 0 5.261101341906549e-13
the O 0 2.569790517534254e-12
gene O 0 5.36685539759274e-12
responsible O 0 2.4512100682549942e-11
for O 0 1.3321120465384362e-12
the O 0 7.526319151240912e-11
human O 0 3.122915259723413e-08
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0004131455207243562
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.6778880507217764e-08
. O 0 1.8105676957702599e-09

In O 0 1.571534125055507e-09
order O 0 2.5451010743360314e-10
to O 0 4.863127695681202e-12
define O 0 2.79007338066517e-11
the O 0 6.9900396235111906e-12
types O 0 8.498351466990073e-10
of O 0 7.471150098581347e-08
disease O 0 0.15149515867233276
- O 0 6.069334546054961e-08
causing O 0 2.3181964792229337e-08
ATM O 0 3.938296231353888e-06
mutations O 0 2.712984559227749e-10
in O 0 1.8685072933344316e-10
Japanese O 0 1.4753086361452006e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.6869958459392365e-09
as O 0 5.997400492896432e-12
well O 0 7.317678581142406e-12
as O 0 1.954780955160107e-12
to O 0 1.0987477204113527e-12
look O 0 4.529530570063223e-11
for O 0 2.210127914015203e-12
possible O 0 3.6420677584914074e-10
mutational O 0 8.804473168311233e-07
hotspots O 0 2.729920254296303e-07
, O 0 5.190142066124892e-11
reverse O 0 7.970955562264237e-10
- O 0 1.1474191596860805e-09
transcribed O 0 5.053628071571836e-10
RNA O 0 2.5894691946248827e-10
derived O 0 1.3376606246284783e-11
from O 0 5.8354306629870845e-12
ten O 0 4.482057086585556e-11
patients O 0 4.293947142297583e-12
belonging O 0 4.5443998564209664e-10
to O 0 5.934183006095495e-11
eight O 0 3.6877647602295838e-09
unrelated O 0 7.263987100714075e-08
Japanese O 0 0.00030963512836024165
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 3.470421866547113e-11
was O 0 1.3616424654472326e-10
analyzed O 0 8.689365893488343e-11
for O 0 4.53751793083601e-12
mutations O 0 1.892378788392879e-11
by O 0 4.197271002981395e-12
the O 0 9.865021126376217e-12
restriction O 0 4.59436915595246e-12
endonuclease O 0 1.2097314261438896e-09
fingerprinting O 0 5.1322537331088824e-09
method O 0 5.013104931173018e-10
. O 0 3.6093855682040044e-10

As O 0 4.249589125038256e-09
has O 0 9.55093469590107e-12
been O 0 1.0137016009589828e-12
reported O 0 1.480123749258988e-12
by O 0 7.106846578244785e-13
others O 0 3.7496949989446193e-11
, O 0 9.945125452326398e-12
mutations O 0 3.918995336582576e-11
that O 0 7.229335619723942e-12
lead O 0 1.76765813098001e-09
to O 0 1.329950316542039e-10
exon O 0 7.11384871010523e-08
skipping O 0 4.031359779332888e-08
or O 0 7.825196601807249e-10
premature O 0 9.160563863019888e-09
protein O 0 1.449344672055375e-10
truncation O 0 3.7147977138829447e-08
were O 0 1.4672691950323724e-09
also O 0 5.406227895909943e-11
predominant O 0 9.224420338682648e-09
in O 0 1.8720459904475462e-10
our O 0 4.133576148035445e-09
mutants O 0 1.434543435152591e-07
. O 0 9.46917921851309e-09

Six O 0 3.7227561477948257e-08
different O 0 5.417789480932633e-11
mutations O 0 2.0774214293250992e-10
were O 0 2.6411159370631765e-10
identified O 0 7.727626871734117e-11
on O 0 5.820463000461018e-10
12 O 0 9.938612155480087e-10
of O 0 4.023090749427638e-10
the O 0 1.2136365523662818e-10
16 O 0 3.120472547024633e-09
alleles O 0 6.11947229001153e-11
examined O 0 1.673797385137732e-07
. O 0 2.0321429872183217e-08

Four O 0 3.959098293648822e-08
were O 0 1.1516969600222637e-09
deletions O 0 1.1765763474613777e-08
involving O 0 2.2806199595493126e-08
a O 0 1.3584783298270509e-09
loss O 0 1.933884448135359e-07
of O 0 1.7513949046588095e-07
a O 0 8.224357306296781e-10
single O 0 5.01743091518847e-09
exon O 0 6.644280858836282e-08
exon O 0 1.0870562050513399e-07
7 O 0 1.0833056762749038e-07
, O 0 6.085186243787177e-10
exon O 0 9.301383130377872e-08
16 O 0 3.015596305999679e-08
, O 0 2.218424888233983e-10
exon O 0 4.614982174189208e-08
33 O 0 4.349363535993689e-08
or O 0 3.5021034960891484e-09
exon O 0 7.520811209360545e-07
35 O 0 1.8138079838081467e-07
. O 0 1.3221489680859122e-08

The O 0 5.493341248552497e-08
others O 0 6.17244866329969e-10
were O 0 2.011701638604535e-10
minute O 0 3.2344713574161688e-09
deletions O 0 3.4922247316160338e-09
, O 0 7.834108362025916e-11
4649delA O 0 1.3952961452901036e-08
in O 0 2.1838397756823724e-10
exon O 0 1.5791639995654805e-08
33 O 0 6.2084999363776205e-09
and O 0 1.775784380653178e-10
7883del5 O 0 1.1633662211352203e-07
in O 0 1.5464026725808822e-09
exon O 0 3.4723876751741045e-07
55 O 0 7.809190094576479e-08
. O 0 8.253590699780489e-09

The O 0 1.7842697275227692e-07
mutations O 0 8.990685529397524e-09
4612del165 O 0 1.7043052480403276e-07
and O 0 4.174011136726108e-10
7883del5 O 0 5.272888259355568e-08
were O 0 1.6462052554455653e-10
found O 0 1.1304350684693265e-11
in O 0 1.0009728506135684e-12
more O 0 2.7826658620562494e-14
than O 0 1.0891284483440997e-13
two O 0 4.945176212967084e-13
unrelated O 0 4.1545891726890716e-11
families O 0 1.1587565217248408e-13
; O 0 4.767772548291971e-13
44 O 0 3.137633902694503e-11
% O 0 2.6974291398619565e-13
( O 0 6.687722207618374e-13
7 O 0 7.634833321112922e-10
of O 0 2.473304006045396e-09
16 O 0 3.2095575086543704e-09
) O 0 2.1017469448852966e-12
of O 0 8.61283544484337e-11
the O 0 1.2797785400864292e-11
mutant O 0 4.407995080057958e-10
alleles O 0 1.644691002312959e-12
had O 0 6.1123883732250306e-12
one O 0 2.2921543135767664e-12
of O 0 1.7507895133661577e-10
the O 0 1.0278255330176123e-10
two O 0 1.4723736119215403e-10
mutations O 0 7.56351159481028e-09
. O 0 6.288301435120047e-09

The O 0 1.8866482776047633e-07
4612del165 O 0 1.0958930261040223e-06
mutations O 0 2.820530475844407e-10
in O 0 3.227713582520941e-11
three O 0 2.0362010688668164e-12
different O 0 4.015694027303951e-13
families O 0 1.5693682789939822e-13
were O 0 6.447441105311702e-12
all O 0 5.550498862610942e-12
ascribed O 0 6.899971149998407e-10
to O 0 2.2542617078569194e-11
the O 0 4.741227410676174e-10
same O 0 1.3576020863048655e-10
T O 0 1.9680919649545103e-06
- O 0 2.348136973751025e-08
- O 0 4.2325853932823065e-09
> O 0 2.1818621909197589e-10
A O 0 2.4740012816160117e-10
substitution O 0 1.7327866919103485e-10
at O 0 1.1553023121502193e-10
the O 0 7.332600672482759e-12
splice O 0 6.044459599507945e-09
donor O 0 3.114564856021573e-11
site O 0 2.993920000804451e-09
in O 0 1.2373427837886197e-09
intron O 0 2.413454012639704e-06
33 O 0 2.762711233117443e-07
. O 0 8.551509722565243e-09

Microsatellite O 0 6.929586561454926e-06
genotyping O 0 2.0124768980167573e-06
around O 0 2.0868424766007365e-09
the O 0 1.105404545675981e-09
ATM O 0 6.219161150511354e-06
locus O 0 1.0353663704165683e-08
also O 0 7.717845806887169e-11
indicated O 0 1.6981310801966742e-10
that O 0 5.610248593815315e-13
a O 0 8.369286166876044e-12
common O 0 3.1928366200917324e-11
haplotype O 0 6.676084129964011e-10
was O 0 3.706209228404589e-10
shared O 0 1.4511418976181911e-11
by O 0 8.66119404929061e-13
the O 0 1.564895261985111e-11
mutant O 0 1.5569855127406385e-10
alleles O 0 6.765006848978572e-13
in O 0 5.656378577328924e-12
both O 0 1.8859361988754486e-11
mutations O 0 4.6084003280100205e-09
. O 0 8.004157336927165e-09

This O 0 6.140403741028422e-10
suggests O 0 3.7543557152019957e-10
that O 0 5.305156812983325e-13
these O 0 1.844705161194171e-12
two O 0 5.995136245079413e-12
founder O 0 3.722301400443939e-08
mutations O 0 1.0398401584232886e-10
may O 0 1.7711459035507637e-11
be O 0 3.769937487185793e-12
predominant O 0 2.3435091645040984e-09
among O 0 2.2825269452297903e-11
Japanese O 0 2.462413206671954e-08
ATM O 0 1.727608105284162e-05
mutant O 0 1.390289128266886e-07
alleles O 0 9.499168118765056e-10
. O 0 2.4944668552961957e-09

W474C O 0 4.778643051395193e-05
amino O 0 1.7478193115039176e-07
acid O 0 2.7332474061836365e-09
substitution O 0 1.2581136132894244e-09
affects O 0 1.3470320692210436e-10
early O 0 1.552370731960906e-11
processing O 0 1.025066975746114e-10
of O 0 7.65606258945617e-11
the O 0 8.552214492141275e-12
alpha O 0 6.937921764871291e-11
- O 0 2.478212426937354e-11
subunit O 0 4.126117850167255e-12
of O 0 3.655700395177597e-11
beta O 0 1.4286837268784325e-09
- O 0 3.4328406783856735e-09
hexosaminidase O 0 1.2095085821783869e-07
A O 0 7.283948555425468e-09
and O 0 3.5062570902244516e-11
is O 0 1.392937523138349e-12
associated O 0 7.911108573788184e-11
with O 0 2.669584275860615e-10
subacute O 1 0.6066930890083313
G B-Disease 1 0.9967902302742004
( I-Disease 0 1.5581136381115357e-07
M2 I-Disease 1 0.9999277591705322
) I-Disease 0 1.375900815503428e-08
gangliosidosis I-Disease 0 0.00016622553812339902
. O 0 2.054109771165713e-08

Mutations O 0 4.6760757044239654e-08
in O 0 1.5545648102133214e-09
the O 0 1.881396816116876e-09
HEXA O 1 0.6711504459381104
gene O 0 2.6081961590485037e-10
, O 0 2.4741023032376352e-12
encoding O 0 3.239813582342488e-12
the O 0 2.441039037570647e-11
alpha O 0 5.398129165889998e-11
- O 0 4.7340138753515504e-11
subunit O 0 3.6314239375973e-12
of O 0 8.34412192118883e-11
beta O 0 1.949035821624534e-09
- O 0 1.4588258601122561e-08
hexosaminidase O 0 8.582745749663445e-07
A O 0 3.2279530159939895e-07
( O 0 1.0010615947297907e-10
Hex O 0 5.012890014199911e-08
A O 0 9.363380826243883e-08
) O 0 7.995644944747138e-12
, O 0 2.222780987048978e-12
that O 0 1.502594435594945e-13
abolish O 0 5.695696803087458e-09
Hex O 0 5.603280328614346e-08
A O 0 5.343146813885369e-09
enzyme O 0 2.699831747055015e-10
activity O 0 1.6291263893464247e-09
cause O 0 5.6274409871548414e-05
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 9.176267745658606e-09
TSD B-Disease 1 1.0
) O 0 2.2023871615317603e-10
, O 0 1.9277086871216653e-11
the O 0 2.358377104716425e-10
fatal O 0 1.1781204193539452e-05
infantile B-Disease 0 2.6730831450549886e-06
form I-Disease 0 7.980816896235865e-09
of I-Disease 0 1.0389883755124174e-05
G I-Disease 1 0.9576770067214966
( I-Disease 0 1.4048670671229502e-08
M2 I-Disease 1 0.9985619187355042
) I-Disease 0 5.700204752656646e-10
gangliosidosis I-Disease 0 3.4052980026899604e-06
, I-Disease 0 6.052889856000832e-10
Type I-Disease 0 1.6664738211602526e-07
1 I-Disease 0 2.2746407069007546e-07
. O 0 3.933722236837411e-09

Less O 0 2.846665552169725e-07
severe O 1 0.9775741696357727
, O 0 2.652254948998234e-08
subacute O 1 0.9945694804191589
( O 0 1.0946251016719089e-08
juvenile O 1 0.8571845889091492
- O 0 2.9713987714785617e-06
onset O 1 0.9998379945755005
) O 0 1.1622711126868523e-10
and O 0 3.4851646013578375e-09
chronic O 1 0.9999998807907104
( O 0 1.3374324980830465e-09
adult O 0 4.9463775297908796e-08
- O 0 5.261110231913335e-07
onset O 0 0.012416163459420204
) O 0 6.324907177862604e-12
variants O 0 3.731418229957484e-10
are O 0 2.6609853643472237e-12
characterized O 0 1.821599260320994e-10
by O 0 9.329261321799898e-12
a O 0 7.272683150150172e-11
broad O 0 3.1399118860520048e-09
spectrum O 0 1.3904609907910981e-08
of O 0 3.4134297610677322e-09
clinical O 0 7.486727326977416e-08
manifestations O 0 3.310085730845458e-06
and O 0 2.3392163206459315e-10
are O 0 1.586572561697308e-12
associated O 0 5.2292326718772486e-11
with O 0 2.803526681638413e-11
residual O 0 2.7945361580350436e-07
levels O 0 7.001394664030158e-08
of O 0 1.629848256357036e-08
Hex O 0 1.714044515210844e-07
A O 0 5.000027414325814e-08
enzyme O 0 7.281236169554006e-10
activity O 0 9.304183201663818e-09
. O 0 1.3205302407115482e-09

We O 0 9.240127774035045e-09
identified O 0 2.8498956528011377e-09
a O 0 4.967133926392364e-10
1422 O 0 1.0137740900972858e-05
G O 0 1.3237029634183273e-05
- O 0 1.1274629514446133e-06
- O 0 5.4922729475492815e-08
> O 0 3.7881067171952054e-09
C O 0 3.1731232752463256e-07
( O 0 4.7584561291280636e-11
amino O 0 1.643200020495783e-10
acid O 0 1.592303927600014e-10
W474C O 0 2.2218220596670335e-09
) O 0 6.15602404122062e-14
substitution O 0 3.078283287993866e-12
in O 0 7.005398865167489e-13
the O 0 2.3485532095468553e-12
first O 0 4.616874590968045e-12
position O 0 4.256943061942131e-11
of O 0 2.9702795778518976e-10
exon O 0 7.689877179473115e-09
13 O 0 9.422660873781297e-09
of O 0 1.5122472163398015e-08
HEXA O 1 0.9999997615814209
of O 0 8.047248911680072e-07
a O 0 2.126167908400589e-09
non O 0 1.6403166682721348e-06
- O 0 1.3421725952866836e-07
Jewish O 0 3.880116494769936e-08
proband O 0 0.00022422302572522312
who O 0 2.609345517434747e-10
manifested O 0 1.0072739975441891e-08
a O 0 3.6934436065116927e-10
subacute O 0 2.7732910439226544e-06
variant O 0 1.924824317711682e-07
of O 0 2.6943336706608534e-05
G B-Disease 1 0.999895453453064
( I-Disease 0 1.2965298878953035e-07
M2 I-Disease 1 0.9999969005584717
) I-Disease 0 1.067067678661715e-08
gangliosidosis I-Disease 0 6.112916889833286e-05
. O 0 1.963098483770409e-08

On O 0 3.073951404530817e-07
the O 0 7.327940920731635e-09
second O 0 1.3940831600223191e-08
maternally O 0 2.4707739498808223e-07
inherited O 0 1.150116759163211e-06
allele O 0 1.26342081241404e-09
, O 0 1.5285606114190387e-10
we O 0 2.111559191386725e-12
identified O 0 1.4842974072060144e-11
the O 0 1.9187737509973601e-10
common O 0 2.2472595162525977e-07
infantile O 1 1.0
disease O 1 1.0
- O 0 2.0421266526682302e-06
causing O 0 3.030712377949385e-06
4 O 0 2.1101185154748237e-07
- O 0 9.530608480190494e-08
bp O 0 1.2548549754853866e-08
insertion O 0 6.01124394705721e-09
, O 0 9.661759170498385e-10
+ O 0 2.3101267565550643e-09
TATC O 1 0.9799633622169495
1278 O 0 2.946742642961908e-05
, O 0 3.4153818662119306e-10
in O 0 3.0816935114863497e-10
exon O 0 2.411803734503337e-07
11 O 0 1.2492898804339347e-07
. O 0 2.5641588852209907e-09

Pulse O 0 0.0003470900992397219
- O 0 1.338804509032343e-06
chase O 0 1.2473001298474173e-08
analysis O 0 3.401811471404059e-11
using O 0 1.8446473515343342e-10
proband O 0 1.2434185236998019e-06
fibroblasts O 0 9.974584713745571e-09
revealed O 0 2.261843823347931e-09
that O 0 1.9542366856695192e-12
the O 0 8.740496520998065e-11
W474C O 0 1.3549622757125235e-08
- O 0 1.6492798238232353e-09
containing O 0 2.2239916852573316e-10
alpha O 0 1.9356680147630811e-10
- O 0 1.0964334995477998e-10
subunit O 0 5.633810692268204e-12
precursor O 0 4.794974417521303e-10
was O 0 1.0543955986097586e-10
normally O 0 4.195717991789527e-12
synthesized O 0 1.8666488355023603e-09
, O 0 4.400766209777807e-12
but O 0 1.5152749931537923e-13
not O 0 7.431801349452524e-14
phosphorylated O 0 4.115621454747753e-10
or O 0 6.591559936763858e-11
secreted O 0 1.3875346704939062e-10
, O 0 6.271382024802818e-11
and O 0 3.039075241462186e-11
the O 0 5.666913049928723e-10
mature O 0 2.8756188541478878e-09
lysosomal O 0 4.894236127483964e-08
alpha O 0 3.4749558786018042e-09
- O 0 6.761198823035386e-10
subunit O 0 6.243525835225583e-11
was O 0 6.472533620183185e-10
not O 0 8.975422835511004e-12
detected O 0 4.8439932953669995e-08
. O 0 1.627408985349632e-09

When O 0 3.464250042384265e-08
the O 0 3.0975060294480272e-09
W474C O 0 5.410011638673495e-08
- O 0 1.3562103662323466e-09
containing O 0 2.884505689859651e-10
alpha O 0 6.728367862862683e-10
- O 0 2.71424743791826e-10
subunit O 0 5.1589933713902525e-11
was O 0 8.554963404350246e-10
transiently O 0 1.4447837592967971e-08
co O 0 7.131262247384029e-09
- O 0 3.019693162187309e-09
expressed O 0 1.774879375415761e-11
with O 0 4.7566568739387804e-12
the O 0 6.416332742897879e-11
beta O 0 8.945381935188124e-11
- O 0 5.927101864866557e-11
subunit O 0 1.8217365550105002e-12
to O 0 1.1202583999336824e-12
produce O 0 2.0917909071549445e-10
Hex O 0 7.837033422219974e-08
A O 0 2.9887468144806917e-07
( O 0 1.2831351259290358e-10
alphabeta O 0 2.3568196638734662e-07
) O 0 5.498949386117946e-12
in O 0 6.363523596952803e-11
COS O 0 0.0009519952582195401
- O 0 2.4330088876922673e-07
7 O 0 2.1541138650604807e-08
cells O 0 3.801522638346988e-11
, O 0 2.5534960430839693e-12
the O 0 1.579857598910106e-11
mature O 0 4.085562096967088e-11
alpha O 0 3.84718472357104e-11
- O 0 1.3582903898856635e-11
subunit O 0 2.2626343073456345e-12
was O 0 3.4249894587112806e-11
present O 0 6.236809246135122e-12
, O 0 2.0836336128704502e-12
but O 0 2.071127693176536e-13
its O 0 6.913770337485525e-12
level O 0 1.9959932318069917e-10
was O 0 1.169045693583115e-10
much O 0 1.571939410235923e-12
lower O 0 5.929069735177706e-11
than O 0 5.395876684377056e-14
that O 0 2.6642835209084517e-14
from O 0 5.147549487355407e-12
normal O 0 2.3874503068954667e-11
alpha O 0 9.264083250526411e-11
- O 0 1.903355112409244e-10
subunit O 0 2.967429774125563e-11
transfections O 0 2.0798616162664985e-08
, O 0 4.49906518290577e-12
although O 0 5.142071122198055e-13
higher O 0 8.692411374022768e-12
than O 0 6.157972894625663e-14
in O 0 1.5748294595469003e-12
those O 0 3.6358175584810803e-12
cells O 0 2.831751846898989e-11
transfected O 0 7.472254481832863e-10
with O 0 1.8592694658176034e-12
an O 0 2.2968371996001657e-12
alpha O 0 6.799517615618811e-10
- O 0 6.494273452339883e-10
subunit O 0 1.2657092041123974e-10
associated O 0 8.087064906625585e-10
with O 0 2.6710373912663954e-09
infantile O 1 0.9999732971191406
TSD B-Disease 1 0.9999998807907104
. O 0 6.826552834127142e-08

Furthermore O 0 6.53782805670744e-08
, O 0 2.577111579693536e-10
the O 0 1.3652362573779442e-10
precursor O 0 2.6179112211366373e-09
level O 0 3.665793224527647e-09
of O 0 5.585337192748341e-10
the O 0 4.122029800823768e-11
W474C O 0 1.0989826826346416e-08
alpha O 0 4.222004967857629e-10
- O 0 1.6142848169309332e-10
subunit O 0 7.152692067108335e-12
was O 0 4.7351154247587957e-11
found O 0 4.4274046234749065e-12
to O 0 6.476105459188308e-13
accumulate O 0 1.982697617197715e-10
in O 0 8.479205185207839e-12
comparison O 0 1.9427503009095126e-11
to O 0 3.2518237234879788e-12
the O 0 5.1015355134742535e-11
normal O 0 2.0629302432961794e-10
alpha O 0 3.686532190627645e-10
- O 0 2.545125499242573e-10
subunit O 0 3.4043493718494133e-11
precursor O 0 6.36322639024911e-09
levels O 0 4.89122831126565e-09
. O 0 5.873480590778968e-10

We O 0 1.2194433907097846e-08
conclude O 0 1.600691668102172e-08
that O 0 1.9791602384744422e-11
the O 0 3.345363985829408e-10
1422 O 0 8.507046004524454e-06
G O 0 1.4952691344660707e-05
- O 0 8.17605723568704e-07
- O 0 8.092442271845357e-08
> O 0 3.956778904523617e-09
C O 0 8.030722398189027e-08
mutation O 0 7.397217387239419e-12
is O 0 7.193881314216874e-14
the O 0 3.580303154643305e-12
cause O 0 4.657040864053386e-10
of O 0 9.474708129175724e-09
Hex B-Disease 0 3.5543540434446186e-05
A I-Disease 1 0.999862551689148
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.342978421334465e-09
the O 0 9.63261737041421e-09
proband O 0 2.869997115340084e-05
. O 0 7.879177310599061e-09

The O 0 5.12869462454546e-08
resulting O 0 1.4437810946787977e-08
W474C O 0 1.1316549830553413e-07
substitution O 0 6.01500582675385e-09
clearly O 0 8.681252938735895e-10
interferes O 0 3.183777408377608e-10
with O 0 1.2040420743764102e-11
alpha O 0 4.395888653085933e-10
- O 0 2.1066937083702442e-10
subunit O 0 7.298999946114826e-12
processing O 0 1.743654387542648e-10
, O 0 1.9586251023828716e-12
but O 0 4.3214750219044626e-14
because O 0 5.936529344280003e-14
the O 0 1.3603353469712753e-12
base O 0 8.874240751965967e-12
substitution O 0 1.6611020892121076e-10
falls O 0 1.0826690655107996e-08
at O 0 1.3642706409022765e-10
the O 0 2.7726621346091385e-11
first O 0 4.224919025741514e-11
position O 0 2.2053717185777089e-10
of O 0 6.256716478247881e-09
exon O 0 9.287538205171586e-08
13 O 0 2.4495125927614936e-08
, O 0 7.8716588802763e-11
aberrant O 0 1.8233880183515794e-08
splicing O 0 2.9586121996771908e-08
may O 0 7.352494169055035e-10
also O 0 4.6556446198220414e-11
contribute O 0 7.142988978081632e-11
to O 0 3.413402061003268e-10
Hex B-Disease 0 0.0001694283273536712
A I-Disease 1 0.9996064305305481
deficiency I-Disease 0 0.0001064703828888014
in O 0 3.659001712730259e-10
this O 0 1.3076161681224718e-11
proband O 0 1.572555106577056e-06
. O 0 2.0373414066909845e-10
. O 0 5.297510208279732e-10

Two O 0 1.1401115607156953e-08
frequent O 0 5.34692183862262e-08
missense O 0 3.4329127629462164e-06
mutations O 0 4.907537913823035e-07
in O 0 1.7083114016713807e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.631657759546215e-07

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 4.328052138902194e-09
an O 0 1.2006246663531783e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 4.276936670066789e-05
by O 0 2.614162497582839e-10
early O 0 4.4614185753744096e-05
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999384880065918
goiter B-Disease 1 1.0
. O 0 3.800499143835623e-06

A O 0 8.265265591944626e-07
century O 0 1.6508542088899958e-08
after O 0 4.6926781904765846e-11
its O 0 1.2588270269925372e-12
recognition O 0 6.725153420261698e-12
as O 0 5.1766368969197174e-11
a O 0 1.6936551050505955e-09
syndrome O 0 9.317254239249451e-07
by O 0 4.5162283635047373e-11
Vaughan O 0 8.397374585911166e-06
Pendred O 0 0.006316447630524635
, O 0 2.726752990067638e-10
the O 0 2.7808531033457484e-09
disease O 0 5.4724168876418844e-05
gene O 0 3.8473188523902024e-10
( O 0 1.929011811396819e-10
PDS O 0 0.016337653622031212
) O 0 1.788487136167305e-10
was O 0 2.00353111878826e-09
mapped O 0 1.1159548840566913e-08
to O 0 1.6587631268549785e-09
chromosome O 0 5.551954700422357e-07
7q22 O 0 2.135415343218483e-05
- O 0 1.0812495020218194e-05
q31 O 0 2.1657933757524006e-05
. O 0 2.167500134930833e-08

1 O 0 9.494556252320763e-08
and O 0 7.00285773813647e-10
, O 0 4.3639900720870983e-11
recently O 0 8.030037051964811e-11
, O 0 2.235267526629059e-12
found O 0 1.7225859410760491e-12
to O 0 7.409696771085161e-13
encode O 0 1.2745758615206881e-10
a O 0 2.0812843115614044e-10
putative O 0 9.439537507205387e-08
sulfate O 0 1.536487417297394e-07
transporter O 0 1.745016015775036e-05
. O 0 6.085261361477023e-08

We O 0 6.659401474706783e-09
performed O 0 1.117096282143848e-08
mutation O 0 1.231601105822211e-11
analysis O 0 1.6855709536467423e-11
of O 0 2.8682661801227027e-10
the O 0 1.3643564056309287e-10
PDS B-Disease 0 1.5315445125452243e-05
gene O 0 2.243855934391803e-10
in O 0 2.8633834886493403e-11
patients O 0 1.0186994303662544e-10
from O 0 2.973624124713581e-10
14 O 0 2.610685889692377e-09
Pendred B-Disease 0 3.7777516581627424e-07
families O 0 5.123666248219028e-13
originating O 0 1.0641763859009501e-10
from O 0 2.276691855873647e-11
seven O 0 4.973900111227003e-11
countries O 0 6.156296175965914e-13
and O 0 1.68770709213506e-11
identified O 0 1.4334514131242315e-10
all O 0 3.298465112155924e-10
mutations O 0 3.681982363445968e-08
. O 0 1.1770814545286612e-08

The O 0 4.439844403236748e-08
mutations O 0 1.3479271032679208e-09
include O 0 4.4175060831541657e-10
three O 0 7.232786591870877e-11
single O 0 1.213606576344617e-10
base O 0 1.623028933472881e-09
deletions O 0 7.38197902805382e-09
, O 0 4.367765038537641e-10
one O 0 4.1475583384409376e-11
splice O 0 8.181619648439664e-08
site O 0 5.574973815924977e-09
mutation O 0 3.2228553159541207e-10
and O 0 2.0476026429960825e-10
10 O 0 9.571082593140545e-09
missense O 0 9.921941455104388e-07
mutations O 0 5.601628458862251e-07
. O 0 5.508944056487053e-08

One O 0 2.903734852566231e-08
missense O 0 7.771046739435405e-07
mutation O 0 1.778955827091977e-08
( O 0 1.1272581756927025e-09
L236P O 0 3.147619338506047e-07
) O 0 4.418110668980013e-11
was O 0 3.441282536709167e-10
found O 0 8.149676246349546e-12
in O 0 3.1502730112042965e-12
a O 0 3.6306617434700428e-12
homozygous O 0 6.134559527026795e-11
state O 0 6.724336365504513e-11
in O 0 3.138723309037417e-11
two O 0 9.906730817632603e-12
consanguineous O 0 2.693441381040884e-08
families O 0 9.08381605612546e-13
and O 0 1.3131297264823427e-11
in O 0 2.1810496117491418e-11
a O 0 1.469990622282591e-11
heterozygous O 0 1.287426935892011e-11
state O 0 4.844096651579477e-11
in O 0 2.5014827015334973e-11
five O 0 3.737905471257186e-11
additional O 0 8.644467780483112e-11
non O 0 1.620486045794678e-06
- O 0 1.8791652109939605e-06
consanguineous O 0 3.3573473046999425e-05
families O 0 5.006187131506579e-10
. O 0 2.19319118421879e-09

Another O 0 5.38096003310784e-08
missense O 0 8.265344604296843e-07
mutation O 0 7.3510113551833456e-09
( O 0 6.658102957857182e-10
T416P O 0 5.406028549259645e-07
) O 0 5.5999489767533106e-11
was O 0 2.137617444164519e-10
found O 0 5.260060182560311e-12
in O 0 3.3324135551709988e-12
a O 0 2.9250076753056797e-12
homozygous O 0 3.6803476932689705e-11
state O 0 2.1687292586780593e-11
in O 0 3.353309296905138e-11
one O 0 3.907409552167396e-12
family O 0 1.3337060405724244e-12
and O 0 1.5654953028354512e-11
in O 0 1.9848647031528444e-11
a O 0 1.0019647438130885e-11
heterozygous O 0 7.043008971169273e-12
state O 0 1.9296585163086633e-11
in O 0 4.353830837522388e-11
four O 0 1.7742846081247876e-10
families O 0 2.899358357566495e-11
. O 0 1.8810020208093192e-09

Pendred B-Disease 1 0.9852626323699951
patients O 0 8.267237916470549e-08
in O 0 9.900054109834855e-10
three O 0 4.2790629373179456e-10
non O 0 1.1774089898608509e-06
- O 0 2.132033500856778e-07
consanguineous O 0 3.1976838954506093e-07
families O 0 2.1300450552680372e-12
were O 0 1.1618648751432481e-11
shown O 0 2.29106187146777e-12
to O 0 6.669926113159197e-13
be O 0 1.2308630677193566e-12
compound O 0 4.048168467107871e-10
heterozygotes O 0 2.8148137154460073e-09
for O 0 1.0661247579202282e-10
L236P O 0 1.130885266320547e-06
and O 0 1.753401335236049e-08
T416P O 0 1.84914988494711e-05
. O 0 3.704439066609666e-08

In O 0 6.037753852439209e-09
total O 0 3.403130555135192e-10
, O 0 1.1676990104014795e-11
one O 0 1.0587555138164007e-12
or O 0 3.4486053335919253e-12
both O 0 4.339618508292231e-12
of O 0 1.0665925087582906e-10
these O 0 6.743942427070437e-13
mutations O 0 8.841734636111376e-12
were O 0 2.8681935299035288e-11
found O 0 8.711864563082372e-12
in O 0 5.6486703335634214e-12
nine O 0 1.7951445885344697e-10
of O 0 4.734476699574941e-10
the O 0 1.8760207276535823e-10
14 O 0 1.6530874447084898e-09
families O 0 2.4725456057583806e-12
analyzed O 0 1.7420406450696646e-08
. O 0 9.15469655637935e-09

The O 0 4.124660613058495e-09
identification O 0 1.1239353447933809e-08
of O 0 6.2586740234849e-09
two O 0 2.3382337732691383e-11
frequent O 0 7.363384901815095e-10
PDS B-Disease 0 0.0002676179865375161
mutations O 0 5.011431825074908e-10
will O 0 1.4371985372629847e-11
facilitate O 0 1.7134879626290456e-10
the O 0 2.206979182739488e-10
molecular O 0 1.6142978154221055e-07
diagnosis O 0 0.003644211683422327
of O 0 0.00037805538158863783
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.846230012844899e-07

Insertional O 0 0.00035168026806786656
mutation O 0 6.741679658972544e-09
by O 0 1.906581698074561e-10
transposable O 0 1.0413197060188395e-06
element O 0 2.082096273170464e-08
, O 0 9.37726007954609e-10
L1 O 0 4.320591870055068e-06
, O 0 1.067934074505672e-10
in O 0 8.9693863447593e-11
the O 0 2.0306154535632004e-09
DMD B-Disease 1 1.0
gene O 0 2.113145658455551e-09
results O 0 6.040780098359733e-10
in O 0 3.73159614319718e-10
X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 0.9999998807907104
dilated I-Disease 1 0.9995003938674927
cardiomyopathy I-Disease 1 1.0
. O 0 1.1517462894516939e-07

X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 0.9999974966049194
dilated I-Disease 1 0.9989763498306274
cardiomyopathy I-Disease 1 1.0
( O 0 1.0363869478169363e-06
XLDCM B-Disease 1 1.0
) O 0 1.0149877605059032e-09
is O 0 1.681723011716374e-12
a O 0 6.676140976852318e-12
clinical O 0 7.111786004543319e-08
phenotype O 0 9.546032408991323e-09
of O 0 2.808594956604793e-07
dystrophinopathy B-Disease 0 0.16569460928440094
which O 0 8.914366467216439e-11
is O 0 1.6664157033441374e-12
characterized O 0 3.459213818168827e-11
by O 0 7.257076883870894e-12
preferential O 0 6.943955099814048e-08
myocardial B-Disease 0 0.06088283285498619
involvement I-Disease 0 8.299750220430724e-09
without O 0 8.456081668217763e-11
any O 0 2.847165211927738e-11
overt O 0 6.591440282477379e-09
clinical O 0 2.570438709881273e-06
signs O 0 1.1288937457720749e-05
of O 0 0.06461548060178757
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 1.4945093425922096e-05

To O 0 4.854828761224894e-10
date O 0 7.978564475763505e-09
, O 0 7.663655300638172e-12
several O 0 1.2638430883435414e-12
mutations O 0 1.6957222084834633e-11
in O 0 9.327094652178403e-11
the O 0 5.761871690879161e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 0.029463710263371468
, O 0 5.751072649218258e-07
DMD O 1 1.0
, O 0 2.763773432334915e-09
have O 0 1.2639709157796775e-12
been O 0 1.4438085059118033e-12
identified O 0 5.504174806908457e-12
in O 0 1.5805325798146086e-11
patients O 0 1.0665497651718425e-10
with O 0 5.930042568103033e-11
XLDCM B-Disease 1 1.0
, O 0 7.372660260074326e-10
but O 0 1.7229835180126996e-12
a O 0 1.6520604328995603e-12
pathogenic O 0 8.300137660510742e-11
correlation O 0 7.313883006176969e-12
of O 0 7.237230259526939e-11
these O 0 1.650917944018282e-11
cardiospecific O 0 8.403499123232905e-07
mutations O 0 5.844172257241098e-09
in O 0 1.2258844606094499e-08
DMD O 1 1.0
with O 0 2.0942350076325056e-09
the O 0 5.0698716336228244e-08
XLDCM B-Disease 1 1.0
phenotype O 0 2.9886610519724854e-08
has O 0 2.6343829895303372e-11
remained O 0 2.6093218696843223e-09
to O 0 1.930100176905647e-11
be O 0 5.718747003724545e-11
elucidated O 0 1.6400913409597706e-06
. O 0 7.479644459351675e-09

We O 0 1.8246751665174088e-08
report O 0 1.319560904988748e-09
here O 0 2.7355239601289938e-11
the O 0 3.9498356842193605e-12
identification O 0 1.6567260063826694e-10
of O 0 9.513740489852651e-11
a O 0 7.278091324058877e-12
unique O 0 1.0208194706207152e-10
de O 0 3.916909463441698e-07
novo O 0 4.389282537431427e-07
L1 O 0 8.988988611235982e-07
insertion O 0 1.0881837653187176e-09
in O 0 2.8525701245563084e-10
the O 0 1.9132528894516554e-09
muscle O 0 4.656255470081305e-08
exon O 0 1.195914762774919e-07
1 O 0 1.1144147826769313e-08
in O 0 7.243531885414711e-10
DMD O 1 1.0
in O 0 1.3962005995793447e-09
three O 0 5.869840724592734e-10
XLDCM B-Disease 1 0.9999997615814209
patients O 0 8.743151758139334e-10
from O 0 1.60626248413287e-10
two O 0 3.94822577409748e-11
unrelated O 0 2.6367898087187314e-08
Japanese O 0 1.7170938235722133e-06
families O 0 3.565926720572321e-10
. O 0 3.4717893004909683e-09

The O 0 2.4927798492058173e-08
insertion O 0 2.3333054599561365e-08
was O 0 4.741193215807016e-09
a O 0 1.0711551784448048e-10
5 O 0 4.908637385447889e-10
- O 0 2.95298285823975e-10
truncated O 0 4.7725993296277025e-11
form O 0 5.780796674681454e-11
of O 0 3.998907871505253e-10
human O 0 1.3261128306574221e-10
L1 O 0 2.053195942153252e-07
inversely O 0 3.937663528574831e-09
integrated O 0 1.3910384666360187e-07
in O 0 1.6673012970258583e-10
the O 0 2.2092619400559954e-10
5 O 0 2.433547585667384e-09
- O 0 5.198409702700246e-09
untranslated O 0 1.5087551219039597e-05
region O 0 9.561699210181018e-10
in O 0 1.3075794613737202e-10
the O 0 9.137177126028462e-10
muscle O 0 1.6932942159542108e-08
exon O 0 4.620725135850989e-08
1 O 0 6.114170059134949e-09
, O 0 6.762946105909329e-12
which O 0 1.3593420009408441e-12
affected O 0 1.1579712015652444e-11
the O 0 7.01572524033911e-12
transcription O 0 1.7646556438322136e-10
or O 0 9.970841860496016e-12
the O 0 4.145509976960504e-11
stability O 0 2.0907217623822305e-10
of O 0 6.067604751969213e-10
the O 0 1.8222040543136586e-10
muscle O 0 1.0661028726488553e-09
form O 0 4.556811317169007e-10
of O 0 1.9286973795829e-08
dystrophin O 0 3.682003324456673e-08
transcripts O 0 1.8826863623644385e-08
but O 0 2.7040344789674986e-12
not O 0 1.5931399537268132e-13
that O 0 5.794620154802449e-14
of O 0 8.501816611827806e-11
the O 0 1.194356724631973e-09
brain O 0 1.317994247074239e-05
or O 0 4.056912583649819e-09
Purkinje O 1 0.9815424084663391
cell O 0 7.522112355218269e-06
form O 0 2.2546174704984878e-08
, O 0 1.7303890265107924e-10
probably O 0 1.342896766010071e-10
due O 0 4.4305514812492675e-10
to O 0 3.72392741643246e-12
its O 0 5.394863375474124e-12
unique O 0 1.0058440191862417e-11
site O 0 3.851401142451749e-10
of O 0 1.0145889683954579e-09
integration O 0 9.37070243622884e-09
. O 0 5.4963780193872935e-09

We O 0 4.72210581747845e-09
speculate O 0 5.175474493412935e-10
that O 0 2.2262133542866325e-12
this O 0 1.8723931639094e-13
insertion O 0 5.918787682190896e-11
of O 0 2.5562663097389304e-10
an O 0 4.439081914553444e-12
L1 O 0 1.1025455251001404e-06
sequence O 0 3.7063435653905685e-10
in O 0 3.07358138940117e-10
DMD O 1 1.0
is O 0 2.5902878800221352e-11
responsible O 0 1.87266743778558e-10
for O 0 2.9406368833029273e-12
some O 0 1.1537773774578097e-12
of O 0 4.366005473821488e-11
the O 0 1.90823160224618e-12
population O 0 7.376551592588789e-15
of O 0 1.1675157368662425e-12
Japanese O 0 1.2797577442213992e-09
patients O 0 5.4865476745158404e-11
with O 0 5.654472029492652e-11
XLDCM B-Disease 1 1.0
. O 0 3.0233757719599907e-09
. O 0 1.871486521309862e-09

Severe O 1 0.9997038245201111
early O 0 0.0072520519606769085
- O 1 0.9986555576324463
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 1.7465711721342814e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.00012685709225479513
red O 1 0.9999988079071045
hair O 1 0.9999986886978149
pigmentation O 1 0.9912109971046448
caused O 0 4.254745817888761e-07
by O 0 2.2594637272277396e-09
POMC O 1 0.9999995231628418
mutations O 0 4.995849067768177e-09
in O 0 9.325890060196684e-10
humans O 0 5.7221023475051425e-09
. O 0 2.0984616266872536e-09

Sequential O 0 8.379556959425827e-08
cleavage O 0 1.0281289064550947e-07
of O 0 8.013952168539618e-08
the O 0 1.4687251415068658e-09
precursor O 0 1.1967060231654614e-08
protein O 0 1.774020652600683e-10
pre O 0 1.5889112319200649e-06
- O 0 1.6945486436270585e-07
pro O 0 4.6036589651521354e-07
- O 0 1.1370759978035494e-07
opiomelanocortin O 0 3.8474772736663e-06
( O 0 6.946545005881433e-10
POMC O 0 0.0024412304628640413
) O 0 1.3700668204108535e-11
generates O 0 3.22657491003131e-11
the O 0 2.0352403096168814e-10
melanocortin O 0 1.1405093118810328e-06
peptides O 0 1.6078640641126185e-08
adrenocorticotrophin O 0 3.1652878078602953e-06
( O 0 2.0853145876742474e-09
ACTH O 0 1.8861763237509876e-05
) O 0 1.3181063185374597e-10
, O 0 6.035513755442423e-11
melanocyte O 0 9.74043132373481e-07
- O 0 5.112999019729614e-07
stimulating O 0 2.3024040274322033e-07
hormones O 0 8.829668018961456e-08
( O 0 1.8397353085397583e-10
MSH O 0 1.223628714797087e-05
) O 0 2.3236900684869832e-12
alpha O 0 2.8062873205780825e-11
, O 0 1.9918904037036916e-13
beta O 0 8.361435675785511e-12
and O 0 8.193937607418877e-13
gamma O 0 2.0224893981790615e-10
as O 0 1.2492356324736442e-12
well O 0 9.466777405389704e-13
as O 0 1.279709628196346e-12
the O 0 3.889237456394801e-12
opioid O 0 1.6524600576772741e-09
- O 0 8.053816502595623e-10
receptor O 0 1.1815040265594767e-11
ligand O 0 1.9899575320891927e-09
beta O 0 7.491969711281854e-08
- O 0 2.1717238496421487e-07
endorphin O 0 1.3283593034429941e-05
. O 0 3.4627025691236213e-09

While O 0 6.096692573009932e-08
a O 0 3.9340955493294416e-10
few O 0 4.4280655531192537e-11
cases O 0 7.731577877923002e-11
of O 0 2.7544757585928892e-08
isolated O 1 0.9998735189437866
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
have O 0 1.4449284824191722e-10
been O 0 1.0336567018986997e-10
reported O 0 1.6395568236404756e-09
( O 0 1.4699751416102913e-09
OMIM O 1 0.9999932050704956
201400 O 0 6.678909267066047e-05
) O 0 1.2094840406984275e-10
, O 0 1.6663656565718554e-11
an O 0 3.50169927776367e-11
inherited O 1 0.9999998807907104
POMC O 1 1.0
defect O 1 0.9999991655349731
has O 0 4.5222559030833054e-10
not O 0 9.497237198063946e-12
been O 0 2.6950353407273475e-11
described O 0 2.0831032732093746e-10
so O 0 1.005940036130637e-11
far O 0 2.2742625838123587e-10
. O 0 8.944721074932716e-10

Recent O 0 6.7664913672160765e-09
studies O 0 2.712762237067068e-10
in O 0 1.9267750589468946e-11
animal O 0 3.4312744312536836e-10
models O 0 3.862823949596361e-11
elucidated O 0 8.616640734260272e-09
a O 0 8.767060688530393e-11
central O 0 1.8981500815584695e-09
role O 0 3.8806230451271517e-10
of O 0 4.350763305183136e-09
alpha O 0 2.4054081393387605e-08
- O 0 8.400311912737379e-08
MSH O 0 0.0005641540046781301
in O 0 5.533081631758918e-11
the O 0 1.401268164002989e-11
regulation O 0 6.978563837911622e-10
of O 0 1.1832501645159255e-10
food O 0 5.179933305204942e-12
intake O 0 9.171175104072393e-13
by O 0 2.2625815338048888e-13
activation O 0 9.477481299757784e-11
of O 0 1.3366826534522147e-09
the O 0 2.0534665079452452e-09
brain O 0 2.498232731795724e-07
melanocortin O 0 2.326106141481432e-06
- O 0 9.775769171938009e-08
4 O 0 6.806566865691366e-09
- O 0 9.32594446112489e-10
receptor O 0 4.629504418707242e-11
( O 0 2.3682521221868313e-11
MC4 O 0 2.9269889637362212e-05
- O 0 7.190088524566818e-08
R O 0 1.8276607249845256e-07
; O 0 1.1646206568571849e-11
refs O 0 9.035726833417357e-09
3 O 0 7.757401943031539e-10
- O 0 5.326964425123037e-10
5 O 0 5.54550676212795e-11
) O 0 2.1979271701277892e-13
and O 0 3.1330618438171753e-13
the O 0 4.995041272964906e-12
linkage O 0 1.4211282151066484e-09
of O 0 1.7470710433897807e-09
human O 0 3.259530245713904e-08
obesity B-Disease 1 1.0
to O 0 9.950480717169086e-11
chromosome O 0 1.07318232078768e-09
2 O 0 4.505080475336598e-10
in O 0 6.747046931571132e-12
close O 0 1.179221217201265e-11
proximity O 0 2.9658808742283327e-10
to O 0 1.890380213476206e-11
the O 0 9.5558283508268e-10
POMC O 0 0.3158828020095825
locus O 0 2.903666862508203e-09
, O 0 2.77112898600107e-11
led O 0 8.388260225311583e-11
to O 0 2.2612666947252613e-12
the O 0 1.6453224199741712e-11
proposal O 0 5.392590020358856e-12
of O 0 1.754828227173988e-10
an O 0 3.654213650422511e-12
association O 0 5.962974558570977e-09
of O 0 9.88161232839957e-08
POMC O 1 1.0
with O 0 1.8144302060818518e-08
human O 0 0.0020256435964256525
obesity B-Disease 1 1.0
. O 0 1.7169508481629236e-08

The O 0 2.283710642814185e-08
dual O 0 2.33417800643565e-08
role O 0 9.607149742407728e-09
of O 0 1.0635083214083352e-07
alpha O 0 3.5213460591876355e-07
- O 0 1.0346143426431809e-06
MSH O 0 0.012441547587513924
in O 0 2.97477015243075e-10
regulating O 0 5.826675142373006e-09
food O 0 3.651207391985878e-10
intake O 0 6.265048480003088e-10
and O 0 6.214941894455706e-10
influencing O 0 2.873967332561733e-06
hair O 0 0.00036489812191575766
pigmentation O 0 5.339835752238287e-06
predicts O 0 3.4322842346057314e-09
that O 0 9.863211592950338e-13
the O 0 1.3316782572492247e-11
phenotype O 0 1.6132228886078792e-10
associated O 0 1.359529988587127e-10
with O 0 1.791292288111368e-11
a O 0 7.196297446832034e-10
defect O 0 8.203040806620265e-07
in O 0 3.2511588976547046e-09
POMC O 1 0.9999418258666992
function O 0 2.1177404274652645e-10
would O 0 1.0194808192087734e-10
include O 0 6.209242542354332e-07
obesity B-Disease 1 1.0
, O 0 2.051457059781825e-10
alteration O 0 8.933390915899508e-08
in O 0 1.3183213631862145e-08
pigmentation O 1 0.9999592304229736
and O 0 0.0007027112878859043
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
. O 0 1.0759625013179175e-07

The O 0 1.4942129311634744e-08
observation O 0 5.716748319173348e-07
of O 0 8.890894775959168e-08
these O 0 1.0588318000159802e-09
symptoms O 0 3.440962973400019e-05
in O 0 2.7433993965431114e-10
two O 0 6.812118924504063e-11
probands O 0 9.578260460330057e-07
prompted O 0 1.8248378363949769e-09
us O 0 2.935225673628139e-11
to O 0 1.958415851363582e-12
search O 0 2.1363773597404823e-11
for O 0 1.9295177434985877e-12
mutations O 0 1.0485054491304879e-10
within O 0 5.446387785212892e-10
their O 0 9.948516677127373e-09
POMC O 1 0.9998645782470703
genes O 0 4.070269099543111e-08
. O 0 1.2242067803924783e-08

Patient O 0 1.6585081539233215e-05
1 O 0 1.3288935463151574e-07
was O 0 2.8306208488260154e-09
found O 0 6.396193037022657e-12
to O 0 5.74989058102493e-13
be O 0 4.229026525671975e-13
a O 0 3.145721747324637e-12
compound O 0 7.44597300483818e-11
heterozygote O 0 4.432005318300014e-10
for O 0 4.719388508461764e-12
two O 0 9.857065684515387e-12
mutations O 0 3.2771674263187833e-11
in O 0 2.2418537859447696e-10
exon O 0 2.6444959999594175e-08
3 O 0 2.541829147162389e-08
( O 0 1.0811863210280492e-10
G7013T O 0 8.956525476833122e-08
, O 0 1.4778177293006678e-10
C7133delta O 0 1.2208813586767064e-06
) O 0 6.401293991403767e-12
which O 0 2.3293555127291976e-13
interfere O 0 9.852648211183812e-12
with O 0 4.7658090581576e-13
appropriate O 0 4.405320205846941e-11
synthesis O 0 2.723895331513404e-09
of O 0 1.4155939531690365e-08
ACTH O 0 2.572038101789076e-05
and O 0 4.464229874656667e-09
alpha O 0 9.096344228964881e-07
- O 0 2.657324330357369e-06
MSH O 1 0.9960548877716064
. O 0 2.6291063548455895e-08

Patient O 0 9.820424565987196e-06
2 O 0 1.592075307144114e-07
was O 0 3.835195272472447e-09
homozygous O 0 2.2568612256801401e-10
for O 0 6.568113240790208e-12
a O 0 1.081651955503471e-11
mutation O 0 8.483831692718269e-12
in O 0 5.287766058348353e-11
exon O 0 1.8162861437076572e-08
2 O 0 1.5381932172431334e-08
( O 0 2.9971009007923044e-10
C3804A O 0 2.762405699741066e-07
) O 0 5.954432780175267e-11
which O 0 1.0618204232537565e-10
abolishes O 0 7.990742233232595e-06
POMC O 1 0.9682595729827881
translation O 0 7.487976176889788e-07
. O 0 1.7760843462610865e-08

These O 0 1.2953100814172558e-09
findings O 0 8.310137578071419e-10
represent O 0 4.764377434240963e-11
the O 0 1.7728559939533817e-11
first O 0 5.0176915573907355e-12
examples O 0 8.64727109362029e-11
of O 0 5.021219551260003e-10
a O 0 6.70847988271106e-10
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 1.9408085805139308e-08
the O 0 3.0131399597621566e-09
POMC O 1 0.9999985694885254
gene O 0 1.4804705239512828e-09
and O 0 4.858568755650161e-11
define O 0 6.214918579772188e-10
a O 0 1.805683519373602e-10
new O 0 1.3751977334663934e-08
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 0 1.4974769868558724e-08
in O 0 2.1684573581204347e-10
early O 0 4.1926784888346447e-07
- O 0 9.69743705354631e-05
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 6.563541887771862e-08
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 7.470134005416185e-05
red O 1 0.999954104423523
hair O 1 0.9996722936630249
pigmentation O 0 0.057653456926345825
. O 0 4.868610847807986e-09
. O 0 5.087470000830763e-09

A O 0 1.8462511661709868e-06
European O 0 1.4412306015287868e-08
multicenter O 0 1.931968654389493e-06
study O 0 1.0178962561724347e-08
of O 0 7.823195119271986e-06
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 5.887604626053644e-09
classification O 0 8.971451848083234e-08
of O 0 3.0448646270997415e-08
105 O 0 2.9649847022028553e-08
mutations O 0 1.589057496698132e-10
and O 0 3.555947550304417e-11
a O 0 3.237109538756222e-11
general O 0 1.225027718154692e-10
system O 0 2.2334500915377475e-10
for O 0 7.436857553388965e-12
genotype O 0 4.322506241827284e-10
- O 0 3.997070174843742e-10
based O 0 1.5116574658691206e-10
prediction O 0 6.881262493152462e-08
of O 0 8.831790410113172e-08
metabolic O 1 0.9279931783676147
phenotype O 0 2.067445166176185e-07
. O 0 1.1210963712926514e-08

Phenylketonuria B-Disease 1 0.9827422499656677
( O 0 9.764557944436092e-07
PKU B-Disease 1 0.9999977350234985
) O 0 3.962821182312837e-09
and O 0 5.681754178255005e-09
mild B-Disease 1 0.9999982118606567
hyperphenylalaninemia I-Disease 1 1.0
( O 0 0.004629094619303942
MHP B-Disease 1 1.0
) O 0 4.782762519361938e-10
are O 0 5.0026049275286866e-11
allelic B-Disease 1 1.0
disorders I-Disease 1 1.0
caused O 0 5.72306532831135e-07
by O 0 5.242014808337636e-11
mutations O 0 5.347097070673712e-11
in O 0 1.4634442963012972e-11
the O 0 4.699359998361352e-11
gene O 0 5.4334675647638164e-11
encoding O 0 3.623401856334141e-10
phenylalanine O 0 1.3847001127942349e-06
hydroxylase O 0 6.456972914747894e-05
( O 0 7.888156972057914e-08
PAH O 1 1.0
) O 0 1.950096439884419e-08
. O 0 3.5774279094624717e-09

Previous O 0 4.037253731326018e-08
studies O 0 9.982954463083615e-10
have O 0 6.504801038087482e-13
suggested O 0 3.1230163854284454e-12
that O 0 6.561570541465181e-14
the O 0 3.669411562795544e-12
highly O 0 1.991369152909428e-10
variable O 0 2.9900735221133345e-09
metabolic O 0 6.0201651649549603e-05
phenotypes O 0 3.98457905248506e-06
of O 1 0.8936553001403809
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 5.693348612112459e-06
with O 0 2.1087505785999383e-07
PAH O 1 1.0
genotypes O 0 0.0004074926837347448
. O 0 4.233920236629274e-08

We O 0 2.9794162692553527e-09
identified O 0 2.849008251537555e-10
both O 0 2.4636685053147644e-11
causative O 0 1.1994070625576114e-08
mutations O 0 8.788712535512389e-10
in O 0 3.02218639003371e-10
686 O 0 1.9385821303785633e-07
patients O 0 4.127633512762685e-10
from O 0 1.3052726677287296e-09
seven O 0 5.348939069449443e-09
European O 0 5.123610335999729e-08
centers O 0 4.009998804122006e-07
. O 0 1.1409338362966537e-08

On O 0 4.774300421672706e-08
the O 0 1.3916429120186535e-10
basis O 0 2.3137448554311213e-11
of O 0 3.6655099094895505e-11
the O 0 6.6474122213666664e-12
phenotypic O 0 5.723354568054617e-10
characteristics O 0 8.507368698396078e-10
of O 0 7.271275581643977e-09
297 O 0 3.57918388260714e-08
functionally O 0 1.4642148471466498e-07
hemizygous O 0 2.6402860839880304e-06
patients O 0 1.7648519312629674e-09
, O 0 2.99664772163144e-11
105 O 0 6.339144320577361e-09
of O 0 6.888767334345403e-10
the O 0 9.330618222502807e-11
mutations O 0 3.8406448160666073e-11
were O 0 3.297155257153683e-11
assigned O 0 1.8240549071180112e-09
to O 0 1.5282801066329732e-11
one O 0 1.978692036608276e-11
of O 0 2.310328178767307e-10
four O 0 2.517113947830829e-11
arbitrary O 0 2.69763905658138e-10
phenotype O 0 4.047306045862342e-09
categories O 0 1.1208569183907002e-08
. O 0 6.218075387920408e-09

We O 0 6.438996003055308e-09
proposed O 0 3.2762517143680725e-09
and O 0 5.387670864998029e-10
tested O 0 1.3806293885920695e-09
a O 0 4.0695780079147426e-12
simple O 0 1.31562100623428e-12
model O 0 2.434387598188731e-13
for O 0 7.266736989702469e-14
correlation O 0 9.314143423547194e-13
between O 0 1.6882727854605761e-12
genotype O 0 2.930382325683212e-10
and O 0 3.3144317151956315e-11
phenotypic O 0 9.482681306849372e-09
outcome O 0 1.907191027328281e-08
. O 0 1.6655960166644945e-08

The O 0 3.98607298279785e-08
observed O 0 1.1044819281380569e-08
phenotype O 0 3.296491968285409e-09
matched O 0 8.75555539181505e-09
the O 0 4.049234281211511e-10
predicted O 0 1.229142343461831e-10
phenotype O 0 4.4636294660449494e-11
in O 0 6.490477426346342e-12
79 O 0 4.2613074180408717e-10
% O 0 2.4681247171899623e-13
of O 0 1.5669052860767252e-11
the O 0 1.0774657208112437e-11
cases O 0 3.2808884081747536e-11
, O 0 2.330125458901988e-12
and O 0 3.109238994741803e-12
in O 0 7.017986886070915e-12
only O 0 2.53420304489535e-13
5 O 0 3.9848808280895653e-11
of O 0 6.509697642043122e-11
184 O 0 9.066641326604952e-10
patients O 0 9.707120524060642e-11
was O 0 7.966942661141729e-10
the O 0 3.065940279434187e-10
observed O 0 2.2081328432399516e-10
phenotype O 0 2.8374072189030208e-11
more O 0 1.2819662052829944e-13
than O 0 3.48302441575965e-13
one O 0 1.0892889238181547e-12
category O 0 4.461723004944851e-11
away O 0 3.933403255884649e-11
from O 0 1.1842249403315463e-11
that O 0 4.606466575372836e-13
expected O 0 6.36213082216841e-10
. O 0 2.1858326260115746e-09

Among O 0 1.2402353810614386e-08
the O 0 1.1821679191115209e-09
seven O 0 1.4262435676926088e-10
contributing O 0 1.056107892111191e-11
centers O 0 9.184453891863953e-11
, O 0 1.9454448902528343e-12
the O 0 6.300441071638296e-12
proportion O 0 1.4368094387873231e-11
of O 0 5.412834069851158e-10
patients O 0 2.5196020617124226e-11
for O 0 2.8304882743190873e-11
whom O 0 3.629348210854033e-11
the O 0 1.9298508624476796e-10
observed O 0 5.698736482706579e-10
phenotype O 0 2.337624260828619e-10
did O 0 8.33815586021025e-11
not O 0 6.67563140183125e-12
match O 0 1.3107944951684658e-08
the O 0 1.9061889566795998e-10
predicted O 0 1.9296519937483936e-10
phenotype O 0 5.991367124646985e-11
was O 0 5.54371160088607e-10
4 O 0 3.4358718647986564e-10
% O 0 1.2033687848272967e-12
- O 0 2.2309849800894455e-10
23 O 0 1.374816704924342e-09
% O 0 1.1869017053911524e-12
( O 0 1.0755643771453993e-11
P O 0 6.009492636849245e-08
< O 0 2.988591152330855e-09
. O 0 3.123565989193722e-11
0001 O 0 1.5696416610921915e-08
) O 0 2.807110230026999e-12
, O 0 4.0958496360168906e-13
suggesting O 0 3.4113417386044675e-12
that O 0 3.436258168201117e-14
differences O 0 1.471078033693507e-12
in O 0 1.398935356661593e-13
methods O 0 1.0701187115255695e-12
used O 0 1.0374815156283246e-12
for O 0 2.0104865038408914e-13
mutation O 0 1.3480594245052213e-11
detection O 0 4.880141801777427e-08
or O 0 2.5391713731615084e-10
phenotype O 0 1.876293787006489e-09
classification O 0 6.577023370368806e-09
may O 0 7.776860752595205e-12
account O 0 1.5722333374448838e-12
for O 0 9.423000574271256e-13
a O 0 1.3673902505076385e-12
considerable O 0 4.089902895521025e-12
proportion O 0 4.406849538063362e-11
of O 0 8.108565485720476e-10
genotype O 0 1.864941907570028e-07
- O 0 3.914477474609157e-06
phenotype O 0 1.2678481198236113e-07
inconsistencies O 0 1.0561275303189177e-06
. O 0 2.5678113857452445e-08

Our O 0 1.7014795616887568e-07
data O 0 7.76894104603798e-09
indicate O 0 2.952881550388753e-10
that O 0 3.0682947502191915e-12
the O 0 1.53042267747594e-09
PAH O 1 1.0
- O 0 2.3603834051755257e-06
mutation O 0 2.1697646457319308e-10
genotype O 0 5.574737338420732e-10
is O 0 1.0609023425381392e-12
the O 0 9.744921883325652e-12
main O 0 2.7589372453284966e-10
determinant O 0 6.187501067067558e-10
of O 0 6.1618066204971456e-09
metabolic O 0 0.00011674822599161416
phenotype O 0 1.761569556890663e-09
in O 0 4.777444759240801e-11
most O 0 3.594598924072656e-11
patients O 0 1.4434534456597703e-08
with O 0 1.961464477062691e-05
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.9666083517222432e-06

In O 0 4.496944150389481e-09
the O 0 3.885844979123476e-10
present O 0 2.4749344934571482e-11
study O 0 2.228394031800196e-11
, O 0 1.1997112287984169e-12
the O 0 3.407218951423374e-12
classification O 0 2.348601313428844e-09
of O 0 7.096553122920568e-09
105 O 0 2.745460051301052e-06
PAH O 1 1.0
mutations O 0 1.0997731614281747e-08
may O 0 7.585565509060643e-11
allow O 0 1.4678610757434818e-11
the O 0 1.2081859124268846e-10
prediction O 0 4.1314476284526336e-09
of O 0 7.069341223520098e-10
the O 0 1.0812811757077156e-10
biochemical O 0 1.2495599222006604e-08
phenotype O 0 1.169527918953861e-09
in O 0 2.714703184469869e-10
> O 0 1.7598065227275583e-09
10 O 0 5.416872506103232e-10
, O 0 9.651140130129132e-12
000 O 0 5.318457341196847e-10
genotypes O 0 3.56238660792485e-09
, O 0 1.737591320827292e-11
which O 0 1.8040740342589734e-12
may O 0 4.10813527293441e-12
be O 0 4.626957454331726e-13
useful O 0 6.53502339048595e-12
for O 0 2.6907196089276386e-12
the O 0 4.6755245508567356e-11
management O 0 3.3333593663087413e-09
of O 0 1.6672139224738203e-08
hyperphenylalaninemia B-Disease 1 1.0
in O 0 2.2765476614949876e-08
newborns O 0 2.413041215731937e-07
. O 0 2.9039106674844106e-09

Somatic O 0 3.949151505366899e-05
instability O 0 1.1786876257247059e-06
of O 0 3.379350914656243e-07
the O 0 1.867126897536764e-08
CTG O 0 0.004855739418417215
repeat O 0 6.938672925116407e-08
in O 0 6.26550256122016e-10
mice O 0 2.779346974790542e-09
transgenic O 0 1.768947477387428e-08
for O 0 7.931127282700956e-11
the O 0 1.382818055617463e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 3.569721911844681e-06
is O 0 5.553678350533886e-11
age O 0 2.2478727212948968e-11
dependent O 0 1.1178619661877942e-11
but O 0 2.405301164406376e-13
not O 0 8.165382703751584e-14
correlated O 0 2.624222714131541e-11
to O 0 3.0912037252833757e-12
the O 0 2.4960778235993963e-11
relative O 0 1.7365651971967822e-10
intertissue O 0 1.3624652694943507e-07
transcription O 0 2.0555011914780152e-08
levels O 0 5.830221194713658e-09
and O 0 2.6517579243545697e-09
proliferative O 0 0.00012903503375127912
capacities O 0 5.6399676395813e-06
. O 0 6.041948807933295e-08

A O 0 5.2682808018289506e-05
( O 0 4.264506969775539e-08
CTG O 0 0.000315212324494496
) O 0 2.8233940185806716e-10
nexpansion O 0 1.1552466361308689e-07
in O 0 1.8954141034477345e-10
the O 0 6.424835108376215e-10
3 O 0 2.239582386209804e-08
- O 0 4.3465359311767315e-08
untranslated O 0 0.00023501613759435713
region O 0 1.1922951514975466e-08
( O 0 1.8798963774546706e-10
UTR O 0 0.005318053532391787
) O 0 6.326612150830968e-11
of O 0 2.1603341338050086e-09
the O 0 3.801678527537433e-09
DM O 1 1.0
protein O 0 1.7663245088783697e-08
kinase O 0 1.3446209834455658e-07
gene O 0 8.03346100752833e-09
( O 0 3.4709929375154047e-10
DMPK O 1 0.9999991655349731
) O 0 3.4049339736608175e-11
is O 0 6.257873451202822e-13
responsible O 0 7.740431212654997e-11
for O 0 3.378580193391656e-10
causing O 1 0.9999996423721313
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.010403051041066647
DM B-Disease 1 1.0
) O 0 5.890213472525829e-08
. O 0 6.229162963222734e-09

Major O 0 4.434906441019848e-05
instability O 0 1.6458684513054322e-06
, O 0 6.323453982659544e-10
with O 0 6.216950999143878e-12
very O 0 1.7015855955163084e-12
large O 0 3.11884914595828e-12
expansions O 0 7.701453919040091e-10
between O 0 3.3777022845349336e-11
generations O 0 3.876382548284596e-11
and O 0 1.903397925384631e-11
high O 0 6.906304417242382e-10
levels O 0 1.2071839361471604e-10
of O 0 2.150966765812612e-10
somatic O 0 8.512798643778297e-08
mosaicism O 0 3.123981286989874e-06
, O 0 8.499644044146493e-11
is O 0 1.2082514893110852e-12
observed O 0 7.355562686717221e-11
in O 0 8.520420480273572e-11
patients O 0 2.0928614397064393e-09
. O 0 2.3389365999548772e-09

There O 0 2.1777854186666445e-08
is O 0 1.1138739930416364e-10
a O 0 5.979630679497916e-11
good O 0 2.781806451856994e-10
correlation O 0 3.2931702503846694e-11
between O 0 7.128775868225912e-12
repeat O 0 8.949614660469507e-11
size O 0 5.1423903330016785e-11
( O 0 2.0186343915873373e-11
at O 0 1.527566823034121e-10
least O 0 6.676111486553227e-13
in O 0 8.80163737032591e-12
leucocytes O 0 2.2979095604114264e-07
) O 0 1.0394707664063141e-11
, O 0 4.0086172228837036e-12
clinical O 0 3.4992857500526497e-09
severity O 0 1.5349070281445165e-07
and O 0 3.5026159750373154e-10
age O 0 5.627812660335962e-10
of O 0 5.759352550427366e-09
onset O 0 0.0001293985260417685
. O 0 5.358987031911511e-09

The O 0 1.7627353372517973e-06
trinucleotide O 0 0.049330491572618484
repeat O 0 6.483103334176121e-07
instability O 0 5.484191589744114e-08
mechanisms O 0 1.888588307963346e-08
involved O 0 1.0394142213598911e-09
in O 0 1.7490447978829593e-09
DM B-Disease 1 1.0
and O 0 1.0048978316135049e-09
other O 0 8.666491135844723e-11
human O 0 1.277696810575435e-07
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.0083450567577312e-11
unknown O 0 5.232198563298596e-10
. O 0 4.608644299519682e-10

We O 0 9.907689779709017e-09
studied O 0 1.0250840887238155e-07
somatic O 0 5.132609430802404e-07
instability O 0 1.284323936090459e-08
by O 0 1.7320729572833926e-10
measuring O 0 2.3805889668437885e-06
the O 0 2.932124232302158e-08
CTG O 0 0.0005825231783092022
repeat O 0 1.419833850491159e-08
length O 0 7.3761441399256e-11
at O 0 6.991469903017133e-11
several O 0 8.550922014731455e-13
ages O 0 1.8205355625799946e-11
in O 0 7.382724531539153e-13
various O 0 3.3317733988402765e-11
tissues O 0 8.018658625985609e-09
of O 0 2.625663597655148e-08
transgenic O 0 5.749328693127609e-07
mice O 0 6.159441845454694e-10
carrying O 0 3.651827173989375e-10
a O 0 4.142176601718006e-10
( O 0 3.325622832672792e-10
CTG O 0 0.00027449685148894787
) O 0 2.464919934830334e-10
55expansion O 0 2.754022432327474e-07
surrounded O 0 1.683241102057309e-08
by O 0 1.1081143641566982e-10
45 O 0 4.3721826159526245e-10
kb O 0 4.133380571147427e-08
of O 0 2.0324570471075276e-08
the O 0 6.408560793147444e-09
human O 0 1.1590230286628866e-07
DM B-Disease 1 1.0
region O 0 2.9258933409437304e-07
, O 0 5.807076347563722e-11
using O 0 2.656164177494702e-11
small O 0 1.9028686959465801e-10
- O 0 1.6708494143813368e-08
pool O 0 3.4392652281667324e-08
PCR O 0 1.7536590348754544e-06
. O 0 5.546824333180211e-09

These O 0 8.711213084211522e-09
mice O 0 8.737971235461828e-09
have O 0 2.573852155712819e-12
been O 0 7.979313390582554e-12
shown O 0 5.839260932422041e-12
to O 0 1.5885104646604087e-12
reproduce O 0 1.8479330565757124e-10
the O 0 3.13299317045157e-11
intergenerational O 0 2.2512292030540948e-10
and O 0 3.9365406767633004e-11
somatic O 0 6.12112671660725e-08
instability O 0 6.124032392307299e-09
of O 0 1.3392888575936013e-08
the O 0 1.4836986084176829e-09
55 O 0 8.265658379968954e-09
CTG O 0 4.5963170123286545e-05
repeat O 0 1.0557107188446935e-08
suggesting O 0 2.1980396669452062e-10
that O 0 2.998634326956129e-13
surrounding O 0 2.0616873486201115e-10
sequences O 0 4.105333087367491e-11
and O 0 5.699513343920826e-12
the O 0 2.8734597166957254e-12
chromatin O 0 3.8807343449853704e-10
environment O 0 3.157049066615514e-10
are O 0 4.911636418761245e-13
involved O 0 2.1674804312477036e-11
in O 0 1.2603562637991672e-10
instability O 0 5.405336622743562e-09
mechanisms O 0 1.0140830397631362e-07
. O 0 5.089838328586893e-09

As O 0 2.8149640396435416e-09
observed O 0 1.07519626535435e-09
in O 0 1.5097895156301888e-11
some O 0 1.454139109471897e-12
of O 0 1.9512404192401078e-10
the O 0 1.754791312258419e-10
tissues O 0 9.378573651019906e-08
of O 0 2.6576637992548058e-06
DM B-Disease 1 1.0
patients O 0 1.21245989248564e-06
, O 0 6.822416936946851e-11
there O 0 1.1379416506307471e-11
is O 0 9.317341819956027e-13
a O 0 4.184433615578298e-12
tendency O 0 2.7679329314689305e-11
for O 0 1.0061817698470144e-11
repeat O 0 4.713995305216656e-10
length O 0 4.107478940307274e-11
and O 0 2.8990266784378882e-11
somatic O 0 8.570928855533566e-08
mosaicism O 0 1.9292940578452544e-07
to O 0 1.1492754664610416e-11
increase O 0 3.57854826500692e-12
with O 0 1.854622358465896e-12
the O 0 3.3647133690362097e-11
age O 0 2.0435361736126367e-11
of O 0 8.945023888262682e-11
the O 0 3.17847415054473e-10
mouse O 0 1.049859310597867e-08
. O 0 1.3548711041977413e-09

Furthermore O 0 3.6294650840318354e-07
, O 0 8.924458949621794e-10
we O 0 3.012532064083917e-12
observed O 0 2.402671638035425e-11
no O 0 1.349175220329013e-12
correlation O 0 1.4676195371834955e-12
between O 0 1.5206030878900378e-12
the O 0 3.387959400871776e-12
somatic O 0 4.11958156476544e-09
mutation O 0 5.355456356159749e-11
rate O 0 1.3206706561685877e-10
and O 0 4.0272363222015883e-10
tissue O 0 3.677677113955724e-06
proliferation O 0 0.07601052522659302
capacity O 0 1.3433776757665328e-07
. O 0 7.770734278267355e-09

The O 0 4.255366548022721e-08
somatic O 0 3.0899286684871186e-07
mutation O 0 5.877918707319907e-10
rates O 0 7.845936400574516e-11
in O 0 2.278832721483437e-12
different O 0 5.750504781555643e-13
tissues O 0 5.518655532554817e-10
were O 0 7.643252003530776e-11
also O 0 2.171683839702343e-12
not O 0 9.329891731153089e-14
correlated O 0 2.979310895212528e-11
to O 0 4.474128532938604e-12
the O 0 4.504433978591571e-11
relative O 0 3.3871036531074594e-10
inter O 0 4.133925699534302e-07
- O 0 1.515278924557606e-08
tissue O 0 3.2661129356625906e-09
difference O 0 4.468084582875953e-11
in O 0 2.9690926366815473e-12
transcriptional O 0 4.439634423980543e-11
levels O 0 2.0067120187761134e-10
of O 0 1.0967597663391615e-10
the O 0 1.5532799005346654e-11
three O 0 1.3590989444978163e-11
genes O 0 2.0327057745350707e-11
( O 0 6.144290631837634e-11
DMAHP O 1 0.999998927116394
, O 0 4.390645180762931e-09
DMPK O 1 0.999916672706604
and O 0 8.225741865430791e-09
59 O 0 1.1099473340436816e-08
) O 0 7.02921271536483e-12
surrounding O 0 8.912551807682689e-10
the O 0 6.763597459880089e-10
repeat O 0 6.6322374259186745e-09
. O 0 1.8578247273914883e-10
. O 0 1.0615091028398638e-09

A O 0 8.794688142188534e-07
novel O 0 6.088114901103836e-09
missense O 0 7.119060541072031e-08
mutation O 0 8.294776532302706e-10
in O 0 3.2463487453782136e-10
patients O 0 5.135346037299371e-10
from O 0 2.1395072380414604e-09
a O 0 5.98908789228858e-09
retinoblastoma B-Disease 0 0.0009816946694627404
pedigree O 0 1.91715707842377e-06
showing O 0 2.772904394987563e-08
only O 0 4.328328667702053e-11
mild O 0 5.106381095743018e-08
expression O 0 5.212316689373608e-10
of O 0 2.9396449718888107e-08
the O 0 1.6381509482243928e-08
tumor B-Disease 0 4.185338639217662e-06
phenotype O 0 6.105909733378212e-08
. O 0 1.2193968501605923e-08

We O 0 6.571480692940668e-09
have O 0 6.537366568221126e-12
used O 0 2.3957709080479894e-11
single O 0 1.4095491440713204e-10
strand O 0 5.772951561233697e-11
conformation O 0 3.8575892480352536e-11
polymorphism O 0 2.640908151885224e-11
analysis O 0 2.8390675227418782e-12
to O 0 1.1680814735598455e-12
study O 0 2.172529864341577e-11
the O 0 2.220819882159386e-11
27 O 0 1.291072471154564e-09
exons O 0 2.905129470320844e-09
of O 0 1.000373117676645e-09
the O 0 5.436320837937103e-10
RB1 O 0 1.1763779184548184e-05
gene O 0 1.2239020907856002e-10
in O 0 6.176659010648233e-12
individuals O 0 2.4206732538584186e-13
from O 0 7.67650457089708e-11
a O 0 1.2220312262112287e-10
family O 0 6.567815041824687e-11
showing O 0 4.874613601657529e-09
mild O 0 1.3122983943958388e-07
expression O 0 5.991507290303844e-10
of O 0 2.2063753490897398e-08
the O 0 1.4292023564621559e-08
retinoblastoma B-Disease 0 2.8468293749028817e-05
phenotype O 0 2.3504966861764842e-07
. O 0 1.5998431024399906e-08

In O 0 7.2316082011525396e-09
this O 0 5.63987485185935e-12
family O 0 2.4269026024925644e-11
affected O 0 9.941337336671907e-11
individuals O 0 1.0888007075798845e-12
developed O 0 1.610030686549635e-08
unilateral B-Disease 0 0.00013620495155919343
tumors I-Disease 1 1.0
and O 0 8.316630584204177e-08
, O 0 2.3711504981704934e-10
as O 0 1.999150671394556e-11
a O 0 7.528740651741028e-12
result O 0 1.9100021911300225e-11
of O 0 3.5630576267209335e-10
linkage O 0 1.4616157173463762e-09
analysis O 0 7.095003057289162e-11
, O 0 8.123200896659188e-12
unaffected O 0 9.465833672450685e-10
mutation O 0 1.716561788545068e-11
carriers O 0 7.800109516620246e-12
were O 0 4.663162911366925e-11
also O 0 6.98830663475869e-12
identified O 0 8.977361909412451e-11
within O 0 1.4301286821449821e-09
the O 0 1.4011787285994615e-09
pedigree O 0 3.9304364918280044e-07
. O 0 1.138151795032627e-08

A O 0 2.5569820536475163e-06
single O 0 1.5666925534674192e-08
band O 0 6.707271182904151e-08
shift O 0 1.385326714453683e-10
using O 0 1.069218047433651e-10
SSCP O 0 0.014449027366936207
was O 0 1.8704480186926276e-09
identified O 0 3.465150388848315e-11
in O 0 1.9392331490619696e-11
exon O 0 9.143946044787299e-09
21 O 0 1.929836956904296e-09
which O 0 8.267754428130381e-13
resulted O 0 5.6202154041784524e-11
in O 0 1.288050829190146e-11
a O 0 2.5004236528514134e-11
missense O 0 1.43722269640989e-08
mutation O 0 6.596769797084789e-10
converting O 0 4.416347820779265e-08
a O 0 1.7999042256633402e-09
cys O 0 8.5315085016191e-05
- O 0 2.121827719747671e-06
- O 0 1.8576820082216727e-07
> O 0 5.662291968633326e-09
arg O 0 6.5480367084092e-07
at O 0 6.4421650236567984e-09
nucleotide O 0 6.78582301461006e-10
position O 0 8.284120056600841e-10
28 O 0 8.109709570547352e-10
in O 0 3.293094963385812e-11
the O 0 4.976882239660085e-10
exon O 0 1.8589260264434415e-07
. O 0 4.973658374041179e-09

The O 0 1.1817316192264116e-07
mutation O 0 1.0800722982651223e-08
destroyed O 0 1.2028845048916992e-06
an O 0 1.062201299140142e-10
NdeI O 0 8.306213317155198e-07
restriction O 0 7.948819935599261e-10
enzyme O 0 1.943541549920269e-09
site O 0 1.144087136140115e-08
. O 0 1.4105342449610703e-09

Analysis O 0 1.1651911435706097e-08
of O 0 2.706748958303251e-08
all O 0 1.5518562823668702e-10
family O 0 3.739402884561649e-11
members O 0 1.7939103978334425e-12
demonstrated O 0 3.31582261647867e-11
that O 0 2.4757108797908434e-13
the O 0 8.665730633072855e-11
missense O 0 7.424484493867567e-08
mutation O 0 5.460099483656222e-09
co O 0 1.6476793973652093e-07
- O 0 5.832421265949961e-07
segregated O 0 3.327966169308638e-06
with O 0 1.3560726153105662e-10
patients O 0 2.6821973531099275e-09
with O 0 4.972349643139751e-09
tumors B-Disease 1 1.0
or O 0 3.1091005325833976e-07
who O 0 1.930411386297237e-09
, O 0 8.152602898325867e-11
as O 0 1.093016996356333e-11
a O 0 9.788214509753868e-12
result O 0 2.2024784773755357e-11
of O 0 5.725429019776129e-10
linkage O 0 1.9291304109714247e-09
analysis O 0 1.4598040831703685e-10
had O 0 5.6862584085770607e-11
been O 0 1.4202812537167375e-11
predicted O 0 1.3020320932533025e-10
to O 0 3.765998797533587e-12
carry O 0 3.8376227196046386e-10
the O 0 1.691792261837577e-09
predisposing O 0 4.0877168316910684e-07
mutation O 0 3.104457491076573e-08
. O 0 9.83310144420102e-09

These O 0 2.405714516484636e-09
observations O 0 7.34613649910898e-08
point O 0 8.286080155350817e-10
to O 0 1.8171627397256529e-12
another O 0 9.42347328641846e-12
region O 0 1.2629360057747618e-10
of O 0 5.378296696889606e-10
the O 0 8.729670875062823e-10
RB1 O 0 0.0009226688416674733
gene O 0 1.4078484211754727e-10
where O 0 3.7349692783017474e-11
mutations O 0 6.3901080607497995e-12
only O 0 4.371650339906469e-13
modify O 0 1.4621949484538987e-10
the O 0 3.0427702024660164e-11
function O 0 4.470000324746648e-12
of O 0 1.1525643633936156e-10
the O 0 5.352872659014629e-11
gene O 0 4.257698013598876e-11
and O 0 2.031690267412234e-11
raise O 0 5.764875035674244e-11
important O 0 1.3714263231989765e-11
questions O 0 8.741191798167236e-12
for O 0 1.248878279437593e-12
genetic O 0 1.5994447433165249e-10
counseling O 0 6.730906110252732e-11
in O 0 1.2550582318207604e-12
families O 0 3.9295881137805036e-14
with O 0 5.840215464014697e-13
these O 0 3.430369530099675e-11
distinctive O 0 6.012805897626095e-08
phenotypes O 0 1.0046955623010945e-07
. O 0 2.2888986261904165e-09
. O 0 1.0134522554494652e-08

Maternal B-Disease 0 0.00019541385699994862
disomy I-Disease 0 0.19564278423786163
and O 0 1.3585895430878736e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.017093336209654808
with O 0 3.7220584392372302e-09
gamete O 0 3.046926394745242e-06
complementation O 1 0.6044806838035583
in O 0 1.0722124299533675e-09
a O 0 1.0282059231814245e-10
case O 0 1.610661742867947e-10
of O 0 1.8195454032365888e-08
familial O 0 4.580623169658793e-08
translocation O 0 6.88430787931793e-08
( O 0 6.594907953072493e-10
3 O 0 4.257150187925163e-09
; O 0 1.505516371291815e-11
15 O 0 6.017412679248935e-10
) O 0 1.606695787699508e-12
( O 0 3.658223463737231e-12
p25 O 0 2.917133867796906e-09
; O 0 1.671567224914572e-11
q11 O 0 2.5306254869406075e-08
. O 0 3.84162666955401e-11
2 O 0 2.685033084759425e-09
) O 0 4.780343482169158e-11
. O 0 6.075212555245457e-10

Maternal B-Disease 0 0.0022569610737264156
uniparental I-Disease 1 0.9954597353935242
disomy I-Disease 1 0.9993351101875305
( I-Disease 0 2.8101242151024053e-06
UPD I-Disease 1 1.0
) I-Disease 0 2.05401495811941e-09
for I-Disease 0 1.2794278136940562e-10
chromosome I-Disease 0 3.598272568794414e-09
15 I-Disease 0 1.1631476892759451e-09
is O 0 3.302705114602289e-12
responsible O 0 1.1030996949212835e-10
for O 0 2.7419477278967097e-12
an O 0 5.277201202066872e-13
estimated O 0 9.158869409414683e-13
30 O 0 1.92859148789859e-11
% O 0 6.236208245765859e-14
of O 0 9.365984550424589e-13
cases O 0 8.621707514588905e-12
of O 0 2.8725340328605853e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.22518430650234222
PWS B-Disease 1 1.0
) O 0 8.05420725669137e-08
. O 0 1.078699085610424e-08

We O 0 6.592597134869038e-09
report O 0 3.4365665868563156e-10
on O 0 1.8063001094859032e-10
an O 0 1.301597989545461e-13
unusual O 0 5.216956640990977e-12
case O 0 4.140263132335065e-11
of O 0 3.6822331850316914e-09
maternal B-Disease 0 2.1714441800213535e-07
disomy I-Disease 0 1.2960076674062293e-05
15 I-Disease 0 1.1973841473889024e-08
in O 0 1.5091288219082344e-09
PWS B-Disease 1 1.0
that O 0 4.4320540293352195e-11
is O 0 2.529230514261571e-12
most O 0 1.3907022235193356e-12
consistent O 0 3.070944332161929e-10
with O 0 4.981511730894894e-12
adjacent O 0 1.690763973272169e-08
- O 0 7.54807683023273e-09
1 O 0 1.0703755659591252e-09
segregation O 0 1.2864371790044515e-08
of O 0 1.2968569274018904e-10
a O 0 8.293566354511395e-12
paternal O 0 1.5260154251350855e-09
t O 0 4.343077897317471e-09
( O 0 3.160578396221858e-11
3 O 0 3.8278924474610676e-10
; O 0 4.648845110949429e-12
15 O 0 1.310003355792233e-10
) O 0 9.361037335911537e-13
( O 0 2.061771543424018e-12
p25 O 0 2.2833002155664417e-09
; O 0 6.9383678490131384e-12
q11 O 0 4.142400200635166e-09
. O 0 2.641163763389409e-12
2 O 0 2.926331746366806e-11
) O 0 2.0020984382081858e-13
with O 0 7.35155412565601e-14
simultaneous O 0 4.980073020632858e-10
maternal O 0 5.561170368650892e-08
meiotic O 0 1.176007845060667e-05
nondisjunction O 0 5.294472884997958e-06
for O 0 1.93398630443653e-09
chromosome O 0 1.0301625508191137e-07
15 O 0 5.2721141230449575e-08
. O 0 2.898045581289921e-09

The O 0 5.070554038866248e-07
patient O 0 4.9635451659924e-07
( O 0 2.9043205618251022e-09
J O 0 0.0031987393740564585
. O 0 1.1230899543690498e-10
B O 0 2.8884230118819687e-08
. O 0 1.3837672327432493e-12
) O 0 2.4334822893747055e-13
, O 0 4.1253602638992304e-13
a O 0 5.662888127172527e-12
17 O 0 4.5611592280891955e-10
- O 0 4.729864833130648e-10
year O 0 5.2515821552523434e-11
- O 0 1.0077774170724751e-08
old O 0 4.0998301642503066e-08
white O 0 8.467378881382714e-11
male O 0 2.2922518050361163e-11
with O 0 2.457112638354353e-11
PWS B-Disease 1 1.0
, O 0 2.5394435443359953e-09
was O 0 2.4206134874305008e-09
found O 0 1.609186915663141e-11
to O 0 3.280317423942636e-12
have O 0 3.2394859364459627e-12
47 O 0 3.3889580031143396e-10
chromosomes O 0 1.1334064242696229e-10
with O 0 3.1812261158670196e-11
a O 0 6.94899748854283e-10
supernumerary O 0 1.2211934290462523e-06
, O 0 7.501356757977362e-10
paternal O 0 2.0808972323038688e-08
der O 0 0.0019772632513195276
( O 0 2.4322250880004503e-09
15 O 0 3.755095345781001e-09
) O 0 3.4040491779518955e-12
consisting O 0 2.4823013089481094e-10
of O 0 3.885009647319748e-09
the O 0 5.487725829311785e-09
short O 0 1.82989605690409e-08
arm O 0 2.183433207392227e-05
and O 0 4.987737334261055e-09
the O 0 8.825303154935682e-09
proximal O 0 2.519409918022575e-06
long O 0 2.23124239084882e-08
arm O 0 7.219783128675772e-06
of O 0 7.702489710936788e-06
chromosome O 0 1.556588244966406e-07
15 O 0 3.027687611734109e-08
, O 0 2.289168299363098e-10
and O 0 1.937759952497231e-09
distal O 0 4.3777145037893206e-05
chromosome O 0 0.0002674310526344925
arm O 1 0.9997088313102722
3p O 1 0.9999221563339233
. O 0 2.2220961000130046e-06

The O 0 1.8144686464438564e-06
t O 0 1.9327229949794855e-07
( O 0 2.2143412103936555e-10
3 O 0 4.487534233099666e-10
; O 0 1.8954484249517067e-12
15 O 0 2.5619466617610165e-11
) O 0 1.2176506547847965e-13
was O 0 6.26055110530821e-12
present O 0 1.4920227596817992e-12
in O 0 2.4433666895307127e-12
the O 0 9.546491201717355e-12
balanced O 0 5.26461998995309e-11
state O 0 9.104983260399546e-12
in O 0 2.3255876391292674e-12
the O 0 1.2516545959406766e-11
patients O 0 5.5642282448253866e-11
father O 0 6.070255409440506e-10
and O 0 4.507555995125756e-10
a O 0 3.973477546992399e-09
sister O 0 9.628761290514376e-07
. O 0 2.4142471133359322e-08

Fluorescent O 0 9.514785688224947e-07
in O 0 1.5478545112301845e-09
situ O 0 1.2138045235587924e-08
hybridization O 0 2.743037220975797e-11
analysis O 0 1.8686559244418532e-11
demonstrated O 0 9.118717586575897e-11
that O 0 2.8935506334731853e-12
the O 0 8.809372120666126e-10
PWS B-Disease 1 1.0
critical O 0 2.8532747720078078e-08
region O 0 1.7677457275766528e-09
resided O 0 3.3879001826164767e-09
on O 0 9.81772885211285e-10
the O 0 8.810493307143119e-11
derivative O 0 3.6755392063270165e-09
chromosome O 0 3.325662634168225e-09
3 O 0 1.3613834504155875e-09
and O 0 1.0459243714178168e-11
that O 0 2.945608980255837e-13
there O 0 1.5259723823088378e-12
was O 0 7.01135399738817e-11
no O 0 1.3962465081687747e-12
deletion O 0 3.742471263445957e-11
of O 0 4.772146566800473e-10
the O 0 3.3438471991331653e-09
PWS B-Disease 1 1.0
region O 0 1.839635928035932e-07
on O 0 7.026690340694586e-09
the O 0 4.332939840256955e-10
normal O 0 1.1930885168709437e-09
pair O 0 8.161538112005928e-10
of O 0 2.142345190137007e-09
15s O 0 1.5922120155664743e-07
present O 0 1.8120464018167581e-09
in O 0 1.8416679736787955e-08
J O 1 0.9999889135360718
. O 0 6.197818436248781e-08

B O 0 0.004206384066492319
. O 0 1.2873827870407695e-07

Methylation O 0 1.2521107350949023e-07
analysis O 0 4.077135962177181e-09
at O 0 3.9893035541638255e-09
exon O 0 8.771267268059546e-09
alpha O 0 3.317217833753716e-09
of O 0 5.874948305617522e-10
the O 0 7.104888899434059e-11
small O 0 5.512866552148665e-11
nuclear O 0 1.715074517960602e-07
ribonucleoprotein O 0 1.1905212886631489e-06
- O 0 1.010524570688176e-07
associated O 0 3.831846395740968e-09
polypeptide O 0 6.616181025265178e-08
N O 0 9.216967100655893e-08
( O 0 1.3875453563905182e-10
SNRPN O 1 0.9998177886009216
) O 0 1.1848896863675407e-10
gene O 0 1.9352619506918245e-10
showed O 0 7.767791965207493e-11
a O 0 1.0923687301933604e-11
pattern O 0 6.232558358298945e-10
characteristic O 0 5.416024850823931e-10
of O 0 3.436278206425669e-10
only O 0 6.718611669613572e-13
the O 0 4.038110124060523e-11
maternal O 0 2.242132923768736e-09
chromosome O 0 1.6225770727018585e-09
15 O 0 2.482245520241122e-09
in O 0 4.801237185603213e-09
J O 1 0.9999589920043945
. O 0 2.9213616414835997e-08

B O 0 0.0057212235406041145
. O 0 1.0592165722300706e-07

Maternal B-Disease 0 5.071368286735378e-05
disomy I-Disease 0 0.0002517322136554867
was O 0 3.4123182501843985e-08
confirmed O 0 3.130969927767069e-10
by O 0 6.405703224798831e-12
polymerase O 0 8.929192385487283e-10
chain O 0 6.346605463392052e-10
reaction O 0 9.595158868835885e-12
analysis O 0 4.298291930715514e-11
of O 0 4.002791986756904e-10
microsatellite O 0 1.8934791512492666e-08
repeats O 0 1.8041867999585293e-09
at O 0 1.5458010427238378e-09
the O 0 1.444922931304049e-10
gamma O 0 2.5969255190716467e-08
- O 0 1.5592783952911304e-08
aminobutyric O 0 1.627871597520425e-07
acid O 0 1.2854309838772338e-09
receptor O 0 7.789335149110954e-11
beta3 O 0 4.6703263478775625e-08
subunit O 0 2.9461980077805094e-10
( O 0 1.048141573534167e-10
GABRB3 O 0 0.2995039224624634
) O 0 2.417078204253187e-10
locus O 0 3.8665506352231205e-09
. O 0 9.32011134935351e-10

A O 0 2.2895366782904603e-05
niece O 0 3.772919853872736e-06
( O 0 6.9810166536399265e-09
B O 0 6.689435281259648e-07
. O 0 2.3519073841238303e-11
B O 0 9.709278714353786e-09
. O 0 2.9194214320321654e-13
) O 0 7.957799322928436e-14
with O 0 1.648776330308993e-13
45 O 0 1.2319064171539829e-11
chromosomes O 0 7.478021674112156e-12
and O 0 7.235267072969176e-12
the O 0 3.25305372916862e-11
derivative O 0 4.037619683039395e-10
3 O 0 6.006954378356966e-10
but O 0 2.0923234932829216e-12
without O 0 5.140897256505905e-12
the O 0 7.725593081930882e-11
der O 0 1.4994315279182047e-05
( O 0 2.769735274466001e-10
15 O 0 1.4169870832247966e-09
) O 0 4.646540530811594e-12
demonstrated O 0 9.252463378794928e-11
a O 0 4.598456337934209e-11
phenotype O 0 4.5317535835032174e-10
consistent O 0 1.3782087693314793e-09
with O 0 9.78298778792075e-12
that O 0 1.0738727615478005e-12
reported O 0 5.492306609511388e-11
for O 0 2.1606532535356493e-11
haploinsufficiency O 0 2.7149083052790957e-06
of O 0 4.787139005202334e-07
distal O 0 2.1558234948315658e-06
3 O 0 1.6477656572533306e-06
p O 0 2.521366013752413e-07
. O 0 2.3330384735231746e-08

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 5.288439979267423e-07
with O 0 5.987165763166047e-10
unbalanced O 0 4.4139821397948253e-07
segregation O 0 8.687646186444908e-06
of O 0 4.614947002323788e-08
non O 0 7.516060122725321e-06
- O 0 2.1654193460562965e-06
Robertsonian O 0 0.00042265388765372336
translocations O 0 2.655322930422699e-07
has O 0 4.8079953213209237e-11
been O 0 9.81524844040349e-12
reported O 0 4.5287100458590857e-11
previously O 0 2.4133836595829905e-10
but O 0 1.07243174844035e-12
has O 0 6.394942220081315e-14
not O 0 1.4575482747830604e-13
, O 0 6.336616344485013e-13
to O 0 9.903344420567062e-13
our O 0 4.4270014737390895e-11
knowledge O 0 2.739232451975937e-10
, O 0 4.996470685109111e-12
been O 0 6.566843965306879e-13
observed O 0 8.682138341598034e-12
in O 0 4.269243378957066e-12
a O 0 1.3726249303847027e-11
case O 0 3.745929677556603e-10
of O 0 1.2343630828581809e-07
PWS B-Disease 1 1.0
. O 0 2.285630671394756e-07

Furthermore O 0 1.2753987448377302e-06
, O 0 5.27463583921417e-09
our O 0 7.053905792808735e-10
findings O 0 6.922275530563127e-10
are O 0 2.2417660176105025e-12
best O 0 4.4424467576797966e-11
interpreted O 0 6.568492277869709e-11
as O 0 1.854878056706255e-11
true O 0 1.6673330771599382e-10
gamete O 0 3.97721784395344e-08
complementation O 0 3.4309227885387372e-06
resulting O 0 7.2580843557545904e-09
in O 0 2.238650154140487e-09
maternal B-Disease 0 2.2114085368230008e-05
UPD I-Disease 1 1.0
15 I-Disease 0 2.3357459213002585e-05
and O 0 2.549171085775015e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.807164192199707
- I-Disease 1 0.9993896484375
Jampel I-Disease 1 1.0
syndrome I-Disease 1 0.9999972581863403
type I-Disease 0 3.3973219615290873e-06
2 I-Disease 0 6.87778424435237e-07
and O 0 4.874799675036456e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 2.4390761632631097e-10
a O 0 6.395708268547295e-11
case O 0 1.3714793190011676e-10
for O 0 1.1117853859765603e-10
" O 0 2.5878310605520483e-09
lumping O 0 3.419326048970106e-07
" O 0 4.049377366754925e-08
. O 0 5.96275828712578e-09

Recent O 0 4.5797121650537065e-09
studies O 0 4.665531849745719e-10
demonstrated O 0 1.4826116723209992e-10
the O 0 1.8681212826665572e-11
existence O 0 1.7873991176031723e-10
of O 0 4.999430869290222e-10
a O 0 3.5213096327701976e-11
genetically O 0 8.498939330081612e-09
distinct O 0 5.989210238865894e-10
, O 0 2.0343813439405167e-11
usually O 0 2.3537057719513754e-12
lethal O 0 5.147800519189616e-10
form O 0 6.822885312285365e-11
of O 0 5.871094721499048e-10
the O 0 9.579588233776803e-10
Schwartz B-Disease 0 6.419643614208326e-05
- I-Disease 1 0.9999178647994995
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.2861088900281175e-08
SJS B-Disease 1 1.0
) O 0 6.957232567827987e-10
of O 0 5.202172133067506e-07
myotonia B-Disease 1 1.0
and O 0 0.0011261769104748964
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 1.7891096604216727e-08
which O 0 8.183298483288581e-10
we O 0 2.590382908174149e-10
called O 0 3.7902626814911855e-08
SJS B-Disease 1 0.9999996423721313
type I-Disease 0 1.3911972018831875e-05
2 I-Disease 0 1.4451043170993216e-06
. O 0 6.144202924218689e-09

This O 0 2.2657570042383668e-08
disorder O 1 0.9956496357917786
is O 0 1.8121182332464514e-10
reminiscent O 0 2.949003373942105e-06
of O 0 8.728280675995848e-08
another O 0 1.430204288332959e-10
rare O 0 5.083987897336328e-09
condition O 0 1.008860621709573e-07
, O 0 2.784354413698509e-10
the O 0 9.113302112950805e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.4677174792486767e-07
SWS B-Disease 1 1.0
) O 0 1.3192815728757523e-09
, O 0 6.837684585203618e-11
which O 0 2.9645785826204474e-11
comprises O 0 5.269567893151361e-09
campomelia B-Disease 0 5.885844529984752e-06
at O 0 4.290443555987622e-08
birth O 0 1.942123759590686e-07
with O 0 2.4924646790935867e-09
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.5500071387796197e-07
contractures B-Disease 1 1.0
, O 0 6.356069892632377e-09
and O 0 1.0841646469472721e-09
early B-Disease 0 1.2674865956796566e-07
death I-Disease 0 5.33370609900885e-07
. O 0 4.794190822110522e-09

To O 0 1.931383719622204e-09
test O 0 2.376730146025352e-09
for O 0 2.346157773266966e-12
possible O 0 4.099339617757991e-11
nosologic O 0 2.726621005422203e-06
identity O 0 8.781972371529889e-11
between O 0 5.447423762072745e-11
these O 0 5.062532615340842e-10
disorders O 1 1.0
, O 0 1.0507196501752247e-10
we O 0 2.5097107551885767e-12
reviewed O 0 1.9132118111997443e-10
the O 0 1.3882303293022424e-11
literature O 0 2.0025930566602845e-11
and O 0 1.2669614706320442e-12
obtained O 0 1.1456510219665095e-11
a O 0 5.543219529224874e-12
follow O 0 1.7171644314806223e-11
- O 0 4.46074677196151e-10
up O 0 1.5357957960926427e-11
of O 0 3.07485807649055e-11
the O 0 2.133354907660201e-12
only O 0 1.4823378798305836e-13
two O 0 1.091562170513205e-12
surviving O 0 4.362846084404737e-09
patients O 0 1.4241367807255045e-10
, O 0 1.6743275169095462e-11
one O 0 2.250523899183232e-11
with O 0 1.721920939168342e-10
SJS B-Disease 1 0.9998620748519897
type I-Disease 0 1.0450543186379946e-06
2 I-Disease 0 6.855886169887526e-08
at O 0 7.70535191207955e-09
age O 0 6.290597903690909e-11
10 O 0 7.066435544350602e-12
years O 0 1.1275790414225217e-12
and O 0 3.138458460130722e-12
another O 0 9.773550892211436e-12
with O 0 5.610276132550496e-11
SWS B-Disease 1 0.9999994039535522
at O 0 8.602899015386356e-08
age O 0 1.0223203394943425e-09
7 O 0 1.239102775940637e-08
years O 0 3.566055783998934e-10
. O 0 1.8275930768751891e-09

Patients O 0 2.809575505580142e-07
reported O 0 2.8112938643687357e-09
as O 0 1.6761526888675604e-10
having O 0 6.248174755363323e-10
either O 0 2.389921576195775e-07
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.00010513451707083732
SWS B-Disease 1 1.0
presented O 0 4.389140073612907e-08
a O 0 3.1862923410841404e-10
combination O 0 5.162463345698143e-09
of O 0 2.7818941816804e-08
a O 0 1.3122596342896031e-09
severe O 1 0.9558828473091125
, O 0 2.3828126138880634e-09
prenatal O 0 0.42685243487358093
- O 1 0.9182053208351135
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 4.78908475542994e-07
with O 0 0.062047604471445084
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.8392446041107178
feeding O 1 0.9827357530593872
difficulties O 0 0.0021172985434532166
, O 0 3.979560236899715e-09
tendency O 0 2.8201982971154393e-09
to O 0 5.481968767817591e-10
hyperthermia B-Disease 1 0.8198162913322449
, O 0 8.135955242849491e-10
and O 0 7.755208975002148e-11
frequent O 0 1.5606067826912096e-10
death O 0 1.1388292975311742e-08
in O 0 2.881931915332814e-10
infancy O 0 1.6503733490935701e-07
) O 0 5.156196650202283e-12
with O 0 1.3374864367074468e-12
a O 0 9.159524527735385e-11
distinct O 0 1.0872879485646081e-08
campomelic B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999998807907104
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 1.9534229522832902e-06

The O 0 9.100603826084352e-09
similarity O 0 1.5970312849944435e-09
of O 0 1.0088966995169812e-08
the O 0 6.665574203701397e-10
clinical O 0 3.5050263136326976e-07
and O 0 1.0347755985407048e-09
radiographic O 0 8.312147110700607e-05
findings O 0 5.6749879462358876e-08
is O 0 2.532253573495069e-11
so O 0 5.831599851451041e-13
extensive O 0 2.4144791721525394e-10
that O 0 2.0808773541075576e-12
these O 0 5.435117911289922e-10
disorders O 1 1.0
appear O 0 9.990650529090317e-10
to O 0 1.5692381422072188e-11
be O 0 1.0972907478479232e-11
a O 0 3.218357177980913e-11
single O 0 6.010725250860105e-10
entity O 0 1.6874778907549626e-08
. O 0 1.0374104242316662e-08

The O 0 5.0255270167554045e-08
follow O 0 6.563038557061418e-09
- O 0 1.1164722479861666e-08
up O 0 9.988740390376449e-11
observation O 0 1.2090263012964897e-08
of O 0 2.9604269036198616e-10
an O 0 7.733649875010795e-13
identical O 0 3.775078860623893e-10
and O 0 2.3473181731681336e-11
unique O 0 9.685519053448388e-11
pattern O 0 9.332763895031349e-09
of O 0 1.4285595284491137e-07
progressive O 1 0.9999998807907104
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 1.048630604572054e-08
the O 0 8.202960977143903e-09
two O 0 2.88829321570816e-10
patients O 0 6.113444195321449e-10
( O 0 5.075543804688998e-11
one O 0 1.4396658865045708e-10
with O 0 2.135581045337176e-09
SJS B-Disease 1 1.0
type I-Disease 0 3.329474930069409e-05
2 I-Disease 0 3.184965464697598e-07
, O 0 4.629522112886697e-11
one O 0 4.770521651320525e-12
with O 0 6.067658875341664e-11
SWS B-Disease 1 1.0
) O 0 2.421277067732319e-10
surviving O 0 4.914572571124154e-08
beyond O 0 3.377642698865202e-08
infancy O 0 1.6303239647186274e-08
adds O 0 7.846680770418057e-12
to O 0 6.390068053689635e-13
the O 0 5.035236116945896e-12
evidence O 0 1.1814725413283877e-11
in O 0 1.934699145680896e-12
favor O 0 2.447869337784958e-11
of O 0 3.346768140399803e-10
identity O 0 3.4739863763455503e-10
. O 0 2.0932846567234265e-09

The O 0 9.78132774775986e-08
hypothesis O 0 1.635241453357139e-08
that O 0 7.936030305133457e-11
SWS B-Disease 1 0.9999984502792358
and O 0 1.1113734643686257e-07
SJS B-Disease 1 0.9999934434890747
type I-Disease 0 9.494834785073181e-07
2 I-Disease 0 2.1330173183287116e-08
are O 0 1.3640793139133023e-12
the O 0 1.3332971879331801e-11
same O 0 1.4517959057158691e-10
disorder O 0 2.4687518816790543e-05
should O 0 1.3991690618608832e-11
be O 0 3.2580444418728316e-12
testable O 0 4.5088652811386964e-09
by O 0 1.5196588779020637e-11
molecular O 0 2.127770404314333e-09
methods O 0 2.758506978395303e-09
. O 0 1.4441210727245135e-10
. O 0 8.600102296973944e-10

A O 0 4.052648819197202e-06
mouse O 0 7.883716790502149e-09
model O 0 1.482786948781012e-10
of O 0 3.798018344269849e-09
severe O 1 0.9999326467514038
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.0022072941064834595
defects O 1 0.9999998807907104
in O 0 4.259337416101516e-08
hemostasis O 1 0.9999984502792358
and O 0 1.0827185406014905e-06
thrombosis B-Disease 1 0.9998388290405273
. O 0 1.6108054978758446e-07

von B-Disease 1 0.9903944134712219
Willebrand I-Disease 1 0.9999481439590454
factor I-Disease 0 7.751057637506165e-06
( I-Disease 0 4.256625061316299e-07
vWf I-Disease 1 0.9986074566841125
) I-Disease 0 2.7946347472607158e-05
deficiency I-Disease 1 1.0
causes O 1 0.9999231100082397
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 1.1419133443268947e-06
humans O 0 6.098286320366242e-08
. O 0 1.3186024494515891e-09

We O 0 2.2986990089179926e-09
generated O 0 3.4178060381861997e-10
a O 0 6.749341363576633e-11
mouse O 0 7.251006045594366e-11
model O 0 1.821014042682756e-12
for O 0 6.287976324521882e-13
this O 0 1.6383913540099493e-12
disease O 0 3.107297752436011e-10
by O 0 1.646523087144025e-13
using O 0 9.647237869669922e-12
gene O 0 2.0258830724095844e-10
targeting O 0 4.456590207979616e-09
. O 0 1.3931946707401721e-09

vWf B-Disease 0 0.0028574601747095585
- I-Disease 0 0.08257269859313965
deficient I-Disease 0 0.0009366927552036941
mice O 0 1.256233730373424e-07
appeared O 0 1.7101192684165767e-09
normal O 0 3.854178642903605e-10
at O 0 1.5016513033039303e-10
birth O 0 5.997106283794906e-11
; O 0 1.5928937043083874e-13
they O 0 2.9771435425436643e-13
were O 0 1.6026078034081515e-11
viable O 0 2.114960206966998e-09
and O 0 1.0730595301211565e-09
fertile O 0 1.016616124616121e-07
. O 0 5.504560807167991e-09

Neither O 0 1.3423519703792408e-05
vWf O 0 6.909006333444268e-05
nor O 0 1.9048027297685621e-06
vWf O 0 2.555688661232125e-05
propolypeptide O 0 7.699309207964689e-05
( O 0 1.3709105850523429e-08
von B-Disease 0 0.002023078268393874
Willebrand I-Disease 0 0.03544055297970772
antigen O 0 2.621296061988687e-06
II O 1 1.0
) O 0 5.819153492403473e-10
were O 0 4.255311034095932e-11
detectable O 0 2.860406134175264e-09
in O 0 7.37308825105032e-12
plasma O 0 7.046133676524846e-10
, O 0 1.6156022700219985e-11
platelets O 0 9.129511591154937e-10
, O 0 2.030473879310879e-11
or O 0 3.061328274212016e-11
endothelial O 0 5.465994323827772e-10
cells O 0 1.6045262341002342e-10
of O 0 4.1899026470559875e-09
the O 0 1.167334895413319e-09
homozygous O 0 1.2645618774342893e-08
mutant O 0 1.8750984054349829e-07
mice O 0 8.618370372914796e-08
. O 0 5.955211435093588e-09

The O 0 3.5829577882395824e-07
mutant O 0 1.7852429436970851e-06
mice O 0 1.4250856850139826e-07
exhibited O 0 1.208708908961853e-06
defects O 0 0.3375646770000458
in O 0 1.128549609319407e-08
hemostasis O 0 0.00013077491894364357
with O 0 5.282889126156931e-10
a O 0 2.252475761466144e-09
highly O 0 5.4137863116920926e-06
prolonged O 1 1.0
bleeding O 1 0.9887866377830505
time O 0 2.035811963452261e-09
and O 0 1.4621455157737273e-09
spontaneous O 0 8.307480356961605e-07
bleeding O 0 1.644348117224581e-06
events O 0 1.0393785832008007e-09
in O 0 4.1769815384284925e-10
approximately O 0 9.19293668966148e-11
10 O 0 1.782527181415361e-10
% O 0 2.375040702301545e-12
of O 0 7.57175044885372e-10
neonates O 0 1.3160533285372367e-07
. O 0 2.4582085700330936e-08

As O 0 3.0206954715339407e-09
in O 0 1.419250272860495e-10
the O 0 7.641050292495066e-11
human O 0 4.623649463297852e-09
disease O 0 4.3588150333562226e-07
, O 0 1.2000431030834147e-12
the O 0 3.746189990161408e-12
factor O 0 1.642735426854447e-11
VIII O 1 0.999855637550354
level O 0 2.1483982592940265e-08
in O 0 4.7028662214509964e-11
these O 0 1.641238360494679e-11
mice O 0 6.252383055738164e-10
was O 0 9.52260006958916e-11
reduced O 0 8.20517473409943e-11
strongly O 0 7.08934516993609e-12
as O 0 1.0539561844796763e-12
a O 0 1.2161310370198408e-12
result O 0 2.8247809907150367e-12
of O 0 5.96297941579671e-11
the O 0 1.2238034370615214e-11
lack O 0 4.696618094435223e-11
of O 0 1.1582633463458336e-10
protection O 0 4.082082727396852e-10
provided O 0 1.4333331396776394e-11
by O 0 5.194995128521285e-11
vWf O 0 1.2216478353366256e-06
. O 0 5.0610866608735705e-09

Defective O 1 0.9999873638153076
thrombosis B-Disease 0 0.027730828151106834
in O 0 1.518557724011771e-07
mutant O 0 3.227251283988153e-07
mice O 0 3.6412171056099396e-08
was O 0 3.0183111565662557e-09
also O 0 8.998683742600377e-12
evident O 0 1.9986674815175576e-10
in O 0 2.3483561015918974e-12
an O 0 3.026327764234747e-14
in O 0 1.6252870902420946e-13
vivo O 0 8.20544118762534e-11
model O 0 8.086937369755631e-11
of O 0 1.9068460233029327e-07
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 1.202063344862836e-06

In O 0 1.0616710843791566e-09
this O 0 6.29110750039602e-13
model O 0 1.9148828356296832e-11
, O 0 1.3863382664069945e-11
the O 0 4.738232375900431e-11
exteriorized O 0 1.1716338121914305e-06
mesentery O 0 3.3531659937580116e-06
was O 0 1.7617013625681466e-08
superfused O 0 1.2966204394615488e-06
with O 0 7.905938681496139e-10
ferric O 0 5.221984906711441e-07
chloride O 0 2.8799824747238745e-09
and O 0 2.0079458096233793e-09
the O 0 1.0351487444992813e-09
accumulation O 0 1.175320747393016e-07
of O 0 2.568615400377894e-07
fluorescently O 0 9.517866601527203e-06
labeled O 0 2.857788103938219e-07
platelets O 0 9.816352530833683e-08
was O 0 2.1772610381276536e-09
observed O 0 1.1994789883562618e-10
by O 0 4.1130061162464315e-11
intravital O 0 1.0361803788327961e-06
microscopy O 0 5.583867732639192e-07
. O 0 7.622412034891113e-09

We O 0 1.5241603534832393e-08
conclude O 0 3.6450948925903504e-08
that O 0 8.86010102091328e-12
these O 0 4.479851906102894e-11
mice O 0 2.8791256045934688e-09
very O 0 1.2166652234302244e-11
closely O 0 5.800616875717424e-09
mimic O 0 0.004308668896555901
severe O 1 0.8994824886322021
human O 0 5.55154338144348e-06
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 6.021092247010529e-08
will O 0 1.0029364838626265e-10
be O 0 6.66285993392024e-12
very O 0 1.2247835124573614e-12
useful O 0 4.519267772506996e-12
for O 0 1.2621447940605601e-12
investigating O 0 1.0615733986307774e-10
the O 0 7.72612390731453e-11
role O 0 8.793403505347186e-11
of O 0 7.758941267255182e-10
vWf O 0 5.474490638590623e-09
in O 0 7.330268336769308e-11
normal O 0 7.117832434566651e-10
physiology O 0 1.7800623197672394e-08
and O 0 9.628824126917124e-11
in O 0 8.898877745799894e-10
disease O 0 8.747647228801725e-08
models O 0 2.587257352804073e-10
. O 0 7.755149994403965e-11
. O 0 5.989861384669837e-10

Oral O 1 0.9419085383415222
contraceptives O 0 0.00014571395877283067
and O 0 3.6194662822452983e-09
the O 0 1.4302323769754821e-09
risk O 0 6.149316789105796e-08
of O 0 8.703314961167052e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.362398039527761e-07

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9995971322059631
Study O 0 5.053199174653855e-07
Group O 0 7.631230403148948e-08
. O 0 2.970349077813239e-09

BACKGROUND O 0 6.581975321751088e-05
Women O 0 1.3271584942131653e-09
with O 0 1.0631290119078596e-11
mutations O 0 5.919848639068803e-11
in O 0 5.133687919212093e-11
either O 0 2.2001871158305875e-10
the O 0 5.4326334542054155e-09
BRCA1 O 0 2.6867761349080865e-08
or O 0 4.829743827095001e-10
the O 0 5.337015274164969e-09
BRCA2 O 0 5.0953580910118035e-08
gene O 0 2.0660016752938049e-10
have O 0 1.7676013647563438e-12
a O 0 3.0493059466341066e-11
high O 0 1.809267224928135e-08
lifetime O 0 2.7564151849901464e-08
risk O 0 2.944092614143301e-07
of O 1 0.9992327690124512
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.0400313256204754e-08

Oral O 1 0.9999914169311523
contraceptives O 1 0.9999983310699463
protect O 1 0.9788174033164978
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 8.373142179607385e-10
general O 0 3.853901198169751e-09
, O 0 1.845132033273522e-11
but O 0 5.455840857218619e-13
it O 0 2.976104876862423e-13
is O 0 6.878223983214013e-14
not O 0 3.348229760937946e-14
known O 0 3.161107443513944e-12
whether O 0 2.612689578573857e-12
they O 0 2.817290888426638e-12
also O 0 1.7549108000114444e-11
protect O 0 8.223572933729884e-10
against O 0 2.7232422539213985e-08
hereditary B-Disease 1 0.985160231590271
forms I-Disease 0 2.1039984858362004e-05
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.206868619074157e-08

METHODS O 0 4.782097676070407e-06
We O 0 1.4196707143199205e-09
enrolled O 0 3.6926282032112567e-09
207 O 0 3.895910261064728e-09
women O 0 5.312189230166631e-11
with O 0 3.6237213230094767e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 9.8910932777585e-09
161 O 0 2.3378582625355193e-08
of O 0 1.5466333991298598e-08
their O 0 7.101441212853388e-09
sisters O 0 2.7941470648329414e-07
as O 0 9.301335396338928e-11
controls O 0 1.8003127877364022e-09
in O 0 1.050160652882326e-10
a O 0 6.224619431005607e-11
case O 0 5.603477681859204e-10
- O 0 1.7355867854007556e-08
control O 0 5.069936914736672e-09
study O 0 5.271032499365447e-10
. O 0 4.4628487017028817e-10

All O 0 1.3703093770800479e-08
the O 0 1.3416250332909385e-09
patients O 0 4.534008238299414e-11
carried O 0 1.746343000763595e-11
a O 0 6.296404370109698e-12
pathogenic O 0 2.3043693342383875e-10
mutation O 0 1.4814292154108344e-11
in O 0 3.009604371273511e-11
either O 0 1.0862137855838228e-09
BRCA1 O 0 2.933382958758557e-08
( O 0 1.25032387221502e-10
179 O 0 3.744060173005437e-09
women O 0 2.8146712391374784e-11
) O 0 1.126698213893551e-11
or O 0 1.6033706584650531e-09
BRCA2 O 0 3.7452730339282425e-07
( O 0 1.0928887794747766e-09
28 O 0 2.0240223363998666e-07
women O 0 2.0962602487184512e-10
) O 0 5.844121714337902e-11
. O 0 9.426898150977081e-10

The O 0 1.576262178559773e-07
control O 0 5.6399827030872984e-08
women O 0 3.041638815814984e-11
were O 0 1.040962715331828e-11
enrolled O 0 5.094524802018441e-11
regardless O 0 2.2901455037915852e-11
of O 0 1.4388285007882473e-10
whether O 0 1.2213153231799279e-11
or O 0 3.492787309378187e-11
not O 0 2.388214192378113e-12
they O 0 4.820508141961666e-12
had O 0 2.177267220682122e-11
either O 0 2.3839660800994977e-10
mutation O 0 1.3789397401708925e-09
. O 0 4.423697408384442e-09

Lifetime O 0 1.4326293751310004e-07
histories O 0 1.3393916731274658e-07
of O 0 1.3806742060751276e-07
oral O 0 6.729587767040357e-05
- O 0 5.489235732625275e-08
contraceptive O 0 3.357914390988981e-09
use O 0 1.2590269105050567e-11
were O 0 1.3665435970311446e-11
obtained O 0 7.454808471918373e-12
by O 0 4.264100357531664e-12
interview O 0 7.617912550772488e-11
or O 0 3.053122208176995e-12
by O 0 2.949116916384914e-13
written O 0 2.585439241170606e-12
questionnaire O 0 7.924863022756856e-12
and O 0 7.028811126880141e-12
were O 0 2.070620237770715e-11
compared O 0 8.310779148201775e-12
between O 0 5.933029068039275e-11
patients O 0 1.9450757671179986e-10
and O 0 2.0015439305964833e-10
control O 0 1.1121687037984884e-07
women O 0 2.5433967432153537e-11
, O 0 3.0401579691197167e-12
after O 0 2.0015275895013396e-11
adjustment O 0 8.716256882923545e-11
for O 0 1.598540418958072e-12
year O 0 2.453070298974458e-12
of O 0 1.494861318063201e-10
birth O 0 6.160079557560039e-09
and O 0 1.0276418604959758e-09
parity O 0 4.7468603270317544e-07
. O 0 6.6610530424782155e-09

RESULTS O 0 2.0919856979162432e-05
The O 0 1.6433585159347786e-08
adjusted O 0 1.9402015993819077e-08
odds O 0 9.972492165388758e-09
ratio O 0 1.689338335886248e-09
for O 0 3.111297885993736e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 2.589173986322635e-09
with O 0 3.85159569168958e-12
any O 0 5.304218436003039e-12
past O 0 3.227005815342743e-11
use O 0 4.3484174594432545e-12
of O 0 1.3879503102387503e-10
oral O 0 2.8068117785551294e-07
contraceptives O 0 3.8226585274969693e-07
was O 0 7.025243053959684e-09
0 O 0 7.125714684974582e-09
. O 0 3.9462552670066486e-10

5 O 0 1.9157337760589144e-07
( O 0 4.784286300463236e-10
95 O 0 3.63666941005647e-09
percent O 0 5.6301074913278626e-11
confidence O 0 3.7196717928011935e-10
interval O 0 1.1296472646193934e-09
, O 0 1.2206143214232856e-11
0 O 0 1.0853221966977689e-11
. O 0 2.537298442097796e-13
3 O 0 7.410195720924939e-12
to O 0 4.698396619678968e-13
0 O 0 2.4002072898654525e-11
. O 0 8.654291476159481e-13
8 O 0 3.136528536895611e-10
) O 0 1.0071649243770242e-11
. O 0 9.414136137309015e-11

The O 0 1.0349759804739733e-07
risk O 0 3.0869427014579287e-09
decreased O 0 4.3975656449646294e-10
with O 0 1.0311351382116807e-12
increasing O 0 1.7570736532412923e-12
duration O 0 1.4915291224326666e-10
of O 0 5.2586383164632267e-11
use O 0 2.4944785820268933e-11
( O 0 1.6696935500881693e-11
P O 0 9.221359675848362e-09
for O 0 1.6594196503016967e-11
trend O 0 2.0674287282140824e-10
, O 0 1.4451915142030258e-12
< O 0 2.1332500002579913e-11
0 O 0 1.0136904336766062e-11
. O 0 4.0342569237496184e-13
001 O 0 5.899652433249969e-10
) O 0 9.417893033361949e-14
; O 0 1.8636024188135696e-14
use O 0 3.604963007795836e-13
for O 0 1.0792711125848231e-12
six O 0 2.5001089740128712e-11
or O 0 4.402210367071557e-12
more O 0 1.1772512489589132e-13
years O 0 3.717044033679784e-12
was O 0 5.4871340110507205e-11
associated O 0 3.5061769459998615e-11
with O 0 2.5197931848713884e-12
a O 0 1.5865794789071685e-11
60 O 0 6.729981849584732e-11
percent O 0 4.361741436781363e-12
reduction O 0 3.711649321225252e-10
in O 0 2.5534352410261363e-10
risk O 0 2.0628693420121635e-08
. O 0 4.41410552554089e-09

Oral O 1 0.964181661605835
- O 0 4.862636615143856e-06
contraceptive O 0 1.2531249637959263e-07
use O 0 2.204203708444652e-09
protected O 0 0.0008181004668585956
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 8.332889933626575e-12
for O 0 2.013419379137682e-12
carriers O 0 1.6056919682760906e-11
of O 0 1.2719439945740874e-09
the O 0 1.9375752113859335e-09
BRCA1 O 0 3.486329802626642e-08
mutation O 0 1.348952755053645e-10
( O 0 2.671666360365421e-11
odds O 0 1.8034472804018264e-09
ratio O 0 4.403270803532422e-11
, O 0 3.027017655629627e-12
0 O 0 1.0218513535331653e-11
. O 0 3.8157568467769853e-13
5 O 0 7.135495753290977e-12
; O 0 2.7818659919034983e-13
95 O 0 1.0828146018715401e-10
percent O 0 6.715565603609974e-12
confidence O 0 1.4931288150332733e-10
interval O 0 3.4793448677739036e-10
, O 0 7.0511812534646e-12
0 O 0 7.327343592988811e-12
. O 0 1.4813260481531115e-13
3 O 0 3.665221771920191e-12
to O 0 2.1468894370602065e-13
0 O 0 4.642394541704009e-12
. O 0 1.8903062166779339e-13
9 O 0 7.623595504879788e-11
) O 0 9.58618560508058e-14
and O 0 2.35908433629875e-13
for O 0 2.717403125435114e-13
carriers O 0 1.7262871687684367e-11
of O 0 8.78988659636093e-10
the O 0 1.777523794821434e-09
BRCA2 O 0 8.090327696663735e-08
mutation O 0 4.209990966952404e-10
( O 0 3.457643893423068e-11
odds O 0 1.3939681631214285e-09
ratio O 0 3.603309664534926e-11
, O 0 6.072147992752797e-12
0 O 0 9.051789699732193e-12
. O 0 2.2469702422485416e-13
4 O 0 2.029637395650763e-11
; O 0 7.886603696494188e-13
95 O 0 1.5086273896791624e-10
percent O 0 7.708750304757928e-12
confidence O 0 3.0857755239921403e-10
interval O 0 5.082424481273051e-10
, O 0 8.840856866032532e-12
0 O 0 6.977838012262039e-12
. O 0 1.3533033201007516e-13
2 O 0 4.475443019652525e-12
to O 0 6.914716737561888e-13
1 O 0 4.345020870877292e-11
. O 0 9.140440140886774e-13
1 O 0 2.4053689595682215e-10
) O 0 1.0191069342579961e-11
. O 0 7.913387306546227e-11

CONCLUSIONS O 0 7.135420310078189e-05
Oral O 1 0.675273597240448
- O 0 8.101954449557525e-07
contraceptive O 0 5.1773064058124874e-08
use O 0 3.954121197136118e-10
may O 0 4.163751982089181e-11
reduce O 0 9.996134475720453e-11
the O 0 1.4095949407710862e-10
risk O 0 9.314197413345937e-09
of O 0 0.006762556731700897
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.4625130273504539e-10
women O 0 7.23998443662166e-13
with O 0 2.627114834268668e-13
pathogenic O 0 7.02284119746821e-10
mutations O 0 9.486054303176061e-11
in O 0 7.234166043978973e-11
the O 0 1.7894160597720088e-09
BRCA1 O 0 2.405087968782027e-07
or O 0 6.33032612995521e-08
BRCA2 O 0 2.382644743192941e-05
gene O 0 3.866276529151946e-06

A O 0 4.419223387230886e-06
Japanese O 0 1.9045174894927186e-06
family O 0 2.934472664861687e-09
with O 0 9.424206304231575e-09
adrenoleukodystrophy B-Disease 1 1.0
with O 0 1.5384271634388824e-09
a O 0 7.067858520670711e-10
codon O 0 2.1949290385236964e-08
291 O 0 5.7886695437048274e-09
deletion O 0 2.1065980071455215e-09
: O 0 3.2910858066559356e-11
a O 0 3.168932477537467e-11
clinical O 0 2.8896911885567533e-07
, O 0 2.1650353732027838e-10
biochemical O 0 4.668136170948856e-06
, O 0 1.6985726158935677e-09
pathological O 0 0.0008558097179047763
, O 0 4.909152528931315e-10
and O 0 6.223150883499784e-10
genetic O 0 4.419887389417454e-08
report O 0 2.9286129077377154e-09
. O 0 3.1164517633186506e-09

We O 0 4.169971035139497e-09
report O 0 2.8729146839268083e-10
a O 0 8.584610106110446e-11
Japanese O 0 1.9789215599530507e-08
family O 0 2.0988646931563437e-10
with O 0 6.822320042232377e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 0 1.3594139090855606e-05
ALD B-Disease 1 1.0
) O 0 5.959253090992433e-10
with O 0 1.6007136588447324e-11
a O 0 8.210513519069096e-11
three O 0 7.722484457461931e-11
base O 0 3.906043932744296e-09
pair O 0 1.2924480152776141e-08
deletion O 0 1.4748681387288798e-08
( O 0 6.207573344241268e-10
delGAG O 0 1.3826429494656622e-06
291 O 0 1.0232786173958175e-08
) O 0 2.84914127880731e-12
in O 0 2.3727509540494296e-11
the O 0 1.436855434633344e-08
ALD B-Disease 1 1.0
gene O 0 1.7160739389510127e-06
. O 0 1.3677659893573946e-08

A O 0 8.053959845710779e-07
variety O 0 8.619122304764915e-09
of O 0 1.2874386889905054e-08
phenotypes O 0 9.865225081284734e-09
were O 0 1.2642953350905373e-10
observed O 0 1.8167485571485287e-10
within O 0 1.3064824222475124e-10
this O 0 3.349765994101195e-12
family O 0 1.202128951938164e-10
. O 0 2.049901359768569e-09

While O 0 3.110212176693494e-08
the O 0 4.021404986787047e-09
proband O 0 1.0129662769031711e-05
( O 0 8.96544005701827e-10
patient O 0 2.4423933098205453e-08
1 O 0 2.037965352030824e-08
) O 0 1.8628909179141395e-11
was O 0 2.4718219138186726e-10
classified O 0 3.345518750919041e-09
as O 0 1.0990716670100653e-10
having O 0 5.027791377676394e-11
a O 0 1.1342643838063715e-11
rare O 0 4.491145302876198e-11
intermediate O 0 2.6779596318249332e-09
type O 0 2.4989195157587574e-09
of O 0 1.7456962098094664e-08
adult O 0 4.556033772473711e-08
cerebral O 0 1.312208723902586e-06
and O 0 2.0483234663970507e-08
cerebello O 1 0.9999655485153198
- O 1 0.6276106238365173
brain O 0 0.031915728002786636
stem O 0 2.0999628702611517e-09
forms O 0 1.4473122700309204e-09
, O 0 3.0454003902002924e-11
his O 0 8.40203462360023e-10
younger O 0 3.0698330544254304e-09
brother O 0 1.3938856113782094e-07
( O 0 3.11167452915484e-10
patient O 0 1.0789542592704038e-08
2 O 0 1.296287077678926e-08
) O 0 1.3440849995494109e-11
and O 0 4.0289804825732745e-10
nephew O 0 2.4113944164128043e-05
( O 0 3.350921318201472e-09
patient O 0 3.9420694974978687e-07
3 O 0 1.4811736548381305e-07
) O 0 4.565604838635551e-11
had O 0 2.412260668993582e-10
a O 0 1.2250733760765797e-08
childhood O 1 0.9999991655349731
ALD B-Disease 1 1.0
type O 0 0.02313576266169548
. O 0 9.55536307856164e-08

Another O 0 5.871503390153521e-07
nephew O 0 4.278523920220323e-05
( O 0 1.4294067263165289e-08
patient O 0 1.4090754518747417e-07
4 O 0 1.1050660475575569e-07
) O 0 3.363096606756599e-11
of O 0 2.234154194979965e-09
patient O 0 5.662445801135618e-08
1 O 0 2.913398944315304e-08
was O 0 2.882136751480857e-09
classified O 0 1.5342748183044819e-09
as O 0 2.819023313394009e-11
having O 0 2.1648278655805875e-11
an O 0 2.7986742697633238e-12
adolescent O 0 6.678993713649106e-08
form O 0 3.321776631537432e-09
. O 0 1.7473441582538385e-09

The O 0 1.7919961692314246e-07
tau O 0 2.2701346580333848e-08
level O 0 2.6210438264229197e-09
in O 0 3.892430128216162e-11
the O 0 1.6947530878663741e-10
cerebrospinal O 0 2.8528338802402686e-08
fluid O 0 1.753193856757207e-08
( O 0 1.0528672156340235e-08
CSF O 1 1.0
) O 0 1.2947813932129293e-09
in O 0 4.311505596987786e-10
patient O 0 1.684047035155345e-08
1 O 0 1.943333938214664e-09
was O 0 4.5052697683622966e-10
as O 0 6.662695135190022e-12
high O 0 1.1528398236038129e-09
as O 0 5.540880796718606e-13
that O 0 1.6595879266103827e-14
of O 0 1.8426210210420457e-11
patients O 0 2.842775320699431e-11
with O 0 8.567749287813342e-10
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
( O 0 9.478313273136862e-11
AD B-Disease 0 1.080010406440124e-06
) O 0 1.830787882406426e-10
. O 0 8.880615687267834e-10

His O 0 3.5912646580982255e-06
brain O 0 2.360802682233043e-05
magnetic O 0 1.3101841886964394e-06
resonance O 0 7.288927150739255e-08
image O 0 1.6795762292076688e-07
( O 0 5.951233950085566e-10
MRI O 1 0.9236260056495667
) O 0 2.1701704322474313e-10
showed O 0 3.091049416426017e-09
abnormalities B-Disease 0 5.674647582054604e-06
in I-Disease 0 1.2960260642458366e-10
the I-Disease 0 5.650442891358409e-10
bilateral I-Disease 0 4.783314579981379e-07
cerebellar I-Disease 1 0.9999998807907104
hemispheres I-Disease 0 1.7350810594507493e-05
and O 0 5.511371341526683e-07
brain O 1 0.9999990463256836
stem O 0 1.1199662708349933e-07
, O 0 1.0625071655834262e-10
but O 0 1.3003778826306545e-12
not O 0 3.4874316975908037e-13
in O 0 1.4714210752608814e-11
the O 0 6.805498942163979e-10
cerebral O 0 1.2558251910377294e-05
white O 0 9.268470435586096e-10
matter O 0 2.2626021889404768e-10
, O 0 7.902463405873306e-12
where O 0 5.948027660684918e-12
marked O 0 1.823941692125075e-11
reductions O 0 2.016112388147917e-09
of O 0 2.1917023751427678e-09
the O 0 1.7602395097071621e-09
cerebral O 0 4.954658265887701e-07
blood O 0 2.3979676022634067e-09
flow O 0 5.57828949698802e-10
and O 0 2.1356613699730076e-10
oxygen O 0 5.097708033474646e-09
metabolism O 0 1.3319170477643638e-07
were O 0 4.432292866063392e-10
clearly O 0 1.2866174792236507e-10
demonstrated O 0 2.373982260772678e-11
by O 0 1.2091621107157557e-12
positron O 0 8.970400533492295e-10
emission O 0 1.2380090730346183e-08
tomography O 0 2.0480740658967989e-07
( O 0 1.0754490631370572e-08
PET O 0 0.00036866922164335847
) O 0 1.2684480132918452e-09
. O 0 1.1521430476335581e-09

In O 0 4.422973631790228e-08
patients O 0 6.594710111329505e-09
2 O 0 4.382964213789364e-09
and O 0 3.438599127658648e-10
3 O 0 2.7044768646788953e-09
, O 0 1.3010459029572097e-11
the O 0 8.011796955031958e-12
autopsy O 0 1.4815953797153725e-08
findings O 0 3.4512673274811334e-10
showed O 0 8.669752138423803e-10
massive O 0 5.2342503664704054e-08
demyelination B-Disease 1 1.0
of I-Disease 0 0.002344854176044464
the I-Disease 0 1.7041603541656514e-06
cerebral I-Disease 0 0.0728781670331955
white I-Disease 0 1.9133767903412036e-09
matter I-Disease 0 1.0588353804852346e-10
with O 0 4.672972512415052e-12
sparing O 0 1.8001307111603637e-09
of O 0 2.878073068757203e-08
the O 0 8.091852521374676e-09
U O 1 0.9503138065338135
- O 0 6.0104148360551335e-06
fibers O 0 1.0979980288539082e-05
, O 0 1.0232171360202713e-10
compatible O 0 4.081990745419262e-09
with O 0 6.5592245176993025e-12
the O 0 2.1470636032971946e-11
findings O 0 7.550204905726332e-10
of O 0 5.956770365855846e-08
childhood O 1 0.9999980926513672
ALD B-Disease 1 1.0
. O 0 3.7249867546051973e-07

Oleic O 0 0.000447755039203912
and O 0 5.308171466822387e-07
erucic O 0 0.00016468123067170382
acids O 0 2.2266686983130057e-07
( O 0 1.8417056768527118e-09
Lorenzos O 0 5.27285101270536e-06
Oil O 0 1.2839222129912287e-08
) O 0 1.2226134167570013e-11
were O 0 5.7503103841061165e-12
administered O 0 1.0375221515257493e-10
to O 0 6.278799095232879e-12
patients O 0 4.3102368896263954e-11
1 O 0 2.658836761870731e-10
and O 0 7.847583000097913e-11
4 O 0 2.6567901212359857e-09
, O 0 2.478022344612474e-12
but O 0 3.205732052968639e-14
sufficient O 0 4.1650684637351e-12
effectiveness O 0 4.919988305651657e-10
was O 0 1.5319522039813904e-10
not O 0 7.459982067845039e-13
obtained O 0 2.2076443451091166e-10
. O 0 7.699295090368707e-10

The O 0 6.997443335876596e-08
findings O 0 3.025504291542802e-09
in O 0 4.5297380429909495e-11
this O 0 5.668731001100269e-13
family O 0 3.3173711173895004e-12
suggest O 0 1.1969278866652555e-11
that O 0 4.63938241122841e-13
delGAG291 O 0 4.710043022271293e-09
is O 0 1.9262267562242252e-12
part O 0 1.5637286604475165e-11
of O 0 3.7853967183032466e-10
the O 0 1.7932691442901216e-10
cause O 0 4.146462728726874e-09
of O 0 3.212229415794354e-08
Japanese O 0 0.022475115954875946
ALD B-Disease 1 1.0
with O 0 6.737588820193707e-10
phenotypic O 0 6.704878785512847e-08
variations O 0 3.858129389300302e-07
. O 0 1.876906630116082e-08

Moreover O 0 1.155450561896032e-07
, O 0 1.4107782997374585e-10
although O 0 6.234430506568689e-12
the O 0 8.260538954252272e-12
scale O 0 7.253596612244451e-10
of O 0 8.098889336949355e-10
the O 0 2.2527830295659967e-11
study O 0 6.848593307046125e-12
is O 0 1.1162330283177868e-13
limited O 0 4.972380146517352e-12
, O 0 2.2400137300593315e-12
there O 0 1.3251507096495585e-12
is O 0 6.501576078725424e-13
a O 0 3.784526511618758e-12
possibility O 0 3.290484829054918e-10
that O 0 6.013210762656485e-11
PET O 1 0.9981203675270081
can O 0 4.188813740313435e-10
detect O 0 1.6125927686516661e-06
an O 0 2.330536597039412e-10
insidious B-Disease 0 2.497204150131438e-06
lesion I-Disease 0 2.5709394321893342e-05
which O 0 3.0339569745407857e-10
is O 0 4.629210643286585e-12
undetectable O 0 3.425038253013213e-09
by O 0 6.175442102129836e-13
computed O 0 1.0399115596415598e-10
tomogram O 0 3.2287533713315497e-07
( O 0 2.287832701064474e-10
CT O 0 0.0009554997086524963
) O 0 3.078819144075595e-11
or O 0 2.0509318202077687e-11
MRI O 0 6.9187367444101255e-06
analysis O 0 3.209996712882912e-10
, O 0 5.892359083298215e-12
and O 0 2.218431167932966e-12
that O 0 7.844847140598896e-14
the O 0 6.101124813695513e-12
higher O 0 5.015292695031981e-11
level O 0 1.9848241106235065e-10
of O 0 7.677177643605759e-11
tau O 0 1.4189986685675393e-10
reflects O 0 6.25198330606036e-12
the O 0 2.568580114228891e-12
process O 0 3.743940053813066e-12
of O 0 5.287708049195317e-10
neuronal B-Disease 0 5.0437233767297585e-06
degeneration I-Disease 1 1.0
in O 0 8.408229064116313e-07
ALD B-Disease 1 1.0
. O 0 4.769103725266177e-07

Lorenzos O 0 0.0007671381463296711
Oil O 0 9.961831892724149e-08
should O 0 5.022462654102888e-11
be O 0 6.657406830673507e-13
given O 0 2.1514476940438787e-13
in O 0 1.3504675893186158e-12
the O 0 3.3959688360007956e-12
early O 0 2.0639613629303e-10
stage O 0 1.931626858464597e-09
. O 0 1.3182615589413249e-11
. O 0 1.8069755414185096e-10

Nonsense O 0 7.277741133293603e-06
mutation O 0 3.4220148936725536e-09
in O 0 7.668956580886288e-10
exon O 0 6.19029236759161e-08
4 O 0 1.1455938420112943e-08
of O 0 1.9380259619339313e-09
human O 0 2.6534563435376413e-10
complement O 0 1.2168944962809292e-08
C9 O 1 0.9999994039535522
gene O 0 4.612005888304793e-09
is O 0 5.649898517784413e-12
the O 0 4.52077889012692e-11
major O 0 9.73527258807394e-10
cause O 0 2.590888170672656e-09
of O 0 1.558068341012131e-08
Japanese O 0 9.113206033362076e-06
complement B-Disease 0 0.001473423675633967
C9 I-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
. O 0 1.0831300301106239e-07

Deficiency B-Disease 1 0.9999967813491821
of I-Disease 0 0.0002765473327599466
the I-Disease 0 2.416066990917898e-07
ninth I-Disease 0 0.0013001750921830535
component I-Disease 0 5.944203351759825e-09
of I-Disease 0 4.788734742078304e-09
human I-Disease 0 2.387487985089365e-10
complement I-Disease 0 1.4351545729596182e-08
( O 0 1.8766659337643432e-09
C9 O 1 1.0
) O 0 8.44497666241395e-11
is O 0 9.261741764146625e-13
the O 0 2.142227367718519e-12
most O 0 1.6295529378998475e-12
common O 0 3.39855299458236e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.0685580198455114e-09
Japan O 0 1.3809005849907408e-07
but O 0 2.674469153085557e-12
is O 0 3.6991202744147966e-13
rare O 0 1.5134194245036703e-11
in O 0 9.273695526779147e-12
other O 0 1.910880308153562e-11
countries O 0 1.623566038555513e-11
. O 0 1.5106379480656074e-09

We O 0 9.508848153316762e-10
studied O 0 4.2569552327620386e-09
the O 0 1.167881590047326e-11
molecular O 0 9.085782820550392e-11
basis O 0 2.1137977479490644e-10
of O 0 4.373821482772655e-08
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.997822642326355
in O 0 3.0592124389272612e-09
four O 0 1.6250547574259144e-09
Japanese O 0 2.0567640603985637e-05
C9 B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
deficient I-Disease 1 0.9217579960823059
patients O 0 3.2093264934474064e-08
who O 0 5.243497303020206e-10
had O 0 4.089441230092916e-09
suffered O 1 0.9999445676803589
from O 0 0.4606160521507263
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 9.757733288040527e-09

Direct O 0 6.588273038232728e-09
sequencing O 0 1.4701189599009012e-08
of O 0 2.765177420371856e-08
amplified O 0 1.0932311624856084e-06
C9 O 0 0.001126992516219616
cDNA O 0 3.8989526274235686e-08
and O 0 6.844473876554957e-10
DNA O 0 6.969790433686285e-08
revealed O 0 1.1655996168258298e-09
a O 0 5.384021353749269e-11
nonsense O 0 3.2786335868451033e-09
substitution O 0 2.7562665483316096e-09
( O 0 1.4047102370184916e-10
CGA O 0 1.3840202655046596e-06
- O 0 2.7055564899569617e-08
- O 0 7.500802645665772e-09
> O 0 9.141395418410525e-10
TGA O 0 7.781179078847344e-08
) O 0 1.4566930561094038e-12
at O 0 3.056170941317937e-11
codon O 0 4.952194210261496e-11
95 O 0 6.506110233894802e-11
in O 0 2.8503586210065768e-12
exon O 0 1.0170846387325128e-09
4 O 0 5.912381140227296e-10
in O 0 1.997416468335622e-11
the O 0 9.76859843015987e-11
four O 0 6.896142545897987e-10
C9 B-Disease 1 1.0
- I-Disease 0 0.00021590471442323178
deficient I-Disease 0 2.7788187253463548e-06
individuals O 0 9.645367143873429e-11
. O 0 3.143471261068953e-09

An O 0 1.1853560355490345e-09
allele O 0 3.5549591048678053e-10
- O 0 1.9909827120301316e-09
specific O 0 2.4555571118134445e-11
polymerase O 0 5.299038985384641e-09
chain O 0 1.3700577339292863e-09
reaction O 0 7.65953446502099e-12
system O 0 2.86026258233818e-10
designed O 0 2.054187264732832e-09
to O 0 2.336526458424082e-11
detect O 0 7.643697230719226e-09
exclusively O 0 2.796313458564015e-10
only O 0 6.169849787324155e-13
one O 0 4.5065001535136984e-13
of O 0 1.3987101407653135e-11
the O 0 8.70465591967795e-12
normal O 0 7.56412432689757e-11
and O 0 8.434878663587941e-12
mutant O 0 8.689498426361908e-11
alleles O 0 1.639141513493092e-12
indicated O 0 1.041709513788236e-11
that O 0 3.805842631061235e-13
all O 0 5.714687837526933e-12
the O 0 4.613074158776875e-11
four O 0 4.6467548558970506e-11
patients O 0 7.623912785803544e-12
were O 0 1.2360536205680006e-11
homozygous O 0 2.8978658014877645e-11
for O 0 4.117540509940287e-12
the O 0 7.601599211204402e-11
mutation O 0 1.1377896888542516e-11
in O 0 3.022720962420067e-11
exon O 0 5.940452130204221e-09
4 O 0 1.718893027913282e-09
and O 0 1.1249846540439812e-11
that O 0 3.243070146197874e-13
the O 0 1.2841724211787309e-11
parents O 0 2.5102136081561754e-12
of O 0 1.187559495186008e-10
patient O 0 8.662627837274783e-10
2 O 0 7.1910877252889804e-09
were O 0 1.189514375887768e-09
heterozygous O 0 3.396906755881446e-09
. O 0 3.264219783361e-09

The O 0 6.670998686786334e-08
common O 0 2.6682416276457843e-09
mutation O 0 1.4843433426836583e-10
at O 0 5.091136956458797e-10
codon O 0 2.955010958149984e-10
95 O 0 3.543180748799557e-10
in O 0 3.3773737279085836e-11
exon O 0 7.392348955193029e-09
4 O 0 2.7589595053001403e-09
might O 0 1.2258825898836534e-11
be O 0 1.7756843087926577e-12
responsible O 0 2.2507612440492153e-10
for O 0 1.2734720396256893e-11
most O 0 7.716786237788043e-11
Japanese O 0 5.32991107320413e-05
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.999729335308075
. O 0 1.3978312951579142e-09
. O 0 3.1032123537499956e-09

BRCA1 O 0 3.39842557650627e-07
required O 0 9.587997062965314e-10
for O 0 1.8048537664405728e-10
transcription O 0 1.1188132731376754e-07
- O 0 1.7792638118407922e-07
coupled O 0 7.006885027749377e-08
repair O 0 4.091104528924916e-06
of O 0 2.8602929802445942e-08
oxidative O 0 1.7195748114318121e-06
DNA O 0 0.000954222516156733
damage O 0 0.0004723007732536644
. O 0 3.779260993042044e-08

The O 0 1.0358975487179123e-05
breast B-Disease 1 0.9999985694885254
and I-Disease 1 0.9990912675857544
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 5.1412494940450415e-05
gene O 0 2.7714820660662554e-08
BRCA1 O 0 2.982237745641214e-08
encodes O 0 1.011887351687335e-09
a O 0 5.402707614621249e-09
zinc O 0 3.264139422753942e-06
finger O 0 1.1246751228100038e-06
protein O 0 1.3409214849602336e-09
of O 0 3.875129550579004e-09
unknown O 0 7.618889963367792e-10
function O 0 4.2796508004094846e-10
. O 0 5.933314395356604e-10

Association O 0 2.781326884360169e-06
of O 0 2.3971807650013943e-07
the O 0 4.570078981913639e-09
BRCA1 O 0 7.117537670353613e-09
protein O 0 7.750004110684827e-11
with O 0 3.4039729368551264e-11
the O 0 6.002441876873377e-10
DNA O 0 2.5413692128495313e-07
repair O 0 9.455562803850626e-07
protein O 0 1.0938647765357246e-09
Rad51 O 0 1.099012365557428e-07
and O 0 2.80706881350401e-11
changes O 0 3.5896366174653638e-12
in O 0 2.9552900925045034e-12
the O 0 1.0310662913737279e-12
phosphorylation O 0 1.718724121357873e-11
and O 0 3.109726712247074e-11
cellular O 0 6.910969019280344e-10
localization O 0 4.128173003437041e-08
of O 0 2.8730806622689897e-09
the O 0 1.345773770200509e-10
protein O 0 4.31754354490721e-11
after O 0 2.651190100788625e-10
exposure O 0 1.1037196046004283e-08
to O 0 8.324823469463283e-11
DNA O 0 3.599488627514802e-05
- O 0 3.028075354905013e-07
damaging O 0 1.105961814573675e-06
agents O 0 4.214570914484739e-10
are O 0 3.367613696583782e-12
consistent O 0 2.475747662433747e-10
with O 0 1.865012484725259e-12
a O 0 9.40343636290919e-12
role O 0 1.6767273333662125e-11
for O 0 1.7102739363616948e-11
BRCA1 O 0 5.479462661384105e-09
in O 0 5.897515253927565e-10
DNA O 0 5.461046384880319e-05
repair O 0 0.017444314435124397
. O 0 3.1284297818956475e-08

Here O 0 3.154675098926418e-08
, O 0 9.551249374739612e-11
it O 0 3.518345554134883e-13
is O 0 1.5727363530428085e-13
shown O 0 9.132424634225589e-13
that O 0 4.752737374665028e-13
mouse O 0 1.5356859117687804e-09
embryonic O 0 8.518674654567349e-09
stem O 0 4.839382672372494e-09
cells O 0 1.5057877167379274e-09
deficient B-Disease 0 2.584458691501368e-08
in I-Disease 0 6.000038244025063e-10
BRCA1 I-Disease 0 4.906711925656282e-09
are O 0 9.179002176396e-12
defective O 0 9.352814345220395e-08
in O 0 2.94764795905067e-10
the O 0 1.3452758351739647e-10
ability O 0 6.0155361594760315e-12
to O 0 2.390844033167694e-12
carry O 0 6.305277133744625e-11
out O 0 8.785691618662383e-11
transcription O 0 9.804522527190329e-09
- O 0 1.2698089690843517e-08
coupled O 0 1.8202328533334367e-08
repair O 0 1.5906699672996183e-06
of O 0 1.216346845467342e-08
oxidative O 0 2.224095752012545e-08
DNA O 0 4.948093646817142e-06
damage O 0 5.747511386289261e-05
, O 0 1.719564352020697e-10
and O 0 1.0771621788974173e-10
are O 0 6.9670124704102054e-12
hypersensitive O 0 1.1185337456254274e-07
to O 0 2.7516008915817736e-10
ionizing O 0 4.793710104422644e-05
radiation O 0 0.00017456579371355474
and O 0 9.139931034241044e-10
hydrogen O 0 8.719673871837585e-09
peroxide O 0 1.3583681379714108e-07
. O 0 1.74129652918964e-08

These O 0 3.872972165197552e-09
results O 0 4.399094422069538e-09
suggest O 0 9.862943795013734e-10
that O 0 4.312095472358557e-11
BRCA1 O 0 2.605235671637729e-08
participates O 0 3.2610336653249306e-09
, O 0 4.122383337468172e-11
directly O 0 4.1238068515525583e-11
or O 0 4.1144105483725824e-11
indirectly O 0 2.905748697212829e-10
, O 0 1.6865293883672194e-11
in O 0 1.1396010003716928e-11
transcription O 0 6.927086459995735e-09
- O 0 1.4461539521448685e-08
coupled O 0 1.0419912932491115e-08
repair O 0 1.240533265445265e-06
of O 0 1.6508700184658665e-08
oxidative O 0 1.5121960927899636e-07
DNA O 0 5.889331077923998e-05
damage O 0 2.5599250875529833e-05
. O 0 5.625558907595973e-10
. O 0 8.28238200245579e-10

Truncation O 0 5.695276740880217e-06
mutations O 0 8.091836534163122e-09
in O 0 3.3168809365768936e-10
the O 0 6.561983734165722e-10
transactivation O 0 2.73676590722971e-07
region O 0 1.16809282246777e-08
of O 0 7.112667788078397e-08
PAX6 O 1 0.9996023774147034
result O 0 3.479864174593672e-09
in O 0 9.091595254417939e-10
dominant O 0 4.414293286458815e-08
- O 0 4.5284664906830585e-08
negative O 0 1.49941958849098e-09
mutants O 0 4.1951505380666276e-08
. O 0 1.8154331371533772e-09

PAX6 O 1 0.9990082383155823
is O 0 1.3677867727324156e-08
a O 0 4.524645658143811e-10
transcription O 0 6.983946754246517e-09
factor O 0 5.467057917485363e-10
with O 0 5.363232861294032e-12
two O 0 7.050670377400925e-12
DNA O 0 1.8018079472881254e-08
- O 0 1.1308157743528113e-09
binding O 0 2.1324782217835292e-10
domains O 0 1.1209974060122363e-09
( O 0 1.3594989023424375e-10
paired O 0 3.814207616414933e-09
box O 0 8.29538535640495e-08
and O 0 9.293644187557959e-10
homeobox O 0 1.1074520855913761e-08
) O 0 1.179221217201265e-11
and O 0 3.9367058224382134e-11
a O 0 1.7011038411229862e-10
proline O 0 9.549739843350835e-07
- O 0 2.2765722462736449e-07
serine O 0 2.426522769383155e-07
- O 0 1.4780947310555348e-07
threonine O 0 6.35394485470897e-07
( O 0 1.0900907954081163e-09
PST O 1 0.9998341798782349
) O 0 8.031481035786214e-10
- O 0 1.021808149204162e-08
rich O 0 4.1173642273406585e-10
transactivation O 0 6.513209314107371e-07
domain O 0 5.575632844312395e-09
. O 0 1.8661148182275156e-09

PAX6 O 1 0.9999985694885254
regulates O 0 0.0005007152212783694
eye O 0 0.1292877197265625
development O 0 1.4026929839872082e-08
in O 0 9.065582312617337e-11
animals O 0 1.4861620267758724e-10
ranging O 0 3.6441474282611352e-09
from O 0 1.816720801572913e-10
jellyfish O 0 3.914482973876865e-11
to O 0 4.647125132622998e-12
Drosophila O 0 1.864336018897461e-09
to O 0 4.035507691901863e-11
humans O 0 1.7352217440702589e-09
. O 0 7.155810943793028e-10

Heterozygous O 0 8.727464972935195e-08
mutations O 0 4.860835289832721e-09
in O 0 2.71833527909493e-10
the O 0 2.019151512655526e-10
human O 0 1.2457446185720755e-09
PAX6 O 1 0.9923215508460999
gene O 0 2.8824320708054074e-10
result O 0 1.2497725077054156e-11
in O 0 4.8455172166339544e-12
various O 0 1.9263524803081467e-11
phenotypes O 0 4.012685295151641e-09
, O 0 7.973764704072295e-11
including O 0 2.237932950066579e-09
aniridia B-Disease 1 1.0
, O 0 3.626046307658726e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 5.265137215104687e-09
autosomal B-Disease 0 0.00033049157354980707
dominant I-Disease 0 2.048362875939347e-05
keratitis I-Disease 1 0.9987263083457947
, O 0 6.256525519887646e-09
and O 0 4.670949849128192e-08
familial B-Disease 1 0.9999997615814209
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 2.6346633603679948e-05

It O 0 2.5572819417618575e-09
is O 0 2.0668045400129564e-11
believed O 0 2.1127648242025288e-11
that O 0 1.0301517126311277e-13
the O 0 1.818887054860774e-11
mutated O 0 1.72586667179786e-10
allele O 0 7.3987170556844e-11
of O 0 7.0824626163812354e-09
PAX6 O 0 0.07496892660856247
produces O 0 5.182055673458308e-09
an O 0 9.785881306678679e-12
inactive O 0 1.5907268391401885e-08
protein O 0 1.5954115806238178e-09
and O 0 1.535987781409176e-09
aniridia B-Disease 1 1.0
is O 0 1.5084690441202753e-10
caused O 0 1.867588972359613e-09
due O 0 1.2839949103948811e-09
to O 0 8.467023610014834e-11
genetic O 0 8.041635624067567e-08
haploinsufficiency O 0 3.7451914977282286e-05
. O 0 9.347496998657334e-09

However O 0 5.712516681910529e-09
, O 0 5.1599381017952695e-11
several O 0 5.065695692779704e-12
truncation O 0 9.054876848324511e-09
mutations O 0 1.1049296200216219e-10
have O 0 1.7400481012661007e-12
been O 0 1.2488217925044065e-11
found O 0 5.4077515035388934e-12
to O 0 6.200912721666951e-13
occur O 0 4.2668984664984144e-12
in O 0 1.043107353965178e-11
the O 0 1.2548248551347285e-10
C O 0 6.150385161163285e-07
- O 0 4.533173836307469e-09
terminal O 0 8.69059657571114e-10
half O 0 2.6272326328347084e-11
of O 0 2.654965136628107e-10
PAX6 O 0 0.003623038064688444
in O 0 5.627082688697271e-10
patients O 0 2.8822616515711275e-10
with O 0 6.598351726117002e-11
Aniridia B-Disease 1 1.0
resulting O 0 1.0370740710641257e-08
in O 0 1.542790062369903e-10
mutant O 0 1.0770697528306172e-10
proteins O 0 1.9938185217421855e-12
that O 0 8.026935236285504e-13
retain O 0 4.889267324337254e-10
the O 0 8.939655682382863e-10
DNA O 0 2.8026576615047816e-07
- O 0 4.381826901322938e-09
binding O 0 2.764784234887685e-10
domains O 0 1.727019222075299e-10
but O 0 2.062943999653344e-12
have O 0 2.8327390346610803e-12
lost O 0 2.919904595888312e-10
most O 0 1.9176231783046838e-12
of O 0 1.1598794147360536e-10
the O 0 1.56326410150065e-10
transactivation O 0 2.0959109292562061e-07
domain O 0 2.6301583133658823e-09
. O 0 1.5531659292022937e-09

It O 0 2.146844702011208e-09
is O 0 1.5915834622459712e-11
not O 0 8.600810493496203e-13
clear O 0 1.952468048349587e-11
whether O 0 1.483549286022956e-12
such O 0 3.314608656990181e-11
mutants O 0 7.046300964930197e-08
really O 0 5.790157242557825e-10
behave O 0 4.912090872943864e-11
as O 0 7.7086656502523e-11
loss O 0 2.9546477264830173e-08
- O 0 2.8283555053576492e-08
of O 0 3.236707257769922e-08
- O 0 6.943118080471322e-09
function O 0 1.692878302816947e-11
mutants O 0 5.946796943767652e-10
as O 0 7.827308246000086e-12
predicted O 0 1.1862374971194356e-10
by O 0 6.186625517434763e-11
haploinsufficiency O 0 1.5397043171105906e-05
. O 0 1.1449603043445222e-08

Contrary O 0 3.1160405455921136e-07
to O 0 2.491237216517561e-10
this O 0 1.4319497193895914e-12
theory O 0 2.5141930204419793e-10
, O 0 4.438463919315128e-12
our O 0 1.1744983458017444e-11
data O 0 3.301321022108894e-11
showed O 0 1.0830846636222802e-11
that O 0 1.9792854353650573e-14
these O 0 4.612735432334147e-13
mutants O 0 1.9599723233287847e-10
are O 0 1.1673487697316798e-12
dominant O 0 5.794808521919492e-10
- O 0 3.982990881556958e-10
negative O 0 6.194237397311175e-12
in O 0 2.2303870989698327e-12
transient O 0 1.1042111669468113e-10
transfection O 0 3.4245810631716722e-09
assays O 0 2.8146188157940344e-10
when O 0 5.163954680531546e-11
they O 0 4.50629637771538e-12
are O 0 3.649630077318111e-12
coexpressed O 0 1.7430501486614958e-07
with O 0 1.0661999755301466e-10
wild O 0 1.3336041320144432e-06
- O 0 1.4122034599495237e-06
type O 0 3.8222169678192586e-06
PAX6 O 1 0.9999998807907104
. O 0 7.479362551521263e-08

We O 0 3.861258868198547e-09
found O 0 3.1497474073383103e-10
that O 0 1.699017012149473e-12
the O 0 5.3652818299276817e-11
dominant O 0 5.392320368002856e-09
- O 0 2.9889104524727372e-09
negative O 0 3.5862028624489284e-11
effects O 0 4.517008100890507e-09
result O 0 1.1953537118469804e-11
from O 0 1.5248849058457914e-11
the O 0 7.357649212114126e-12
enhanced O 0 2.646400598660392e-10
DNA O 0 3.303176177027467e-09
binding O 0 6.923856626928071e-11
ability O 0 5.535235117481996e-11
of O 0 7.859001227572548e-10
these O 0 6.763955368027652e-11
mutants O 0 2.7814220260324873e-08
. O 0 2.143628607953474e-09

Kinetic O 0 2.2953140899062419e-07
studies O 0 1.7789414386015778e-09
of O 0 6.377293138015716e-10
binding O 0 5.47244138893177e-10
and O 0 4.0360026432040286e-10
dissociation O 0 6.168462629574378e-09
revealed O 0 2.2377750763524773e-09
that O 0 6.451250666485164e-13
various O 0 1.0988956272717232e-10
truncation O 0 1.3371447948884452e-08
mutants O 0 4.179095736134286e-09
have O 0 6.793210525352089e-12
3 O 0 9.480179974374892e-10
- O 0 1.7122733231289544e-09
5 O 0 6.796146423404537e-10
- O 0 5.67249303085049e-10
fold O 0 2.8929175027725407e-11
higher O 0 1.9241603102515548e-11
affinity O 0 1.4353076019379962e-12
to O 0 8.625386646241018e-13
various O 0 2.4070200693726562e-11
DNA O 0 5.833903582441735e-09
- O 0 1.183512038371859e-10
binding O 0 8.786491499657156e-12
sites O 0 1.718445524767631e-11
when O 0 1.7244926190165821e-12
compared O 0 2.6189612544608165e-12
with O 0 9.81067549248038e-13
the O 0 1.591059228811531e-10
wild O 0 1.743071749160663e-07
- O 0 2.825372007464466e-07
type O 0 6.43299529201613e-07
PAX6 O 1 0.9999703168869019
. O 0 4.533642794513071e-08

These O 0 2.4121378228159074e-09
results O 0 6.829737331237595e-10
provide O 0 5.063167593521989e-11
a O 0 1.5908460312963335e-11
new O 0 5.237497935350888e-11
insight O 0 1.371829871921193e-10
into O 0 9.029475951660704e-12
the O 0 8.721690036850305e-12
role O 0 2.5731415262408852e-11
of O 0 1.0253276006011447e-09
mutant O 0 1.3102470219905626e-08
PAX6 O 1 0.6498587131500244
in O 0 3.567309336816038e-09
causing O 0 2.598462288005976e-06
aniridia B-Disease 1 1.0
. O 0 6.779383721067234e-09
. O 0 4.6447037327368434e-09

Reversal O 0 3.877375092997681e-06
of O 0 7.533206371590495e-05
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 0.00023213594977278262
excellent O 0 4.494059248827398e-05
neuropsychologic O 0 0.26684918999671936
outcome O 0 4.778327138410532e-07
in O 0 2.881236760288175e-08
very B-Disease 0 3.8161136473036095e-09
- I-Disease 0 4.623339918907732e-06
long I-Disease 0 3.397990866460532e-08
- I-Disease 0 8.330217724505928e-07
chain I-Disease 0 7.715222949400413e-08
acyl I-Disease 0 4.02364719320758e-08
- I-Disease 0 6.665147225248802e-07
coenzyme I-Disease 0 5.2872696443273526e-08
A I-Disease 0 0.00019775608961936086
dehydrogenase I-Disease 0 0.009191200137138367
deficiency I-Disease 1 0.9999532699584961
. O 0 3.869060449801509e-08

Very B-Disease 0 5.969759513391182e-07
- I-Disease 0 7.660508344997652e-06
long I-Disease 0 3.342841381481776e-08
- I-Disease 0 2.518366954973317e-07
chain I-Disease 0 1.3733759018919045e-08
acyl I-Disease 0 8.214202651402047e-09
- I-Disease 0 1.2404530735921071e-08
coenzyme I-Disease 0 9.725917848868448e-10
A I-Disease 0 3.7596191049260597e-08
dehydrogenase I-Disease 0 1.4404830217529252e-08
( I-Disease 0 7.272981328299011e-09
VLCAD I-Disease 1 1.0
) I-Disease 0 1.9846866905481875e-07
deficiency I-Disease 0 0.20367775857448578
is O 0 3.680095117530868e-11
a O 0 3.990732189151913e-10
disorder O 1 0.9999949932098389
of O 1 0.9999234676361084
fatty O 0 3.244379331590608e-05
acid O 0 4.3342915034827456e-08
beta O 0 1.5019614441058593e-09
oxidation O 0 1.5175108947218519e-09
that O 0 4.6319753588264234e-12
reportedly O 0 2.6797825070090653e-10
has O 0 9.915591568307458e-13
high O 0 3.0935190520331446e-10
rates O 0 9.725058952581023e-11
of O 0 4.1728648314531824e-10
morbidity O 0 2.5682088562462013e-06
and O 0 6.313780165356775e-09
mortality O 0 5.811417054246704e-07
. O 0 1.6936939628564573e-09

We O 0 3.188725727909514e-09
describe O 0 3.4543250482244048e-09
the O 0 1.8665981260657105e-10
outcome O 0 4.721986135436396e-10
of O 0 1.7165832089105493e-09
a O 0 8.637381088139051e-11
5 O 0 1.426859075337461e-09
- O 0 2.8430926501954445e-09
year O 0 6.193130036580285e-11
- O 0 9.950946733283672e-09
old O 0 6.715066547258175e-08
girl O 0 1.9206028767371208e-08
with O 0 1.860613219051288e-09
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 8.92817553221903e-09
was O 0 5.695414806439203e-09
first O 0 7.194499995755166e-10
seen O 0 6.215771786166613e-10
at O 0 1.6462186058774364e-09
5 O 0 2.2515556086233346e-10
months O 0 7.346122841977998e-12
of O 0 1.0677587980456593e-10
age O 0 1.8864444728539098e-10
with O 0 1.581202668798909e-10
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9892036318778992
hepatomegaly B-Disease 1 1.0
, O 1 0.9999995231628418
encephalopathy B-Disease 1 1.0
, O 0 1.4124135532256332e-06
and O 0 1.9482064089970663e-05
hypotonia B-Disease 1 1.0
. O 0 1.0779544936667662e-06

Biochemical O 0 3.243414175813086e-05
studies O 0 1.1192801139259245e-06
indicated O 1 0.9870525002479553
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.0009084360208362341
by O 0 1.3408389676339283e-10
a O 0 2.5730839681159523e-10
stable O 0 6.854340650619406e-09
yet O 0 3.731524811367848e-10
inactive O 0 1.5238005346418504e-07
enzyme O 0 1.9136443540901382e-08
. O 0 3.3056088977190257e-09

Molecular O 0 3.748056371932762e-07
genetic O 0 5.23139265240502e-09
analysis O 0 4.684721499614852e-10
of O 0 1.2821748995861526e-08
her O 0 8.765949743860801e-09
VLCAD O 1 1.0
gene O 0 1.3277964683311438e-07
revealed O 0 3.22700444144175e-08
a O 0 6.839149246928855e-10
T1372C O 0 7.256301159941358e-07
( O 0 8.905923776225677e-10
F458L O 0 7.634104690623644e-07
) O 0 2.879124161303537e-10
missense O 0 1.4040504936474463e-07
mutation O 0 3.835188167045089e-09
and O 0 6.709507172075746e-09
a O 0 2.491548656280429e-08
1668 O 1 0.956234335899353
ACAG O 1 1.0
1669 O 0 0.0006007190095260739
splice O 0 3.1877552828518674e-05
site O 0 2.513685899430129e-07
mutation O 0 6.955063014402185e-08
. O 0 1.0340007072784374e-08

After O 0 8.343127966270458e-09
initial O 0 4.692698452046784e-10
treatment O 0 5.416678661163132e-09
with O 0 6.209595337924867e-11
intravenous O 0 7.853943628788329e-08
glucose O 0 1.6207549151658895e-06
and O 0 1.007650674011984e-08
carnitine O 0 4.7489430698988144e-07
, O 0 1.611473038343192e-10
the O 0 3.6570479977626746e-10
patient O 0 8.507925031153718e-09
has O 0 5.205824053083896e-12
thrived O 0 1.1572149904992557e-09
on O 0 4.072672477040129e-10
a O 0 8.502951814870485e-11
low O 0 2.7805148405946056e-08
- O 0 5.20128899950123e-08
fat O 0 1.0606798994672317e-08
diet O 0 9.3382079846549e-10
supplemented O 0 3.875652299090149e-10
with O 0 1.2124837592275561e-11
medium O 0 5.0894136904844345e-08
- O 0 1.1425207446791319e-07
chain O 0 1.1878507955032092e-08
triglyceride O 0 3.861686526107633e-09
oil O 0 8.519190353162287e-10
and O 0 1.0003649991707775e-10
carnitine O 0 1.2477332056448631e-08
and O 0 8.898414644020747e-11
avoidance O 0 1.4835460433459957e-06
of O 0 8.189348221776527e-08
fasting O 0 3.6366710531865465e-08
. O 0 1.0266308914097522e-09

Her O 0 1.9662571503431536e-05
ventricular O 1 0.9999805688858032
hypertrophy O 0 0.050239622592926025
resolved O 0 4.6106626427899755e-07
significantly O 0 2.136644416950162e-09
over O 0 6.8661526464453e-10
1 O 0 6.175875366665196e-10
year O 0 8.23357788198864e-12
, O 0 3.50648286448485e-12
and O 0 7.612970150117082e-12
cognitively O 0 2.4284165078825026e-07
, O 0 8.162841236281082e-11
she O 0 2.8576858761286683e-12
is O 0 1.573396361115309e-13
in O 0 4.2922989381549703e-13
the O 0 9.013405473379255e-12
superior O 0 4.047307555765656e-08
range O 0 1.9933965589302716e-08
for O 0 2.467940296568827e-10
age O 0 3.0975473297445433e-09
. O 0 1.3608304483270217e-09

Clinical O 0 8.23234222480096e-06
recognition O 0 3.815130185103044e-07
of O 1 0.9999991655349731
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.2755249079177133e-09
important O 0 7.710371924263271e-11
because O 0 2.789316303972167e-12
it O 0 3.58981290873861e-13
is O 0 7.163962755267136e-14
one O 0 3.6507700074822624e-13
of O 0 5.2407050921132736e-11
the O 0 5.551073142817664e-11
few O 0 5.553350140852231e-11
directly O 0 4.7365293909251704e-09
treatable O 1 1.0
causes O 0 4.4978986579735647e-07
of O 0 0.10124063491821289
cardiomyopathy B-Disease 1 1.0
in O 0 1.1314186565414275e-07
children O 0 4.064278247284392e-09
. O 0 1.5494754090905616e-10
. O 0 6.047166101197377e-10

Cloning O 0 2.2199090210506256e-07
of O 0 3.900462530737059e-08
a O 0 1.7957128839451997e-10
novel O 0 2.1558668739096731e-10
member O 0 2.1977503150694133e-10
of O 0 6.988073453229049e-10
the O 0 2.875875093621971e-10
low O 0 1.0713463005629364e-08
- O 0 1.1640443053906324e-09
density O 0 3.211158422500304e-11
lipoprotein O 0 1.4345269505611213e-07
receptor O 0 2.4284934063700803e-09
family O 0 1.9002910356391567e-09
. O 0 2.5403348313801644e-09

A O 0 1.1379431725799805e-06
gene O 0 4.3358744372667957e-10
encoding O 0 9.406884993179432e-11
a O 0 1.276634076230465e-10
novel O 0 5.458347107634154e-10
transmembrane O 0 2.4625481653828274e-09
protein O 0 5.556287652197511e-10
was O 0 7.25896620590305e-10
identified O 0 1.0077067652547456e-11
by O 0 1.2327849244903044e-12
DNA O 0 3.092152089934075e-09
sequence O 0 2.7707046726388462e-12
analysis O 0 1.6204684078965914e-12
within O 0 1.2233692357754844e-11
the O 0 3.820902622075906e-11
insulin B-Disease 0 9.846052080320078e-07
- I-Disease 0 0.0003399801207706332
dependent I-Disease 1 0.5202566385269165
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.0748773604518647e-07
IDDM B-Disease 1 1.0
) O 0 2.3611856914129703e-10
locus O 0 2.911403118588396e-09
IDDM4 O 0 0.013982855714857578
on O 0 1.186583133971908e-07
chromosome O 0 5.824816753374762e-07
11q13 O 0 3.210657496310887e-06
. O 0 1.2323125631041876e-08

Based O 0 2.4247603391813755e-07
on O 0 9.966065306343808e-09
its O 0 2.658862019444541e-10
chromosomal O 0 4.5389903391424014e-08
position O 0 8.025420328294786e-09
, O 0 2.5217848642622442e-11
this O 0 1.053094135332333e-12
gene O 0 1.3779235565059e-11
is O 0 4.464357215069187e-13
a O 0 8.237500308608259e-13
candidate O 0 1.9247097405444835e-12
for O 0 3.5413393138089555e-12
conferring O 0 5.7566431621580705e-08
susceptibility O 0 4.5072352804709226e-05
to O 0 1.2089891470168368e-06
diabetes B-Disease 1 1.0
. O 0 1.6588073492584954e-07

The O 0 2.3828280859561346e-07
gene O 0 9.395651368038216e-09
, O 0 2.3296833906449876e-10
termed O 0 1.3100946105737421e-08
low O 0 1.3766594975095359e-08
- O 0 1.7180179501252724e-09
density O 0 2.0645351747616836e-11
lipoprotein O 0 5.342148501341626e-09
receptor O 0 4.6481912069351594e-11
related O 0 3.636974499343637e-09
protein O 0 2.5666285763392693e-10
5 O 0 2.3149300254488026e-09
( O 0 5.4048876485524033e-11
LRP5 O 1 0.9250732660293579
) O 0 1.516346423424686e-11
, O 0 9.044691536529148e-13
encodes O 0 1.2390719960481134e-12
a O 0 4.0328513098430996e-12
protein O 0 6.572627164747047e-11
of O 0 2.386196351622516e-09
1615 O 0 2.948096096133668e-07
amino O 0 8.890853053777903e-10
acids O 0 5.746881442947327e-11
that O 0 1.2433871749047143e-13
contains O 0 3.544738504460132e-12
conserved O 0 2.437400802024481e-11
modules O 0 1.477597766363914e-10
which O 0 1.41702285755968e-12
are O 0 1.7351056572426082e-13
characteristic O 0 1.6271908820364445e-10
of O 0 2.091312262253453e-10
the O 0 1.0960863466857873e-10
low O 0 2.6122302099196304e-09
- O 0 1.1504082131352789e-09
density O 0 5.5698241158141926e-11
lipoprotein O 0 2.3353543099347007e-07
( O 0 2.781956442987621e-09
LDL O 0 0.00039059569826349616
) O 0 1.4406520421061941e-10
receptor O 0 3.490471522926697e-10
family O 0 3.0637070658201537e-10
. O 0 1.6493553189889099e-09

These O 0 2.149528555150937e-09
modules O 0 3.917095270367099e-08
include O 0 7.127125001282764e-10
a O 0 5.955341081387289e-11
putative O 0 9.971765635441443e-10
signal O 0 2.0831201208437733e-09
peptide O 0 2.2187379711269273e-10
for O 0 1.2939803742395561e-11
protein O 0 4.1389523752766166e-11
export O 0 1.9194850153780862e-09
, O 0 2.5239888304384728e-11
four O 0 2.3643122182281928e-11
epidermal O 0 8.275213292385786e-10
growth O 0 3.586640706654265e-11
factor O 0 5.168369551777907e-11
( O 0 4.6204713666231356e-11
EGF O 0 5.207239723858947e-07
) O 0 3.1490553220603346e-11
repeats O 0 9.192322597550984e-11
with O 0 3.147702584693768e-12
associated O 0 5.286477922084032e-10
spacer O 0 2.448214075911892e-08
domains O 0 2.9688764779933763e-09
, O 0 3.8215164366306453e-10
three O 0 2.2019756851232586e-10
LDL O 0 3.0473618608084507e-05
- O 0 4.1052106780625763e-07
receptor O 0 1.3365831774692083e-09
( O 0 7.242067501245231e-10
LDLR O 1 0.9999985694885254
) O 0 3.3871036531074594e-10
repeats O 0 9.086411623115964e-10
, O 0 7.991529313300383e-12
a O 0 1.2657712551711331e-11
single O 0 3.841159612605338e-10
transmembrane O 0 2.926976661044023e-09
spanning O 0 1.4399502035189471e-08
domain O 0 3.046383423299659e-10
, O 0 2.2975919777845633e-11
and O 0 6.415182968178001e-11
a O 0 2.0319858295980708e-10
cytoplasmic O 0 1.5739287206884e-08
domain O 0 7.712115390745566e-09
. O 0 1.326596721362705e-09

The O 0 3.299991391259027e-08
encoded O 0 9.100651343629806e-10
protein O 0 2.3954660477443213e-10
has O 0 1.0805893940063482e-12
a O 0 1.0258229812473707e-12
unique O 0 5.741498856209892e-12
organization O 0 1.0542929723689198e-10
of O 0 2.6571245204110028e-09
EGF O 0 7.862410711823031e-06
and O 0 2.5216815302542273e-09
LDLR O 1 0.9999990463256836
repeats O 0 4.661602659439268e-09
; O 0 1.1246671129117036e-11
therefore O 0 1.2510777136487405e-10
, O 0 1.908095070835003e-10
LRP5 O 1 0.999988317489624
likely O 0 3.394016456770288e-10
represents O 0 1.0894203941735903e-11
a O 0 2.2440675619822548e-12
new O 0 7.861091985694735e-12
category O 0 1.7065765467449978e-10
of O 0 4.748159643241934e-10
the O 0 2.16649054252116e-09
LDLR O 1 0.9999997615814209
family O 0 6.947940445201084e-09
. O 0 2.8034761179185352e-09

Both O 0 2.301420032324586e-08
human O 0 2.8865779100328837e-08
and O 0 2.1231135960420033e-08
mouse O 0 1.542240511298587e-06
LRP5 O 1 1.0
cDNAs O 0 1.2128994058002718e-05
have O 0 2.8438003688013858e-11
been O 0 2.2877748306893153e-11
isolated O 0 1.5116430329698005e-10
and O 0 9.926704423735e-12
the O 0 2.936849374801653e-11
encoded O 0 2.4063773543248068e-11
mature O 0 7.242229038695314e-11
proteins O 0 9.58993951957754e-13
are O 0 3.35877213628738e-13
95 O 0 4.806729667072851e-11
% O 0 7.67993389152663e-14
identical O 0 3.423349798081787e-11
, O 0 6.134520842693281e-12
indicating O 0 2.42316531423592e-11
a O 0 5.839305167870679e-12
high O 0 2.12654824305325e-10
degree O 0 3.5966787881314133e-10
of O 0 2.2363785823209525e-10
evolutionary O 0 3.0411703710875315e-10
conservation O 0 1.904060686896969e-09
. O 0 3.000754505988468e-11
. O 0 3.728266584346329e-10

The O 0 3.458856951965572e-07
APC B-Disease 0 1.9600754512794083e-06
variants O 0 7.325736817165307e-08
I1307K O 0 9.04259763956361e-07
and O 0 1.3377665641911562e-09
E1317Q O 0 1.8429089720939373e-07
are O 0 2.9556409403275197e-11
associated O 0 6.766829585558298e-08
with O 0 0.006318387575447559
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.7854961953389648e-08
but O 0 6.0709549366821935e-12
not O 0 1.4701832416405547e-12
always O 0 1.1943987465734551e-11
with O 0 1.6762021458338605e-12
a O 0 7.221717668315364e-11
family O 0 1.4860712660436093e-10
history O 0 8.95555203328513e-08
. O 0 2.8835551724171182e-09

Classical O 1 0.9995604157447815
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.7485239141024067e-06
FAP B-Disease 0 0.03515827655792236
) O 0 8.22338475092721e-10
is O 0 1.650187451962548e-11
a O 0 3.6625905086573596e-10
high O 1 0.9999194145202637
- O 1 0.9999997615814209
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
that O 0 1.8892411940418796e-11
predisposes O 0 5.7858882129835365e-09
to O 0 2.3153914549545185e-11
hundreds O 0 2.2073748384698888e-10
or O 0 1.2994814946321043e-10
thousands O 0 7.372237820213456e-10
of O 0 0.002203231444582343
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9996598958969116
carcinoma I-Disease 1 1.0
and O 0 6.187389089973294e-08
that O 0 2.4766719924906866e-11
results O 0 2.822596878448991e-10
from O 0 2.761832984532475e-10
truncating O 0 1.8983284277851453e-08
mutations O 0 1.2844084129604028e-10
in O 0 2.9220495467718877e-10
the O 0 4.905336137284166e-09
APC B-Disease 0 8.713343959243502e-06
gene O 0 5.370921485337021e-08
. O 0 1.1547285794222262e-08

A O 0 9.869722816802096e-07
variant O 0 2.2975983426931634e-07
of O 0 7.829085291177762e-08
FAP B-Disease 0 0.0006915671983733773
is O 0 7.899702225699912e-09
attenuated B-Disease 1 0.7559707164764404
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999985694885254
coli I-Disease 1 0.9999997615814209
, O 0 1.049430320421152e-09
which O 0 2.0796562388847306e-11
results O 0 3.3005545518882684e-10
from O 0 7.024234527364115e-10
germ O 0 0.12278386205434799
- O 0 6.643937808803457e-07
line O 0 1.5043131185166203e-08
mutations O 0 2.2668948315707205e-11
in O 0 9.155030900043215e-12
the O 0 1.1326413418277781e-10
5 O 0 1.4094873879155756e-10
and O 0 9.745367707258978e-12
3 O 0 3.837878903567571e-10
regions O 0 1.3763843363656658e-11
of O 0 4.137928333314278e-10
the O 0 2.0929373789613237e-09
APC B-Disease 0 4.931803687213687e-06
gene O 0 5.2055764143688066e-08
. O 0 4.171721190715516e-09

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 8.760771379456855e-06
have O 0 4.2574729852695725e-10
" O 0 2.4686018562647405e-08
multiple O 0 0.00025830030790530145
" O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 4.155520372250976e-09
typically O 0 1.7202859969867035e-10
fewer O 0 1.1741108085772112e-11
than O 0 6.054312324914324e-13
100 O 0 5.718223464179495e-11
) O 0 7.176315748244622e-13
without O 0 6.254797461219264e-12
the O 0 6.858871803849809e-11
florid O 0 9.932973199511252e-08
phenotype O 0 5.725451224236622e-10
of O 0 2.623314454552883e-09
classical O 0 2.8331021439953474e-07
FAP B-Disease 0 4.488952981773764e-05
. O 0 6.449283329601485e-09

Another O 0 1.3991208902552899e-07
group O 0 8.399058337715815e-09
of O 0 1.1782831599305155e-08
patients O 0 1.9807409046279645e-09
with O 0 3.199226994432536e-10
multiple O 0 1.4301561350293923e-05
adenomas B-Disease 1 0.7522231936454773
has O 0 3.4510896917971934e-10
no O 0 9.729586580853322e-11
mutations O 0 3.9503501164661614e-11
in O 0 9.525979310920363e-11
the O 0 5.141578829359617e-10
APC B-Disease 0 1.3889030014979653e-07
gene O 0 1.1020950818618758e-09
, O 0 3.566482872918719e-11
and O 0 6.003583741254204e-11
their O 0 1.7011134167965736e-10
phenotype O 0 7.463750728575747e-10
probably O 0 3.790519009783111e-10
results O 0 1.4974324558103547e-10
from O 0 2.301189377940105e-10
variation O 0 1.6145565995273614e-09
at O 0 1.300508700730063e-09
a O 0 1.6087818577315005e-11
locus O 0 7.93969404111472e-11
, O 0 1.0762704096001219e-11
or O 0 1.5710471118479674e-11
loci O 0 7.662782214312713e-11
, O 0 8.247676847039642e-12
elsewhere O 0 6.881947789416643e-11
in O 0 9.594883915164942e-12
the O 0 1.127507115450399e-10
genome O 0 7.057269768573349e-10
. O 0 6.981945022133118e-10

Recently O 0 2.1545665163102967e-07
, O 0 3.014696270398076e-10
however O 0 2.1892059345884896e-11
, O 0 5.743031918081787e-12
a O 0 4.596507636317471e-12
missense O 0 6.432759658281384e-09
variant O 0 1.063423056280044e-07
of O 0 2.059957978417515e-06
APC B-Disease 0 0.0001272025692742318
( O 0 1.807635641171146e-08
I1307K O 0 3.7855991195101524e-06
) O 0 1.009970163057261e-10
was O 0 5.523267954110622e-10
described O 0 1.21082047166432e-10
that O 0 4.0217341176068677e-13
confers O 0 1.939048054067083e-11
an O 0 1.807041658235392e-13
increased O 0 1.3201563106579606e-11
risk O 0 8.584013500012588e-09
of O 1 0.906544029712677
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.453154263586498e-09
including O 0 1.3416991961889835e-09
multiple O 0 6.199497306624835e-07
adenomas B-Disease 0 0.00027718665660358965
, O 0 7.378150090886493e-09
in O 0 8.370671267243779e-09
Ashkenazim O 0 0.00012848842015955597
. O 0 1.149823560808727e-07

We O 0 4.219656180026732e-09
have O 0 1.14645107643363e-11
studied O 0 1.4734052866671732e-09
a O 0 2.0466411551622876e-11
set O 0 2.0574446313315065e-10
of O 0 2.0790626165112513e-10
164 O 0 7.985214156569498e-10
patients O 0 4.6670247527691444e-11
with O 0 2.814757281421887e-11
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.00010888196266023442
/ I-Disease 1 0.998611330986023
or I-Disease 0 0.00017811685393098742
carcinoma I-Disease 1 1.0
and O 0 4.535813857842186e-08
analyzed O 0 1.3475838045451383e-07
codons O 0 1.4371191525697213e-07
1263 O 0 4.663126219384139e-06
- O 0 8.057880052092514e-08
1377 O 0 1.6448658470835653e-06
( O 0 6.356963844211805e-10
exon O 0 4.3334566157682275e-08
15G O 0 2.031285220027712e-07
) O 0 1.6902779523264577e-11
of O 0 4.547686116573857e-10
the O 0 4.170605250042314e-10
APC B-Disease 0 1.6521873646979657e-07
gene O 0 6.435529886772429e-10
for O 0 1.4745375753744128e-10
germ O 0 0.4769527018070221
- O 0 4.5631450120708905e-06
line O 0 7.58560503300032e-08
variants O 0 1.3586086033967604e-08
. O 0 7.012775360415446e-10

Three O 0 1.1465648697139841e-07
patients O 0 1.7410166641695923e-09
with O 0 3.8218206377393926e-11
the O 0 3.137230253358325e-09
I1307K O 0 1.3548981314670527e-07
allele O 0 2.9099512730001997e-11
were O 0 2.1131556574016663e-11
detected O 0 1.187191012164135e-09
, O 0 1.1659713992917542e-12
each O 0 2.6245103095998146e-13
of O 0 4.325887703604536e-10
Ashkenazi O 0 2.528819322833442e-07
descent O 0 2.8115533723394037e-07
. O 0 1.3923028063800302e-08

Four O 0 7.322697115341725e-07
patients O 0 2.928765141518852e-08
had O 0 7.12247705259017e-10
a O 0 1.400088822656187e-09
germ O 1 0.9998897314071655
- O 0 6.860149005660787e-05
line O 0 3.6319440255283553e-07
E1317Q O 0 1.0851213261275916e-07
missense O 0 9.982008108977425e-09
variant O 0 3.097094136705891e-08
of O 0 1.4708500373217248e-07
APC O 0 4.922354150949104e-07
that O 0 4.149402002551206e-11
was O 0 9.232336561915133e-10
not O 0 3.688960215856435e-13
present O 0 6.421324843380871e-12
in O 0 1.0870707112253797e-11
controls O 0 3.576409723926588e-10
; O 0 6.337067155748333e-12
one O 0 3.019953211114146e-12
of O 0 5.099958996779286e-11
these O 0 2.7738668566951175e-12
individuals O 0 9.95506520100331e-13
had O 0 6.559753434887128e-11
an O 0 9.501835082637022e-13
unusually O 0 1.0389321347670233e-10
large O 0 3.9629379638972395e-11
number O 0 2.517651712108382e-11
of O 0 6.9960122139889336e-09
metaplastic B-Disease 0 5.764406159869395e-05
polyps I-Disease 0 5.997663947709952e-07
of I-Disease 0 6.280931330593376e-08
the I-Disease 0 2.1197953614660037e-08
colorectum I-Disease 0 0.0002947091998066753
. O 0 2.943746224559618e-08

There O 0 5.580335304955497e-09
is O 0 2.1166731561939045e-11
increasing O 0 3.4013362872759023e-12
evidence O 0 7.737139401386983e-11
that O 0 1.7391678917323683e-13
there O 0 3.544473200188525e-13
exist O 0 9.809390279225116e-12
germ O 0 4.177245216396841e-07
- O 0 4.186531121774806e-09
line O 0 7.920065714372981e-10
variants O 0 1.1988431081189077e-10
of O 0 3.3666025522904874e-10
the O 0 4.82749673569316e-10
APC B-Disease 0 2.3483771371957118e-07
gene O 0 2.0776512454911966e-10
that O 0 5.203666816021302e-13
predispose O 0 1.297087021123744e-10
to O 0 3.6038234028923366e-12
the O 0 2.7987502940196585e-11
development O 0 1.9417545349398324e-10
of O 0 3.2480969025527884e-09
multiple O 1 0.9999879598617554
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999758005142212
carcinoma I-Disease 1 1.0
, O 0 6.294288645847246e-09
but O 0 9.173314018118273e-12
without O 0 8.587378030888715e-11
the O 0 1.0680155371201039e-10
florid O 0 1.4030226225258957e-07
phenotype O 0 1.764316803765098e-09
of O 0 5.514986245458431e-09
classical O 0 7.211129116058146e-08
FAP B-Disease 0 2.297965011166525e-06
, O 0 4.818957038965621e-11
and O 0 9.935304315367155e-12
possibly O 0 1.1216042677952842e-10
with O 0 3.1579493794259283e-12
importance O 0 6.2453895388614455e-09
for O 0 3.819828270934522e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 1.792805015554677e-09
in O 0 2.135024795846263e-11
the O 0 4.1156585084412e-11
general O 0 5.897893978756841e-11
population O 0 1.318692876249583e-13
. O 0 2.6657298330540202e-12
. O 0 1.224887552497833e-10

Genomic O 0 1.9051483945986547e-07
structure O 0 3.931766556775074e-08
of O 0 1.0776585845917452e-08
the O 0 2.65762123419222e-09
human O 0 0.054445765912532806
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 1.8609478502185084e-05
CLD B-Disease 1 1.0
) O 0 9.527188815638965e-09
gene O 0 3.444891660819849e-08
. O 0 6.68174315876513e-09

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9997408986091614
CLD B-Disease 1 1.0
) O 0 1.1583617620658515e-08
is O 0 1.2221611743468141e-11
caused O 0 3.676350612824564e-10
by O 0 1.1774097322114763e-11
mutations O 0 1.2145282002329338e-10
in O 0 3.3666520959929613e-11
a O 0 4.88492128691842e-11
gene O 0 6.084927700600318e-11
which O 0 9.902951722540188e-12
encodes O 0 6.998714108252813e-11
an O 0 4.158117253294513e-11
intestinal O 0 1.0242080179523327e-06
anion O 0 8.455496924852923e-08
transporter O 0 1.7847129129222594e-05
. O 0 9.161826852732702e-08

We O 0 7.394887369116532e-09
report O 0 7.166437443473228e-10
here O 0 4.4413455552172465e-11
the O 0 7.790683029251788e-12
complete O 0 8.958136316072896e-11
genomic O 0 1.3244545737922664e-10
organization O 0 1.4183004770629282e-10
of O 0 4.674340914334607e-10
the O 0 2.311663777065931e-10
human O 0 2.0632933139808074e-09
CLD B-Disease 1 0.9999994039535522
gene O 0 6.186497980564809e-10
which O 0 1.5698968167110472e-11
spans O 0 4.922692253828131e-10
approximately O 0 1.465237306486067e-11
39kb O 0 1.2714478714315192e-07
, O 0 1.2071400823376877e-10
and O 0 3.126864045466249e-10
comprises O 0 1.2524040471362241e-08
21 O 0 7.518538325257396e-08
exons O 0 5.378947776080167e-07
. O 0 8.36874036735935e-09

All O 0 1.815583487996264e-07
exon O 0 9.97885854303604e-06
/ O 0 1.4808462083237828e-06
intron O 0 2.0758636765094707e-07
boundaries O 0 3.960297423333259e-09
conform O 0 3.438220375073797e-09
to O 0 1.702671614811635e-10
the O 0 3.8535925561689055e-09
GT O 0 0.10695961117744446
/ O 0 0.00015615885786246508
AG O 1 1.0
rule O 0 2.2518354114708927e-07
. O 0 6.7745236087546346e-09

An O 0 2.6909482975234766e-10
analysis O 0 1.8974613547051433e-10
of O 0 1.4137636616951e-09
the O 0 2.486907346721523e-10
putative O 0 5.76130041451961e-08
promoter O 0 9.535274330119137e-06
region O 0 1.5232739514203786e-08
sequence O 0 4.149649235341002e-10
shows O 0 2.888519146093671e-10
a O 0 2.054762193726134e-10
putative O 0 2.498678384199593e-07
TATA O 1 0.9999979734420776
box O 0 1.8197488316218369e-06
and O 0 9.451130988935574e-10
predicts O 0 2.457049674831069e-09
multiple O 0 1.9016968555440883e-10
transcription O 0 6.212574898967205e-09
factor O 0 2.6264773689277376e-10
binding O 0 9.79775038878472e-10
sites O 0 6.163969334949115e-09
. O 0 1.2817438221901511e-09

The O 0 1.1613394690357381e-08
genomic O 0 2.7407400793322267e-08
structure O 0 5.641561440228315e-09
was O 0 4.427578026433565e-10
determined O 0 5.584214080728289e-12
using O 0 1.7790133515632744e-12
DNA O 0 1.7105661331839883e-09
from O 0 3.092678240237956e-12
several O 0 2.2512170621581673e-13
sources O 0 1.6021484269476693e-12
including O 0 4.157884540140211e-12
multiple O 0 9.957031033014374e-11
large O 0 1.0167664488136552e-09
- O 0 1.0203804094999214e-06
insert O 0 1.0573050701623288e-07
libaries O 0 7.70936708249792e-07
and O 0 4.366754527418415e-11
genomic O 0 1.0290756025099768e-09
DNA O 0 3.8158322723802485e-08
from O 0 1.3007915855567376e-09
Finnish O 0 0.15448735654354095
CLD B-Disease 1 1.0
patients O 0 1.0960334861920273e-07
and O 0 3.836709616678036e-09
controls O 0 1.4056839745535399e-06
. O 0 2.2963249080021342e-08

Exon O 0 2.5621940949349664e-05
- O 0 1.55614145569416e-07
specific O 0 1.2943511540353114e-10
primers O 0 1.6468476360387285e-08
developed O 0 3.772976930882521e-10
in O 0 4.501580098265068e-12
this O 0 1.1477664894627825e-14
study O 0 1.4186067143033554e-13
will O 0 5.147681800678032e-14
facilitate O 0 4.548843940410663e-12
mutation O 0 1.6980775509670143e-12
screening O 0 4.459287539920753e-12
studies O 0 2.5099117662713555e-12
of O 0 3.561975714383436e-11
patients O 0 2.4560443956378464e-11
with O 0 2.5093961630862083e-11
the O 0 1.8154015606342e-06
disease O 1 0.9998581409454346
. O 0 2.455873504558781e-09

Genomic O 0 3.3230453055921316e-08
sequencing O 0 5.054912488589025e-09
of O 0 2.794961773133764e-08
a O 0 6.820211950753219e-09
BAC O 1 0.9999996423721313
clone O 0 8.74579418450594e-05
H O 1 1.0
_ O 0 6.311756894916698e-09
RG364P16 O 0 1.3389625053150667e-07
revealed O 0 1.533923654761793e-09
the O 0 5.1143662221919683e-11
presence O 0 3.555283151213118e-11
of O 0 6.635638150065404e-10
another O 0 6.499512039681576e-11
, O 0 1.0698662442076845e-11
highly O 0 1.1761802642951125e-10
homologous O 0 1.2602625887314645e-10
gene O 0 1.783846959035884e-10
3 O 0 9.416780688553672e-10
of O 0 6.274927244476203e-10
the O 0 1.314639619387492e-09
CLD B-Disease 1 1.0
gene O 0 2.3478488042627532e-09
, O 0 1.685837927589695e-11
with O 0 8.051070118746118e-13
a O 0 3.52776813837552e-12
similar O 0 1.890012452099299e-11
genomic O 0 1.7923399431296616e-09
structure O 0 4.3211234590501135e-09
, O 0 5.946760445185717e-11
recently O 0 3.9645859511994175e-11
identified O 0 1.4142261146876667e-11
as O 0 1.2001397271810266e-11
the O 0 4.04710487345028e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 2.0612764828342733e-08
( O 0 4.6513065621311966e-10
PDS B-Disease 0 0.052819475531578064
) O 0 2.2915884467789027e-10
. O 0 1.0061745880918238e-10
. O 0 9.17689368939989e-10

The O 0 4.5311099938771804e-07
APCI1307K O 1 1.0
allele O 0 6.032736621364165e-08
and O 0 1.805688754075163e-08
cancer B-Disease 0 4.232528226566501e-05
risk O 0 8.759960534732159e-10
in O 0 1.0117747611948502e-10
a O 0 2.5253660274060508e-11
community O 0 1.0066770333994057e-11
- O 0 3.341053267380545e-10
based O 0 2.926019149196435e-11
study O 0 9.288034751031571e-12
of O 0 3.839026319063521e-11
Ashkenazi O 0 1.0267352301696064e-08
Jews O 0 6.595565871236886e-09
. O 0 6.695955789837171e-09

Mutations O 0 3.7918502471256943e-07
in O 0 1.2162841400709112e-08
APC O 0 8.008372560652788e-07
are O 0 4.5199510800841836e-11
classically O 0 9.643556495575467e-07
associated O 0 4.528276420501243e-08
with O 0 1.0631919167281012e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.514287871235865e-06
FAP B-Disease 1 0.9914783835411072
) O 0 1.3513404839571308e-09
, O 0 1.3812391334855345e-11
a O 0 3.563681294505017e-11
highly O 0 7.663437827432062e-06
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.0020896061323583126
by O 0 2.5415758386770904e-09
multiple O 0 0.21624428033828735
intestinal O 1 1.0
polyps B-Disease 0 0.00010716781252995133
and O 0 8.914306626195412e-09
, O 0 2.4363050465936453e-10
without O 0 1.2621267919676882e-10
surgical O 0 0.21316570043563843
intervention O 0 9.195368733116993e-08
, O 0 6.562506094098808e-11
the O 0 3.597390441090198e-11
development O 0 1.9683727980890353e-09
of O 0 0.0066805556416511536
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 9.909356890602794e-08
CRC B-Disease 1 1.0
) O 0 6.304173294502391e-10
. O 0 1.226679091637095e-09

APC B-Disease 0 0.00010711580398492515
is O 0 4.207408199619067e-09
a O 0 2.9282161140287144e-09
tumour O 1 1.0
- O 0 4.783784675055358e-07
suppressor O 0 3.401926917945275e-08
gene O 0 3.194263464845193e-10
, O 0 6.6952047204915655e-12
and O 0 2.0757649071834194e-11
somatic O 0 1.4519534943246981e-06
loss O 0 1.0325036782887764e-05
occurs O 0 7.112950228815862e-09
in O 0 2.0376310416736487e-08
tumours B-Disease 1 1.0
. O 0 7.579675553870402e-08

The O 0 9.136153948929859e-07
germline O 0 1.5098288713488728e-05
T O 0 0.00029453393653966486
- O 0 8.251485184018748e-08
to O 0 3.073053755908717e-10
- O 0 1.6200019103962404e-08
A O 0 2.2034818414340407e-08
transversion O 0 1.2260660753327102e-07
responsible O 0 1.2344715250023341e-09
for O 0 4.825726623858273e-11
the O 0 1.1521561482652487e-09
APC O 0 2.8666073603744735e-07
I1307K O 0 1.0050826659835366e-07
allele O 0 1.8678862276355623e-11
converts O 0 1.3837105072855849e-10
the O 0 1.1616838047068256e-10
wild O 0 5.2211053258588436e-09
- O 0 1.973568197755071e-09
type O 0 9.388892996398113e-10
sequence O 0 4.278407836344478e-11
to O 0 7.803636209446907e-12
a O 0 2.9960092740033417e-10
homopolymer O 0 0.0011037524091079831
tract O 0 0.0009374566143378615
( O 0 1.4236711365356314e-08
A8 O 0 0.21352234482765198
) O 0 1.0965255092809656e-10
that O 0 3.365867046883908e-12
is O 0 1.2406688523758369e-11
genetically O 0 9.919803005686845e-07
unstable O 0 0.00012004714517388493
and O 0 7.819996739044655e-08
prone O 0 5.235451681073755e-05
to O 0 8.460312450608853e-10
somatic O 0 1.1928343155886978e-05
mutation O 0 6.328503587837986e-08
. O 0 1.0389549665035247e-08

The O 0 1.6671096148002107e-07
I1307K O 0 1.3325133068065043e-06
allele O 0 2.3988917519091046e-09
was O 0 1.8908437038334114e-09
found O 0 1.9021140218455912e-10
in O 0 3.0947053253349566e-10
6 O 0 6.32329104632845e-08
. O 0 3.1901310482140843e-09

1 O 0 1.2514875891156407e-07
% O 0 2.7048094666803912e-11
of O 0 1.5054453517127087e-10
unselected O 0 2.6984782834915677e-06
Ashkenazi O 0 7.369517618371901e-08
Jews O 0 3.5069964710032764e-09
and O 0 2.996437820090847e-10
higher O 0 7.636843935010518e-10
proportions O 0 1.3811404242503045e-09
of O 0 3.9059400158691915e-09
Ashkenazim O 0 1.1267862731756395e-07
with O 0 6.402396668381272e-11
family O 0 6.266276386668324e-11
or O 0 4.168495756906587e-11
personal O 0 8.575008481059854e-10
histories O 0 8.526009054321548e-08
of O 0 3.0058515676500974e-06
CRC B-Disease 1 0.9999997615814209
( O 0 7.805192603349553e-10
ref O 0 2.8014068220727495e-07
. O 0 1.0113407333811608e-10
2 O 0 4.686063981296229e-09
) O 0 5.3208288469663856e-11
. O 0 1.823483447571661e-10

To O 0 7.624705311570779e-10
evaluate O 0 2.1554825480052386e-08
the O 0 1.172704156005011e-09
role O 0 5.304880978940218e-10
of O 0 3.988603225479892e-09
I1307K O 0 1.2870586374447157e-07
in O 0 1.7226575721451809e-09
cancer B-Disease 0 2.756991932528763e-07
, O 0 7.941814567091754e-11
we O 0 3.484423166666417e-11
genotyped O 0 1.4346229590955772e-06
5 O 0 2.0368151609773122e-08
, O 0 6.096175786396429e-10
081 O 0 1.3843523447576445e-05
Ashkenazi O 0 1.1515201236989014e-07
volunteers O 0 2.9121973721402128e-09
in O 0 2.2270905952748166e-10
a O 0 8.85439568887314e-11
community O 0 7.659071293852904e-11
survey O 0 1.7507536531624623e-09
. O 0 1.638496893718866e-09

Risk O 0 8.051364375205594e-07
of O 0 3.822275175480172e-06
developing O 1 0.950523853302002
colorectal B-Disease 1 1.0
, I-Disease 0 3.893067628268909e-07
breast I-Disease 0 0.00591990165412426
and I-Disease 0 9.63717550206411e-09
other I-Disease 0 1.3674138266139835e-08
cancers I-Disease 1 0.9979756474494934
were O 0 9.761879082859082e-10
compared O 0 2.636485474383221e-10
between O 0 3.281109273167715e-10
genotyped O 0 1.1972057336606667e-06
I1307K O 0 1.3894343453557667e-07
carriers O 0 2.281901195777536e-10
and O 0 1.4346249188612603e-10
non O 0 4.917798079873137e-08
- O 0 1.0399541672256873e-08
carriers O 0 4.104526440951162e-11
and O 0 1.0201142881804959e-11
their O 0 1.5874331363296967e-11
first O 0 1.380865838340739e-10
- O 0 5.902905386712121e-10
degree O 0 3.4575549090476443e-09
relatives O 0 6.113482164948891e-09
. O 0 3.1674491918209924e-09

Sperm O 0 7.740276863898998e-09
DNA O 0 3.3672801436068767e-08
analysis O 0 1.898924073540087e-10
in O 0 4.883281626288927e-11
a O 0 7.694920256540172e-10
Friedreich B-Disease 1 0.9999998807907104
ataxia I-Disease 1 1.0
premutation O 1 0.9993738532066345
carrier O 0 7.19815744787411e-08
suggests O 0 2.672729149111319e-09
both O 0 7.874211005454157e-11
meiotic O 0 3.806557060670457e-07
and O 0 4.2093489804884143e-10
mitotic O 0 9.134254241871531e-09
expansion O 0 6.207007796632524e-09
in O 0 3.965737738198527e-10
the O 0 2.4500719231212997e-09
FRDA B-Disease 1 0.999995231628418
gene O 0 9.210447160512558e-08
. O 0 3.3119893494415464e-09

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 3.867062048357184e-07
usually O 0 9.279530921446622e-09
caused O 0 6.838526633856645e-09
by O 0 7.317623069991175e-12
an O 0 4.613668388303571e-13
expansion O 0 3.5052427627135785e-10
of O 0 1.1547220069019204e-08
a O 0 3.542317328353306e-09
GAA O 0 0.38136279582977295
trinucleotide O 0 1.9232962586102076e-05
repeat O 0 2.9175362570299512e-08
in O 0 1.3288911082653954e-09
intron O 0 5.794670698833215e-08
1 O 0 5.414943160531038e-09
of O 0 3.9610981161786185e-09
the O 0 4.3708587860180614e-09
FRDA B-Disease 1 1.0
gene O 0 1.7392892459611176e-07
. O 0 9.109270671103786e-09

Occasionally O 0 1.2225544878674555e-06
, O 0 1.6951320347402543e-09
a O 0 1.5545255360738253e-10
fully O 0 7.105840915677675e-10
expanded O 0 2.53811555106509e-10
allele O 0 2.245113123189313e-11
has O 0 6.922370120697463e-13
been O 0 5.52544067358024e-13
found O 0 2.015313480333014e-12
to O 0 1.5565502445996637e-12
arise O 0 1.1326758975194196e-10
from O 0 1.0642982328779027e-10
a O 0 1.7015321096547353e-10
premutation O 0 5.295747769196169e-07
of O 0 2.065172388654446e-08
100 O 0 2.5201813969033537e-09
or O 0 1.1006660166623661e-10
less O 0 2.539607135698674e-10
triplet O 0 5.209676146478159e-06
repeats O 0 6.447219789151859e-07
. O 0 1.852003173041794e-08

We O 0 8.299307019399293e-09
have O 0 8.289517509918465e-12
examined O 0 3.5407230480899443e-09
the O 0 4.4529831211281845e-11
sperm O 0 2.769564785842782e-11
DNA O 0 1.682669648062074e-08
of O 0 2.1343593559208784e-09
a O 0 8.835471243529014e-10
premutation O 0 2.0125067749177106e-05
carrier O 0 2.562674694672751e-07
. O 0 2.8329987245001576e-08

This O 0 1.7422923104248866e-09
mans O 0 2.388440805134451e-07
leucocyte O 0 2.5849915346043417e-06
DNA O 0 2.9776180099361227e-07
showed O 0 9.641141218708071e-10
one O 0 3.5114420052217987e-12
normal O 0 2.746450462887129e-11
allele O 0 5.9024378266936406e-12
and O 0 8.689891688173912e-12
one O 0 5.4891933012890526e-12
allele O 0 1.2659596461406242e-11
of O 0 1.4075852983186365e-10
approximately O 0 4.889871146884772e-11
100 O 0 1.282071449004718e-09
repeats O 0 1.120279868871421e-08
. O 0 2.9659559253047973e-09

His O 0 3.330479501073569e-07
sperm O 0 2.7245812272980174e-09
showed O 0 1.102864688462546e-09
an O 0 1.717025935495109e-12
expanded O 0 1.6886868292598223e-10
allele O 0 1.123882237274998e-11
in O 0 1.9960985989109226e-11
a O 0 5.6154577515732385e-11
tight O 0 1.589274489788295e-08
range O 0 4.142449228083933e-08
centering O 0 5.474419850770573e-08
on O 0 4.2458603299877495e-10
a O 0 7.308109846448918e-12
size O 0 1.2220726167133655e-11
of O 0 6.869977919876646e-10
approximately O 0 4.5249043401085487e-10
320 O 0 2.763954221052245e-08
trinucleotide O 0 3.605690289987251e-05
repeats O 0 4.960946853316273e-07
. O 0 1.5130176223010494e-08

His O 0 1.0000646852859063e-06
affected O 0 2.59922302348059e-07
son O 0 2.7357114049664233e-06
has O 0 4.438771225578897e-11
repeat O 0 1.9158774566818693e-10
sizes O 0 7.317211281332447e-10
of O 0 1.5504467043570003e-08
1040 O 0 1.4532484726714756e-07
and O 0 4.624796101637685e-09
540 O 0 2.1502435743059323e-07
. O 0 1.1421771972663919e-08

These O 0 1.177954511710766e-09
data O 0 4.1338657497114184e-10
suggest O 0 1.728346285534421e-11
that O 0 2.1585862166727948e-14
expansion O 0 9.008179618907874e-12
occurs O 0 1.2117156236723936e-12
in O 0 3.9793174181138036e-13
two O 0 4.967334594867256e-13
stages O 0 8.08391908968531e-10
, O 0 1.8509046292164433e-12
the O 0 4.69969809596682e-12
first O 0 1.506981518739625e-11
during O 0 4.412434653766617e-11
meiosis O 0 4.236864470374968e-10
followed O 0 5.0838760284888096e-11
by O 0 1.6348514339167841e-12
a O 0 1.7498171314689337e-11
second O 0 6.545183284245581e-10
mitotic O 0 2.071942795112136e-08
expansion O 0 9.32091879235486e-08
. O 0 1.6223674847992697e-08

We O 0 1.004262184522986e-08
also O 0 1.030908067245484e-10
show O 0 4.0516499877352175e-11
that O 0 7.176517138798161e-14
in O 0 1.60680919524675e-12
all O 0 2.849987769653478e-13
informative O 0 2.0885288290473092e-11
carrier O 0 9.944997603206218e-11
father O 0 3.295283212967348e-10
to O 0 2.7905310007181328e-11
affected O 0 4.976484224705757e-10
child O 0 5.079904830118664e-10
transmissions O 0 6.408646502364945e-09
, O 0 7.894358777793542e-12
with O 0 7.755319281731177e-13
the O 0 7.573244982517213e-12
notable O 0 2.872376295148804e-11
exception O 0 7.681762864697461e-11
of O 0 9.286378888084812e-10
the O 0 4.134662334731587e-10
premutation O 0 8.978707342066627e-07
carrier O 0 5.800329549998651e-09
, O 0 4.4164758655762526e-11
the O 0 5.144254466848963e-11
expansion O 0 4.3602485511051725e-10
size O 0 7.893428272121028e-11
decreases O 0 1.3675827137404895e-09
. O 0 2.0845022929982804e-10
. O 0 1.4521013280699435e-09

The O 0 9.337751549765017e-08
R496H O 0 1.1154610319863423e-06
mutation O 0 2.4545856458502158e-09
of O 0 1.897419998897476e-08
arylsulfatase O 0 0.0001798706507543102
A O 0 8.279614121420309e-06
does O 0 1.8323390027497055e-10
not O 0 2.3189195008654906e-10
cause O 0 0.0001089650540961884
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 1.602621608753907e-07

Deficiency B-Disease 1 0.9999997615814209
of I-Disease 0 0.08998455852270126
arylsulfatase I-Disease 1 0.9996386766433716
A I-Disease 0 0.03944895416498184
( O 0 1.4782421509096366e-08
ARSA O 1 0.9999862909317017
) O 0 2.0234773578930998e-10
enzyme O 0 1.6198867802685868e-09
activity O 0 9.96650317830472e-09
causes O 0 1.4753049981663935e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 9.47234127579577e-07
MLD B-Disease 1 1.0
) O 0 4.140014553399851e-09
. O 0 8.264140483049687e-10

A O 0 4.438020368979778e-07
number O 0 3.6893177401964294e-10
of O 0 2.003432797437199e-08
ARSA O 1 0.9999945163726807
gene O 0 1.5484399540355298e-08
mutations O 0 4.375771744946633e-09
responsible O 0 1.5227829663899684e-08
for O 0 6.191731127813682e-09
MLD B-Disease 1 1.0
have O 0 1.2664529147610182e-10
been O 0 2.3245644992231362e-11
identified O 0 1.215554878974956e-10
. O 0 2.2972163060686057e-10

Recently O 0 2.8451862021938723e-07
, O 0 2.450725178348989e-10
the O 0 9.769828002159642e-11
R496H O 0 4.391652552726555e-08
mutation O 0 2.7472585317767084e-10
of O 0 6.128215712664087e-09
ARSA O 1 0.9999469518661499
was O 0 6.488581671959537e-09
proposed O 0 8.101758153244987e-11
to O 0 6.987853438250591e-12
be O 0 1.1305731524580143e-11
a O 0 2.387551822913281e-10
cause O 0 3.177652985186796e-08
of O 0 2.799815092657809e-06
MLD B-Disease 1 1.0
( O 0 5.5610613891587946e-09
Draghia O 0 2.167617822124157e-05
et O 0 1.0192347872362006e-06
al O 0 4.962612365488894e-07
. O 0 4.7317389589851544e-11
, O 0 2.3455369591030006e-11
1997 O 0 1.4903298595214665e-09
) O 0 3.833969947075744e-11
. O 0 2.3040178098732156e-10

We O 0 8.985199251299036e-09
have O 0 1.87249486749419e-11
investigated O 0 3.9963556908162445e-09
the O 0 3.479171950537818e-10
R496H O 0 1.5119127283469425e-08
mutation O 0 2.6876329287106593e-11
and O 0 6.364807118852678e-12
found O 0 4.710485040221313e-12
this O 0 9.978060993556456e-14
mutation O 0 3.378853837346374e-12
at O 0 1.2064495236163708e-10
a O 0 2.2614566469458808e-12
relatively O 0 2.801269849764254e-12
high O 0 6.95504001613223e-11
frequency O 0 9.484638768819664e-12
in O 0 7.117440859773227e-13
an O 0 2.1753764425664485e-13
African O 0 9.367668966919762e-12
American O 0 1.6218823159497298e-11
population O 0 2.15784116649239e-14
( O 0 4.1923078506964084e-13
f O 0 9.346493579087678e-10
= O 0 1.3573484003437386e-10
0 O 0 9.990874100251901e-11
. O 0 3.669103649378558e-12
09 O 0 1.5943834030807125e-09
, O 0 2.5340159658104877e-12
n O 0 2.315709429767665e-11
= O 0 1.5542556131009633e-10
61 O 0 7.825733949751168e-10
subjects O 0 4.852933610521859e-09
) O 0 2.0476417783577006e-10
. O 0 4.638327499861816e-10

The O 0 5.518481884791981e-07
ARSA O 0 0.0014863640535622835
enzyme O 0 1.0804859229551766e-09
activity O 0 2.6254456941821047e-10
in O 0 5.227654680667326e-12
subjects O 0 2.312192937115043e-10
with O 0 2.9720557612189502e-12
and O 0 5.4336434657242805e-11
without O 0 3.0715634896649746e-11
the O 0 9.359386182739016e-11
R496H O 0 1.5436862454976108e-08
mutation O 0 8.686085184450576e-11
was O 0 1.488857370723906e-10
determined O 0 1.7324297552079315e-10
and O 0 2.6215661586004302e-11
found O 0 1.364319421326421e-11
to O 0 3.677181389244444e-12
be O 0 1.1899260222991703e-11
normal O 0 1.8863671513713598e-08
. O 0 3.3529927723208175e-09

It O 0 2.036099289171034e-09
is O 0 1.8117680966600602e-11
therefore O 0 1.3609770428690826e-11
concluded O 0 1.4810655479813306e-10
that O 0 4.684732419699134e-13
the O 0 2.4741177856446583e-11
R496H O 0 1.2175074282083642e-08
mutation O 0 2.364209383820537e-10
of O 0 5.553779214295673e-09
ARSA O 1 0.9747637510299683
does O 0 5.7983326473554087e-11
not O 0 1.5191188151159052e-12
negatively O 0 4.933574382359751e-11
influence O 0 1.015626333034092e-10
the O 0 9.496517461293763e-11
activity O 0 1.2745174360340172e-10
of O 0 1.7006343000502966e-09
ARSA O 0 0.37424975633621216
and O 0 3.182599461748481e-10
is O 0 2.8332093615635046e-12
not O 0 1.424472085426176e-12
a O 0 1.1619674666896174e-10
cause O 0 1.6051500040248357e-07
of O 0 8.524831173417624e-06
MLD B-Disease 1 1.0

Down O 0 1.6160249288077466e-05
- O 0 2.848427982371504e-07
regulation O 0 9.564844560827623e-08
of O 0 3.521597236044727e-08
transmembrane O 0 2.7751883635573904e-07
carbonic O 0 4.566507777781226e-05
anhydrases O 0 5.511512790690176e-05
in O 0 8.429973519241685e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999972581863403
lines O 0 8.552701729058754e-07
by O 0 5.976577566180197e-10
wild O 0 1.4782358448428567e-06
- O 0 1.7451992562200758e-07
type O 0 3.2463958632433787e-07
von B-Disease 1 0.9999996423721313
Hippel I-Disease 1 1.0
- I-Disease 1 0.999945878982544
Lindau I-Disease 1 0.9999808073043823
transgenes O 0 0.0002535854000598192
. O 0 2.6244068251912722e-08

To O 0 4.078504645121939e-09
discover O 0 3.493097366913389e-09
genes O 0 4.508224002441885e-11
involved O 0 5.640555383878976e-11
in O 0 4.86463591631292e-10
von B-Disease 1 0.9997220635414124
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999971389770508
Lindau I-Disease 1 0.9999998807907104
( O 0 1.5294129696030723e-07
VHL B-Disease 1 1.0
) O 0 1.055975973329737e-09
- O 0 3.262640291268326e-08
mediated O 0 1.343806843578932e-07
carcinogenesis O 0 0.03729779273271561
, O 0 7.957279973824782e-11
we O 0 2.161575606007826e-12
used O 0 2.4005395449222533e-09
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999927282333374
lines O 0 2.3783584765624255e-05
stably O 0 9.226971997122746e-06
transfected O 0 8.629569379081659e-07
with O 0 6.099199478803996e-10
wild O 0 2.673552216947428e-06
- O 0 1.8163332242693286e-06
type O 0 4.174695277470164e-05
VHL O 1 1.0
- O 0 1.7227266653208062e-05
expressing O 0 8.829819364564173e-08
transgenes O 0 3.102040136582218e-05
. O 0 3.2057478449587506e-08

Large O 0 3.095965794841504e-08
- O 0 2.9813335800099594e-08
scale O 0 1.4103331835713107e-08
RNA O 0 6.502780092176863e-09
differential O 0 4.612619175503596e-10
display O 0 2.649396924070402e-09
technology O 0 7.09351855032736e-10
applied O 0 4.392005856224124e-11
to O 0 7.963603734784108e-13
these O 0 1.7874893188871144e-12
cell O 0 1.0186940180290094e-09
lines O 0 5.311175804711965e-11
identified O 0 2.1426812147479213e-12
several O 0 7.283545511507783e-13
differentially O 0 2.2530505239259924e-10
expressed O 0 5.0565051278039785e-12
genes O 0 2.365972175122355e-11
, O 0 6.717692374591522e-12
including O 0 7.744090091410527e-12
an O 0 1.8639137542436623e-12
alpha O 0 3.771136736219205e-09
carbonic O 0 8.309191912303504e-07
anhydrase O 0 9.449655408388935e-06
gene O 0 2.0989189053466362e-08
, O 0 9.699944181207343e-10
termed O 0 2.2240506041271146e-06
CA12 O 1 1.0
. O 0 4.181123003377252e-08

The O 0 6.076712821823094e-08
deduced O 0 1.4797315373016318e-08
protein O 0 7.015544811750374e-10
sequence O 0 2.9760072184359387e-10
was O 0 3.6212183252004593e-10
classified O 0 1.1852248071875238e-09
as O 0 3.3802863286247486e-11
a O 0 9.143517887277852e-11
one O 0 1.3591720804395635e-10
- O 0 1.5880750936503318e-07
pass O 0 2.47056448188232e-07
transmembrane O 0 2.86304680230387e-06
CA O 0 0.10308316349983215
possessing O 0 1.347744841950771e-06
an O 0 1.1723995385626296e-10
apparently O 0 9.80089009949836e-10
intact O 0 1.113857561740872e-09
catalytic O 0 6.64835686503551e-10
domain O 0 1.382080561107557e-10
in O 0 4.843671644327863e-11
the O 0 9.695172442647504e-10
extracellular O 0 3.4195349485344195e-07
CA O 0 0.0006757140508852899
module O 0 4.261447884346126e-06
. O 0 4.313483970008747e-08

Reintroduced O 0 6.672832569165621e-06
wild O 0 9.85539190878626e-06
- O 0 1.0951304147965857e-06
type O 0 1.43443969591317e-06
VHL B-Disease 1 0.9997058510780334
strongly O 0 4.13394651843646e-09
inhibited O 0 2.6990711887719954e-09
the O 0 3.3409641719828187e-10
overexpression O 0 1.965480223020677e-09
of O 0 1.883141642622377e-09
the O 0 6.184457390645548e-10
CA12 O 1 0.9964002370834351
gene O 0 6.97635074708991e-11
in O 0 1.0346857919063535e-11
the O 0 1.3330410386647173e-10
parental O 0 3.415353262425924e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999997615814209
lines O 0 0.0004951732698827982
. O 0 9.934678502077077e-08

Similar O 0 4.269917752708352e-09
results O 0 1.6314710693521306e-09
were O 0 8.083837765848756e-11
obtained O 0 1.1805403876685716e-10
with O 0 3.898968994886509e-11
CA9 O 1 0.5597584843635559
, O 0 2.4769805651025933e-10
encoding O 0 4.2800751831606476e-10
another O 0 1.0283986995318628e-09
transmembrane O 0 8.173866490324144e-07
CA O 0 0.00040894129779189825
with O 0 3.052997299413107e-10
an O 0 5.697625010681051e-11
intact O 0 4.382598461916132e-08
catalytic O 0 6.452694378822343e-08
domain O 0 2.577364988098907e-08
. O 0 5.2777355818989236e-09

Although O 0 5.287529081243747e-09
both O 0 2.828374201513384e-10
domains O 0 5.858275531345214e-10
of O 0 4.978195189409007e-09
the O 0 4.980037271451465e-09
VHL B-Disease 1 0.9449893236160278
protein O 0 4.770235872975093e-10
contribute O 0 3.8839313709626566e-11
to O 0 1.5807619102581327e-11
regulation O 0 2.6266501862437508e-08
of O 0 6.202950686429176e-08
CA12 O 1 0.9999998807907104
expression O 0 4.508315054607692e-09
, O 0 1.350159983815047e-10
the O 0 2.0235621511766055e-10
elongin O 0 9.844890058730016e-08
binding O 0 1.2201126775579496e-09
domain O 0 1.2648891933864093e-09
alone O 0 1.11418423098808e-10
could O 0 8.00635859693477e-12
effectively O 0 2.3833217621671565e-09
regulate O 0 1.4754034793895698e-07
CA9 O 1 0.9991311430931091
expression O 0 4.456974878053188e-08
. O 0 4.8753294734638075e-09

We O 0 7.692696613048611e-08
mapped O 0 3.5376342566451058e-06
CA12 O 1 0.9999860525131226
and O 0 1.2462103882171505e-07
CA9 O 1 0.8131353855133057
loci O 0 1.1403725963532452e-08
to O 0 3.1427385693838517e-10
chromosome O 0 5.101523470329994e-08
bands O 0 1.2654577403736766e-06
15q22 O 0 1.6885230706975562e-06
and O 0 7.861898687622215e-09
17q21 O 0 7.3228698056482244e-06
. O 0 2.091713113827609e-08

2 O 0 4.479978770177695e-07
respectively O 0 1.232044688492806e-08
, O 0 6.944422120680471e-11
regions O 0 8.462088252336741e-10
prone O 0 2.767510522971861e-07
to O 0 4.132247669041966e-11
amplification O 0 5.101649946936959e-08
in O 0 1.8608180274437558e-10
some O 0 8.359399283897062e-11
human O 0 9.011977653017311e-08
cancers B-Disease 1 0.9995278120040894
. O 0 1.2761631751345703e-08

Additional O 0 1.0860852217575712e-09
experiments O 0 1.9563589859217245e-08
are O 0 3.7227486718305336e-12
needed O 0 2.8040830074571588e-11
to O 0 2.4149052983007957e-12
define O 0 4.5838676604459394e-11
the O 0 2.517229133469634e-11
role O 0 1.0108604925340714e-10
of O 0 8.767854886571058e-09
CA O 0 6.006288094795309e-05
IX O 1 1.0
and O 0 2.915242589551781e-07
CA O 0 0.00031596756889484823
XII O 1 0.9999997615814209
enzymes O 0 2.2535662225209308e-10
in O 0 8.264104678357143e-11
the O 0 3.665006492736822e-11
regulation O 0 1.2565883888981944e-09
of O 0 3.1225191876593783e-10
pH O 0 6.025303034284946e-10
in O 0 2.329424500513433e-11
the O 0 7.912496352568965e-11
extracellular O 0 7.951306280062909e-10
microenvironment O 0 1.6774976074884762e-08
and O 0 6.398758606307453e-11
its O 0 5.6539328774363184e-11
potential O 0 5.346668940919841e-11
impact O 0 1.5301578670801064e-08
on O 0 5.039704547016299e-07
cancer B-Disease 0 1.741690721246414e-05
cell O 0 2.67718519353366e-07
growth O 0 6.564027543731754e-09
. O 0 1.4577569151796865e-09

A O 0 2.3361480998573825e-06
gene O 0 2.1809518635507175e-09
encoding O 0 4.1260905803142123e-10
a O 0 2.7459176599187174e-10
transmembrane O 0 2.9514302113398116e-09
protein O 0 3.0246719018300894e-10
is O 0 1.953692633019366e-12
mutated O 0 9.418554824947023e-11
in O 0 3.2175592051819635e-11
patients O 0 1.395838444828712e-09
with O 0 9.673901502083027e-08
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9997221827507019
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 1.4659655711568575e-09
. O 0 9.458092087299974e-10

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.024601341574453e-05
WFS B-Disease 1 1.0
; O 0 2.5524010993649426e-07
OMIM O 1 1.0
222300 O 0 0.000373065093299374
) O 0 6.639837984989683e-11
is O 0 4.868795796218739e-13
an O 0 6.209271811996597e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 9.788752031170134e-09
by O 0 6.089493909122723e-10
young O 0 2.306099666782302e-08
- O 0 7.712477554377983e-07
onset O 1 0.9999351501464844
non O 1 0.9999481439590454
- O 1 0.998832643032074
immune O 1 0.9837019443511963
insulin B-Disease 1 0.9999921321868896
- I-Disease 1 0.9999206066131592
dependent I-Disease 1 0.9998471736907959
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9942612648010254
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 4.6051695790083613e-07

Linkage O 0 2.14222109207185e-06
to O 0 2.5242608003850364e-09
markers O 0 1.3762216610757605e-07
on O 0 9.82498704615864e-08
chromosome O 0 2.113798274194778e-07
4p O 0 1.0060730346594937e-05
was O 0 1.112431391447899e-08
confirmed O 0 5.567171723619424e-10
in O 0 3.674869436531836e-11
five O 0 6.113266143303875e-11
families O 0 4.155165361091617e-12
. O 0 5.802029967583167e-10

On O 0 6.292406595775901e-08
the O 0 8.004072404865781e-11
basis O 0 1.1055430876316663e-10
of O 0 1.7427244092260707e-09
meiotic O 0 0.00023721808975096792
recombinants O 1 0.7825717926025391
and O 0 2.346740473058162e-07
disease O 1 0.9996005892753601
- O 0 3.93665899878215e-08
associated O 0 8.024559350339189e-10
haplotypes O 0 2.612239979882247e-09
, O 0 1.0646637044198215e-10
the O 0 1.0100843494953438e-09
WFS B-Disease 1 0.9999657869338989
gene O 0 6.229661675405396e-09
was O 0 1.230742951996433e-09
localized O 0 1.732600019010988e-08
to O 0 3.1642230502448854e-10
a O 0 1.1368239682951753e-08
BAC O 1 0.9999996423721313
/ O 0 7.864546773816983e-07
P1 O 0 3.114311402896419e-05
contig O 0 4.332252501626499e-06
of O 0 2.0857134686025347e-08
less O 0 4.228192101995987e-11
than O 0 7.732105754276741e-12
250 O 0 4.444688617155634e-09
kb O 0 2.775241227936931e-06
. O 0 2.3013848604591658e-08

Mutations O 0 3.8144712277699e-08
in O 0 1.1185540271796413e-09
a O 0 1.4446693841208003e-10
novel O 0 6.512731465235788e-10
gene O 0 2.7707180993985503e-10
( O 0 1.4398553183081475e-10
WFS1 O 1 0.9999179840087891
) O 0 2.487655741123529e-11
encoding O 0 1.0133018556179874e-11
a O 0 3.8726133411159935e-11
putative O 0 2.9499556131185045e-09
transmembrane O 0 6.693044785066604e-09
protein O 0 1.1196235050192627e-09
were O 0 5.455516594032872e-10
found O 0 4.6912640438989683e-11
in O 0 1.895608323088105e-11
all O 0 1.3960394472378734e-11
affected O 0 8.729467149137804e-11
individuals O 0 5.008175406502613e-13
in O 0 8.802195777812827e-11
six O 0 3.5466849457321814e-09
WFS B-Disease 0 0.012486371211707592
families O 0 3.818132008476249e-12
, O 0 8.468731792221629e-12
and O 0 2.9544333559478053e-12
these O 0 2.1260673343376224e-12
mutations O 0 3.7372212963182605e-11
were O 0 4.196168065795369e-11
associated O 0 3.408126003634493e-10
with O 0 1.3920729846628177e-10
the O 0 1.7670463137164916e-07
disease O 0 0.16817566752433777
phenotype O 0 1.929411119760971e-08
. O 0 5.054892948663792e-09

WFS1 O 1 0.9999992847442627
appears O 0 1.5050822810280806e-08
to O 0 6.700723743230386e-12
function O 0 4.326626296818903e-12
in O 0 8.05635853168285e-12
survival O 0 1.0749892087602575e-09
of O 0 6.292953380615529e-10
islet O 0 5.045049267238255e-09
beta O 0 3.1704108227614825e-09
- O 0 8.220158775884556e-09
cells O 0 9.31287880145959e-10
and O 0 6.334596180934682e-10
neurons O 0 4.466080483211954e-08
. O 0 1.3434321710636965e-10
. O 0 1.6626846566225595e-09

Stable O 0 3.3726220749485947e-07
interaction O 0 1.6287162729611282e-09
between O 0 1.2298317919601232e-10
the O 0 1.1598461774342539e-10
products O 0 6.541564512296816e-10
of O 0 2.3506181445753782e-09
the O 0 8.825164488079906e-10
BRCA1 O 0 1.766856883023138e-08
and O 0 2.7869060392760048e-09
BRCA2 O 0 5.3836807012430654e-08
tumor B-Disease 0 7.340643648490186e-09
suppressor O 0 1.2474190569378152e-08
genes O 0 6.089502513351164e-11
in O 0 3.565333445143537e-11
mitotic O 0 2.717482772141011e-08
and O 0 8.806453344334386e-09
meiotic O 0 7.588615699205548e-05
cells O 0 1.201083250634838e-07
. O 0 3.8470640006949e-09

BRCA1 O 0 9.811231575440615e-05
and O 0 1.2982856389953668e-07
BRCA2 O 0 1.6058343987879198e-07
account O 0 7.321451084285613e-11
for O 0 2.2501075655489977e-11
most O 0 2.0845877107822375e-12
cases O 0 4.212284167304237e-12
of O 0 1.1893912243987614e-10
familial O 0 2.6823303578282776e-09
, O 0 4.868085795584065e-11
early O 0 1.4774021117602842e-08
onset O 0 0.44723960757255554
breast B-Disease 0 2.015246309383656e-06
and I-Disease 0 7.674524482581546e-08
/ I-Disease 1 0.9999998807907104
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.5370207590877953e-10
encode O 0 4.402917613832713e-11
products O 0 1.140180616587827e-09
that O 0 1.4238446576289587e-12
each O 0 7.251095882586378e-13
interact O 0 1.3658843153740996e-11
with O 0 7.827521963932327e-11
hRAD51 O 0 2.686351308511803e-06
. O 0 9.98353133496721e-09

Results O 0 1.6348305109659123e-07
presented O 0 5.9048709033504565e-08
here O 0 6.971538901723306e-10
show O 0 1.199758209446955e-10
that O 0 9.255385086809342e-13
BRCA1 O 0 7.095998455497465e-09
and O 0 9.38953803597542e-10
BRCA2 O 0 3.414395166601025e-08
coexist O 0 8.308584376059969e-10
in O 0 8.857942851436817e-11
a O 0 1.9458318636922378e-11
biochemical O 0 1.5256320651246824e-08
complex O 0 2.1892640234000282e-07
and O 0 2.339413995855466e-09
colocalize O 0 1.4037389064469608e-06
in O 0 5.931130586667166e-10
subnuclear O 0 2.282827153976541e-07
foci O 0 4.631648664599197e-08
in O 0 4.387275265305135e-11
somatic O 0 1.1542419464660725e-08
cells O 0 3.3597513660055256e-10
and O 0 1.4621003019410495e-10
on O 0 7.199235096955192e-10
the O 0 9.83618221594984e-12
axial O 0 3.3812150995737866e-11
elements O 0 3.835829709419869e-10
of O 0 1.9949397689345005e-09
developing O 0 7.995322626186407e-09
synaptonemal O 0 1.3220276741776615e-05
complexes O 0 4.5251422875480785e-07
. O 0 3.472665000003872e-08

Like O 0 3.498725163808558e-06
BRCA1 O 0 7.054065463307779e-06
and O 0 3.366272380844748e-07
RAD51 O 1 0.9998421669006348
, O 0 1.3520224229068845e-07
BRCA2 O 0 6.136803563094873e-07
relocates O 0 1.1479105666012401e-07
to O 0 3.587520502890129e-09
PCNA O 0 0.00010588214354356751
+ O 0 3.6080913257130476e-10
replication O 0 2.7429534338319073e-11
sites O 0 6.2320647774283255e-12
following O 0 3.237262237790195e-12
exposure O 0 6.609868763440829e-10
of O 0 1.045047937076049e-09
S O 0 6.712274398523732e-07
phase O 0 4.742190995443707e-08
cells O 0 1.1936410193591485e-10
to O 0 5.5703976153953505e-11
hydroxyurea O 0 6.604845737001597e-08
or O 0 8.888851876776016e-10
UV O 1 0.9697602987289429
irradiation O 0 7.452746331182425e-07
. O 0 4.708767598060604e-09

Thus O 0 9.810493395434605e-08
, O 0 8.510067317502035e-09
BRCA1 O 0 4.230925298998045e-08
and O 0 9.943503798126585e-10
BRCA2 O 0 8.594727596289431e-09
participate O 0 7.114249189754673e-10
, O 0 1.3466826265240428e-10
together O 0 3.1696700819594525e-11
, O 0 5.302266438411696e-12
in O 0 7.445558058982726e-12
a O 0 1.4368779603646242e-11
pathway O 0 1.632428914266626e-10
( O 0 2.136026945598335e-11
s O 0 9.01843599798724e-10
) O 0 3.551038586444011e-12
associated O 0 3.785748450835236e-11
with O 0 4.5104241522264665e-12
the O 0 1.0363018776438082e-10
activation O 0 1.460428666888447e-09
of O 0 1.8213857089222074e-08
double O 0 1.2367794788303854e-08
- O 0 2.8415499286893464e-07
strand O 0 7.11547398779544e-09
break O 0 2.4112911667373282e-09
repair O 0 3.847767118259071e-07
and O 0 3.548545679521453e-09
/ O 0 2.2115829168001255e-08
or O 0 4.452490459661007e-11
homologous O 0 2.2794174880935714e-10
recombination O 0 6.704489741160558e-10
. O 0 9.021188240865285e-10

Dysfunction O 0 0.2236262857913971
of O 0 5.9157368923479225e-06
this O 0 1.4145290494482765e-10
pathway O 0 1.4880461307598125e-09
may O 0 1.6774120287221805e-11
be O 0 8.209706243815507e-13
a O 0 3.0962077519902653e-12
general O 0 1.2758545955837697e-11
phenomenon O 0 4.475701406714272e-11
in O 0 9.516708168039179e-13
the O 0 2.736550569482077e-12
majority O 0 1.1314002713218654e-13
of O 0 4.7081141069105215e-12
cases O 0 1.2565271739761741e-11
of O 0 7.48993755905758e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.9811946749687195
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.345804160976741e-09
. O 0 2.943301380398111e-09

A O 0 2.556479785198462e-06
novel O 0 1.4582388629946763e-08
Arg362Ser O 0 1.4232184639695333e-06
mutation O 0 2.9356297948091026e-10
in O 0 8.62793031464193e-11
the O 0 2.3344248756274055e-10
sterol O 0 1.4154919369957497e-07
27 O 0 8.39438598632114e-08
- O 0 3.1381773624161724e-08
hydroxylase O 0 8.988491799755138e-07
gene O 0 3.741632781384396e-09
( O 0 7.087103820468954e-11
CYP27 O 1 0.9999847412109375
) O 0 1.210431841563997e-11
: O 0 6.051045081667539e-13
its O 0 1.5794168273589038e-12
effects O 0 1.4179224461230433e-09
on O 0 2.4068283477340913e-10
pre O 0 7.378913124966857e-08
- O 0 6.088076709431789e-10
mRNA O 0 6.538816710310869e-11
splicing O 0 6.720954348615749e-10
and O 0 4.079916612886869e-11
enzyme O 0 2.649744312854807e-10
activity O 0 2.04557371041858e-09
. O 0 9.123244937292441e-10

A O 0 1.2052798865624936e-06
novel O 0 8.773794135663593e-09
C O 0 2.0104192799408338e-07
to O 0 1.6955345114033626e-11
A O 0 2.674616084163972e-09
mutation O 0 2.055897986574795e-11
in O 0 1.0392783855728283e-11
the O 0 7.28848578712693e-11
sterol O 0 5.349819076627682e-08
27 O 0 4.7984105577825176e-08
- O 0 1.8867917006559765e-08
hydroxylase O 0 1.4607659295506892e-06
gene O 0 7.486881337115392e-09
( O 0 2.3223808987005157e-10
CYP27 O 1 0.9999487400054932
) O 0 3.441976564877436e-11
was O 0 5.500546546022278e-11
identified O 0 1.3694913258976982e-12
by O 0 2.2674330674762183e-13
sequencing O 0 1.2152627515416015e-10
amplified O 0 1.068279829041785e-07
CYP27 O 1 0.999727189540863
gene O 0 1.3416634470075905e-09
products O 0 9.665648281753647e-10
from O 0 1.877542010753075e-10
a O 0 4.51266315981691e-11
patient O 0 3.6808709413804763e-09
with O 0 4.789234564483991e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.029655720685696e-07
CTX B-Disease 1 0.9999998807907104
) O 0 7.43200478936501e-09
. O 0 4.087600480318088e-09

The O 0 2.2217808037794384e-08
mutation O 0 1.3680732102727688e-09
changed O 0 7.845222249613926e-10
the O 0 1.7442532140865552e-10
adrenodoxin O 0 1.240680660430371e-07
cofactor O 0 3.4439681662057353e-10
binding O 0 1.5405442477245401e-09
residue O 0 1.207271793646214e-07
362Arg O 0 8.756478564464487e-08
to O 0 2.1484410084315897e-10
362Ser O 0 5.907596118959191e-07
( O 0 4.194284031200368e-09
CGT O 0 0.4635013937950134
362Arg O 0 4.118521701457212e-06
to O 0 4.787227947389283e-09
AGT O 1 0.9187597036361694
362Ser O 0 9.83758582151495e-07
) O 0 1.186884757142792e-10
, O 0 6.523366916089124e-12
and O 0 1.3511278033895291e-11
was O 0 7.034651750004173e-10
responsible O 0 1.1074034134139765e-08
for O 0 2.916399566288419e-09
deficiency O 0 0.00029924893169663846
in O 0 8.635178128102439e-10
the O 0 2.4196717962610137e-09
sterol O 0 1.1763883378534956e-07
27 O 0 3.5821614119413425e-08
- O 0 5.364100719162934e-09
hydroxylase O 0 5.8244779665983515e-08
activity O 0 6.437457233943178e-10
, O 0 3.53089844688792e-12
as O 0 6.143065656855073e-13
confirmed O 0 1.7170849160932922e-12
by O 0 2.9008601618897567e-13
expression O 0 1.2970938559342393e-11
of O 0 2.1188312215869587e-10
mutant O 0 1.6892312548755228e-10
cDNA O 0 2.7404656322005394e-10
into O 0 5.945969272502794e-10
COS O 0 0.00033571894164197147
- O 0 8.929879982133571e-07
1 O 0 4.438218681457329e-08
cells O 0 3.910956891672868e-09
. O 0 1.5147350040933816e-09

Quantitative O 0 9.180718052448356e-08
analysis O 0 6.454205614403463e-09
showed O 0 7.033954529944708e-10
that O 0 2.845891924896371e-13
the O 0 2.56851159265159e-12
expression O 0 2.4087239147707606e-11
of O 0 6.35706098872646e-10
CYP27 O 0 0.06203816086053848
gene O 0 3.368958237381925e-11
mRNA O 0 2.234885020102606e-11
in O 0 8.556978910168045e-12
the O 0 3.229037523477807e-11
patient O 0 9.912373144516096e-10
represented O 0 8.544152607647959e-10
52 O 0 5.800000479894152e-08
. O 0 6.615825220990246e-09

5 O 0 7.565217430283155e-08
% O 0 4.2182198706219864e-11
of O 0 3.278562976660737e-10
the O 0 7.204011692740764e-11
normal O 0 8.507405446778193e-09
level O 0 5.74428220545542e-08
. O 0 1.1585246095791035e-09

As O 0 1.8086900865910138e-09
the O 0 4.4234252372099547e-10
mutation O 0 1.912991813568521e-11
occurred O 0 2.0847726323047766e-10
at O 0 1.3825735001304906e-10
the O 0 3.047079602525038e-11
penultimate O 0 5.863018515128715e-09
nucleotide O 0 1.5588010049416567e-10
of O 0 4.913405793338654e-10
exon O 0 4.39633485171953e-09
6 O 0 8.104703574929317e-09
( O 0 5.858317303486515e-11
- O 0 4.2795957888586145e-09
2 O 0 6.96205093575486e-10
position O 0 6.542687502886224e-10
of O 0 1.3357701611482753e-09
exon O 0 3.977262963417161e-08
6 O 0 6.523453777163013e-08
- O 0 6.538526520216692e-08
intron O 0 1.269996090513814e-07
6 O 0 9.653014387822623e-09
splice O 0 1.1573812130905026e-08
site O 0 8.667289108643672e-10
) O 0 1.079339092061038e-12
of O 0 2.3357643944010853e-11
the O 0 8.795717626464139e-11
gene O 0 2.3114302138971254e-10
, O 0 4.7139660230843816e-11
we O 0 3.8475936846305014e-12
hypothesized O 0 5.549951123673402e-11
that O 0 9.713852985870908e-13
the O 0 9.435852793560073e-11
mutation O 0 6.905839788906576e-11
may O 0 4.140768283811269e-11
partially O 0 9.505293219191913e-10
affect O 0 1.309044261876835e-10
the O 0 2.839161197809581e-11
normal O 0 3.916432456119168e-11
splicing O 0 3.439909468383462e-11
efficiency O 0 7.909615323820063e-11
in O 0 5.168901764940337e-11
exon O 0 4.292143529482928e-09
6 O 0 4.018690269447234e-09
and O 0 2.4575111043367848e-11
cause O 0 6.932802248948988e-11
alternative O 0 3.523784319892087e-10
splicing O 0 1.001530081090607e-09
elsewhere O 0 3.592736108615213e-10
, O 0 1.099972326765175e-12
which O 0 8.052463047487218e-14
resulted O 0 1.2976232935391074e-11
in O 0 2.423890081704183e-12
decreased O 0 3.708180290606933e-11
transcript O 0 8.622143554681827e-10
in O 0 2.7472990896115768e-11
the O 0 2.799728782143518e-10
patient O 0 2.059512027585697e-08
. O 0 3.019554828398441e-09

Transfection O 0 9.53458311414579e-06
of O 0 3.111301509761688e-07
constructed O 0 1.0841764606084325e-06
minigenes O 0 3.954699059249833e-05
, O 0 1.2330025889184526e-10
with O 0 3.2916490713685853e-12
or O 0 1.6501591759698897e-11
without O 0 1.1038885083802796e-11
the O 0 2.595173728692224e-11
mutation O 0 5.0178446467374904e-12
, O 0 3.543886538392993e-12
into O 0 1.914777780775978e-10
COS O 0 0.33487993478775024
- O 0 3.5371684248275415e-07
1 O 0 3.0546762896932478e-09
cells O 0 3.760976252653592e-11
confirmed O 0 1.302717048817792e-11
that O 0 1.3076848360670662e-13
the O 0 1.0067634226285094e-11
mutant O 0 1.1095022678375699e-09
minigene O 0 5.936999869504689e-08
was O 0 3.626429989633806e-10
responsible O 0 1.9802863515661073e-10
for O 0 4.236957139303055e-12
a O 0 7.352094627544048e-12
mRNA O 0 1.5807503916942522e-10
species O 0 9.34867201013434e-13
alternatively O 0 1.4052300989497724e-10
spliced O 0 1.7751089487205718e-08
at O 0 8.234343873425587e-09
an O 0 1.9199955861304296e-11
activated O 0 9.915055670717265e-06
cryptic O 0 3.484914543605555e-07
5 O 0 6.322167234174003e-09
splice O 0 1.0641088721285996e-07
site O 0 1.7230725291028648e-08
88 O 0 8.130917272808347e-09
bp O 0 3.1132316724580278e-09
upstream O 0 4.523713625914638e-10
from O 0 8.131560008672878e-11
the O 0 7.66678873165283e-11
3 O 0 9.304604864368571e-10
end O 0 2.3179376473780877e-10
of O 0 1.0426070007341082e-09
exon O 0 1.2984948227767745e-07
6 O 0 1.8692350067794905e-07
. O 0 4.306609291404584e-09

Our O 0 6.008839648075082e-08
data O 0 1.8120221989548213e-09
suggest O 0 9.175209203515777e-11
that O 0 1.2808321298105746e-13
the O 0 2.6192921095957722e-11
C O 0 2.3946643779027e-08
to O 0 3.515013800858835e-12
A O 0 2.776867180642739e-09
mutation O 0 2.6162863542289472e-11
at O 0 2.774366847368981e-10
the O 0 4.8011771641709444e-11
penultimate O 0 1.0907318603869953e-08
nucleotide O 0 4.3547962458312384e-10
of O 0 8.072871815478777e-10
exon O 0 1.2344768762773128e-08
6 O 0 6.7548602267208935e-09
of O 0 2.204372018255185e-09
the O 0 6.697689625134728e-10
CYP27 O 1 0.9999998807907104
gene O 0 4.06730066293548e-10
not O 0 1.3302305220883048e-12
only O 0 3.2729552575105902e-12
causes O 0 1.6716804607241897e-09
the O 0 8.27023161065199e-09
deficiency B-Disease 0 8.467567340630922e-07
in I-Disease 0 7.994007122924529e-10
the I-Disease 0 1.111126635144899e-09
sterol I-Disease 0 1.0105033965146504e-07
27 I-Disease 0 6.18860482859418e-08
- I-Disease 0 4.435187328510892e-09
hydroxylase I-Disease 0 8.954287977758213e-08
activity I-Disease 0 1.7519529160736624e-09
, O 0 7.345086344701102e-12
but O 0 6.079886485758912e-13
also O 0 2.305646559092045e-12
partially O 0 1.9293953101851002e-09
leads O 0 3.9839614246472976e-11
to O 0 8.092823828610707e-13
alternative O 0 7.891109987667733e-11
pre O 0 1.4775712209313951e-08
- O 0 4.964519906280884e-10
mRNA O 0 3.735845660601811e-11
splicing O 0 6.443623967733458e-10
of O 0 2.950134303514318e-10
the O 0 3.064192233281915e-10
gene O 0 4.178776880081614e-09
. O 0 1.5095377170482038e-09

To O 0 2.5582380658306647e-09
our O 0 1.907739299866762e-09
knowledge O 0 2.0634587372114765e-09
, O 0 1.0544453331318149e-11
this O 0 1.1129761527542761e-13
is O 0 7.95030477541113e-14
the O 0 9.797361489802259e-13
first O 0 4.035167165683529e-12
report O 0 1.0279225387543889e-12
regarding O 0 1.7573771604606492e-10
effects O 0 1.2013851247161256e-08
on O 0 8.325637401718211e-10
pre O 0 5.270013048175315e-08
- O 0 4.585321289329869e-10
mRNA O 0 1.1842746401591331e-11
splicing O 0 1.7531655294167336e-10
of O 0 6.012201153593466e-11
a O 0 5.655149092065326e-12
mutation O 0 1.4521554098090306e-11
at O 0 2.441775948103242e-10
the O 0 1.2741699362273096e-10
- O 0 3.2492868395905816e-09
2 O 0 6.436978727819564e-10
position O 0 3.0647417936791044e-10
of O 0 4.052541080490357e-10
a O 0 1.7254453421600147e-10
5 O 0 5.310168749161903e-09
splice O 0 8.944675187194662e-07
site O 0 1.352890421912889e-07
. O 0 6.248654482732263e-09

ATM O 0 0.0001776419667294249
germline O 0 1.1697927675413666e-06
mutations O 0 2.3686430594693775e-09
in O 0 5.020444060477303e-10
classical O 1 0.9999524354934692
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 1.0297062544850633e-06
in O 0 6.341341896032304e-10
the O 0 7.961368231335086e-10
Dutch O 0 1.9220249214413343e-06
population O 0 1.089096261092104e-11
. O 0 1.482391015494855e-10

Germline O 0 6.563700026163133e-06
mutations O 0 3.8664915713582104e-09
in O 0 3.458912045672946e-10
the O 0 3.054307640137921e-10
ATM O 0 6.578972715942655e-06
gene O 0 2.863963788346524e-10
are O 0 4.5021701210873344e-13
responsible O 0 9.038992471177565e-11
for O 0 9.917960550054339e-12
the O 0 3.223012257080882e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.5230968594551086
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.7063979501917856e-08
. O 0 2.7837503413508102e-09

In O 0 6.139226371715267e-08
our O 0 2.0939714406864596e-09
study O 0 1.4746416587829714e-10
, O 0 7.549851369081928e-12
we O 0 6.215608540013906e-13
have O 0 4.879698872078432e-14
determined O 0 7.589960777931726e-12
the O 0 2.7408615307922268e-11
ATM O 0 1.8590164074794302e-07
mutation O 0 1.1505875419093314e-10
spectrum O 0 5.109054845853223e-10
in O 0 1.2093016865666328e-10
19 O 0 2.551659328275946e-09
classical O 0 3.4467291243345244e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.9241998217012224e-08
, O 0 3.7572315050860006e-12
including O 0 1.708238910567983e-12
some O 0 8.115325089447928e-14
immigrant O 0 1.2593336746677397e-12
populations O 0 4.609173286096446e-13
, O 0 1.8903314243784441e-13
as O 0 4.3250394043091445e-13
well O 0 3.3158146367506802e-12
as O 0 4.325949320982403e-12
12 O 0 1.7329981893965396e-10
of O 0 3.3989772801890084e-11
Dutch O 0 1.1322947024439145e-08
ethnic O 0 2.3278332386689193e-12
origin O 0 3.0892604446774996e-11
. O 0 2.3360818834916586e-10

Both O 0 5.884797982247392e-09
the O 0 1.6623136200877298e-09
protein O 0 1.1875822547580128e-10
truncation O 0 1.708952801493524e-08
test O 0 2.4745604676468247e-08
( O 0 1.7968504462118062e-10
PTT O 0 2.71315616373613e-06
) O 0 1.3144152433142153e-11
and O 0 4.5229241359134864e-12
the O 0 7.209327752832895e-12
restriction O 0 1.9425305548131933e-12
endonuclease O 0 3.7118971785154997e-10
fingerprinting O 0 4.720962287763086e-09
( O 0 2.8327565987362746e-11
REF O 0 6.949698558855744e-07
) O 0 7.055429374416833e-13
method O 0 6.063742715410603e-13
were O 0 1.696095656500765e-13
used O 0 6.656517784892069e-13
and O 0 2.3026272728821073e-12
compared O 0 3.3931588008101476e-12
for O 0 2.2113495930231597e-13
their O 0 2.262297770991295e-12
detection O 0 1.3171846946491428e-09
efficiency O 0 5.185493701098665e-10
, O 0 5.2992228660730945e-12
identifying O 0 8.936923423519261e-11
76 O 0 2.2754818862491533e-10
% O 0 1.3898105756526835e-13
and O 0 7.72717664593997e-13
60 O 0 7.419430521349302e-12
% O 0 8.823564573217854e-14
of O 0 1.6923939680224542e-11
the O 0 8.498995951455868e-11
mutations O 0 1.1290097745586536e-09
, O 0 5.59092272478523e-10
respectively O 0 1.3174465962606519e-08
. O 0 4.459464353345766e-09

Most O 0 2.8201673885064338e-08
patients O 0 2.5104087697513933e-09
were O 0 2.1457299825833331e-10
found O 0 1.1237799579788543e-10
to O 0 9.504450178277057e-12
be O 0 2.3959169717646667e-11
compound O 0 3.561056871603796e-08
heterozygote O 0 1.0558253507042537e-06
. O 0 1.531334348214841e-08

Seventeen O 0 2.188004600611748e-06
mutations O 0 1.8183545780203758e-09
were O 0 3.845337936958515e-10
distinct O 0 1.0027490643382819e-10
, O 0 2.9804252815734955e-11
of O 0 6.250248651973322e-10
which O 0 1.2081852879264332e-11
10 O 0 1.0097312569401495e-10
were O 0 8.19872555263279e-12
not O 0 1.2630116136974623e-12
reported O 0 1.8595407158539246e-10
previously O 0 8.044915844607203e-09
. O 0 2.660923481556665e-09

Mutations O 0 4.3257688275843975e-07
are O 0 2.3072103949584033e-10
small O 0 1.952364658830419e-10
deletions O 0 1.5512068074485796e-08
or O 0 5.393606006265372e-09
point O 0 1.4361431155407445e-08
mutations O 0 1.7856928158366259e-09
frequently O 0 5.362614241555264e-10
affecting O 0 1.715072173169574e-08
splice O 0 6.067002686904743e-07
sites O 0 2.807973054075319e-08
. O 0 1.0937651673259552e-08

Moreover O 0 1.0381465926911915e-06
, O 0 6.992597167965187e-09
a O 0 1.6397131430423428e-09
16 O 0 1.1221108309200645e-07
. O 0 2.8406048624418645e-09

7 O 0 1.3811089729642845e-06
- O 0 6.657143813981747e-08
kb O 0 8.155446096225205e-08
genomic O 0 2.8652111794258417e-09
deletion O 0 2.8441287103220247e-09
of O 0 1.1167043290072343e-08
the O 0 1.6623421528194626e-09
3 O 0 2.0362818098362823e-09
end O 0 1.2697085050028534e-10
of O 0 2.9671878842840727e-10
the O 0 1.570119173566198e-10
gene O 0 1.1685953593687515e-10
, O 0 4.4882912490773474e-12
most O 0 1.4585780500064871e-12
likely O 0 2.8910847240520843e-12
a O 0 1.9000888102499447e-12
result O 0 1.4490453975612994e-11
of O 0 1.1522940240871193e-10
recombination O 0 1.1225753833443708e-11
between O 0 1.823899885289304e-11
two O 0 1.3022996743494719e-11
LINE O 0 8.996141218631237e-07
elements O 0 3.193789899214039e-09
, O 0 7.062436746529954e-11
was O 0 7.648228717016536e-10
identified O 0 9.620715335501018e-10
. O 0 2.130812193357201e-09

The O 0 2.0977541481670414e-08
most O 0 1.1195732708968453e-11
frequently O 0 1.0861028222619584e-11
found O 0 1.980477197169317e-12
mutation O 0 1.433359832735126e-12
, O 0 8.610758048428757e-13
identified O 0 4.124449913545103e-12
in O 0 6.984868846510173e-12
three O 0 1.3475915695837504e-11
unrelated O 0 3.827251848775859e-09
Turkish O 0 4.723099067405201e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 2.2867494356426654e-11
, O 0 9.907907133621663e-11
was O 0 1.4471991383047111e-09
previously O 0 5.278699144461996e-10
described O 0 2.0087482024977454e-11
to O 0 1.3130239083503081e-12
be O 0 2.109667041755303e-12
a O 0 4.3170331892605773e-11
Turkish O 0 7.857970274471882e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 0.028796065598726273
mutation O 0 1.2460160903060569e-08
. O 0 1.5330403613234012e-09

The O 0 2.4413687071955792e-08
presence O 0 1.8218435648975628e-09
of O 0 9.588952742944912e-09
a O 0 5.085682430738814e-10
founder O 0 5.571096153289545e-07
mutation O 0 5.297611238574973e-10
among O 0 1.5163001063078774e-11
relatively O 0 5.7841136394398696e-12
small O 0 9.17516496806714e-13
ethnic O 0 5.866527153387119e-14
population O 0 1.136260605665517e-15
groups O 0 2.8049652749421398e-15
in O 0 2.420442318795679e-13
Western O 0 2.6810861863957314e-10
Europe O 0 1.5964526367540088e-09
could O 0 3.595997805083684e-11
indicate O 0 4.784083199038669e-11
a O 0 1.2759275407059345e-11
high O 0 4.674742259958009e-10
carrier O 0 1.3835594128708273e-11
frequency O 0 2.22509372038715e-11
in O 0 2.7769583507697426e-12
such O 0 2.6139918354872727e-11
communities O 0 4.5564119144358983e-10
. O 0 1.0669531924634157e-09

In O 0 1.1863654059141027e-08
patients O 0 4.147267529397425e-10
of O 0 1.812184624583324e-09
Dutch O 0 2.7893253218280734e-07
ethnic O 0 3.7703256315635425e-12
origin O 0 8.021491457177454e-12
, O 0 2.0605372876708605e-12
however O 0 2.0745605754102225e-12
, O 0 4.281524353805244e-12
no O 0 7.634825931190914e-12
significant O 0 1.6308666916931003e-10
founder O 0 1.5341095149778994e-07
effect O 0 3.784106361592876e-09
could O 0 1.6235233990524733e-10
be O 0 2.6400114733204916e-11
identified O 0 2.3157293860265327e-09
. O 0 1.9225552261303847e-09

The O 0 1.34573143739658e-08
observed O 0 1.1158945989464542e-09
genetic O 0 4.453800939163699e-10
heterogeneity O 0 6.016173670353453e-10
including O 0 9.577501292046264e-11
the O 0 4.9938532475923836e-11
relative O 0 1.7494675152995853e-10
high O 0 8.97262886212502e-09
percentage O 0 3.0201752210246013e-10
of O 0 2.58292454091702e-09
splice O 0 2.208288151450688e-06
- O 0 1.761127634836157e-07
site O 0 9.926265143178625e-09
mutations O 0 8.088360536895323e-10
had O 0 8.198041551166213e-11
no O 0 2.995356393475923e-11
reflection O 0 1.3094844097949476e-09
on O 0 2.9107534160743853e-09
the O 0 1.1219642992443823e-09
phenotype O 0 2.5185585172948777e-08
. O 0 4.3399723814729896e-09

All O 0 2.3833683471252698e-08
patients O 0 1.3106713492305744e-09
manifested O 0 6.4788117093428355e-09
classical O 0 3.0596104352298426e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999849796295166
T I-Disease 1 1.0
and O 0 2.5623794197571215e-09
increased O 0 2.918212060887271e-10
cellular O 0 3.586427510526846e-08
radioresistant O 0 1.076877651939867e-06
DNA O 0 3.304983806629025e-07
synthesis O 0 8.791101890892605e-08
. O 0 1.7824567377644485e-09

Determination O 0 1.1307272274052593e-07
of O 0 2.549097111170795e-08
the O 0 1.868742521837774e-10
genomic O 0 3.3317240633046197e-10
structure O 0 4.32894192714528e-10
of O 0 7.439943661147197e-10
the O 0 3.137096971084219e-10
COL4A4 O 1 0.9999990463256836
gene O 0 7.25410426172246e-11
and O 0 3.525656112543518e-12
of O 0 9.612400458935966e-11
novel O 0 8.002336016055267e-10
mutations O 0 4.116960283795379e-08
causing O 0 0.00023309093376155943
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.5523130514338845e-06

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.7765145798875892e-08
a O 0 4.720613588915512e-08
progressive O 1 0.9999997615814209
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.00010741325240815058
by O 0 9.634676167991074e-09
glomerular B-Disease 1 0.7775742411613464
basement I-Disease 1 1.0
membrane I-Disease 0 2.7574295017984696e-05
abnormalities I-Disease 1 0.9999986886978149
and O 0 1.4304779583085292e-09
associated O 0 3.777068435795172e-09
with O 0 6.259001650299467e-11
mutations O 0 3.033986117895182e-10
in O 0 2.0263507538587078e-10
either O 0 6.339721525527864e-10
the O 0 1.0316466791948642e-08
COL4A3 O 1 1.0
or O 0 1.4674259585234495e-09
the O 0 1.1543382916201494e-09
COL4A4 O 1 0.9999985694885254
gene O 0 3.799668635284803e-10
, O 0 4.818127667671757e-12
which O 0 3.9735150391372043e-13
encode O 0 2.7952081621540614e-11
the O 0 1.695399515222462e-10
alpha3 O 0 4.631313004210824e-07
and O 0 6.839175337169934e-10
alpha4 O 0 3.0772851005167468e-06
type O 0 4.073977379448479e-06
IV O 1 1.0
collagen O 1 1.0
chains O 0 0.026866979897022247
, O 0 1.691383211266384e-08
respectively O 0 2.6210951631355783e-08
. O 0 2.3137602944700575e-09

To O 0 1.3553466127191882e-09
date O 0 1.6021882487393668e-08
, O 0 1.191511212611518e-11
mutation O 0 1.6855893850836745e-12
screening O 0 1.558981589655506e-11
in O 0 2.858857898677125e-12
the O 0 1.6795760962584616e-11
two O 0 5.502914963984029e-12
genes O 0 1.7521149461852126e-11
has O 0 2.2350929700792888e-12
been O 0 1.3805095087915387e-11
hampered O 0 1.3145751154297614e-08
by O 0 2.737161408986055e-12
the O 0 3.581786950368482e-11
lack O 0 5.861872098833487e-11
of O 0 1.3092589512542219e-10
genomic O 0 5.835436023282625e-10
structure O 0 9.164701775254969e-10
information O 0 4.989961222001682e-10
. O 0 3.0315927546098465e-09

We O 0 1.4830261463316674e-08
report O 0 1.69270897298901e-09
here O 0 5.081646214932789e-11
the O 0 2.0958793728320657e-11
complete O 0 3.0010063878371795e-11
characterization O 0 4.695957511735571e-10
of O 0 1.061417953529542e-09
the O 0 4.350653726170606e-10
48 O 0 1.9353476599093256e-09
exons O 0 2.3773469859378338e-09
of O 0 2.423311107335735e-09
the O 0 3.6292688854189237e-09
COL4A4 O 1 1.0
gene O 0 2.2966522017497937e-09
, O 0 9.829036022590554e-12
a O 0 2.9724074764037045e-12
comprehensive O 0 1.5525795094006867e-09
gene O 0 7.168880766794672e-11
screen O 0 2.970557133608054e-10
, O 0 1.122962920568904e-11
and O 0 6.973034996637928e-12
the O 0 3.860428903629254e-12
subsequent O 0 1.0310766129784099e-11
detection O 0 8.515749883031276e-09
of O 0 8.024096664893676e-11
10 O 0 1.7487095105295225e-11
novel O 0 7.96555182924763e-12
mutations O 0 8.114157783178921e-12
in O 0 7.350453579135774e-12
eight O 0 1.5938634856382805e-09
patients O 0 7.115151134939879e-08
diagnosed O 0 0.01633550599217415
with O 0 3.5006959109296076e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.6229140555878985e-06

Furthermore O 0 1.4637862477684394e-07
, O 0 3.185277597239633e-10
we O 0 3.4857045635300343e-12
identified O 0 1.1883428269188201e-11
a O 0 1.0703602067174689e-11
glycine O 0 1.0868520528006798e-09
to O 0 2.0883773876878564e-11
alanine O 0 3.920120672518124e-09
substitution O 0 1.9090353742257093e-09
in O 0 1.5279194576223176e-10
the O 0 2.390477260583168e-10
collagenous O 0 7.599303444294492e-07
domain O 0 6.777386291068055e-11
that O 0 4.83786892924859e-13
is O 0 5.479890629808692e-13
apparently O 0 3.355209513000723e-11
silent O 0 3.562575234816734e-10
in O 0 4.530185254703056e-12
the O 0 1.103859018081188e-11
heterozygous O 0 5.465029904311303e-12
carriers O 0 1.50619985234135e-11
, O 0 2.234186100014135e-11
in O 0 4.915992612986031e-10
11 O 0 4.1000884465347553e-08
. O 0 3.729947017916402e-09

5 O 0 7.229017739973642e-08
% O 0 1.962728417292947e-11
of O 0 2.153417583139472e-10
all O 0 5.640670656253954e-12
control O 0 3.3449684688768855e-10
individuals O 0 1.4513985716405053e-12
, O 0 2.100978419017352e-11
and O 0 1.6161816676629748e-11
in O 0 3.804286052844219e-11
one O 0 5.575263341273118e-12
control O 0 6.001935060062635e-11
individual O 0 1.9057290467916488e-12
homozygous O 0 3.5683265370289874e-11
for O 0 3.215165113312768e-12
this O 0 1.973866382842804e-12
glycine O 0 1.7859356660210324e-08
substitution O 0 6.584846090618157e-08
. O 0 7.46221662240032e-09

There O 0 1.7296184040560547e-08
has O 0 3.261372422125319e-11
been O 0 9.860205534006905e-12
no O 0 2.039065531006523e-12
previous O 0 4.3950815209470306e-11
finding O 0 1.9824017427616525e-11
of O 0 5.204019506988011e-11
a O 0 6.303855007439019e-12
glycine O 0 9.13198461294229e-10
substitution O 0 1.1420916434801143e-09
that O 0 1.8788835504796042e-12
is O 0 2.6733357281344405e-13
not O 0 2.2545387865641198e-13
associated O 0 2.7235496843913687e-11
with O 0 4.959214896377295e-12
any O 0 5.74020969645872e-11
obvious O 0 1.3042124047402126e-09
phenotype O 0 4.932786401568023e-10
in O 0 8.970738041291781e-11
homozygous O 0 2.9129416656559215e-09
individuals O 0 1.2915102320931737e-10
. O 0 1.4985340968109995e-08

Founder O 0 0.023533163592219353
BRCA1 O 0 2.5820110749918967e-05
and O 0 4.6180637980342e-08
BRCA2 O 0 3.864768984840339e-07
mutations O 0 8.011254992723593e-10
in O 0 2.000406645885633e-10
French O 0 1.689541250016191e-06
Canadian O 1 0.9999699592590332
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.359341166879858e-09
. O 0 6.673719354921559e-09

We O 0 4.828530464351388e-09
have O 0 5.135330528871496e-12
identified O 0 6.062754465130382e-11
four O 0 5.790195579946644e-12
mutations O 0 2.2428181273986825e-12
in O 0 6.253652977405988e-12
each O 0 2.4826206628664194e-12
of O 0 4.671669717737359e-09
the O 0 4.991251785213535e-07
breast B-Disease 1 1.0
cancer I-Disease 1 0.9816482067108154
- O 0 1.6703541405149736e-05
susceptibility O 0 2.590213341591152e-07
genes O 0 7.597471540776723e-10
, O 0 3.838230289154865e-10
BRCA1 O 0 2.1827551321962346e-08
and O 0 2.1279855655365054e-09
BRCA2 O 0 2.5820247273600216e-08
, O 0 2.0956715529596437e-11
in O 0 1.99399819572621e-11
French O 0 2.8866364232271735e-07
Canadian O 1 0.9791821241378784
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9863827228546143
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.0591513617304074e-11
from O 0 1.8970460757827823e-09
Quebec O 0 3.003235178766772e-06
. O 0 2.9934646761375916e-08

To O 0 6.2002869505306535e-09
identify O 0 6.666889618145433e-08
founder O 0 1.9293915102025494e-05
effects O 0 0.3235502243041992
, O 0 9.525511490693361e-10
we O 0 3.0863612447001865e-12
examined O 0 5.187749119173191e-10
independently O 0 2.1161615515463694e-10
ascertained O 0 5.9763074489183055e-09
French O 0 7.341976271391104e-08
Canadian O 0 2.3844947918405524e-06
cancer B-Disease 0 1.844331478650929e-07
families O 0 3.1629389320338153e-13
for O 0 8.120068202902009e-13
the O 0 1.3053410782837283e-11
distribution O 0 6.402701979713044e-11
of O 0 3.2295255358860686e-10
these O 0 1.8232183124355927e-11
eight O 0 1.28638255603164e-09
mutations O 0 4.674334697085669e-09
. O 0 4.70688199527558e-09

Mutations O 0 4.736947545325165e-08
were O 0 1.049400344399487e-09
found O 0 5.80302333963445e-11
in O 0 3.116840813222055e-11
41 O 0 7.574855742653597e-10
of O 0 1.1228741270130627e-09
97 O 0 1.952634853807922e-08
families O 0 1.8219007899555884e-11
. O 0 1.4337010467713185e-09

Six O 0 8.56694128970048e-08
of O 0 1.7288732223619263e-08
eight O 0 2.4492075034743266e-09
mutations O 0 4.830453814719249e-10
were O 0 5.087777976697794e-10
observed O 0 1.3727022851739434e-09
at O 0 2.956940914344841e-09
least O 0 5.046728659974242e-11
twice O 0 7.856861827804096e-09
. O 0 2.5966120364984135e-09

The O 0 3.3481107948318822e-06
BRCA1 O 0 1.0296503205609042e-05
C4446T O 0 8.759785487200134e-06
mutation O 0 3.792806069213839e-09
was O 0 1.6629890797759117e-09
the O 0 6.215590542257843e-11
most O 0 1.226174435424443e-12
common O 0 7.18561928708672e-12
mutation O 0 9.013199041285613e-12
found O 0 1.3539810765628157e-11
, O 0 4.2598563565476866e-12
followed O 0 2.7331041943523537e-11
by O 0 8.416124568089156e-12
the O 0 1.0039474807044257e-09
BRCA2 O 0 5.81291317303112e-07
8765delAG O 0 3.349059170432156e-06
mutation O 0 4.080358451119537e-08
. O 0 8.799049489027766e-09

Together O 0 1.7763451154451104e-08
, O 0 1.0448521214900808e-10
these O 0 3.530911890994859e-12
mutations O 0 8.310034084468843e-12
were O 0 2.1597468605194514e-11
found O 0 1.1484909377690311e-11
in O 0 1.37490444376831e-11
28 O 0 1.4198981990176662e-09
of O 0 1.1184432269217837e-09
41 O 0 3.3277991473568136e-10
families O 0 2.0872482887034083e-13
identified O 0 1.093154559927978e-11
to O 0 3.063980666406785e-11
have O 0 1.075242412468258e-11
a O 0 6.553965703481879e-10
mutation O 0 7.578428551369143e-09
. O 0 8.652080829563147e-09

The O 0 2.8300068066755557e-08
odds O 0 2.798231513168048e-08
of O 0 1.3937181408962829e-09
detection O 0 1.6256105794809628e-08
of O 0 1.2213001721050887e-09
any O 0 1.9777112239549588e-11
of O 0 2.089598716281671e-09
the O 0 2.941256960209415e-10
four O 0 2.2704961522013178e-10
BRCA1 O 0 7.0803829466115076e-09
mutations O 0 2.7131101809629854e-09
was O 0 4.364046901628171e-08
18 O 0 3.425209982310662e-08
. O 0 2.4657769159830423e-09

7x O 0 0.0163556020706892
greater O 0 1.8601390650019312e-07
if O 0 2.0540528999912766e-10
one O 0 2.088763884078304e-11
or O 0 2.8946988035738475e-12
more O 0 4.844200398885362e-14
cases O 0 3.4734416731740936e-11
of O 0 3.4095313594662e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 3.172157259090369e-10
also O 0 8.588516182961303e-13
present O 0 1.5763470173277283e-12
in O 0 7.301756421718153e-12
the O 0 1.6373558064941562e-10
family O 0 1.5855940171949356e-10
. O 0 1.434882879181032e-09

The O 0 6.505412386559328e-08
odds O 0 4.344049386872939e-08
of O 0 1.223253942583824e-09
detection O 0 3.2103244507197815e-08
of O 0 1.4769505618517087e-09
any O 0 4.347888715727777e-11
of O 0 6.101390503943094e-09
the O 0 1.2561954809697795e-09
four O 0 1.7834124177440458e-09
BRCA2 O 0 5.081023957131947e-08
mutations O 0 1.5972689837440157e-09
was O 0 4.913775697445999e-08
5 O 0 1.2482442457439902e-07
. O 0 7.258457834780074e-09

3x O 0 4.207492384011857e-05
greater O 0 1.778209579583745e-08
if O 0 3.6711075152018324e-11
there O 0 4.054067411635165e-12
were O 0 2.562845942410963e-11
at O 0 1.653102377208171e-10
least O 0 5.204471294033286e-13
five O 0 1.1236972723843719e-12
cases O 0 9.354865840305315e-12
of O 0 1.269772731404828e-08
breast B-Disease 1 0.9995135068893433
cancer I-Disease 0 1.3506757568393368e-05
in O 0 4.713114343246616e-10
the O 0 9.128227951293866e-09
family O 0 1.6019248150200838e-09
. O 0 1.7803467589061484e-09

Interestingly O 0 2.715703715239215e-07
, O 0 6.424148990546996e-10
the O 0 9.401934092378994e-11
presence O 0 1.3491199823967293e-10
of O 0 2.0081996510157296e-08
a O 0 5.536384151128004e-08
breast B-Disease 1 0.9999912977218628
cancer I-Disease 0 1.2695237273874227e-05
case O 0 5.728946761429654e-10
< O 0 9.0595020374451e-10
36 O 0 2.589498615535035e-10
years O 0 2.3822818717711414e-12
of O 0 4.0569780174193326e-11
age O 0 1.0480171418192352e-11
was O 0 4.0499735509680335e-11
strongly O 0 1.873208402627946e-12
predictive O 0 8.873297235867383e-11
of O 0 1.7903813154251935e-10
the O 0 1.5046436319110512e-11
presence O 0 8.568853092361106e-12
of O 0 7.594366802088359e-11
any O 0 1.3329692384600467e-11
of O 0 1.3850869340359395e-09
the O 0 3.1628594188148895e-10
eight O 0 4.560011257481733e-10
mutations O 0 1.3544783072916289e-09
screened O 0 8.150003338869283e-08
. O 0 9.147626656158536e-09

Carriers O 0 8.96910457015565e-09
of O 0 8.803413109603753e-09
the O 0 6.239870425917005e-11
same O 0 3.8723460202283455e-12
mutation O 0 3.16289854550289e-12
, O 0 2.968756967688946e-13
from O 0 5.271879937804314e-13
different O 0 1.587946218744793e-13
families O 0 1.2928712462591252e-13
, O 0 9.24384592308758e-13
shared O 0 2.4569239871763404e-12
similar O 0 4.898335209668758e-12
haplotypes O 0 1.1365279550812346e-10
, O 0 1.0800685866507731e-11
indicating O 0 2.5346407264703608e-11
that O 0 1.7993548003577414e-13
the O 0 1.3268231131846608e-11
mutant O 0 5.793822019373174e-11
alleles O 0 1.7456417984295508e-13
were O 0 3.5945009989324372e-12
likely O 0 3.739558142312749e-12
to O 0 1.0016851714408914e-12
be O 0 1.428305499047433e-12
identical O 0 1.671472404929375e-10
by O 0 6.49181489814632e-12
descent O 0 2.1471466271627548e-10
for O 0 2.4968050630486127e-12
a O 0 1.4364806219524517e-11
mutation O 0 2.09965638625631e-11
in O 0 2.788722031077384e-11
the O 0 5.799574154252696e-10
founder O 0 6.084611214873803e-08
population O 0 9.175361859181663e-12
. O 0 2.6179650114421804e-10

The O 0 2.490905925967013e-09
identification O 0 5.58346568979573e-09
of O 0 4.141673226598641e-09
common O 0 2.6047868306733335e-09
BRCA1 O 0 9.003387191341972e-08
and O 0 8.67553051620007e-09
BRCA2 O 0 3.643937986907986e-07
mutations O 0 2.303622292920693e-10
will O 0 2.573573645858751e-11
facilitate O 0 1.0921839127542299e-10
carrier O 0 3.7969880017918456e-10
detection O 0 2.6381883344583912e-08
in O 0 4.393790539736209e-11
French O 0 7.833148174540838e-08
Canadian O 0 0.0023190064821392298
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 1 0.5063881278038025
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.5503305306197035e-09
. O 0 4.92934626450392e-09

Are O 0 1.5353675664186994e-08
Dp71 O 0 7.790103700244799e-05
and O 0 4.290419042263238e-08
Dp140 O 0 4.255776002537459e-05
brain O 0 2.477860834915191e-05
dystrophin O 0 1.89791990123922e-07
isoforms O 0 6.020857146182834e-10
related O 0 6.520951334465508e-09
to O 0 1.065643351338963e-09
cognitive B-Disease 0 0.030843792483210564
impairment I-Disease 1 0.9999979734420776
in O 0 0.0034422562457621098
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9941219687461853

Molecular O 0 1.3199124850871158e-06
study O 0 6.25565466094713e-09
and O 0 1.9783120974725676e-10
neuropsychological O 0 1.2105165296816267e-06
analysis O 0 3.2501898394876605e-10
were O 0 7.362173370939473e-11
performed O 0 9.424309110883655e-10
concurrently O 0 2.656261599565113e-10
on O 0 1.3927322628504157e-09
49 O 0 1.9364851944203565e-09
patients O 0 6.385204587289195e-10
with O 0 3.1622835905409374e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999969005584717
DMD B-Disease 1 1.0
) O 0 1.1768265528733224e-10
in O 0 9.478669585338828e-12
order O 0 3.132216708223723e-11
to O 0 4.574886042912896e-12
find O 0 4.648171170879012e-12
a O 0 1.3712163999743399e-12
molecular O 0 1.4439668905019687e-10
explanation O 0 8.830930778302992e-12
for O 0 4.314512289105288e-12
the O 0 4.6255876906542426e-10
cognitive B-Disease 0 8.806028745311778e-06
impairment I-Disease 0 4.4829215767094865e-05
observed O 0 1.1289888135479487e-08
in O 0 1.3187734237973814e-09
most O 0 6.172746314092592e-09
DMD B-Disease 1 1.0
patients O 0 2.7791026013801456e-07
. O 0 5.409255265931279e-09

Complete O 0 2.8992134915029055e-08
analysis O 0 5.830941840478943e-10
of O 0 2.1677886152815518e-09
the O 0 4.2325271065735137e-10
dystrophin O 0 1.414315278225331e-07
gene O 0 1.3432919221401107e-09
was O 0 1.2882462874230782e-09
performed O 0 3.3932676668513295e-09
to O 0 2.1799671443001323e-12
define O 0 4.977791095983619e-11
the O 0 3.5050670699199316e-11
localization O 0 6.366819960135217e-09
of O 0 3.013385652117506e-10
deletions O 0 6.239135874608337e-10
and O 0 1.0894416618834057e-10
duplications O 0 8.298831843944754e-09
in O 0 5.6477031384893905e-11
relation O 0 5.318089371653123e-11
to O 0 2.5205922418725102e-11
the O 0 3.907025813987275e-10
different O 0 4.93171636861689e-09
DMD B-Disease 1 1.0
promoters O 0 0.0003170018317177892
. O 0 6.845720434967006e-08

Qualitative O 0 6.831424315123513e-08
analysis O 0 4.552973997817844e-09
of O 0 1.6175997430423195e-08
the O 0 1.0282810158912525e-09
Dp71 O 0 6.916407983226236e-06
transcript O 0 2.426800094212922e-08
and O 0 2.283323877194654e-11
testing O 0 1.9400848982886743e-10
for O 0 3.897091525352503e-13
the O 0 1.0546137530972888e-12
specific O 0 3.778098439568417e-13
first O 0 3.35453748112613e-11
exon O 0 1.2919297853741796e-09
of O 0 7.554036285384313e-10
Dp140 O 0 4.582073742653847e-08
were O 0 2.914518626440099e-10
also O 0 5.667080086452225e-12
carried O 0 2.654539643653919e-10
out O 0 4.665673958292871e-10
. O 0 7.891821640626517e-10

Neuropsychological O 0 0.0001570148451719433
analysis O 0 1.707910080028796e-08
assessed O 0 7.546756108922636e-08
verbal O 0 3.366394594195299e-07
and O 0 3.3176608127405416e-09
visuospatial O 0 1.0671450354493572e-06
intelligence O 0 1.5695459154585478e-08
, O 0 1.2785349168265014e-10
verbal O 0 4.299077360769843e-08
memory O 0 8.934421930462122e-05
, O 0 2.617730199272472e-10
and O 0 4.875243542201702e-10
reading O 0 4.003972549071477e-07
skills O 0 9.915294185702805e-08
. O 0 2.3601602894274265e-09

Comparison O 0 1.535013183229239e-08
of O 0 3.428765893431773e-08
molecular O 0 4.975207801294346e-08
and O 0 4.167154399326023e-10
psychometric O 0 8.202806611734559e-07
findings O 0 1.3872073489906711e-09
demonstrated O 0 2.7415739123348715e-10
that O 0 6.620279953579999e-13
deletions O 0 3.604432030623883e-10
and O 0 1.0735829586439039e-10
duplications O 0 9.54242818096418e-09
that O 0 4.662057632304206e-12
were O 0 3.1035170960924674e-11
localized O 0 3.1011710976969198e-09
in O 0 8.547734742236912e-11
the O 0 4.815633447563528e-10
distal O 0 3.2669105198834814e-09
part O 0 3.840280593525591e-10
of O 0 1.1287131229664737e-08
the O 0 5.007220860164807e-09
gene O 0 4.598800784627599e-10
seemed O 0 6.977867589297304e-11
to O 0 3.187223705444775e-13
be O 0 2.1152422532717124e-13
preferentially O 0 1.0436411457259709e-10
associated O 0 9.11114184098949e-10
with O 0 9.258647182264212e-10
cognitive B-Disease 1 0.9960902333259583
impairment I-Disease 1 0.9999842643737793
. O 0 7.132576911317301e-07

Two O 0 1.8634054299582203e-08
altered O 0 1.1391023946316636e-07
Dp71 O 0 7.0958362812234554e-06
transcripts O 0 2.9710088256251765e-07
and O 0 7.69336427897116e-10
two O 0 3.226704320402618e-11
deleted O 0 7.053179151839117e-10
Dp140 O 0 1.0143224926650873e-08
DNA O 0 5.231253208393127e-09
sequences O 0 1.6940865377179648e-11
were O 0 4.51097449324922e-12
found O 0 5.935968296760796e-12
in O 0 1.5363164299758703e-12
four O 0 1.7045163891449278e-11
patients O 0 2.512606234184034e-10
with O 0 2.2251385178861938e-09
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 1.8561107708592317e-06

These O 0 2.8007502983484756e-09
findings O 0 2.003569310460307e-09
suggest O 0 1.17486187445337e-10
that O 0 1.4687727488242597e-13
some O 0 5.395228534765817e-14
sequences O 0 8.495632040743384e-13
located O 0 1.0611396310256094e-11
in O 0 1.1192395751521977e-12
the O 0 2.975517748859957e-11
distal O 0 7.300565707524242e-10
part O 0 1.6590850915321198e-10
of O 0 4.757154226098237e-09
the O 0 7.242564881160263e-10
gene O 0 9.410886653293815e-11
and O 0 1.3696860312606418e-10
, O 0 9.447120169481238e-12
in O 0 4.08383830224901e-12
particular O 0 1.3939985450683867e-11
, O 0 7.724911856021865e-12
some O 0 1.2268884692911985e-11
DMD B-Disease 1 1.0
isoforms O 0 2.5318977470156767e-10
expressed O 0 1.987793436797336e-11
in O 0 2.0396431765767886e-10
the O 0 1.1516470443950766e-08
brain O 1 0.6877855062484741
may O 0 7.670532958803378e-11
be O 0 7.247527773236728e-13
related O 0 9.844614012877173e-11
to O 0 3.1016335333422518e-12
the O 0 7.501167048618029e-11
cognitive B-Disease 0 5.838035690430843e-07
impairment I-Disease 0 3.2258099963655695e-05
associated O 0 3.319206598462188e-08
with O 0 3.766021094975258e-08
DMD B-Disease 1 1.0
. O 0 1.4520855629029938e-08
. O 0 3.372426782277671e-09

I1307K O 0 0.0002298505132785067
APC O 0 2.8426817152649164e-05
and O 0 2.7408709968312905e-08
hMLH1 O 0 1.7494813846496982e-06
mutations O 0 1.928519566263276e-09
in O 0 2.3704813112424006e-10
a O 0 1.4015014149215688e-10
non O 0 1.7753248471308325e-07
- O 0 7.447301442198295e-09
Jewish O 0 6.753800296799284e-10
family O 0 4.626309058064493e-11
with O 0 7.676767554976038e-11
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.66572547755095e-07

We O 0 6.5064278409465715e-09
describe O 0 4.229268935063146e-09
a O 0 1.6632738242261524e-10
French O 0 1.5688880239395075e-07
Canadian O 0 1.1715282198565546e-05
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.3888613466406241e-05
HNPCC B-Disease 1 1.0
) O 0 1.1933007471043311e-08
kindred O 0 1.8095661289407872e-06
which O 0 1.0977475872753217e-10
carries O 0 3.9701802956315646e-10
a O 0 4.098815384323551e-11
novel O 0 4.829799338246232e-10
truncating O 0 3.191848918504547e-08
mutation O 0 3.2568422958512144e-10
in O 0 6.345382552730428e-10
hMLH1 O 0 2.027029267992475e-06
. O 0 2.130033216474203e-08

Interestingly O 0 7.420279644065886e-07
, O 0 1.6846662953540203e-09
the O 0 6.386178807993304e-10
I1307K O 0 1.7621357528696535e-07
APC O 0 4.756176963383041e-08
polymorphism O 0 2.627781547914765e-09
, O 0 1.8999664688768014e-11
associated O 0 5.158245358627411e-11
with O 0 8.859640451830408e-13
an O 0 4.667767908306253e-13
increased O 0 1.0939054349845545e-11
risk O 0 4.610809511973457e-09
of O 0 0.1650155782699585
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.1770151520096306e-10
is O 0 3.491078953699045e-13
also O 0 1.7621707315996354e-13
present O 0 1.2187526378729108e-12
in O 0 2.8079296700289635e-12
this O 0 1.0221082877640009e-12
family O 0 6.481413322712015e-11
. O 0 1.356197487645261e-09

The O 0 2.1105351777350734e-07
I1307K O 0 7.478092243218271e-07
polymorphism O 0 8.509288385027958e-09
has O 0 6.556196991552854e-12
previously O 0 4.448831927850172e-11
only O 0 1.9498348790593367e-13
been O 0 3.9450902397306087e-13
identified O 0 1.9388661683106267e-12
in O 0 8.256723213126427e-13
individuals O 0 7.87670709906374e-14
of O 0 4.883805582167611e-10
self O 0 8.005412155398517e-08
- O 0 1.8185329508924042e-07
reported O 0 1.2038803287595101e-09
Ashkenazi O 0 2.8816105057671848e-08
Jewish O 0 1.1173691305543798e-08
origins O 0 1.9144698626405443e-07
. O 0 3.506795964725029e-09

In O 0 3.0372993009564198e-09
addition O 0 2.5237012479806253e-10
, O 0 9.650790583348723e-12
in O 0 4.666933506314308e-12
this O 0 1.8232512938656797e-13
family O 0 3.4960183619564544e-12
, O 0 7.017505066625462e-12
there O 0 1.2988113189116302e-12
appears O 0 2.86968062160331e-12
to O 0 4.02792924882045e-13
be O 0 8.550204272893269e-13
no O 0 9.655595767377179e-12
relationship O 0 2.556088370478382e-12
between O 0 1.0502864203343343e-11
the O 0 2.0862752497796677e-11
I1307K O 0 1.4940925163742236e-09
polymorphism O 0 1.1172188174590758e-10
and O 0 4.484876445914887e-12
the O 0 1.4450103440200035e-11
presence O 0 3.372307641469341e-11
or O 0 5.583140894049876e-11
absence O 0 1.7042394162558594e-08
of O 0 1.6535146585283655e-07
cancer B-Disease 0 2.889497409341857e-06
. O 0 4.4792027725781836e-11
. O 0 5.618953080599454e-10

Identification O 0 2.398420235749654e-07
of O 0 3.793039837773904e-08
a O 0 8.652253913332686e-11
novel O 0 1.5156069455013466e-10
mutation O 0 1.0178952819517306e-10
of O 0 1.4558563243838307e-09
the O 0 4.3799719406933946e-09
CPO O 1 0.9837487936019897
gene O 0 4.6103676432096563e-10
in O 0 4.245372456357366e-11
a O 0 2.3592364173374847e-10
Japanese O 0 1.786564553185599e-06
hereditary B-Disease 1 0.9999996423721313
coproporphyria I-Disease 1 0.999967098236084
family O 0 2.9607980422952096e-07
. O 0 5.710058204044799e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 5.762933869846165e-05
HCP B-Disease 1 1.0
) O 0 5.396816771252588e-09
is O 0 1.2256347846351101e-11
an O 0 2.3727329129252794e-11
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 1.522277770504843e-08
by O 0 1.6295420568468444e-10
a O 0 3.9582904065582625e-08
deficiency B-Disease 1 0.9994975328445435
of I-Disease 1 0.7513725161552429
coproporphyrinogen I-Disease 1 0.9997808337211609
oxidase I-Disease 0 6.568181447619281e-07
( O 0 1.5517040097279278e-08
CPO O 1 0.9999998807907104
) O 0 1.5037493472647157e-10
caused O 0 4.463700242762769e-10
by O 0 3.3303928191619203e-12
a O 0 7.775778285146195e-12
mutation O 0 1.1820383213900776e-11
in O 0 1.8265911352899344e-11
the O 0 1.6759872378813157e-09
CPO O 1 0.9999078512191772
gene O 0 3.9869551216042964e-08
. O 0 1.9642998339008955e-09

Only O 0 1.0935100602793568e-09
11 O 0 5.301060923557088e-09
mutations O 0 1.0800856736770115e-10
of O 0 5.261068802830948e-10
the O 0 4.743127002271308e-10
gene O 0 7.139284302626336e-11
have O 0 1.3987066713183616e-12
been O 0 2.3119405695437578e-11
reported O 0 1.772708368985576e-10
in O 0 2.4210289328863155e-09
HCP B-Disease 1 1.0
patients O 0 4.3525798787413805e-07
. O 0 2.776571861318189e-08

We O 0 5.948467496352805e-09
report O 0 3.1465530181407075e-10
another O 0 2.4034921622395622e-11
mutation O 0 1.2411706211412632e-11
in O 0 6.329722336551047e-12
a O 0 2.4680849378122538e-11
Japanese O 0 1.144162879995747e-07
family O 0 2.3505910551335774e-09
. O 0 4.6459267544207705e-09

Polymerase O 0 5.51590073882835e-06
chain O 0 4.98343752042274e-07
reaction O 0 2.42587305798736e-09
- O 0 2.742486593376725e-08
single O 0 3.481946952987869e-10
strand O 0 6.662596863105108e-11
conformational O 0 2.6351872073338e-11
polymorphism O 0 1.961812517992101e-10
and O 0 3.94109137685783e-12
direct O 0 5.590639930164176e-12
sequence O 0 6.737659041800015e-12
analyses O 0 9.452172378132673e-11
demonstrated O 0 1.3169955404013223e-10
a O 0 4.126938721316087e-11
C O 0 3.478213628227422e-08
to O 0 4.509996195944943e-11
T O 0 4.1783724924471244e-08
substitution O 0 1.5904948191813872e-10
in O 0 2.287936159972581e-11
exon O 0 5.099689004417485e-10
1 O 0 1.4194967423719618e-10
of O 0 1.6770608513017038e-10
the O 0 3.057221975577562e-10
CPO O 0 7.551942690042779e-05
gene O 0 9.372266157603448e-11
at O 0 2.3224605572025325e-10
nucleotide O 0 4.016910692961062e-10
position O 0 2.709411306422993e-10
85 O 0 6.598921964418025e-10
, O 0 2.127771049631466e-12
which O 0 2.8459149099824277e-12
lies O 0 1.1041191294580699e-09
in O 0 1.739139735001949e-11
the O 0 1.0894541518924328e-10
putative O 0 3.6451834883877154e-09
presequence O 0 7.728404227691499e-08
for O 0 1.2514590058687602e-11
targeting O 0 5.553956738957311e-10
to O 0 1.3019078870524226e-10
mitochondria O 0 4.593799829422096e-08
. O 0 5.116068901855897e-09

This O 0 3.606687726254165e-10
mutation O 0 1.0350415663440415e-10
changes O 0 1.3508804318218548e-11
the O 0 5.184977447392214e-11
codon O 0 7.74647568313469e-10
for O 0 5.044512550733682e-12
glutamine O 0 1.109722425063353e-09
to O 0 1.909470324912288e-11
a O 0 4.0621814939578726e-11
termination O 0 4.364011374491383e-09
codon O 0 1.6991242191011224e-08
at O 0 9.400652700719547e-09
amino O 0 1.8619266128894196e-09
acid O 0 3.6398337677212567e-09
position O 0 5.689508419948197e-09
29 O 0 1.3223828432273876e-07
. O 0 1.1208114436556116e-09

MaeI O 0 1.8019089111476205e-05
restriction O 0 3.7525083040890195e-10
analysis O 0 1.6989863682592699e-10
showed O 0 1.820036482635956e-10
two O 0 1.1727204493952592e-12
other O 0 3.612561909772244e-13
carriers O 0 4.399675502392286e-12
in O 0 2.2055891835126573e-11
the O 0 5.312414397273812e-10
family O 0 6.424847320829485e-10
. O 0 3.4490714728718785e-09

The O 0 1.1135521162941586e-06
C O 1 0.9645686745643616
- O 0 0.0005699807079508901
T O 0 0.00023566820891574025
mutation O 0 5.9782165329203e-11
is O 0 6.097445682043401e-13
located O 0 1.2009945815627532e-10
within O 0 6.07646155614816e-11
a O 0 1.8495293838127758e-11
recently O 0 1.1135808247741963e-10
proposed O 0 4.923271859635925e-11
putative O 0 4.5857237451762956e-10
alternative O 0 3.192667519247294e-10
translation O 0 3.0365102099416674e-10
initiation O 0 3.395829728525257e-10
codon O 0 2.7949336178778594e-09
( O 0 2.335416929288847e-11
TIC O 0 2.8184800271446875e-07
- O 0 2.6179277412552437e-08
1 O 0 1.2469616450516696e-09
) O 0 1.8142743167179343e-12
, O 0 1.1626358513081025e-12
supporting O 0 4.918726016767128e-12
that O 0 1.9890363227997865e-12
TIC O 0 5.835754109284608e-06
- O 0 1.4499495648578886e-07
1 O 0 1.9844732523921493e-09
is O 0 1.575721757934856e-12
the O 0 4.6083432209131914e-11
real O 0 6.24276985661254e-09
TIC O 0 3.79603989131283e-06
rather O 0 1.4094174438650242e-10
than O 0 1.03123004926986e-11
TIC O 0 1.5847964505155687e-06
- O 0 8.818357599693627e-08
2 O 0 5.21507415029987e-09
. O 0 2.6804759800658218e-11
. O 0 1.5928566798883992e-10

Human B-Disease 0 2.0174136139416987e-08
complement I-Disease 0 1.1223484364109027e-07
factor I-Disease 0 2.0665693227783777e-06
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999977350234985
associated O 0 3.807613495609985e-07
with O 0 5.113705628900789e-05
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.758276266627945e-05

This O 0 6.570371330338887e-11
study O 0 1.046541464599926e-10
reports O 0 7.524696837846179e-11
on O 0 1.7481868730406802e-10
six O 0 1.1928983842390828e-11
cases O 0 1.2732922355374043e-11
of O 0 1.1710307390444541e-08
deficiency B-Disease 0 1.3842829957866343e-06
in I-Disease 0 2.4893373473666713e-10
the I-Disease 0 3.1239488773593393e-10
human I-Disease 0 1.149784087384198e-11
complement I-Disease 0 4.188939473070974e-11
regulatory I-Disease 0 3.381958324499834e-10
protein I-Disease 0 2.365080076227599e-10
Factor I-Disease 0 1.4836704087528574e-09
H I-Disease 1 0.9999998807907104
( O 0 3.9184813727111134e-10
FH O 0 2.1282153284118976e-06
) O 0 4.978754496350046e-13
in O 0 2.9457100821084214e-13
the O 0 7.75378079884842e-13
context O 0 4.439090588170824e-12
of O 0 5.979391287658231e-11
an O 0 2.508803997880449e-10
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 5.766401045548264e-08

Five O 0 5.204623576560152e-08
of O 0 1.2167830298892568e-08
the O 0 6.339355429485494e-11
cases O 0 5.588209582574333e-12
were O 0 1.94410568372938e-12
observed O 0 1.0374920540734411e-11
in O 0 2.586189075393097e-12
children O 0 2.7852331985905865e-12
presenting O 0 1.8568409032582167e-09
with O 0 5.6502837963989805e-09
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999963045120239
HUS B-Disease 1 1.0
) O 0 2.884538844227791e-06
. O 0 1.3524582698209997e-07

Two O 0 2.7208939545886324e-09
of O 0 8.37084712657088e-09
the O 0 9.964958858077466e-10
children O 0 8.782440746868403e-11
exhibited O 0 2.8838977428335966e-08
a O 0 1.4113773261215101e-08
homozygous O 0 5.9041540225734934e-05
deficiency O 1 0.9728710651397705
characterized O 0 4.413181997620086e-08
by O 0 1.7708326471854718e-10
the O 0 1.2355503287153624e-09
absence O 0 9.155953328843225e-09
of O 0 3.5677585330518014e-09
the O 0 2.475445681771049e-10
150 O 0 1.92018692612983e-10
- O 0 4.0326783579125447e-10
kD O 0 5.588985274584957e-09
form O 0 5.883019071895035e-11
of O 0 6.893393633689016e-10
Factor O 0 9.102457121379359e-10
H O 1 1.0
and O 0 9.735898198748316e-11
the O 0 5.090745880398373e-11
presence O 0 1.650722614154887e-11
, O 0 9.67277148135326e-13
upon O 0 2.1626899923687937e-11
immunoblotting O 0 3.57917713245115e-08
, O 0 1.5133529845945404e-11
of O 0 3.7717248768665e-10
the O 0 1.9853467481123488e-10
42 O 0 2.4128876674467392e-09
- O 0 3.2581488618177445e-09
kD O 0 7.334572416084484e-08
Factor O 0 4.3026684437563745e-09
H O 1 0.9997177720069885
- O 0 3.378222501737582e-08
like O 0 1.9902755832301722e-10
protein O 0 1.0618832202435868e-10
1 O 0 8.805223217223102e-10
( O 0 2.9734638362644006e-11
FHL O 0 2.5552863007760607e-05
- O 0 6.153514586770825e-09
1 O 0 2.947985466850156e-10
) O 0 4.085745142819869e-13
and O 0 2.330921046456158e-12
other O 0 1.3619637535822182e-11
FH O 0 2.7446801595942816e-06
- O 0 5.964805538383189e-09
related O 0 9.965039460269054e-09
protein O 0 7.342096375317908e-10
( O 0 1.4194263819877762e-10
FHR O 1 0.9999822378158569
) O 0 1.361818990908148e-10
bands O 0 3.018399183929432e-07
. O 0 8.128199224799459e-10

Southern O 0 2.964764007629128e-06
blot O 0 2.487551682861522e-06
and O 0 8.608406210086628e-10
PCR O 0 1.4918407842401393e-08
analysis O 0 7.509756705381676e-11
of O 0 1.7024961995737442e-10
DNA O 0 3.162645612064807e-08
of O 0 2.1342818623537596e-09
one O 0 2.3994750630862427e-11
patient O 0 9.059713867998198e-09
with O 0 1.1466053662090303e-09
homozygous O 0 8.759407501202077e-05
deficiency O 1 0.998698353767395
ruled O 0 7.398896855193016e-07
out O 0 4.0719580485237827e-10
the O 0 2.9429500503219685e-11
presence O 0 1.319305428792994e-11
of O 0 2.0335795547499202e-10
a O 0 1.7125092576647516e-12
large O 0 3.229035745386244e-12
deletion O 0 2.9456134753580443e-10
of O 0 2.186278713622869e-09
the O 0 2.4381192620381853e-09
FH O 0 0.0006052421522326767
gene O 0 1.3319845226789084e-09
as O 0 4.6778615703235715e-11
the O 0 2.6605107006361095e-10
underlying O 0 4.997834253117617e-07
defect O 0 4.4494413486972917e-07
for O 0 7.75439934486144e-10
the O 0 4.757283932121936e-06
deficiency O 1 0.999997615814209
. O 0 5.1169109838156146e-08

The O 0 5.3250602150001214e-08
other O 0 2.601558413140026e-10
four O 0 9.599410849547851e-11
children O 0 3.5957625765803414e-12
presented O 0 4.959314625629929e-10
with O 0 9.65192370472323e-10
heterozygous O 0 7.746733672320261e-07
deficiency O 0 0.4874134361743927
and O 0 7.993187445265448e-09
exhibited O 0 7.230975711536303e-07
a O 0 3.978346096999985e-09
normal O 0 1.7832906706871654e-08
immunoblotting O 0 2.749705174664996e-07
pattern O 0 2.195865933529717e-09
of O 0 6.253086382024264e-10
proteins O 0 1.4493661479320075e-11
of O 0 1.7665997553706347e-09
the O 0 3.5615712601355654e-09
FH O 0 0.0011566750472411513
family O 0 1.7840315891248792e-09
. O 0 5.313958162389554e-09

Factor B-Disease 1 0.9904560446739197
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.8384303801521895e-10
the O 0 1.0765521807343248e-10
only O 0 4.561330826935439e-11
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 1.496599452366354e-06
with O 0 1.0116836079987479e-07
HUS B-Disease 1 1.0
. O 0 4.3926911530434154e-07

These O 0 7.471271379344557e-10
observations O 0 1.5191277569215345e-08
suggest O 0 4.2580414194581806e-10
a O 0 2.4381075283685938e-11
role O 0 2.4597244380197836e-11
for O 0 9.688212038172495e-12
FH O 0 4.683699444285594e-06
and O 0 3.3901154106175113e-10
/ O 0 1.218150824655595e-08
or O 0 1.6282494796904246e-10
FH O 0 1.2953869372722693e-06
receptors O 0 4.060175459730253e-11
in O 0 8.360240451310563e-12
the O 0 7.114869804425439e-11
pathogenesis O 0 7.753783961561567e-07
of O 0 6.250110828887045e-08
idiopathic O 1 0.8005542159080505
HUS B-Disease 1 1.0
. O 0 2.610836702388042e-08
. O 0 8.509839055648172e-09

Further O 0 2.6260580376913367e-09
evidence O 0 1.4642050905067094e-09
for O 0 7.57148250346562e-12
a O 0 9.578135160004386e-12
major O 0 1.0323247812138447e-10
ancient O 0 1.7360305193392378e-08
mutation O 0 3.00553608667542e-08
underlying O 0 0.006283205468207598
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 2.2616795547492075e-07
linkage O 0 6.371584504449856e-08
disequilibrium O 0 7.026733328530099e-08
studies O 0 1.2757676859376232e-10
in O 0 8.369605355995624e-12
the O 0 4.41282149710176e-11
Japanese O 0 6.417049558393728e-09
population O 0 1.4351433453088647e-12
. O 0 1.1639949420994e-10

The O 0 0.0002930033078882843
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.09309123456478119
DM B-Disease 1 1.0
) O 0 6.890216397437143e-09
mutation O 0 2.421036982003244e-10
is O 0 2.876069825005767e-12
an O 0 7.099195797194424e-12
unstable O 0 3.660021548057557e-07
( O 0 4.965838407144929e-09
CTG O 0 0.023821938782930374
) O 0 1.202585253601285e-10
n O 0 9.407602474809096e-11
repeat O 0 3.382913393856768e-10
, O 0 9.392681077358134e-12
present O 0 2.055760943420193e-11
at O 0 3.674723858537732e-10
a O 0 3.8411556921302825e-12
copy O 0 4.08495681725185e-10
number O 0 1.1760450252529253e-11
of O 0 2.8178956390512155e-10
5 O 0 4.811483433897479e-10
- O 0 3.4729414899459243e-09
37 O 0 9.47396272543699e-10
repeats O 0 1.082952963415984e-10
on O 0 1.893361856186715e-10
normal O 0 1.4431408845716476e-10
chromosomes O 0 2.8960531889277163e-11
but O 0 1.8246125096932353e-12
amplified O 0 4.289148591851699e-09
to O 0 4.760417060545308e-11
50 O 0 6.022327081467438e-10
- O 0 6.664226948061014e-10
3000 O 0 9.487573920941017e-11
copies O 0 2.0048757098933834e-10
on O 0 5.413745007842863e-09
DM B-Disease 1 1.0
chromosomes O 0 3.3418913858440646e-08
. O 0 2.96306068570118e-09

Previous O 0 1.9527116990047944e-07
findings O 0 3.4228440082273437e-09
in O 0 7.405578927865974e-11
Caucasian O 0 1.2253883463486659e-09
populations O 0 3.093187164737721e-11
of O 0 1.6365324650990942e-09
a O 0 1.7836240928659208e-08
DM B-Disease 1 1.0
founder O 1 0.9999998807907104
chromosome O 0 6.330682253974373e-07
raise O 0 1.0310697851068085e-09
a O 0 1.3505462026497383e-10
question O 0 1.434142648387704e-11
about O 0 4.2319153823605626e-13
the O 0 2.625623243129871e-12
molecular O 0 6.398587909517417e-11
events O 0 4.7170128046614135e-12
involved O 0 6.2949636822628996e-12
in O 0 9.011806058334404e-12
the O 0 4.3655138531883964e-11
expansion O 0 3.92558252571007e-09
mutation O 0 1.2277511229896731e-09
. O 0 5.563328686619684e-10

To O 0 2.582372982118386e-09
investigate O 0 2.183299319113985e-09
whether O 0 1.038977723299972e-10
a O 0 2.3848481522925624e-10
founder O 0 1.8373582122421794e-07
chromosome O 0 4.720457802420697e-09
for O 0 8.790485006571203e-11
the O 0 7.4147736839336176e-09
DM B-Disease 1 1.0
mutation O 0 1.8205374985313938e-09
exists O 0 2.481509268903448e-11
in O 0 1.8361787784693107e-12
the O 0 3.755046187187139e-12
Japanese O 0 4.160372046868588e-10
population O 0 1.2993458305826655e-13
, O 0 7.484509973593179e-13
we O 0 1.0256116702439533e-12
genotyped O 0 8.272219353955279e-09
families O 0 7.992252557464594e-14
using O 0 3.723366233387981e-12
polymorphic O 0 1.5770230676892538e-09
markers O 0 3.0550801000117644e-08
near O 0 1.6604613506387977e-07
the O 0 5.193028229655283e-09
( O 0 7.369201360241107e-10
CTG O 0 0.00013171251339372247
) O 0 8.820817687382743e-11
n O 0 1.634292007279825e-10
repeat O 0 1.8711081573030697e-09
region O 0 9.126935318626295e-10
and O 0 9.184419197394433e-11
constructed O 0 5.159041052138491e-07
haplotypes O 0 3.1166143799055135e-07
. O 0 4.174960821501372e-09

Six O 0 1.6196960217484957e-08
different O 0 2.8606212884585425e-11
haplotypes O 0 4.806191000739091e-10
were O 0 1.0103747699607979e-10
found O 0 1.1313415482216982e-10
and O 0 1.0342448009126315e-09
DM B-Disease 1 1.0
alleles O 0 3.1866206895436733e-10
were O 0 9.010027723910241e-10
always O 0 5.201838959578708e-10
haplotype O 0 4.2015724233124274e-08
A O 0 2.2869193117003306e-07
. O 0 5.719843709783845e-09

To O 0 8.906280712928094e-10
find O 0 1.856421266710484e-11
an O 0 1.3700131795083698e-13
origin O 0 1.836571042815316e-12
of O 0 1.56263224582176e-10
the O 0 2.3870327936492686e-10
( O 0 2.1279764061965523e-10
CTG O 0 0.0001654821098782122
) O 0 2.8289877385123674e-11
n O 0 4.6988579693874044e-11
repeat O 0 2.614770899800334e-10
mutation O 0 4.7432148486681314e-11
and O 0 1.088373575292012e-11
to O 0 2.1113898390073826e-12
investigate O 0 2.757727102231655e-10
the O 0 4.79217429627532e-11
mechanism O 0 1.512721753416102e-10
of O 0 1.4473833243044965e-10
the O 0 1.464831511296949e-12
expansion O 0 8.406867216259606e-12
mutation O 0 4.774761315495812e-13
in O 0 7.886769037325492e-13
the O 0 1.940642091469158e-12
Japanese O 0 2.0738227801686548e-10
population O 0 2.263098223902714e-14
we O 0 3.449536256682276e-14
have O 0 2.4732506556548843e-14
studied O 0 3.389940828046889e-10
90 O 0 5.099611288805761e-10
Japanese O 0 6.973420596523283e-08
DM B-Disease 1 1.0
families O 0 4.04728611735905e-11
comprising O 0 4.773630379872884e-10
190 O 0 6.182027667556156e-10
affected O 0 4.073651416192092e-10
and O 0 3.623070177205534e-10
130 O 0 7.335940299668664e-09
unaffected O 0 6.556096820986568e-08
members O 0 5.910667510988787e-10
. O 0 2.3546746774627536e-09

The O 0 9.811522261315986e-08
results O 0 5.707931460818827e-09
suggest O 0 5.152918092221626e-10
that O 0 8.491031228824442e-13
a O 0 6.0099967537363685e-12
few O 0 3.3056415677662487e-12
common O 0 4.877768328137577e-12
ancestral O 0 1.5806568554044276e-10
mutations O 0 9.736413064675986e-12
in O 0 4.831839789387615e-12
both O 0 7.103787610235335e-12
Caucasian O 0 1.0096721236863004e-09
and O 0 2.8760273676486925e-11
Japanese O 0 5.1720427940438185e-09
populations O 0 2.7028173536086664e-12
have O 0 2.16095079384835e-14
originated O 0 5.366425619851567e-12
by O 0 2.3467339183014246e-13
expansion O 0 5.0143261071111667e-11
of O 0 1.5557802268695298e-10
an O 0 9.792317781295856e-13
ancestral O 0 6.631158955272554e-10
n O 0 1.0414100831690476e-10
= O 0 1.0929737670473116e-10
5 O 0 2.570190171802267e-10
repeat O 0 2.3217341937886715e-10
to O 0 3.603069578805851e-11
n O 0 6.620846093596811e-10
= O 0 7.881096886208638e-10
19 O 0 7.625610365380453e-09
- O 0 8.650316019043203e-09
37 O 0 2.246323349552881e-09
copies O 0 9.545190193804842e-10
. O 0 5.756461418648939e-10

These O 0 8.753380797976718e-10
data O 0 9.857358262976845e-10
support O 0 3.818097574215251e-11
multistep O 0 2.545311295065744e-09
models O 0 7.114575040212401e-10
of O 0 1.2511935487680148e-08
triplet O 0 2.675153893960669e-07
repeat O 0 4.997317226695941e-09
expansion O 0 2.2096424689976857e-09
that O 0 1.3772765480174476e-12
have O 0 1.723100964213034e-13
been O 0 2.766700171914771e-13
proposed O 0 4.2966585150905345e-12
for O 0 5.926612933054853e-12
both O 0 4.802003794601717e-10
DM B-Disease 1 1.0
and O 0 1.5653310470042925e-07
Friedreichs B-Disease 1 0.9999990463256836
ataxia I-Disease 1 1.0
. O 0 2.6360456928387066e-08
. O 0 1.2694191475759453e-08

The O 0 1.929760706786965e-08
molecular O 0 1.975926799957506e-08
basis O 0 1.8915480737291546e-08
of O 0 0.0002851140161510557
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.8470176499363333e-09
the O 0 9.002104617295004e-11
western O 0 4.746728565763192e-10
Cape O 0 4.8239119365689476e-08
, O 0 2.148866154461082e-11
South O 0 5.775402378560557e-09
Africa O 0 2.1741570765954066e-09
. O 0 3.4786412639320474e-10

Deficiency B-Disease 1 0.9999880790710449
of I-Disease 0 9.166524978354573e-05
the I-Disease 0 3.7570959676713755e-08
sixth I-Disease 0 2.121398892995785e-06
component I-Disease 0 3.296542150366122e-09
of I-Disease 0 4.071944115224824e-09
human I-Disease 0 2.408807875386998e-10
complement I-Disease 0 8.449108968022756e-09
( O 0 1.1242178299397665e-09
C6 O 1 0.9995208978652954
) O 0 3.3216842471039953e-11
has O 0 3.1818297996366596e-13
been O 0 2.8428428773367986e-13
reported O 0 2.473451348253275e-12
in O 0 5.712265513033166e-13
a O 0 4.2167674517076814e-13
number O 0 1.6947181776406223e-13
of O 0 6.879621872180053e-12
families O 0 1.1610655843610328e-14
from O 0 1.3876339313712016e-12
the O 0 8.870077415623623e-12
western O 0 7.268082247158247e-10
Cape O 0 6.840081567816014e-08
, O 0 4.3648393927009366e-11
South O 0 5.1674282630642665e-09
Africa O 0 2.197898085753991e-09
. O 0 2.357819495202307e-10

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999974966049194
is O 0 2.2020636702979601e-10
endemic O 0 1.47830903074464e-09
in O 0 2.9636907511454424e-11
the O 0 1.828889262256439e-10
Cape O 0 1.0426716556821702e-07
and O 0 1.7687084435946687e-11
almost O 0 1.764250095841191e-12
all O 0 6.874423990124723e-13
pedigrees O 0 1.0711904696592e-09
of O 0 4.422440191831356e-09
total O 0 1.5079002935181052e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.315151673177752e-07
C6Q0 O 1 1.0
) O 0 3.777107793201395e-11
have O 0 1.5499725797545744e-13
been O 0 2.911497269404012e-13
ascertained O 0 2.2851809333701567e-10
because O 0 1.665266362305129e-11
of O 0 4.633053762859163e-08
recurrent O 1 1.0
disease O 1 0.9999998807907104
. O 0 1.2576295560506878e-08

We O 0 4.858462521184492e-09
have O 0 9.892266693289908e-12
sequenced O 0 1.072801625312536e-09
the O 0 7.276872854289351e-11
expressed O 0 1.3899630578462219e-11
exons O 0 7.622528386264094e-09
of O 0 6.387778306304881e-09
the O 0 2.667102094733309e-09
C6 O 1 0.6402882933616638
gene O 0 5.73272873616304e-10
from O 0 1.611521333044763e-11
selected O 0 3.34540069257816e-11
cases O 0 7.678901785268533e-12
and O 0 5.043666005677405e-12
have O 0 3.228467569237753e-13
found O 0 7.992900612208143e-12
three O 0 1.1861260237888693e-11
molecular O 0 3.735965776741068e-07
defects O 1 0.9989429116249084
leading O 0 6.3163901131702e-07
to O 0 1.0418338414197592e-09
total O 0 5.213436082840417e-08
deficiency O 1 0.9989057779312134
879delG O 0 2.2187663489603437e-05
, O 0 2.4721805158556265e-10
which O 0 4.4902263331147996e-12
is O 0 5.052935608991505e-13
the O 0 2.157334207109063e-11
common O 0 3.208172616453453e-10
defect O 0 1.0075506651219257e-08
in O 0 1.4243051182916133e-10
the O 0 1.1623759732515282e-09
Cape O 0 1.8403834189939516e-07
and O 0 2.109068648892265e-11
hitherto O 0 2.3627805267878443e-10
unreported O 0 7.141167102098223e-10
, O 0 1.6313821821212215e-11
and O 0 2.7169913888180908e-11
1195delC O 0 2.8638249105483737e-08
and O 0 2.1602999944470014e-10
1936delG O 0 1.0748507150992737e-07
, O 0 1.4583868834794345e-11
which O 0 9.985301431189586e-13
have O 0 1.4815237795243186e-13
been O 0 2.10986024658244e-12
previously O 0 3.5691297139983647e-11
reported O 0 6.881616804177426e-12
in O 0 1.6792461518533308e-11
African O 0 6.527207108142363e-10
- O 0 1.1408859634798318e-08
Americans O 0 7.190736894813199e-11
. O 0 2.512587082836859e-10

We O 0 1.4216251287280102e-08
also O 0 1.0883700191088863e-10
show O 0 4.5335152298875414e-11
that O 0 2.4526946229216917e-13
the O 0 1.8982640112574778e-11
879delG O 0 1.3395468734245242e-08
and O 0 4.544364884395691e-10
1195delC O 0 1.834605654948973e-06
defects O 0 1.4548693798133172e-05
are O 0 2.7170380528795945e-11
associated O 0 2.618860017733482e-09
with O 0 3.2403129068825365e-09
characteristic O 1 0.9709259271621704
C6 O 1 1.0
/ O 1 0.9999991655349731
C7 O 1 0.9999998807907104
region O 0 4.7760945420805e-08
DNA O 0 7.567842885691789e-07
marker O 0 3.3887417316691426e-08
haplotypes O 0 2.2729931270504267e-09
, O 0 8.279720659087886e-12
although O 0 2.898162612674504e-12
small O 0 4.736522372233987e-12
variations O 0 2.8746811597812894e-09
were O 0 1.6396067836765837e-09
observed O 0 1.4673846138180124e-08
. O 0 4.2898848917616306e-09

The O 0 4.7348339649033733e-07
1936delG O 0 1.4397585800907109e-05
defect O 0 2.2328893010126194e-06
was O 0 5.980823392093271e-09
observed O 0 2.6935156882679223e-10
only O 0 7.971946670501384e-13
once O 0 8.7045223459703e-12
in O 0 2.676551254937598e-12
the O 0 1.7266296031825945e-11
Cape O 0 1.3926692687959985e-08
, O 0 1.0042046404493132e-12
but O 0 5.2141261143792694e-14
its O 0 1.260941654909753e-12
associated O 0 1.2723412601278739e-10
haplotype O 0 3.619452515479793e-09
could O 0 1.3136414178660516e-10
be O 0 1.5654244567286923e-10
deduced O 0 9.47496445746765e-08
. O 0 1.2236138324794865e-08

The O 0 9.739176576317732e-09
data O 0 1.3696057621359614e-09
from O 0 8.305854615198172e-11
the O 0 1.975490604433361e-11
haplotypes O 0 1.4471900067203336e-10
indicate O 0 9.4883658222078e-12
that O 0 1.2167591695484703e-13
these O 0 2.7802866345988386e-12
three O 0 3.9458769585110076e-11
molecular O 0 1.8500230680729146e-07
defects O 0 1.9686456198542146e-06
account O 0 7.595526291259702e-11
for O 0 2.057193582150063e-10
the O 0 2.2097697893741497e-08
defects O 0 0.0001764477783581242
in O 0 5.410130121674683e-10
all O 0 6.412723824178457e-11
the O 0 2.4724255975883125e-10
38 O 0 8.07726052709512e-10
unrelated O 0 1.1022027734952644e-08
C6Q0 O 1 0.9897679686546326
individuals O 0 5.248425392206935e-12
we O 0 5.251979840609211e-12
have O 0 2.4669906417175425e-13
studied O 0 5.841806482997924e-10
from O 0 8.357023406624364e-11
the O 0 2.9855243277587817e-10
Cape O 0 3.9231150594787323e-07
. O 0 7.251522160522939e-10

We O 0 7.1361605513686754e-09
have O 0 2.2106601271776327e-11
also O 0 7.682198627234627e-12
observed O 0 2.0297780123357256e-10
the O 0 2.404552668089366e-10
879delG O 0 1.1403817268273997e-07
defect O 0 2.693415446231029e-08
in O 0 1.6412893266704032e-10
two O 0 2.0085960672489023e-10
Dutch O 1 0.9999831914901733
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 3.0070728826103732e-05
, O 0 3.3918098885088455e-10
but O 0 6.5637920446115494e-12
the O 0 9.934286032686757e-11
879delG O 0 1.4568799144853983e-07
defect O 0 4.971081679627787e-08
in O 0 4.605076875385805e-10
the O 0 1.798840298938842e-09
Cape O 0 1.2306411463214317e-06
probably O 0 1.7834998755628106e-10
did O 0 4.3507402541775875e-12
not O 0 3.7932471833729275e-13
come O 0 4.996832808634721e-12
from O 0 1.635806767819048e-11
The O 0 1.8407179946944296e-10
Netherlands O 0 9.893456365261954e-08
. O 0 1.1271458766337616e-10
. O 0 4.820761567714271e-10

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 3.9316692124202746e-08
seven O 0 1.349496292490926e-09
further O 0 7.802613416485471e-11
molecular O 0 6.721152772115602e-07
defects O 0 0.11142129451036453
and O 0 1.5417258580896487e-09
their O 0 1.7314527589462614e-09
associated O 0 1.6689256199242664e-08
marker O 0 5.356363885766768e-07
haplotypes O 0 3.629994864695618e-07
. O 0 9.269536249689736e-09

Seven O 0 2.4182149616081006e-08
further O 0 3.8872662033728744e-11
molecular O 0 4.59886440040691e-09
bases O 0 4.973623290993601e-08
of O 0 0.1849084198474884
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.1957643198410324e-09
described O 0 2.73442744003205e-08
. O 0 3.907400625280388e-09

All O 0 2.8556306208571414e-09
these O 0 1.5856658000523716e-11
new O 0 1.2773258839526846e-10
molecular O 0 1.7152234477180173e-07
defects O 0 2.574547806943883e-06
involve O 0 2.7435842486767115e-09
single O 0 7.231994114675899e-09
- O 0 5.2593458477190325e-09
nucleotide O 0 1.3049316072155648e-09
events O 0 1.7816775832457665e-10
, O 0 1.118779201225717e-11
deletions O 0 3.1735009065059216e-10
and O 0 2.761341676149609e-11
substitutions O 0 7.643347288421865e-09
, O 0 1.3457576199249477e-11
some O 0 3.9772989047191787e-13
of O 0 3.0201965928178254e-11
which O 0 1.0542517379918959e-12
alter O 0 4.626302674282101e-10
splice O 0 3.639889278872488e-09
sites O 0 5.415498605110258e-10
, O 0 5.1687931712507407e-11
and O 0 6.854817408141756e-11
others O 0 2.844675328628199e-10
codons O 0 6.809634101045958e-08
. O 0 6.076235514740347e-09

They O 0 1.3598885351129297e-09
are O 0 4.502739760908758e-12
distributed O 0 5.668345133547081e-12
along O 0 7.81472248023718e-11
the O 0 4.457523239409511e-10
C7 O 0 0.0010264326119795442
gene O 0 6.664786500465425e-10
, O 0 5.013902921319202e-12
but O 0 1.8338362241503842e-13
predominantly O 0 2.8648459472757626e-12
towards O 0 2.2524735548978825e-11
the O 0 4.85315954090737e-11
3 O 0 2.4829842626417076e-09
end O 0 5.123783619609412e-09
. O 0 7.246682698358597e-10

All O 0 8.322085243150923e-09
were O 0 2.177301672290355e-10
found O 0 1.4044255342016143e-11
in O 0 1.0756361946973048e-11
compound O 0 4.202065084779605e-10
heterozygous O 0 1.256017512218932e-10
individuals O 0 7.879195559890029e-12
. O 0 5.050806439754751e-09

The O 0 9.60026682150783e-06
C6 O 1 1.0
/ O 1 0.9979096055030823
C7 O 1 0.9999672174453735
marker O 0 3.939856014767429e-07
haplotypes O 0 3.075689747333854e-08
associated O 0 2.6470128311473218e-09
with O 0 6.662549401070805e-10
most O 0 2.7760583165559183e-08
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999998807907104
are O 0 7.109908217728389e-10
tabulated O 0 2.633485962633131e-07
. O 0 4.5436718276725685e-10
. O 0 1.7247026029565404e-09

A O 0 1.3577425306721125e-05
genome O 0 1.724019327298265e-08
- O 0 3.908408530151064e-08
wide O 0 7.337056517897622e-10
search O 0 3.2965640633930704e-11
for O 0 3.5541420067425333e-12
chromosomal O 0 1.7850662459295563e-07
loci O 0 9.457843397342458e-09
linked O 0 4.699035685007402e-07
to O 0 3.0238773707225164e-09
mental O 1 1.0
health O 0 5.173035788175184e-06
wellness O 0 8.398456884606276e-06
in O 0 6.778291122833124e-11
relatives O 0 9.214388280165409e-11
at O 0 2.2834218960099406e-09
high O 0 1.570196275224589e-07
risk O 0 7.393984535752907e-09
for O 0 1.9254260408274604e-08
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 1.6723957330100347e-08
the O 0 7.405064117449456e-09
Old O 0 3.6512639667307667e-07
Order O 0 2.2365044927141753e-08
Amish O 0 5.006792434869567e-06
. O 0 5.400194069693498e-09

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9952422380447388
BPAD B-Disease 1 1.0
; O 1 0.9999990463256836
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 2.3431617535152327e-08
is O 0 1.7015798492447942e-11
characterized O 0 5.018012672053374e-10
by O 0 4.280611975993054e-11
episodes O 0 2.3227375578471765e-08
of O 0 1.1069351302239738e-07
mania B-Disease 0 2.0967372620361857e-05
and O 0 2.4774319484777152e-08
/ O 0 5.016160230297828e-06
or O 0 4.7305547923315316e-08
hypomania B-Disease 1 0.9999721050262451
interspersed O 0 1.1122690466436325e-06
with O 0 1.4951151428022058e-10
periods O 0 1.390602193396262e-07
of O 0 1.7429168792659766e-06
depression B-Disease 1 0.9999954700469971
. O 0 2.751236216624875e-08

Compelling O 0 3.080851058712142e-07
evidence O 0 3.190223907267864e-08
supports O 0 2.7585161932464075e-10
a O 0 1.1703702243459624e-11
significant O 0 9.956056812310266e-12
genetic O 0 2.3015933603431904e-10
component O 0 1.9861116917763155e-10
in O 0 7.581772015763377e-12
the O 0 3.445569871085574e-11
susceptibility O 0 3.054390740331314e-09
to O 0 3.483428545614231e-10
develop O 0 3.722900146385655e-05
BPAD B-Disease 1 1.0
. O 0 1.3543167654006538e-07

To O 0 6.837714838781039e-10
date O 0 4.422735511155906e-09
, O 0 1.2747258977541254e-11
however O 0 9.423378960829454e-13
, O 0 1.6793318038249572e-12
linkage O 0 9.349358787158479e-11
studies O 0 7.766173121259712e-12
have O 0 6.407224197816502e-14
attempted O 0 1.1281029582699276e-10
only O 0 3.9574349656665286e-13
to O 0 1.1855215160255783e-12
identify O 0 1.6914784850552422e-10
chromosomal O 0 3.1114288390199363e-07
loci O 0 2.064529436296425e-09
that O 0 6.234430506568689e-12
cause O 0 2.103839547018538e-09
or O 0 7.604629426172238e-11
increase O 0 4.939644613483063e-12
the O 0 2.256951570078769e-10
risk O 0 1.0199616706785264e-09
of O 0 3.879746657275973e-08
developing O 0 6.760753876733361e-06
BPAD B-Disease 1 1.0
. O 0 2.8184717848489527e-07

To O 0 1.9749275548264222e-09
determine O 0 5.60707258401294e-09
whether O 0 2.0718894655491482e-10
there O 0 1.26723518831251e-11
could O 0 1.2218116275664048e-11
be O 0 6.248490440341481e-12
protective O 0 6.05890093652306e-08
alleles O 0 5.886180865638524e-12
that O 0 5.163397921031931e-13
prevent O 0 3.7458008916857466e-10
or O 0 9.579528836844986e-11
reduce O 0 8.759209468856e-10
the O 0 1.5704965106166924e-10
risk O 0 2.2632236362785108e-10
of O 0 1.8351694608398361e-09
developing O 0 2.80331789781485e-07
BPAD B-Disease 1 1.0
, O 0 1.2976239527340283e-10
similar O 0 1.0850986775778892e-11
to O 0 3.014877193383003e-12
what O 0 1.637241774446463e-12
is O 0 3.6009616919156426e-14
observed O 0 1.7783382188704677e-12
in O 0 1.2504705387481052e-12
other O 0 1.4497041067595973e-10
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 1.893297740807043e-09
we O 0 9.934602619721122e-12
used O 0 4.002595588303848e-09
mental O 1 0.9999994039535522
health O 0 6.744704933225876e-06
wellness O 0 0.0002734034787863493
( O 0 5.032341765520698e-10
absence O 0 1.4220129074260512e-08
of O 0 1.663459414658064e-08
any O 0 4.323448266063679e-09
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 1.929725684801653e-10
as O 0 7.158865167333772e-11
the O 0 4.628623873070836e-10
phenotype O 0 3.6633732158897203e-10
in O 0 1.0374687220426893e-10
our O 0 1.2624885581402623e-09
genome O 0 4.813778264889379e-10
- O 0 3.2701411356583776e-08
wide O 0 7.985415884093072e-09
linkage O 0 4.871490322244654e-09
scan O 0 2.292045486740335e-08
of O 0 3.508374701866046e-09
several O 0 9.544566526020759e-11
large O 0 3.20565268774331e-10
multigeneration O 0 1.0856822882487904e-05
Old O 0 2.1493434587682714e-07
Order O 0 1.9287256236566463e-09
Amish O 0 4.0382059296462103e-07
pedigrees O 0 5.517050993830708e-08
exhibiting O 0 1.9889871083478283e-08
an O 0 4.330987998790725e-11
extremely O 0 5.232819955125478e-09
high O 0 1.428632117494999e-06
incidence O 0 6.1858359003963415e-06
of O 0 2.2610872747463873e-06
BPAD B-Disease 1 1.0
. O 0 2.517036818971974e-07

We O 0 6.362644189294997e-09
have O 0 9.14375779953458e-12
found O 0 2.575248000957764e-11
strong O 0 7.52126312619783e-12
evidence O 0 5.280166581744794e-11
for O 0 4.100087890729354e-12
a O 0 1.70309946700975e-11
locus O 0 8.70223615390131e-11
on O 0 3.3383795727814913e-09
chromosome O 0 1.708561647717488e-08
4p O 0 4.309057658247184e-06
at O 0 1.4679564230846154e-07
D4S2949 O 0 6.654686330875847e-07
( O 0 2.0077763063230947e-10
maximum O 0 1.7145872499568782e-09
GENEHUNTER O 1 0.9981850981712341
- O 0 2.54518198516962e-07
PLUS O 0 1.4122005609351618e-07
nonparametric O 0 1.4122248614967248e-07
linkage O 0 1.0765244695676301e-08
score O 0 3.5137521781081205e-09
= O 0 8.433241605043662e-11
4 O 0 1.702255975066791e-10
. O 0 2.543598795132218e-12
05 O 0 4.912152018476945e-09
, O 0 2.2968031990200366e-11
P O 0 6.8722614265936954e-09
= O 0 8.111174926161979e-11
5 O 0 6.089363041583695e-11
. O 0 9.558201669382371e-13
22 O 0 6.685688808127921e-11
x O 0 9.46866474116348e-11
10 O 0 1.7683383923827733e-10
( O 0 1.0017315969779172e-11
- O 0 1.7841677024676983e-09
4 O 0 9.740360740195797e-10
) O 0 1.6444713429528135e-12
; O 0 7.998818621346437e-12
SIBPAL O 0 5.243310806690715e-05
Pempirical O 0 2.571846096088848e-07
value O 0 9.046754317898476e-11
< O 0 2.9804608780992226e-10
3 O 0 3.3165897805886857e-10
x O 0 2.2682540568030873e-10
10 O 0 2.51836385078974e-10
( O 0 9.703801998051098e-12
- O 0 8.095846215638858e-10
5 O 0 1.9439780341024004e-10
) O 0 5.403573096786352e-13
) O 0 2.1631085594595034e-13
and O 0 4.118773898331707e-12
suggestive O 0 2.5836783823507403e-09
evidence O 0 1.5520397467216895e-10
for O 0 3.984369691817369e-12
a O 0 2.1291605631357235e-11
locus O 0 1.5869736080809105e-10
on O 0 8.513476146276844e-09
chromosome O 0 1.3989794922508736e-07
4q O 0 1.5330082533182576e-05
at O 0 1.2517143943568954e-07
D4S397 O 0 2.375698642254065e-07
( O 0 1.9517951144187862e-10
maximum O 0 2.09066719492057e-09
GENEHUNTER O 1 0.9284149408340454
- O 0 8.515883820336967e-08
PLUS O 0 6.786903128386257e-08
nonparametric O 0 1.69768590296826e-08
linkage O 0 2.8884654668104304e-09
score O 0 3.8269579172300894e-10
= O 0 2.0273354175981417e-11
3 O 0 5.020853177661877e-11
. O 0 1.9320586797100248e-12
29 O 0 7.877279939449977e-10
, O 0 2.7698923016350463e-11
P O 0 8.10587863497858e-09
= O 0 8.488740266265893e-11
2 O 0 1.1720194259545735e-10
. O 0 1.3874381244588507e-12
57 O 0 3.912990070853439e-11
x O 0 3.349652846762474e-11
10 O 0 1.2345416355863392e-10
( O 0 9.754108111492688e-12
- O 0 1.4807697290564192e-09
3 O 0 7.098255316861923e-10
) O 0 2.1621942517674464e-12
; O 0 6.255167391000516e-12
SIBPAL O 0 6.07433175900951e-05
Pempirical O 0 1.0010343487465434e-07
value O 0 5.480638165522578e-11
< O 0 1.849773806350541e-10
1 O 0 2.1396405480711422e-10
x O 0 1.8427941117504787e-10
10 O 0 5.842263339772558e-10
( O 0 1.5866580618806303e-11
- O 0 1.4364766043328814e-09
3 O 0 5.11603703845509e-10
) O 0 5.945756040293126e-13
) O 0 4.795605102261846e-14
that O 0 5.894688203674598e-15
are O 0 2.3709300581847836e-13
linked O 0 1.2264107063231222e-08
to O 0 1.2053783526866368e-09
mental O 1 1.0
health O 0 0.0003039234725292772
wellness O 0 0.1819668412208557
. O 0 2.4917243379718457e-08

These O 0 3.1726852256497295e-09
findings O 0 4.6494990080248044e-09
are O 0 1.0313362143465898e-11
consistent O 0 4.292714794740249e-10
with O 0 9.652590142114614e-13
the O 0 9.623163377270316e-12
hypothesis O 0 5.284325060861406e-12
that O 0 4.9203703448869734e-15
certain O 0 8.20851687403229e-13
alleles O 0 2.941714146581509e-12
could O 0 1.0905013871076452e-11
prevent O 0 1.1380013598127903e-09
or O 0 1.1217284046072251e-10
modify O 0 1.3566450185464873e-09
the O 0 1.3859054182052688e-10
clinical O 0 2.0465973804562054e-08
manifestations O 0 1.985534026971436e-06
of O 0 1.5235505088639911e-06
BPAD B-Disease 1 1.0
and O 0 1.1882533845763987e-09
perhaps O 0 2.037538714139142e-11
other O 0 8.835732492884496e-12
related O 0 6.772077176719904e-05
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 7.551823273388436e-07

Segregation O 0 0.0018420919077470899
distortion O 0 0.0032980339601635933
in O 0 2.223529008915648e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 9.923692232405301e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999727010726929
DM B-Disease 1 1.0
) O 0 2.3932443582452834e-08
is O 0 2.334112243762565e-11
an O 0 9.393361088960717e-12
autosomal B-Disease 1 0.9999961853027344
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999995231628418
which O 0 6.048132134006678e-11
, O 0 3.679187596944411e-12
in O 0 3.0795752233025997e-12
the O 0 3.660591274545766e-11
typical O 0 7.259243761659206e-10
pedigree O 0 1.4364766043328814e-09
, O 0 2.7096425797568102e-11
shows O 0 6.885926551181143e-11
a O 0 5.335604874590061e-11
three O 0 9.286763719140723e-11
generation O 0 1.2773174518088126e-08
anticipation O 0 6.516061148431618e-07
cascade O 0 0.0019142949022352695
. O 0 1.8971761051034264e-07

This O 0 2.808205612492287e-10
results O 0 8.28674351360803e-10
in O 0 2.0858794691491767e-09
infertility B-Disease 1 0.9377960562705994
and O 1 0.7892692685127258
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.00015598353638779372
CDM B-Disease 1 0.9999889135360718
) O 0 7.113797745317285e-11
with O 0 5.183926204965772e-12
the O 0 7.668221613243986e-11
disappearance O 0 2.1695838459123706e-09
of O 0 4.70185952394786e-08
DM B-Disease 1 1.0
in O 0 1.0187004129136312e-08
that O 0 1.1054587106817948e-10
pedigree O 0 1.361823507295412e-07
. O 0 4.447843426902409e-09

The O 0 6.215348236082718e-09
concept O 0 2.4369335438478856e-09
of O 0 5.263962599144634e-09
segregation O 0 2.9362891496020893e-07
distortion O 0 1.340549289352566e-07
, O 0 7.728330995993016e-12
where O 0 1.0481864941985775e-12
there O 0 8.737115712994722e-14
is O 0 2.937629184503708e-14
preferential O 0 1.4083257997288268e-11
transmission O 0 6.392125717624708e-10
of O 0 1.6899627530708727e-10
the O 0 2.964194167898171e-11
larger O 0 3.426380706939014e-11
allele O 0 3.5309612872458374e-11
at O 0 1.767031188038004e-09
the O 0 3.1885616369464742e-09
DM B-Disease 1 1.0
locus O 0 1.1488607398746353e-08
, O 0 9.452279930988183e-11
has O 0 2.0806709220139163e-12
been O 0 7.400378920774386e-12
put O 0 5.766139649088231e-11
forward O 0 2.56382026719848e-10
to O 0 9.334743047983984e-12
explain O 0 1.6075313302721383e-10
partially O 0 9.894395525122945e-09
the O 0 1.9838097831126333e-10
maintenance O 0 8.639632369522587e-07
of O 0 1.377819813797032e-07
DM B-Disease 1 1.0
in O 0 6.495921023308426e-10
the O 0 1.2207429511690293e-10
population O 0 8.259211457112281e-13
. O 0 3.5495235223281796e-11

In O 0 2.0052182136964802e-08
a O 0 3.644187174245417e-10
survey O 0 2.376765173561779e-10
of O 0 6.634881977163332e-09
DM B-Disease 1 1.0
in O 0 1.6837347072140574e-09
Northern O 0 3.902464129623695e-08
Ireland O 0 2.1052656506981293e-08
, O 0 7.719332811850776e-11
59 O 0 1.6419570147974127e-09
pedigrees O 0 1.931561399715065e-08
were O 0 1.1355665296974848e-09
ascertained O 0 3.7013606402069854e-07
. O 0 1.847670638710497e-08

Sibships O 0 0.00011090753832831979
where O 0 2.5875941389585932e-09
the O 0 5.2592402655093906e-11
status O 0 4.0951193824856347e-11
of O 0 2.8352661884945007e-10
all O 0 2.667321875524098e-12
the O 0 2.7448217310155343e-11
members O 0 1.3299110077080734e-12
had O 0 1.8470537599402093e-12
been O 0 1.190324965330558e-12
identified O 0 3.1195512752851817e-12
were O 0 4.4997347861674974e-12
examined O 0 4.669190589723371e-10
to O 0 4.496114418273134e-12
determine O 0 1.1702458446727348e-10
the O 0 1.5845358358745898e-10
transmission O 0 1.4534987435865787e-08
of O 0 6.164910359984788e-09
the O 0 1.8384873623489284e-09
DM B-Disease 1 1.0
expansion O 0 1.1374421404752866e-08
from O 0 3.809290660683473e-10
affected O 0 2.2012280886940516e-10
parents O 0 6.120426214450969e-12
to O 0 1.1726851260884796e-11
their O 0 3.735698139717414e-10
offspring O 0 1.4809060644438432e-08
. O 0 2.1166026709096286e-09

Where O 0 1.2826787632036485e-08
the O 0 2.015159150658974e-09
transmitting O 0 1.0825915524037555e-06
parent O 0 9.131902345416165e-09
was O 0 1.696184170896231e-08
male O 0 1.7543705377320862e-09
, O 0 3.6864689079152413e-10
58 O 0 1.8643227406300866e-08
. O 0 3.239861490200724e-09

3 O 0 5.982525408398942e-08
% O 0 2.7486094997253296e-11
of O 0 8.087029657044553e-11
the O 0 1.2988565084581793e-11
offspring O 0 5.700375241279865e-11
were O 0 2.232729105766662e-11
affected O 0 1.776299385358726e-10
, O 0 1.0550085978444645e-11
and O 0 9.361595700030367e-12
in O 0 7.826353280726561e-12
the O 0 1.5188038327007547e-11
case O 0 1.1768057014971411e-11
of O 0 1.9035657772281667e-10
a O 0 1.205970392992306e-11
female O 0 6.858007911558772e-11
transmitting O 0 2.2383488840205246e-07
parent O 0 2.7951911008017305e-08
, O 0 6.129162066770277e-09
68 O 0 1.3204928563936846e-06
. O 0 1.9126954242665306e-08

7 O 0 1.1513217259562225e-06
% O 0 3.068017229157505e-10
were O 0 3.8663569568164746e-10
affected O 0 9.736353945299925e-09
. O 0 6.335034274940199e-09

Studies O 0 3.8244660771624694e-08
on O 0 1.8407057211788924e-08
meiotic O 0 1.3394916322795325e-06
drive O 0 1.247067071830088e-08
in O 0 6.860013668230636e-10
DM B-Disease 1 1.0
have O 0 1.0291157682973395e-11
shown O 0 4.068204106921769e-12
increased O 0 1.8605180330394377e-12
transmission O 0 8.35894020667638e-10
of O 0 5.298497751660136e-11
the O 0 5.006009929503508e-12
larger O 0 5.068440025318699e-12
allele O 0 1.5486622401139627e-11
at O 0 7.84408538123671e-10
the O 0 8.400111717321579e-10
DM B-Disease 1 1.0
locus O 0 4.766072869699656e-09
in O 0 3.035618145741381e-10
non O 0 4.54664677818073e-06
- O 0 0.00012056659761583433
DM O 1 1.0
heterozygotes O 0 1.4892871149640996e-06
for O 0 3.959043759493852e-09
CTGn O 0 0.0005335552850738168
. O 0 4.976175560500451e-08

This O 0 3.6013672599644053e-10
study O 0 1.814175754066838e-10
provides O 0 2.94887118196252e-12
further O 0 2.592387025532328e-12
evidence O 0 1.0087245622125707e-10
that O 0 6.007174467061172e-13
the O 0 2.3089978540280498e-10
DM B-Disease 1 1.0
expansion O 0 2.2351441586465626e-08
tends O 0 7.145527503027438e-10
to O 0 9.938374775919634e-12
be O 0 1.8030155493620192e-11
transmitted O 0 2.528252096567485e-08
preferentially O 0 1.5251025331508572e-08
. O 0 3.529389225320756e-09

Diagnosis O 1 0.9999991655349731
of O 1 0.9997143149375916
hemochromatosis B-Disease 1 1.0
. O 0 3.494003522064304e-06

If O 0 7.693560633015295e-07
untreated O 1 1.0
, O 0 1.5881760191405192e-05
hemochromatosis B-Disease 1 1.0
can O 0 5.574274268838053e-07
cause O 1 0.9999934434890747
serious O 1 1.0
illness O 1 1.0
and O 0 2.870625126494275e-10
early B-Disease 0 4.082987725695375e-09
death I-Disease 0 1.06776401054276e-08
, O 0 2.6500145394042773e-12
but O 0 7.456155376277251e-13
the O 0 4.816147480823929e-10
disease O 0 3.384904994163662e-05
is O 0 1.7489453895541685e-12
still O 0 6.610946165497289e-12
substantially O 0 4.3845255204288947e-10
under O 0 1.105162596104492e-06
- O 1 0.9999973773956299
diagnosed O 0 0.07964733242988586
. O 0 4.1508152470726145e-09

The O 0 8.538084017573055e-08
cornerstone O 0 3.438437852310017e-05
of O 0 2.8046059696862358e-08
screening O 0 1.0835196073699649e-09
and O 0 1.10693936655748e-11
case O 0 2.1071497411512263e-12
detection O 0 2.8953162090061824e-09
is O 0 1.6263290085298532e-13
the O 0 6.382564832554949e-13
measurement O 0 2.1540953742960056e-10
of O 0 4.262787067776941e-10
serum O 0 3.93271498699832e-10
transferrin O 0 1.1789659248861994e-09
saturation O 0 4.409693998841391e-10
and O 0 8.521541805528443e-11
the O 0 2.3934154658178386e-10
serum O 0 1.751108591463435e-08
ferritin O 0 5.404147600529541e-07
level O 0 8.363382164588984e-08
. O 0 1.3627915462777196e-09

Once O 0 9.646006304819821e-08
the O 0 2.785003783145612e-09
diagnosis O 0 3.0345820505317533e-06
is O 0 1.3574227679391537e-11
suspected O 0 1.0147695128637224e-08
, O 0 4.335045517001035e-11
physicians O 0 2.655533570816715e-09
must O 0 2.1830974528125324e-11
use O 0 1.3211752802888554e-09
serum O 0 1.246969958401678e-07
ferritin O 0 3.160959067827207e-06
levels O 0 1.0887453072427888e-07
and O 0 1.821455342110312e-08
hepatic O 0 0.0940675362944603
iron O 0 0.4228883683681488
stores O 0 1.495365324899467e-07
on O 0 1.5101841199793853e-07
liver O 0 6.925715297256829e-06
biopsy O 0 1.602960963964506e-07
specimens O 0 3.798322989467806e-09
to O 0 2.6894280205636e-11
assess O 0 1.4532048453475e-08
patients O 0 2.2076190875353063e-10
for O 0 1.885806615031793e-11
the O 0 2.9815638846741876e-10
presence O 0 1.9890393776478277e-09
of O 0 9.194419590130565e-07
iron B-Disease 1 0.999996542930603
overload I-Disease 0 0.025335000827908516
. O 0 2.3500993151515104e-08

Liver O 1 0.999970555305481
biopsy O 0 0.004039924591779709
is O 0 4.71140626512323e-10
also O 0 1.0366532285366326e-11
used O 0 2.0913749898543443e-11
to O 0 5.3376591341303126e-12
establish O 0 2.5712001971989196e-10
the O 0 5.636360822514064e-11
presence O 0 2.855660326261944e-11
or O 0 4.4027160389648046e-11
absence O 0 1.0155924989874165e-08
of O 0 1.6227672006152716e-07
cirrhosis B-Disease 1 1.0
, O 0 1.1118659465347847e-10
which O 0 3.54830314436283e-12
can O 0 4.003368383326267e-12
affect O 0 3.376668500365554e-09
prognosis O 0 1.924007392517524e-06
and O 0 1.5374100215126418e-08
management O 0 4.6903060137992725e-06
. O 0 1.303952057440938e-08

A O 0 4.035459369333694e-06
DNA O 0 8.061029461714497e-07
- O 0 1.0806307848554297e-08
based O 0 1.9664128658725133e-10
test O 0 1.503471236397047e-10
for O 0 6.337921723900686e-13
the O 0 2.2141542072029452e-11
HFE O 0 0.012218879535794258
gene O 0 1.2618284195298202e-10
is O 0 7.494992040196768e-14
commercially O 0 5.1991185662236816e-11
available O 0 4.071953711715093e-12
, O 0 4.988545384068677e-13
but O 0 3.296131474857765e-14
its O 0 3.297793353500278e-13
place O 0 3.961061947194144e-12
in O 0 4.5415160889773765e-13
the O 0 2.8783527211001525e-12
diagnosis O 0 1.4654736446573224e-07
of O 0 6.23267126798055e-08
hemochromatosis B-Disease 1 1.0
is O 0 2.5322455243781405e-10
still O 0 1.449986103407852e-10
being O 0 1.7946377717237283e-10
evaluated O 0 4.10108143000798e-08
. O 0 7.9940418729052e-09

Currently O 0 1.7971458987631195e-07
, O 0 1.42759887244992e-10
the O 0 2.3264362658537152e-11
most O 0 7.788791855402322e-13
useful O 0 5.903878948221308e-12
role O 0 7.914062634395425e-12
for O 0 4.0681788992212586e-13
this O 0 6.549716145961768e-14
test O 0 4.194072172891694e-11
is O 0 4.196465833790526e-14
in O 0 4.678249432808756e-13
the O 0 3.1525090697648306e-12
detection O 0 6.554209619480389e-08
of O 0 4.47446204532298e-08
hemochromatosis B-Disease 1 1.0
in O 0 5.17630383001233e-10
the O 0 3.862546393840205e-10
family O 0 1.8679646371366765e-11
members O 0 7.365595980357575e-12
of O 0 5.503238309501057e-09
patients O 0 6.744017566617799e-10
with O 0 3.6427052346743594e-11
a O 0 9.604360640125265e-10
proven O 0 1.3786070951482543e-07
case O 0 7.722532613385624e-10
of O 0 9.704060488502364e-08
the O 0 5.049812443758128e-07
disease O 0 0.13623245060443878
. O 0 6.99708957441203e-10

It O 0 3.2979885489226035e-09
is O 0 7.13337722224594e-11
crucial O 0 5.981872330806937e-09
to O 0 4.528861285990615e-09
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 0.00020637422858271748
because O 0 1.6286083592831346e-08
phlebotomy O 1 1.0
therapy O 1 0.9999938011169434
can O 0 9.580141124843067e-09
avert O 1 1.0
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 2.8408218000208763e-09
can O 0 1.3613404674372998e-11
even O 0 3.2342708372601336e-11
lead O 0 7.634892162933227e-10
to O 0 1.8990826272657912e-11
normal O 0 4.660100305642345e-09
life O 0 6.484939807371859e-10
expectancy O 0 1.0525293969720906e-09
. O 0 1.6672559166597267e-11
. O 0 4.909695983101869e-10

Prevalence O 0 3.1615711577615002e-06
of O 0 3.714769292173514e-08
the O 0 1.256377557545818e-09
I1307K O 0 9.187091905005218e-07
APC B-Disease 0 3.2303580610459903e-07
gene O 0 3.570030382427092e-10
variant O 0 4.1691974872470894e-10
in O 0 1.7641120769046337e-12
Israeli O 0 8.413159752196364e-11
Jews O 0 6.302487698395254e-11
of O 0 3.9092451498135006e-11
differing O 0 3.518495174034686e-12
ethnic O 0 9.241585497083218e-14
origin O 0 7.663505789158587e-13
and O 0 8.15315870372757e-12
risk O 0 2.2434460955622626e-09
for O 0 8.472204058307398e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.31839026759917e-08

BACKGROUND O 0 0.0017026971327140927
& O 0 5.930816405452788e-05
AIMS O 0 2.1436834174437536e-07
Israeli O 0 2.0699311154004363e-09
Jews O 0 3.932069947421013e-10
of O 0 1.4021785954554389e-09
European O 0 1.1085377060737756e-09
birth O 0 1.1546750044999499e-07
, O 0 1.4997278419137672e-10
i O 0 7.481933822495179e-11
. O 0 1.470073845641351e-12
e O 0 1.6255677359744425e-11
. O 0 1.288649742470227e-12
, O 0 4.235761481147238e-12
Ashkenazim O 0 4.3343661104700004e-08
, O 0 3.6116977464306643e-11
have O 0 8.269773212575549e-13
the O 0 1.675986571747501e-10
highest O 1 0.9999935626983643
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 3.1392255550599657e-07
of O 0 5.906430344815305e-10
any O 0 1.741061461668636e-11
Israeli O 0 1.3974589485599154e-08
ethnic O 0 4.5888559618845193e-10
group O 0 2.0013082302483554e-09
. O 0 2.1314423559459783e-09

The O 0 5.103353259983123e-07
I1307K O 0 8.536488167010248e-06
APC B-Disease 0 1.396854713675566e-06
gene O 0 2.0059822691820273e-09
variant O 0 1.4070364429130677e-08
was O 0 2.922480479838896e-09
found O 0 1.089115464480983e-10
in O 0 3.065794007550693e-10
6 O 0 1.5282232368463156e-07
. O 0 2.672178922580315e-09

1 O 0 1.890350631583715e-08
% O 0 5.907889195216898e-12
of O 0 3.797927944360069e-11
American O 0 1.3298888032475809e-11
Jews O 0 6.401371099862274e-11
, O 0 2.282417093865674e-12
28 O 0 5.280751183556198e-11
% O 0 1.4830816425209087e-13
of O 0 1.7657559442385562e-11
their O 0 3.3055207460108704e-09
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 8.052882805031913e-09
, O 0 1.385820191240894e-11
but O 0 3.35613400135118e-13
not O 0 1.7528884702251724e-13
in O 0 7.557919567968696e-12
non O 0 4.488540028546595e-08
- O 0 1.4819120153219956e-08
Jews O 0 5.059446195332384e-09
. O 0 1.7050318934508368e-09

We O 0 7.882258401537001e-09
assessed O 0 1.083095000353751e-07
the O 0 6.1975207188424974e-09
I1307K O 0 3.075432175592141e-07
prevalence O 0 1.4727198349717696e-09
in O 0 5.824485316795192e-13
Israeli O 0 9.55286631049157e-12
Jews O 0 1.743523901642785e-11
of O 0 7.958520994999496e-12
differing O 0 3.660559539948177e-13
ethnic O 0 4.211283828169793e-14
origin O 0 6.704684008505823e-13
and O 0 4.330258807777598e-12
risk O 0 3.561904104998348e-09
for O 0 4.6368285211428883e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.2888692658161744e-08

METHODS O 0 2.5872952846839326e-06
DNA O 0 1.8681140545595554e-07
samples O 0 1.582470821048787e-09
from O 0 2.552021961810258e-11
500 O 0 1.7383041187035708e-11
unrelated O 0 6.547952458024753e-11
Jews O 0 6.489168924428412e-11
of O 0 5.312972284343687e-10
European O 0 1.2127209236822978e-09
or O 0 2.644271190899161e-10
non O 0 1.3058527770226647e-07
- O 0 3.4459608500014838e-09
European O 0 2.4696812303548477e-11
origin O 0 2.4208681934090315e-12
, O 0 4.0826448667076465e-13
with O 0 1.33196649239678e-13
or O 0 9.86157856763814e-12
without O 0 2.6278189693695886e-11
a O 0 1.6702670496693273e-11
personal O 0 2.9040200799634874e-10
and O 0 2.0724162386187572e-09
/ O 0 1.9650052252018213e-08
or O 0 3.81286530126701e-11
family O 0 7.045414165268715e-12
history O 0 1.8503780729872688e-09
of O 0 6.5612866251285595e-09
neoplasia B-Disease 0 0.0007021814817562699
, O 0 2.367295803828995e-10
were O 0 7.816928354609232e-11
examined O 0 5.102941624812729e-09
for O 0 3.5524427149935534e-11
the O 0 2.143381999664129e-10
I1307K O 0 3.2317352349764406e-08
variant O 0 6.728649859510938e-10
by O 0 9.156707510282747e-12
the O 0 4.7433054012335774e-11
allele O 0 1.4762562700054715e-11
- O 0 8.102458703973525e-10
specific O 0 6.52187678862326e-11
oligonucleotide O 0 1.6319518181262538e-07
( O 0 4.266791364671008e-09
ASO O 0 0.4293365478515625
) O 0 6.47737211090238e-11
method O 0 7.330761553347998e-10
. O 0 2.5342650200599337e-10

RESULTS O 0 2.164085799449822e-06
In O 0 5.647857181934057e-10
persons O 0 1.6131819838283157e-11
at O 0 4.704330813787294e-10
average O 0 6.04289673855618e-11
risk O 0 1.8128691881003078e-09
for O 0 1.5263458408298902e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.436739616167415e-09
I1307K O 0 4.3523591841676534e-08
was O 0 6.553678155718501e-10
found O 0 2.4633396017437192e-11
in O 0 3.1303831055096154e-11
5 O 0 3.5422094146753125e-09
. O 0 6.432425148084064e-10

0 O 0 1.9667675488221903e-08
% O 0 1.0015940334062723e-11
of O 0 4.2645820902409426e-11
120 O 0 2.8211225022722886e-10
European O 0 1.2929157744423492e-09
and O 0 4.06508471328948e-09
1 O 0 4.8688544751485097e-08
. O 0 2.049166614170872e-09

6 O 0 5.411620804807171e-07
% O 0 6.364191118546358e-11
of O 0 4.903369377196043e-10
188 O 0 1.3528620446123796e-09
non O 0 9.882536033956058e-08
- O 0 1.8524941580722043e-08
European O 0 7.319752026724302e-10
Jews O 0 1.8183025085605209e-09
( O 0 1.5894273397432102e-10
P O 0 7.494170972677239e-08
= O 0 3.2886024459166663e-10
0 O 0 1.1893368234705548e-10
. O 0 2.211747061539593e-12
08 O 0 1.2381360381397144e-09
) O 0 1.187835333565923e-11
. O 0 9.5981292358438e-11

It O 0 2.3885551314606346e-09
occurred O 0 1.136611516017183e-08
in O 0 3.304409523785523e-10
15 O 0 4.218030813518681e-09
. O 0 8.297862952311164e-10

4 O 0 1.0791625015826867e-07
% O 0 4.2255154236725545e-11
of O 0 2.8183147482430115e-10
52 O 0 2.0524981714231672e-10
Ashkenazi O 0 2.754206418487115e-09
Israelis O 0 1.9039433918344173e-10
with O 0 5.106619571648707e-10
familial O 1 0.9602394700050354
cancer B-Disease 1 0.9988986253738403
( O 0 5.519974255463467e-09
P O 0 1.546185899314878e-06
= O 0 5.378030243363696e-10
0 O 0 5.802868602300393e-11
. O 0 1.1719646520608196e-12
02 O 0 8.927251160528726e-10
) O 0 1.566822978868801e-13
and O 0 1.670138636764018e-12
was O 0 1.2365966584049204e-10
not O 0 7.929304456956443e-13
detected O 0 7.384932665388533e-10
in O 0 4.187254015741715e-11
51 O 0 6.209704417337036e-10
non O 0 1.7765957593951498e-08
- O 0 4.1701619934997325e-09
European O 0 2.6142624176550555e-10
Jews O 0 3.3536051713412007e-10
at O 0 2.809439125783797e-09
increased O 0 8.025830000590872e-10
cancer B-Disease 0 6.023974037816515e-06
risk O 0 7.383978317676565e-09
. O 0 2.7545898895198206e-09

Colorectal B-Disease 1 0.9999998807907104
neoplasia I-Disease 1 0.9998985528945923
occurred O 0 1.928026222230983e-06
personally O 0 1.5190378732654608e-08
or O 0 1.0508198478031971e-10
in O 0 4.2926145277233374e-11
the O 0 2.7791850418235065e-11
families O 0 4.0992255705314673e-13
of O 0 2.8911539828868627e-10
13 O 0 7.334006180137465e-10
of O 0 1.4086710686811443e-09
20 O 0 1.7902694882110382e-09
Ashkenazi O 0 1.2581958586110886e-08
I1307K O 0 1.4847574902887573e-07
carriers O 0 6.395126095348758e-10
, O 0 1.427686024957353e-10
8 O 0 1.5188372781693715e-09
of O 0 8.958722097496263e-10
whom O 0 6.240858524408921e-11
also O 0 1.565474312681392e-11
had O 0 1.9700008985212847e-11
a O 0 1.519719593223723e-11
personal O 0 4.1872638689710584e-10
or O 0 2.827225398238653e-10
family O 0 3.4728983577814176e-11
history O 0 1.650696823674025e-08
of O 0 8.972941145657387e-08
noncolonic O 0 0.0012325799325481057
neoplasia B-Disease 1 0.9840906262397766
. O 0 2.3738280674479029e-07

CONCLUSIONS O 0 5.2492796385195106e-05
The O 0 3.3994112413893163e-07
I1307K O 0 9.67633786785882e-06
APC O 0 2.963042334158672e-06
variant O 0 2.5869204023365455e-07
may O 0 4.722292556991192e-10
represent O 0 5.4889971040639196e-11
a O 0 1.0516018611461675e-10
susceptibility O 0 2.2497376406249714e-08
gene O 0 1.387752468495762e-09
for O 0 1.9716981380923926e-09
colorectal B-Disease 1 1.0
, I-Disease 0 5.718073792237988e-10
or I-Disease 0 8.820985608615217e-11
other I-Disease 0 2.0015668289463662e-10
, I-Disease 0 8.65347904444036e-10
cancers I-Disease 0 1.7121559721999802e-05
in O 0 5.3149661755069744e-11
Ashkenazi O 0 8.034549026092463e-09
Jews O 0 2.2663739773776115e-09
, O 0 4.0407707735390375e-10
and O 0 3.761924938228134e-10
partially O 0 1.9946902796164068e-07
explains O 0 2.408582777668755e-10
the O 0 6.532135249370796e-11
higher O 0 2.3721016262356898e-09
incidence O 0 3.014785932009545e-07
of O 0 3.0483210139209405e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 4.2685638357298217e-10
European O 0 3.366719569797283e-09
Israelis O 0 2.96852542547299e-09
. O 0 3.752825605829457e-09

Systematic O 0 1.8131432355517063e-08
analysis O 0 3.4966705086958427e-09
of O 0 1.3540916832255334e-08
coproporphyrinogen O 0 1.2997642443224322e-05
oxidase O 0 1.1582886827454786e-06
gene O 0 3.456083561559353e-07
defects O 0 3.773077696678229e-05
in O 0 1.0026583119326915e-08
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999969005584717
and O 0 1.4676693638193683e-07
mutation O 0 9.453786198321268e-09
update O 0 1.7270248520162568e-07
. O 0 1.1854289994062128e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 4.0293511119671166e-05
HC B-Disease 1 1.0
) O 0 4.472721215620368e-08
is O 0 3.1977490100310035e-11
an O 0 1.297747742601274e-10
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 3.6912824725732207e-06
autosomal O 1 1.0
dominant O 1 0.9983982443809509
inheritance O 0 3.6960977922717575e-07
caused O 0 2.571291872754955e-07
by O 0 1.6297098393014409e-10
deficient B-Disease 0 1.585287101590893e-08
activity I-Disease 0 9.777364473606553e-10
of I-Disease 0 8.459235090185757e-09
coproporphyrinogen I-Disease 0 3.550244582584128e-05
III I-Disease 1 1.0
oxidase I-Disease 0 8.244144282798516e-07
( O 0 1.7769551163837605e-08
CPO O 1 0.9947032332420349
) O 0 1.8069211682458786e-09
. O 0 1.6297481142402148e-09

Clinical O 0 4.214491855236702e-05
manifestations O 0 0.10695911198854446
of O 0 3.255949923186563e-05
the O 0 3.833363007288426e-05
disease O 1 1.0
are O 0 2.5535641309804014e-12
characterized O 0 2.624885031554669e-10
by O 0 1.3988781487339619e-11
acute O 0 1.375569172523683e-05
attacks O 0 5.10045028434547e-09
of O 1 0.9179984331130981
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 1.7328709134289966e-08
precipitated O 0 1.3696142886487905e-08
by O 0 8.657669026135295e-11
drugs O 0 5.1939725409511084e-08
, O 0 8.02859723147975e-11
fasting O 0 6.089972970357849e-09
, O 0 6.91959198273473e-11
cyclical O 0 1.5501368579862174e-06
hormonal O 0 6.217749614734203e-06
changes O 0 3.256272806950733e-09
, O 0 1.8211695484993129e-09
or O 0 7.083740911184577e-06
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 2.5139414105979085e-08

Skin O 1 1.0
photosensitivity O 1 0.9999998807907104
may O 0 6.337157856250997e-07
also O 0 1.0559074725691175e-09
be O 0 2.8671325730256214e-11
present O 0 1.8043658789324013e-09
. O 0 1.8306701710102402e-09

The O 0 1.7032816401751916e-07
seven O 0 1.994956022599581e-08
exons O 0 1.01698036658604e-08
, O 0 5.125058710753194e-11
the O 0 6.411784991833258e-10
exon O 0 9.695587266378425e-08
/ O 0 3.381226321153008e-08
intron O 0 3.269935788807743e-08
boundaries O 0 2.1965904650755874e-09
and O 0 6.17188106177835e-11
part O 0 5.829540183910353e-10
of O 0 8.09080358266101e-09
3 O 0 4.10352862800778e-09
noncoding O 0 9.533622780111273e-09
sequence O 0 2.7857022244504037e-11
of O 0 1.5359195859598884e-10
the O 0 2.482291594496644e-10
CPO O 0 0.07975441217422485
gene O 0 2.0319317062256204e-10
were O 0 2.2906433694291906e-11
systematically O 0 2.545222643757228e-10
analyzed O 0 2.3168768292780584e-10
by O 0 5.0927144445989114e-12
an O 0 1.0898401972547767e-11
exon O 0 6.571781785424946e-09
- O 0 7.545183144941348e-09
by O 0 6.207289127146964e-10
- O 0 2.464537658397603e-07
exon O 0 2.5194839281539316e-07
denaturing O 0 2.3385130134556675e-06
gradient O 0 1.1975783031914489e-08
gel O 0 1.5834137556680616e-08
electrophoresis O 0 4.636914407996073e-09
( O 0 3.716197349845629e-10
DGGE O 1 0.9999960660934448
) O 0 2.421165004595771e-11
strategy O 0 1.6068622127329846e-11
followed O 0 2.7354390454148447e-12
by O 0 3.281421900695747e-14
direct O 0 9.011647222716135e-13
sequencing O 0 7.189982637045844e-11
in O 0 1.6404684902160405e-11
seven O 0 1.793666049021425e-10
unrelated O 0 1.456907128272178e-08
heterozygous O 0 2.506902774257469e-08
HC B-Disease 1 1.0
patients O 0 5.881745757108092e-09
from O 0 7.192098583352902e-10
France O 0 5.184273277336615e-08
, O 0 2.0952568846599462e-10
Holland O 0 4.3799161630886374e-07
, O 0 5.0148621366652435e-11
and O 0 7.058263001846754e-11
Czech O 0 3.4974905247509014e-06
Republic O 0 4.234366770106135e-06
. O 0 6.900807392185015e-08

Seven O 0 1.2657278603001032e-07
novel O 0 2.447041014264073e-09
mutations O 0 3.277518811906077e-10
and O 0 1.0683068318861899e-10
two O 0 1.975215477290071e-11
new O 0 2.1829735241674086e-10
polymorphisms O 0 2.2201582794423302e-08
were O 0 1.422158613095803e-09
detected O 0 1.6087084020455222e-07
. O 0 2.7438982197480755e-09

Among O 0 7.3311285930799386e-09
these O 0 1.0418749890606094e-10
mutations O 0 1.2838327623221346e-10
two O 0 5.674221509321953e-11
are O 0 8.533752697548191e-12
missense O 0 1.7337272950612714e-08
( O 0 9.31549060112502e-10
G197W O 0 5.580029096563521e-07
, O 0 1.157334117429798e-09
W427R O 0 7.800110068956201e-08
) O 0 2.2793726975334216e-11
, O 0 9.770326908631333e-12
two O 0 3.1273139459997434e-12
are O 0 4.284685453659343e-12
nonsense O 0 5.027722593808903e-08
( O 0 4.364442418580694e-10
Q306X O 0 3.861136406158039e-07
, O 0 1.6105204669880635e-10
Q385X O 0 6.967862731244168e-08
) O 0 1.930181188491975e-11
, O 0 2.246594186725015e-12
two O 0 9.564348011498192e-13
are O 0 2.7731880377149243e-13
small O 0 3.260700390250726e-11
deletions O 0 4.9807025170878205e-09
( O 0 1.8304466831153832e-09
662de14bp O 0 4.3549422912292357e-07
; O 0 7.680843183699437e-10
1168del3bp O 0 1.150144157691102e-06
removing O 0 7.792436917952728e-08
a O 0 5.476983311325512e-10
glycine O 0 2.2717115299997204e-08
at O 0 5.219671361800238e-09
position O 0 6.877385327896945e-10
390 O 0 1.8827035486168597e-09
) O 0 5.1709504733654654e-12
, O 0 4.189960010891891e-12
and O 0 1.0774184495965233e-11
one O 0 3.997119475684929e-12
is O 0 4.942856562419051e-13
a O 0 4.68626266264538e-12
splicing O 0 2.750332406264988e-09
mutation O 0 2.3303367568949795e-10
( O 0 9.85039827483547e-11
IVS1 O 1 0.5928633809089661
- O 0 7.20051858138504e-08
15c O 0 9.494556252320763e-08
- O 0 5.479465414737206e-08
- O 0 1.4523652502873574e-08
> O 0 1.5305394729381305e-09
g O 0 1.3184842106994665e-09
) O 0 5.965672400520816e-12
which O 0 1.0006082334229616e-12
creates O 0 2.2110986652723597e-11
a O 0 4.3102678544404416e-12
new O 0 1.5541956610576335e-11
acceptor O 0 3.130030609699297e-11
splice O 0 3.033202631286258e-07
site O 0 5.164800498391742e-08
. O 0 4.042491674738358e-09

The O 0 3.3088969786376765e-08
pathological O 0 2.0719198801089078e-07
significance O 0 1.642092506415338e-08
of O 0 3.6890540400236205e-08
the O 0 1.1704496261089048e-09
point O 0 5.933721847206641e-10
mutations O 0 9.435852793560073e-11
G197W O 0 2.8816433683687137e-08
, O 0 6.137215735613211e-11
W427R O 0 2.985988700743292e-08
, O 0 7.097249871135247e-11
and O 0 2.6319774484862002e-11
the O 0 9.4227591007634e-11
in O 0 2.0156115665415086e-10
- O 0 1.0870931710371678e-08
frame O 0 3.0219171609502382e-09
deletion O 0 9.711551562929799e-10
390delGly O 0 1.2670244409207498e-08
were O 0 7.49983686265665e-11
assessed O 0 8.476965795978231e-10
by O 0 9.474078639659655e-12
their O 0 7.031241561206159e-11
respective O 0 8.082686187016463e-10
expression O 0 4.210744253274612e-11
in O 0 1.1267798326330958e-11
a O 0 4.040697030444074e-12
prokaryotic O 0 2.010692723430907e-10
system O 0 9.982493304194762e-11
using O 0 1.5064987451962608e-11
site O 0 1.5116899954037422e-09
- O 0 2.3274371319104148e-09
directed O 0 1.1714166303633533e-09
mutagenesis O 0 3.200652543000615e-07
. O 0 3.106321422308156e-09

These O 0 1.3381366015252638e-09
mutations O 0 5.085526999515366e-10
resulted O 0 1.173852237634776e-09
in O 0 5.848358602955628e-11
the O 0 1.1284839035452521e-10
absence O 0 1.6812604641813778e-09
or O 0 3.212175664346617e-11
a O 0 1.6468765587362988e-11
dramatic O 0 1.1938738886385636e-09
decrease O 0 2.5143238602254314e-09
of O 0 3.818591309823205e-08
CPO O 0 0.49002498388290405
activity O 0 4.976716638793732e-08
. O 0 1.8990591321710326e-09

The O 0 5.1845891135826605e-08
two O 0 3.119542402174602e-10
polymorphisms O 0 2.6994624313658733e-09
were O 0 1.4139087123332672e-10
localized O 0 6.91673562869255e-09
in O 0 1.719826780988143e-10
noncoding O 0 7.824827008562352e-09
part O 0 9.293359970463655e-10
of O 0 2.459999093318288e-09
the O 0 4.965770017406612e-10
gene O 0 5.912231815230484e-11
1 O 0 2.761980366638994e-10
) O 0 1.5788505485642146e-12
a O 0 2.5054553917658318e-11
C O 0 4.733226717235084e-07
/ O 0 3.0139517548377626e-08
G O 0 8.559460695778398e-08
polymorphism O 0 6.42147834906126e-10
in O 0 2.104387324119994e-11
the O 0 2.542243360270646e-10
promotor O 0 8.224008524848614e-06
region O 0 1.1334658545081311e-08
, O 0 1.9595687572593334e-10
142 O 0 5.223635302087359e-09
bp O 0 3.240918644564772e-09
upstream O 0 1.1080050210665604e-09
from O 0 2.7477289540889238e-11
the O 0 9.160725129853109e-12
transcriptional O 0 3.6743576931064226e-11
initiation O 0 6.48175887962843e-11
site O 0 6.178208500351445e-10
( O 0 3.4646792813203264e-12
- O 0 1.3203288462548812e-09
142C O 0 8.838800624744181e-08
/ O 0 1.2803860194310346e-08
G O 0 1.3342003057914553e-07
) O 0 1.8907190049710643e-11
, O 0 9.327161439032228e-12
and O 0 1.837097488022188e-11
2 O 0 4.612979720430843e-10
) O 0 1.6113299930453628e-12
a O 0 2.0417362245339632e-11
6 O 0 1.2245097158469775e-09
bp O 0 1.242029146197865e-09
deletion O 0 1.1041038222581179e-10
polymorphism O 0 1.664682974800158e-10
in O 0 3.628766731544886e-11
the O 0 7.391889877972346e-11
3 O 0 6.652898232317739e-10
noncoding O 0 6.89540957665713e-09
part O 0 2.224967571295977e-10
of O 0 1.9544186269371266e-09
the O 0 2.2933954735293582e-09
CPO O 0 0.23161965608596802
gene O 0 2.953975952735277e-09
, O 0 5.966437760518417e-11
574 O 0 1.2423615025625168e-08
bp O 0 6.055410395333638e-09
downstream O 0 2.9862434747229827e-09
of O 0 3.4690224026689975e-09
the O 0 3.040358242945018e-10
last O 0 9.538269479802963e-11
base O 0 6.094210691642843e-10
of O 0 4.004502562882095e-10
the O 0 7.65162377902584e-11
normal O 0 4.114773799468452e-10
termination O 0 4.112194584848794e-09
codon O 0 9.022690150572998e-09
( O 0 1.9854261290586095e-10
+ O 0 1.1868378502200017e-09
574 O 0 1.8086707598286011e-07
delATTCTT O 0 5.45539342056145e-06
) O 0 1.1857856918595644e-09
. O 0 1.4122921720982617e-09

Five O 0 7.737282317066274e-07
intragenic O 0 4.7740613808855414e-05
dimorphisms O 0 4.4178359530633315e-05
are O 0 1.0313387643900995e-10
now O 0 3.591891714616047e-11
well O 0 3.759025382632508e-11
characterized O 0 4.645888951326782e-10
and O 0 1.6956058085382253e-11
the O 0 3.427753567097902e-11
high O 0 3.667484094194151e-10
degree O 0 2.5822730065350186e-10
of O 0 2.808494825590202e-10
allelic O 0 1.7360635595764506e-08
heterogeneity O 0 1.515278924557606e-08
in O 0 6.377515848754456e-09
HC B-Disease 1 1.0
is O 0 1.192335563615643e-09
demonstrated O 0 3.9945169394428603e-10
with O 0 7.611576299804135e-12
seven O 0 5.0679693081034927e-11
new O 0 5.468460319985047e-12
different O 0 2.609343080148263e-12
mutations O 0 2.94160321101522e-11
making O 0 1.9434441556054338e-10
a O 0 3.041261339986612e-11
total O 0 2.676062323125894e-11
of O 0 1.5434912237211051e-09
nineteen O 0 2.1931166429567384e-06
CPO O 1 1.0
gene B-Disease 0 4.023890141979791e-05
defects I-Disease 0 0.08537627756595612
reported O 0 1.134162275207018e-08
so O 0 9.103545695055004e-11
far O 0 2.4512392116093906e-10
. O 0 6.366850102690336e-11
. O 0 6.347005143680917e-10

Coincidence O 0 9.418340027878003e-07
of O 0 3.250602844673267e-07
two O 0 5.584826490157013e-10
novel O 0 2.454576319976809e-09
arylsulfatase O 0 8.869347993822885e-07
A O 0 5.835509497842395e-08
alleles O 0 6.46890249700327e-11
and O 0 2.5008828341555045e-10
mutation O 0 2.771479157281931e-10
459 O 0 2.215221961421321e-08
+ O 0 6.765807469832907e-09
1G O 0 0.00019781719311140478
> O 0 4.2643037545531115e-08
A O 0 4.330366465410407e-08
within O 0 3.407859550108583e-10
a O 0 4.01970609575919e-11
family O 0 3.8625293935501404e-11
with O 0 8.74020078533988e-10
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.0802422151234836e-10
molecular O 0 3.128910186500633e-10
basis O 0 5.070454126010482e-11
of O 0 5.172277051102014e-10
phenotypic O 0 3.672933601706063e-08
heterogeneity O 0 6.361135547194863e-07
. O 0 3.7575258460265104e-08

In O 0 2.9205594387349265e-08
a O 0 6.957644460570123e-10
family O 0 4.8359729415414776e-11
with O 0 1.2980838626219793e-11
three O 0 2.128171111559496e-10
siblings O 0 2.297296353148681e-09
, O 0 8.290403086252951e-12
one O 0 2.0062584406288497e-12
developed O 0 3.0196972700125e-10
classical O 0 1.5257869279139413e-07
late O 0 1.4736057892150711e-05
infantile O 1 0.9999972581863403
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.9214735402783845e-07
MLD B-Disease 1 1.0
) O 0 1.4528577230166206e-09
, O 0 7.121712941593472e-11
fatal O 0 4.096923191809765e-07
at O 0 7.714115568546731e-09
age O 0 4.5269246684576103e-10
5 O 0 2.414405619877158e-10
years O 0 2.474972136956577e-11
, O 0 1.980145561408797e-11
with O 0 3.123220432277307e-11
deficient O 0 4.386739874462364e-06
arylsulfatase O 0 0.00017762230709195137
A O 0 1.2370148397167213e-05
( O 0 1.7332040247453051e-09
ARSA O 0 0.2577785551548004
) O 0 8.19400450269292e-12
activity O 0 2.1700450464345877e-11
and O 0 3.690791595956089e-12
increased O 0 2.0310354093000527e-11
galactosylsulfatide O 0 9.008907682073186e-07
( O 0 3.105995682872731e-09
GS O 1 1.0
) O 0 8.703469056570157e-10
excretion O 0 8.325149458698888e-09
. O 0 4.946825171714408e-10

The O 0 2.7204439589922913e-08
two O 0 1.373992863928919e-10
other O 0 5.418543738699988e-11
siblings O 0 2.8603515112024525e-09
, O 0 8.197885426053375e-11
apparently O 0 1.246248326758348e-09
healthy O 0 9.187962612955403e-10
at O 0 6.344248681955378e-09
12 O 0 3.7875289571331905e-09
( O 0 2.7789626502738862e-11
1 O 0 2.315384994844294e-09
/ O 0 2.7434219340705113e-09
2 O 0 6.1542393403613e-10
) O 0 1.218187876961263e-12
and O 0 1.156192329376804e-11
15 O 0 7.187706679845363e-11
years O 0 5.469618247905261e-12
, O 0 1.0925577933681985e-12
respectively O 0 1.8278144622851933e-11
, O 0 2.3491892025412353e-12
and O 0 2.9193782807857005e-12
their O 0 4.4048327485501915e-11
father O 0 9.76708047772945e-09
, O 0 1.4701538597616803e-10
apparently O 0 1.2383437608676218e-09
healthy O 0 4.2562550706115587e-10
as O 0 1.877193886445916e-11
well O 0 4.3870827109993016e-11
, O 0 4.440989936904671e-11
presented O 0 1.4659887526136117e-08
ARSA O 1 0.999772846698761
and O 0 2.9992254013677666e-08
GS O 1 1.0
values O 0 2.85302825808742e-09
within O 0 5.090738941504469e-10
the O 0 7.28535842764444e-11
range O 0 1.2304289143116875e-08
of O 0 1.1142112299467044e-07
MLD B-Disease 1 1.0
patients O 0 3.466779219252203e-07
. O 0 3.6617611165468134e-09

Mutation O 0 6.309325506492769e-09
screening O 0 4.333917225096684e-09
and O 0 4.1793787181054753e-11
sequence O 0 5.496768405027774e-12
analysis O 0 2.5084474428171966e-12
disclosed O 0 8.116265992619276e-11
the O 0 3.2795811205632575e-11
involvement O 0 1.3028170209317125e-10
of O 0 3.5727004688013153e-10
three O 0 8.162790755827931e-12
different O 0 2.7094566174001855e-11
ARSA O 1 0.9035606980323792
mutations O 0 3.9389308481574403e-10
being O 0 2.34592189424232e-11
the O 0 6.674231046305268e-12
molecular O 0 8.398281375887606e-11
basis O 0 5.520895199340181e-11
of O 0 1.391343706913517e-09
intrafamilial O 0 2.921991381299449e-06
phenotypic O 0 2.6538447173152235e-07
heterogeneity O 0 1.55638645082945e-06
. O 0 6.509545613653245e-08

The O 0 1.1828083756881824e-07
late O 0 6.3563302319380455e-06
infantile O 0 0.024538885802030563
patient O 0 7.130461199267302e-07
inherited O 0 1.0597010486890213e-06
from O 0 2.1993082910398698e-08
his O 0 3.4627049672053545e-07
mother O 0 1.2224078638212177e-08
the O 0 7.685620473374399e-10
frequent O 0 2.8801075413475985e-10
0 O 0 1.291146412008004e-09
- O 0 3.2720364195881757e-09
type O 0 3.2689986273481964e-09
mutation O 0 2.181912150955867e-10
459 O 0 8.022896125225998e-09
+ O 0 7.024475445760459e-10
1G O 0 1.0279401976731606e-05
> O 0 5.5545101851350864e-09
A O 0 2.612370941790232e-08
, O 0 1.278095337897689e-11
and O 0 5.294969324109999e-12
from O 0 2.8461172654759004e-11
his O 0 3.08670561333102e-10
father O 0 1.11044229367252e-09
a O 0 3.762253356076606e-11
novel O 0 7.702625343108949e-11
, O 0 1.776945604547997e-11
single O 0 1.6645654299374257e-10
basepair O 0 1.6486052345499047e-07
microdeletion O 0 4.6861111968610203e-07
of O 0 3.594673003703974e-08
guanine O 0 7.0015659936473185e-09
at O 0 5.450038198517859e-09
nucleotide O 0 9.589716798430459e-10
7 O 0 1.8991568317971996e-09
in O 0 4.320921398459632e-11
exon O 0 1.9556090080641297e-08
1 O 0 8.473866941471897e-09
( O 0 3.0047481169859225e-10
7delG O 0 4.978530228072486e-07
) O 0 6.417866238450642e-10
. O 0 1.4645962220782849e-09

The O 0 3.2688384976609086e-07
two O 0 3.642208756815535e-09
clinically O 0 1.785228778317105e-05
unaffected O 0 7.091948077686538e-07
siblings O 0 1.8425534875632366e-08
carried O 0 9.529982358813527e-10
the O 0 6.388907736187832e-10
maternal O 0 1.2111196490138809e-08
mutation O 0 3.7092290350315693e-10
459 O 0 2.0351491158976387e-08
+ O 0 1.4848536844525029e-09
1G O 0 1.7847043636720628e-05
> O 0 1.2717650044180573e-08
A O 0 4.8815756770181906e-08
and O 0 1.3272211107917542e-10
, O 0 7.838169349683177e-12
on O 0 2.233291329645226e-11
their O 0 3.330932751843818e-12
paternal O 0 2.3448046282403823e-10
allele O 0 1.7759359954849785e-11
, O 0 3.3131913011741343e-12
a O 0 5.007174796317626e-12
novel O 0 2.4891177660690822e-11
cytosine O 0 1.9897450354022794e-09
to O 0 1.2200766438819066e-11
thymidine O 0 3.003513171506711e-08
transition O 0 4.793404340119878e-09
at O 0 4.714501233848978e-09
nucleotide O 0 2.6621163051743224e-09
2435 O 0 2.3502595922764158e-06
in O 0 3.775777468462138e-10
exon O 0 1.7692984854988936e-08
8 O 0 3.313999075160723e-09
, O 0 4.209288733542094e-12
resulting O 0 3.845554083503622e-12
in O 0 6.753442206505755e-13
substitution O 0 7.424841991232611e-11
of O 0 6.850011113890275e-10
alanine O 0 1.0616108880867614e-08
464 O 0 1.0665468508364029e-08
by O 0 7.197079598952882e-10
valine O 0 7.246699624374742e-06
( O 0 4.627248806343687e-09
A464V O 0 4.266596533852862e-06
) O 0 9.737203265913763e-10
. O 0 1.4308381146577176e-09

The O 0 5.688859872066132e-08
fathers O 0 6.930934404181244e-08
genotype O 0 9.867068939684032e-09
thus O 0 8.651400151826749e-10
was O 0 8.931700712366819e-09
7delG O 0 5.787926966149826e-06
/ O 0 2.7338046493241563e-06
A464V O 0 5.307241735863499e-06
. O 0 4.835480016396332e-09

Mutation O 0 3.675124276014685e-07
A464V O 0 1.7135374719146057e-06
was O 0 5.824653204200558e-09
not O 0 3.1731043573929307e-12
found O 0 6.364940692560328e-12
in O 0 1.3997696231282664e-11
18 O 0 1.2288897677237287e-09
unrelated O 0 3.8254444234553375e-07
MLD B-Disease 1 1.0
patients O 0 8.01572230813008e-09
and O 0 8.299239628861699e-10
50 O 0 2.7407494052056336e-09
controls O 0 7.488797848509421e-08
. O 0 9.407037815378771e-09

A464V O 0 6.46950866212137e-05
, O 0 4.401511599638752e-09
although O 0 2.832174772482432e-10
clearly O 0 2.2175037361904515e-09
modifying O 0 2.2124947918200633e-07
ARSA O 1 0.9997530579566956
and O 0 2.132668015519812e-07
GS O 1 1.0
levels O 0 2.1098830416121928e-07
, O 0 6.617838221867345e-11
apparently O 0 2.363195195087542e-10
bears O 0 2.7460864693296116e-09
little O 0 6.612207309464324e-12
significance O 0 1.0201610389781735e-11
for O 0 2.3882781603062897e-12
clinical O 0 1.1210023131980051e-08
manifestation O 0 5.66555684144987e-07
of O 0 9.714553016237915e-06
MLD B-Disease 1 1.0
, O 0 9.848868387507537e-09
mimicking O 0 3.683464626647037e-07
the O 0 4.9408304114706425e-09
frequent O 0 1.4785430835217994e-07
ARSA O 1 0.9999991655349731
pseudodeficiency O 0 0.004193164873868227
allele O 0 1.0341511114120294e-07
. O 0 6.517009154549669e-09

Our O 0 2.18206665181242e-07
results O 0 4.274888443234204e-09
demonstrate O 0 2.83397944000896e-10
that O 0 6.70813719242519e-13
in O 0 8.664250415214847e-13
certain O 0 7.591612234680856e-12
genetic O 0 2.8311499811195517e-09
conditions O 0 2.438217052258551e-06
MLD B-Disease 1 1.0
- O 0 8.909554890124127e-05
like O 0 5.1466567896341076e-08
ARSA O 1 0.999995231628418
and O 0 5.3654741094533165e-08
GS O 1 1.0
values O 0 1.6686064752136076e-09
need O 0 4.3800515298064724e-11
not O 0 1.2064666756947395e-12
be O 0 1.0782854643898165e-12
paralleled O 0 1.7455945022781805e-10
by O 0 1.6088647775136522e-11
clinical O 1 0.8872809410095215
disease O 1 0.9144700169563293
, O 0 1.57482134971465e-11
a O 0 9.935739730959625e-12
finding O 0 1.112425984661769e-10
with O 0 2.6135930225601456e-11
serious O 0 2.7072994157606445e-07
diagnostic O 0 0.47619491815567017
and O 0 5.2317147947178455e-08
prognostic O 0 0.004637671168893576
implications O 0 6.7234618654765654e-06
. O 0 4.739315428992086e-08

Moreover O 0 3.069583272008458e-07
, O 0 4.0858449956715504e-10
further O 0 7.738221174946602e-10
ARSA O 1 0.5690200328826904
alleles O 0 8.391912720284722e-10
functionally O 0 5.660585333799872e-09
similar O 0 7.22524540197611e-11
to O 0 3.393872682888599e-11
A464V O 0 5.125985680365375e-08
might O 0 2.923497555151755e-11
exist O 0 4.84895908148264e-11
which O 0 6.192477086663928e-12
, O 0 8.734525255849057e-12
together O 0 4.664539154236591e-12
with O 0 3.1439763986673697e-12
0 O 0 7.508557109403569e-10
- O 0 2.571074020352171e-09
type O 0 7.364821197342053e-09
mutations O 0 3.5860767688689066e-09
, O 0 3.404987680699634e-10
may O 0 1.5752613657937786e-09
cause O 0 2.288300322561554e-07
pathological O 1 0.9994353652000427
ARSA O 1 1.0
and O 0 1.1474633083707886e-06
GS O 1 1.0
levels O 0 2.427411800454138e-07
, O 0 1.9679428225893858e-11
but O 0 1.7464277094793312e-13
not O 0 9.050399318866198e-14
clinical O 0 5.453667295540754e-09
outbreak O 0 2.24416507599301e-09
of O 0 2.191535397599864e-09
the O 0 4.362465588769737e-08
disease O 0 0.004927025176584721
. O 0 5.926898555275173e-11
. O 0 7.755819320109936e-10

Human O 1 0.9998015761375427
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 0.00010630460747051984
to O 0 7.204324248277771e-08
hematological B-Disease 1 1.0
malignancy I-Disease 1 0.9999998807907104
and O 0 2.614978882320429e-07
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9367660880088806
1 I-Disease 0 0.00017315785225946456
. O 0 3.065972720150967e-08

Heterozygous O 0 1.1273403970335494e-06
germ O 0 0.015651986002922058
- O 0 4.306358732719673e-06
line O 0 3.70301229679626e-08
mutations O 0 1.0238340730772677e-10
in O 0 3.4472199400559234e-11
the O 0 1.771930657756826e-10
DNA O 0 2.393131353528588e-06
mismatch O 0 9.837913239607587e-05
repair O 0 0.0006183634977787733
genes O 0 1.0604857436646853e-08
lead O 0 1.9505986159629174e-08
to O 0 1.9940460393996773e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.333628827955181e-07

The O 0 2.1116293282830156e-06
disease O 0 0.0011426910059526563
susceptibility O 0 7.988390393620648e-08
of O 0 4.437237066667876e-08
individuals O 0 9.327340115550253e-12
who O 0 6.875431335373605e-10
constitutionally O 0 3.814631952536729e-07
lack O 0 2.8818194053314983e-08
both O 0 3.489526445576985e-10
wild O 0 6.413490893919516e-08
- O 0 5.528298263612896e-09
type O 0 2.2180282055472844e-09
alleles O 0 2.4136860912737923e-11
is O 0 3.610600533832109e-12
unknown O 0 9.483471785642905e-10
. O 0 1.190422205255004e-09

We O 0 3.839989659581988e-09
have O 0 4.4667529223996194e-12
identified O 0 3.1462756011624293e-11
three O 0 6.376557268317207e-12
offspring O 0 1.1227858226492415e-10
in O 0 6.556075127228667e-11
a O 0 5.109837442063281e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.330279388866984e-07
who O 0 2.6811080022781653e-09
developed O 0 6.814897005824605e-06
hematological B-Disease 1 1.0
malignancy I-Disease 1 0.9999991655349731
at O 0 6.700647503521395e-08
a O 0 3.4936067927482384e-11
very O 0 1.2579389569930544e-12
early O 0 3.0336619327719916e-10
age O 0 3.008755050659673e-11
, O 0 8.440152331375128e-13
and O 0 1.9512570812590946e-12
at O 0 1.4632886569110326e-10
least O 0 9.319723812128977e-13
two O 0 4.787330254441002e-12
of O 0 3.101873480293449e-10
them O 0 2.0887517410139722e-11
displayed O 0 5.0001798257426344e-08
signs O 0 3.2245409897768695e-07
of O 0 8.303236853635099e-08
neurofibromatosis B-Disease 1 0.9999654293060303
type I-Disease 0 0.00013438631140161306
1 I-Disease 0 1.0153851690120064e-05
( O 0 2.1392306592815657e-08
NF1 B-Disease 1 0.999983549118042
) O 0 2.6576467693217865e-09
. O 0 1.9726045241696966e-09

DNA O 0 4.546901379853807e-07
sequence O 0 1.3421593003659638e-10
analysis O 0 1.8257098957641382e-11
and O 0 3.0207195252096586e-12
allele O 0 4.824399126718282e-12
- O 0 7.87661463830247e-11
specific O 0 3.3170102949064972e-12
amplification O 0 7.137766377951493e-09
in O 0 5.797127014539605e-11
two O 0 4.9812296648577004e-11
siblings O 0 3.779201396270082e-09
revealed O 0 2.837399204480562e-09
a O 0 3.6638972411573434e-10
homozygous O 0 9.989363292106646e-08
MLH1 O 1 0.9999849796295166
mutation O 0 2.2259248666500753e-08
( O 0 2.06569916727517e-09
C676T O 0 2.9448410714394413e-06
- O 0 4.9361042329110205e-06
- O 0 1.5250465139615699e-06
> O 0 1.0771081804250571e-07
Arg226Stop O 0 8.545863965991884e-05
) O 0 1.501531676773027e-09
. O 0 5.507856393194288e-10

Thus O 0 4.441784184905373e-08
, O 0 1.0061406152672703e-09
a O 0 6.055291268403096e-10
homozygous O 0 3.163846074016874e-08
germ O 1 0.9999408721923828
- O 0 0.0004055618483107537
line O 0 6.660040526185185e-06
MLH1 O 1 0.9999998807907104
mutation O 0 6.195062685065977e-09
and O 0 5.853729723170886e-10
consequent O 0 0.0007691442151553929
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 1.9403077544666303e-07
in O 0 1.590131692985608e-09
a O 0 3.917315638535257e-10
mutator O 0 3.262619793531485e-05
phenotype O 0 7.74797204172728e-09
characterized O 0 2.0305532810738214e-09
by O 0 5.078974463224029e-10
leukemia B-Disease 1 1.0
and O 0 1.4739393350282626e-07
/ O 1 0.997836172580719
or O 0 0.01629251055419445
lymphoma B-Disease 1 1.0
associated O 0 0.000617185898590833
with O 0 5.269912506378205e-08
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9996354579925537
1 I-Disease 0 2.866140494006686e-05
. O 0 8.789517447205242e-10
. O 0 5.85881232417762e-10

Missense O 0 1.5209348930511624e-05
mutations O 0 3.635048528849438e-08
in O 0 8.509916660237593e-10
the O 0 6.975073296722201e-11
most O 0 9.975783220317336e-13
ancient O 0 1.6430183602533788e-10
residues O 0 1.6749199804877435e-09
of O 0 5.268500080646277e-10
the O 0 8.113577587565146e-10
PAX6 O 1 0.9938281178474426
paired O 0 4.626836513921262e-08
domain O 0 6.86191103937972e-10
underlie O 0 8.45715817376913e-08
a O 0 2.3255368464258908e-10
spectrum O 0 4.3837186325390576e-08
of O 0 9.435304377802822e-07
human O 1 0.9999961853027344
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 1.1191915291419718e-05

Mutations O 0 6.267420360472897e-08
of O 0 6.850135036984284e-08
the O 0 1.1066786376190407e-09
human O 0 5.858859619678469e-09
PAX6 O 1 0.9999998807907104
gene O 0 7.575077916044393e-07
underlie O 1 0.9995255470275879
aniridia B-Disease 1 1.0
( O 1 0.7242125272750854
congenital B-Disease 1 1.0
absence I-Disease 1 0.5113798975944519
of I-Disease 0 0.060964979231357574
the I-Disease 0 4.2118350052078313e-07
iris I-Disease 0 1.097861968446523e-05
) O 0 3.21117243906599e-10
, O 0 4.0397123146629355e-11
a O 0 1.331618010302904e-10
rare O 0 1.2027442153339507e-07
dominant O 0 0.029805397614836693
malformation B-Disease 1 1.0
of I-Disease 1 0.999994158744812
the I-Disease 1 0.9981178045272827
eye I-Disease 1 1.0
. O 0 4.013748480247159e-07

The O 0 5.2384649507075665e-08
spectrum O 0 1.1305687053209112e-07
of O 0 2.564701446772233e-07
PAX6 O 1 0.999997615814209
mutations O 0 9.26819652136146e-08
in O 0 2.1651779036346852e-08
aniridia B-Disease 1 1.0
patients O 0 2.4913537899351468e-08
is O 0 5.238084705566637e-12
highly O 0 4.946787424131571e-10
biased O 0 1.9161707776049752e-09
, O 0 2.3379081656726974e-11
with O 0 2.449460773101819e-12
92 O 0 1.8390204914453534e-09
% O 0 1.2478633035738207e-13
of O 0 2.5121736288435947e-11
all O 0 4.481807286405015e-12
reported O 0 2.4115245911282557e-10
mutations O 0 1.25542409801227e-09
leading O 0 1.3656076269796813e-08
to O 0 1.9538064222057727e-10
premature O 0 2.4976628765216446e-08
truncation O 0 1.3451571589939704e-07
of O 0 2.671498009476636e-07
the O 0 1.0515266879451701e-08
protein O 0 1.9551156249519863e-09
( O 0 2.366822016153236e-10
nonsense O 0 4.960530120001749e-08
, O 0 4.6980693640952254e-11
splicing O 0 1.1821001955070187e-09
, O 0 1.370720290744254e-11
insertions O 0 7.647688593515056e-10
and O 0 5.280630099857575e-11
deletions O 0 1.7164457633001007e-09
) O 0 3.2031939600773995e-11
and O 0 5.37400783595654e-11
just O 0 3.7972756883331016e-11
2 O 0 1.0567854230592033e-10
% O 0 1.364042207093949e-13
leading O 0 1.1279173775524676e-11
to O 0 1.0845678196681752e-13
substitution O 0 2.6769114702673846e-10
of O 0 3.7774792183142836e-09
one O 0 3.297406445113005e-11
amino O 0 3.806676085460481e-10
acid O 0 1.4242046431078847e-10
by O 0 6.583665904114078e-12
another O 0 1.675216215746289e-10
( O 0 1.5852370804925187e-10
missense O 0 1.0335871536426566e-07
) O 0 4.049605095701736e-10
. O 0 1.3382031038844389e-09

The O 0 3.929989489392938e-08
extraordinary O 0 4.796303354481779e-09
conservation O 0 3.007784243891365e-08
of O 0 4.301757616786972e-09
the O 0 7.059235418438448e-10
PAX6 O 0 4.89817357447464e-05
protein O 0 5.584272488867725e-10
at O 0 1.6315271356148742e-09
the O 0 3.2811781069952417e-10
amino O 0 3.641354551220388e-09
acid O 0 5.0369535209426886e-09
level O 0 5.405945024961056e-09
amongst O 0 7.314437944216934e-09
vertebrates O 0 8.321104871811258e-08
predicts O 0 4.061875724659103e-09
that O 0 1.5052004781468398e-11
pathological O 0 8.876000720192678e-06
missense O 0 4.695013160471717e-07
mutations O 0 3.7903040706055435e-09
should O 0 1.207351996157513e-10
in O 0 3.998320563525226e-10
fact O 0 9.636320214001515e-11
be O 0 1.7987561093391058e-11
common O 0 1.6443726935655434e-10
even O 0 8.280383323455709e-12
though O 0 3.019838068843428e-12
they O 0 8.534139107202465e-13
are O 0 8.153947894488922e-13
hardly O 0 1.8282546310199876e-10
ever O 0 2.960748868297003e-10
seen O 0 3.1718791482227005e-10
in O 0 1.8338154328390033e-09
aniridia B-Disease 1 1.0
patients O 0 1.446273358851613e-07
. O 0 1.5006277109819166e-08

This O 0 3.332188136528913e-10
indicates O 0 2.921380914955307e-10
that O 0 3.929132952155967e-13
there O 0 1.1365463691709321e-12
is O 0 4.665497588957068e-13
a O 0 4.4840212272412305e-12
heavy O 0 7.547151312792266e-07
ascertainment O 0 2.2561232981388457e-05
bias O 0 4.964465283308073e-09
in O 0 8.142874569072589e-11
the O 0 1.5035707054411596e-11
selection O 0 1.2477319177861546e-10
of O 0 9.728590155688721e-10
patients O 0 9.500430997455567e-11
for O 0 1.2619198741514737e-10
PAX6 O 1 0.9977116584777832
mutation O 0 2.0475011963672074e-10
analysis O 0 6.217155956722564e-11
and O 0 2.9747853486084e-11
that O 0 1.1407009234756793e-12
the O 0 2.408380439522517e-10
missing O 0 2.864250880918462e-08
PAX6 O 1 0.9999977350234985
missense O 0 2.8138008474343223e-06
mutations O 0 3.876758114529366e-08
frequently O 0 1.9606687384765564e-09
may O 0 2.0071990736170164e-09
underlie O 0 3.1923414098855574e-06
phenotypes O 0 1.1494080354168545e-07
distinct O 0 2.3547959138170427e-09
from O 0 1.292167084443463e-08
textbook O 0 0.0001964107941603288
aniridia B-Disease 1 1.0
. O 0 2.1043288711553032e-07

Here O 0 4.581025336847233e-08
we O 0 1.0338814526722473e-10
present O 0 3.9093517312238646e-10
four O 0 2.7871863150785714e-10
novel O 0 2.226734796551e-09
PAX6 O 1 0.6894187331199646
missense O 0 4.659827084196877e-07
mutations O 0 1.567699925431043e-08
, O 0 3.8805714197565067e-10
two O 0 4.102937781191862e-11
in O 0 3.37403355255006e-10
association O 0 3.567773987356304e-08
with O 0 2.0430851455088828e-10
atypical O 0 4.082132818439277e-06
phenotypes O 0 1.9645276552182622e-06
ectopia B-Disease 0 0.0006540570757351816
pupillae I-Disease 0 7.817489677108824e-05
( O 0 3.4924027558780324e-10
displaced B-Disease 0 1.2378277222668821e-11
pupils I-Disease 0 1.370486391039094e-09
) O 0 1.6552541282077726e-10
and O 0 5.995262313263083e-07
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999997615814209
( O 0 1.5165916522619227e-08
searching B-Disease 0 4.2742790640204475e-08
gaze I-Disease 0 1.8760302111786586e-07
) O 0 1.2659361059430552e-10
, O 0 3.877255114193012e-11
and O 0 6.313304046212664e-11
two O 0 1.7028071661040478e-11
in O 0 1.214461031739944e-10
association O 0 1.6478907127748244e-08
with O 0 2.851464030173556e-11
more O 0 1.5906609363014468e-11
recognizable O 0 0.00043838098645210266
aniridia B-Disease 1 1.0
phenotypes O 0 8.045346476137638e-06
. O 0 4.556937938104966e-08

Strikingly O 0 4.613790679286467e-06
, O 0 3.0003282081025873e-09
all O 0 2.3185821318438826e-11
four O 0 1.1100727108359632e-11
mutations O 0 2.377040578260825e-11
are O 0 5.708301127789472e-13
located O 0 1.346020739312337e-09
within O 0 4.592936586611529e-10
the O 0 3.197776710095468e-09
PAX6 O 1 0.6910728812217712
paired O 0 1.0011792284103649e-08
domain O 0 3.0703470321746806e-10
and O 0 8.127203077190615e-11
affect O 0 4.0944497792239076e-10
amino O 0 7.31659732799983e-10
acids O 0 5.203562927769134e-11
which O 0 1.0332712333319116e-12
are O 0 1.6883427978158644e-13
highly O 0 4.116718077540327e-11
conserved O 0 1.0680888812286682e-10
in O 0 9.906466272302517e-12
all O 0 4.926246476716356e-12
known O 0 7.897238418763664e-11
paired O 0 8.305289234122881e-10
domain O 0 5.69628122448762e-10
proteins O 0 7.282291436538912e-10
. O 0 3.346667387660318e-09

Our O 0 1.1137289135376705e-07
results O 0 3.454588393125846e-09
support O 0 5.834276117777648e-11
the O 0 3.244322865914029e-11
hypothesis O 0 1.194054750908169e-11
that O 0 2.61055977860249e-14
the O 0 4.230109752062505e-12
under O 0 4.992481775212276e-11
- O 0 1.4464007769277032e-10
representation O 0 1.525653041400954e-11
of O 0 1.765352586335922e-10
missense O 0 4.728426361566562e-08
mutations O 0 4.172437506611004e-09
is O 0 9.404337725227307e-11
caused O 0 2.460158743389229e-09
by O 0 1.9421175778688848e-10
ascertainment O 0 0.00010221813136013225
bias O 0 4.072257198117768e-08
and O 0 5.093195865057965e-10
suggest O 0 1.3491661954301293e-10
that O 0 5.821065201042086e-13
a O 0 4.619755099299905e-12
substantial O 0 8.49820144810387e-11
burden O 0 2.900734585864484e-08
of O 0 2.7712130759027787e-06
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
related I-Disease 1 1.0
disease I-Disease 1 1.0
remains O 0 8.841034571105411e-10
to O 0 3.3727048931453396e-12
be O 0 1.5179602366743872e-12
uncovered O 0 6.235605809479239e-09
. O 0 5.908409872468212e-11
. O 0 3.2405519934108895e-10

The O 0 6.781248629295078e-08
chromosomal O 0 2.0287239976823912e-07
order O 0 3.927035585604699e-09
of O 0 4.152590804551437e-08
genes O 0 7.809272672965051e-10
controlling O 0 1.1401577637570881e-07
the O 0 6.3662857208157675e-09
major O 0 7.176730321134528e-08
histocompatibility O 0 0.0003689471632242203
complex O 0 8.921826520236209e-06
, O 0 9.678027268478218e-10
properdin O 0 2.713516096264357e-07
factor O 0 2.2466062343795556e-09
B O 0 9.312066708844213e-07
, O 0 3.4918949676221445e-11
and O 0 2.795390585674795e-10
deficiency B-Disease 0 1.7271153183173737e-06
of I-Disease 0 2.3444610519618436e-07
the I-Disease 0 2.5885122933999583e-09
second I-Disease 0 3.4848322005842647e-09
component I-Disease 0 3.5398657338703288e-09
of I-Disease 0 1.023917040043898e-08
complement I-Disease 0 7.354969966399949e-08
. O 0 1.5503934136518183e-08

The O 0 4.968616806877435e-08
relationship O 0 5.790863899512999e-10
of O 0 2.429373591184003e-09
the O 0 6.535649799133125e-11
genes O 0 1.6500639830191455e-12
coding O 0 5.064760763562326e-11
for O 0 1.220735318385735e-11
HLA O 0 1.665878812673327e-08
to O 0 1.2418644237954801e-11
those O 0 7.810500510241347e-12
coding O 0 1.4892323485504733e-10
for O 0 7.16645753157108e-12
properdin O 0 3.434368522903242e-08
Factor O 0 9.79139880286084e-10
B O 0 1.5817178677934862e-07
allotypes O 0 1.946272654151926e-08
and O 0 2.7375022387809977e-11
for O 0 5.943789210816064e-11
deficiency B-Disease 0 7.717900416537304e-07
of I-Disease 0 2.2172432068146009e-07
the I-Disease 0 2.868070891892671e-09
second I-Disease 0 1.1863784399324118e-09
component I-Disease 0 3.921315216981469e-10
of I-Disease 0 1.0230849500914019e-09
complement I-Disease 0 5.674119396559263e-09
( O 0 1.0982591502894934e-09
C2 O 0 3.5584809666033834e-05
) O 0 4.6323461559694135e-12
was O 0 1.209363338638969e-11
studied O 0 2.089620664003089e-11
in O 0 2.161925017262964e-13
families O 0 2.3348742711937383e-14
of O 0 3.5232042977506595e-11
patients O 0 3.402884085623725e-10
with O 0 5.793320045910377e-09
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 4.5001226681051776e-05

Patients O 0 4.621800542281562e-07
were O 0 2.193626391644443e-09
selected O 0 1.3000548415575963e-09
because O 0 2.3952681851846513e-11
they O 0 3.4769661108602357e-12
were O 0 2.043138574991943e-11
heterozygous O 0 4.815355753029493e-11
or O 0 1.5459801494532854e-10
homozygous O 0 9.41716606916998e-08
for O 0 1.6858297158250934e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 3.624141697855521e-07

12 O 0 4.969944029653561e-07
families O 0 7.311543037680224e-11
with O 0 6.7492643418543e-11
15 O 0 1.6242305278524327e-09
matings O 0 3.3391199139032324e-08
informative O 0 3.225619948921121e-08
for O 0 3.8514974676218117e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 4.882469539779777e-08
found O 0 4.470126491185056e-09
. O 0 1.5782567475142173e-09

Of O 0 8.325037015310954e-06
57 O 0 1.0634961000732801e-07
informative O 0 1.4864017572335797e-08
meioses O 0 3.0579010399378603e-06
, O 0 1.635788865472776e-10
two O 0 4.201251759677893e-12
crossovers O 0 1.180096992348112e-10
were O 0 1.25700477804358e-10
noted O 0 9.221808039416857e-11
between O 0 2.711577629099793e-10
the O 0 2.0962488633813336e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.8329413542517159e-09
and O 0 1.315105385701898e-10
the O 0 7.353896935846649e-10
HLA O 0 3.023968702109414e-07
- O 0 8.172791865490581e-08
B O 0 1.0518907629375462e-06
gene O 0 2.5294152189436758e-11
, O 0 5.342789470390297e-13
with O 0 1.9574812148807907e-13
a O 0 1.4389203804171524e-12
recombinant O 0 1.242142361190801e-10
fraction O 0 3.1077761891706857e-11
of O 0 1.8533310441881667e-09
0 O 0 6.181417600004124e-09
. O 0 7.539124324829061e-10

035 O 0 0.026636919006705284
. O 0 2.5343458673887653e-06

A O 0 3.269161425123457e-06
lod O 0 8.440497367701028e-06
score O 0 3.991733166230915e-08
of O 0 5.198270702777563e-09
13 O 0 1.1558892731855508e-09
was O 0 5.2876650974420514e-11
calculated O 0 9.325275794613841e-12
for O 0 1.671994487306705e-11
linkage O 0 2.472237667916488e-07
between O 0 4.16525426771841e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.0863800525839906e-08
HLA O 0 1.0782372328321799e-06
- O 0 4.878010528841514e-08
B O 0 4.6535738817965466e-08
at O 0 3.3702114016209705e-11
a O 0 1.4482592371450193e-13
maximum O 0 3.4696440056984634e-13
likelihood O 0 2.5670177788983395e-12
value O 0 3.7415986108013666e-12
of O 0 4.26882244830562e-11
the O 0 4.3275504707507295e-12
recombinant O 0 9.767959878448362e-12
fraction O 0 3.2912975730242655e-12
of O 0 4.143211884688469e-10
0 O 0 2.3527890746777302e-09
. O 0 4.1459388699927047e-10

04 O 0 0.0019236523658037186
. O 0 4.2348614215370617e-07

18 O 0 1.9727474409592105e-07
families O 0 1.4688413679797563e-11
with O 0 7.721379785552429e-11
21 O 0 1.9310446575104834e-09
informative O 0 5.363094968124926e-10
matings O 0 3.1641644859803364e-09
for O 0 3.7290469323547626e-11
both O 0 7.545564867372789e-11
properdin O 0 9.626538712836918e-07
Factor O 0 1.1274437383690383e-08
B O 0 9.638132496547769e-07
allotype O 0 3.8298762206068204e-07
and O 0 5.380605405669314e-10
HLA O 0 1.1800473203038564e-06
- O 0 1.1248901898852637e-07
B O 0 5.978259878247627e-07
were O 0 1.0203581729539835e-10
found O 0 1.1170525615611382e-10
. O 0 2.818831001949462e-10

Of O 0 1.3494010090653319e-05
72 O 0 5.378173568715283e-07
informative O 0 5.9442630373496286e-08
meioses O 0 6.212391781446058e-06
, O 0 4.745407400363888e-10
three O 0 3.893246836028652e-11
recombinants O 0 8.141240925851889e-08
were O 0 1.3970202772384255e-10
found O 0 7.890884473615856e-11
, O 0 3.380768321542549e-12
giving O 0 3.0693425231986815e-12
a O 0 3.894121136660544e-12
recombinant O 0 3.049191177328936e-10
fraction O 0 1.1174361436161462e-10
of O 0 1.1205042227402373e-08
0 O 0 1.3670827136991193e-08
. O 0 1.2625462897375428e-09

042 O 0 0.02720559574663639
. O 0 2.4069699975370895e-06

A O 0 2.3981051526789088e-06
lod O 0 9.933019100571983e-06
score O 0 1.3750775451626396e-07
of O 0 1.5192291868970642e-08
16 O 0 1.828381113178068e-09
between O 0 3.57008970996997e-11
HLA O 0 8.524155958866686e-08
- O 0 2.785711927799639e-08
B O 0 5.5988039093790576e-08
and O 0 1.3737564037719086e-11
Factor O 0 3.46872947032395e-10
B O 0 1.0924603799367105e-07
allotypes O 0 3.460393571685927e-08
was O 0 5.5928612435751646e-11
calculated O 0 2.5226398660954663e-12
at O 0 3.173965604230666e-11
a O 0 3.850278657100553e-13
maximum O 0 1.8313345631626454e-12
likelihood O 0 7.719314770726626e-12
value O 0 1.9443470271329755e-12
of O 0 6.376608963076791e-11
the O 0 7.138272611895147e-12
recombinant O 0 2.8546692787401184e-11
fraction O 0 1.5757947030570207e-11
of O 0 4.503809269973402e-10
0 O 0 2.3772470658656175e-09
. O 0 3.2903843538711897e-10

04 O 0 0.0027036448009312153
. O 0 6.908885552547872e-07

A O 0 7.787234608258586e-07
crossover O 0 1.410785177569096e-08
was O 0 2.862556414129358e-09
shown O 0 9.877221436582762e-12
to O 0 8.960587805605102e-13
have O 0 3.20158870660385e-14
occurred O 0 1.7369982188708555e-11
between O 0 3.8456840793441027e-13
genes O 0 1.2737306055807945e-13
for O 0 8.255778330933106e-13
Factor O 0 9.54753359705407e-11
B O 0 6.015524434133113e-08
and O 0 3.589884986499037e-11
HLA O 0 4.267916509093084e-08
- O 0 2.269390186881992e-08
D O 0 2.224497279712523e-07
, O 0 4.88092335645951e-12
in O 0 1.1375157543333514e-12
which O 0 2.79363966855517e-12
HLA O 0 1.2591854670063185e-07
- O 0 1.463357790498776e-07
D O 0 2.3574227725475794e-06
segregared O 0 1.2311987802604563e-06
with O 0 4.012865387204023e-11
HLA O 0 1.0498692972760182e-06
- O 0 2.470433990708898e-08
A O 0 5.486074883265246e-08
and O 0 2.52730059102646e-09
B O 0 3.827495220320998e-06
. O 0 4.838613953950244e-10

These O 0 1.0419868301525526e-09
studies O 0 3.709257345718697e-10
suggest O 0 1.3333710004170829e-11
that O 0 3.2843458584296686e-14
the O 0 1.1768949530199802e-12
genes O 0 1.8517583571121127e-13
for O 0 1.4785239005332684e-12
Factor O 0 2.209010085962859e-09
B O 0 0.1478453129529953
and O 0 4.385199190437561e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 4.439039847509152e-12
located O 0 2.1794246962691943e-10
outside O 0 1.9745084733902019e-10
those O 0 5.268052920975874e-12
for O 0 3.120683572666039e-11
HLA O 0 1.9529110772964486e-07
, O 0 3.207975204921887e-11
that O 0 1.7694356993069177e-13
the O 0 5.324866849537591e-12
order O 0 5.502603234175396e-11
of O 0 1.1683551903729494e-09
genese O 0 8.890231697478157e-07
is O 0 4.0302310100326366e-11
HLA O 0 2.62272550344278e-08
- O 0 6.697156607060606e-09
A O 0 8.019809172310488e-08
, O 0 8.317332239604625e-11
- O 0 3.471683163169814e-09
B O 0 7.035087890017167e-08
, O 0 6.73867428871433e-12
- O 0 1.030476037833239e-09
D O 0 2.5786778934389076e-08
, O 0 2.3704257307022303e-11
Factor O 0 1.0937437622260404e-09
B O 0 5.8164291658613365e-06
allotype O 0 0.00020659752772189677
, O 0 2.5645252321737644e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.606740435144971e-10
that O 0 1.7916321638083987e-13
the O 0 5.13441025806749e-12
genes O 0 6.3546542160286545e-12
coding O 0 4.481386373100804e-09
for O 0 2.1380763826073235e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 4.037760348296615e-09
Factor O 0 4.018813282158362e-09
B O 0 1.9729372979782056e-07
allotypes O 0 1.3065860393624007e-08
are O 0 3.6777194787826484e-13
approximately O 0 5.1520285433703794e-12
3 O 0 1.542704575197007e-10
- O 0 1.5484952209376956e-09
- O 0 5.067751551735e-09
5 O 0 3.316760754934478e-10
centimorgans O 0 2.0006986289899942e-08
from O 0 1.0778465620031596e-10
the O 0 1.3216130967386164e-10
HLA O 0 5.194844732159254e-08
- O 0 6.152505616086046e-09
A O 0 1.0866577859758308e-08
and O 0 1.4637074885470724e-10
HLA O 0 2.930143523371953e-07
- O 0 3.168007012277485e-08
B O 0 9.72824523159943e-08
loci O 0 2.918043931487979e-11
, O 0 1.7257923605809578e-12
and O 0 6.194151636919332e-13
that O 0 9.87864439772404e-14
the O 0 1.1172630529077132e-11
apparent O 0 5.982234707602174e-10
lack O 0 2.628613549049419e-09
of O 0 7.811228108778323e-09
recombinants O 0 2.4475912141497247e-07
between O 0 4.066165806837496e-11
the O 0 5.108799494557559e-11
Factor O 0 4.815505216804183e-10
B O 0 4.680298297898844e-05
gene O 0 2.2378316089088912e-08
and O 0 1.1625913884927286e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 4.781880225124269e-09
suggests O 0 4.027979685905514e-11
that O 0 3.476458690690985e-14
these O 0 4.857378063140294e-13
two O 0 5.999333842210408e-12
genes O 0 2.1912069381180288e-11
lie O 0 4.322046720517392e-09
in O 0 5.8648245981896e-11
close O 0 1.7738244206810805e-10
proximity O 0 8.579757349025385e-09
to O 0 1.233729507443826e-10
one O 0 1.7309435829115927e-10
another O 0 2.697064127588078e-09
. O 0 8.320942157524769e-09

Distribution O 0 1.9332631495672103e-07
of O 0 4.6050462287894334e-07
emerin O 0 4.417292439029552e-05
and O 0 8.257211803197606e-09
lamins O 0 4.3841591832460836e-06
in O 0 1.1879701666828169e-09
the O 0 2.4197130965575298e-09
heart O 0 7.686564913456095e-07
and O 0 1.034090452156633e-10
implications O 0 2.573173674136342e-09
for O 0 3.444809160146889e-10
Emery B-Disease 1 0.9998024106025696
- I-Disease 1 0.9999991655349731
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.1296131560811773e-05

Emerin O 0 0.001272528781555593
is O 0 2.5442239426354263e-09
a O 0 3.138162230076347e-10
nuclear O 0 1.617853371271849e-07
membrane O 0 5.202119623959334e-09
protein O 0 1.7029834487036766e-10
which O 0 1.3840819115817915e-11
is O 0 2.5547623912214323e-12
missing O 0 3.8099373655953173e-10
or O 0 5.750850837205057e-11
defective O 0 2.6182453893852653e-06
in O 0 4.1300767250618264e-09
Emery B-Disease 1 0.9998629093170166
- I-Disease 1 0.9999974966049194
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9717869758605957
EDMD B-Disease 1 1.0
) O 0 5.842146322265762e-08
. O 0 1.8733292694861348e-09

It O 0 7.278518232567421e-09
is O 0 5.6008031545928816e-11
one O 0 4.844426942929303e-12
member O 0 1.12136050445244e-10
of O 0 6.868877133747731e-10
a O 0 1.4742648768439892e-10
family O 0 1.0543010908747874e-10
of O 0 7.592046102899985e-08
lamina O 1 0.544090747833252
- O 0 1.2965598443770432e-06
associated O 0 1.8014015834566521e-09
proteins O 0 6.918760703245042e-11
which O 0 3.255195071827366e-11
includes O 0 7.296404036516435e-10
LAP1 O 1 0.9999639987945557
, O 0 3.4274563187608464e-09
LAP2 O 1 0.9944183826446533
and O 0 1.0603319111623932e-08
lamin O 0 3.1772765396453906e-06
B O 0 8.308127689815592e-06
receptor O 0 9.333191108851224e-09
( O 0 1.0910807812791745e-09
LBR O 0 0.1976826786994934
) O 0 2.5446995621791757e-09
. O 0 1.0635397007519032e-09

A O 0 5.824472282256465e-06
panel O 0 1.0152945151276072e-07
of O 0 4.1555541230309245e-08
16 O 0 3.6367873157416852e-09
monoclonal O 0 2.4646722440735402e-09
antibodies O 0 1.2241384572675429e-09
( O 0 2.0616873486201115e-10
mAbs O 0 8.54639381486777e-08
) O 0 1.3500458563575624e-11
has O 0 4.4967550733368555e-13
been O 0 5.077765465044681e-13
mapped O 0 4.928514193980327e-11
to O 0 3.0817022111245818e-12
six O 0 4.77764269118941e-12
specific O 0 5.624820813114606e-13
sites O 0 7.315560657250586e-11
throughout O 0 6.512479444609198e-11
the O 0 8.983442462140445e-11
emerin O 0 1.8308423221924386e-08
molecule O 0 5.216899481852444e-11
using O 0 6.440929734008449e-11
phage O 0 2.6100586136834636e-09
- O 0 1.5492367388958428e-09
displayed O 0 1.0303030650860023e-09
peptide O 0 1.3404043153197875e-10
libraries O 0 3.126247871687582e-11
and O 0 5.385929115891974e-12
has O 0 8.568615109984246e-14
been O 0 8.068944275761714e-14
used O 0 5.862335898838833e-13
to O 0 8.47046044416544e-12
localize O 0 3.5845403090206673e-07
emerin O 0 9.214793976752844e-07
in O 0 3.4818342653508694e-10
human O 0 1.2533282189863826e-09
and O 0 7.3101560360555595e-09
rabbit O 0 2.4234055672422983e-05
heart O 0 0.0005352338775992393
. O 0 1.184848041901887e-08

Several O 0 1.42061594488041e-07
mAbs O 0 5.744622285419609e-06
against O 0 5.820591297833744e-08
different O 0 4.1620545898624073e-10
emerin O 0 6.448218300647568e-06
epitopes O 0 8.257355261775956e-07
did O 0 1.016198458714257e-09
not O 0 3.1974804748369223e-11
recognize O 0 1.2039514940553886e-09
intercalated O 0 4.15598321978905e-07
discs O 0 1.6514485423613223e-06
in O 0 7.260212986359704e-10
the O 0 1.3874453808071507e-09
heart O 0 8.722528264115681e-07
, O 0 1.254599375777321e-11
though O 0 9.07910519768601e-13
they O 0 2.8273450204327477e-13
recognized O 0 4.252568783225108e-11
cardiomyocyte O 0 1.3713662383452174e-07
nuclei O 0 8.159973674537468e-08
strongly O 0 2.4414232857594698e-09
, O 0 3.148738492164682e-10
both O 0 7.111315009078467e-11
at O 0 5.137464675897263e-09
the O 0 1.7042970368308374e-09
rim O 0 3.5226761951889785e-07
and O 0 1.8973021764789877e-10
in O 0 3.835214923419983e-10
intranuclear O 0 4.890680429525673e-06
spots O 0 2.908035767745787e-08
or O 0 5.559213089867399e-10
channels O 0 3.4878446797392826e-09
. O 0 5.901928723517358e-09

A O 0 3.59709702024702e-05
polyclonal O 0 0.00010090279101859778
rabbit O 0 2.996775037900079e-06
antiserum O 0 2.4720095552765997e-06
against O 0 4.08880453051097e-07
emerin O 0 1.970881385204848e-05
did O 0 2.4271171183976037e-10
recognize O 0 2.705264900981774e-10
both O 0 3.042793100815899e-11
nuclear O 0 1.7379494465785683e-07
membrane O 0 6.5703025242669355e-09
and O 0 2.1142614048397235e-10
intercalated O 0 7.787266298464601e-08
discs O 0 1.3185696445816575e-07
but O 0 7.677056906851831e-12
, O 0 1.3967259423694478e-12
after O 0 3.4210635626447106e-12
affinity O 0 1.805802144101698e-12
purification O 0 6.389496043368581e-09
against O 0 2.158242029537405e-09
a O 0 1.6772272459775195e-10
pure O 0 6.24137896920729e-08
- O 0 1.1709909131241147e-07
emerin O 0 7.671810635656584e-06
band O 0 3.0325082889248733e-07
on O 0 4.250057250576589e-10
a O 0 2.765194323517406e-11
western O 0 9.192449579309425e-10
blot O 0 4.049623839819105e-06
, O 0 3.457803765538614e-10
it O 0 2.4471737136710914e-11
stained O 0 1.113631788030034e-05
only O 0 5.132924293937968e-11
the O 0 3.405909998477341e-10
nuclear O 0 9.555797078064643e-07
membrane O 0 1.7500909166301426e-07
. O 0 3.9183265521103294e-09

These O 0 2.649058306047891e-09
results O 0 1.0379066495147526e-09
would O 0 4.6342196573234684e-12
not O 0 6.348447700692261e-13
be O 0 1.3202562957823072e-12
expected O 0 7.5530956489267e-11
if O 0 1.3849217779526857e-11
immunostaining O 0 2.388572966083302e-07
at O 0 2.404677568179636e-09
intercalated O 0 1.3424269695860858e-08
discs O 0 7.60553930945207e-08
were O 0 1.0720013071674472e-10
due O 0 3.0259297845169897e-10
to O 0 3.5417580326879694e-12
a O 0 8.81264072133403e-12
product O 0 2.439763668871109e-11
of O 0 3.715998619924221e-10
the O 0 1.6615551989840327e-10
emerin O 0 1.005687408905942e-06
gene O 0 3.0179006516029006e-10
and O 0 4.6470740450166304e-11
, O 0 1.2806869280346245e-11
therefore O 0 2.310397706484224e-11
, O 0 1.3325828288057728e-11
cast O 0 3.8234172772266817e-11
some O 0 3.5422309616756076e-12
doubt O 0 8.576084287170715e-11
upon O 0 3.0774396919674984e-11
the O 0 2.0915186249581552e-11
hypothesis O 0 1.6886160525420024e-10
that O 0 1.3341518861897939e-11
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999997615814209
in O 0 5.089132173452526e-07
EDMD B-Disease 1 1.0
are O 0 6.122440887601499e-10
caused O 0 9.409549583949683e-09
by O 0 9.709860693263295e-11
absence O 0 1.5096830452421273e-07
of O 0 2.4102195084196865e-07
emerin O 0 3.985623698099516e-05
from O 0 2.226455642073688e-08
intercalated O 0 1.2840177987527568e-05
discs O 0 0.00035574252251535654
. O 0 4.16393248769964e-08

Although O 0 1.527963888747763e-07
emerin O 0 1.0633206329657696e-05
was O 0 7.184945527427544e-09
abundant O 0 9.054215710513347e-10
in O 0 3.99639731030188e-11
the O 0 1.3307978330434622e-10
membranes O 0 3.21317150664413e-09
of O 0 1.0441399744820501e-08
cardiomyocyte O 0 1.3161929928173777e-06
nuclei O 0 8.591139248892432e-07
, O 0 5.876337749732841e-10
it O 0 1.6901714403050327e-11
was O 0 2.5122146585232485e-09
absent O 0 4.1516385884676765e-09
from O 0 9.659690408669874e-11
many O 0 4.577007176043146e-12
non O 0 5.726308671683e-08
- O 0 5.131953173531656e-08
myocyte O 0 3.914865828846814e-06
cells O 0 1.6862479190749013e-09
in O 0 2.32839497682491e-10
the O 0 9.368164910483756e-09
heart O 0 5.373038584366441e-05
. O 0 1.5660232222103332e-08

This O 0 1.651047770723224e-10
distribution O 0 3.629031519736259e-10
of O 0 1.1686627221507706e-09
emerin O 0 6.609193405893166e-07
was O 0 2.4378435381500196e-10
similar O 0 5.637401136182607e-12
to O 0 2.476963729611259e-12
that O 0 5.955153362623145e-13
of O 0 1.0775881298386025e-09
lamin O 0 2.293762548788436e-07
A O 0 1.4404147918867238e-07
, O 0 2.4863085548720854e-11
a O 0 9.000349077137315e-12
candidate O 0 2.0111674478573427e-11
gene O 0 2.4789404903802215e-11
for O 0 4.8281643440228894e-12
an O 0 4.540461322893874e-12
autosomal O 0 8.857482924895521e-08
form O 0 1.282223109910774e-07
of O 0 0.022908618673682213
EDMD B-Disease 1 1.0
. O 0 1.350487877971318e-06

In O 0 1.9999125910885596e-08
contrast O 0 1.9761154490538502e-08
, O 0 5.947004666495559e-09
lamin O 0 8.983702173281927e-06
B1 O 0 0.01679847203195095
was O 0 1.321516691632496e-07
absent O 0 6.010971276282362e-08
from O 0 2.4509880791612204e-09
cardiomyocyte O 0 5.52641324702563e-07
nuclei O 0 3.6778064327336324e-07
, O 0 6.240504224486187e-10
showing O 0 5.8719491491388e-09
that O 0 4.9480114450162205e-11
lamin O 0 3.6749493119714316e-06
B1 O 0 0.2918565273284912
is O 0 3.0778622706062464e-11
not O 0 6.130973550025343e-13
essential O 0 3.030959511152176e-11
for O 0 1.6621239974645707e-12
localization O 0 5.04246386867635e-08
of O 0 3.169274398473476e-09
emerin O 0 2.1023289775712328e-07
to O 0 1.275509697862276e-10
the O 0 2.3125692472092396e-09
nuclear O 0 5.954447988187894e-05
lamina O 1 0.9998329877853394
. O 0 4.875899151102203e-08

Lamin O 1 0.9052913784980774
B1 O 1 0.9999926090240479
is O 0 5.992721430203574e-09
also O 0 1.0314056553273332e-10
almost O 0 3.871875042804618e-11
completely O 0 8.062981393663904e-09
absent O 0 2.5626103905551645e-08
from O 0 5.904586153349101e-09
skeletal O 0 0.00010389996896265075
muscle O 0 4.936786808684701e-06
nuclei O 0 0.0006983464700169861
. O 0 2.6464849156582204e-07

In O 0 4.90678019104962e-07
EDMD B-Disease 1 1.0
, O 0 1.5522358953745652e-09
the O 0 4.699924477380435e-11
additional O 0 1.8021147074609445e-11
absence O 0 1.0855453425051564e-08
of O 0 1.0660163951570212e-07
lamin O 0 1.1212267054361291e-05
B1 O 1 0.998263418674469
from O 0 5.991695388729568e-07
heart O 1 0.9989987015724182
and O 0 5.112033818477357e-07
skeletal O 1 0.9999998807907104
muscle O 0 0.0007471039425581694
nuclei O 0 0.013520173728466034
which O 0 1.8212434227393715e-08
already O 0 7.845645022541703e-09
lack O 0 9.030423342437643e-08
emerin O 0 6.788894097553566e-05
may O 0 1.1026789897838896e-10
offer O 0 5.4287616069181865e-12
an O 0 4.562301057775553e-13
alternative O 0 6.282540460089692e-11
explanation O 0 2.1156680574119235e-11
of O 0 1.377620129083823e-09
why O 0 5.959829851853726e-11
these O 0 3.8817095371346255e-11
tissues O 0 5.6876121590221373e-08
are O 0 2.9960020575536817e-11
particularly O 0 1.2063581245058685e-09
affected O 0 1.9356654057389733e-09
. O 0 3.4807584592400076e-10
. O 0 3.391850356138093e-09

Genetic O 0 7.471363971944811e-08
mapping O 0 1.9459461597648442e-08
of O 0 3.1530987598671345e-08
the O 0 1.4746712295732323e-08
copper B-Disease 0 6.6177094595332164e-06
toxicosis I-Disease 0 0.0006078982842154801
locus O 0 8.045897281760972e-09
in O 0 7.476446128862335e-10
Bedlington O 0 3.901865056832321e-06
terriers O 0 3.645846220479143e-07
to O 0 5.059221375169898e-10
dog O 0 3.106501367255987e-07
chromosome O 0 3.779965673800234e-09
10 O 0 1.065793897581102e-09
, O 0 1.1686393172616327e-11
in O 0 1.7795777004780966e-11
a O 0 8.611258928148402e-11
region O 0 2.5560238370303523e-09
syntenic O 0 3.3388703286618693e-06
to O 0 1.0947492218305044e-10
human O 0 1.6885427500668015e-09
chromosome O 0 2.3277491933981764e-08
region O 0 2.1126430382878425e-08
2p13 O 0 1.1904353414138313e-05
- O 0 4.265014013071777e-06
p16 O 0 4.548757601696707e-07
. O 0 1.0753896440007793e-08

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9960978031158447
accumulation I-Disease 0 0.0002896942605730146
is O 0 3.925550717820414e-10
recognized O 0 2.0532343880663717e-10
as O 0 2.217391548153813e-11
an O 0 3.1268085343150176e-11
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 3.1808426115276234e-08
man O 0 1.4745748444511264e-07
, O 0 5.38877054090392e-10
mouse O 0 1.0521205240365816e-08
, O 0 1.4708136930607907e-09
rat O 0 6.04914885116159e-06
and O 0 2.493221984423144e-08
dog O 0 0.0005022608092986047
. O 0 2.8724025824544697e-08

The O 0 1.1878545791432771e-07
major O 0 2.115411774639142e-07
cause O 0 2.76095147455635e-06
of O 0 0.0017063211416825652
hepatic B-Disease 1 0.9999997615814209
copper I-Disease 1 0.837641179561615
accumulation I-Disease 0 0.00036421106779016554
in O 0 7.268199908594397e-08
man O 0 7.605626706208568e-08
is O 0 1.0537979343305803e-11
a O 0 1.713481440068776e-10
dysfunctional O 0 1.5365751551144058e-06
ATP7B O 1 1.0
gene O 0 5.861534191353712e-08
, O 0 4.736472880573217e-10
causing O 0 2.538917897254578e-06
Wilson B-Disease 0 0.02999766357243061
disease I-Disease 1 0.9991555213928223
( O 0 3.6048670715160824e-09
WD B-Disease 1 0.9940215945243835
) O 0 2.7293975968234463e-09
. O 0 2.7046367367944413e-09

Mutations O 0 2.0497584785061918e-07
in O 0 5.511989087381153e-09
the O 0 8.30674995455638e-09
ATP7B O 1 0.9999963045120239
genes O 0 3.56879137353161e-10
have O 0 1.9609125521263815e-12
also O 0 2.5238621956247265e-12
been O 0 1.515264367972502e-12
demonstrated O 0 5.546850478932441e-11
in O 0 1.4122861213827775e-10
mouse O 0 1.0653756987721863e-08
and O 0 5.206566289217562e-09
rat O 0 6.022899924573721e-06
. O 0 3.288447292248975e-09

The O 0 1.2930048569614883e-06
ATP7B O 1 0.9999998807907104
gene O 0 2.7677208080945093e-08
has O 0 1.4460442392116857e-11
been O 0 3.068505302281088e-12
excluded O 0 1.3721752900597295e-10
in O 0 6.896437847875303e-12
the O 0 1.439069349795652e-11
much O 0 9.429550890116545e-12
rarer O 0 2.2688880108034937e-08
human O 0 7.5640201657734e-08
copper B-Disease 1 0.6674835085868835
overload I-Disease 1 0.9999998807907104
disease O 1 0.9984384179115295
non B-Disease 0 1.2840614544984419e-06
- I-Disease 0 1.1709619229804957e-07
Indian I-Disease 0 3.231585443685958e-09
childhood I-Disease 0 0.00013194682833272964
cirrhosis I-Disease 1 0.9999954700469971
, O 0 1.0660251154037681e-10
indicating O 0 2.5593411834279323e-09
genetic O 0 3.2611222167133747e-08
heterogeneity O 0 6.333568762784125e-07
. O 0 2.9788951749765147e-08

By O 0 2.515187391693985e-09
investigating O 0 5.166031868952814e-08
the O 0 3.6905438705048255e-09
common O 0 1.2976728669400472e-07
autosomal O 1 0.9035851359367371
recessive O 1 0.6133498549461365
copper B-Disease 1 0.8954504132270813
toxicosis I-Disease 1 0.9984371066093445
( O 0 1.008808325764221e-08
CT B-Disease 1 0.9860439300537109
) O 0 1.071361471760568e-10
in O 0 2.526195919116958e-10
Bedlington O 0 0.00011299675679765642
terriers O 0 1.8486472981749102e-05
, O 0 2.704944879194926e-10
we O 0 3.5995095792884513e-12
have O 0 3.689044783625889e-13
identified O 0 7.251320637696734e-12
a O 0 3.2060467562017303e-12
new O 0 1.299617271438569e-11
locus O 0 3.2006168548814884e-11
involved O 0 1.6950430642426184e-11
in O 0 9.358891439603667e-10
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.4730601566602672e-08

We O 0 2.6614968007265816e-09
examined O 0 2.6559504817669222e-08
whether O 0 3.1241037534712746e-10
the O 0 1.3546332944258666e-09
WD B-Disease 0 0.03221682459115982
gene O 0 4.446437884553234e-08
ATP7B O 1 0.9999731779098511
was O 0 2.164917844993397e-08
also O 0 1.4230037287399355e-11
causative O 0 3.118025559967208e-10
for O 0 4.1177547482895704e-11
CT B-Disease 0 6.8165609263814986e-06
by O 0 3.894985028951581e-11
investigating O 0 1.7945018804255142e-09
the O 0 1.529625981433469e-09
chromosomal O 0 6.122352829152078e-07
co O 0 1.8045805916244717e-07
- O 0 1.0343029543946614e-07
localization O 0 1.4249879995986703e-06
of O 0 1.0053913968022243e-07
ATP7B O 1 0.9999994039535522
and O 0 1.018220063819797e-09
C04107 O 0 3.9181191624493295e-08
, O 0 2.407464201950593e-12
using O 0 2.1726934487653615e-13
fluorescence O 0 1.9768749137671904e-10
in O 0 1.9062680253756348e-11
situ O 0 1.0408630402025665e-08
hybridization O 0 6.102527927431822e-10
( O 0 1.4584849994392357e-10
FISH O 0 4.1442993392593053e-07
) O 0 3.994400643581031e-11
. O 0 1.894647910782865e-10

C04107 O 0 4.9797708925325423e-05
is O 0 4.858747293390309e-10
an O 0 3.690115921162196e-12
anonymous O 0 7.496708254173257e-10
microsatellite O 0 1.1186639170546187e-07
marker O 0 1.568358527492819e-07
closely O 0 4.967401601163601e-09
linked O 0 1.4510008838897193e-07
to O 0 4.380356521949125e-09
CT B-Disease 1 0.9999961853027344
. O 0 7.380320710126398e-08

However O 0 5.0778655946714935e-08
, O 0 1.1295961499513396e-08
BAC O 1 0.8153385519981384
clones O 0 2.6132735797546047e-07
containing O 0 4.818321386323987e-08
ATP7B O 1 0.9999969005584717
and O 0 3.800866732461827e-09
C04107 O 0 2.047019762585478e-07
mapped O 0 9.33477473097355e-09
to O 0 1.258597809306039e-10
the O 0 3.6750114063011097e-10
canine O 0 8.057186278165318e-07
chromosome O 0 3.576911211666811e-08
regions O 0 1.0073585521297446e-08
CFA22q11 O 0 1.3896947166358586e-05
and O 0 4.264716579882588e-09
CFA10q26 O 0 6.575061706826091e-05
, O 0 2.755876360449605e-10
respectively O 0 2.602670023943432e-10
, O 0 8.30233451432072e-12
demonstrating O 0 2.1811172312702354e-10
that O 0 3.934624327739389e-12
WD B-Disease 0 4.736301889352035e-06
cannot O 0 2.99326757824403e-10
be O 0 1.722031718609518e-11
homologous O 0 1.5704605671462701e-10
to O 0 7.056166761998384e-10
CT B-Disease 1 0.9086132049560547
. O 0 2.463709947164716e-08

The O 0 1.0576334261713782e-06
copper O 0 7.824381214049936e-07
transport O 0 1.7630416948577476e-07
genes O 0 9.278805279677727e-09
CTR1 O 1 0.9999613761901855
and O 0 9.473514417379647e-09
CTR2 O 1 0.999995231628418
were O 0 1.802862414912454e-09
also O 0 9.68499759557151e-12
excluded O 0 1.0256322180435262e-10
as O 0 5.1273347546898496e-12
candidate O 0 4.597770081327113e-12
genes O 0 2.8153783557943735e-12
for O 0 8.877862854583807e-12
CT B-Disease 0 0.012179414741694927
since O 0 7.721748240818727e-11
they O 0 9.943185597799387e-13
both O 0 1.8052236138224598e-12
mapped O 0 4.6195924863212667e-10
to O 0 1.1979196801181757e-10
canine O 0 2.028605194936972e-06
chromosome O 0 1.5464483738014678e-07
region O 0 7.514638866723544e-08
CFA11q22 O 0 0.03714407980442047
. O 0 5.238445055510965e-08

2 O 0 1.1553162039490417e-05
- O 0 1.7042741546902107e-06
22 O 0 7.671801682818113e-08
. O 0 1.8470353024824249e-09

5 O 0 2.3079419406712987e-05
. O 0 1.106949838458604e-07

A O 0 1.2831690128223272e-06
transcribed O 0 3.834780315514763e-08
sequence O 0 3.494455003139052e-10
identified O 0 9.336760531386545e-11
from O 0 1.1256719861796327e-10
the O 0 8.066448897725564e-11
C04107 O 0 7.010361002812715e-08
- O 0 1.9543449525372125e-08
containing O 0 1.0850443210586036e-08
BAC O 1 0.9979058504104614
was O 0 1.305075936208766e-09
found O 0 2.772338131631913e-12
to O 0 3.6715937365081053e-13
be O 0 1.1284391119009002e-13
homologous O 0 7.612114064081688e-12
to O 0 2.9495462062351097e-12
a O 0 5.1294010705582593e-11
gene O 0 4.522486551916671e-11
expressed O 0 9.493995867249083e-12
from O 0 4.619239712955192e-10
human O 0 1.650053871316004e-09
chromosome O 0 7.938006696406319e-09
2p13 O 0 2.434819350582984e-07
- O 0 4.698811650882817e-08
p16 O 0 2.9192210870832014e-09
, O 0 4.0547811636093556e-11
a O 0 1.3940412192658957e-11
region O 0 2.2247978459510875e-10
devoid O 0 3.963729966471874e-08
of O 0 1.7391913464948061e-09
any O 0 6.473765273851129e-11
positional O 0 1.728720121718652e-06
candidate O 0 1.5058230218301105e-08
genes O 0 9.248027232899858e-09
. O 0 1.2926699710646972e-08

Molecular O 0 1.4486089128240565e-07
analysis O 0 4.070173975634361e-09
of O 0 1.6610497866054175e-08
the O 0 2.0976089754043414e-09
APC B-Disease 0 8.181682886743147e-08
gene O 0 1.7338214197692992e-10
in O 0 1.6691649798450392e-11
205 O 0 5.597025620751594e-10
families O 0 3.654629767216311e-13
: O 0 5.368022432811204e-12
extended O 0 5.436403549552438e-10
genotype O 0 1.851635822447406e-08
- O 0 2.2820385581212577e-08
phenotype O 0 8.964037845338169e-10
correlations O 0 1.4987963092849554e-09
in O 0 9.221279989590769e-11
FAP B-Disease 0 1.0913836234749397e-07
and O 0 2.3317538871969745e-11
evidence O 0 1.1128759025424984e-10
for O 0 1.3666888801222576e-12
the O 0 7.141241157443412e-12
role O 0 5.993538304549517e-11
of O 0 2.797685860755905e-09
APC B-Disease 0 3.014210960827768e-07
amino O 0 5.346368681102831e-09
acid O 0 2.4944384335867653e-09
changes O 0 1.180802344791232e-09
in O 0 3.0068376872804947e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.02273024246096611
. O 0 2.96869675509015e-08

BACKGROUND O 0 0.0006948164664208889
/ O 0 1.7111207171183196e-06
AIMS O 0 1.3205213633682433e-07
The O 0 1.8152072900345928e-10
development O 0 9.524820931972044e-10
of O 0 9.097446309169754e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.9660041650215732e-10
a O 0 4.010215770566816e-12
variable O 0 3.559346914427941e-11
range O 0 8.118922423250297e-09
of O 0 1.8264232792830626e-08
extracolonic O 0 2.9835873647243716e-05
manifestations O 0 9.394832886755466e-05
in O 0 1.0278622397663639e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 8.768076753540299e-08
FAP B-Disease 0 6.468984065577388e-05
) O 0 1.0772279596116263e-10
is O 0 6.470475197306591e-13
the O 0 3.3557388638694174e-12
result O 0 2.0858773042142786e-11
of O 0 3.9840622467757214e-10
the O 0 1.254408521500494e-10
dominant O 0 3.5699980749370752e-09
inheritance O 0 5.473174802261838e-09
of O 0 3.589932703107479e-06
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999994039535522
coli I-Disease 1 1.0
( O 0 4.988529411775744e-08
APC B-Disease 0 2.983985723403748e-05
) O 0 9.541190948425537e-09
gene O 0 3.1378302622897536e-08
mutations O 0 3.806868420497267e-08
. O 0 1.912279756766111e-08

In O 0 2.4867379266879652e-09
this O 0 7.858179710239221e-13
study O 0 3.997043147851986e-12
, O 0 9.476129597804292e-14
direct O 0 2.2308453099129794e-13
mutation O 0 3.245390609897536e-13
analysis O 0 2.10522940226332e-12
of O 0 8.497439557553221e-11
the O 0 2.884379124434844e-10
APC B-Disease 0 4.473937167404074e-07
gene O 0 4.341115023009934e-09
was O 0 2.9342879237503894e-09
performed O 0 3.1108811082702914e-09
to O 0 4.028246486376119e-12
determine O 0 2.7129742896647713e-10
genotype O 0 1.5664952002225618e-08
- O 0 2.4054173763943254e-08
phenotype O 0 9.497700403926501e-10
correlations O 0 2.3762225520584934e-09
for O 0 1.5552223397996556e-10
nine O 0 5.375376588290237e-09
extracolonic O 0 1.2731504739349475e-06
manifestations O 0 1.0424432730360422e-05
and O 0 2.915624963684138e-10
to O 0 1.0318241920603821e-11
investigate O 0 1.9957419050697922e-10
the O 0 1.2696479978480113e-10
incidence O 0 8.234627202341471e-09
of O 0 1.4879695253711134e-09
APC B-Disease 0 1.7070462376977957e-07
mutations O 0 1.4023338046342815e-09
in O 0 1.1081783268807044e-09
non O 1 0.9999490976333618
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.925448245287953e-08

METHODS O 0 1.0110320545209106e-05
The O 0 8.636701664954671e-08
APC B-Disease 0 9.956196436178288e-07
gene O 0 1.9548660468160506e-09
was O 0 6.676033059704878e-10
analysed O 0 2.9923101774187444e-09
in O 0 6.787813366937456e-11
190 O 0 1.0529129790270986e-09
unrelated O 0 3.8922709499900066e-09
FAP B-Disease 0 1.403487203788245e-06
and O 0 2.5262982816798285e-09
15 O 0 3.34558407644181e-08
non O 0 0.3867732286453247
- O 1 0.9999992847442627
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.1928882326373014e-09
using O 0 1.158493162511931e-10
denaturing O 0 2.4528842459403677e-06
gradient O 0 9.107775866823431e-09
gel O 0 5.039547890106633e-09
electrophoresis O 0 1.0575643694110681e-09
, O 0 2.6495711874519046e-11
the O 0 1.3694738051905908e-11
protein O 0 7.967572782097143e-12
truncation O 0 8.387047722990815e-10
test O 0 5.892612509050821e-10
, O 0 1.0732481526762316e-12
and O 0 8.989072507181728e-13
direct O 0 1.58512144382561e-11
sequencing O 0 1.8713044447338234e-09
. O 0 1.347757461189758e-09

RESULTS O 0 0.0001145253045251593
Chain O 0 1.0794234412969672e-06
terminating O 0 9.014677004870464e-08
signals O 0 1.808342631193227e-08
were O 0 1.0981161813194973e-10
only O 0 5.038691902950476e-13
identified O 0 5.658569533079083e-12
in O 0 6.580828330188249e-12
patients O 0 1.0474315859099192e-11
belonging O 0 4.819272203526737e-10
to O 0 6.934693791427193e-11
the O 0 3.118503233423553e-09
FAP B-Disease 0 7.686091521463823e-06
group O 0 2.1500368152516103e-09
( O 0 8.99613092353313e-11
105 O 0 7.764766252194022e-08
patients O 0 1.096333690497886e-09
) O 0 1.368688495873016e-10
. O 0 1.8043038174653248e-09

Amino O 0 2.546218809129641e-07
acid O 0 4.5892432076755085e-09
changes O 0 3.8536181190540475e-11
were O 0 3.189038963458124e-11
identified O 0 1.9324724112590452e-11
in O 0 1.4716736509989836e-11
four O 0 3.426636058234678e-11
patients O 0 3.439135087823786e-11
, O 0 5.097447637603114e-12
three O 0 2.6569193026237947e-11
of O 0 4.648896378967038e-09
whom O 0 2.9006266832887206e-10
belonged O 0 9.371152742687627e-08
to O 0 6.592945633876468e-10
the O 0 7.624243458792535e-09
non O 0 2.3802758732927032e-05
- O 0 2.9624152375617996e-06
FAP O 0 6.140804180176929e-05
group O 0 2.0625467556101285e-08
of O 0 0.016784261912107468
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 4.659898877434898e-06
. O 0 9.923274646439495e-09

Genotype O 0 0.0001219003097503446
- O 0 9.89589807431912e-06
phenotype O 0 3.984240848353693e-08
correlations O 0 2.3305567253828485e-08
identified O 0 1.0430645236425562e-09
significant O 0 2.985558467116789e-10
differences O 0 4.520643026584281e-10
in O 0 7.555501363443184e-11
the O 0 6.258261964209311e-11
nature O 0 6.285348352896847e-10
of O 0 3.3178235159248004e-10
certain O 0 1.0650210574558727e-10
extracolonic O 0 2.812464799717418e-06
manifestations O 0 2.729462039496866e-06
in O 0 4.4819570277354615e-10
FAP B-Disease 0 2.7547496301849606e-06
patients O 0 2.4259783071300944e-10
belonging O 0 1.3862789804974796e-09
to O 0 1.0682925377647479e-10
three O 0 8.315829691518672e-10
mutation O 0 2.187209080517505e-09
subgroups O 0 4.318151169968587e-08
. O 0 1.8657953404499494e-08

CONCLUSIONS O 0 2.3814611267880537e-05
Extended O 0 2.970294872284285e-07
genotype O 0 2.6284303089596506e-07
- O 0 1.1544174327582368e-07
phenotype O 0 8.297656450828583e-10
correlations O 0 1.3671497267608856e-09
made O 0 2.1704643637932008e-10
in O 0 1.890012452099299e-11
this O 0 3.0733187804561635e-13
study O 0 8.611846478989715e-12
may O 0 3.9968067917783845e-12
have O 0 2.6118262283839067e-13
the O 0 1.0071226838603842e-11
potential O 0 1.2735303263344822e-11
to O 0 2.6928346705257233e-12
determine O 0 1.2641022950621306e-10
the O 0 3.561248518302307e-11
most O 0 4.019280025989447e-13
appropriate O 0 2.620991097768144e-11
surveillance O 0 1.1752530504338665e-08
and O 0 3.523029784568976e-11
prophylactic O 0 2.93944367513177e-07
treatment O 0 1.4597721254006046e-08
regimens O 0 7.603332186079115e-09
for O 0 7.1471830190295016e-12
those O 0 5.0973500594075905e-12
patients O 0 2.160101091053246e-11
with O 0 2.9039394586899414e-12
mutations O 0 5.594603114111862e-10
associated O 0 5.470252695261024e-09
with O 0 9.520934041162832e-10
life O 0 4.2044828774123744e-07
threatening O 0 4.032964716316201e-05
conditions O 0 0.00011908011947525665
. O 0 3.053023434063107e-08

This O 0 1.8944165680601088e-10
study O 0 1.610047373201695e-10
also O 0 1.5074465113673607e-12
provided O 0 4.175296827030328e-12
evidence O 0 7.220079395464651e-11
for O 0 1.6335485481661083e-12
the O 0 2.485853363431989e-11
pathological O 0 2.9027271253312392e-08
nature O 0 8.579790211626914e-09
of O 0 1.4782307822258645e-08
amino O 0 4.171941958563963e-10
acid O 0 6.006160846450115e-11
changes O 0 6.379817247409436e-12
in O 0 6.447099798467804e-11
APC O 0 5.886305132207781e-08
associated O 0 5.815891102045612e-10
with O 0 1.9003000562012318e-11
both O 0 2.0190976668388316e-10
FAP B-Disease 0 6.52063818051829e-06
and O 0 6.5800347393008e-09
non O 1 0.9999843835830688
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 4.93369469722893e-08
. O 0 1.0630565872027375e-10
. O 0 7.957769998512276e-10

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 4.521019582170993e-05
cancer B-Disease 1 0.9998747110366821
risk O 0 3.656102975924114e-08
of O 0 1.4085008842812385e-05
the O 0 2.356559662075597e-06
APC O 0 0.0005721401539631188
I1307K O 0 7.120565896912012e-06
polymorphism O 0 1.9917173688099865e-07
. O 0 7.594374906716439e-09

Germ O 1 0.9911288022994995
- O 0 5.155842245585518e-06
line O 0 1.7799131057927298e-08
and O 0 6.096498306185083e-11
somatic O 0 2.7350271381010316e-08
truncating O 0 2.581271196788748e-08
mutations O 0 1.7654275819012355e-09
of O 0 2.1172134267999354e-08
the O 0 2.909687601970745e-09
APC B-Disease 0 9.635153901399462e-07
gene O 0 6.03136263155335e-10
are O 0 2.494515444900758e-12
thought O 0 3.5025808642341616e-11
to O 0 3.44039484401204e-11
initiate O 0 3.2161549370357534e-06
colorectal B-Disease 1 1.0
tumor I-Disease 0 7.740048022242263e-05
formation O 0 7.574012852273881e-05
in O 0 1.2264216309176845e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 1.4252966138883494e-05
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 0.9999973773956299
, O 0 6.015352482791059e-08
respectively O 0 1.5838234901366377e-07
. O 0 7.489366460333713e-09

Recently O 0 3.2716673104005167e-07
, O 0 5.000823644074615e-10
an O 0 6.469137031617223e-11
isoleucine O 0 4.3917375478486065e-06
- O 0 1.2687228263530415e-06
- O 0 2.2864351478801836e-07
> O 0 1.1136498834218855e-08
lysine O 0 1.700845864149869e-08
polymorphism O 0 1.462535981211488e-09
at O 0 3.8994843465367524e-10
codon O 0 3.9651348870961556e-09
1307 O 0 4.4882662564305065e-07
( O 0 6.924952972164888e-11
I1307K O 0 2.1949373874008415e-08
) O 0 8.046621528812192e-12
of O 0 2.3198085119524592e-10
the O 0 4.687706889328069e-10
APC B-Disease 0 3.1096848829292867e-07
gene O 0 5.089981214290162e-10
has O 0 1.2025749319966028e-12
been O 0 1.09333755157065e-12
identified O 0 3.402231621429941e-12
in O 0 2.60941767325773e-12
6 O 0 2.6012506038064487e-10
% O 0 3.422164624160978e-13
- O 0 9.598512956676686e-11
7 O 0 1.824683737439159e-10
% O 0 2.1233186107798285e-13
of O 0 5.563939066421941e-12
the O 0 1.1342276076686808e-11
Ashkenazi O 0 1.452804987422951e-09
Jewish O 0 5.184010443137765e-10
population O 0 3.768657694941391e-12
. O 0 1.7527242157644451e-10

To O 0 2.665754283981414e-09
assess O 0 4.127409169996099e-08
the O 0 1.2515509739685626e-09
risk O 0 3.583545127305854e-10
of O 0 3.1996724714211666e-10
this O 0 1.1143191404328068e-12
common O 0 2.140032456798835e-10
APC B-Disease 0 1.0504986391879356e-07
allelic O 0 4.1825748553492303e-07
variant O 0 9.506558740213222e-07
in O 0 2.0474784889756847e-07
colorectal O 1 1.0
carcinogenesis O 1 0.9999971389770508
, O 0 3.528628278459678e-09
we O 0 1.919717336484883e-11
have O 0 6.152715598291281e-13
analyzed O 0 6.985178407914461e-11
a O 0 4.7176065137710665e-12
large O 0 3.8930983436991085e-11
cohort O 0 1.5336349079575484e-08
of O 0 2.1005879258240157e-09
unselected O 0 6.906021098984638e-06
Ashkenazi O 0 6.771167448960114e-08
Jewish O 0 2.844867985629662e-08
subjects O 0 5.442758492790745e-07
with O 0 7.372297883279089e-09
adenomatous B-Disease 0 0.04485231265425682
polyps I-Disease 0 1.639271999920311e-06
and O 0 3.1343474482525835e-09
. O 0 1.3731081827117464e-09
or O 0 0.0765928253531456
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 2.410655286499974e-10
for O 0 3.302542614380677e-11
the O 0 1.910200886356961e-09
APC O 0 2.2920053197594825e-06
I1307K O 0 2.3959494228620315e-06
polymorphism O 0 7.309322569426513e-08
. O 0 3.369610590553407e-09

The O 0 9.574488331054454e-07
APC O 0 3.765177325476543e-06
I1307K O 0 8.689591481925163e-07
allele O 0 4.3975320607181345e-10
was O 0 7.729576978476871e-10
identified O 0 2.6328961580390775e-11
in O 0 2.0415570275988948e-11
48 O 0 5.821650939097367e-10
( O 0 5.099975563388481e-12
10 O 0 3.320550431840097e-11
. O 0 5.269798269633141e-13
1 O 0 2.424640349607543e-11
% O 0 2.348157746804441e-13
) O 0 2.8215700175610037e-13
of O 0 5.993423812800103e-11
476 O 0 4.69648178125226e-08
patients O 0 1.128407500772255e-08
. O 0 6.768027471792948e-09

Compared O 0 2.4260073949733396e-09
with O 0 1.292313044770621e-11
the O 0 1.8849579883073453e-11
frequency O 0 1.9397769848716884e-11
in O 0 9.317804774283678e-13
two O 0 6.104937112479461e-14
separate O 0 2.9552207035654643e-13
population O 0 5.169325186546274e-15
control O 0 1.2066860531623202e-11
groups O 0 9.784868228168708e-13
, O 0 4.96584023901292e-12
the O 0 1.2318318587389854e-10
APC O 0 1.9550093099951482e-07
I1307K O 0 5.63052395818886e-08
allele O 0 4.6453018515135724e-11
is O 0 8.557447827607645e-13
associated O 0 9.784779757271433e-12
with O 0 9.734513542469792e-13
an O 0 4.964303707694073e-13
estimated O 0 7.187219569493308e-13
relative O 0 3.848865323674566e-11
risk O 0 4.5182638186425095e-10
of O 0 1.6830323801286795e-08
1 O 0 5.186498697185016e-08
. O 0 2.061609771786266e-09

5 O 0 7.303445272555109e-06
- O 0 3.2100051612360403e-06
1 O 0 1.243866449840425e-07
. O 0 2.645665020395427e-09

7 O 0 4.313062618166441e-06
for O 0 5.3981786152235145e-08
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9997782111167908
( O 0 1.998753340615167e-08
both O 0 3.601355214044588e-09
P O 0 4.069736860401463e-06
= O 0 5.679424486260132e-09
. O 0 1.1334214816693944e-10
01 O 0 5.629814836538571e-07
) O 0 5.0874457424576747e-11
. O 0 2.3659010861543095e-10

Furthermore O 0 1.1405992239588159e-07
, O 0 3.5757002914138525e-10
compared O 0 8.437409104722349e-11
with O 0 6.222695969615444e-11
noncarriers O 0 2.6026040359283797e-05
, O 0 6.763291704459107e-09
APC O 0 1.3121924666847917e-06
I1307K O 0 1.7618954473164194e-07
carriers O 0 1.652976228116998e-10
had O 0 8.731260506267269e-12
increased O 0 8.746408003239281e-13
numbers O 0 1.6883565942885093e-12
of O 0 5.698432281597832e-10
adenomas B-Disease 0 0.00016781347221694887
and O 0 1.2539666386146564e-05
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999899864196777
per O 0 2.1443318232172714e-09
patient O 0 1.3003773347008973e-07
( O 0 2.4792552455465966e-09
P O 0 8.478868039674126e-06
= O 0 2.064683091163033e-09
. O 0 1.8239139365494594e-11
03 O 0 6.628026127941666e-09
) O 0 8.577972858934968e-13
, O 0 1.8071796229618409e-13
as O 0 4.832833352258481e-13
well O 0 2.6067910850746667e-12
as O 0 3.687217631914708e-12
a O 0 1.3419026306804582e-11
younger O 0 1.1230728153011071e-10
age O 0 1.314448411227076e-10
at O 0 4.007622234070141e-09
diagnosis O 0 8.931813226809027e-07
. O 0 1.3133264475939654e-09

We O 0 1.1913290798304388e-08
conclude O 0 3.5345173898804205e-08
that O 0 1.313540509001454e-11
the O 0 6.025613341620328e-10
APC O 0 3.10029491856767e-07
I1307K O 0 2.139792343314184e-07
variant O 0 8.299088705143731e-08
leads O 0 9.832084035821254e-10
to O 0 1.285429662017945e-11
increased O 0 1.0974781083916696e-09
adenoma B-Disease 1 1.0
formation O 0 0.000107352010672912
and O 0 2.02165750806671e-09
directly O 0 3.7149780474088345e-10
contributes O 0 7.30541044324795e-11
to O 0 9.068932237121796e-12
3 O 0 4.719752921822362e-10
% O 0 5.540320806296517e-13
- O 0 2.7045412784310052e-11
4 O 0 3.032792766921588e-11
% O 0 5.588949374374201e-14
of O 0 2.3560548043782825e-12
all O 0 2.9580535070017344e-12
Ashkenazi O 0 8.063181553552567e-07
Jewish O 1 0.9998688697814941
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.423038487047279e-08

The O 0 1.0588202314920636e-08
estimated O 0 8.477463175893263e-11
relative O 0 2.784216468487699e-10
risk O 0 2.0081900031776456e-10
for O 0 1.9946752582988836e-11
carriers O 0 4.854291968392488e-10
may O 0 1.067086974337883e-10
justify O 0 6.741136537868897e-10
specific O 0 2.1413298217920484e-11
clinical O 0 8.792535588497685e-10
screening O 0 4.5107872298499885e-11
for O 0 1.2407487147078622e-12
the O 0 9.650366443458847e-12
360 O 0 1.804399407667745e-10
, O 0 8.841864415111422e-13
000 O 0 2.947871460823315e-11
Americans O 0 8.365435080759376e-13
expected O 0 1.943872146581427e-12
to O 0 2.5477406642715472e-12
harbor O 0 6.347601555489746e-09
this O 0 1.4958687229432027e-13
allele O 0 2.5338370724520276e-12
, O 0 8.912061626870083e-13
and O 0 1.8984189220638825e-12
genetic O 0 1.5507609085751994e-11
testing O 0 1.5114498541635157e-10
in O 0 1.5502217565188658e-12
the O 0 5.217454506628583e-12
setting O 0 1.0828337115853515e-09
of O 0 1.0442031683766118e-09
long O 0 7.323127521052797e-11
- O 0 5.8915365919176566e-09
term O 0 7.172741844918562e-10
- O 0 1.264541804602004e-09
outcome O 0 1.1027126434193235e-10
studies O 0 3.335219253552957e-11
may O 0 4.353330196327221e-12
impact O 0 2.443173441335489e-10
significantly O 0 9.629967934188244e-10
on O 0 0.04718998819589615
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 4.1021345964509237e-07
in O 0 4.878603489071043e-13
this O 0 3.7311469289636606e-14
population O 0 6.165741203191522e-14
. O 0 2.3416525662955934e-11

Localization O 0 8.826737030176446e-06
of O 0 2.7391183721192647e-07
human O 0 6.7522063496028295e-09
BRCA1 O 0 1.7091352333409304e-08
and O 0 1.028329504881853e-10
its O 0 2.4994425973368095e-10
loss O 0 1.8332952933519664e-08
in O 0 1.6600600061256188e-10
high O 0 2.58446419820757e-07
- O 0 4.062489722400642e-08
grade O 0 2.038683106775352e-07
, O 0 5.557959648072597e-11
non B-Disease 0 3.06579313473776e-05
- I-Disease 1 0.9831833839416504
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 6.97179757480626e-07

Although O 0 6.231669846812338e-09
the O 0 3.922302482806117e-10
link O 0 1.0924302573656064e-09
between O 0 1.3385291486311957e-10
the O 0 1.0778389292198653e-09
BRCA1 O 0 1.257474195881514e-07
tumour B-Disease 1 1.0
- O 0 2.6988956847162626e-07
suppressor O 0 1.1197483473779357e-07
gene O 0 4.461863323257376e-09
and O 0 3.280272498074055e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 4.269652686961223e-11
established O 0 8.216831104412847e-10
, O 0 6.678840640261807e-12
the O 0 1.994713422215355e-11
role O 0 4.4138991073250367e-11
, O 0 2.0846670743812634e-12
if O 0 4.483127532942978e-14
any O 0 1.3483004860162517e-12
, O 0 5.863982476678187e-12
of O 0 2.811206545327849e-10
BRCA1 O 0 4.4538372989677555e-09
in O 0 3.447372387554992e-10
non B-Disease 1 0.999504804611206
- I-Disease 1 0.9999862909317017
familial I-Disease 1 0.9999998807907104
cancers I-Disease 1 1.0
is O 0 1.6640734623596387e-10
unclear O 0 4.08833367160355e-09
. O 0 5.647988743362475e-09

BRCA1 O 0 3.789777838392183e-05
mutations O 0 3.2216416201436004e-08
are O 0 6.293658649791922e-11
rare O 0 1.8689787495418386e-09
in O 0 6.887164727409356e-10
sporadic B-Disease 0 9.113924170378596e-05
cancers I-Disease 1 0.998301088809967
, O 0 1.4434299588916844e-10
but O 0 2.846090203789675e-11
loss O 0 1.5818928034150304e-07
of O 0 1.501351334809442e-06
BRCA1 O 0 1.1508251418490545e-07
resulting O 0 3.996972974817936e-09
from O 0 9.000718503848759e-10
reduced O 0 4.204422088260884e-10
expression O 0 2.1838218733361003e-11
or O 0 1.1546740126544552e-11
incorrect O 0 5.123731994238767e-10
subcellular O 0 3.3152964817873e-08
localization O 0 1.0129367211675344e-07
is O 0 1.9448364359936354e-12
postulated O 0 4.742907108723493e-11
to O 0 1.9632667887237165e-12
be O 0 1.864382996943914e-12
important O 0 1.0969223793177996e-11
in O 0 1.9124153649574538e-11
non B-Disease 0 2.9706734494538978e-06
- I-Disease 0 7.881247438490391e-05
familial I-Disease 1 0.9999939203262329
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 5.002245302421215e-07

Epigenetic O 0 3.868939165840857e-05
loss O 0 0.0006018421845510602
, O 0 1.3679166688262967e-09
however O 0 6.665265561700551e-11
, O 0 5.804725190100557e-12
has O 0 4.299326804399657e-14
not O 0 2.026053004294988e-14
received O 0 2.1582963281169265e-12
general O 0 8.931402145639922e-11
acceptance O 0 2.3972437923625023e-10
due O 0 9.09091857348443e-10
to O 0 4.832181096231514e-12
controversy O 0 1.5521760265979623e-10
regarding O 0 2.709426849545338e-10
the O 0 6.830151028092146e-11
subcellular O 0 3.1909298314758416e-08
localization O 0 6.608740221736298e-08
of O 0 7.075334096384722e-09
BRCA1 O 0 1.91848203989764e-09
proteins O 0 2.753846456426956e-11
, O 0 1.4127164715826979e-11
reports O 0 6.704434230009326e-11
of O 0 3.6146904913714195e-10
which O 0 2.7829975737109214e-12
have O 0 2.733221093030591e-13
ranged O 0 7.353097575268919e-10
from O 0 5.360964797085366e-11
exclusively O 0 1.3402713661125887e-10
nuclear O 0 5.5221995864940254e-08
, O 0 2.2046050748847357e-11
to O 0 3.1272720957958855e-12
conditionally O 0 5.573092209942843e-09
nuclear O 0 3.1999294947127055e-07
, O 0 2.65263540299987e-11
to O 0 4.770686016369874e-12
the O 0 2.28112681521786e-10
ER O 0 0.4898746907711029
/ O 0 3.108468860091307e-08
golgi O 0 1.3799831322103273e-07
, O 0 4.1358905883415176e-11
to O 0 1.3650430612244246e-11
cytoplasmic O 0 1.9326107381090196e-09
invaginations O 0 2.77520683766852e-07
into O 0 1.0985901077731342e-09
the O 0 1.96176852540475e-09
nucleus O 0 1.3445645663523464e-07
. O 0 4.353867932849198e-09

In O 0 1.1381214193306732e-08
an O 0 2.682946573240308e-11
attempt O 0 1.5298682320974422e-09
to O 0 6.533431434752046e-11
resolve O 0 2.065328796874155e-09
this O 0 1.9932024780677793e-12
issue O 0 1.6821249254617143e-11
, O 0 1.0180034766549273e-11
we O 0 1.907205296469705e-12
have O 0 8.213042876001331e-13
comprehensively O 0 1.6138915270857979e-07
characterized O 0 1.7977640709432308e-08
19 O 0 6.680038922013409e-08
anti O 0 1.3665686537933652e-06
- O 0 2.497363766451599e-06
BRCA1 O 0 3.0984239174358663e-07
antibodies O 0 3.6389192104024914e-08
. O 0 9.433540171244204e-09

These O 0 3.816652327515158e-09
reagents O 0 1.2694560780346364e-07
detect O 0 3.2170831332223315e-07
a O 0 3.413792859507936e-10
220 O 0 1.8649548572113872e-09
- O 0 6.976463851060544e-09
kD O 0 5.077642484252465e-08
protein O 0 1.5678748577219181e-10
localized O 0 3.0845885845565135e-09
in O 0 3.1766669156274574e-11
discrete O 0 2.104540847147618e-10
nuclear O 0 3.9264982376607804e-08
foci O 0 1.2859189268965565e-07
in O 0 1.917551811780882e-10
all O 0 6.453386436344744e-11
epithelial O 0 1.4436729589561992e-09
cell O 0 3.282358207457037e-08
lines O 0 1.5262017205586176e-09
, O 0 3.2261116521270505e-12
including O 0 6.66166557680703e-12
those O 0 2.6376800049687787e-12
derived O 0 1.643748609447826e-10
from O 0 1.4569961237498319e-08
breast B-Disease 0 2.3865128241595812e-05
malignancies I-Disease 0 0.000328854686813429
. O 0 5.3546781231261775e-08

Immunohistochemical O 0 2.1946038032183424e-05
staining O 0 4.091451955900993e-06
of O 0 4.98456870445807e-07
human O 0 1.0051708443370444e-07
breast O 0 6.6764991970558185e-06
specimens O 0 1.248243108875613e-07
also O 0 8.9340307374286e-10
revealed O 0 1.3557783518081123e-07
BRCA1 O 0 3.901880631929089e-07
nuclear O 0 4.1728406358743086e-05
foci O 0 8.561598951928318e-05
in O 0 2.234138385404094e-08
benign O 1 0.9999998807907104
breast O 1 0.9999953508377075
, O 0 4.146702181628825e-08
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 1.1407181546019274e-06
low B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999942779541016
grade I-Disease 1 0.9999995231628418
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 7.560499284409161e-07

Conversely O 0 1.7153638509626035e-06
, O 0 1.1098880925430876e-08
BRCA1 O 0 3.649094892921312e-08
expression O 0 9.029881842259613e-10
was O 0 4.425604771540748e-09
reduced O 0 2.184077224631764e-10
or O 0 1.9904113079949326e-11
undetectable O 0 7.566194781816193e-09
in O 0 2.461802463271656e-12
the O 0 2.6040977100377782e-12
majority O 0 4.387837681629585e-14
of O 0 1.4523159584667322e-11
high O 0 5.0667107842627956e-08
- O 0 7.125213414838072e-07
grade O 0 6.140454388514627e-06
, O 0 2.3027273421405425e-09
ductal B-Disease 1 0.9999995231628418
carcinomas I-Disease 1 1.0
, O 0 2.4208950399895457e-09
suggesting O 0 7.56151752323575e-10
that O 0 3.579995674907188e-12
absence O 0 7.979782168376914e-09
of O 0 1.066105369318393e-06
BRCA1 O 0 2.9051733463347773e-07
may O 0 1.7645547523148508e-10
contribute O 0 1.7401319968302076e-11
to O 0 5.1899439607039355e-11
the O 0 1.3145142752080119e-09
pathogenesis O 0 2.5393052283106954e-07
of O 0 3.573793039279849e-09
a O 0 9.748101631457118e-12
significant O 0 5.963863517616241e-12
percentage O 0 2.4929200370671367e-10
of O 0 3.864220943228247e-09
sporadic B-Disease 1 0.809232234954834
breast I-Disease 1 1.0
cancers I-Disease 1 0.9999996423721313
. O 0 6.565242127720694e-09
. O 0 8.728676448299666e-09

